WO2023225459A2 - Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections - Google Patents
Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections Download PDFInfo
- Publication number
- WO2023225459A2 WO2023225459A2 PCT/US2023/066918 US2023066918W WO2023225459A2 WO 2023225459 A2 WO2023225459 A2 WO 2023225459A2 US 2023066918 W US2023066918 W US 2023066918W WO 2023225459 A2 WO2023225459 A2 WO 2023225459A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptide
- activity
- seq
- sequence identity
- polynucleotide
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 56
- 238000000034 method Methods 0.000 title claims abstract description 35
- 230000003032 phytopathogenic effect Effects 0.000 title claims abstract description 20
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 17
- 230000003405 preventing effect Effects 0.000 title claims abstract description 13
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 335
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 325
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 138
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 138
- 239000002157 polynucleotide Substances 0.000 claims abstract description 138
- 241000607479 Yersinia pestis Species 0.000 claims abstract description 39
- 238000009472 formulation Methods 0.000 claims abstract description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 846
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 843
- 229920001184 polypeptide Polymers 0.000 claims description 842
- 230000000694 effects Effects 0.000 claims description 564
- 241000196324 Embryophyta Species 0.000 claims description 164
- 150000001413 amino acids Chemical class 0.000 claims description 162
- 238000003780 insertion Methods 0.000 claims description 102
- 230000037431 insertion Effects 0.000 claims description 102
- 238000006467 substitution reaction Methods 0.000 claims description 102
- 238000012217 deletion Methods 0.000 claims description 101
- 230000037430 deletion Effects 0.000 claims description 101
- 239000012634 fragment Substances 0.000 claims description 98
- 239000002299 complementary DNA Substances 0.000 claims description 93
- 210000004027 cell Anatomy 0.000 claims description 41
- 102100031415 Hepatic triacylglycerol lipase Human genes 0.000 claims description 32
- 230000008635 plant growth Effects 0.000 claims description 32
- 201000010099 disease Diseases 0.000 claims description 30
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 30
- 239000000126 substance Substances 0.000 claims description 30
- 238000011282 treatment Methods 0.000 claims description 25
- 229920001503 Glucan Polymers 0.000 claims description 23
- 108090000637 alpha-Amylases Proteins 0.000 claims description 22
- 108090001060 Lipase Proteins 0.000 claims description 21
- 238000012360 testing method Methods 0.000 claims description 21
- 239000001963 growth medium Substances 0.000 claims description 19
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 claims description 18
- 102000015439 Phospholipases Human genes 0.000 claims description 18
- 108010064785 Phospholipases Proteins 0.000 claims description 18
- 241000700605 Viruses Species 0.000 claims description 17
- 239000000575 pesticide Substances 0.000 claims description 17
- 241000894006 Bacteria Species 0.000 claims description 16
- 241000233866 Fungi Species 0.000 claims description 15
- 241000237858 Gastropoda Species 0.000 claims description 15
- 241000238631 Hexapoda Species 0.000 claims description 15
- 102000003992 Peroxidases Human genes 0.000 claims description 15
- 102000037865 fusion proteins Human genes 0.000 claims description 15
- 108020001507 fusion proteins Proteins 0.000 claims description 15
- 108010024976 Asparaginase Proteins 0.000 claims description 14
- 206010061217 Infestation Diseases 0.000 claims description 14
- 239000002689 soil Substances 0.000 claims description 14
- 241000244206 Nematoda Species 0.000 claims description 13
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 13
- 102000016938 Catalase Human genes 0.000 claims description 12
- 108010053835 Catalase Proteins 0.000 claims description 12
- 108010015776 Glucose oxidase Proteins 0.000 claims description 12
- 108010029541 Laccase Proteins 0.000 claims description 12
- 102000004317 Lyases Human genes 0.000 claims description 12
- 108090000856 Lyases Proteins 0.000 claims description 12
- 241000233654 Oomycetes Species 0.000 claims description 12
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 claims description 11
- 102100022624 Glucoamylase Human genes 0.000 claims description 11
- 108010051815 Glutamyl endopeptidase Proteins 0.000 claims description 11
- 108020002496 Lysophospholipase Proteins 0.000 claims description 11
- 108010029182 Pectin lyase Proteins 0.000 claims description 11
- 108010005400 cutinase Proteins 0.000 claims description 11
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 claims description 11
- 235000019626 lipase activity Nutrition 0.000 claims description 11
- 108010087558 pectate lyase Proteins 0.000 claims description 11
- 108020004410 pectinesterase Proteins 0.000 claims description 11
- 230000005070 ripening Effects 0.000 claims description 11
- 108010059892 Cellulase Proteins 0.000 claims description 10
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 10
- 239000004366 Glucose oxidase Substances 0.000 claims description 10
- 102100023177 Glycoprotein endo-alpha-1,2-mannosidase Human genes 0.000 claims description 10
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 10
- 108090000787 Subtilisin Proteins 0.000 claims description 10
- 102000014384 Type C Phospholipases Human genes 0.000 claims description 10
- 108010079194 Type C Phospholipases Proteins 0.000 claims description 10
- 108010012864 alpha-Mannosidase Proteins 0.000 claims description 10
- 229960003272 asparaginase Drugs 0.000 claims description 10
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 claims description 10
- 108010047754 beta-Glucosidase Proteins 0.000 claims description 10
- 229940106157 cellulase Drugs 0.000 claims description 10
- 238000011161 development Methods 0.000 claims description 10
- 229940116332 glucose oxidase Drugs 0.000 claims description 10
- 235000019420 glucose oxidase Nutrition 0.000 claims description 10
- 235000010335 lysozyme Nutrition 0.000 claims description 10
- 230000008121 plant development Effects 0.000 claims description 10
- 108010001682 Dextranase Proteins 0.000 claims description 9
- 108010087427 Endo-1,3(4)-beta-Glucanase Proteins 0.000 claims description 9
- 108010001817 Endo-1,4-beta Xylanases Proteins 0.000 claims description 9
- 108010033128 Glucan Endo-1,3-beta-D-Glucosidase Proteins 0.000 claims description 9
- 101710093549 Lytic cellulose monooxygenase Proteins 0.000 claims description 9
- 101710136501 Mannan endo-1,4-beta-mannosidase Proteins 0.000 claims description 9
- 108050008500 Mannan endo-1,6-alpha-mannosidases Proteins 0.000 claims description 9
- 108010014251 Muramidase Proteins 0.000 claims description 9
- 101000973640 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) Endo-1,6-beta-D-glucanase Proteins 0.000 claims description 9
- 102000003667 Serine Endopeptidases Human genes 0.000 claims description 9
- 108090000083 Serine Endopeptidases Proteins 0.000 claims description 9
- 102000004139 alpha-Amylases Human genes 0.000 claims description 9
- 102000019199 alpha-Mannosidase Human genes 0.000 claims description 9
- 108010084650 alpha-N-arabinofuranosidase Proteins 0.000 claims description 9
- 229940024171 alpha-amylase Drugs 0.000 claims description 9
- 102000006995 beta-Glucosidase Human genes 0.000 claims description 9
- 108010026119 cellobiose oxidase Proteins 0.000 claims description 9
- YERABYSOHUZTPQ-UHFFFAOYSA-P endo-1,4-beta-Xylanase Chemical compound C=1C=CC=CC=1C[N+](CC)(CC)CCCNC(C(C=1)=O)=CC(=O)C=1NCCC[N+](CC)(CC)CC1=CC=CC=C1 YERABYSOHUZTPQ-UHFFFAOYSA-P 0.000 claims description 9
- -1 gastropodicide Substances 0.000 claims description 9
- 238000003306 harvesting Methods 0.000 claims description 9
- 108010090785 inulinase Proteins 0.000 claims description 9
- 108010076363 licheninase Proteins 0.000 claims description 9
- 239000004325 lysozyme Substances 0.000 claims description 9
- 229960000274 lysozyme Drugs 0.000 claims description 9
- 101710162064 Glycoprotein endo-alpha-1,2-mannosidase Proteins 0.000 claims description 8
- 108010044302 Phosphoinositide phospholipase C Proteins 0.000 claims description 8
- 235000021232 nutrient availability Nutrition 0.000 claims description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 7
- 231100000674 Phytotoxicity Toxicity 0.000 claims description 7
- 230000002255 enzymatic effect Effects 0.000 claims description 7
- 239000003337 fertilizer Substances 0.000 claims description 7
- 241000239223 Arachnida Species 0.000 claims description 6
- 108010059820 Polygalacturonase Proteins 0.000 claims description 5
- 108700023418 Amidases Proteins 0.000 claims description 4
- 102000004157 Hydrolases Human genes 0.000 claims description 4
- 108090000604 Hydrolases Proteins 0.000 claims description 4
- 102000005922 amidase Human genes 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- 108090000915 Aminopeptidases Proteins 0.000 claims description 3
- 102000004400 Aminopeptidases Human genes 0.000 claims description 3
- 239000004382 Amylase Substances 0.000 claims description 3
- 102000013142 Amylases Human genes 0.000 claims description 3
- 108010065511 Amylases Proteins 0.000 claims description 3
- 102100032487 Beta-mannosidase Human genes 0.000 claims description 3
- 108010022172 Chitinases Proteins 0.000 claims description 3
- 102000012286 Chitinases Human genes 0.000 claims description 3
- 108010073324 Glutaminase Proteins 0.000 claims description 3
- 102000009127 Glutaminase Human genes 0.000 claims description 3
- 108010013563 Lipoprotein Lipase Proteins 0.000 claims description 3
- 235000019418 amylase Nutrition 0.000 claims description 3
- 108010019077 beta-Amylase Proteins 0.000 claims description 3
- 108010055059 beta-Mannosidase Proteins 0.000 claims description 3
- 229910052796 boron Inorganic materials 0.000 claims description 3
- 210000004899 c-terminal region Anatomy 0.000 claims description 3
- 108010089807 chitosanase Proteins 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 3
- 230000000855 fungicidal effect Effects 0.000 claims description 3
- 239000000417 fungicide Substances 0.000 claims description 3
- 239000002917 insecticide Substances 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 102100026189 Beta-galactosidase Human genes 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 claims description 2
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 2
- 108010022769 Glucan 1,3-beta-Glucosidase Proteins 0.000 claims description 2
- 108010032083 Glucan 1,4-beta-Glucosidase Proteins 0.000 claims description 2
- 101710130153 Glucan 1,6-alpha-glucosidase Proteins 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 108010046334 Urease Proteins 0.000 claims description 2
- 108010045422 Xylan Endo-1,3-beta-Xylosidase Proteins 0.000 claims description 2
- 108010030291 alpha-Galactosidase Proteins 0.000 claims description 2
- 102000005840 alpha-Galactosidase Human genes 0.000 claims description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 claims description 2
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 108010022356 mannan 1,2-(1,3)-alpha mannosidase Proteins 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- 235000021231 nutrient uptake Nutrition 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 238000012794 pre-harvesting Methods 0.000 claims description 2
- 238000013138 pruning Methods 0.000 claims description 2
- 102000015790 Asparaginase Human genes 0.000 claims 4
- 102000016943 Muramidase Human genes 0.000 claims 4
- 102000006486 Phosphoinositide Phospholipase C Human genes 0.000 claims 4
- 108010058940 Glutamyl Aminopeptidase Proteins 0.000 claims 2
- 102000006485 Glutamyl Aminopeptidase Human genes 0.000 claims 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- 108010004098 Leucyl aminopeptidase Proteins 0.000 claims 2
- 102000002704 Leucyl aminopeptidase Human genes 0.000 claims 2
- 230000000895 acaricidal effect Effects 0.000 claims 2
- 239000000642 acaricide Substances 0.000 claims 2
- 238000009825 accumulation Methods 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 2
- 239000003899 bactericide agent Substances 0.000 claims 2
- 238000007598 dipping method Methods 0.000 claims 2
- 230000002363 herbicidal effect Effects 0.000 claims 2
- 239000004009 herbicide Substances 0.000 claims 2
- 239000005645 nematicide Substances 0.000 claims 2
- 239000002423 protozoacide Substances 0.000 claims 2
- 238000002791 soaking Methods 0.000 claims 2
- 102100022749 Aminopeptidase N Human genes 0.000 claims 1
- 101710130006 Beta-glucanase Proteins 0.000 claims 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims 1
- 108010049990 CD13 Antigens Proteins 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 102000005367 Carboxypeptidases Human genes 0.000 claims 1
- 108010006303 Carboxypeptidases Proteins 0.000 claims 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- 108091000069 Cystinyl Aminopeptidase Proteins 0.000 claims 1
- 102000030900 Cystinyl aminopeptidase Human genes 0.000 claims 1
- 102100034560 Cytosol aminopeptidase Human genes 0.000 claims 1
- 108010059378 Endopeptidases Proteins 0.000 claims 1
- 102000005593 Endopeptidases Human genes 0.000 claims 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 claims 1
- 108090000192 Methionyl aminopeptidases Proteins 0.000 claims 1
- 102000034452 Methionyl aminopeptidases Human genes 0.000 claims 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 108010070926 Tripeptide aminopeptidase Proteins 0.000 claims 1
- 108030000963 Tryptophanyl aminopeptidases Proteins 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 108010057455 alpha-1,4-glucan lyase Proteins 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims 1
- 229910052750 molybdenum Inorganic materials 0.000 claims 1
- 239000011733 molybdenum Substances 0.000 claims 1
- 108010017378 prolyl aminopeptidase Proteins 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 307
- 235000001014 amino acid Nutrition 0.000 description 162
- 229940024606 amino acid Drugs 0.000 description 160
- 125000003275 alpha amino acid group Chemical group 0.000 description 81
- 241000228212 Aspergillus Species 0.000 description 55
- 241000193830 Bacillus <bacterium> Species 0.000 description 49
- 238000007792 addition Methods 0.000 description 48
- 102000004190 Enzymes Human genes 0.000 description 43
- 108090000790 Enzymes Proteins 0.000 description 43
- 229940088598 enzyme Drugs 0.000 description 43
- 241000228143 Penicillium Species 0.000 description 37
- 241000228341 Talaromyces Species 0.000 description 31
- 241000223259 Trichoderma Species 0.000 description 25
- 239000000306 component Substances 0.000 description 23
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 21
- 241000223218 Fusarium Species 0.000 description 21
- 241000678519 Rasamsonia Species 0.000 description 21
- 241000226677 Myceliophthora Species 0.000 description 19
- 150000007523 nucleic acids Chemical class 0.000 description 19
- 239000000463 material Substances 0.000 description 18
- 241000221955 Chaetomium Species 0.000 description 16
- 241000223198 Humicola Species 0.000 description 16
- 241000223257 Thermomyces Species 0.000 description 16
- 239000003795 chemical substances by application Substances 0.000 description 14
- 108020004414 DNA Proteins 0.000 description 13
- 241000228178 Thermoascus Species 0.000 description 13
- 230000000813 microbial effect Effects 0.000 description 13
- 241001507755 Neosartorya Species 0.000 description 12
- 230000003197 catalytic effect Effects 0.000 description 12
- 102000039446 nucleic acids Human genes 0.000 description 12
- 108020004707 nucleic acids Proteins 0.000 description 12
- 241000626621 Geobacillus Species 0.000 description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 description 10
- 241000142531 Clonostachys Species 0.000 description 9
- 108091026890 Coding region Proteins 0.000 description 9
- 241000209219 Hordeum Species 0.000 description 9
- 241000800402 Myriococcum Species 0.000 description 9
- 102000004316 Oxidoreductases Human genes 0.000 description 9
- 108090000854 Oxidoreductases Proteins 0.000 description 9
- 241000589596 Thermus Species 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 230000009467 reduction Effects 0.000 description 9
- 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 description 8
- 241000123650 Botrytis cinerea Species 0.000 description 8
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 7
- 241000572100 Acrophialophora Species 0.000 description 7
- 241000588722 Escherichia Species 0.000 description 7
- 241001099157 Komagataella Species 0.000 description 7
- 241000947859 Microdochium Species 0.000 description 7
- 241000221960 Neurospora Species 0.000 description 7
- 241001123663 Penicillium expansum Species 0.000 description 7
- 241000589516 Pseudomonas Species 0.000 description 7
- 241000235070 Saccharomyces Species 0.000 description 7
- 241001494489 Thielavia Species 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 241001147780 Alicyclobacillus Species 0.000 description 6
- 241000235349 Ascomycota Species 0.000 description 6
- 241000611330 Chryseobacterium Species 0.000 description 6
- 241000863031 Lysobacter Species 0.000 description 6
- 102100033468 Lysozyme C Human genes 0.000 description 6
- 229920000057 Mannan Polymers 0.000 description 6
- 241000183011 Melanocarpus Species 0.000 description 6
- 241000179039 Paenibacillus Species 0.000 description 6
- 241000205160 Pyrococcus Species 0.000 description 6
- 241001247902 Remersonia Species 0.000 description 6
- 241000223255 Scytalidium Species 0.000 description 6
- 241000272533 Struthio Species 0.000 description 6
- 230000027455 binding Effects 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102100030492 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 Human genes 0.000 description 5
- 230000001627 detrimental effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000009036 growth inhibition Effects 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- 241000228245 Aspergillus niger Species 0.000 description 4
- 241000132181 Aspergillus niveoglaucus Species 0.000 description 4
- 240000006439 Aspergillus oryzae Species 0.000 description 4
- 241000228232 Aspergillus tubingensis Species 0.000 description 4
- 241000223651 Aureobasidium Species 0.000 description 4
- 241000222490 Bjerkandera Species 0.000 description 4
- 241000193403 Clostridium Species 0.000 description 4
- 241001085790 Coprinopsis Species 0.000 description 4
- 241000221755 Cryphonectria Species 0.000 description 4
- 241000079572 Effusibacillus Species 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 241000223195 Fusarium graminearum Species 0.000 description 4
- 241000235058 Komagataella pastoris Species 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 4
- 241000203622 Nocardiopsis Species 0.000 description 4
- 241000418647 Ostropa Species 0.000 description 4
- 102000004020 Oxygenases Human genes 0.000 description 4
- 108090000417 Oxygenases Proteins 0.000 description 4
- 241001236817 Paecilomyces <Clavicipitaceae> Species 0.000 description 4
- 241000864371 Penicillium viridicatum Species 0.000 description 4
- 108010076504 Protein Sorting Signals Proteins 0.000 description 4
- 241000383860 Pseudoplectania Species 0.000 description 4
- 241000235346 Schizosaccharomyces Species 0.000 description 4
- 108010006152 Serine racemase Proteins 0.000 description 4
- 241000320255 Sodiomyces Species 0.000 description 4
- 241000692760 Stenocarpella Species 0.000 description 4
- 241000187747 Streptomyces Species 0.000 description 4
- 241001489203 Talaromyces bacillisporus Species 0.000 description 4
- 241001238980 Thermothelomyces Species 0.000 description 4
- 241001149964 Tolypocladium Species 0.000 description 4
- 241000222354 Trametes Species 0.000 description 4
- 241001360088 Zymoseptoria tritici Species 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 230000035784 germination Effects 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 231100000350 mutagenesis Toxicity 0.000 description 4
- 238000003359 percent control normalization Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- 241000187362 Actinomadura Species 0.000 description 3
- 241000187844 Actinoplanes Species 0.000 description 3
- 241000590031 Alteromonas Species 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 241001455623 Anaerocellum Species 0.000 description 3
- 241001626813 Anoxybacillus Species 0.000 description 3
- 241000222211 Arthromyces Species 0.000 description 3
- 241001205401 Aspergillus cristatus Species 0.000 description 3
- 241000228197 Aspergillus flavus Species 0.000 description 3
- 241001465318 Aspergillus terreus Species 0.000 description 3
- 108090000145 Bacillolysin Proteins 0.000 description 3
- 241000223679 Beauveria Species 0.000 description 3
- 241000751139 Beauveria bassiana Species 0.000 description 3
- 241000346770 Bispora Species 0.000 description 3
- 241000283725 Bos Species 0.000 description 3
- 241001465180 Botrytis Species 0.000 description 3
- 241000178334 Caldicellulosiruptor Species 0.000 description 3
- 241000992952 Cinereomyces Species 0.000 description 3
- 241000223203 Coccidioides Species 0.000 description 3
- 241001252397 Corynascus Species 0.000 description 3
- 241000723247 Cylindrocarpon Species 0.000 description 3
- 241000605056 Cytophaga Species 0.000 description 3
- 241001508802 Diaporthe Species 0.000 description 3
- 241000189559 Dichomitus Species 0.000 description 3
- 108090000371 Esterases Proteins 0.000 description 3
- 241001468125 Exiguobacterium Species 0.000 description 3
- 241000221779 Fusarium sambucinum Species 0.000 description 3
- 241000222336 Ganoderma Species 0.000 description 3
- 241000329158 Geomicrobium Species 0.000 description 3
- 241000682923 Gliomastix Species 0.000 description 3
- 241000222684 Grifola Species 0.000 description 3
- 241001150697 Haloquadratum Species 0.000 description 3
- 241000116139 Hamigera <sponge> Species 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- 241000026993 Jeotgalibacillus Species 0.000 description 3
- 108010008292 L-Amino Acid Oxidase Proteins 0.000 description 3
- 241000222634 Lenzites Species 0.000 description 3
- 241000568397 Lysinibacillus Species 0.000 description 3
- 102100037611 Lysophospholipase Human genes 0.000 description 3
- 241001444195 Madurella Species 0.000 description 3
- 241001344131 Magnaporthe grisea Species 0.000 description 3
- 241000228423 Malbranchea Species 0.000 description 3
- 241000123315 Meripilus Species 0.000 description 3
- 241001520613 Neolentinus Species 0.000 description 3
- 241001231450 Neonectria Species 0.000 description 3
- 241000208125 Nicotiana Species 0.000 description 3
- 241000331251 Oculimacula Species 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 241000985540 Penicillium adametzii Species 0.000 description 3
- 241000894166 Penicillium amagasakiense Species 0.000 description 3
- 241000228150 Penicillium chrysogenum Species 0.000 description 3
- 241000985535 Penicillium decumbens Species 0.000 description 3
- 241000864301 Penicillium polonicum Species 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 241000233622 Phytophthora infestans Species 0.000 description 3
- 241000221945 Podospora Species 0.000 description 3
- 241000222640 Polyporus Species 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 241000430096 Pseudomyllocerus Species 0.000 description 3
- 241000228453 Pyrenophora Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 241000235003 Saccharomycopsis Species 0.000 description 3
- 241000489588 Salipaludibacillus Species 0.000 description 3
- 241000221948 Sordaria Species 0.000 description 3
- 241000101515 Staphylotrichum Species 0.000 description 3
- 241000203590 Streptosporangium Species 0.000 description 3
- 241000228343 Talaromyces flavus Species 0.000 description 3
- 241001136489 Talaromyces stipitatus Species 0.000 description 3
- 241001121162 Trichocladium Species 0.000 description 3
- 241000601794 Trichothecium Species 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 241000918129 Typhula variabilis Species 0.000 description 3
- 241001464837 Viridiplantae Species 0.000 description 3
- 241000329465 Xylanibacterium Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 3
- 108010076637 carbon-sulfur lyase Proteins 0.000 description 3
- 102000028406 carbon-sulfur lyase Human genes 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 239000005648 plant growth regulator Substances 0.000 description 3
- 235000019833 protease Nutrition 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108010080981 3-phytase Proteins 0.000 description 2
- 241000238876 Acari Species 0.000 description 2
- 108010051457 Acid Phosphatase Proteins 0.000 description 2
- 102000057234 Acyl transferases Human genes 0.000 description 2
- 108700016155 Acyl transferases Proteins 0.000 description 2
- 108010052875 Adenine deaminase Proteins 0.000 description 2
- 102000055025 Adenosine deaminases Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 108030007025 Alpha-lytic endopeptidases Proteins 0.000 description 2
- 101000895977 Amycolatopsis orientalis Exo-beta-D-glucosaminidase Proteins 0.000 description 2
- 108090000886 Ananain Proteins 0.000 description 2
- 102000004452 Arginase Human genes 0.000 description 2
- 108700024123 Arginases Proteins 0.000 description 2
- 108010082340 Arginine deiminase Proteins 0.000 description 2
- 108010005694 Aspartate 4-decarboxylase Proteins 0.000 description 2
- 108030001851 Aspartyltransferases Proteins 0.000 description 2
- 241001065417 Aspergillus chevalieri Species 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- 108010004032 Bromelains Proteins 0.000 description 2
- 108090000391 Caricain Proteins 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 102100024539 Chymase Human genes 0.000 description 2
- 108090000227 Chymases Proteins 0.000 description 2
- 108090000317 Chymotrypsin Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 244000251987 Coprinus macrorhizus Species 0.000 description 2
- 108010053515 Cyclohexylamine oxidase Proteins 0.000 description 2
- 108010083493 Cysteine lyase Proteins 0.000 description 2
- 108010080611 Cytosine Deaminase Proteins 0.000 description 2
- 102000000311 Cytosine Deaminase Human genes 0.000 description 2
- 108010070357 D-Aspartate Oxidase Proteins 0.000 description 2
- 108030001311 D-alanine gamma-glutamyltransferases Proteins 0.000 description 2
- 108010003989 D-amino-acid oxidase Proteins 0.000 description 2
- 102000004674 D-amino-acid oxidase Human genes 0.000 description 2
- 108030003853 D-arginases Proteins 0.000 description 2
- 102000005680 D-aspartate oxidase Human genes 0.000 description 2
- 108010004365 D-glutamate oxidase Proteins 0.000 description 2
- 108030000902 D-glutamate(D-aspartate) oxidases Proteins 0.000 description 2
- 108030001819 D-glutamyltransferases Proteins 0.000 description 2
- 108700033211 EC 3.4.22.67 Proteins 0.000 description 2
- 231100000491 EC50 Toxicity 0.000 description 2
- 108020002908 Epoxide hydrolase Proteins 0.000 description 2
- 108091092566 Extrachromosomal DNA Proteins 0.000 description 2
- YXWOAJXNVLXPMU-ZXXMMSQZSA-N Fructose 2,6-diphosphate Chemical compound OP(=O)(O)O[C@]1(CO)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O YXWOAJXNVLXPMU-ZXXMMSQZSA-N 0.000 description 2
- 241000567163 Fusarium cerealis Species 0.000 description 2
- 241000146406 Fusarium heterosporum Species 0.000 description 2
- 108010015133 Galactose oxidase Proteins 0.000 description 2
- 108010062866 Gellan lyase Proteins 0.000 description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108091022930 Glutamate decarboxylase Proteins 0.000 description 2
- 102000008214 Glutamate decarboxylase Human genes 0.000 description 2
- 108010004237 Glycine oxidase Proteins 0.000 description 2
- 108010012029 Guanine Deaminase Proteins 0.000 description 2
- 102000013587 Guanine deaminase Human genes 0.000 description 2
- 102000030789 Histidine Ammonia-Lyase Human genes 0.000 description 2
- 108700006308 Histidine ammonia-lyases Proteins 0.000 description 2
- 108010014095 Histidine decarboxylase Proteins 0.000 description 2
- 102100037095 Histidine decarboxylase Human genes 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 102000007070 L-amino-acid oxidase Human genes 0.000 description 2
- 108030000910 L-aspartate oxidases Proteins 0.000 description 2
- 108060004316 L-cysteine desulfidase Proteins 0.000 description 2
- 108010069325 L-glutamate oxidase Proteins 0.000 description 2
- 108030000927 L-lysine 6-oxidases Proteins 0.000 description 2
- 108030003041 L-lysine cyclodeaminases Proteins 0.000 description 2
- 108010004733 L-lysine oxidase Proteins 0.000 description 2
- 108010043135 L-methionine gamma-lyase Proteins 0.000 description 2
- 108030003060 L-tryptophan ammonia lyases Proteins 0.000 description 2
- 108030005763 L-tryptophan decarboxylases Proteins 0.000 description 2
- 108030007165 Leucyl endopeptidases Proteins 0.000 description 2
- 108010054320 Lignin peroxidase Proteins 0.000 description 2
- 102100025357 Lipid-phosphate phosphatase Human genes 0.000 description 2
- 102100022119 Lipoprotein lipase Human genes 0.000 description 2
- 241000227653 Lycopersicon Species 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 108010048581 Lysine decarboxylase Proteins 0.000 description 2
- 108010053229 Lysyl endopeptidase Proteins 0.000 description 2
- 108030006797 Lytic chitin monooxygenases Proteins 0.000 description 2
- 108030006252 Lytic starch monooxygenases Proteins 0.000 description 2
- 102000001696 Mannosidases Human genes 0.000 description 2
- 108010054377 Mannosidases Proteins 0.000 description 2
- 108010033974 Methionine decarboxylase Proteins 0.000 description 2
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 2
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 2
- 108010091219 N-acetylglucosamine deacetylase Proteins 0.000 description 2
- 108091005461 Nucleic proteins Chemical group 0.000 description 2
- 241000418646 Ostropa barbara Species 0.000 description 2
- 102100026367 Pancreatic alpha-amylase Human genes 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 241001507673 Penicillium digitatum Species 0.000 description 2
- 241000122123 Penicillium italicum Species 0.000 description 2
- 108030005277 Peptidoglycan-N-acetylglucosamine deacetylases Proteins 0.000 description 2
- 108700020962 Peroxidase Proteins 0.000 description 2
- 241000682645 Phakopsora pachyrhizi Species 0.000 description 2
- 108030005432 Phenylalanine 3-monooxygenases Proteins 0.000 description 2
- 108700023158 Phenylalanine ammonia-lyases Proteins 0.000 description 2
- 108010044588 Phenylalanine decarboxylase Proteins 0.000 description 2
- 102100038223 Phenylalanine-4-hydroxylase Human genes 0.000 description 2
- 108030003033 Phenylalanine/tyrosine ammonia-lyases Proteins 0.000 description 2
- 102100035200 Phospholipase A and acyltransferase 4 Human genes 0.000 description 2
- 108090000553 Phospholipase D Proteins 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 108010003894 Protein-Lysine 6-Oxidase Proteins 0.000 description 2
- 102000004669 Protein-Lysine 6-Oxidase Human genes 0.000 description 2
- 108030001310 Protein-glutamine gamma-glutamyltransferases Proteins 0.000 description 2
- 241000959173 Rasamsonia emersonii Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 102100035717 Serine racemase Human genes 0.000 description 2
- 241000223258 Thermomyces lanuginosus Species 0.000 description 2
- 241001313536 Thermothelomyces thermophila Species 0.000 description 2
- 241000723873 Tobacco mosaic virus Species 0.000 description 2
- 241000016010 Tomato spotted wilt orthotospovirus Species 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 241001521901 Tribulus lanuginosus Species 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000885 Tryptophan 5-monooxygenases Proteins 0.000 description 2
- 102000004271 Tryptophan 5-monooxygenases Human genes 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 2
- 102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 2
- 108091000100 Tyrosine Phenol-Lyase Proteins 0.000 description 2
- 108010035075 Tyrosine decarboxylase Proteins 0.000 description 2
- 108030003572 Valine decarboxylases Proteins 0.000 description 2
- 108090000350 actinidain Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000019835 bromelain Nutrition 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 108020001778 catalytic domains Proteins 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000002361 compost Substances 0.000 description 2
- 108090000200 cucumisin Proteins 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 231100001160 nonlethal Toxicity 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 108010052410 pectin lyase B Proteins 0.000 description 2
- 230000029553 photosynthesis Effects 0.000 description 2
- 238000010672 photosynthesis Methods 0.000 description 2
- 229940085127 phytase Drugs 0.000 description 2
- 108090000822 phytepsin Proteins 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001902 propagating effect Effects 0.000 description 2
- 108060006632 protein arginine deiminase Proteins 0.000 description 2
- 102000001235 protein arginine deiminase Human genes 0.000 description 2
- 238000000455 protein structure prediction Methods 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000007226 seed germination Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229960001153 serine Drugs 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 108050004163 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 Proteins 0.000 description 1
- 108050004626 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 Proteins 0.000 description 1
- 108050004186 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 Proteins 0.000 description 1
- 108050004161 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 Proteins 0.000 description 1
- 108050004167 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1 Proteins 0.000 description 1
- 108050004168 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 Proteins 0.000 description 1
- 108050004159 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1 Proteins 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- CHUGKEQJSLOLHL-UHFFFAOYSA-N 2,2-Bis(bromomethyl)propane-1,3-diol Chemical compound OCC(CO)(CBr)CBr CHUGKEQJSLOLHL-UHFFFAOYSA-N 0.000 description 1
- 108010055053 3-dehydroshikimate dehydratase Proteins 0.000 description 1
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
- 241000963729 Acartia clausii Species 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 102100036426 Acid phosphatase type 7 Human genes 0.000 description 1
- 101001058938 Acidaminococcus fermentans (strain ATCC 25085 / DSM 20731 / CCUG 9996 / CIP 106432 / VR4) Glutaconyl-CoA decarboxylase subunit beta Proteins 0.000 description 1
- 241000838140 Acrophialophora fusispora Species 0.000 description 1
- 108700040115 Adenosine deaminases Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 102100025677 Alkaline phosphatase, germ cell type Human genes 0.000 description 1
- 101710199313 Alpha-L-arabinofuranosidase Proteins 0.000 description 1
- 102000004092 Amidohydrolases Human genes 0.000 description 1
- 108090000531 Amidohydrolases Proteins 0.000 description 1
- 108090000673 Ammonia-Lyases Proteins 0.000 description 1
- 102000004118 Ammonia-Lyases Human genes 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 102100040894 Amylo-alpha-1,6-glucosidase Human genes 0.000 description 1
- 102100032252 Antizyme inhibitor 2 Human genes 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 241000216674 Armillaria tabescens Species 0.000 description 1
- 102000030431 Asparaginyl endopeptidase Human genes 0.000 description 1
- 108030003579 Aspartate 1-decarboxylases Proteins 0.000 description 1
- 108700016171 Aspartate ammonia-lyases Proteins 0.000 description 1
- 108030004804 Aspartic endopeptidases Proteins 0.000 description 1
- 102000009422 Aspartic endopeptidases Human genes 0.000 description 1
- 102100032948 Aspartoacylase Human genes 0.000 description 1
- 241000228215 Aspergillus aculeatus Species 0.000 description 1
- 241001513093 Aspergillus awamori Species 0.000 description 1
- 241000892910 Aspergillus foetidus Species 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 241001480052 Aspergillus japonicus Species 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 241000193752 Bacillus circulans Species 0.000 description 1
- 241001328122 Bacillus clausii Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000680658 Bacillus deramificans Species 0.000 description 1
- 241000193747 Bacillus firmus Species 0.000 description 1
- 241000193422 Bacillus lentus Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 241000206775 Balclutha brevis Species 0.000 description 1
- 101710204694 Beta-xylosidase Proteins 0.000 description 1
- 108010039206 Biotinidase Proteins 0.000 description 1
- 102100026044 Biotinidase Human genes 0.000 description 1
- 241000222478 Bjerkandera adusta Species 0.000 description 1
- 241001646078 Bjerkandera fumosa Species 0.000 description 1
- 241001480061 Blumeria graminis Species 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 102000004031 Carboxy-Lyases Human genes 0.000 description 1
- 241001045230 Carex inops Species 0.000 description 1
- 108090000751 Ceramidases Proteins 0.000 description 1
- 102000004201 Ceramidases Human genes 0.000 description 1
- 241000146399 Ceriporiopsis Species 0.000 description 1
- 241001466517 Ceriporiopsis aneirina Species 0.000 description 1
- 241001646018 Ceriporiopsis gilvescens Species 0.000 description 1
- 241001277875 Ceriporiopsis rivulosa Species 0.000 description 1
- 241000524302 Ceriporiopsis subrufa Species 0.000 description 1
- 241001515917 Chaetomium globosum Species 0.000 description 1
- 241000101925 Cheiracanthium erraticum Species 0.000 description 1
- 108010054033 Chitin deacetylase Proteins 0.000 description 1
- 241001006001 Chryseobacterium viscerum Species 0.000 description 1
- 241000123346 Chrysosporium Species 0.000 description 1
- 241000985909 Chrysosporium keratinophilum Species 0.000 description 1
- 241001674013 Chrysosporium lucknowense Species 0.000 description 1
- 241001556045 Chrysosporium merdarium Species 0.000 description 1
- 241001674001 Chrysosporium tropicum Species 0.000 description 1
- 241000355696 Chrysosporium zonatum Species 0.000 description 1
- 102100039501 Chymotrypsinogen B Human genes 0.000 description 1
- 108020004638 Circular DNA Proteins 0.000 description 1
- 102100029057 Coagulation factor XIII A chain Human genes 0.000 description 1
- 241000222199 Colletotrichum Species 0.000 description 1
- 241001345407 Colletotrichum queenslandicum Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 241000222511 Coprinus Species 0.000 description 1
- 241000222356 Coriolus Species 0.000 description 1
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
- 241000254171 Curculionidae Species 0.000 description 1
- 108010076010 Cystathionine beta-lyase Proteins 0.000 description 1
- 102000003950 Cysteine Endopeptidases Human genes 0.000 description 1
- 108090000395 Cysteine Endopeptidases Proteins 0.000 description 1
- 102100026278 Cysteine sulfinic acid decarboxylase Human genes 0.000 description 1
- 108030006828 D-glutaminases Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000468577 Desulfomicrobium thermophilum Species 0.000 description 1
- 108700033181 EC 3.4.22.34 Proteins 0.000 description 1
- 241000616920 Effusibacillus pohliae Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 102100023164 Epididymis-specific alpha-mannosidase Human genes 0.000 description 1
- 108030006192 Exo-(1->4)-alpha-D-glucan lyases Proteins 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 108050008991 Fructose-1,6-bisphosphatase class 1 Proteins 0.000 description 1
- 102100030892 Fructose-1,6-bisphosphatase isozyme 2 Human genes 0.000 description 1
- 241000145614 Fusarium bactridioides Species 0.000 description 1
- 241000223194 Fusarium culmorum Species 0.000 description 1
- 241000008045 Fusarium longipes Species 0.000 description 1
- 241000223221 Fusarium oxysporum Species 0.000 description 1
- 241001112697 Fusarium reticulatum Species 0.000 description 1
- 241001014439 Fusarium sarcochroum Species 0.000 description 1
- 241000427940 Fusarium solani Species 0.000 description 1
- 241001556359 Fusarium solani f. sp. glycines Species 0.000 description 1
- 241000223192 Fusarium sporotrichioides Species 0.000 description 1
- 241001465753 Fusarium torulosum Species 0.000 description 1
- 241000567178 Fusarium venenatum Species 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 101710085727 Galactan endo-beta-1,3-galactanase Proteins 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 241000146398 Gelatoporia subvermispora Species 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 101710179023 Glucose-1-phosphatase Proteins 0.000 description 1
- 102000003638 Glucose-6-Phosphatase Human genes 0.000 description 1
- 108010086800 Glucose-6-Phosphatase Proteins 0.000 description 1
- 102100036264 Glucose-6-phosphatase catalytic subunit 1 Human genes 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 108010018127 Glutamin-(asparagin-)ase Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- 241000498254 Heterodera glycines Species 0.000 description 1
- 101000798222 Homo sapiens Antizyme inhibitor 2 Proteins 0.000 description 1
- 101000797251 Homo sapiens Aspartoacylase Proteins 0.000 description 1
- 241001480714 Humicola insolens Species 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 241000411968 Ilyobacter Species 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- 241001138401 Kluyveromyces lactis Species 0.000 description 1
- 241001099156 Komagataella phaffii Species 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- 108030000922 L-arginine oxidases Proteins 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 108030006633 L-cystine beta-lyases Proteins 0.000 description 1
- 102100023162 L-serine dehydratase/L-threonine deaminase Human genes 0.000 description 1
- 241000235087 Lachancea kluyveri Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 102100030985 Legumain Human genes 0.000 description 1
- 241001049209 Lycianthes lenta Species 0.000 description 1
- 241000053197 Lysobacter gummosus Species 0.000 description 1
- 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 description 1
- 241001344133 Magnaporthe Species 0.000 description 1
- 241000243785 Meloidogyne javanica Species 0.000 description 1
- 108090000131 Metalloendopeptidases Proteins 0.000 description 1
- 102000003843 Metalloendopeptidases Human genes 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 244000292688 Micromeria chamissonis Species 0.000 description 1
- 241001459558 Monographella nivalis Species 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000233892 Neocallimastix Species 0.000 description 1
- 241000221961 Neurospora crassa Species 0.000 description 1
- 108010019703 Nicotinamidase Proteins 0.000 description 1
- 241001072230 Oceanobacillus Species 0.000 description 1
- 108010026867 Oligo-1,6-Glucosidase Proteins 0.000 description 1
- 108030006200 Oligo-alginate lyases Proteins 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 241000194109 Paenibacillus lautus Species 0.000 description 1
- 241001507806 Penicillium thomii Species 0.000 description 1
- 108030006249 Pentanamidases Proteins 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 241000222385 Phanerochaete Species 0.000 description 1
- 241000222393 Phanerochaete chrysosporium Species 0.000 description 1
- 108010069013 Phenylalanine Hydroxylase Proteins 0.000 description 1
- 241000222395 Phlebia Species 0.000 description 1
- 241000222397 Phlebia radiata Species 0.000 description 1
- 102000011420 Phospholipase D Human genes 0.000 description 1
- 102100032967 Phospholipase D1 Human genes 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 241000235379 Piromyces Species 0.000 description 1
- 241000222350 Pleurotus Species 0.000 description 1
- 244000252132 Pleurotus eryngii Species 0.000 description 1
- 235000001681 Pleurotus eryngii Nutrition 0.000 description 1
- 101710118538 Protease Proteins 0.000 description 1
- 108030006244 Protein-glutamine glutaminases Proteins 0.000 description 1
- 241001281805 Pseudoperonospora cubensis Species 0.000 description 1
- 241000587468 Puccinia graminicola Species 0.000 description 1
- 241001123583 Puccinia striiformis Species 0.000 description 1
- 101710148480 Putative beta-xylosidase Proteins 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 1
- 241000235403 Rhizomucor miehei Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 244000206963 Saccharomyces cerevisiae var. diastaticus Species 0.000 description 1
- 241001407717 Saccharomyces norbensis Species 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 241001292348 Salipaludibacillus agaradhaerens Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000222480 Schizophyllum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 241000692746 Stenocarpella maydis Species 0.000 description 1
- 241000063122 Streptacidiphilus griseus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000264435 Streptococcus dysgalactiae subsp. equisimilis Species 0.000 description 1
- 241000194048 Streptococcus equi Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000194054 Streptococcus uberis Species 0.000 description 1
- 241000958303 Streptomyces achromogenes Species 0.000 description 1
- 241001468227 Streptomyces avermitilis Species 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 241000187398 Streptomyces lividans Species 0.000 description 1
- 102100027918 Sucrase-isomaltase, intestinal Human genes 0.000 description 1
- 241000638881 Talaromyces aurantiacus Species 0.000 description 1
- 241000606507 Talaromyces pinophilus Species 0.000 description 1
- 241001540751 Talaromyces ruber Species 0.000 description 1
- 241000589499 Thermus thermophilus Species 0.000 description 1
- 108010006873 Threonine Dehydratase Proteins 0.000 description 1
- 108030003022 Threonine ammonia-lyases Proteins 0.000 description 1
- 241001414989 Thysanoptera Species 0.000 description 1
- 244000079568 Tragia hirsuta Species 0.000 description 1
- 241000222357 Trametes hirsuta Species 0.000 description 1
- 241000222355 Trametes versicolor Species 0.000 description 1
- 108010087472 Trehalase Proteins 0.000 description 1
- 102100029677 Trehalase Human genes 0.000 description 1
- 241000894120 Trichoderma atroviride Species 0.000 description 1
- 241000223260 Trichoderma harzianum Species 0.000 description 1
- 241000378866 Trichoderma koningii Species 0.000 description 1
- 241000223262 Trichoderma longibrachiatum Species 0.000 description 1
- 241000499912 Trichoderma reesei Species 0.000 description 1
- 241000223261 Trichoderma viride Species 0.000 description 1
- 241000215642 Trichophaea Species 0.000 description 1
- 241000259813 Trichophaea saccata Species 0.000 description 1
- 240000001274 Trichosanthes villosa Species 0.000 description 1
- 102100040653 Tryptophan 2,3-dioxygenase Human genes 0.000 description 1
- 101710136122 Tryptophan 2,3-dioxygenase Proteins 0.000 description 1
- 108010052982 Tyrosine 2,3-aminomutase Proteins 0.000 description 1
- 108030003031 Tyrosine ammonia-lyases Proteins 0.000 description 1
- 241000202898 Ureaplasma Species 0.000 description 1
- 241000122124 Urnula Species 0.000 description 1
- 101710171917 Xylan 1,3-beta-xylosidase Proteins 0.000 description 1
- 101710158370 Xylan 1,4-beta-xylosidase Proteins 0.000 description 1
- 241000235013 Yarrowia Species 0.000 description 1
- 241000235015 Yarrowia lipolytica Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 238000012867 alanine scanning Methods 0.000 description 1
- 108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
- 102000012086 alpha-L-Fucosidase Human genes 0.000 description 1
- 102000002014 alpha-N-Acetylgalactosaminidase Human genes 0.000 description 1
- 108010015684 alpha-N-Acetylgalactosaminidase Proteins 0.000 description 1
- 125000000266 alpha-aminoacyl group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 108010006759 amylo-1,6-glucosidase Proteins 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 108010055066 asparaginylendopeptidase Proteins 0.000 description 1
- 108010002447 aspartate-alpha-decarboxylase Proteins 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000009141 biological interaction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 108010052085 cellobiose-quinone oxidoreductase Proteins 0.000 description 1
- 108010029402 cellobiosidase Proteins 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000011118 depth filtration Methods 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000024346 drought recovery Effects 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000002003 electron diffraction Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 108010091371 endoglucanase 1 Proteins 0.000 description 1
- 108010091384 endoglucanase 2 Proteins 0.000 description 1
- 108010092450 endoglucanase Z Proteins 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 108090000285 fruit bromelain Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 108010018734 hexose oxidase Proteins 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000017730 intein-mediated protein splicing Effects 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000011963 major mineral Nutrition 0.000 description 1
- 239000011738 major mineral Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000000442 meristematic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 108010086105 peptidyl-glutaminase Proteins 0.000 description 1
- 230000000361 pesticidal effect Effects 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical class C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
- 238000005222 photoaffinity labeling Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000003976 plant breeding Methods 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 108091022901 polysaccharide lyase Proteins 0.000 description 1
- 102000020244 polysaccharide lyase Human genes 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 230000001124 posttranscriptional effect Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000003128 rodenticide Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- KZRPHCQLJZXMJV-UHFFFAOYSA-N sodium 4-(pyridin-2-yldiazenyl)benzene-1,3-diol Chemical compound [Na+].OC1=CC(O)=CC=C1N=NC1=CC=CC=N1 KZRPHCQLJZXMJV-UHFFFAOYSA-N 0.000 description 1
- 239000002364 soil amendment Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000004763 spore germination Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 108090000346 stem bromelain Proteins 0.000 description 1
- 108010008005 sugar-phosphatase Proteins 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000012384 transportation and delivery Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000010977 unit operation Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P7/00—Arthropodicides
- A01P7/04—Insecticides
Definitions
- Fig. 1 is a table showing significant results of efficacy testing of various enzyme treatments against Blumeria graminis. Results are presented as percent disease control relative to an untreated, uninoculated control (none – uninoculated control) and an untreated, inoculated control (none – inoculated control) at two timepoints / disease pressures.
- Fig. 2 is a table showing significant results of efficacy testing of various enzyme treatments against Botrytis cinerea. Results are presented as percentage increase of the spectral parameters (Fv/Fm, ChlIdx and mARI) and the percentage of water-soaked lesions (%WSL) as compared to the untreated, inoculated control (none – inoculated control).
- Fig. 3 is a table showing significant results of efficacy testing of various enzyme treatments against Fusarium graminearum.
- Results are presented as percentage increase of the spectral parameters (Fv/Fm, ChlIdx and cGFP) as compared to the untreated, inoculated control (none – inoculated control) after 72 hours.
- Fig. 4 is a table showing significant results of efficacy testing of various enzyme treatments against Magnaporthe grisea. Results are presented as the half maximal effective concentration for absorbance at 612 nm (Abs EC 50 ; indicator of mycelia growth inhibition) and half maximal effective concentration for fluorescence after reaction with Resazurin (ex 570 nm – em 585 nm) (Fluorescence EC 50 ; indicator of cell viability).
- Fig.5 is a table showing significant results of efficacy testing of various enzyme treatments against Phakopsora pachyrhizi. Results are presented as the mean number of combined Phakopsora pachyrhizi lesions and pustules.
- Fig.6A, Fig.6B, Fig.6C and Fig.6D are tables showing significant results of efficacy testing of various enzyme treatments against Phytophthora infestans. Results for pipette-treated tomato leaf discs treated are presented in Fig. 6A as mean percent disease. Results for spray-treated tomato leaf discs are presented in Fig. 6B as (-) no disease reduction, (+) mild disease reduction, (++) moderate disease reduction or (+++) extreme disease reduction and in Fig. 6C as mean percent disease.
- Results for spray-treated potato leaf discs are presented in Fig.6D as mean percent healthy.
- Fig. 7 is a table showing significant results of efficacy testing of various enzyme treatments against Pseudoperonospora cubensis. Results are presented as (-) no disease reduction, (+) mild disease reduction, (++) moderate disease reduction or (+++) extreme disease reduction.
- Fig. 8A and Fig. 8B are tables showing significant results of efficacy testing of various enzyme treatments against Zymoseptoria tritici. Results are presented as percent disease control relative to untreated, inoculated control at various timepoints / disease pressures.
- Fig. 9 is a table showing significant results of efficacy testing of various enzyme treatments against Botrytis cinerea, Fusarium graminearum, Fusarium virguliforme, and Zymoseptoria tritici. Results are presented as the minimum inhibitory concentration (MIC 50 ) for average hyphal branch length and mycelial area (i.e., the minimum enzyme concentration required to inhibit average hyphal branch length / total mycelium area to 50% or less of the corresponding untreated control).
- MIC 50 minimum inhibitory concentration
- FIG. 10B are tables showing significant results of efficacy testing of various enzyme treatments against Botrytis cinerea, Fusarium graminerum, Magnaporthe grisea, Penicillium digitatum, Penicillium expansum, Penicillium italicum, Phytophthora infestans and Zymoseptoria tritici. Results are presented as (-) no growth inhibition, (+) visible stress reaction and/or mild growth inhibition, (++) moderate growth inhibition or (+++) extreme growth inhibition.
- Fig. 11 is a table showing significant results of efficacy testing of various enzyme treatments against leaf-eating insect larvae. Results are presented as relative growth rates of the larvae after two days of feeding on treated leaf discs. Fig.
- Fig. 12 is a table showing significant results of efficacy testing of various enzyme treatments against leaf-eating insect larvae. Results are presented as relative growth rates of the larvae after two days of feeding on treated leaf discs.
- Fig. 13 is a table showing significant results of efficacy testing of various enzyme treatments against gray mold (Botrytis cinerea). Results are presented as percent disease.
- Fig. 14A and Fig. 14B are tables showing significant results of efficacy testing of various enzyme treatments against Fusarium graminearum.
- Results are presented as percentage increase of the spectral parameters (Fv/Fm, ChlIdx and cGFP) as compared to corresponding untreated, inoculated controls (none – inoculated control; none- inoculated SilwetTM control; none – inoculated pH 6 buffer control; none – inoculated pH 7 buffer control; none – inoculated pH 8 buffer control).
- Fig. 15A and Fig. 15B are tables showing significant results of efficacy testing of various enzyme treatments against Puccinia striiformis. Results are presented as area under the disease progress curve.
- Fig.16 is a table showing results of significant results of efficacy testing of various enzyme treatments against Botrytis cinerea, Fusarium graminerum, Penicillium digitatum, Penicillium expansum, Penicillium italicum, Phytophthora infestans, Pyricularia grisea and Zymoseptoria tritici. Results are presented as the amount of oligosaccharides solubilized after hydrolysis of crude cell wall preparations ( mg glucose equivalents per gram of crude cell wall material (mg Glc/g CW))
- Fig. 17 is a table showing significant results of efficacy testing of various enzyme treatments against Botrytis cinerea and Penicillium expansum.
- Results are presented as minimum enzyme concentrations necessary to prevent spore germination in the presence of enzyme, 24 hours after enzyme washout, or 48 hours after enzyme washout.
- Fig.18 is a table showing significant results of efficacy testing of various enzyme treatments against Botrytis cinerea. Results are presented as the minimum inhibitory concentration (MIC 50 ) for average total mycelial area (i.e., the minimum enzyme concentration required to inhibit average total mycelium area to 50% or less of the corresponding untreated control).
- Fig. 19 is a table showing significant results of efficacy testing of various enzyme treatments against Botrytis cinerea and Penicillium expansum. Results are presented as percent inhibition of germ tube elongation as compared to the corresponding buffer control solution.
- additive when referring to effects of combinations within a composition means that the effects of the combinations are generally about the same as the sum of effects of the individual components of the combination alone.
- the combination of individual components producing this effect may be called an additive combination.
- the terms “agricultural, floricultural, horticultural and/or silvicultural apparatus/facility” and “agricultural/floricultural/horticultural/silvicultural apparatus/facility” refer to an apparatus or facility utilized in one or more aspects of the plant propagation, cultivation and/or harvesting, including, but not limited to, breeding, planting, irrigating, fertilizing, growing, monitoring, testing, pruning, harvesting, processing, packaging and/or storing plants and plant parts.
- Exemplary apparatuses and facilities include cultivators, seed containers, seeders, planting pots, hydroponic growth systems, growth chambers, greenhouses, broadcasters, fertilization drills, fertilizer spreaders, irrigation systems, harvesting apparatuses, postharvest storage containers, postharvest treatment chambers, and postharvest shipping containers.
- the term “agriculturally acceptable carrier” refers to a substance or composition that can be used to deliver a beneficial agent to a plant, plant part or plant growth medium (e.g., soil) without causing/having an unduly adverse effect on plant growth, development and/or yield.
- the term “foliar-compatible carrier” refers to a material that can be foliarly applied to a plant or plant part without causing/having an unduly adverse effect on the plant, plant part, plant growth, plant health, or the like.
- the term “seed-compatible carrier” refers to a material that can be applied to a seed without causing/having an unduly adverse effect on the seed, the plant that grows from the seed, seed germination, or the like.
- the term “soil-compatible carrier” refers to a material that can be added to a soil without causing/having an unduly adverse effect on plant growth, soil structure, soil drainage, or the like.
- the term “and/or” is intended to include any and all combinations of one or more of the associated listed items, as well as the lack of combinations when interpreted in the alternative (“or”).
- the phrase “A, B and/or C” is to be interpreted as “A, A and B, A and B and C, A and C, B, B and C, or C.”
- antagonistic when referring to effects of combinations within a composition means that the effects of the combinations are generally less than the sum of effects of the individual components of the combination alone. These compositions may be called antagonistic combinations.
- aqueous refers to a composition that contains more than a trace amount of water (i.e., more than 0.5% water by weight, based upon the total weight of the composition).
- the terms “associated with,” in association with” and “associated therewith,” when used in reference to a relationship between a composition of the present disclosure and a plant or plant part refer to at least a juxtaposition or close proximity of the composition and the plant or plant part. Such a juxtaposition or close proximity may be achieved by contacting or applying the composition directly to the plant or plant part and/or by applying the composition to the plant growth medium (e.g., soil) in which the plant or plant part will be grown (or is currently being grown).
- the plant growth medium e.g., soil
- the composition is applied as a coating to the outer surface of the plant or plant part.
- the composition is applied to soil at, near or surrounding the site in which the plant or plant part will be grown (or is currently being grown).
- the term “beneficial agent” may refer to any agent having at least one agriculturally/floriculturally/horticulturally/silviculturally beneficial property (e.g., an ability to fix atmospheric nitrogen, an ability to solubilize phosphate, an ability to produce one or more agriculturally/floriculturally/horticulturally/silviculturally beneficial small molecules, such as plant signal molecules, an ability to stimulate one or more plant defense systems, and ability to produce one or more phytoprotective agents, such as pesticidal toxins).
- agriculturally/floriculturally/horticulturally/silviculturally beneficial property e.g., an ability to fix atmospheric nitrogen, an ability to solubilize phosphate, an ability to produce one or more agriculturally/floriculturally/horticulturally/silvicultural
- biostimulant refers to an agent or combination of agents the application of which enhances one or more metabolic and/or physiological processes of a plant or plant part (e.g., carbohydrate biosynthesis, ion uptake, nucleic acid uptake, nutrient delivery, photosynthesis and/or respiration).
- binding module refers to the region of an enzyme that mediates binding to the enzyme to a substrate.
- catalytic domain refers to the region of an enzyme containing the catalytic machinery of the enzyme.
- cDNA refers to a DNA molecule that can be prepared by reverse transcription from a mature, spliced, mRNA molecule obtained from a eukaryotic or prokaryotic cell. cDNAs lack intron sequences that may be present in the corresponding genomic DNA.
- the initial, primary RNA transcript is a precursor to mRNA that is processed through a series of steps, including splicing, before appearing as mature spliced mRNA.
- coding sequence refers to a polynucleotide that directly specifies the amino acid sequence of a polypeptide.
- the boundaries of the coding sequence are generally determined by an open reading frame, which begins with a start codon, such as ATG, GTG, or TTG, and ends with a stop codon, such as TAA, TAG, or TGA.
- the coding sequence may be a genomic DNA, cDNA, synthetic DNA, or a combination thereof.
- colony forming unit and cfu refer to a microbial cell/spore capable of propagating on or in a suitable growth medium or substrate (e.g., a soil) when conditions (e.g., temperature, moisture, nutrient availability, pH, etc.) are favorable for germination and/or microbial growth.
- the term “consists essentially of,” when used in reference to compositions and methods of the present disclosure, means that the compositions/methods may contain additional components/steps so long as the additional components/steps do not materially alter the composition/method.
- the term “materially alter,” as applied to a composition/method of the present disclosure, refers to an increase or decrease in the effectiveness of the composition/method of at least 20%.
- a component added to a composition of the present disclosure may be deemed to “materially alter” the composition if it increases or decreases the composition's ability to inhibit the growth of a target phytopathogen by at least 20%.
- control sequences refers to nucleic acid sequences involved in regulation of expression of a polynucleotide in a specific organism or in vitro.
- Each control sequence may be native (i.e., from the same gene) or heterologous (i.e., from a different gene) to the polynucleotide encoding the polypeptide, and native or heterologous to each other.
- control sequences include, but are not limited to leader, polyadenylation, prepropeptide, propeptide, signal peptide, promoter, terminator, enhancer, and transcription or translation initiator and terminator sequences.
- the control sequences include a promoter, and transcriptional and translational stop signals.
- control sequences may be provided with linkers for the purpose of introducing specific restriction sites facilitating ligation of the control sequences with the coding region of the polynucleotide encoding a polypeptide.
- linkers for the purpose of introducing specific restriction sites facilitating ligation of the control sequences with the coding region of the polynucleotide encoding a polypeptide.
- derived from when used in reference to a relationship between an organism and a protein and/or polynucleotide, means that the protein and/or polynucleotide is naturally occurring in said organism.
- diazotroph refers to an organism capable of converting atmospheric nitrogen (N 2 ) into a form that may be utilized by a plant or plant part (e.g., ammonia (NH 3 ), ammonium (NH 4 +), etc.).
- the term “dispersant” refers to an agent or combination of agents the application of which reduces the cohesiveness of like particles, the surface tension of a liquid, the interfacial tension between two liquids and/or the interfacial tension between or a liquid and a solid.
- the terms “effective amount,” “effective concentration” and “effective amount/concentration” refer to an amount or concentration that is sufficient to cause a desired effect (e.g. ⁇ inhibiting plant disease, enhancing plant yield).
- the absolute value of the amount/concentration that is sufficient to cause the desired effect may be affected by factors such as the type and magnitude of effect desired, the type, size and volume of material to which the composition will be applied, the type(s) of enzymes in the composition, the amount(s) of enzyme(s) in the composition, the stability of the enzyme(s) in the composition and the storage conditions (e.g., temperature, relative humidity, duration).
- factors such as the type and magnitude of effect desired, the type, size and volume of material to which the composition will be applied, the type(s) of enzymes in the composition, the amount(s) of enzyme(s) in the composition, the stability of the enzyme(s) in the composition and the storage conditions (e.g., temperature, relative humidity, duration).
- Those skilled in the art will understand how to select an effective amount/concentration using routine dose-response experiments.
- an effective amount of a substance when used alone may be different than an effective amount of the same substance when used as part of a combination.
- endogenous gene refers to a gene consisting of an endogenous polynucleotide.
- endogenous polynucleotide refers to a polynucleotide that is native to the referenced host cell.
- enhanced growth and “enhanced plant growth” refer to an improvement in one or more characteristics of plant growth and/or development as compared to one or more control plants (e.g., a plant germinated from an untreated seed or an untreated plant).
- Exemplary plant growth/development characteristics include, but are not limited to, biomass, carbohydrate biosynthesis, chlorophyll content, cold tolerance, drought tolerance, height, leaf length, leaf mass, leaf number, leaf surface area, leaf volume, nutrient uptake (e.g., calcium, magnesium, nitrogen, phosphorous and/or potassium uptake), rate(s) of photosynthesis, root area, root diameter, root length, root mass, root nodulation (e.g., nodule mass, nodule number, nodule volume), root number, root surface area, root volume, salt tolerance, seed germination, seedling emergence, shoot diameter, shoot length, shoot mass, shoot number, shoot surface area, shoot volume, spread, stomatal conductance and survival rate.
- nutrient uptake e.g., calcium, magnesium, nitrogen, phosphorous and/or potassium uptake
- rate(s) of photosynthesis root area, root diameter, root length, root mass, root nodulation (e.g., nodule mass, nodule number, nodule volume),
- the terms “enhanced stability” and “enhanced enzyme stability” refer to an improvement in one or more characteristics of enzyme stability as compared to one or more controls (e.g., a control composition that is identical to a composition of the present disclosure except that it lacks one or more of the components found in the composition of the present disclosure).
- Exemplary enzyme stability characteristics include, but are not limited to, maintenance of enzymatic activity after being applied to a plant or plant part and/or stored for a defined period of time and the ability to cause a desired effect (e.g., reduced phytopathogenicity of a target pest) after being applied to a plant or plant part and/or stored for a defined period of time.
- the terms “enhanced yield” and “enhanced plant yield” refer to an improvement in one or more characteristics of plant yield as compared to one or more control plants (e.g., a control plant germinated from an untreated seed).
- Exemplary plant yield characteristics include, but are not limited to, biomass; bushels per acre; grain weight per plot (GWTPP); nutritional content; percentage of plants in a given area (e.g., plot) that fail to produce grain; yield at standard moisture percentage (YSMP), such as grain yield at standard moisture percentage (GYSMP); yield per plot (YPP), such as grain weight per plot (GWTPP); and yield reduction (YRED).
- expression refers to any step involved in the production of a polypeptide including, but not limited to, transcription, post-transcriptional modification, translation, post-translational modification, and secretion. Expression can be measured—for example, to detect increased expression—by techniques known in the art, such as measuring levels of mRNA and/or translated polypeptide.
- expression vector refers to a linear or circular DNA construct comprising a DNA sequence encoding a polypeptide, which coding sequence is operably linked to a suitable control sequence capable of effecting expression of the DNA in a suitable host.
- control sequences may include a promoter to effect transcription, an optional operator sequence to control transcription, a sequence encoding suitable ribosome binding sites on the mRNA, enhancers and sequences which control termination of transcription and translation.
- extension refers to an addition of one or more amino acids to the amino and/or carboxyl terminus of a polypeptide.
- foliage refers to those portions of a plant that normally grow above the ground, including, but not limited to, leaves, stalks, stems, flowers, fruiting bodies and fruits.
- foliar application and “foliarly applied” refer to the application of one or more active ingredients to the foliage of a plant (e.g., to the leaves of the plant). Application may be affected by any suitable means, including, but not limited to, spraying/fogging the plant with a composition comprising the active ingredient(s). In some embodiments, the active ingredient(s) is/are applied to the leaves, stems and/or stalk of the plant and not to the flowers, fruiting bodies or fruits of the plant.
- fragment refers to a polypeptide having one or more amino acids absent from the amino and/or carboxyl terminus of the mature polypeptide.
- fusion protein refers to a polypeptide in which one polypeptide is fused at the N-terminus and/or the C-terminus of a polypeptide of the present disclosure.
- a fusion protein is produced by fusing a polynucleotide encoding another polypeptide to a polynucleotide of the present disclosure, or by fusing two or more polynucleotides of the present disclosure together.
- Techniques for producing fusion proteins are known in the art and include ligating the coding sequences encoding the polypeptides so that they are in frame and that expression of the fusion protein is under control of the same promoter(s) and terminator.
- Fusion proteins may also be constructed using intein technology in which fusion proteins are created post- translationally (Cooper et al., 1993, EMBO J. 12: 2575-2583; Dawson et al., 1994, Science 266: 776-779).
- a fusion protein can further comprise a cleavage site between the two polypeptides. Upon secretion of the fusion protein, the site is cleaved releasing the two polypeptides. Examples of cleavage sites include, but are not limited to, the sites disclosed in Martin et al., 2003, J. Ind. Microbiol. Biotechnol.3: 568-576; Svetina et al., 2000, J. Biotechnol.
- heterologous when used to describe the relationship between a polynucleotide or polypeptide and a host cell, refers to a polynucleotide or polypeptide that does not naturally occur in the host cell.
- extraneous copies of polynucleotides that are otherwise native to the referenced host cell are deemed heterologous polynucleotides.
- the term “heterologous,” when used to describe the relationship between a polynucleotide or polypeptide and a control sequence refers to a polynucleotide or polypeptide is not naturally associated with the control sequence (i.e., the control sequence is from a gene other than the gene encoding the mature polypeptide).
- the terms “host strain” and “host cell” refer to an organism into which an expression vector, phage, virus, or other DNA construct, including a polynucleotide encoding a polypeptide of interest (e.g., an amylase) has been introduced.
- Exemplary host strains are microorganism cells (e.g., bacteria, filamentous fungi, and yeast) and plant cells capable of expressing a protein of interest.
- the term “host cell” includes protoplasts created from cells.
- the terms “inoculant composition” and “inoculum” refer to a composition comprising microbial cells and/or spores, said cells/spores being capable of propagating/germinating on or in a suitable growth medium or substrate (e.g., a soil) when conditions (e.g., temperature, moisture, nutrient availability, pH, etc.) are favorable for germination and/or microbial growth.
- the term “isolated” refers to a polypeptide, nucleic acid, cell, or other specified material or component that has been separated from at least one other material or component, including but not limited to, other proteins, nucleic acids, cells, etc.
- An isolated polypeptide, nucleic acid, cell or other material is thus in a form that does not occur in nature.
- An isolated polypeptide includes, but is not limited to, a culture broth containing the secreted polypeptide expressed in a host cell.
- the term “isomer” includes all stereoisomers of the compounds and/or molecules to which it refers, including enantiomers and diastereomers, as well as all conformers, roatmers and tautomers, unless otherwise indicated.
- Compounds and/or molecules disclosed herein include all enantiomers in either substantially pure levorotatory or dextrorotatory form, or in a racemic mixture, or in any ratio of enantiomers. Where embodiments disclose a (D)-enantiomer, that embodiment also includes the (L)-enantiomer; where embodiments disclose a (L)-enantiomer, that embodiment also includes the (D)-enantiomer.
- embodiments disclose a (+)-enantiomer, that embodiment also includes the (-)-enantiomer; where embodiments disclose a (-)-enantiomer, that embodiment also includes the (+)-enantiomer.
- embodiments disclose a (S)-enantiomer, that embodiment also includes the (R)-enantiomer; where embodiments disclose a (R)- enantiomer, that embodiment also includes the (S)-enantiomer.
- Embodiments are intended to include any diastereomers of the compounds and/or molecules referred to herein in diastereomerically pure form and in the form of mixtures in all ratios.
- the chemical structure or chemical name is intended to embrace all possible stereoisomers, conformers, rotamers and tautomers of compounds and/or molecules depicted.
- the term “mature polypeptide” refers to a polypeptide in its mature form following N-terminal and/or C-terminal processing (e.g., removal of signal peptide).
- the term “mature polypeptide coding sequence” refers to a polynucleotide that encodes a mature polypeptide.
- the term “modified microbial strain” refers to a microbial strain that is modified from a strain isolated from nature.
- Modified microbial strains may be produced by any suitable method(s), including, but not limited to, chemical or other form of induced mutation to a polynucleotide within any genome within the strain; the insertion or deletion of one or more nucleotides within any genome within the strain, or combinations thereof; an inversion of at least one segment of DNA within any genome within the strain; a rearrangement of any genome within the strain; generalized or specific transduction of homozygous or heterozygous polynucleotide segments into any genome within the strain; introduction of one or more phage into any genome of the strain; transformation of any strain resulting in the introduction into the strain of stably replicating autonomous extrachromosomal DNA; any change to any genome or to the total DNA composition within the strain isolated from nature as a result of conjugation with any different microbial strain; and any combination of the foregoing.
- modified microbial strains includes a strain with (a) one of more heterologous nucleotide sequences, (b) one or more non-naturally occurring copies of a nucleotide sequence isolated from nature (i.e., additional copies of a gene that naturally occurs in the microbial strain from which the modified microbial strain was derived), (c) a lack of one or more nucleotide sequences that would otherwise be present in the natural reference strain by for example deleting nucleotide sequence, and (d) added extrachromosomal DNA.
- modified microbial strains comprise a combination of two or more nucleotide sequences (e.g., two or more naturally occurring genes that do not naturally occur in the same microbial strain) or comprise a nucleotide sequence isolated from nature at a locus that is different from the natural locus.
- nucleotide sequences e.g., two or more naturally occurring genes that do not naturally occur in the same microbial strain
- nucleotide sequence isolated from nature at a locus that is different from the natural locus e.g., two or more naturally occurring genes that do not naturally occur in the same microbial strain
- native refers to a polynucleotide or polypeptide naturally occurring in a host cell.
- naturally occurring refers to anything (e.g., proteins, amino acids, or nucleic acid sequences) that is found in nature.
- non-naturally occurring refers to anything that is not found in nature (e.g., recombinant nucleic acids and protein sequences produced in a laboratory, modification of a wild-type sequence, formulations comprising one or more synthetic components, formulations comprising an artificial combination of otherwise naturally occurring components).
- non-aqueous refers to a composition that comprises no more than a trace amount of water (i.e., no more than 0.5% water by weight, based upon the total weight of the composition).
- nutrient refers to a compound or element useful for nourishing a plant (e.g., vitamins, macrominerals, micronutrients, trace minerals, organic acids, etc.
- the term “obtained from,” when used in reference to a relationship between an organism and a protein, means that the protein is expressed in the organism, whether from a naturally occurring polynucleotide therein or from a heterologous polynucleotide that was introduced into the organism.
- the term “polynucleotide” encompasses DNA, RNA, heteroduplexes, and synthetic molecules capable of encoding a polypeptide. Polynucleotides may be single-stranded or double-stranded and may comprise chemical modifications.
- the terms “nucleic acid” and “polynucleotide” are used interchangeably.
- nucleic acid construct refers to a polynucleotide, either single- or double- stranded, which is isolated from a naturally occurring gene or is modified to contain segments of nucleic acids in a manner that would not otherwise exist in nature or which is synthetic, and which comprises one or more control sequences operably linked to the nucleic acid sequence.
- operably linked means that specified components are in a relationship (including but not limited to juxtaposition) permitting them to function in an intended manner.
- a regulatory sequence is operably linked to a coding sequence such that expression of the coding sequence is under control of the regulatory sequence.
- phosphate-solubilizing microorganism refers to a microorganism capable of converting insoluble phosphate into a soluble form of phosphate.
- phytopathogenic pest includes any organism or virus that negatively affects a plant, including, but not limited to, organisms and viruses that spread disease, damage host plants and/or compete for soil nutrients.
- phytopathogenic pest encompasses organisms and viruses that are known to associate with plants and to cause a detrimental effect on the plant's health and/or vigor.
- Phytopathogenic pests include, but are not limited to, arachnids (e.g., mites, ticks, spiders, etc.), bacteria, fungi, gastropods (e.g., slugs, snails, etc.), invasive plants (e.g., weeds), insects (e.g., white flies, thrips, weevils, etc.), nematodes (e.g., root-knot nematode, soybean cyst nematode, etc.), rodents and viruses (e.g., tobacco mosaic virus (TMV), tomato spotted wilt virus (TSWV), cauliflower mosaic virus (CaMV), etc.).
- TMV tobacco mosaic virus
- TSWV tomato spotted wilt virus
- CaMV cauliflower mosaic virus
- the term “plant” includes all plant populations, including, but not limited to, agricultural, floricultural, horticultural and silvicultural plants.
- the term “plant” encompasses plants obtained by conventional plant breeding and optimization methods (e.g., marker-assisted selection) and plants obtained by genetic engineering, including cultivars protectable and not protectable by plant breeders' rights.
- the term “plant cell” refers to a cell of an intact plant, a cell taken from a plant, or a cell derived from a cell taken from a plant.
- the term “plant cell” includes cells within seeds, suspension cultures, embryos, meristematic regions, callus tissue, leaves, shoots, gametophytes, sporophytes, pollen and microspores.
- plant growth regulator refers to an agent or combination of agents the application of which accelerates or retards the growth/maturation rate of a plant through direct physiological action on the plant or which otherwise alters the behavior of a plant through direct physiological action on the plant.
- Plant growth regulator shall not be interpreted to include any agent or combination of agents excluded from the definition of “plant regulator” that is set forth section 2(v) of the Federal Insecticide, Fungicide, and Rodenticide Act (7 U.S.C. ⁇ 136(v)).
- plant growth regulator does not encompass microorganisms applied to a plant, plant part or plant growth medium for the purpose of enhancing the availability and/or uptake of nutrients, nutrients necessary to normal plant growth, soil amendments applied for the purpose of improving soil characteristics favorable for plant growth or vitamin hormone products as defined by 40 C.F.R. ⁇ 152.6(f).
- plant part refers to any part of a plant, including cells and tissues derived from plants.
- plant part may refer to any of plant components or organs (e.g., leaves, stems, roots, etc.), plant tissues, plant cells and seeds.
- plant parts include, but are not limited to, anthers, embryos, flowers, fruits, fruiting bodies, leaves, ovules, pollen, rhizomes, roots, seeds, shoots, stems and tubers, as well as scions, rootstocks, protoplasts, calli and the like.
- plant propagation material refers to a plant part from which a whole plant can be generated. Examples of plant propagation materials include, but are not limited to, cuttings (e.g., leaves, stems), rhizomes, seeds, tubers and cells/tissues that can be cultured into a whole plant.
- the term “protein” is not meant to refer to a specific amino acid chain length and encompasses peptides, oligopeptides and polypeptides. It is to be understood that the term “protein” also encompasses two or more polypeptides combined to form an encoded product, as well as hybrid polypeptides and fusion proteins.
- the term “purified” refers to a polynucleotide, protein or cell that is substantially free from other components as determined by analytical techniques well known in the art (e.g., a purified polynucleotide or protein may form a discrete band in an electrophoretic gel, chromatographic eluate, and/or a media subjected to density gradient centrifugation).
- a purified polynucleotide or protein is at least about 50% pure, usually at least about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, about 99.5%, about 99.6%, about 99.7%, about 99.8% or more pure (e.g., percent by weight or on a molar basis).
- a composition is enriched for a molecule when there is a substantial increase in the concentration of the molecule after application of a purification or enrichment technique.
- enriched refers to a compound, polynucleotide, protein, cell, nucleic acid, amino acid, or other specified material or component that is present in a composition at a relative or absolute concentration that is higher than a starting composition.
- purified refers to the protein or cell being essentially free from components (especially insoluble components) from the production organism. In other aspects. the term “purified” refers to the protein being essentially free of insoluble components (especially insoluble components) from the native organism from which it is obtained. In one aspect, the protein is separated from some of the soluble components of the organism and culture medium from which it is recovered.
- the protein may be purified (i.e., separated) by one or more of the unit operations filtration, precipitation, or chromatography. Accordingly, the protein may be purified such that only minor amounts of other proteins, in particular, other proteins, are present.
- the term “purified” as used herein may refer to removal of other components, particularly other proteins and most particularly other enzymes present in the cell of origin of the protein.
- the protein may be “substantially pure”, i.e., free from other components from the organism in which it is produced, e.g., a host organism for recombinantly produced protein. In one aspect, the protein is at least 40% pure by weight of the total protein material present in the preparation.
- the protein is at least 50%, 60%, 70%, 80% or 90% pure by weight of the total protein material present in the preparation.
- a “substantially pure protein” may denote a protein preparation that contains at most 10%, preferably at most 8%, more preferably at most 6%, more preferably at most 5%, more preferably at most 4%, more preferably at most 3%, even more preferably at most 2%, most preferably at most 1%, and even most preferably at most 0.5% by weight of other protein material with which the protein is natively or recombinantly associated.
- the substantially pure protein is at least 92% pure, preferably at least 94% pure, more preferably at least 95% pure, more preferably at least 96% pure, more preferably at least 97% pure, more preferably at least 98% pure, even more preferably at least 99% pure, most preferably at least 99.5% pure by weight of the total protein material present in the preparation.
- Proteins of the present disclosure are preferably in a substantially pure form (i.e., the preparations are essentially free of other protein material). This can be accomplished, for example by preparing the protein by well-known recombinant methods or by classical purification methods.
- recombinant is used in its conventional meaning to refer to the manipulation, e.g., cutting and rejoining, of nucleic acid sequences to form constellations different from those found in nature.
- the term recombinant refers to a cell, nucleic acid, protein or vector that has been modified from its native state.
- recombinant cells express genes that are not found within the native (non-recombinant) form of the cell, or express native genes at different levels or under different conditions than found in nature.
- the term “recombinant” is synonymous with “genetically modified” and “transgenic”.
- the terms “recover” and “recovery” refer to the removal of a protein from at least one fermentation broth component selected from the list of a cell, a nucleic acid, or other specified material, e.g., recovery of the protein from the whole fermentation broth, or from the cell-free fermentation broth, by protein crystal harvest, by filtration, e.g.
- depth filtration by use of filter aids or packed filter medias, cloth filtration in chamber filters, rotary-drum filtration, drum filtration, rotary vacuum-drum filters, candle filters, horizontal leaf filters or similar, using sheed or pad filtration in framed or modular setups
- membrane filtration using sheet filtration, module filtration, candle filtration, microfiltration, ultrafiltration in either cross flow, dynamic cross flow or dead end operation
- centrifugation using decanter centrifuges, disc stack centrifuges, hyrdo cyclones or similar
- Recovery encompasses isolation and/or purification of the protein.
- sequence identity As used herein, the relatedness between two amino acid sequences or between two nucleotide sequences is described by the parameter “sequence identity”.
- sequence identity is determined as the output of “longest identity” using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends Genet.16: 276- 277), preferably version 6.6.0 or later.
- the parameters used are a gap open penalty of 10, a gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix.
- the -nobrief option In order for the Needle program to report the longest identity, the -nobrief option must be specified in the command line.
- the output of Needle labeled “longest identity” is calculated as follows: (Identical Residues x 100)/(Length of Alignment – Total Number of Gaps in Alignment)
- sequence identity between two polynucleotide sequences is determined as the output of “longest identity” using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, supra) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, supra), preferably version 6.6.0 or later.
- Needle program In order for the Needle program to report the longest identity, the nobrief option must be specified in the command line.
- the output of Needle labeled “longest identity” is calculated as follows: (Identical Deoxyribonucleotides x 100)/(Length of Alignment – Total Number of Gaps in Alignment).
- signal peptide refers to a sequence of amino acids attached to the N-terminal portion of a protein, which facilitates the secretion of the protein outside the cell.
- the mature form of an extracellular protein lacks the signal peptide, which is cleaved off during the secretion process.
- the terms “stabilizing compound” and “stabilizer” refer to an agent or combination of agents the application of which enhances the stability of an enzyme.
- the term “subsequence” refers to a polynucleotide having one or more nucleotides absent from the 5' and/or 3' end of a mature protein coding sequence; wherein the subsequence encodes a fragment having enzymatic activity.
- the term “variant” refers to a protein comprising a man-made mutation, i.e., a substitution, insertion (including extension), and/or deletion (e.g., truncation), at one or more positions.
- a substitution means replacement of the amino acid occupying a position with a different amino acid;
- a deletion means removal of the amino acid occupying a position; and
- an insertion means adding 1-5 amino acids (e.g., 1-3 amino acids, in particular, 1 amino acid) adjacent to and immediately following the amino acid occupying a position.
- wild-type in reference to an amino acid sequence or nucleic acid sequence means that the amino acid sequence or nucleic acid sequence is a native or naturally occurring sequence.
- the present disclosure provides proteins useful for a) preventing, treating, suppressing and/or eliminating infestations/infections of/by myriad pests, including, but not limited to, phytopathogenic pests, such as arachnids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa, viruses and weeds; b) treating surfaces/substances that are susceptible to infestation/infection; c) cleansing infested/infected surfaces/substances; d) reducing disease severity in plants and plant parts affected directly or indirectly by phytopathogenic pests; e) enhancing plant growth environments; f) improving nutrient availability in plant growth media; g) reducing the amount(s) of exogenous fertilizer needed to achieve a desired result; h) improving plant growth, development and yield characteristics; i) prolonging the shelf-life of harvested plants and plant parts; j) delaying the ripening of plants and plant parts; k) hastening the ripening of
- proteins, polynucleotides and organisms of the present disclosure may be used (and may be formulated for use) at any time(s) throughout the agricultural, floricultural, horticultural, and silvicultural processes, such as prior to planting, at the time of planting, after planting, prior to germination, after germination, prior to seedling emergence, at the time of seedling emergence, after seedling emergence, prior to the vegetative stage, during the vegetative stage, after the vegetative stage, prior to the reproductive stage, during the reproductive stage, after the reproductive stage, prior to flowering, at the time of flowering, after flowering, prior to fruiting, at the time of fruiting, after fruiting, prior to ripening, at the time of ripening, after ripening, prior to harvest, at the time of harvest, after harvesting, prior to transport/storage, at the time of transport/storage, and/or after transport/storage.
- proteins of the present disclosure may be formulated for any suitable method of application, including, but not limited to, on-seed application, in-furrow application, foliar application, preharvest application, and postharvest application.
- proteins, polynucleotides, organisms and formulations of the present disclosure may affect the desired outcome(s)—including prevention, treatment, suppression and/or elimination of infestations/infections—without being toxic.
- compositions of the present disclosure may exert their effects through various non-lethal means, such as reducing the attraction of a pest to a treated surface by degrading a food source, for example.
- proteins of the present disclosure may be used in non-lethal doses to enhance the efficacy of and/or expand the target pest range of various chemical pesticides and biological pesticides.
- proteins, polynucleotides, organisms and formulations of the present disclosure may be used in combination to achieve the desire outcome(s).
- the present disclosure thus extends to formulations comprising two or more proteins of the present disclosure, to hybrid proteins comprising two or more distinct catalytic domains, to fusion proteins comprising two or more enzymatic polypeptides, etc.
- proteins of the present disclosure exhibit one or more catalytic activities belonging to Enzyme Commission classification number 1 (EC 1).
- proteins of the present disclosure exhibit glucose oxidase, cellobiose dehydrogenase, amino acid oxidase, laccase, catalase, peroxidase and/or oxygenase activity useful for a) preventing/treating/suppressing/eliminating/reducing the detrimental effects of infestations/infections of/by various pests, including, but not limited to, phytopathogenic pests, such as acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa, viruses and weeds; b) reducing one or more aspects of disease severity in plants affected by one or more phytopathogenic pests; c) pretreating surfaces/substances that are susceptible to infestation/infection by pests; d) cleaning surfaces/substances that are infested/infected by pests; e) enhancing the environments in which plants are grown by; f) improving nutrient availability in plant growth media;
- proteins of the present disclosure exhibit one or more oxidoreductase activities belonging to EC 1 and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 1–15 and 183–2755.
- proteins of the present disclosure exhibit one or more oxidoreductase activities belonging to EC 1.1, such as oxidase activities belonging to EC 1.1.3 (e.g., glucose oxidase activity belonging to EC 1.1.3.4, hexose oxidase activity belonging to EC 3.1.1.5, galactose oxidase activity belonging to EC 1.1.3.9) and/or EC 1.1.99 (e.g., cellobiose oxidase activity belonging to EC 1.1.99.18), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 1–5; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89,
- proteins that exhibit glucose oxidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 1–5 are set forth herein as SEQ ID NOs: 183–2205.
- the protein is derived from Aspergillus (e.g., A.. chevalieri, A. cristatus, A. flavus, A. niger, A. niveoglaucus, A. nomiae, A. oryzae., A. terreus, A. tubingensis), Beauveria (e.g., B. bassiana), Escherichia (e.g., E. coli), Komagataella (e.g., K.
- the protein is a native Aspergillus (e.g., A. chevalieri, A. cristatus, A. flavus, A. niger, A. niveoglaucus, A. nomiae, A. oryzae., A. terreus, A.
- Penicillium e.g., P. adametzii, P. amagasakiense, P. chrysogenum, P. decumbens, P. expansum, P. polonicum, P. viridicatum
- Talaromyces e.g., T. bacillisporus, T. flavus, T. stipitatus, T. variabilis.
- the protein is a native Aspergillus (e.g., A. chevalieri, A. cristatus, A. flavus, A. niger, A. niveoglaucus, A. nomiae, A. oryzae., A. terre
- tubingensis Beauveria (e.g., B. bassiana), Escherichia (e.g., E. coli), Komagataella (e.g., K. pastoris), Penicillium (e.g., P. adametzii, P. amagasakiense, P. chrysogenum, P. decumbens, P. expansum, P. polonicum, P. viridicatum), or Talaromyces (e.g., T. bacillisporus, T. flavus, T. stipitatus, T.
- Beauveria e.g., B. bassiana
- Escherichia e.g., E. coli
- Komagataella e.g., K. pastoris
- Penicillium e.g., P. adametzii, P. amagasakiense, P. chrysogenum, P. decumbens, P. expansum
- variabilis glucose oxidase or is a functional fragment/mutant/variant of a native Aspergillus (e.g., A.. chevalieri, A. cristatus, A. flavus, A. niger, A. niveoglaucus, A. nomiae, A. oryzae., A. terreus, A. tubingensis), Beauveria (e.g., B. bassiana), Escherichia (e.g., E. coli), Komagataella (e.g., K. pastoris), Penicillium (e.g., P. adametzii, P. amagasakiense, P. chrysogenum, P.
- a native Aspergillus e.g., A.. chevalieri, A. cristatus, A. flavus, A. niger, A. niveoglaucus, A. nomiae, A. oryzae., A.
- decumbens P. expansum, P. polonicum, P. viridicatum), or Talaromyces (e.g., T. bacillisporus, T. flavus, T. stipitatus, T. variabilis) glucose oxidase.
- Talaromyces e.g., T. bacillisporus, T. flavus, T. stipitatus, T. variabilis glucose oxidase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 6–8; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89,
- proteins that exhibit cellobiose oxidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 6–8 are set forth herein as SEQ ID NOs: 2206–2217.
- the protein is derived from Chaetomium, Humicola, Microdochium, Myceliophthora, Myriococcum, Neurospora or Remersonia.
- the protein is a native Chaetomium, Humicola, Microdochium, Myceliophthora, Myriococcum, Neurospora or Remersonia cellobiose oxidase or is a functional fragment/mutant/variant of a native Chaetomium, Humicola, Microdochium, Myceliophthora, Myriococcum, Neurospora or Remersonia cellobiose oxidase.
- Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more oxidoreductase activities belonging to EC 1.1.
- proteins of the present disclosure exhibit one or more oxidoreductase activities belonging to EC 1.4, such as oxidase activities belonging to EC 1.4.3 (e.g., D-aspartate oxidase activity belonging to EC 1.4.3.1, L-amino acid oxidase activity belonging to EC 1.4.3.2, D-amino acid oxidase activity belonging to EC 1.4.3.3, D-glutamate oxidase activity belonging to EC 1.4.3.7, L-glutamate oxidase activity belonging to EC 1.4.3.11, cyclohexylamine oxidase activity belonging to EC 1.4.3.12, protein-lysine 6-oxidase activity belonging to EC 1.4.3.13, L-lysine oxidase activity belonging to EC 1.4.3.14, D- glutamate(D-aspartate) oxidase activity belonging to EC 1.4.3.15, L-aspartate oxidase activity belonging to
- proteins of the present disclosure exhibit one or more oxidase activities belonging to EC 1.10, such as activities belonging to EC 1.10.3 (e.g., laccase activity belonging to EC 1.10.3.2), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to the amino acid sequence set forth herein as SEQ ID NO: 9.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 9; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- proteins that exhibit laccase activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 9 are set forth herein as SEQ ID NOs: 2218–2251.
- the protein is derived from Chaetomium, Chrysocorona, Melanocarpus, Myceliophthoora, Myriococcum, or Thermothelomyces.
- the protein is a native Chaetomium, Chrysocorona, Melanocarpus, Myceliophthoora, Myriococcum, or Thermothelomyces laccase or is a functional fragment/mutant/variant of a native Chaetomium, Chrysocorona, Melanocarpus, Myceliophthoora, Myriococcum, or Thermothelomyces laccase.
- Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more oxidase activities belonging to EC 1.10.
- enzymes of the present disclosure exhibit peroxidase activity belonging to EC 1.11, such as peroxidase activity belonging to EC 1.11.1 (e.g., catalase activity belonging to EC 1.11.1.6, peroxidase activity belonging to EC 1.11.1.7, lignin peroxidase activity belonging to EC 1.11.1.14), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 10–
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 10–12; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89,
- proteins that exhibit catalase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 10–12 are set forth herein as SEQ ID NOs: 2252–2296.
- the protein is derived from Aspergillus, Myceliophthora, Penicillium, Rasamsonia, Talaromyces or Thermoascus.
- the protein is a native Aspergillus, Myceliophthora, Penicillium, Rasamsonia, Talaromyces or Thermoascus catalase or is a functional fragment/mutant/variant of a native Aspergillus, Myceliophthora, Penicillium, Rasamsonia, Talaromyces or Thermoascus catalase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 13; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- proteins that exhibit peroxidase activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 13 are set forth herein as SEQ ID NOs: 2297–2381.
- the protein is derived from Arthromyces or Coprinopsis.
- the protein is a native A Arthromyces or Coprinopsis peroxidase or is a functional fragment/mutant/variant of a native Arthromyces or Coprinopsis peroxidase.
- Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more peroxidase activities belonging to EC 1.11.
- proteins of the present disclosure exhibit one or more oxygenase activities belonging to EC 1.14, such as oxygenase activities belonging to EC 1.14.16 (e.g., phenylalanine 4- monooxygenase activity belonging to EC 1.14.16.1, tyrosine 3-monooxygenase activity belonging to EC 1.14.16.2, tryptophan 5-monooxygenase activity belonging to EC 1.14.16.4, phenylalanine 3-monooxygenase activity belonging to EC 1.14.16.7), EC 1.14.18 (e.g., tyrosinase activity belonging to EC 1.14.18.1) and/or EC 1.14.99 (e.g., lytic chitin monooxygenase activity belonging to EC 1.14.99.53, lytic cellulose monooxygenase activity belonging to EC 1.14.99.54, lytic starch monooxygenase activity belonging to EC 1.14.99.55, lytic cellulose monooxygen
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 14–15; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89,
- proteins that exhibit lytic cellulose monooxygenase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 14–15 are set forth herein as SEQ ID NOs: 2382–2755.
- the protein is derived from Penicillium, Rasamsonia, or Thermoascus.
- the protein is a native Penicillium, Rasamsonia, or Thermoascus monooxygenase or is a functional fragment/mutant/variant of a native Penicillium, Rasamsonia, or Thermoascus monooxygenase.
- proteins of the present disclosure exhibit one or more catalytic activities belonging to Enzyme Commission classification number 2 (EC 2).
- proteins of the present disclosure exhibit aminoacyltransferase activity useful for a) preventing/treating/ suppressing/eliminating/reducing the detrimental effects of infestations/infections of/by various pests, including, but not limited to, phytopathogenic pests, such as acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa, viruses and weeds; b) reducing one or more aspects of disease severity in plants affected by one or more phytopathogenic pests; c) pretreating surfaces/substances that are susceptible to infestation/infection by pests; d) cleaning surfaces/substances that are infested/infected by pests; e) enhancing the environments in which plants are grown by; f) improving nutrient availability in plant growth media; g) reducing the amounts of exogen
- proteins of the present disclosure exhibit transferase activity belonging to EC 2 and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 16 and 2756–2769.
- proteins of the present disclosure exhibit one or more acyltransferase activities belonging to EC 2.3, such as aminoacyl transferase activities belonging to EC 2.3.2 (e.g., D-glutamyl transferase activity belonging to EC 2.3.2.1, gamma-glutamyl transferase activity belong to EC 2.3.2.2, aspartyl transferase activity belonging to EC 2.3.2.7, protein-glutamine gamma-glutamyl transferase activity belonging to EC 2.3.2.13, D-alanine gamma-glutamyl transferase activity belonging to EC 2.3.2.14), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82,
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 16; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- proteins that exhibit gamma-glutamyl transferase activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 16 are set forth herein as SEQ ID NOs: 2756–2769.
- the protein is derived from Bacillus.
- the protein is a native Bacillus gamma-glutamyl transferase or is a fragment/mutant/variant of a native Bacillus gamma-glutamyl transferase.
- Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more acyltransferase activities belonging to EC 2.3.
- proteins of the present disclosure exhibit one or more catalytic activities belonging to Enzyme Commission classification number 3 (EC 3).
- proteins of the present disclosure exhibit lipase, triacylglycerol lipase, pectinesterase, phospholipase, lysophospholipase, cutinase, amylase, glucosidase, galactosidase, cellulase, glucanase, xylanase, ceramidase, dextranase, chitinase, chitosanase, galacturonase, fucosidase, lysozymes, xylosidase, lucosidass, pullulanase, mannosidase, amidase, aminidase, maltohydrolases, cellobiosidase, pectinase, mannanase, aminopeptidase, serine peptidase and/or metallopeptidase, asparaginase and/or glut
- proteins of the present disclosure exhibit esterase activity belonging to EC 3 and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 17–90 and 2770–72141.
- proteins of the present disclosure exhibit one or more esterase activities belonging to EC 3.1, such as lipase activities belonging to EC 3.1.1 (e.g., triacylglycerol lipase activity belong to EC 3.1.1.3, phospholipase A 2 activity belonging to EC 3.1.1.4, lysophospholipase activity belonging to 3.1.1.5, pectinesterase activity belonging to 3.1.1.11, phospholipase A 1 activity belonging to 3.1.1.32, lipoprotein lipase activity belonging to EC 3.1.1.34, cutinase activity belonging to 3.1.1.74), phosphatase activities belonging to EC 3.1.3 (e.g., alkaline phosphatase activity belonging to EC 3.1.3.1, acid phosphatase activity belonging to EC 3.1.3.2, 3-phytase activity belonging to EC 3.1.3.8, glucose-6-phosphatase activity belonging to EC 3.1.3.9, glucose-1-phosphatase activity belonging to EC 3.1.1 (e
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 17–22; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89,
- proteins that exhibit triacylglycerol lipase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 17–22 are set forth herein as SEQ ID NOs: 2778–10223.
- the protein is derived from Aspergillus, Bacillus, Cryphonectria, Fusarium, Haloquadratum, Humicola, Penicillium, Scytalidium, Talaromyces, Thermomyces or Thermus.
- the protein is a native Aspergillus, Bacillus, Cryphonectria, Fusarium, Haloquadratum, Humicola, Penicillium, Scytalidium, Talaromyces, Thermomyces or Thermus triacylglycerol lipase or is a fragment/mutant/variant of a native Aspergillus, Bacillus, Cryphonectria, Fusarium, Haloquadratum, Humicola, Penicillium, Scytalidium, Talaromyces, Thermomyces or Thermus triacylglycerol lipase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 23; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- proteins that exhibit triacylglycerol lipase activity and/or phospholipase A 1 activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 23 are set forth herein as SEQ ID NOs: 10243–15978.
- the protein is derived from Aspergillus, Bacillus, Fusarium, Struthio, Talaromyces or Thermomyces.
- the protein is a native Aspergillus, Bacillus, Fusarium, Struthio, Talaromyces or Thermomyces triacylglycerol lipase or is a fragment/mutant/variant of a native Aspergillus, Bacillus, Fusarium, Struthio, Talaromyces or Thermomyces triacylglycerol lipase.
- the protein is derived from Aspergillus, Bacillus, Fusarium, Struthio, Talaromyces or Thermomyces.
- the protein is a native Aspergillus, Bacillus, Fusarium, Struthio, Talaromyces or Thermomyces phospholipase A 1 or is a fragment/mutant/variant of a native Aspergillus, Bacillus, Fusarium, Struthio, Talaromyces or Thermomyces phospholipase A 1 .
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 24; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- proteins that exhibit lysophospholipase activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 24 are set forth herein as SEQ ID NOs: 15979–15981.
- the protein is derived from Aspergillus.
- the protein is a native Aspergillus lysophospholipase or is a fragment/mutant/variant of a native Aspergillus lysophospholipase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 25; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- proteins that exhibit pectinesterase activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 25 are set forth herein as SEQ ID NOs: 2770–2777.
- the protein is derived from Aspergillus.
- the protein is a native Aspergillus pectinesterase or is a fragment/mutant/variant of a native Aspergillus pectinesterase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 26; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- proteins that exhibit phospholipase A 1 activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 26 are set forth herein as SEQ ID NOs: 10224–10242.
- the protein is derived from Evansstolkia.
- the protein is a native Evansstolkia phospholipase A 1 or is a fragment/mutant/variant of a native Evansstolkia phospholipase A 1 .
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 27–31, 72147 and 72149; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87,
- the protein is derived from Acrophialophora, Ascomycota, Chaetomium, Humicola, Hypocrea, Myceliophthora, Myriococcum, Pyrenophora, Thermochaetoides or Trichoderma.
- the protein is a native Acrophialophora, Ascomycota, Chaetomium, Humicola, Hypocrea, Myceliophthora, Myriococcum, Pyrenophora, Thermochaetoides or Trichoderma cutinase or is a fragment/mutant/variant of a native Acrophialophora, Ascomycota, Chaetomium, Humicola, Hypocrea, Myceliophthora, Myriococcum, Pyrenophora, Thermochaetoides or Trichoderma cutinase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 32; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- proteins that exhibit phospholipase C activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 32 are set forth herein as SEQ ID NOs: 16396–16412.
- the protein is derived from Pseudomonas.
- the protein is a native Pseudomonas phospholipase C or is a fragment/mutant/variant of a native Pseudomonas phospholipase C.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 33; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- proteins that exhibit phosphoinositide phospholipase C activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 33 are set forth herein as SEQ ID NOs: 16005–16395.
- the protein is derived from Bacillus, Komagataella or Lysinibacillus.
- the protein is a native Bacillus, Komagataella or Lysinibacillus phosphoinositide phospholipase C or is a fragment/mutant/variant of a native Bacillus, Komagataella or Lysinibacillus phosphoinositide phospholipase C.
- proteins of the present disclosure exhibit one or more glycosylase activities belonging to EC 3.2, such as glycosidase activities belonging to EC 3.2.1 (e.g., alpha-amylase activity belong to EC 3.2.1.1, beta-amylase activity belong to EC 3.2.1.2, glucan 1,4-alpha-glucosidase activity belong to 3.2.1.3, cellulase activity belong to 3.2.1.4, endo-1,3(4)-beta-glucanase activity belong to 3.2.1.6, inulinase activity belong to 3.2.1.7, endo-1,4-beta-xylanase activity belong to 3.2.1.8, oligo-1,6-glucosidase activity belong to 3.2.1.10, dextranase activity belong to 3.2.1.11, chitinase activity belong to 3.2.1.14, endo- polygalacturonase (pectinase) activity belong to 3.2.1.15, ly
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 34–40; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89,
- proteins that exhibit alpha-amylase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 34–40 are set forth herein as SEQ ID NOs: 16413–45041.
- the protein is derived from Alicyclobacillus, Alkalihalobacillus, Anoxybacillus, Aspergillus, Bacillus, Cytophaga, Exiguobacterium, Geobacillus, Hamigera, Homo sapiens, Jeotgalibacillus, Neosartorya, Penicillium, Priestia, Pyrococcus, Rasamsonia, Sutcliffiella or Thermoascus.
- the protein is a native Alicyclobacillus, Alkalihalobacillus, Anoxybacillus, Aspergillus, Bacillus, Cytophaga, Exiguobacterium, Geobacillus, Hamigera, Homo sapiens, Jeotgalibacillus, Neosartorya, Penicillium, Priestia, Pyrococcus, Rasamsonia, Sutcliffiella or Thermoascus alpha-amylase or is a fragment/mutant/variant of a native Alicyclobacillus, Alkalihalobacillus, Anoxybacillus, Aspergillus, Bacillus, Cytophaga, Exiguobacterium, Geobacillus, Hamigera, Homo sapiens, Jeotgalibacillus, Neosartorya, Penicillium, Priestia, Pyrococcus, Rasamsonia, Sutcliffiella or Thermoascus alpha-amylase or is a fragment/mut
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 41–42; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89,
- proteins that exhibit glucan 1,4-alpha-glucosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 41–42 are set forth herein as SEQ ID NOs: 45756–45904.
- the protein is derived from Aspergillus, Bos, Elaphocordyceps, Fusarium, Penicillium, Rasamsonia or Saccharomycopsis.
- the protein is a native Aspergillus, Bos, Elaphocordyceps, Fusarium, Penicillium, Rasamsonia or Saccharomycopsis glucan 1,4- alpha-glucosidase or is a fragment/mutant/variant of a native Aspergillus, Bos, Elaphocordyceps, Fusarium, Penicillium, Rasamsonia or Saccharomycopsis glucan 1,4-alpha-glucosidase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 43–45; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89,
- proteins that exhibit cellulase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 43–45 are set forth herein as SEQ ID NOs: 45913–48750.
- the protein is derived from Acremonium, Alteromonas, Ascomycota, Aspergillus, Bacillus, Chaetomium, Clonostachys, Corynascus, Cylindrocarpon, Escherichia, Fusarium, Humicola, Madurella, Melanocarpus, Myceliophthora, Neurospora, Podospora, Remersonia, Scytalidium, Sordaria, Staphylotrichum, Thermocarpiscus, Thermochaetoides, Thermothielavioides, Thielavia, Trichocladium, Trichothecium or Triticum.
- the protein is a native Acremonium, Alteromonas, Ascomycota, Aspergillus, Bacillus, Chaetomium, Clonostachys, Corynascus, Cylindrocarpon, Escherichia, Fusarium, Humicola, Madurella, Melanocarpus, Myceliophthora, Neurospora, Podospora, Remersonia, Scytalidium, Sordaria, Staphylotrichum, Thermocarpiscus, Thermochaetoides, Thermothielavioides, Thielavia, Trichocladium, Trichothecium or Triticum cellulase or is a fragment/mutant/variant of a native Acremonium, Alteromonas, Ascomycota, Aspergillus, Bacillus, Chaetomium, Clonostachys, Corynascus, Cylindrocarpon, Escherichia, Fusarium, Hum
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 46; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- proteins that exhibit endo-1,3(4)-beta-glucanase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 46 are set forth herein as SEQ ID NOs: 49229–49346.
- the protein is derived from Bacillus, Bispora, Hordeum or Paenibacillus.
- the protein is a native Bacillus, Bispora, Hordeum or Paenibacillus endo- 1,3(4)-beta-glucanase or is a fragment/mutant/variant of a native Bacillus, Bispora, Hordeum or Paenibacillus endo-1,3(4)-beta-glucanase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 47; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- proteins that exhibit inulinase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 47 are set forth herein as SEQ ID NOs: 49347–49419.
- the protein is derived from Aspergillus, Penicillium, Pseudomonas or Talaromyces.
- the protein is a native Aspergillus, Penicillium, Pseudomonas or Talaromyces inulinase or is a fragment/mutant/variant of a native Aspergillus, Penicillium, Pseudomonas or Talaromyces inulinase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 48–53; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89,
- proteins that exhibit endo-1,4-beta-xylanase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 48–53 are set forth herein as SEQ ID NOs: 49453–49912.
- the protein is derived from Anaerocellum, Aspergillus, Bacillus, Caldicellulosiruptor, Clostridium, Dicytoglomus, Evansstolkia, Hordeum, Lactobacillus, Malbranchea, Neosartorya, Nicotiana, Paecilomyces, Paenibacillus, Penicillium, Pyrococcus, Rasamsonia, Saccharomyces, Talaromyces, Thermoclostridium, Thermomyces, Thermus or Viridiplantae.
- the protein is a native Anaerocellum, Aspergillus, Bacillus, Caldicellulosiruptor, Clostridium, Dicytoglomus, Evansstolkia, Hordeum, Lactobacillus, Malbranchea, Neosartorya, Nicotiana, Paecilomyces, Paenibacillus, Penicillium, Pyrococcus, Rasamsonia, Saccharomyces, Talaromyces, Thermoclostridium, Thermomyces, Thermus or Viridiplantae endo-1,4-beta-xylanase or is a fragment/mutant/variant of a native Anaerocellum, Aspergillus, Bacillus, Caldicellulosiruptor, Clostridium, Dicytoglomus, Evansstolkia, Hordeum, Lactobacillus, Malbranchea, Neosartorya, Nicotiana, Paecilomyces,
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 54; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- proteins that exhibit dextranase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 54 are set forth herein as SEQ ID NOs: 45063–45071.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 56; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70,
- proteins that exhibit lysozyme activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 56 are set forth herein as SEQ ID NOs: 45443–45456.
- the protein is derived from Clonostachys or Sodiomyces.
- the protein is a native Clonostachys or Sodiomyces lysozyme or is a fragment/mutant/variant of a native Clonostachys or Sodiomyces lysozyme.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 57; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90
- proteins that exhibit beta-glucosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 57 are set forth herein as SEQ ID NOs: 45457–45754.
- the protein is derived from Aspergillus, Coccidioides, Evansstolkia, Neosartorya, Penicillium, Rasamsonia, Schizosaccharomyces or Thermoascus.
- the protein is a native Aspergillus, Coccidioides, Evansstolkia, Neosartorya, Penicillium, Rasamsonia, Schizosaccharomyces or Thermoascus beta-glucosidase or is a fragment/mutant/variant of a native Aspergillus, Coccidioides, Evansstolkia, Neosartorya, Penicillium, Rasamsonia, Schizosaccharomyces or Thermoascus beta-glucosidase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 58; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90
- proteins that exhibit alpha-mannosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 58 are set forth herein as SEQ ID NOs: 45755.
- the protein is derived from Neobacillus.
- the protein is a native Neobacillus alpha-mannosidase or is a fragment/mutant/variant of a native Neobacillus alpha-mannosidase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 59–60 and 45906; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87,
- proteins that exhibit glucan endo-1,3-beta-D-glucosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 59–60 and 45906 are set forth herein as SEQ ID NOs: 45905–45912.
- the protein is derived from Trichoderma.
- the protein is a native Trichoderma glucan endo-1,3-beta-D-glucosidase or is a fragment/mutant/variant of a native Trichoderma glucan endo-1,3-beta-D-glucosidase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 61; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90
- proteins that exhibit pullulanase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 61 are set forth herein as SEQ ID NOs: 48751–49148.
- the protein is derived from Bacillus, Geobacillus or Pulluanibacillus.
- the protein is a native Bacillus, Geobacillus or Pulluanibacillus pullulanase or is a fragment/mutant/variant of a native Bacillus, Geobacillus or Pulluanibacillus pullulanase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 62; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90
- proteins that exhibit alpha-L-arabinofuranosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 62 are set forth herein as SEQ ID NOs: 49149–49209.
- the protein is derived from Acremonium, ACrophialophora, Actinomadura, Actinoplanes, Aspergillus, Aureobasidium, Chaetomium, Gliomastix, Humicola, Hypocrea, Microdochium, Myceliophthora, Oculimacula, Penicillium, Streptomyces, Streptosporangium, Talaromyces, Thielavia, Trichoderma or Xylanibacterium.
- the protein is a native Acremonium, ACrophialophora, Actinomadura, Actinoplanes, Aspergillus, Aureobasidium, Chaetomium, Gliomastix, Humicola, Hypocrea, Microdochium, Myceliophthora, Oculimacula, Penicillium, Streptomyces, Streptosporangium, Talaromyces, Thielavia, Trichoderma or Xylanibacterium alpha-L-arabinofuranosidase or is a fragment/mutant/variant of a native Acremonium, ACrophialophora, Actinomadura, Actinoplanes, Aspergillus, Aureobasidium, Chaetomium, Gliomastix, Humicola, Hypocrea, Microdochium, Myceliophthora, Oculimacula, Penicillium, Streptomyces, Streptosporangium, or is a fragment/
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 63–64; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89
- proteins that exhibit glucan endo-1,3-alpha-glucosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 63–64 are set forth herein as SEQ ID NOs: 49210–49228.
- the protein is derived from Clonostachys, Hypocrea, Myceliophthora or Trichoderma.
- the protein is a native Clonostachys, Hypocrea, Myceliophthora or Trichoderma glucan endo-1,3-alpha-glucosidase or is a fragment/mutant/variant of a native Clonostachys, Hypocrea, Myceliophthora or Trichoderma glucan endo-1,3-alpha-glucosidase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 65; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- proteins that exhibit licheninase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 65 are set forth herein as SEQ ID NOs: 49420–49446.
- the protein is derived from Bacillus or Salipaludibacillus.
- the protein is a native Bacillus or Salipaludibacillus licheninase or is a fragment/mutant/variant of a native Bacillus or Salipaludibacillus licheninase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 66–67; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89
- proteins that exhibit glucan endo-1,6-beta-glucosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 66–67 are set forth herein as SEQ ID NOs: 49447–49451.
- the protein is derived from Trichoderma.
- the protein is a native Trichoderma glucan endo-1,6-beta-glucosidase or is a fragment/mutant/variant of a native Trichoderma glucan endo-1,6-beta-glucosidase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 68 and 72144; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88,
- proteins that exhibit mannan endo-1,4-beta-mannosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 68 and 72144 are set forth herein as SEQ ID NOs: 49452.
- the protein is derived from Alkalihalobacillus.
- the protein is a native Alkalihalobacillus mannan endo-1,4-beta-mannosidase or is a fragment/mutant/variant of a native Alkalihalobacillus mannan endo-1,4-beta-mannosidase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 69; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90
- proteins that exhibit mannan endo-1,6-alpha-mannosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 69 are set forth herein as SEQ ID NOs: 45042.
- the protein is derived from Talaromyces.
- the protein is a native Talaromyces mannan endo-1,6-alpha-mannosidase or is a fragment/mutant/variant of a native Talaromyces mannan endo-1,6-alpha-mannosidase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 70–75; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89,
- proteins that exhibit endogalactosaminidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 70–75 are set forth herein as SEQ ID NOs: 45043–45062.
- the protein is derived from Bjerkandera, Diaporthe, Fusarium, Neonectria, Ostropa, Pseudoplectania, Stenocarpella or Urunula.
- the protein is a native Bjerkandera, Diaporthe, Fusarium, Neonectria, Ostropa, Pseudoplectania, Stenocarpella or Urunula endogalactosaminidase or is a fragment/mutant/variant of a native Bjerkandera, Diaporthe, Fusarium, Neonectria, Ostropa, Pseudoplectania, Stenocarpella or Urunula endogalactosaminidase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 76–77; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89
- the protein is derived from Chryseobacterium or Lysobacter.
- the protein is a native Chryseobacterium or Lysobacter glycoprotein endo-alpha-1,2- mannosidase or is a fragment/mutant/variant of a native Chryseobacterium or Lysobacter glycoprotein endo- alpha-1,2-mannosidase.
- the protein is a native Chryseobacterium or Lysobacter alpha-mannan endo-1,2-alpha-mannanase or is a fragment/mutant/variant of a native Chryseobacterium or Lysobacter alpha-mannan endo-1,2-alpha-mannanase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 78; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90
- proteins that exhibit glucan 1,4-alpha-maltohydrase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 78 are set forth herein as SEQ ID NOs: 45072–45408.
- the protein is derived from Alicyclobacillus, Bacillus, Effusibacillus or Geobacillus.
- the protein is a native Alicyclobacillus, Bacillus, Effusibacillus or Geobacillus glucan 1,4-alpha-maltohydrase or is a fragment/mutant/variant of a native Alicyclobacillus, Bacillus, Effusibacillus or Geobacillus glucan 1,4-alpha-maltohydrase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 79; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90
- proteins that exhibit 1,6-alpha-D-mannosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 79 are set forth herein as SEQ ID NOs: 45437–45442.
- the protein is derived from Aspergillus, Evansstolkia, Penicillium, Rasamsonia, Talaromyces or Thermomyces.
- the protein is a native Aspergillus, Evansstolkia, Penicillium, Rasamsonia, Talaromyces or Thermomyces 1,6-alpha-D-mannosidase or is a fragment/mutant/variant of a native Aspergillus, Evansstolkia, Penicillium, Rasamsonia, Talaromyces or Thermomyces 1,6-alpha-D-mannosidase.
- Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more glycosylase activities belong to EC 3.2.
- proteins of the present disclosure exhibit one or more peptidase activities belonging to EC 3.4, such as aminopeptidase activities belonging to EC 3.4.11, serine endopeptidase activities belonging to EC 3.4.21 (e.g., chymotrypsin activity belonging to EC 3.4.21.1, trypsin activity belonging to EC 3.4.21.4, alpha-lytic endopeptidase activity belonging to EC 3.4.21.12, glutamyl endopeptidase activity belonging to EC 3.4.21.19, cucumisin activity belonging to EC 3.4.21.25, chymase activity belonging to EC 3.4.21.39, lysyl endopeptidase activity belonging to EC 3.4.21.50, leucyl endopeptidase activity belonging to EC 3.4.21.57, subtilisin activity belonging to 3.4.21.62), cysteine endopeptidase activities belonging to 3.4.22 (e.g., papain activity belonging to EC 3.4.11
- proteins of the present disclosure exhibit serine endoprotease activity belonging to EC 3.4.21 and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 80–86.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 80–81; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89,
- proteins that exhibit serine endopeptidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 80–81 are set forth herein as SEQ ID NOs: 49913–50777.
- the protein is derived from Cinereomyces, Dichomitus, Ganoderma, Grifola, Lenzites, Meripilus, Neolentinus, Nocardiopsis, Polyporus or Trametes.
- the protein is a native Cinereomyces, Dichomitus, Ganoderma, Grifola, Lenzites, Meripilus, Neolentinus, Nocardiopsis, Polyporus or Trametes serine endopeptidase or is a fragment/mutant/variant of a native Cinereomyces, Dichomitus, Ganoderma, Grifola, Lenzites, Meripilus, Neolentinus, Nocardiopsis, Polyporus or Trametes serine endopeptidase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 82; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90
- proteins that exhibit glutamyl endopeptidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 82 are set forth herein as SEQ ID NOs: 50778–50953.
- the protein is derived from Bacillus.
- the protein is a native Bacillus glutamyl endopeptidase or is a fragment/mutant/variant of a native Bacillus glutamyl endopeptidase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 83–87; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89
- proteins that exhibit subtilisin activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 83–87 are set forth herein as SEQ ID NOs: 50954–70838.
- the protein is derived from Alkalihalobacillus, Aspergillus, Bacillus, Brevia, Geomicrobium, Homo, Hordeum, Lederbergia, Saccharomyces, Shouchella or Thermus.
- the protein is a native Alkalihalobacillus, Aspergillus, Bacillus, Brevia, Geomicrobium, Homo, Hordeum, Lederbergia, Saccharomyces, Shouchella or Thermus subtilisin or is a fragment/mutant/variant of a native Alkalihalobacillus, Aspergillus, Bacillus, Brevia, Geomicrobium, Homo, Hordeum, Lederbergia, Saccharomyces, Shouchella or Thermus subtilisin.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 88; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90
- proteins that exhibit bacillolycin activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 88 are set forth herein as SEQ ID NOs: 70839–71903.
- the protein is derived from Bacillus.
- the protein is a native Bacillus bacillolycin or is a fragment/mutant/variant of a native Bacillus bacillolycin.
- Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more peptidase activities belong to EC 3.4.
- proteins of the present disclosure exhibit one or more hydrolase activities belonging to EC 3.5, such as amidohydrolase and amidase activities belonging to EC 3.5.1 (e.g., asparaginase activity belong to EC 3.5.1.1, glutaminase activity belonging to 3.5.1.2, amidase activity belonging to 3.5.1.4, urease activity belonging to 3.5.1.5, biotinidase activity belonging to 3.5.1.12, nicotinamidase activity belonging to 3.5.1.19, N-acetylglucosamine deacetylase activity belonging to EC 3.5.1.33, D-glutaminase activity belonging to 3.5.1.35, glutamin-(asparagin-)ase activity belonging to 3.5.1.38, chitin deacetylase activity belonging to 3.5.1.41, peptidyl-glutaminase activity belonging to 3.5.1.43, protein-glutamine glutaminase activity belonging to 3.5.1.44, pentanamidas
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 89–90; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89
- proteins that exhibit asparaginase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 89–90 are set forth herein as SEQ ID NOs: 71904–72141.
- the protein is derived from Aspergillus.
- the protein is a native Aspergillus asparaginase or is a fragment/mutant/variant of a native Aspergillus asparaginase.
- Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more hydrolase activities belong to EC 3.5.
- proteins of the present disclosure exhibit one or more lyase activities belonging to Enzyme Commission classification number 4 (EC 4).
- proteins of the present disclosure exhibit lyase activity useful for a) preventing/treating/suppressing/eliminat- ing/reducing the detrimental effects of infestations/infections of/by various pests, including, but not limited to, phytopathogenic pests, such as acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa, viruses and weeds; b) reducing one or more aspects of disease severity in plants affected by one or more phytopathogenic pests; c) pretreating surfaces/substances that are susceptible to infestation/infection by pests; d) cleaning surfaces/substances that are infested/infected by pests; e) enhancing the environments in which plants are grown by; f) improving nutrient availability in plant growth media; g) reducing the amounts of exogenous fertilizer needed to achieve a desired result; h) improving plant growth, development, and yield characteristics; i) prolonging
- phytopathogenic pests
- proteins of the present disclosure exhibit one or more carbon-carbon lyase activities belonging to EC 4.1, such as carboxy-lyase activities belonging to EC 4.1.1 (e.g., aspartate 1- decarboxylase activity belonging to EC 4.1.1.11, aspartate 4-decarboxylase activity belonging to EC 4.1.1.12, valine decarboxylase activity belonging to EC 4.1.1.14, glutamate decarboxylase activity belonging to EC 4.1.1.15, lysine decarboxylase activity belonging to EC 4.1.1.18, arginine decarboxylase activity belonging to EC 4.1.1.19, histidine decarboxylase activity belonging to EC 4.1.1.22, tyrosine decarboxylase activity belonging to EC 4.1.1.25, phenylalanine decarboxylase activity belonging to EC 4.1.1.53, methionine decarboxylase activity belonging to EC 4.1.1.57, L-tryptophan decarboxylase activity belonging to
- proteins of the present disclosure exhibit one or more carbon-oxygen lyase activities belonging to EC 4.2, such as polysaccharide lyase activities belonging to EC 4.2.2 (e.g., pectate lyase activity belong to EC 4.2.2.2, pectin lyase activity belonging to EC 4.2.2.10, glucan lyase activity belonging to EC 4.2.2.13, gellan lyase activity belonging to EC 4.2.2.25, oligo-alginase lyase activity belonging to EC 4.2.2.26, pectin monosaccharide-lyase activity belonging to EC 4.2.2.27), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 91; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90
- proteins that exhibit pectate lyase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 91 are set forth herein as SEQ ID NOs: 72142–72143.
- the protein is derived from Bacillus.
- the protein is a native Bacillus pectate lyase or is a fragment/mutant/variant of a native Bacillus pectate lyase.
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 55; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- proteins that exhibit pectin lyase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 55 are set forth herein as SEQ ID NOs: 45409–45436.
- the protein is derived from Aspergillus, Botrytis, Neosartorya, Penicillium or Pseudomyllocerus.
- the protein is a native Aspergillus, Botrytis, Neosartorya, Penicillium or Pseudomyllocerus pectin lyase or is a fragment/mutant/variant of a native Aspergillus, Botrytis, Neosartorya, Penicillium or Pseudomyllocerus pectin lyase.
- Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more carbon-oxygen lyase activities belong to EC 4.2. See, e.g., US2015045535-A1; WO9927083-A1.
- proteins of the present disclosure exhibit one or more carbon-nitrogen lyase activities belonging to EC 4.3, such as ammonia-lyase activities belonging to EC 4.3.1 (e.g., aspartate ammonia-lyase activity belonging to EC 4.3.1.1, histidine ammonia-lyase activity belong to EC 4.3.1.3, L- serine ammonia-lyase activity belonging to EC 4.3.1.17, D-serine ammonia-lyase activity belonging to EC 4.3.1.18, threonine ammonia-lyase activity belonging to EC 4.3.1.19, tyrosine ammonia-lyase activity belonging to EC 4.3.1.23, phenylalanine ammonia-lyase activity belonging to EC 4.3.1.24, phenylalanine/tyrosine ammonia-lyase activity belonging to EC 4.3.1.25, L-lysine cyclodeaminase activity
- proteins of the present disclosure exhibit one or more carbon-sulfur lyase activities belonging to 4.4, such as carbon-sulfur lyase activities belonging to EC 4.4.1 (e.g., cysteine lyase activity belonging to EC 4.4.1.10, methionine gamma-lyase activity belonging to EC 4.4.1.11, L-cysteine desulfidase activity belonging to EC 4.4.1.28, L-cysteine beta-lyase activity belonging to EC 4.4.1.35).
- cysteine lyase activity belonging to EC 4.4.1.10 methionine gamma-lyase activity belonging to EC 4.4.1.11
- L-cysteine desulfidase activity belonging to EC 4.4.1.28 L-cysteine beta-lyase activity belonging to EC 4.4.1.35.
- the protein comprises, consists essentially of, or consists of a wild-type polypeptide.
- the protein comprises, consists essentially of, or consists of a wild-type polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof.
- the protein comprises, consists essentially of, or consists of a variant polypeptide.
- the protein comprises, consists essentially of, or consists of a variant polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof.
- the protein comprises, consists essentially of or consists of a catalytic domain, a binding module and a linker between said catalytic domain and said binder module.
- the present disclosure extends to proteins capable of exhibiting two, three, four, five or more distinct catalytic activities, including, but not limited to, proteins that inherently exhibit two or more distinct catalytic activities and fusion proteins comprising two or more polypeptides that exhibit distinct catalytic activities.
- the protein is a hybrid protein.
- the protein comprises two or more catalytic domains.
- the protein comprises two or more binding modules.
- the protein is a fusion protein (e.g., a fusion protein comprising a first polypeptide having a first enzymatic activity and a second polypeptide having a second enzymatic activity).
- the protein is a fusion protein comprising a first polypeptide and a second polypeptide, said second polypeptide being distinct from said first polypeptide, wherein said first polypeptide is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(
- proteins of the present disclosure comprise, consist essentially of or consist of the amino acid sequence of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof.
- proteins of the present disclosure are encoded by a polynucleotide that comprises, consists essentially of or consists of one of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA thereof.
- proteins of the present disclosure comprise, consist essentially of or consist of a fragment of one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof.
- the protein may be a fragment of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof, said fragment comprising at least 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99 % of the amino acids found in the original protein.
- proteins of the present disclosure comprise, consist essentially of or consist of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof with an N-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), a C-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more substitutions), one or more insertions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more insertions), and/or one or more deletions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more deletions), and/or one or
- the amino acid changes may be of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of 1-30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino-terminal methionine residue; a small linker peptide of up to 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding module.
- Essential amino acids in a polypeptide can be identified according to procedures known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (Cunningham and Wells, 1989, Science 244: 1081-1085).
- the active site of the enzyme or other biological interaction can also be determined by physical analysis of structure, as determined by such techniques as nuclear magnetic resonance, crystallography, electron diffraction, or photoaffinity labeling, in conjunction with mutation of putative contact site amino acids. See, for example, de Vos et al., 1992, Science 255: 306-312; Smith et al., 1992, J. Mol.
- the identity of essential amino acids can also be inferred from an alignment with a related polypeptide, and/or be inferred from sequence homology and conserved catalytic machinery with a related polypeptide or within a polypeptide or protein family with polypeptides/proteins descending from a common ancestor, typically having similar three-dimensional structures, functions, and significant sequence similarity. Additionally or alternatively, protein structure prediction tools can be used for protein structure modelling to identify essential amino acids and/or active sites of polypeptides.
- Mutagenized DNA molecules that encode active polypeptides can be recovered from the host cells and rapidly sequenced using standard methods in the art. These methods allow the rapid determination of the importance of individual amino acid residues in a polypeptide.
- Table 1 provides a non-exhaustive list of proteins useful in compositions and methods of the present disclosure. TABLE 1. Exemplary proteins of the present disclosure Proteins of the present disclosure may be derived from microorganisms of any genus. In some embodiments, the protein is derived from and/or obtained from a Gram-negative bacterium, such as Campylobacter, Chryseobacterium (e.g., C. viscerum), Dicytoglomus (e.g., D. thermophilum), Escherichia (e.g., E.
- a Gram-negative bacterium such as Campylobacter, Chryseobacterium (e.g., C. viscerum), Dicytoglomus (e.g., D. thermophilum), Escherichia (e.g.
- the protein is derived from a Gram-positive bacterium, such as Alkalihalobacillus (e.g., A. akibai, A. clausii), Bacillus (e.g., B. agaradhaerens, B. alkalophilus, B. amyloliquefaciens, B. brevis, B. circulans, B. clausii, B. coagulans, B. deramificans, B. firmus, B.
- Alkalihalobacillus e.g., A. akibai, A. clausii
- Bacillus e.g., B. agaradhaerens, B. alkalophilus, B. amyloliquefaciens, B. brevis, B. circulans, B. clausii, B. coagulans, B. deramificans, B. firmus, B.
- the protein is derived from a fungus, such as Acremonium, Acrophialophora (e.g., A. fusispora), Aspergillus (e.g., A. aculeatus, A. awamori, A. chevalieri, A.
- Chrysosporium e.g., C. inops, C. keratinophilum, C. lucknowense, C. merdarium, C. pannicola, C. queenslandicum, C. tropicum, C. zonatum
- Colletotrichum e.g., C. graminicola
- Coprinopsis e.g., C. cinereus
- Coprinus e.g., C. cinereus
- Coriolus e.g., C. hirsutus
- Cryphonectria e.g., C. parasitica
- Cryptococcus Evansstolkia (e.g., E.
- leycettana Filibasidium, Fusarium (e.g., F. bactridioides, F. cerealis, F. crookwellense, F. culmorum, F. graminearum, F. graminum, F. heterosporum, F. longipes, F. negundi, F. oxysporum, F. reticulatum, F. roseum, F. sambucinum, F. sarcochroum, F. solani, F. sporotrichioides, F. sulphureum, F. torulosum, F. trichothecioides, F. venenatum), Humicola (e.g., H. insolens, H.
- Fusarium e.g., F. bactridioides, F. cerealis, F. crookwellense, F. culmorum, F. graminearum, F. graminum, F. heterosporum, F. long
- M. nivale e.g., M. nivale
- Mucor e.g., M. miehei
- Myceliophthora e.g., M. thermophila
- Neocallimastix Neurospora (e.g., Neurospora crassa), Ostropa (e.g., O. barbara), Paecilomyces
- Penicillium e.g., P. emersonii, P. purpurogenum, P. thomii, P. viridicatum
- Phanerochaete e.g., P.
- Phlebia e.g., Phlebia radiata
- Piromyces Pleurotus (e.g., Pleurotus eryngii), Pseudoplectania (e.g., P. vogesiaca), Schizophyllum, Sodiomyces (e.g., S. alcalophilus), Stenocarpella (e.g., S. maydis), Talaromyces (e.g., T. bacillisporus, T. emersonii, T. pinophilus), Thermoascus (e.g., T. aurantiacus), Themochaetoides (e.g., T.
- thermophila Thermomyces (e.g., T. lanuginosus), Thermothielavioides (e.g., T. terrestris), Thermothelomyces (e.g., T. thermophilus), Thielavia (e.g., T. terrestris), Tolypocladium, Trametes (e.g., T. hirsuta, T. villosa, T. versicolor), Trichoderma (e.g., T. atroviride, T. harzianum, T. koningii, T. longibrachiatum, T. reesei, T. viride), Trichophaea (e.g., T., T.
- the protein is derived from a yeast, such as Candida, Hansenula, Komagataella (e.g., K. phaffii), Kluyveromyces (e.g., Kluyveromyces lactis), Pichia (e.g., P. pastoris), Saccharomyces (e.g., S. carlsbergensis, S. cerevisiae, S. diastaticus, S. douglasii, S. kluyveri, S. norbensis, S.
- Candida Hansenula
- Komagataella e.g., K. phaffii
- Kluyveromyces e.g., Kluyveromyces lactis
- Pichia e.g., P. pastoris
- Saccharomyces e.g., S. carlsbergensis, S. cerevisiae, S. diastaticus, S. douglasii, S. kluyver
- oviformis a corthelial growth factor (e.g., a corthelial growth factor (BTC), a corthelial growth factor (BTC), or a corthelial growth factor (BTC), a corthelial growth factor (BTC), or a corthelial growth factor (BTC), a corthelial growth factor (BTC), or a corthelial growth factor (BTC), a corthelial growth factor, or Yarrowia lipolytica).
- the proteins may be identified and derived from other sources including microorganisms isolated from nature (e.g., soil, composts, water, etc.) or DNA samples obtained directly from natural materials (e.g., soil, composts, water, etc.) using the above-mentioned probes.
- microorganisms isolated from nature (e.g., soil, composts, water, etc.) or DNA samples obtained directly from natural materials (e.g., soil, composts, water, etc.) using the above-menti
- a polynucleotide encoding the protein may then be obtained by similarly screening a genomic DNA or cDNA library of another microorganism or mixed DNA sample. Once a polynucleotide encoding a protein has been detected with the probe(s), the polynucleotide can be isolated or cloned by utilizing techniques that are known to those of ordinary skill in the art (see, e.g., Davis et al., 2012, Basic Methods in Molecular Biology, Elsevier). Proteins of the present disclosure may likewise be derived from plants of any genus.
- the protein is derived from a plant selected from the families Amaranthaceae (e.g., chard, spinach, sugar beet, quinoa), Asteraceae (e.g., artichoke, asters, chamomile, chicory, chrysanthemums, dahlias, daisies, echinacea, goldenrod, guayule, lettuce, marigolds, safflower, sunflowers, zinnias), Brassicaceae (e.g., arugula, broccoli, bok choy, Brussels sprouts, cabbage, cauliflower, canola, collard greens, daikon, garden cress, horseradish, kale, mustard, radish, rapeseed, rutabaga, turnip, wasabi, watercress, Arabidopsis thaliana), Caricaceae (e.g., papaya), Cucurbitaceae (e.g., cantal
- Proteins of the present disclosure may be produced by and obtained from using any suitable method(s), including, but not limited to, shake flask cultivation and large-scale fermentation (including continuous, batch, fed-batch, solid-state and/or microcarrier-based fermentation) methods.
- the present disclosure extends to methods of producing a protein of the present disclosure, comprising (a) cultivating a cell, which in its wild-type form produces the protein, under conditions conducive for production of the protein; and optionally, (b) recovering the protein.
- the present disclosure also extends to methods of producing a protein of the present disclosure, comprising (a) cultivating a recombinant host cell of the present disclosure under conditions conducive for production of the protein; and optionally, (b) recovering the protein.
- the protein is produced by and obtained from a Gram-negative bacterium, such as Campylobacter, Chryseobacterium (e.g., C. viscerum), Dicytoglomus (e.g., D. thermophilum), Escherichia (e.g., E. coli), Flavobacterium, Fusobacterium, Helicobacter, Ilyobacter, Lysobacter (e.g., L. gummosus), Neisseria, Pseudomonas, Salmonella or Ureaplasma.
- a Gram-positive bacterium such as Alkalihalobacillus (e.g., A. akibai, A.
- Bacillus e.g., B. agaradhaerens, B. alkalophilus, B. amyloliquefaciens, B. brevis, B. circulans, B. clausii, B. coagulans, B. deramificans, B. firmus, B. lautus, B. lentus, B. licheniformis, B. megaterium, B. pumilus, B. stearothermophilus, B. subtilis, B. thuringiensis), Clostridium, Effusibacillus (e.g., E. pohliae), Enterococcus, Geobacillus (e.g., G.
- Lactobacillus Lactococcus, Lederbergia (e.g., L. lenta), Neobacillus (e.g., N. novalis), Nocardiopsis, Oceanobacillus (e.g., O. barbara), Staphylococcus, Streptococcus (e.g., S. equisimilis, S. pyogenes, S. uberis, and S. equi subsp. Zooepidemicus) or Streptomyces (e.g., S. achromogenes, S. avermitilis, S. coelicolor, S. griseus, S.
- S. achromogenes e. achromogenes
- S. avermitilis S. coelicolor
- S. griseus S.
- the protein is produced by and obtained from a fungal cell, such as Acremonium, Acrophialophora (e.g., A. fusispora), Aspergillus (e.g., A. aculeatus, A. awamori, A. chevalieri, A. foetidus, A. fumigatus, A. japonicus, A. nidulans, A. niger, A. niveoglaucus, A. oryzae, A. tubingensis), Aureobasidium, Bjerkandera (e.g., B. adusta, B.
- a fungal cell such as Acremonium, Acrophialophora (e.g., A. fusispora), Aspergillus (e.g., A. aculeatus, A. awamori, A. chevalieri, A. foetidus, A. fumigatus, A. japonicus, A. nidulans
- Ceriporiopsis e.g., C. aneirina, C. caregiea, C. gilvescens, C. pannocinta, C. rivulosa, Ceriporiopsis subrufa, C. subvermispora
- Chaetomium e.g., C. erraticum, C. globosum
- Chrysosporium e.g., C. inops, C. keratinophilum, C. lucknowense, C. merdarium, C. pannicola, C. queenslandicum, C. tropicum, C. zonatum
- Colletotrichum e.g., C.
- Coprinopsis e.g., C. cinereus
- Coprinus e.g., C. cinereus
- Coriolus e.g., C. hirsutus
- Cryphonectria e.g., C. parasitica
- Cryptococcus Evansstolkia (e.g., E. leycettana)
- Filibasidium Fusarium (e.g., F. bactridioides, F. cerealis, F. crookwellense, F. culmorum, F. graminearum, F. graminum, F. heterosporum, F. longipes, F. negundi, F. oxysporum, F.
- reticulatum reticulatum, F. roseum, F. sambucinum, F. sarcochroum, F. solani, F. sporotrichioides, F. sulphureum, F. torulosum, F. trichothecioides, F. venenatum), Humicola (e.g., H. insolens, H. lanuginosa), Magnaporthe, Microdochium (e.g., M. nivale), Mucor (e.g., M. miehei), Myceliophthora (e.g., M. thermophila), Neocallimastix, Neurospora (e.g., Neurospora crassa), Ostropa (e.g., O.
- M. nivale Microdochium
- Mucor e.g., M. miehei
- Myceliophthora e.g., M. thermophila
- Neocallimastix Neurospora (
- Penicillium e.g., P. emersonii, P. purpurogenum, P. thomii, P. viridicatum
- Phanerochaete e.g., P. chrysosporium
- Phlebia e.g., Phlebia radiata
- Piromyces Pleurotus (e.g., Pleurotus eryngii)
- Pseudoplectania e.g., P. vogesiaca
- Schizophyllum Sodiomyces (e.g., S. alcalophilus
- Stenocarpella e.g., S.
- T. bacillisporus e.g., T. bacillisporus, T. emersonii, T. pinophilus
- Thermoascus e.g., T. aurantiacus
- Themochaetoides e.g., T. thermophila
- Thermomyces e.g., T. lanuginosus
- Thermothielavioides e.g., T. terrestris
- Thermothelomyces e.g., T. thermophilus
- Thielavia e.g., T. terrestris
- Tolypocladium Trametes (e.g., T. hirsuta, T. villosa, T.
- Trichoderma e.g., T. atroviride, T. harzianum, T. koningii, T. longibrachiatum, T. reesei, T. viride
- Trichophaea e.g., T. saccata
- Urnula e.g., U. criterium
- the protein is produced by and obtained from a yeast cell, such as Candida, Hansenula, Komagataella (e.g., K. phaffii), Kluyveromyces (e.g., K. lactis), Pichia (e.g., P. pastoris), Saccharomyces (e.g., S.
- the protein is produced by and obtained from a plant cell selected from the families Amaranthaceae (e.g., chard, spinach, sugar beet, quinoa), Asteraceae (e.g., artichoke, asters, chamomile, chicory, chrysanthemums, dahlias, daisies, echinacea, goldenrod, guayule, lettuce, marigolds, safflower, sunflowers, zinnias), Brassicaceae (e.g., arugula, broccoli, bok choy, Brussels sprouts, cabbage, cauliflower, canola, collard greens, daikon, garden cress, horseradish, kale, mustard, radish, rapeseed, rutabaga, turnip, wasabi, watercress, Arabidopsis thaliana), Caricaceae (e.g., papaya), Cucurbitaceae (e.g., papaya
- Cells may be cultivated in a nutrient medium suitable for production of the protein using methods known in the art.
- the cell may be cultivated by shake flask cultivation, or small-scale or large- scale fermentation (including continuous, batch, fed-batch, or solid-state, and/or microcarrier-based fermentations) in laboratory or industrial fermentors in a suitable medium and under conditions allowing the protein to be expressed and/or isolated.
- Suitable media are available from commercial suppliers or may be prepared according to published compositions (e.g., in catalogues of the American Type Culture Collection). If the protein is secreted into the nutrient medium, the protein can be recovered directly from the medium. If the protein is not secreted, it can be recovered from cell lysates.
- the protein may be detected using methods known in the art that are specific for the protein, including, but not limited to, the use of specific antibodies, formation of an enzyme product, disappearance of an enzyme substrate, or an assay determining the relative or specific activity of the protein.
- the protein may be recovered from the medium using methods known in the art, including, but not limited to, collection, centrifugation, filtration, extraction, spray-drying, evaporation, or precipitation.
- a whole fermentation broth comprising the protein is recovered.
- a cell-free fermentation broth comprising the protein is recovered.
- the protein is secreted extracellularly.
- the protein is isolated.
- the protein is purified.
- the protein may be purified by a variety of procedures known in the art to obtain substantially pure proteins and/or protein fragments (see, e.g., Wingfield, 2015, Current Protocols in Protein Science; 80(1): 6.1.1-6.1.35; Labrou, 2014, Protein Downstream Processing, 1129: 3-10). In an alternative aspect, the protein is not recovered.
- the present disclosure also provides cells that naturally express native proteins of the present disclosure and cells that have been engineered to express heterologous proteins of the present disclosure (e.g., recombinant host cells comprising a polynucleotide of the present disclosure operably linked to one or more control sequences that direct the production of a protein of the present disclosure), as well as tools and methods for producing such recombinant host cells, including polynucleotides encoding proteins of the present disclosure and nucleic acid constructs comprising such polynucleotides.
- the cell is a Gram-negative bacterium, such as Campylobacter, Chryseobacterium (e.g., C. viscerum), Dicytoglomus (e.g., D.
- thermophilum Escherichia (e.g., E. coli), Flavobacterium, Fusobacterium, Helicobacter, Ilyobacter, Lysobacter (e.g., L. gummosus), Neisseria, Pseudomonas, Salmonella or Ureaplasma.
- the cell is a Gram-positive bacterium, such as Alkalihalobacillus (e.g., A. akibai, A. clausii), Bacillus (e.g., B. agaradhaerens, B. alkalophilus, B. amyloliquefaciens, B. brevis, B. circulans, B. clausii, B. coagulans, B.
- Alkalihalobacillus e.g., A. akibai, A. clausii
- Bacillus e.g., B. agaradhaerens, B. alkalophilus, B. amyloliquefaciens
- the cell is a fungal cell, such as Acremonium, Acrophialophora (e.g., A. fusispora), Aspergillus (e.g., A.
- aculeatus A. awamori, A. chevalieri, A. foetidus, A. fumigatus, A. japonicus, A. nidulans, A. niger, A. niveoglaucus, A. oryzae, A. tubingensis
- Aureobasidium Bjerkandera (e.g., B. adusta, B. fumosa)
- Ceriporiopsis e.g., C. aneirina, C. caregiea, C. gilvescens, C. pannocinta, C. rivulosa, Ceriporiopsis subrufa, C.
- Chaetomium e.g., C. erraticum, C. globosum
- Chrysosporium e.g., C. inops, C. keratinophilum, C. lucknowense, C. merdarium, C. pannicola, C. queenslandicum, C. tropicum, C. zonatum
- Colletotrichum e.g., C. graminicola
- Coprinopsis e.g., C. cinereus
- Coprinus e.g., C. cinereus
- Coriolus e.g., C. hirsutus
- Cryphonectria e.g., C.
- F. bactridioides e.g., F. bactridioides, F. cerealis, F. crookwellense, F. culmorum, F. graminearum, F. graminum, F. heterosporum, F. longipes, F. negundi, F. oxysporum, F. reticulatum, F. roseum, F. sambucinum, F. sarcochroum, F. solani, F. sporotrichioides, F. sulphureum, F. torulosum, F. trichothecioides, F.
- Fusarium e.g., F. bactridioides, F. cerealis, F. crookwellense, F. culmorum, F. graminearum, F. graminum, F. heterosporum, F. longipes, F. negundi, F. oxysporum, F. reticulatum, F. roseum, F.
- Humicola e.g., H. insolens, H. lanuginosa
- Magnaporthe Microdochium (e.g., M. nivale), Mucor (e.g., M. miehei), Myceliophthora (e.g., M. thermophila), Neocallimastix, Neurospora (e.g., Neurospora crassa), Ostropa (e.g., O. barbara), Paecilomyces, Penicillium (e.g., P. emersonii, P. purpurogenum, P. thomii, P. viridicatum), Phanerochaete (e.g., P.
- Phlebia e.g., Phlebia radiata
- Piromyces Pleurotus (e.g., Pleurotus eryngii), Pseudoplectania (e.g., P. vogesiaca), Schizophyllum, Sodiomyces (e.g., S. alcalophilus), Stenocarpella (e.g., S. maydis), Talaromyces (e.g., T. bacillisporus, T. emersonii, T. pinophilus), Thermoascus (e.g., T. aurantiacus), Themochaetoides (e.g., T.
- thermophila Thermomyces (e.g., T. lanuginosus), Thermothielavioides (e.g., T. terrestris), Thermothelomyces (e.g., T. thermophilus), Thielavia (e.g., T. terrestris), Tolypocladium, Trametes (e.g., T. hirsuta, T. villosa, T. versicolor), Trichoderma (e.g., T. atroviride, T. harzianum, T. koningii, T. longibrachiatum, T. reesei, T. viride), Trichophaea (e.g., T., T.
- the cell is a yeast cell, such as Candida, Hansenula, Komagataella (e.g., K. phaffii), Kluyveromyces (e.g., Kluyveromyces lactis), Pichia (e.g., P. pastoris), Saccharomyces (e.g., S. carlsbergensis, S. cerevisiae, S. diastaticus, S. douglasii, S. kluyveri, S. norbensis, S.
- Candida Hansenula
- Komagataella e.g., K. phaffii
- Kluyveromyces e.g., Kluyveromyces lactis
- Pichia e.g., P. pastoris
- Saccharomyces e.g., S. carlsbergensis, S. cerevisiae, S. diastaticus, S. douglasii, S. kluyveri,
- the cell is a plant cell, optionally a plant cell selected from the families Amaranthaceae (e.g., chard, spinach, sugar beet, quinoa), Asteraceae (e.g., artichoke, asters, chamomile, chicory, chrysanthemums, dahlias, daisies, echinacea, goldenrod, guayule, lettuce, marigolds, safflower, sunflowers, zinnias), Brassicaceae (e.g., arugula, broccoli, bok choy, Brussels sprouts, cabbage, cauliflower, canola, collard greens, daikon, garden cress, horseradish, kale, mustard, radish, rapeseed, rutabaga, turnip, wasabi,
- Amaranthaceae e.g., chard, spinach, sugar beet, quinoa
- Asteraceae e.g.
- the cell expresses: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86,
- the cell expresses a polypeptide that comprises, consists essentially of or consists of the amino acid sequence of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof. In some embodiments, the cell expresses a polypeptide that comprises, consists essentially of or consists of a fragment of one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof.
- the microorganism may express a fragment of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof, said fragment comprising at least 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99 % of the amino acids found in the original protein.
- the cell expresses a polypeptide that comprises, consists essentially of or consists of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof with an N-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), a C-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more substitutions), one or more insertions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more insertions), and/or one or more deletions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more
- amino acid changes may be of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of 1-30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino-terminal methionine residue; a small linker peptide of up to 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding module.
- the cell comprises a homologous or heterologous nucleic acid sequence that is at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the nucleic acid sequences set forth herein as SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA sequence thereof.
- the cell comprises a polynucleotide encodes a polypeptide that comprises, consists essentially of or consists of the amino acid sequence of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof.
- the cell comprises a polynucleotide that comprises, consists essentially of or consists of a nucleic acid sequence encoding a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149.
- the cell comprises a polynucleotide that comprises, consists essentially of or consists of a nucleic acid sequence encoding a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149.
- the cell comprises a polynucleotide that comprises, consists essentially of or consists of the nucleic acid sequence of any one of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or a cDNA sequence thereof.
- the cell comprises a polynucleotide that encodes a polypeptide that comprises, consists essentially of or consists of a fragment of one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof.
- the microorganism comprises a polynucleotide that encodes a fragment of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof, said fragment comprising at least 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99 % of the amino acids found in the original protein.
- the cell comprises a polynucleotide that encodes a polypeptide that comprises, consists essentially of or consists of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof with an N-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), a C-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more substitutions), one or more insertions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more insertions), and/or one or more deletions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12,
- amino acid changes may be of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of 1-30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino- terminal methionine residue; a small linker peptide of up to 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding module.
- the present disclosure thus encompasses plants and plant parts expressing one or more proteins of the present disclosure, including plants and plant parts that have been engineered to (over)express one or more proteins of the present disclosure, as well as methods producing proteins of the present disclosure comprising cultivating a (transgenic) plant or a plant part comprising a polynucleotide that encodes the protein under conditions conducive for production of the protein, and, optionally, recovering the protein.
- plants may be used as is to enhance one or more food/feed characteristics (e.g., improve nutritional value, palatability and/or rheological properties, destroy an antinutritive factor, etc.).
- the plant expresses: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86,
- the plant expresses a polypeptide that comprises, consists essentially of or consists of the amino acid sequence of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof.
- the plant expresses a polypeptide that comprises, consists essentially of or consists of a fragment of one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof.
- the microorganism may express a fragment of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof, said fragment comprising at least 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99 % of the amino acids found in the original protein.
- the plant expresses a polypeptide that comprises, consists essentially of or consists of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof with an N-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), a C-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more substitutions), one or more insertions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more insertions), and/or one or more deletions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more
- amino acid changes may be of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of 1-30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino-terminal methionine residue; a small linker peptide of up to 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding module.
- the plant comprises a homologous or heterologous nucleic acid sequence that is at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the nucleic acid sequences set forth herein as SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA sequence thereof.
- the plant comprises a polynucleotide encodes a polypeptide that comprises, consists essentially of or consists of the amino acid sequence of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof.
- the plant comprises a polynucleotide that comprises, consists essentially of or consists of a nucleic acid sequence encoding a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149.
- the plant comprises a polynucleotide that comprises, consists essentially of or consists of a nucleic acid sequence encoding a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149.
- the plant comprises a polynucleotide that comprises, consists essentially of or consists of the nucleic acid sequence of any one of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or a cDNA sequence thereof.
- the plant comprises a polynucleotide that encodes a polypeptide that comprises, consists essentially of or consists of a fragment of one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof.
- the microorganism comprises a polynucleotide that encodes a fragment of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof, said fragment comprising at least 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99 % of the amino acids found in the original protein.
- the plant comprises a polynucleotide that encodes a polypeptide that comprises, consists essentially of or consists of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof with an N-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), a C-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more substitutions), one or more insertions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more insertions), and/or one or more deletions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12,
- the amino acid changes may be of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of 1-30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino- terminal methionine residue; a small linker peptide of up to 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding module. Also included within the scope of the present disclosure are the progeny of such plants, plant parts, and plant cells.
- the present disclosure extends to tools and methods for producing such recombinant host cells that express one or more proteins of the present disclosure, including polynucleotides encoding proteins of the present disclosure and nucleic acid constructs comprising such polynucleotides.
- the present disclosure provides polynucleotides encoding proteins of the present disclosure, including, but not limited to, nucleic acid constructs and recombinant expression vectors that encode one or more enzymes of the present disclosure, as well as methods of producing such polynucleotides.
- the polynucleotide may be a genomic DNA, a cDNA, a synthetic DNA, a synthetic RNA, a mRNA, or a combination thereof.
- the polynucleotide may be cloned from any suitable genus, species or strain.
- the protein is cloned from a Gram-negative bacterium, such as Campylobacter, Chryseobacterium (e.g., C. viscerum), Dicytoglomus (e.g., D. thermophilum), Escherichia (e.g., E. coli), Flavobacterium, Fusobacterium, Helicobacter, Ilyobacter, Lysobacter (e.g., L. gummosus), Neisseria, Pseudomonas, Salmonella or Ureaplasma.
- Campylobacter Chryseobacterium (e.g., C. viscerum), Dicytoglomus (e.g., D. thermophilum), Escherichia (e.g., E. coli), Flavobacterium, Fusobacterium, Helicobacter, Ilyobacter, Lysobacter (e.g., L. gum
- the polynucleotide is cloned from a Gram-positive bacterium, such as Alkalihalobacillus (e.g., A. akibai, A. clausii), Bacillus (e.g., B. agaradhaerens, B. alkalophilus, B. amyloliquefaciens, B. brevis, B. circulans, B. clausii, B. coagulans, B. deramificans, B. firmus, B. lautus, B. lentus, B. licheniformis, B. megaterium, B. pumilus, B. stearothermophilus, B. subtilis, B.
- Alkalihalobacillus e.g., A. akibai, A. clausii
- Bacillus e.g., B. agaradhaerens, B. alkalophilus, B. amyloliquefaciens, B. brevis, B
- Clostridium Clostridium, Effusibacillus (e.g., E. pohliae), Enterococcus, Geobacillus (e.g., G. stearothermophilus), Lactobacillus, Lactococcus, Lederbergia (e.g., L. lenta), Neobacillus (e.g., N. novalis), Nocardiopsis, Oceanobacillus (e.g., O. barbara), Staphylococcus, Streptococcus (e.g., S. equisimilis, S. pyogenes, S. uberis, and S. equi subsp.
- Effusibacillus e.g., E. pohliae
- Enterococcus e.g., Geobacillus (e.g., G. stearothermophilus)
- Lactobacillus Lactococcus
- Lederbergia e.g
- the polynucleotide is cloned from a fungus, such as Acremonium, Acrophialophora (e.g., A. fusispora), Aspergillus (e.g., A. aculeatus, A. awamori, A. chevalieri, A. foetidus, A. fumigatus, A. japonicus, A.
- a fungus such as Acremonium, Acrophialophora (e.g., A. fusispora), Aspergillus (e.g., A. aculeatus, A. awamori, A. chevalieri, A. foetidus, A. fumigatus, A. japonicus, A.
- nidulans A. niger, A. niveoglaucus, A. oryzae, A. tubingensis
- Aureobasidium Bjerkandera (e.g., B. adusta, B. fumosa)
- Ceriporiopsis e.g., C. aneirina, C. caregiea, C. gilvescens, C. pannocinta, C. rivulosa, Ceriporiopsis subrufa, C. subvermispora
- Chaetomium e.g., C. erraticum, C. globosum
- Chrysosporium e.g., C. inops, C.
- keratinophilum C. lucknowense, C. merdarium, C. pannicola, C. queenslandicum, C. tropicum, C. zonatum
- Colletotrichum e.g., C. graminicola
- Coprinopsis e.g., C. cinereus
- Coprinus e.g., C. cinereus
- Coriolus e.g., C. hirsutus
- Cryphonectria e.g., C. parasitica
- Cryptococcus Evansstolkia (e.g., E. leycettana)
- Filibasidium Fusarium (e.g., F. bactridioides, F. cerealis, F.
- miehei Myceliophthora (e.g., M. thermophila), Neocallimastix, Neurospora (e.g., Neurospora crassa), Ostropa (e.g., O. barbara), Paecilomyces, Penicillium (e.g., P. emersonii, P. purpurogenum, P. thomii, P. viridicatum), Phanerochaete (e.g., P.
- Phlebia e.g., Phlebia radiata
- Piromyces Pleurotus (e.g., Pleurotus eryngii), Pseudoplectania (e.g., P. vogesiaca), Schizophyllum, Sodiomyces (e.g., S. alcalophilus), Stenocarpella (e.g., S. maydis), Talaromyces (e.g., T. bacillisporus, T. emersonii, T. pinophilus), Thermoascus (e.g., T. aurantiacus), Themochaetoides (e.g., T.
- thermophila Thermomyces (e.g., T. lanuginosus), Thermothielavioides (e.g., T. terrestris), Thermothelomyces (e.g., T. thermophilus), Thielavia (e.g., T. terrestris), Tolypocladium, Trametes (e.g., T. hirsuta, T. villosa, T. versicolor), Trichoderma (e.g., T. atroviride, T. harzianum, T. koningii, T. longibrachiatum, T. reesei, T. viride), Trichophaea (e.g., T., T.
- the polynucleotide is cloned from a yeast, such as Candida, Hansenula, Komagataella (e.g., K. phaffii), Kluyveromyces (e.g., K. lactis), Pichia (e.g., P. pastoris), Saccharomyces (e.g., S. carlsbergensis, S. cerevisiae, S. diastaticus, S. douglasii, S. kluyveri, S. norbensis, S.
- Candida Hansenula
- Komagataella e.g., K. phaffii
- Kluyveromyces e.g., K. lactis
- Pichia e.g., P. pastoris
- Saccharomyces e.g., S. carlsbergensis, S. cerevisiae, S. diastaticus, S. douglasii, S. kluy
- the polynucleotide is cloned from a plant cell selected from the families Amaranthaceae (e.g., chard, spinach, sugar beet, quinoa), Asteraceae (e.g., artichoke, asters, chamomile, chicory, chrysanthemums, dahlias, daisies, echinacea, goldenrod, guayule, lettuce, marigolds, safflower, sunflowers, zinnias), Brassicaceae (e.g., arugula, broccoli, bok choy, Brussels sprouts, cabbage, cauliflower, canola, collard greens, daikon, garden cress, horseradish, kale, mustard, radish, rapeseed, rutabaga, turnip,
- Amaranthaceae e.g., chard, spinach, sugar beet, quinoa
- Asteraceae e.
- the polynucleotide encodes: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85
- the polynucleotide encodes a polypeptide that comprises, consists essentially of or consists of the amino acid sequence of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof.
- the polynucleotide comprises, consists essentially of or consists of a nucleic acid sequence having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA sequence thereof;
- the polynucleotide comprises, consists essentially of or consists of the nucleic acid sequence of any one of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or a cDNA sequence thereof.
- the polynucleotide encodes a polypeptide that comprises, consists essentially of or consists of a fragment of one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof.
- the polynucleotide may encode a fragment of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof, said fragment comprising at least 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99 % of the amino acids found in the original protein.
- polynucleotides of the present disclosure encode a polypeptide that comprises, consists essentially of or consists of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof with an N-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), a C-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more substitutions), one or more insertions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more insertions), and/or one or more deletions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 11, 12, 13, 14,
- amino acid changes may be of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of 1-30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino- terminal methionine residue; a small linker peptide of up to 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding module.
- Polynucleotides of the present disclosure may be mutated by introduction of nucleotide substitutions that do not result in a change in the amino acid sequence of the protein, but which correspond to the codon usage of the host organism intended for production of the enzyme, or by introduction of nucleotide substitutions that may give rise to a different amino acid sequence.
- nucleotide substitutions see, e.g., Ford et al., 1991, Protein Expression and Purification 2: 95-107.
- the polynucleotide is isolated.
- the polynucleotide is purified.
- the present disclosure also provides nucleic acid constructs comprising a polynucleotide of the present disclosure, wherein the polynucleotide is operably linked to one or more control sequences that direct the expression of the coding sequence in a suitable host cell under conditions compatible with the control sequences.
- the polynucleotide may be manipulated in a variety of ways to provide for expression of the protein. Manipulation of the polynucleotide prior to its insertion into a vector may be desirable or necessary depending on the expression vector. Techniques for modifying polynucleotides utilizing recombinant DNA methods are well known in the art.
- the control sequence may be a promoter, a polynucleotide that is recognized by a host cell for expression of a polynucleotide encoding a protein of the present disclosure.
- the promoter contains transcriptional control sequences that mediate the expression of the protein.
- the promoter may be any polynucleotide that shows transcriptional activity in the host cell including mutant, truncated, and hybrid promoters, and may be obtained from genes encoding extracellular or intracellular proteins either homologous or heterologous to the host cell.
- Suitable promoters for directing transcription of the polynucleotide of the present disclosure in a bacterial host cell are described in Sambrook et al., 1989, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Lab., NY, Davis et al., 2012, supra, and Song et al., 2016, PLOS One 11(7): e0158447.
- promoters for directing transcription of the polynucleotide of the present disclosure in a filamentous fungal host cell are promoters obtained from Aspergillus, Fusarium, Rhizomucor and Trichoderma cells, such as the promoters described in Mukherjee et al., 2013, “Trichoderma: Biology and Applications”, and by Schmoll and Dattenböck, 2016, “Gene Expression Systems in Fungi: Advancements and Applications”, Fungal Biology.
- control sequence may also be a transcription terminator, which is recognized by a host cell to terminate transcription.
- the terminator is operably linked to the 3’-terminus of the polynucleotide encoding the protein. Any terminator that is functional in the host cell may be used in the present disclosure.
- Preferred terminators for bacterial host cells may be obtained from the genes for Bacillus clausii alkaline protease (aprH), Bacillus licheniformis alpha-amylase (amyL), and Escherichia coli ribosomal RNA (rrnB).
- aprH Bacillus clausii alkaline protease
- AmyL Bacillus licheniformis alpha-amylase
- rrnB Escherichia coli ribosomal RNA
- Preferred terminators for filamentous fungal host cells may be obtained from Aspergillus or Trichoderma species, such as obtained from the genes for Aspergillus niger glucoamylase, Trichoderma reesei beta-glucosidase, Trichoderma reesei cellobiohydrolase I, and Trichoderma reesei endoglucanase I, such as the terminators described in Mukherjee et al., 2013, “Trichoderma: Biology and Applications”, and by Schmoll and Dattenböck, 2016, “Gene Expression Systems in Fungi: Advancements and Applications”, Fungal Biology.
- Preferred terminators for yeast host cells may be obtained from the genes for Saccharomyces cerevisiae enolase, Saccharomyces cerevisiae cytochrome C (CYC1), and Saccharomyces cerevisiae glyceraldehyde- 3-phosphate dehydrogenase. Other useful terminators for yeast host cells are described by Romanos et al., 1992, Yeast 8: 423-488.
- the control sequence may also be an mRNA stabilizer region downstream of a promoter and upstream of the coding sequence of a gene which increases expression of the gene.
- mRNA stabilizer regions are obtained from a Bacillus thuringiensis cryIIIA gene (WO 94/25612) and a Bacillus subtilis SP82 gene (Hue et al., 1995, J. Bacteriol.177: 3465-3471).
- mRNA stabilizer regions for fungal cells are described in Geisberg et al., 2014, Cell 156(4): 812-824, and in Morozov et al., 2006, Eukaryotic Cell 5(11): 1838-1846.
- the control sequence may also be a leader, a non-translated region of an mRNA that is important for translation by the host cell.
- the leader is operably linked to the 5’-terminus of the polynucleotide encoding the protein.
- Any leader that is functional in the host cell may be used. Suitable leaders for bacterial host cells are described by Hambraeus et al., 2000, Microbiology 146(12): 3051-3059, and by Kaberdin and Bläsi, 2006, FEMS Microbiol. Rev.30(6): 967-979.
- Preferred leaders for filamentous fungal host cells may be obtained from the genes for Aspergillus oryzae TAKA amylase and Aspergillus nidulans triose phosphate isomerase.
- Suitable leaders for yeast host cells may be obtained from the genes for Saccharomyces cerevisiae enolase (ENO-1), Saccharomyces cerevisiae 3-phosphoglycerate kinase, Saccharomyces cerevisiae alpha- factor, and Saccharomyces cerevisiae alcohol dehydrogenase/glyceraldehyde-3-phosphate dehydrogenase (ADH2/GAP).
- the control sequence may also be a polyadenylation sequence, a sequence operably linked to the 3’-terminus of the polynucleotide which, when transcribed, is recognized by the host cell as a signal to add polyadenosine residues to transcribed mRNA.
- polyadenylation sequence that is functional in the host cell may be used.
- Preferred polyadenylation sequences for filamentous fungal host cells are obtained from the genes for Aspergillus nidulans anthranilate synthase, Aspergillus niger glucoamylase, Aspergillus niger alpha- glucosidase, Aspergillus oryzae TAKA amylase, and Fusarium oxysporum trypsin-like protease.
- Useful polyadenylation sequences for yeast host cells are described by Guo and Sherman, 1995, Mol. Cellular Biol.15: 5983-5990.
- the control sequence may also be a signal peptide coding region that encodes a signal peptide linked to the N-terminus of a protein and directs the protein into the cell’s secretory pathway.
- the 5’-end of the coding sequence of the polynucleotide may inherently contain a signal peptide coding sequence naturally linked in translation reading frame with the segment of the coding sequence that encodes the protein.
- the 5’-end of the coding sequence may contain a signal peptide coding sequence that is heterologous to the coding sequence.
- a heterologous signal peptide coding sequence may be required where the coding sequence does not naturally contain a signal peptide coding sequence.
- a heterologous signal peptide coding sequence may simply replace the natural signal peptide coding sequence to enhance secretion of the protein. Any signal peptide coding sequence that directs the expressed protein into the secretory pathway of a host cell may be used.
- Effective signal peptide coding sequences for bacterial host cells are the signal peptide coding sequences obtained from the genes for Bacillus NCIB 11837 maltogenic amylase, Bacillus licheniformis subtilisin, Bacillus licheniformis beta-lactamase, Bacillus stearothermophilus alpha-amylase, Bacillus stearothermophilus neutral proteases (nprT, nprS, nprM), and Bacillus subtilis prsA. Further signal peptides are described by Freudl, 2018, Microbial Cell Factories 17: 52.
- Effective signal peptide coding sequences for filamentous fungal host cells are the signal peptide coding sequences obtained from the genes for Aspergillus niger neutral amylase, Aspergillus niger glucoamylase, Aspergillus oryzae TAKA amylase, Humicola insolens cellulase, Humicola insolens endoglucanase V, Humicola lanuginosa lipase, and Rhizomucor miehei aspartic proteinase, such as the signal peptide described by Xu et al., 2018, Biotechnology Letters 40: 949-955
- Useful signal peptides for yeast host cells are obtained from the genes for Saccharomyces cerevisiae alpha-factor and Saccharomyces cerevisiae invertase.
- the control sequence may also be a propeptide coding sequence that encodes a propeptide positioned at the N-terminus of a protein.
- the resultant protein is known as a proenzyme or proprotein (or a zymogen in some cases).
- a proprotein is generally inactive and can be converted to an active protein by catalytic or autocatalytic cleavage of the propeptide from the proprotein.
- the propeptide coding sequence may be obtained from the genes for Bacillus subtilis alkaline protease (aprE), Bacillus subtilis neutral protease (nprT), Myceliophthora thermophila laccase (WO 95/33836), Rhizomucor miehei aspartic proteinase, and Saccharomyces cerevisiae alpha-factor. Where both signal peptide and propeptide sequences are present, the propeptide sequence is positioned next to the N-terminus of a protein and the signal peptide sequence is positioned next to the N-terminus of the propeptide sequence.
- the protein may comprise only a part of the signal peptide sequence and/or only a part of the propeptide sequence.
- the final or isolated protein may comprise a mixture of mature proteins and proteins which comprise, either partly or in full length, a propeptide sequence and/or a signal peptide sequence.
- regulatory sequences are those that cause expression of the gene to be turned on or off in response to a chemical or physical stimulus, including the presence of a regulatory compound. Regulatory sequences in prokaryotic systems include the lac, tac, and trp operator systems.
- the ADH2 system or GAL1 system may be used.
- filamentous fungi the Aspergillus niger glucoamylase promoter, Aspergillus oryzae TAKA alpha-amylase promoter, and Aspergillus oryzae glucoamylase promoter, Trichoderma reesei cellobiohydrolase I promoter, and Trichoderma reesei cellobiohydrolase II promoter may be used.
- Other examples of regulatory sequences are those that allow for gene amplification.
- these regulatory sequences include the dihydrofolate reductase gene that is amplified in the presence of methotrexate, and the metallothionein genes that are amplified with heavy metals.
- the control sequence may also be a transcription factor, a polynucleotide encoding a polynucleotide- specific DNA-binding protein that controls the rate of the transcription of genetic information from DNA to mRNA by binding to a specific polynucleotide sequence.
- the transcription factor may function alone and/or together with one or more other proteins or transcription factors in a complex by promoting or blocking the recruitment of RNA polymerase.
- Transcription factors are characterized by comprising at least one DNA- binding domain which often attaches to a specific DNA sequence adjacent to the genetic elements which are regulated by the transcription factor.
- the transcription factor may regulate the expression of a protein of interest either directly, i.e., by activating the transcription of the gene encoding the protein of interest by binding to its promoter, or indirectly, i.e., by activating the transcription of a further transcription factor which regulates the transcription of the gene encoding the protein of interest, such as by binding to the promoter of the further transcription factor.
- Suitable transcription factors for fungal host cells are described in WO 2017/144177.
- Suitable transcription factors for prokaryotic host cells are described in Seshasayee et al., 2011, Subcellular Biochemistry 52: 7-23, as well in Balleza et al., 2009, FEMS Microbiol. Rev.33(1): 133-151.
- the present disclosure also provides recombinant expression vectors comprising a polynucleotide of the present disclosure, a promoter, and transcriptional and translational stop signals.
- the various nucleotide and control sequences may be joined together to produce a recombinant expression vector that may include one or more convenient restriction sites to allow for insertion or substitution of the polynucleotide encoding the protein at such sites.
- the polynucleotide may be expressed by inserting the polynucleotide or a nucleic acid construct comprising the polynucleotide into an appropriate vector for expression.
- the coding sequence is located in the vector so that the coding sequence is operably linked with the appropriate control sequences for expression.
- the recombinant expression vector may be any vector (e.g., a plasmid or virus) that can be conveniently subjected to recombinant DNA procedures and can bring about expression of the polynucleotide.
- the choice of the vector will typically depend on the compatibility of the vector with the host cell into which the vector is to be introduced.
- the vector may be a linear or closed circular plasmid.
- the vector may be an autonomously replicating vector, i.e., a vector that exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g., a plasmid, an extrachromosomal element, a minichromosome, or an artificial chromosome.
- the vector may contain any means for assuring self-replication.
- the vector may be one that, when introduced into the host cell, is integrated into the genome and replicated together with the chromosome(s) into which it has been integrated.
- a single vector or plasmid or two or more vectors or plasmids that together contain the total DNA to be introduced into the genome of the host cell, or a transposon may be used.
- the vector preferably contains one or more selectable markers that permit easy selection of transformed, transfected, transduced, or the like cells.
- a selectable marker is a gene the product of which provides for biocide or viral resistance, resistance to heavy metals, prototrophy to auxotrophs, and the like.
- the vector preferably contains at least one element that permits integration of the vector into the host cell's genome or autonomous replication of the vector in the cell independent of the genome.
- the vector may rely on the polynucleotide’s sequence encoding the protein or any other element of the vector for integration into the genome by homologous recombination, such as homology-directed repair (HDR), or non-homologous recombination, such as non- homologous end-joining (NHEJ).
- the vector may further comprise an origin of replication enabling the vector to replicate autonomously in the host cell in question.
- the origin of replication may be any plasmid replicator mediating autonomous replication that functions in a cell.
- the term “origin of replication” or “plasmid replicator” means a polynucleotide that enables a plasmid or vector to replicate in vivo.
- More than one copy of a polynucleotide of the present disclosure may be inserted into a host cell to increase production of a protein. For example, 2 or 3 or 4 or 5 or more copies are inserted into a host cell.
- An increase in the copy number of the polynucleotide can be obtained by integrating at least one additional copy of the sequence into the host cell genome or by including an amplifiable selectable marker gene with the polynucleotide where cells containing amplified copies of the selectable marker gene, and thereby additional copies of the polynucleotide, can be selected for by cultivating the cells in the presence of the appropriate selectable agent.
- the present disclosure also provides methods for producing recombinant host cells comprising a polynucleotide of the present disclosure operably linked to one or more control sequences that direct the production of a protein of the present disclosure.
- a construct or vector comprising a polynucleotide is introduced into a host cell so that the construct or vector is maintained as a chromosomal integrant or as a self-replicating extra-chromosomal vector as described earlier.
- the choice of a host cell will to a large extent depend upon the gene encoding the protein and its source.
- the protein can be native or heterologous to the recombinant host cell.
- at least one of the one or more control sequences can be heterologous to the polynucleotide encoding the protein.
- the recombinant host cell may comprise a single copy, or at least two copies, e.g., three, four, five, or more copies of the polynucleotide of the present disclosure.
- the host cell may be any cell useful in the recombinant production of a protein of the present disclosure, including, not limited to, prokaryotic cells, fungal cells and plant cells, as described above.
- the host cell is isolated.
- the host cell is purified.
- the host cell is a Gram-negative bacterium, such as Campylobacter, Chryseobacterium (e.g., C. viscerum), Dicytoglomus (e.g., D.
- thermophilum Escherichia (e.g., E. coli), Flavobacterium, Fusobacterium, Helicobacter, Ilyobacter, Lysobacter (e.g., L. gummosus), Neisseria, Pseudomonas, Salmonella or Ureaplasma.
- the host cell is a Gram-positive bacterium, such as Alkalihalobacillus (e.g., A. akibai, A. clausii), Bacillus (e.g., B. agaradhaerens, B. alkalophilus, B. amyloliquefaciens, B. brevis, B. circulans, B. clausii, B. coagulans, B.
- Staphylococcus e.g., Staphylococcus, Streptococcus (e.g., S. equisimilis, S. pyogenes, S. uberis, and S. equi subsp. Zooepidemicus) or Streptomyces (e.g., S. achromogenes, S. avermitilis, S. coelicolor, S. griseus, S. lividans), Sutcliffiella (e.g., S. halmapala).
- Streptococcus e.g., S. equisimilis, S. pyogenes, S. uberis, and S. equi subsp. Zooepidemicus
- Streptomyces e.g., S. achromogenes, S. avermitilis, S. coelicolor, S. griseus, S. lividans
- Methods for introducing DNA into prokaryotic host cells are well-known in the art, and any suitable method can be used including but not limited to protoplast transformation, competent cell transformation, electroporation, conjugation, transduction, with DNA introduced as linearized or as circular polynucleotide. Persons skilled in the art will be readily able to identify a suitable method for introducing DNA into a given prokaryotic cell depending, e.g., on the genus. Methods for introducing DNA into prokaryotic host cells are for example described in Heinze et al., 2018, BMC Microbiology 18:56, Burke et al., 2001, Proc. Natl. Acad. Sci.
- the host cell is a fungal cell, such as Acremonium, Acrophialophora (e.g., A. fusispora), Aspergillus (e.g., A. aculeatus, A. awamori, A. chevalieri, A. foetidus, A. fumigatus, A. japonicus, A. nidulans, A. niger, A. niveoglaucus, A. oryzae, A.
- a fungal cell such as Acremonium, Acrophialophora (e.g., A. fusispora), Aspergillus (e.g., A. aculeatus, A. awamori, A. chevalieri, A. foetidus, A. fumigatus, A. japonicus, A. nidulans, A. niger, A. niveoglaucus, A. oryzae, A.
- Acremonium e.g
- tubingensis Aureobasidium, Bjerkandera (e.g., B. adusta, B. fumosa), Ceriporiopsis (e.g., C. aneirina, C. caregiea, C. gilvescens, C. pannocinta, C. rivulosa, Ceriporiopsis subrufa, C. subvermispora), Chaetomium (e.g., C. erraticum, C. globosum), Chrysosporium (e.g., C. inops, C. keratinophilum, C. lucknowense, C. merdarium, C. pannicola, C. queenslandicum, C.
- Bjerkandera e.g., B. adusta, B. fumosa
- Ceriporiopsis e.g., C. aneirina, C. caregiea, C. gilvescens, C. pan
- tropicum C. zonatum
- Colletotrichum e.g., C. graminicola
- Coprinopsis e.g., C. cinereus
- Coprinus e.g., C. cinereus
- Coriolus e.g., C. hirsutus
- Cryphonectria e.g., C. parasitica
- Cryptococcus Evansstolkia (e.g., E. leycettana)
- Filibasidium Fusarium (e.g., F. bactridioides, F. cerealis, F. crookwellense, F. culmorum, F. graminearum, F. graminum, F. heterosporum, F.
- thermophila Neocallimastix
- Neurospora e.g., Neurospora crassa
- Ostropa e.g., O. barbara
- Paecilomyces Penicillium (e.g., P. emersonii, P. purpurogenum, P. thomii, P. viridicatum), Phanerochaete (e.g., P. chrysosporium), Phlebia (e.g., Phlebia radiata), Piromyces, Pleurotus (e.g., Pleurotus eryngii), Pseudoplectania (e.g., P.
- vogesiaca Schizophyllum
- Sodiomyces e.g., S. alcalophilus
- Stenocarpella e.g., S. maydis
- Talaromyces e.g., T. bacillisporus, T. emersonii, T. pinophilus
- Thermoascus e.g., T. aurantiacus
- Themochaetoides e.g., T. thermophila
- Thermomyces e.g., T. lanuginosus
- Thermothielavioides e.g., T. terrestris
- Thermothelomyces e.g., T., T.
- thermophilus Thielavia (e.g., T. terrestris), Tolypocladium, Trametes (e.g., T. hirsuta, T. villosa, T. versicolor), Trichoderma (e.g., T. atroviride, T. harzianum, T. koningii, T. longibrachiatum, T. reesei, T. viride), Trichophaea (e.g., T. saccata), or Urnula (e.g., U. criterium).
- the host cell is a yeast cell, such as Candida, Hansenula, Komagataella (e.g., K.
- Kluyveromyces e.g., Kluyveromyces lactis
- Pichia e.g., P. pastoris
- Saccharomyces e.g., S. carlsbergensis, S. cerevisiae, S. diastaticus, S. douglasii, S. kluyveri, S. norbensis, S. oviformis
- Schizosaccharomyces or Yarrowia (e.g., Yarrowia lipolytica).
- Fungal cells may be transformed by a process involving protoplast-mediated transformation, Agrobacterium-mediated transformation, electroporation, biolistic method and shock-wave-mediated transformation as reviewed by Li et al., 2017, Microbial Cell Factories 16: 168 and procedures described in EP 238023, Yelton et al., 1984, Proc. Natl. Acad. Sci. USA 81: 1470-1474, Christensen et al., 1988, Bio/Technology 6: 1419-1422, and Lubertozzi and Keasling, 2009, Biotechn. Advances 27: 53-75.
- the host cell is a plant cell, optionally a plant cell selected from the families Amaranthaceae (e.g., chard, spinach, sugar beet, quinoa), Asteraceae (e.g., artichoke, asters, chamomile, chicory, chrysanthemums, dahlias, daisies, echinacea, goldenrod, guayule, lettuce, marigolds, safflower, sunflowers, zinnias), Brassicaceae (e.g., arugula, broccoli, bok choy, Brussels sprouts, cabbage, cauliflower, canola, collard greens, daikon, garden cress, horseradish, kale, mustard, radish, rapeseed, rutabaga
- Amaranthaceae e.g., chard, spinach, sugar beet, quinoa
- Asteraceae e.g., artichoke, as
- Transgenic plants and plant cells expressing the protein may be constructed in accordance with methods known in the art.
- the plant or plant cell is constructed by incorporating one or more expression constructs encoding the protein into the plant host genome or chloroplast genome and propagating the resulting modified plant or plant cell into a transgenic plant or plant cell.
- a plant cell does not belong to plant varieties.
- the expression construct is conveniently a nucleic acid construct that comprises a polynucleotide encoding a protein, wherein the polynucleotide is operably linked with appropriate regulatory sequences required for expression of the polynucleotide in the plant or plant part of choice.
- the expression construct may comprise a selectable marker useful for identifying plant cells into which the expression construct has been integrated and DNA sequences necessary for introduction of the construct into the plant in question (the latter depends on the DNA introduction method to be used).
- the choice of regulatory sequences, such as promoter and terminator sequences and optionally signal or transit sequences, is determined, for example, on the basis of when, where, and how the protein is desired to be expressed (Sticklen, 2008, Nature Reviews 9: 433-443).
- the expression of the gene encoding a protein may be constitutive or inducible, or may be developmental, stage or tissue specific, and the gene product may be targeted to a specific tissue or plant part such as seeds or leaves.
- Regulatory sequences are, for example, described by Tague et al., 1988, Plant Physiology 86: 506.
- the 35S-CaMV, the maize ubiquitin 1, or the rice actin 1 promoter may be used (Franck et al., 1980, Cell 21: 285-294; Christensen et al., 1992, Plant Mol. Biol. 18: 675-689; Zhang et al., 1991, Plant Cell 3: 1155-1165).
- Organ-specific promoters may be, for example, a promoter from storage sink tissues such as seeds, potato tubers, and fruits (Edwards and Coruzzi, 1990, Ann. Rev.
- the storage protein napA promoter from Brassica napus, or any other seed specific promoter known in the art, e.g., as described in WO 91/14772.
- the promoter may be a leaf specific promoter such as the rbcs promoter from rice or tomato (Kyozuka et al., 1993, Plant Physiol.102: 991-1000), the chlorella virus adenine methyltransferase gene promoter (Mitra and Higgins, 1994, Plant Mol. Biol.26: 85-93), the aldP gene promoter from rice (Kagaya et al., 1995, Mol. Gen.
- the promoter may be induced by abiotic treatments such as temperature, drought, or alterations in salinity or induced by exogenously applied substances that activate the promoter, e.g., ethanol, oestrogens, plant hormones such as ethylene, abscisic acid, and gibberellic acid, and heavy metals.
- a promoter enhancer element may also be used to achieve higher expression of a protein in the plant.
- the promoter enhancer element may be an intron that is placed between the promoter and the polynucleotide encoding a protein.
- the promoter enhancer element may be an intron that is placed between the promoter and the polynucleotide encoding a protein.
- Xu et al., 1993, supra disclose the use of the first intron of the rice actin 1 gene to enhance expression.
- the selectable marker gene and any other parts of the expression construct may be chosen from those available in the art.
- the nucleic acid construct is incorporated into the plant genome according to conventional techniques known in the art, including Agrobacterium-mediated transformation, virus-mediated transformation, microinjection, particle bombardment, biolistic transformation, and electroporation (Gasser et al., 1990, Science 244: 1293; Potrykus, 1990, Bio/Technology 8: 535; Shimamoto et al., 1989, Nature 338: 274).
- Agrobacterium tumefaciens-mediated gene transfer is a method for generating transgenic dicots (for a review, see Hooykas and Schilperoort, 1992, Plant Mol. Biol. 19: 15-38) and for transforming monocots, although other transformation methods may be used for these plants.
- a method for generating transgenic monocots is particle bombardment (microscopic gold or tungsten particles coated with the transforming DNA) of embryonic calli or developing embryos (Christou, 1992, Plant J.2: 275-281; Shimamoto, 1994, Curr. Opin. Biotechnol. 5: 158-162; Vasil et al., 1992, Bio/Technology 10: 667-674).
- An alternative method for transformation of monocots is based on protoplast transformation as described by Omirulleh et al., 1993, Plant Mol. Biol. 21: 415-428. Additional transformation methods include those described in U.S. Patent Nos. 6,395,966 and 7,151,204 (both of which are herein incorporated by reference in their entirety).
- transgenic plants may be made by crossing a plant having the construct to a second plant lacking the construct.
- a construct encoding a protein can be introduced into a particular plant variety by crossing, without the need for ever directly transforming a plant of that given variety.
- the present disclosure encompasses not only a plant directly regenerated from cells which have been transformed in accordance with the present disclosure, but also the progeny of such plants.
- progeny may refer to the offspring of any generation of a parent plant prepared in accordance with the present disclosure.
- Such progeny may include a DNA construct prepared in accordance with the present disclosure.
- Crossing results in the introduction of a transgene into a plant line by cross pollinating a starting line with a donor plant line. Non- limiting examples of such steps are described in U.S. Patent No.7,151,204.
- Plants may be generated through a process of backcross conversion. For example, plants include plants referred to as a backcross converted genotype, line, inbred, or hybrid.
- Genetic markers may be used to assist in the introgression of one or more transgenes of the disclosure from one genetic background into another. Marker assisted selection offers advantages relative to conventional breeding in that it can be used to avoid errors caused by phenotypic variations. Further, genetic markers may provide data regarding the relative degree of elite germplasm in the individual progeny of a particular cross. For example, when a plant with a desired trait which otherwise has a non-agronomically desirable genetic background is crossed to an elite parent, genetic markers may be used to select progeny which not only possess the trait of interest, but also have a relatively large proportion of the desired germplasm. In this way, the number of generations required to introgress one or more traits into a particular genetic background is minimized.
- the present disclosure encompasses methods of producing a mutant of a parent cell, which comprises disrupting or deleting a polynucleotide, or a portion thereof, encoding a protein of the present disclosure, which results in the mutant cell producing less of the protein than the parent cell when cultivated under the same conditions.
- the mutant cell may be constructed by reducing or eliminating expression of the polynucleotide using methods well known in the art, for example, one or more nucleotide insertions, one or more gene disruptions, one or more nucleotide replacements, or one or more nucleotide deletions.
- the polynucleotide to be modified or inactivated may be, for example, the coding region or a part thereof essential for activity, or a regulatory or control element required for expression of the coding region, e.g., a functional part of a promoter sequence, and/or a regulatory or control element required for the transcription or translation of the polynucleotide.
- Other control sequences for possible modification include, but are not limited to, a leader, polyadenylation sequence, propeptide sequence, signal peptide sequence, transcription terminator, and transcriptional activator. Modification or inactivation of the polynucleotide may be performed by subjecting the parent cell to mutagenesis and selecting for mutant cells in which expression of the polynucleotide has been reduced or eliminated.
- the mutagenesis which may be specific or random, may be performed, for example, by use of a suitable physical or chemical mutagenizing agent, by use of a suitable oligonucleotide, or by subjecting the DNA sequence to PCR generated mutagenesis. Furthermore, the mutagenesis may be performed by use of any combination of these mutagenizing agents.
- a physical or chemical mutagenizing agent include ultraviolet (UV) irradiation, hydroxylamine, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), O-methyl hydroxylamine, nitrous acid, ethyl methane sulphonate (EMS), sodium bisulphite, formic acid, and nucleotide analogues (see J. L.
- nucleotides may be inserted or removed so as to result in the introduction of a stop codon, the removal of the start codon, or a change in the open reading frame.
- modification or inactivation may be accomplished by site-directed mutagenesis or PCR generated mutagenesis in accordance with methods known in the art, or by targeted gene editing using one or more nucleases, e.g., zinc-finger nucleases or CRISPR-associated nucleases.
- the modification or inactivation may be achieved by gene silencing, genetic repression, genetic activation, and/or post-translational mutagenesis, e.g., by methods employing non-coding RNA, RNAi, siRNA, miRNA, ribozymes, catalytically inactive nucleases, CRISPRi, nucleotide methylation, and/or histone acetylation.
- the modification may be transient and/or reversible, irreversible and/or stable, or the modification may be dependent on chemical inducers or dependent on cultivation conditions, such as the cultivation temperature.
- the modification may be performed in vivo, i.e., directly on the cell expressing the polynucleotide to be modified, or the modification be performed in vitro.
- An example of a convenient way to eliminate or reduce expression of a polynucleotide is based on techniques of gene replacement, gene deletion, or gene disruption.
- a nucleic acid sequence corresponding to the endogenous polynucleotide is mutagenized in vitro to produce a defective nucleic acid sequence that is then transformed into the parent cell to produce a defective gene.
- the defective nucleic acid sequence replaces the endogenous polynucleotide.
- the defective polynucleotide also encodes a marker that may be used for selection of transformants in which the polynucleotide has been modified or destroyed.
- the polynucleotide is disrupted with a selectable marker such as those described herein.
- the present disclosure further relates to a mutant cell of a parent cell that comprises a disruption or deletion of a polynucleotide encoding a protein or a control sequence thereof or a silenced gene encoding the protein, which results in the mutant cell producing less of the protein or no protein compared to the parent cell. Protein-deficient mutant cells are useful as host cells for expression of native and heterologous proteins.
- the present disclosure further relates to methods of producing a native or heterologous protein, comprising (a) cultivating a protein-deficient mutant cell under conditions conducive for production of a desired protein (e.g., a protein of the present disclosure); and (b) recovering the desired protein.
- a desired protein e.g., a protein of the present disclosure
- heterologous proteins means proteins that are not native to the host cell, e.g., a variant of a native protein.
- the host cell may comprise more than one copy of a polynucleotide encoding a desired native or heterologous protein.
- the present disclosure relates to a protein product essentially free from [enzyme] activity that is produced by a method of the present disclosure.
- Proteins, polynucleotides and organisms of the present disclosure may be incorporated into any suitable formulation(s), including, but not limited to, formulations comprising one or more seed-compatible carriers, soil-compatible carriers, foliar-compatible carriers, preharvest carriers, and/or postharvest carriers. Selection of appropriate carrier materials will depend on the intended application(s) and the protein(s) to be included in the formulation, as well as any other components that may be present in and/or added to the formulation.
- the carrier is a liquid, a gel, a slurry, or a solid.
- the carrier consists essentially of or consists of one or more protein-stabilizing compounds.
- the present disclosure encompasses granules/particles comprising one or more proteins of the disclosure.
- the granule comprises a core, and optionally one or more coatings (outer layers) surrounding the core.
- the core may have a diameter, measured as equivalent spherical diameter (volume based average particle size), of 20-2000 ⁇ m, particularly 50-1500 ⁇ m, 100-1500 ⁇ m or 250-1200 ⁇ m.
- the core diameter, measured as equivalent spherical diameter can be determined using laser diffraction, such as using a Malvern Mastersizer and/or the method described under ISO13320 (2020).
- the core comprises one or more proteins of the present disclosure.
- the core may include additional materials such as fillers, fiber materials (cellulose or synthetic fibers), stabilizing agents, solubilizing agents, suspension agents, viscosity regulating agents, light spheres, plasticizers, salts, lubricants and fragrances.
- the core may include a binder, such as synthetic polymer, wax, fat, or carbohydrate.
- the core may include a salt of a multivalent cation, a reducing agent, an antioxidant, a peroxide decomposing catalyst and/or an acidic buffer component, typically as a homogenous blend.
- the core may include an inert particle with the protein absorbed into it, or applied onto the surface, e.g., by fluid bed coating.
- the core may have a diameter of 20-2000 ⁇ m, particularly 50-1500 ⁇ m, 100-1500 ⁇ m or 250-1200 ⁇ m.
- the core may be surrounded by at least one coating, e.g., to improve the storage stability, to reduce dust formation during handling, or for coloring the granule.
- the optional coating(s) may include a salt coating, or other suitable coating materials, such as polyethylene glycol (PEG), methyl hydroxy-propyl cellulose (MHPC) and polyvinyl alcohol (PVA).
- PEG polyethylene glycol
- MHPC methyl hydroxy-propyl cellulose
- PVA polyvinyl alcohol
- the coating may be applied in an amount of at least 0.1% by weight of the core, e.g., at least 0.5%, at least 1%, at least 5%, at least 10%, or at least 15%.
- the amount may be at most 100%, 70%, 50%, 40% or 30%.
- the coating is preferably at least 0.1 ⁇ m thick, particularly at least 0.5 ⁇ m, at least 1 ⁇ m or at least 5 ⁇ m. In some embodiments, the thickness of the coating is below 100 ⁇ m, such as below 60 ⁇ m, or below 40 ⁇ m.
- the coating should encapsulate the core unit by forming a substantially continuous layer.
- a substantially continuous layer is to be understood as a coating having few or no holes, so that the core unit has few or no uncoated areas.
- the layer or coating should, in particular, be homogeneous in thickness.
- the coating can further contain other materials as known in the art, e.g., fillers, antisticking agents, pigments, dyes, plasticizers and/or binders, such as titanium dioxide, kaolin, calcium carbonate or talc.
- a salt coating may comprise at least 60% by weight of a salt, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 99% by weight.
- the salt coating is preferably at least 0.1 ⁇ m thick, e.g., at least 0.5 ⁇ m, at least 1 ⁇ m, at least 2 ⁇ m, at least 4 ⁇ m, at least 5 ⁇ m, or at least 8 ⁇ m.
- the thickness of the salt coating is below 100 ⁇ m, such as below 60 ⁇ m, or below 40 ⁇ m.
- the salt may be added from a salt solution where the salt is completely dissolved or from a salt suspension wherein the fine particles are less than 50 ⁇ m, such as less than 10 ⁇ m or less than 5 ⁇ m.
- the salt coating may comprise a single salt or a mixture of two or more salts.
- the salt may be water soluble, in particular, having a solubility at least 0.1 g in 100 g of water at 20°C, preferably at least 0.5 g per 100 g water, e.g., at least 1 g per 100 g water, e.g., at least 5 g per 100 g water.
- the salt may be an inorganic salt, e.g., salts of sulfate, sulfite, phosphate, phosphonate, nitrate, chloride or carbonate or salts of simple organic acids (less than 10 carbon atoms, e.g., 6 or less carbon atoms) such as citrate, malonate or acetate.
- simple organic acids e.g., 6 or less carbon atoms
- Examples of cations in these salts are alkali or earth alkali metal ions, the ammonium ion or metal ions of the first transition series, such as sodium, potassium, magnesium, calcium, zinc or aluminum.
- anions include chloride, bromide, iodide, sulfate, sulfite, bisulfite, thiosulfate, phosphate, monobasic phosphate, dibasic phosphate, hypophosphite, dihydrogen pyrophosphate, tetraborate, borate, carbonate, bicarbonate, metasilicate, citrate, malate, maleate, malonate, succinate, lactate, formate, acetate, butyrate, propionate, benzoate, tartrate, ascorbate or gluconate.
- alkali- or earth alkali metal salts of sulfate, sulfite, phosphate, phosphonate, nitrate, chloride or carbonate or salts of simple organic acids such as citrate, malonate or acetate may be used.
- the salt in the coating may have a constant humidity at 20°C above 60%, particularly above 70%, above 80% or above 85%, or it may be another hydrate form of such a salt (e.g., anhydrate).
- the salt coating may be as described in WO 00/01793 or WO 2006/034710.
- the salt may be in anhydrous form, or it may be a hydrated salt, i.e., a crystalline salt hydrate with bound water(s) of crystallization, such as described in WO 99/32595.
- Specific examples include anhydrous sodium sulfate (Na 2 SO 4 ), anhydrous magnesium sulfate (MgSO 4 ), magnesium sulfate heptahydrate (MgSO 4 . 7H 2 O), zinc sulfate heptahydrate (ZnSO 4 .
- the salt is applied as a solution of the salt, e.g., using a fluid bed.
- the coating materials can be waxy coating materials and film-forming coating materials.
- waxy coating materials are poly(ethylene oxide) products (polyethyleneglycol, PEG) with mean molar weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids.
- PEG poly(ethylene oxide) products
- PEG polyethyleneglycol
- the core can be prepared by granulating a blend of the ingredients, e.g., by a method comprising granulation techniques such as crystallization, precipitation, pan-coating, fluid bed coating, fluid bed agglomeration, rotary atomization, extrusion, prilling, spheronization, size reduction methods, drum granulation, and/or high shear granulation.
- granulation techniques such as crystallization, precipitation, pan-coating, fluid bed coating, fluid bed agglomeration, rotary atomization, extrusion, prilling, spheronization, size reduction methods, drum granulation, and/or high shear granulation.
- Preparation methods include known feed and granule formulation technologies, e.g., (a) Spray dried products, wherein a liquid protein-containing solution is atomized in a spray drying tower to form small droplets which during their way down the drying tower dry to form a protein-containing particulate material. Exceedingly small particles can be produced this way (Michael S. Showell (editor); Powdered detergents; Surfactant Science Series; 1998; Vol.71; pages 140-142; Marcel Dekker).
- the liquid and the powder in a suitable proportion are mixed and as the moisture of the liquid is absorbed in the dry powder, the components of the dry powder will start to adhere and agglomerate and particles will build up, forming granulates comprising the protein.
- agglomerate and particles will build up, forming granulates comprising the protein.
- various high-shear mixers can be used as granulators. Granulates consisting of protein, fillers and binders etc. are mixed with cellulose fibers to reinforce the particles to produce a so-called T-granulate. Reinforced particles, are more robust, and release less enzymatic dust.
- the cores may be subjected to drying, such as in a fluid bed drier.
- drying preferably takes place at a product temperature of from 25 to 90°C.
- the cores comprising the protein contain a low amount of water before coating with the salt. If water sensitive proteins are coated with a salt before excessive water is removed, the excessive water will be trapped within the core and may affect the activity of the protein negatively.
- the cores preferably contain 0.1-10% w/w water.
- Non-dusting granulates may be produced, e.g., as disclosed in US 4,106,991 and US 4,661,452 and may optionally be coated by methods known in the art.
- the granulate may further comprise one or more additional enzymes, e.g., hydrolase, isomerase, ligase, lyase, oxidoreductase, and transferase.
- the one or more additional enzymes are preferably selected from the group consisting of acetylxylan esterase, acylglycerol lipase, amylase, alpha-amylase, beta-amylase, arabinofuranosidase, cellobiohydrolases, cellulase, feruloyl esterase, galactanase, alpha-galactosidase, beta- galactosidase, beta-glucanase, beta-glucosidase, lysophospholipase, lysozyme, alpha-mannosidase, beta- mannosidase (mannanase), phytase, phospholipase A1, phospholipase A2, phospholipase D, protease, pullulanase, pectin esterase, triacylglycerol lipase, xylanase, beta-xylosidase or any
- Each enzyme will then be present in more granules securing a more uniform distribution of the enzymes, and also reduces the physical segregation of different enzymes due to different particle sizes.
- Methods for producing multi-enzyme co-granulates is disclosed in the ip.com disclosure IPCOM000200739D.
- Another example of formulation of proteins by the use of co-granulates is disclosed in WO 2013/188331.
- the present disclosure also relates to protected proteins prepared according to the method(s) disclosed in EP 238216.
- the present disclosure likewise encompasses liquid formulations comprising one or more proteins of the disclosure.
- the formulation may comprise an enzyme stabilizer (examples of which include polyols such as propylene glycol or glycerol, sugar or sugar alcohol, lactic acid, reversible protease inhibitor, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid).
- an enzyme stabilizer examples of which include polyols such as propylene glycol or glycerol, sugar or sugar alcohol, lactic acid, reversible protease inhibitor, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid.
- filler(s) or carrier material(s) are included to increase the volume of such formulation. Suitable filler or carrier materials include, but are not limited to, various salts of sulfate, carbonate and si
- Suitable filler or carrier materials for liquid formulation include, but are not limited to, water or low molecular weight primary and secondary alcohols including polyols and diols. Examples of such alcohols include, but are not limited to, methanol, ethanol, propanol and isopropanol. In some embodiments, the formulation contain from about 5% to about 90% of such materials. In an aspect, the liquid formulation comprises 20-80% w/w of polyol. In one embodiment, the liquid formulation comprises 0.001-2% w/w preservative.
- the disclosure relates to liquid formulations comprising: (A) 0.001-25% w/w of one or more proteins of the present disclosure; (B) 20-80% w/w of polyol; (C) optionally 0.001-2% w/w preservative; and (D) water.
- the disclosure relates to liquid formulations comprising: (A) 0.001-25% w/w one or more proteins of the present disclosure; (B) 0.001-2% w/w preservative; (C) optionally 20-80% w/w of polyol; and (D) water.
- the liquid formulation comprises one or more formulating agents, such as a formulating agent selected from the group consisting of polyol, sodium chloride, sodium benzoate, potassium sorbate, sodium sulfate, potassium sulfate, magnesium sulfate, sodium thiosulfate, calcium carbonate, sodium citrate, dextrin, glucose, sucrose, sorbitol, lactose, starch, PVA, acetate and phosphate, preferably selected from the group consisting of sodium sulfate, dextrin, cellulose, sodium thiosulfate, kaolin and calcium carbonate.
- a formulating agent selected from the group consisting of polyol, sodium chloride, sodium benzoate, potassium sorbate, sodium sulfate, potassium sulfate, magnesium sulfate, sodium thiosulfate, calcium carbonate, sodium citrate, dextrin, glucose, sucrose, sorbitol, lactose, starch, PVA,
- the polyols is selected from the group consisting of glycerol, sorbitol, propylene glycol (MPG), ethylene glycol, diethylene glycol, triethylene glycol, 1,2-propylene glycol or 1,3-propylene glycol, dipropylene glycol, polyethylene glycol (PEG) having an average molecular weight below about 600 and polypropylene glycol (PPG) having an average molecular weight below about 600, more preferably selected from the group consisting of glycerol, sorbitol and propylene glycol (MPG) or any combination thereof.
- MPG propylene glycol
- the liquid formulation comprises 20-80% polyol (i.e., total amount of polyol), e.g., 25-75% polyol, 30-70% polyol, 35-65% polyol, or 40-60% polyol.
- the liquid formulation comprises 20-80% polyol, e.g., 25-75% polyol, 30-70% polyol, 35-65% polyol, or 40-60% polyol, wherein the polyol is selected from the group consisting of glycerol, sorbitol, propylene glycol (MPG), ethylene glycol, diethylene glycol, triethylene glycol, 1,2-propylene glycol or 1,3-propylene glycol, dipropylene glycol, polyethylene glycol (PEG) having an average molecular weight below about 600 and polypropylene glycol (PPG) having an average molecular weight below about 600.
- MPG propylene glycol
- the liquid formulation comprises 20-80% polyol (i.e., total amount of polyol), e.g., 25-75% polyol, 30-70% polyol, 35-65% polyol, or 40-60% polyol, wherein the polyol is selected from the group consisting of glycerol, sorbitol and propylene glycol (MPG).
- the preservative is selected from the group consisting of sodium sorbate, potassium sorbate, sodium benzoate and potassium benzoate or any combination thereof.
- the liquid formulation comprises 0.02-1.5% w/w preservative, e.g., 0.05-1% w/w preservative or 0.1-0.5% w/w preservative.
- the liquid formulation comprises 0.001-2% w/w preservative (i.e., total amount of preservative), e.g., 0.02-1.5% w/w preservative, 0.05-1% w/w preservative, or 0.1-0.5% w/w preservative, wherein the preservative is selected from the group consisting of sodium sorbate, potassium sorbate, sodium benzoate and potassium benzoate or any combination thereof.
- preservative is selected from the group consisting of sodium sorbate, potassium sorbate, sodium benzoate and potassium benzoate or any combination thereof.
- formulations of the present disclosure may comprise combinations of the enzymes, including, but not limited to combinations of enzymes expressly disclosed herein and combinations with enzymes that are not expressly disclosed herein.
- formulations of the present disclosure comprise 2, 3, 4, 5, 6, 7, 8, 9, 10 or more proteins of the present disclosure.
- formulations of the present disclosure comprise 2, 3, 4, 5, 6, 7, 8, 9, 10 or more of the polypeptides set forth herein as SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149, a mature polypeptide thereof, or a functional fragment/mutant/variant thereof.
- formulations of the present disclosure comprise two or more distinct amylases, cellulases, glucanases, hemicellulases, lipases, mannanases, oxidases, pectinases, peptidases, proteases and/or xylanases.
- formulations of the present disclosure comprise at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof) and at least one xylanase (e.g., an endo-1,4-beta-xylanase, such as any one of SEQ ID NOs: 48–53 or a functional fragment/mutant/variant thereof).
- glucanase e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof
- xylanase e.g., an endo-1,4-beta-xylanase, such as any one of SEQ ID NOs: 48–53 or a functional fragment/mutant/variant thereof.
- formulations of the present disclosure comprise at least one arabanase, at least one cellulase, at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof) and at least one xylanase (e.g., an endo-1,4-beta-xylanase, such as any one of SEQ ID NOs: 48–53 or a functional fragment/mutant/variant thereof).
- arabanase e.g., at least one cellulase
- at least one glucanase e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof
- xylanase e.g., an endo-1,4-beta-xylanase, such as any one
- formulations of the present disclosure comprise at least one glucanase (e.g., glucan 1,4-alpha-glucosidase), at least one lipase (e.g., a lysophospholipase, such as SEQ ID NO: 24 or a functional fragment/mutant/variant thereof) and at least one pullulanase (e.g., SEQ ID NO: 61 or a functional fragment/mutant/variant thereof).
- glucanase e.g., glucan 1,4-alpha-glucosidase
- lipase e.g., a lysophospholipase, such as SEQ ID NO: 24 or a functional fragment/mutant/variant thereof
- pullulanase e.g., SEQ ID NO: 61 or a functional fragment/mutant/variant thereof.
- formulations of the present disclosure comprise at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof) and at least one pectinase.
- formulations of the present disclosure comprise at least one catalase (e.g., any one of SEQ ID NOs: 11–12 or a functional fragment/mutant/variant thereof) and at least one glucose oxidase (e.g., any one of SEQ ID NOs: 1–5 or a functional fragment/mutant/variant thereof).
- formulations of the present disclosure comprise at least one amylase (e.g., any one of SEQ ID NOs: 34–40 or a functional fragment/mutant/variant thereof), at least one chitinase, and at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof).
- amylase e.g., any one of SEQ ID NOs: 34–40 or a functional fragment/mutant/variant thereof
- chitinase e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof.
- glucanase e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof.
- formulations of the present disclosure comprise at least one amylase (e.g., any one of SEQ ID NOs: 34–40 or a functional fragment/mutant/variant thereof), at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof), and at least one bacillolycin (e.g., SEQ ID NO: 88 or a functional fragment/mutant/variant thereof).
- amylase e.g., any one of SEQ ID NOs: 34–40 or a functional fragment/mutant/variant thereof
- glucanase e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof
- bacillolycin e.g., SEQ ID NO: 88 or a functional fragment/mutant/vari
- formulations of the present disclosure comprise at least one cellulase (e.g., any one of SEQ ID NOs: 43–45 or a functional fragment/mutant/variant thereof), at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof), at least one pectinase and at least one pectin lyase (e.g., SEQ ID NO: 88 or a functional fragment/mutant/variant thereof).
- cellulase e.g., any one of SEQ ID NOs: 43–45 or a functional fragment/mutant/variant thereof
- glucanase e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof
- formulations of the present disclosure comprise at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof), at least one oxygenase (e.g., a lytic cellulose monooxygenase, such as any one of SEQ ID NOs: 14–15 or a functional fragment/mutant/variant thereof) and at least one xylanase (e.g., an endo-1,4-beta-xylanase, such as any one of SEQ ID NOs: 48–53 or a functional fragment/mutant/variant thereof).
- glucanase e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof
- oxygenase e.g., a lytic cellulose monooxygenase, such
- formulations of the present disclosure comprise at least one cellulase(e.g., any one of SEQ ID NOs: 43–45 or a functional fragment/mutant/variant thereof), at least one furanosidase (e.g., an arabinofuranosidase, such as SEQ ID NO: 62 or a functional fragment/mutant/variant thereof) and at least one xylanase (e.g., an endo-1,4-beta-xylanase, such as any one of SEQ ID NOs: 48–53 or a functional fragment/mutant/variant thereof).
- xylanase e.g., an endo-1,4-beta-xylanase, such as any one of SEQ ID NOs: 48–53 or a functional fragment/mutant/variant thereof.
- formulations of the present disclosure comprise at least one subtilisin (e.g., any one of SEQ ID NOs: 83–87 or a functional fragment/mutant/variant thereof), and at least one bacillolysin (e.g., SEQ ID NO: 88 or a functional fragment/mutant/variant thereof).
- subtilisin e.g., any one of SEQ ID NOs: 83–87 or a functional fragment/mutant/variant thereof
- bacillolysin e.g., SEQ ID NO: 88 or a functional fragment/mutant/variant thereof.
- formulations of the present disclosure comprise at least one catalase (e.g., any one of SEQ ID NOs: 11–12 or a functional fragment/mutant/variant thereof) and at least one peptidase (e.g., a bacillolysin, SEQ ID NO: 88 or a functional fragment/mutant/variant thereof; a serine endopeptidase, such as any one of SEQ ID NOs: 80–81 or a functional fragment/mutant/variant thereof).
- catalase e.g., any one of SEQ ID NOs: 11–12 or a functional fragment/mutant/variant thereof
- peptidase e.g., a bacillolysin, SEQ ID NO: 88 or a functional fragment/mutant/variant thereof
- a serine endopeptidase such as any one of SEQ ID NOs: 80–81 or a functional fragment/mutant/variant thereof.
- formulations of the present disclosure comprise at least one catalase (e.g., any one of SEQ ID NOs: 11–12 or a functional fragment/mutant/variant thereof), at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof) and at least one xylanase (e.g., an endo-1,4-beta-xylanase, such as any one of SEQ ID NOs: 48–53 or a functional fragment/mutant/variant thereof).
- catalase e.g., any one of SEQ ID NOs: 11–12 or a functional fragment/mutant/variant thereof
- glucanase e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof
- formulations of the present disclosure comprise at least one peptidase (e.g., a bacillolysin, SEQ ID NO: 88 or a functional fragment/mutant/variant thereof; a serine endopeptidase, such as any one of SEQ ID NOs: 80–81 or a functional fragment/mutant/variant thereof), at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof) and at least one xylanase (e.g., an endo-1,4-beta-xylanase, such as any one of SEQ ID NOs: 48–53 or a functional fragment/mutant/variant thereof).
- peptidase e.g., a bacillolysin, SEQ ID NO: 88 or a functional fragment/mutant/variant thereof; a serine endo
- formulations of the present disclosure comprise at least one amylase (e.g., any one of SEQ ID NOs: 34–40 or a functional fragment/mutant/variant thereof), at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof) and at least one peptidase (e.g., a bacillolysin, SEQ ID NO: 88 or a functional fragment/mutant/variant thereof; a serine endopeptidase, such as any one of SEQ ID NOs: 80–81 or a functional fragment/mutant/variant thereof).
- amylase e.g., any one of SEQ ID NOs: 34–40 or a functional fragment/mutant/variant thereof
- glucanase e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO
- formulations of the present disclosure comprise a fermentation broth that comprises 2, 3, 4, 5, 6, 7, 8, 9, 10 or more enzymes. In some embodiments, formulations of the present disclosure comprise a fermentation broth that comprises 2, 3, 4, 5, 6, 7, 8, 9, 10 or more proteins of the present disclosure (2, 3, 4, 5, 6, 7, 8, 9, 10 or more of SEQ ID NOs: 1–91, 45906, 72144, 72147 and 72149 or functional fragments/mutants/variants thereof).
- Formulations of the present disclosure may comprise myriad components, including, but not limited to, adhesives (stickers), biological actives, chemical actives, dispersants (spreaders), drying agents, emulsifiers, nutrients, pest attractants and feeding stimulants, pH control components, postharvest treatments, preservatives, rain fasteners, rhealogical agents, safeners, stabilizers, UV protectants and/or wetting agents.
- actives examples include, but not are not limited to, acaracides and miticides (e.g., carvacrol, sanguinarine, azobenzene, benzoximate, benzyl benzoate, bromopropylate, chlorbenside, chlorfenethol, chlorfenson, chlorfensulphide, chlorobenzilate, chloropropylate, cyflumetofen, DDT, dicofol, diphenyl sulfone, dofenapyn, fenson, fentrifanil, fluorbenside, genit, hexachlorophene, phenproxide, proclonol, tetradifon, tetrasul, benomyl, carbanolate, carbaryl, carbofuran, methiocarb, metolcarb, promacyl, propoxur, aldicarb, butocarboxim, oxamy
- miticides e.g.,
- Non-limiting examples of actives that may be incorporated into formulations of the present disclosure—or into which proteins and other compositions of the present disclosure may be incorporated— include, but are not limited to, commercial products sold under the tradenames ABACUS®, ACROBAT®, ACRONIS®, ADHERE®, ADMIRAL®, AGCELENCE®, AGMUSA®, ALLEGRO®, ALITE 27®, ALTREVIN®, AMP®, AMPLEXUS®, AMPLO®, ARMEZON®, ARESENAL®, ASSIST®, ATECTRA®, ATIVUM®, AUMENAX®, AURA®, BASAGRAN®, BELLIS®, BEYOND®, BLAVITY®, BLITZ®, BOMVORO®, BRIO®, CABRIO®, CARAMBA®, CADRE®, CANTUS®, CAPACITY®, CARAMBA®, CAURIFIX®, CEPTIVA®, CEYVA®, CHOPPER®, CLARITY®
- Post-Harvest, Inc. (Monrovia, CA, USA); ACCUDO®, AFFINITY®, AGILITY®, AIM®, ALLY®, ALTACOR®, ANTHEM®, ATHENA®, AUTHORITY®, AVAUNT®, BELEAF®, BRIGADE®, CADET®, CAPTURE®, CARBINE®, COMMAND®, CORAGEN®, DISPLAY®, ELEVEST®, ETHOS®, EXIREL®, EXPRESS®, FINESSE®, FIRSTSHOT®, FURAGRO®, GLADIATOR®, HARMONY®, HERO®, LUCENTO®, MARVEL®, MUSTANG®, OBEY®, PANOFLEX®, PRESENCE®, PREVATHON®, QUARTZO®, RHYME®, ROVRAL®, SEAMAC®, SHARK®, SOLIDA®, SPARTAN®, STEWARD®, TEMITRY
- Formulations of the present disclosure may comprise any suitable combination of actives and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned actives. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned actives are expressly excluded from formulations of the present disclosure.
- adhesives that may be included in formulations of the present disclosure include, but not are not limited to, disaccharides (e.g.
- maltose sucrose, trehalose
- gums e.g., cellulose gum, guar gum, gum arabic, gum combretum, xantham gum
- maltodextrins e.g., maltodextrins having a DEV of about 10 to about 20
- monosaccharides e.g., mineral oil, olive oil, peanut oil, soybean oil and/or sunflower oil
- oils e.g., mineral oil, olive oil, peanut oil, soybean oil and/or sunflower oil
- oligosaccharides e.g., maltose, sucrose, trehalose
- oils e.g., mineral oil, olive oil, peanut oil, soybean oil and/or sunflower oil
- POWERBLOXTM (Dow, Midland, MI, USA), such as POWERBLOXTM ADJ-65 and POWERBLOXTM ADJ-65; EP0 0245970; US 5496568; WO 2008/144024; WO 2009/135049; WO 2011/126832; WO 2017/083049; WO 2020/225276; WO 2021/055316; WO 2022/096688; WO 2022/096691; WO 2022/096692; WO 2022/096693; WO 2022/096694; WO/2022/096695; WO 2022/096696.
- Formulations of the present disclosure may comprise any suitable combination of adhesives (stickers) and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned adhesives (stickers). Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned adhesives (stickers) are expressly excluded from formulations of the present disclosure.
- dispersants that may be included in formulations of the present disclosure include, but not are not limited to, anionic surfactants, cationic surfactants and non-ionic surfactants.
- formulations of the present disclosure comprise one or more anionic surfactants.
- formulations of the present disclosure comprise one or more anionic surfactants selected from the group consisting of alkyl carboxylates (e.g., sodium stearate), alkyl sulfates (e.g., alkyl lauryl sulfate, sodium lauryl sulfate), alkyl ether sulfates, alkyl amido ether sulfates, alkyl aryl polyether sulfates, alkyl aryl sulfates, alkyl aryl sulfonates, alkyl sulfonates, alkyl amide sulfonates, alkyl aryl sulfonates, alkyl benzene sulfonates, alkyl diphenyloxide sulfonate, alpha-olefin sulfonates, alkyl naphthalene sulfonates, paraffin sulfonates, alkyl
- formulations of the present disclosure comprise one or more cationic surfactants.
- formulations of the present disclosure comprise one or more cationic surfactants selected from the group consisting of alkyltrimethylammonium salts (e.g., cetyl trimethylammonium bromide, cetyl trimethylammonium chloride), cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, 5-Bromo-5-nitro-1,3-dioxane, dimethyldioctadecylammonium chloride, cetrimonium bromide, dioctadecyldimethylammonium bromide and/or octenidine dihydrochloride.
- alkyltrimethylammonium salts e.g., cetyl trimethylammonium bromide, cetyl trimethylammonium chloride
- cetylpyridinium chloride e.g., benzalkonium chloride, benzethon
- formulations of the present disclosure comprise one or more nonionic surfactants.
- formulations of the present disclosure comprise one or more nonionic surfactants selected from the group consisting of alcohol ethoxylates (e.g., TERGITOLTM 15-S surfactants (The Dow Chemical Company, Midland, MI), such as TERGITOLTM15-S-9, alkanolamides, alkanolamine condensates, carboxylic acid esters, cetostearyl alcohol, cetyl alcohol, cocamide DEA, dodecyldimethylamine oxides, ethanolamides, ethoxylates of glycerol ester and glycol esters, ethylene oxide polymers, ethylene oxide-propylene oxide copolymers, glucoside alkyl ethers, glycerol alkyl ethers, glycerol esters, glycol alkyl ethers (e.g., polyoxyethylene glycol alkyl ethers)
- formulations of the present disclosure comprise one or more zwitterionic surfactants.
- formulations of the present disclosure comprise one or more zwitterionic surfactants selected from the group consisting of 3-[(3-cholamidopropyl)dimethylammonio]-1- propanesulfonate, cocamidopropyl betaine, cocamidopropyl hydroxysultaine, phosphatidylserine, phosphatidylethanolamine, phosphatidylcholine and/or one or more sphingomyelins.
- formulations of the present disclosure comprise one or more soaps and/or organosilicone surfactants.
- Non-limiting examples of dispersants that may be incorporated into formulations of the present disclosure—or into which proteins and other compositions of the present disclosure may be incorporated— include ATLOXTM (e.g., 4916, 4991; Croda International PLC, Edison, NJ), ATLOX METASPERSETM (Croda International PLC, Edison, NJ), BIO-SOFT® (e.g., N series, such as N1-3, N1-7, N1-5, N1-9, N23-3, N2.3-6.5, N25-3, N25-7, N25-9, N91-2.5, N91-6, N91-8; Stepan Company, Northfield, IL), MAKON® nonionic surfactants (e.g., DA-4, DA-6 and DA-9; Stepan Company, Northfield, IL), MORWET® powders (Akzo Nobel Surface Chemistry LLC, Chicago, IL), MULTIWETTM surfactants (e.g., MO-85P-PW-(AP); Croda International PLC
- SOIL FACTS USING WETTING AGENTS (NONIONIC SURFACTANTS) ON SOIL (North Carolina Cooperative Extension Service Publication AG-439-25) (1993); BURGES, FORMULATION OF MICROBIAL BIOPESTICIDES: BENEFICIAL MICROORGANISMS, NEMATODES AND SEED TREATMENTS (Springer Science & Business Media) (2012); MCCARTY, WETTING AGENTS (Clemson University Cooperative Extension Service Publication) (2001).
- Formulations of the present disclosure may comprise any suitable combination of dispersants (spreaders) and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned dispersants (spreaders). Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned dispersants (spreaders) are expressly excluded from formulations of the present disclosure.
- drying agents examples include, but not are not limited to, calcium stearate, clay (e.g., attapulgite clay, montmorillonite clay), graphite, magnesium stearate, magnesium sulfate, powdered milk, silica (e.g., fumed silica, hydrophobically-coated silica, precipitated silica), soy lecithin and talc. Additional examples of drying agents may be found in Burges, Formulation of Microbial Biopesticides: Beneficial Microorganisms, Nematodes and Seed Treatments (Springer Science & Business Media) (2012).
- Non-limiting examples of drying agents that may be incorporated into formulations of the present disclosure—or into which proteins and other compositions of the present disclosure may be incorporated— include, but are not limited to, commercial products sold under the tradenames AEROSIL® and SIPERNAT® from Evonik Corporation (Parsippany, NJ), BENTOLITE® from BYK-Chemie GmbH (Wesel, Germany), and INCOTEC® from INCOTEC Inc. (Salinas, CA).
- Formulations of the present disclosure may comprise any suitable combination of drying agents and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned drying agents.
- one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned drying agents are expressly excluded from formulations of the present disclosure.
- microbes that may be included in formulations of the present disclosure include, but not are not limited to, diazotrophs, phosphate-solubilizing microorganisms and biopesticides.
- formulations of the present disclosure comprise one or more of the following: Azospirillum brasilense Ab-V5, Azospirillum brasilense Ab-V6, Azospirillum brasilense INTA Az-39, Bacillus amyloliquefaciens D747, Bacillus amyloliquefaciens NRRL B-50349, Bacillus amyloliquefaciens TJ1000, Bacillus amyloliquefaciens FZB24, Bacillus amyloliquefaciens FZB42, Bacillus amyloliquefaciens IN937a, Bacillus amyloliquefaciens IT-45, Bacillus amyloliquefaciens TJ1000, Bacillus amyloliquefaciens MBI600, Bacillus amyloliquefaciens BS27 (deposited as NRRL B-5015), Bacillus amyloliquefaciens BS2084
- Bacillus subtilis AQ175 (deposited as ATCC 55608), Bacillus sp. AQ177 (deposited as ATCC 55609), Bacillus subtilis AQ713 (deposited as NRRL B-21661), Bacillus subtilis AQ743 (deposited as NRRL B-21665), Bacillus subtilis ATCC 55078, Bacillus subtilis ATCC 55079, Bacillus subtilis MBI 600, Bacillus subtilis NRRL B-21661, Bacillus subtilis NRRL B-21665, Bacillus subtilis CX-9060, Bacillus subtilis GB03, Bacillus subtilis GB07, Bacillus subtilis QST-713, Bacillus subtilis FZB24, Bacillus subtilis D747, Bacillus subtilis 3BP5 (deposited as NRRL B-50510), Bacillus thuringiensis AQ52 (deposited as NRRL B- 21619), Bacillus thuringiensis ATCC 13367, Bacillus thuringiens
- Non-limiting examples of microbial compositions that may be incorporated into formulations of the present disclosure—or into which proteins and other compositions of the present disclosure may be incorporated—include, but are not limited to, commercial products sold under the tradenames SERIFEL® from BASF (Ludwigshafen, Germany); VOTIVO® from Bayer Crop Science (Creve Coeur, MO, USA); AGREE®, AGRIPHAGETM, AGSIL®, ANCORA, AZATIN®, BOTANIGARD®, BOTEGHA®, BUG-N-SLUGGO®, CARB-O-NATOR®, CRYMAX®, CUEVA®, CYD-X®, DEFGUARD®, DELIVER®, DES-X®, DOUBLE NICKEL®, FIREFIGHTERTM, GEMSTAR®, GROTTO®, HOMEPLATE®, JAVELIN®, KALMOR®, KOCIDE®, LIFEGARD®, MADEX®, MELOCON®, MYCO
- Formulations of the present disclosure may comprise any suitable combination of microbial compositions and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned microbial compositions. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned microbial compositions are expressly excluded from formulations of the present disclosure.
- nutrients examples include, but not are not limited to, organic acids (e.g., acetic acid, citric acid, lactic acid, malic acid, taurine, etc.), macrominerals (e.g., phosphorous, calcium, magnesium, potassium, sodium, iron, etc.), trace minerals (e.g., boron, cobalt, chloride, chromium, copper, fluoride, iodine, manganese, molybdenum, selenium, zinc, etc.), vitamins, (e.g., vitamin A, vitamin B complex (i.e., vitamin B 1 , vitamin B 2 , vitamin B 3 , vitamin B 5 , vitamin B 6 , vitamin B 7 , vitamin B 8 , vitamin B 9 , vitamin B 12 , choline) vitamin C, vitamin D, vitamin E, vitamin K, carotenoids ( ⁇ - carotene, ⁇ -carotene, cryptoxanthin, lutein, lycopene, zea
- organic acids e.g.,
- Formulations of the present disclosure may comprise any suitable combination of nutrients and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned nutrients.
- pest attractants and feeding stimulants that may be included in formulations of the present disclosure include, but not are not limited to, brevicomin, ceralure, codlelure, cue-lure, disparlure, dominicalure, eugenol, frontalin, gossyplure, grandlure, hexalure, ipsdienol, ipsenol, japonilure, latitlure, lineatin, litlure, looplure, medlure, megatomic acid, methyl eugenol, moguchun, ⁇ -multistriatin, muscalure, orfalure, oryctalure, ostramone, rescalure, siglure, sulcatol, trimedlure, trunc-call, and combinations
- Formulations of the present disclosure may comprise any suitable combination of pest attractants and/or feeding stimulants and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned pest attractants and/or feeding stimulants.
- pH control components that may be included in formulations of the present disclosure include phosphate and other salts capable of buffering at the desired pH, and having an aqueous solubility of more than 1% w/w.
- a preferred pH control component is a phosphate buffer containing the ionic species HPO 4 2- and H 2 PO 4 -.
- a pH control component may be a single ionic species that can maintain a constant pH but only provide a buffering effect towards either acidification or basification.
- HPO4 2- which can ensure an alkaline pH (of approximately 9) and provide a buffering effect against acidification. This may be beneficial in an agricultural setting to keep the pH constant at an alkaline pH, as most environmental factors will cause acidification of the droplet and deposit.
- the pH control component does not significantly change pH (+/- 0.5 pH units) or change in a desired direction upon drying when the solvent evaporates from the droplet on the leaf surface. Some buffers will, upon drying, change pH as a result of differences in solubility of the buffer components.
- the pH of a sodium phosphate buffer constituting of Na 2 HPO 4 and NaH 2 PO 4 can reduce to pH 4 or lower upon drying since the dibasic form (Na 2 HPO 4 ) will crystallize to a larger degree.
- the pH of a potassium phosphate buffer constituting of K 2 HPO 4 and KH 2 PO 4 will approach pH 9 upon drying since the monobasic form (KH 2 PO 4 ) has the lowest solubility (Sarciaux 1999).
- a pH control component is most effective (highest buffer capacity) when the pKa is close to the desired pH of the composition. This will reduce the amount of buffer needed to maintain a desired pH.
- the buffer includes salts having a neutral/alkaline pKa, such as a pKa in the range of 6.5 to 10.
- a pH control component can be used to control the pH of a solution at a pH +/- 1 pH-unit from its pKa value. pH control components with a pKa value above 6.5 are useful for controlling the pH at 7.5 or above.
- pH control component includes, but are not limited to: Sodium/potassium phosphate (pKa 1 2.12, pKa 2 7.21, pKa 3 12.67), sodium/potassium carbonate (pKa 1 6.37, pKa 2 10.32), 2-amino-2-(hydroxymethyl)-1,3-propanediol (TRIS) (pKa 8.1), [Bis(2- hydroxyethyl)amino]acetic acid (Bicine) (pKa 8.35), N-[tris(hydroxymethyl)methyl]glycine (Tricine) (pKa 8.15), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pKa 1 3.0, pKa 2 7.5), N- [tris(hydroxymethyl)methyl]- 2-aminoethanesulfonic acid (TES) (pKa 7.55), 3-(N-morpholino)propanesulfonic acid (MOPS)
- Non-preferred pH control components include, but are not limited to, pH control components with an unfavorable pKa (pKa ⁇ 6.5 for an enzyme that requires an alkaline pH), volatile pH control component, pH control component that display significant phytotoxicity (this may sometimes include the above-mentioned “suitable” pH control components, as phytotoxicity is depended on buffer concentration, pH and target crop), and pH control components that are unwanted in the environment and therefore regulated by authorities (this may sometimes include the above-mentioned “suitable” pH control component, as regulations varies throughout the world).
- formulations of the present disclosure comprise one or more pH control components in an amount of about/at least 0.01–10 % w/w, preferably about/at least 0.05–5 % w/w.
- formulations of the present disclosure can maintain an alkaline pH. pH control components may be used to obtain such formulations.
- formulations of the present disclosure comprise one or more pH control components selected to provide a composition having an alkaline pH within the operable pH range(s) of each enzyme in the formulation, most preferably within +/- 1 pH-unit from the optimal pH value of each enzyme in the formulation.
- formulations of the present disclosure comprise a pH control component, such as a buffer, where an 1% w/w aqueous solution of the pH control component (buffer) has an alkaline pH in which each enzymne in the formulation is operable.
- pH control components may be used to obtain such formulations.
- formulations of the present disclosure comprise one or more pH control components selected to provide a composition having an acidic pH within the operable pH range(s) of each enzyme in the formulation, most preferably within +/- 1 pH-unit from the optimal pH value of each enzyme in the formulation.
- formulations of the present disclosure comprise a pH control component, such as a buffer, where an 1% w/w aqueous solution of the pH control component (buffer) has an acidic pH in which each enzyme in the formulation is operable.
- a pH control component such as a buffer
- an 1% w/w aqueous solution of the pH control component (buffer) has an acidic pH in which each enzyme in the formulation is operable.
- Formulations of the present disclosure may comprise any suitable combination of pH control components and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned pH control components.
- one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned pH control components are expressly excluded from formulations of the present disclosure.
- postharvest treatments include, but not are not limited to, essential oils, ethylene biosynthesis inhibitors (e.g., cyclopropenes), pesticides and waxes. See generally, e.g., WO 00/10386; WO 01/43548; US 2002/058592; US 2002/061822; US 2002/043730; US 2002/198107; US 2004/072694; US 2003/100450; US 2004/077502; US 2005/043179; US 2005/250649; US 2005/261131; US 2005/261132; US 2005/288189; CA 2512254; CA 2512256; US 2007/117720; US 2007/265166; US 2008/113867; US 2010/144533; US 2008/206823; US 2009/035380; US2009/077684; US 2009/118492; US 2009/230350; US 2010/047408; US 2011/321191; US 2011/034335; US 2011/014334; US 2012/27
- Non-limiting examples of postharvest treatment compositions that may be incorporated into formulations of the present disclosure—or into which proteins and other compositions of the present disclosure may be incorporated—include commercial products sold under the tradenames ACTISEALTM, ACTISEALTM, CONTORL-TECTM, ETHYLBLOC, FRESHCLOUDTM, FRESHSTART, HARVISTATM, SMARTCITRUS, SMARTFRESHTM, TEYCER, VITAFRESH from AgroFresh, Inc.
- Formulations of the present disclosure may comprise any suitable combination of postharvest treatment compositions and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned postharvest treatment compositions. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned v are expressly excluded from formulations of the present disclosure.
- preservatives examples include, but are not limited to, benzoates (e.g., sodium benzoate), benzoic acid, methyl paraben, phenoxy ethanol, proprionates (e.g., ammonium proprionate, calcium proprionate, sodium proprionate), proprionic acid, sorbates (e.g., potassium sorbate, sodium sorbate), and 1,2-benzisothiazolin-3-one (PROXEL®; Basel, Switzerland).
- Formulations of the present disclosure may comprise any suitable combination of preservatives and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned preservatives.
- one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned preservatives are expressly excluded from formulations of the present disclosure.
- Examples of rain fasteners that may be included in formulations of the present disclosure include, but not are not limited to, organo-modified siloxanes (organosiloxanes), such as trisiloxanes and polysiloxanes.
- formulations of the present disclosure comprise one or more organo-modified siloxanes having the general molecular structure of Formula 1: in which R 1 represents identical or different from each other hydrocarbon substituents of 1-10 carbons or hydrogen, preferred are methyl, ethyl, propyl and phenyl substituents, particularly preferred are methyl substituents; R 2 represents identical or different from each other polyether substituents of the general Formula II: -R 3 O[CH 2 CH 2 O] C [CH 2 CH(CH 3 )O] D [CHR 4 CHR 4 O] E R 5 wherein R 3 represents identical or different from each other hydrocarbon moieties of 1-8 carbons, which optionally is interrupted by oxygen atoms.
- R 1 represents identical or different from each other hydrocarbon substituents of 1-10 carbons or hydrogen, preferred are methyl, ethyl, propyl and phenyl substituents, particularly preferred are methyl substituents
- R 2 represents identical or different from each other polyether substituents of the general Formula II:
- linear hydrocarbons of 2-4 carbons particularly preferred is -CH 2 -CH 2 -CH 2 - R 4 represents identical or different from each other hydrocarbon substituents of 1-12 carbons or hydrogen, preferred is methyl, ethyl, phenyl or hydrogen substituents R 5 represents identical or different from each other hydrocarbon substituents of 1-16 carbons, which optionally contains urethane, carbonyl or carboxylic acid functionality, or hydrogen. Methyl or hydrogen substituents are preferred, with hydrogen being most preferred.
- A is 0-200, preferably 0-1, more preferably 0.
- B is 0-200, preferably 0.5-2, more preferably 1.
- C is 0- 60, preferably 1-15.
- organo-modified siloxanes examples include, but are not limited to SILWETTM surfactants (Momentive Performance Materials, Inc., Niskayuna, NY), such as SILWETTM L-77 (polyalkyleneoxide modified heptamethyltrisiloxane), SILWETTM HS-312, SILWETTM 408, SILWETTM 618, SILWETTM 625, SILWETTM 636, SILWETTM 641, SILWETTM 806, SILWETTM DA-40, SILWETTM DRS-60, SILWETTM ECO, SILWETTM HS-604, SILWETTM STIK 2 and SILWETTM) and BREAK-THRU® surfactants (Evonik Operations Gmbh, Essen, Germany), such as BREAK-THRU® S 200, BREAK-THRU® S 233, BREAK- THRU® S 240, BREAK-THRU® S 255
- formulations of the present disclosure comprise one or more organo-modified siloxanes in an amount of about/at least 0.001-50% w/w, preferably about/at least 0.005-25% w/w.
- Formulations of the present disclosure may comprise any suitable combination of rain fasteners and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned rain fasteners. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned rain fasteners are expressly excluded from formulations of the present disclosure.
- Suitable stabilizers include, but not are not limited to, boric acid, boric acid derivatives, inorganic salts, lactic acid, polyols, sugars, sugar alcohols and reversible protease inhibitors. See generally, e.g., WO 2007/113241; WO 01/04279; WO 2013/004636; WO 95/02046; WO 2009/118375; WO 2020/115179; WO 96/41859; WO 2007/025549; WO 96/23062; WO 2018/130654; WO 96/22366; WO 92/17571; WO 2017/044473; WO 2017/044545, WO 2017/116837, WO 2017/116846, WO 2017/210163, WO 2017/210166, WO 2018/118740, WO 2018/175681, WO 2018/183491, WO 2018/218008, WO 2018/218016; WO 2018/218035.
- Formulations of the present disclosure may comprise any suitable combination of stabilizers and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned stabilizers. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned stabilizers are expressly excluded from formulations of the present disclosure.
- UV protectants include, but not are not limited to, aromatic amino acids (e.g., tryptophan, tyrosine), carotenoids, cinnamates, lignosulfonates (e.g., calcium lignosulfonate, sodium lignosulfonate), melanins, mycosporines, polyphenols and/or salicylates).
- aromatic amino acids e.g., tryptophan, tyrosine
- carotenoids e.g., carotenoids
- cinnamates e.g., lignosulfonates (e.g., calcium lignosulfonate, sodium lignosulfonate), melanins, mycosporines, polyphenols and/or salicylates).
- lignosulfonates e.g., calcium lignosulfonate, sodium lignosulfonate
- melanins e.g., melanins
- mycosporines
- UV protectants include Borregaard LignoTechTM lignosulfonates (e.g., Borresperse 3A, Borresperse CA, Borresperse NA, Marasperse AG, Norlig A, Norlig 11D, Ufoxane 3A, Ultrazine NA, Vanisperse CB; Borregaard Lignotech, Sarpsborg, Norway) and combinations thereof. Additional examples of UV protectants may be found in BURGES, FORMULATION OF MICROBIAL BIOPESTICIDES: BENEFICIAL MICROORGANISMS, NEMATODES AND SEED TREATMENTS (Springer Science & Business Media) (2012).
- Formulations of the present disclosure may comprise any suitable combination of UV protectants and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned UV protectants. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned UV protectants are expressly excluded from formulations of the present disclosure.
- naphthalene sulfonates such as alkyl naphthalene sulfonates (e.g., sodium alkyl naphthalene sulfonate), isopropyl naphthalene sulfonates (e.g., sodium isopropyl naphthalene sulfonate) and butyl naphthalene sulfonates (e.g., sodium n-butyl naphthalene sulfonate).
- alkyl naphthalene sulfonates e.g., sodium alkyl naphthalene sulfonate
- isopropyl naphthalene sulfonates e.g., sodium isopropyl naphthalene sulfonate
- butyl naphthalene sulfonates e.g., sodium n-butyl naphthalene
- Formulations of the present disclosure may comprise any suitable combination of wetting agents and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned wetting agents. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned wetting agents are expressly excluded from formulations of the present disclosure.
- compositions of the present disclosure have many uses, including, but not limited to a) preventing, treating, suppressing and/or eliminating infestations/infections of/by myriad pests, including, but not limited to, phytopathogenic pests, such as arachnids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa, viruses and weeds; b) treating surfaces/substances that are susceptible to infestation/infection; c) cleansing infested/infected surfaces/substances; d) reducing disease severity in plants and plant parts affected directly or indirectly by phytopathogenic pests; e) enhancing plant growth environments; f) improving nutrient availability/uptake/accumulation; g) reducing the amount(s) of exogenous fertilizer needed to achieve a desired result; h) improving plant growth, development and yield characteristics; i) prolonging the shelf-life of harvested plants and plant parts; j) delaying the phytopathogenic pests, such as arach
- compositions of the present disclosure may be particularly useful for protecting plants from environmental pathogens.
- compositions of the present disclosure are useful for preventing, treating, suppressing, eliminating and/or reducing the severity of acarid infestations by, for example, reducing attraction of an acarid to a surface, inhibiting entry of an acarid into a material, inhibiting inhabitation by an acarid, inhibiting feeding of an acarid, inhibiting amino acid production, degrading one or more amino acids, preventing an acarid from utilizing one or more essential amino acids, producing ammonia in the gut of an acarid, inhibiting the growth of an acarid, inhibiting the reproduction and/or proliferation of an acarid, degrading on one or more structural components of an acarid (e.g.
- procuticle components such as chitin, and epicuticle components, such as lipoproteins, hydrocarbons, polyphenols and esters of fatty acids and alcohols
- killing an acarid and/or reducing one or more symptoms of an acarid infestation.
- inhibition is complete or substantially complete, such that the acarid fails to inhabit/feed/grow/reproduce/proliferate at a rate effective to initiate and/or sustain an appreciable infestation.
- spraying a plant with an enzyme of the present disclosure may reduce the attractiveness of the plant to an acarid, reduce an acarid's desire/ability to inhabit the plant, inhibit an acarid's desire/ability to feed on the plant, inhibit production of one or more amino acids, degrade one or more amino acids, prevent an acarid from utilizing one or more essential amino acids, produce ammonia in the gut of an acarid, inhibiting the growth of an acarid after it inhabits/feeds on the plant, inhibit the reproduction and/or proliferation of an acarid on/in the plant, degrade one or more structural components of an acarid (e.g.
- compositions of the present disclosure may be used to prevent, treat, suppress, eliminate and/or reduce the severity of infestations of/by myriad acarids, including, but not limited to, herbivorous acarids, such as broad mites, bulb mites, cyclamen mites, earth mites, eriophyid mites, Lewis mites, russet mites, rust mites, and spider mites.
- herbivorous acarids such as broad mites, bulb mites, cyclamen mites, earth mites, eriophyid mites, Lewis mites, russet mites, rust mites, and spider mites.
- enzymes of the present disclosure are used to prevent and/or treat an infestation of a plant or plant part by one or more Auculops, (e.g., A. lycopersici), Calacarus (e.g., C.
- Eutetranychus e.g., E. lewesi
- Halotydeus e.g., H. destructor
- Polyphagotarsonemus e.g., P. latus
- Rhizoglyphus Tarsonemus
- Tetranychus e.g., T. cinnabarinus, T. evansi, T. ludeni, T. urticae.
- compositions of the present disclosure are useful for preventing, treating, suppressing, eliminating and/or reducing the severity of bacterial infestations/infections by, for example, inhibiting adhesion of a bacterium to a surface, inhibiting entry of a bacterium into a material, inhibiting habitation by a bacterium, inhibiting the growth of a bacterium, inhibiting the reproduction and/or proliferation of a bacterium, degrading on one or more structural components of a bacterium (e.g. cell wall components, such as peptidoglycans and lipopolysaccharides), killing a bacterium, and/or reducing one or more symptoms of a bacterial infestation/infection.
- a bacterium e.g. cell wall components, such as peptidoglycans and lipopolysaccharides
- such inhibition is complete or substantially complete, such that the bacterium fails to inhabit/feed/grow/reproduce/proliferate at a rate effective to initiate and/or sustain an appreciable infestation/infection.
- spraying a plant with an enzyme of the present disclosure may inhibit a bacterium's ability to adhere to the surface of a plant, inhibit a bacterium's ability to enter into the plant, inhibit a bacterium's ability to inhabit the plant, inhibit growth of a bacterium on/in the plant, inhibit the reproduction and/or proliferation of a bacterium on/in the plant, degrade one or more structural components of a bacterium (e.g.
- compositions of the present disclosure may be used to prevent, treat, suppress, eliminate and/or reduce the severity of infestations/infections of/by myriad phytopathogenic bacteria, including, but not limited to, phytopathogenic Erwiniaceae and Xanthomonadales.
- enzymes of the present disclosure are used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part by one or more Agrobacterium (e.g., A. rhizogenes, A. tumefaciens, A. vitis), Burkholderia (e.g., B. gladioli), Clostridium, Dickeya (e.g., D. dadantii, D. solani), Erwinia (e.g., E. amylovora, E. aphidicola, E. carotovora, E. chrysanthemi, E. papayae, E. persicina, E.
- Agrobacterium e.g., A. rhizogenes, A. tumefaciens, A. vitis
- Burkholderia e.g., B. gladioli
- Clostridium Dickeya (e.g., D.
- P. atrosepticum e.g., P. carotovorum
- Pseudomonas e.g., P. agarici, P. amygdali, P. avellanae,P. cannabina, P. caricapapayae, P. cichorii, P. coronafaciens, P. costantinii, P. ficuserectae, P. fuscovaginae, P. helianthin, P. meliae, P. savastanoi, P. syringae, P.
- tolaasii P. tomato, P. turbinellae, P. viridiflava), Ralstonia (e.g., R. solanacearum), Xanthomonas (e.g., X. alfalfae, X. ampelina, X. arboricola, X. axonopodia, X. boreopolis, X. badrii, X. bromi, X. campestris, X. cassavae, X. citri, X. cucrurbitae, X. cyanopsidis, X. cynarae, X.euvesicatoria , X.
- Xanthomonas e.g., X. alfalfae, X. ampelina, X. arboricola, X. axonopodia, X. boreopolis, X. badrii, X. bromi, X. campestr
- frageriae X.gardneri, X. holcicola, X. hortorum, X. hyacinthi, X. maliensis, X. malvacearum, X. manihotis, X. melonis, X. oryzae, X. papavericola, X. perforans, X. phaseoli, X. pisi, X. populi, X. sacchari, X. theicola, X. translucens, X. vasicola, X. vesicatoria), and/or Xylella (e.g., X. fastidiosa).
- X. fastidiosa e.g., X. fastidiosa
- compositions of the present disclosure are useful for preventing, treating, suppressing, eliminating and/or reducing the severity of fungal infestations/infections by, for example, inhibiting adhesion of a fungus to a surface, inhibiting entry of a fungus into a material, inhibiting habitation by a fungus, inhibiting production of one or more amino acids, degrading one or more amino acids, inhibiting the growth of a fungus, inhibiting the reproduction and/or proliferation of a fungus, degrading on one or more structural components of a fungus (e.g.
- cell wall components such as chitins, glucans and mannans, and cell membrane components, such as ergosterols
- killing a fungus and/or reducing one or more symptoms of a fungal infestation/infection.
- inhibition is complete or substantially complete, such that the fungus fails to inhabit/feed/grow/reproduce/proliferate at a rate effective to initiate and/or sustain an appreciable infestation/infection.
- spraying a plant with an enzyme of the present disclosure may inhibit a fungus' ability to adhere to the surface of a plant, inhibit a fungus' ability to enter into the plant, inhibit a fungus' ability to inhabit the plant, inhibit the ability of a fungus to produce one or more amino acids, degrade one or more amino acids, inhibit growth of a fungus on/in the plant, inhibit the reproduction and/or proliferation of a fungus on/in the plant, degrade one or more structural components of a fungus (e.g.
- compositions of the present disclosure may be used to prevent, treat, suppress, eliminate and/or reduce the severity of infestations/infections of/by myriad phytopathogenic fungi, including, but not limited to, phytopathogenic Ascomycetes, Basidiomycetes, Chytridiomycota, Deueromycota, Peronosporomycota, Plasmodiophoromycota and Zygomycota, such as blasts, blights, bunts, galls, mildews, molds, rots, rusts, scabs, smuts and wilts.
- enzymes of the present disclosure are used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part by one or more Aecidium (e.g., A. aechmantherae, A. amaryllidis, A. breyniae, A. campanulastri, A. cannabis, A. cantensis, A. capsicum, A. foeniculi, A. narcissi), Alternaria (e.g. ⁇ A. alternata, A. alternantherae, A. arachidis, A. arborescens, A. arbusti, A. blumeae, A. brassicae, A. brassicicola, A.
- Aecidium e.g., A. aechmantherae, A. amaryllidis, A. breyniae, A. campanulastri, A. cannabis, A. cantensis, A. capsicum, A. foenicul
- medicaginicola A. pinodes, A. pisi, A. prasadii, A. rabiei, A. rhei, A. sorghi, A. sorghinia, A. spinaciae, A. tarda, A. tritici, A. viciae, A. vindobonensis), Ascospora (e.g., A. ruborum), Aspergillus (e.g., A. aculeatus, A. candidus, A. clavatus, A. fisherianus, A. flavus, A. fumigatus, A. niger, A. parasiticus, A. restrictus, A. sojae, A.
- Aspergillus e.g., A. aculeatus, A. candidus, A. clavatus, A. fisherianus, A. flavus, A. fumigatus, A. niger, A. parasiticus, A. restrictus, A. so
- Asteroma e.g., A. caryae
- Austropuccinia e.g., A. psidii
- Bipolaris e.g., B. cactivora, B. cookei, B. incurvata, B. sacchari, B. sorghicola, B. sorokiniana, B. zeae
- Blumeria e.g., B. graminis
- Boeremia e.g., B. lycopersici
- Botrytis e.g., B. allii, B. anthophila, B. cinerea, B. citricola, B. citrina, B. elliptica, B. fabae, B.
- C. costaricensis Candida (e.g., C. albicans), Capnodium (e.g., C. theae), Cephalosporium (e.g., C. gramineum), Ceratocystis (e.g., C. fimbriata), Ceratobasidium (e.g., C. cereale), Cercoseptoria (e.g., C. ocellata), Cercospora (e.g., C. angreci, C. apii, C. apiicola, C. arachidicola, C. asparagi, C. atrofiliformis, C. beticola, C. bolleana, C.
- brachypus C. brassicola, C. brunkii, C. canescens, C. cannabis, C. cantuariensis, C. capsici, C. caribaea, C. carotae, C. circumscissa, C. citrulline, C. clemensiae, C. coffeicola, C. coryli, C. corylina, C. eleusine, C. fragariae, C. fuchsiae, C. fusca, C. fusimaculans, C. gerberae, C. halstedii, C. handelii, C. hayi, C. hydrangeae, C. kaki, C. kikuchii, C.
- sojina C. solani, C. solani-tuberosi, C. sorghi, C. theae, C. tuberculans, C. vexans, C. vicosae, C. zeae-maydis, C. zebrina, C. zonata), Cercosporella (e.g., C. rubi), Choanephora (e.g., C. cucurbitarum), Cladosporium (e.g., C. arthropodii, C. brassicae, C. brassicola, C. chrysanthemi, C. citri, C. cladosporioides, C. cucumerinum, C. fulvum, C.
- Cercosporella e.g., C. rubi
- Choanephora e.g., C. cucurbitarum
- Cladosporium e.g., C. arthropodii, C. brassicae, C. brassicola, C
- Coccidioides e.g., C. immitus
- Cochliobolus e.g., C. carbonum, C. cymbopogonis, C. hawaiiensis, C. heterostrophus, C. lunatus, C. miyabeanus, C. ravenelii, C. sativus, C. setariae, C. spicifer, C. stenospilus, C. tuberculatus, C. victoriae
- Coleosporium e.g., C. helianthi, C. ipomoeae, C. madiae, C. pacificum, C.
- Colletotrichum e.g., C. acutatum, C. agaves, C. arachidis, C. boninense, C. brasiliense, C. brassicola, C. brevisporum, C. cacao, C. capsici, C. caudatum, C. cereale, C. citri, C. citricola, C. coccodes, C. coffeanum, C. crassipes, C. curcumae, C. dematium, C. derridis, C. destructivum, C. fioriniae, C. fragariae, C. fructi, C. fruticola, C. fructivorum, C.
- C. acutatum e.g., C. agaves, C. arachidis, C. boninense, C. brasiliense, C. brassicola, C. brevisporum, C. cacao, C. capsici, C. caudatum, C.
- gloeosporioides C. glycines, C. graminicola, C. gossypii, C. hanaui, C. higginsianum, C. jacksonii, C. kahawae, C. lentis, C. limonicola, C. lindemuthianum, C. lini, C. lupini, C. mangenotii, C. melonis, C. miscanthi, C. musae, C. nicholsonii, C. nigrum, C. orbiculare, C. orchidis, C. paspali, C. pisi, C. pisicola, C. radicis, C. roseum, C.
- Cryphonectria e.g., C. parasitica
- Cylindrocarpon e.g., C. ianthothele, C. magnusianum, C. musae
- Cylindrocladiella e.g., C. camelliae, C. parva
- Cylindrocladium e.g., C. lanceolatum, C. peruvianum
- Cylindrosporium e.g., C. cannabinum, C. juglandis, C. rubi
- Cymadothea e.g., C. trifolii
- Cytospora e.g, C. palmarum, C. personata, C. sacchari, C. sacculus, C.
- Cytosporina e.g., C. ludibunda
- Diaporthe e.g., D. arctii, D. asparagi, D. capsici, D. citri, D. coffeae, D. dulcamarae, D. eres, D. helianthi, D. lagunensis, D. lokoyae, D. melonis, D. musae, D. orthoceras, D. perniciosa, D. phaseolorum, D. rudis, D. tanakae, D. viticola), Diplodia (e.g., D.
- Dreschlera e.g., D. avenacea, D. campanulata, D. dematioidea, D. gigantea, D. glycines, D. graminea, D. hawaiiensis, D. musae, D. poae, D. teres, D. wirreganensis
- Eremothcium originally Nematospora
- Erysiphe e.g., E. betae, E. cichoracearum, E. communis, E. cruciferarum, E. flexuosa, E. heraclei, E. necator, E.
- E. polygoni E. robiniae, E. syringae
- Exserohilum e.g., E. oryzicola, E. oryzinum
- Fusarium e.g., F. affine, F. arthrosporioides, F. avenaceum, F. circinatum, F. crookwellense, F. culmorum, F. fujikuroi, F. graminearum, F. incarnatum, F. langsethiae, F. mangiferae, F. merismoides, F. moniliforme, F. oxysporum, F. pallidoroseum, F. poae, F.
- proliferatum proliferatum, F. redolens, F. roseum, F. sacchari, F. solani, F. sporotrichioides, F. sterilihyphosum, F. subglutinans, F. sulphureum, F. tricinctum, F. verticillioides, F. virguliforme), Gaeumannomyces (e.g., G. graminis), Geotrichum (e.g., G. candidum), Gibberella (e.g., G. fujikuroi, G. pulicaris, G. stilboides, G. tricincta, G. xylarioides, G. zeae), Gilbertella (e.g., G., G.
- Glomerella e.g., G. cingulata
- Gymnosporangium e.g., G. juniperi-virginianae
- Helminthosporium e.g., H. oryzae, H. solani
- Hemileia e.g., H. coffeicola, H. vastatrix
- Laetisaria e.g., L. fuciformis
- Leptosphaeria e.g., L. acuta, L. asparagi, L. cannabina, L. coffaeicida, L. coniothyrium, L. glyceriae, L. gossypii, L.
- grisea L. korrae, L. longispora, L. maculans, L. maydis, L. musae, L. oryzicola, L. oryzina, L. pini, L. platanicola, L. pratensis, L. raphani, L. saccharicola, L. solani, L. solanicola, L. trifolii, L. viciae, L. woroninii, L. zeae, L. zeae-maydis), Macrophomina (e.g., M. phaseolina), Magnaporthe (e.g., M. grisea, M. oryzae, M. poae), Melamspora (e.g., M.
- Microdochium e.g., M. nivale
- Monilinia e.g., M. fructicola
- Mucor e.g., M. piriformis
- Mycosphaerella e.g., M. fijiensis, M. graminicola, M. tassiana, M. zeae-maydis
- Neofabraea e.g., N. malicorticus
- Ophiostoma e.g., O. novo-ulmi, O. ulmi
- Paracoccidioides e.g., P. braziliensis
- Penicillium e.g., P. digitatum, P. expansum, P. italicum, P.
- P. verrucosum rugulosum, P. verrucosum
- Phakopsora e.g., P. gossypii, P. meibomiae, P. pachyrhizi
- Phialophora e.g., P. gregata
- Phoma e.g., P. glycinicola
- Phomopsis e.g., P. asparagi, P. coffeae, P. logicolla, P. mangiferae, P. obscurans, P. perseae, P. purnorum, P. sojae, P. sclerotioides, P. tanakae, P. theae, P.
- Phymatotrichopsis e.g., P. omnivora
- Physalospora e.g., P. obtusa
- Phytomyxea Pneumocystis (e.g., P. carinii)
- Podosphaera e.g., P. oxyacanthae
- Pseudocercosporella Puccinia (e.g. , P. asparagi, P. cacahata, P. coronata, P. graminis, P. kuehnii, P. melanocephala, P. porri, P. punctiformis, P. recondita, P.
- S. sclerotiorum S. spermophila, S. trifoliorum
- Sclerotium e.g., S. rolfsii
- Scopulariopsis e.g., S. brevicaulis
- Septoria e.g., S. apiicola, S. aciculosa, S. ampelina, S. avenae, S. azalea, S. bataticola, S. campanulae, S. caryae, S. citri, S. cucurbitacearum, S. cytisi, S. dianthi, S. eumusae, fragariae, S. fragariaecola, S. glycines, S.
- Tilletia e.g., T. barclayana, T. caries, T. controversa, T. foetida, T. indica, T. laevis, T. tritici
- Typhula e.g., T. incarnata, T. ishikariensis
- Uncinula Urocystis (e.g., U. agropyri), Uromyces (e.g., U. melanocephala), Ustilago (e.g., U. esculenta, U. maydis, U. nuda, U. scitaminea, U. striiformis, U. tritici, U.
- fungi e.g., V. alfalfae, V. dahliae, V. isaacii, V. longisporum, V. theobromae, V. zaregamsianum), Waitea (e.g., W. circinata) and/or Zymoseptoria (e.g., Z. tritici).
- Verticillium e.g., V. alfalfae, V. dahliae, V. isaacii, V. longisporum, V. theobromae, V. zaregamsianum
- Waitea e.g., W. circinata
- Zymoseptoria e.g., Z. tritici
- compositions of the present disclosure are useful for preventing, treating, suppressing, eliminating and/or reducing the severity of oomycete infestations/infections by, for example, inhibiting adhesion of an oomycete to a surface, inhibiting entry of an oomycete into a material, inhibiting habitation by an oomycete, inhibiting production of one or more amino acids, degrading one or more amino acids, inhibiting the growth of an oomycete, inhibiting the reproduction and/or proliferation of an oomycete, degrading on one or more structural components of an oomycete (e.g.
- cell wall components such as celluloses and other beta-glucans
- killing an oomycete and/or reducing one or more symptoms of an oomycete infestation/infection.
- inhibition is complete or substantially complete, such that the oomycete fails to inhabit/feed/grow/reproduce/proliferate at a rate effective to initiate and/or sustain an appreciable infestation/infection.
- spraying a plant with an enzyme of the present disclosure may inhibit an oomycete's ability to adhere to the surface of a plant, inhibit an oomycete's ability to enter into the plant, inhibit an oomycete's ability to inhabit the plant, inhibit production of one or more amino acids, degrade one or more amino acids, inhibit growth of an oomycete on/in the plant, inhibit the reproduction and/or proliferation of an oomycete on/in the plant, degrade one or more structural components of an oomycete (e.g.
- one or more beta-glucans on/in the plant, and/or kill an oomycete, thereby reducing one or more symptoms of infestation and/or enhancing one or more characteristics of growth and/or yield in the plant, as compared to an untreated control plant.
- compositions of the present disclosure may be used to prevent and/or treat infestations/infections of myriad phytopathogenic oomycetes, including, but not limited to, phytopathogenic Albuginaceae, Peronosporaceae and Pythiaceae, such as blights, mildews, molds, root rots and rusts
- proteins of the present disclosure are used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part by one or more Achlya, Albugo (e.g., A. candida), Aphanomyces (e.g., A. cochlioides, A. euteiches, A. invadans, A. iridis, A.
- raphani raphani
- Bremia e.g., B. lactucae
- Hyaloperonospora e.g., H. arabidopsidis
- Peronospora e.g., P. belbahrii, P. destructor, P. effusa, P. farinose, P. fulva, P. lotorum, P. manshurica, P. parasitica, P. potentillae, P. rubi, P. schachtii, P. sparsa, P. tabacina, P. trifolii, P. viciae
- Phytophthora e.g., P. agathidicia, P. boehmeriae, P. cactorum, P.
- Pseudeoperonospora e.g., P. cubensis, P. humuli
- Pseudosclerospora e.g., P. philippinesis, P. sacchari, P. sorghi
- Pythium e.g., P. acanthicum, P. aphanidermatum, P. aristosporum, P. arrhenomanes, P. butleri, P. chondricola, P. citrinum, P. cucurbitacearum, P. debaryanum, P. delicense, P. emineosum, P. graminicola, P. heterothallicum, P.
- compositions of the present disclosure may be particularly useful for preventing, treating, suppressing, eliminating and/or reducing the severity of infestations/infections of/by phytopathogenic fungi and oomycetes, such as Albugo (e.g., A. candida, A. occidentalis), Alternaria (e.g. ⁇ A.
- alternata A. alternantherae, A. arachidis, A. arborescens, A. arbusti, A. blumeae, A. brassicae, A. brassicicola, A. burnsii. A. carotiincultae, A. carthami, A. celosiae, A. cinerariae, A. citri, A. conjuncta, A. cucumerina, A. dauci, A. dianthi, A. dianthicola, A. eichhorniae, A. euphorbiicola, A. gaisen, A. helianthi, A. helianthicola, A. hungarica, A. infectoria, A.
- japonica japonica, A. leucanthemi, A. linicola, A. longipes, A. mali, A. molesta, A. padwickii, A. panax, A. perloisata, A. patroselini, A. porri, A. quericola, A. radicina, A. raphani, A. saponariae, A. selini, A. senecionis, A. smyrnii, A. solani, A. sonchi, A. tenuissima, A. triticina, A. ventricosa, A. zinniae), Blumeria (e.g., B. graminis), Botrytis (e.g., B.
- aclada B. allii, B. cinerea, B. elliptica, B. fabae, B. squamosa
- Ceratocystis e.g., C. fimbriata
- Colletotrichum Diplodia (e.g., D. gossypina)
- Erwinia e.g., E. amylovora, E. aphidicola, E. carotovora, E. chrysanthemi, E. papayae, E. persicina, E. psidii, E. pyrifoliae, E. rhapontici, E. tracheiphila
- Fusarium e.g., F.
- G. candidum e.g., G. candidum
- Gibberella e.g., G. fujikuroi, G. pulicaris, G. zeae
- Gilbertella e.g., G. persicaria
- Glomerella e.g., G. cingulata
- Hyaloperonospora e.g., H. arabidopsidis
- Macrophomina e.g., M. phaseolina
- Magnaporthe e.g., M. grisea, M. oryzae
- Melampsora e.g., M.
- Neofabraea e.g., N. malicorticus
- Penicillium e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum
- Phakopsora e.g., P. pachyrhizi
- Physalospora e.g., P. obtusa
- Phytophthora e.g., P. capsici, P. cinnamomi, P.
- P. parasitica infestans, P. parasitica, P. ramorum, P. sojae
- Plasmopara e.g., P. vit ⁇ cola
- Pseudoperonospora e.g., P. cubensis
- Puccinia e.g. , P. asparagi, P. cacahata, P. graminis, P. kuehnii, P. melanocephala, P. porri, P. punctiformis, P. recondita, P. schedonnardii, P. sessilis, P. sorghi, P. striiformis, P. tritici, P. triticina
- Pythium e.g., P.
- Rhizoctonia e.g., R. solani
- Rhizopus e.g., R. nigricans, R. stolonifer
- Sclerotinia e.g., S. borealis, S. bulborum, S. homoeocarpa, S. libertiana, S. minor, S. ricini, S. sclerotiorum, S. spermophila, S. trifoliorum
- Septoria e.g., S. cucurbitacearum, S. glycines, S. lycospersici
- Ustilago e.g., U. esculenta, U. maydis, U.
- Blast infestations/infections such as those mediated by Magnaporthe (e.g., M. grisea, M. oryzae), may be prevented, treated, suppressed and/or eliminated with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 1.1.3 (e.g., 1.1.3.4), EC 1.1.99 (e.g., 1.1.99.18), 1.11.1 (e.g., 1.11.1.6), 3.1.1 (e.g., 3.1.1.3), 3.2.1 (e.g., 3.2.1.1, 3.2.1.4, 3.2.1.6, 3.2.1.8, 3.2.1.21), 3.4.11 and/or 3.4.21 (and corresponding formulations, polynucleotides and organisms).
- EC 1.1.3 e.g.3.4
- EC 1.1.99 e.g., 1.1.99.18
- 1.11.1 e.g., 1.11.1.6
- 3.1.1 e.g., 3.1.1.3
- infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–8, 10–12, 14–15, 17–23, 34–40, 43–46, 48–53, 57, and enzymatically active fragments/mutants/variants thereof.
- infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as one or more cellulases, one or more hemicellulases and one or more xylanases; one or more peptidases and one or more proteases; one or more cellulases, one or more glucosidases and one or more xylanases.
- Blight infestations/infections such as those mediated by Alternaria (e.g. ⁇ A. alternata, A. carotiincultae, A. panax, A. petroselini, A. solani, A. triticina), Colletotrichum, Fusarium (e.g., F.
- EC 1.1.3 e.g., 1.1.3.4
- EC 1.1.99 e.g., 1.1.99.18
- 1.10.3 e.g., 1.10.3.2
- 1.11.1 e.g., 1.11.1.6
- 3.1.1 e.g., 3.1.1.5
- 3.2.1 e.g., 3.2.1.1, 3.2.1.3, 3.2.1.4, 3.2.1.5, 3.2.1.6, 3.2.1.8, 3.2.1.11, 3.2.1.15, 3.2.1.39, 3.2.1.41, 3.2.1.58, 3.2.1.75, 3.2.1.78, 3.2.1.111
- 3.4.11 e.g., 3.4.11.1
- 3.4.11 e.g., 3.4.11.1
- 3.4.11 e.g., 3.4.11.1
- infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–15, 17–25, 34–55, 57, 61, 65, 68, 80–88, 91, 72144, and enzymatically active fragments/mutants/variants thereof.
- infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as two or more cellulases; two or more pectinases; two or more glucanases; two or more peptidases; two or more pectinases; one or more cellulases, one or more hemicellulases and one or more xylanases; one or more glucanses and one or more xylanases; one or more amylases, one or more glucanases and one or more xylanases.
- Blotch infestations/infections such as those mediated by Mycosphaerella (e.g., M.
- EC 1.1.3 e.g., 1.1.3.4
- EC 1.1.99 e.g., 1.1.99.18
- 1.10.3 e.g., 1.10.3.2
- 1.11.1 e.g., 1.11.1.6
- 3.1.1 e.g., 3.1.1.5
- 3.2.1 e.g., 3.2.1.1, 3.2.1.3, 3.2.1.6, 3.2.1.8, 3.2.1.11, 3.2.1.15, 3.2.1.39, 3.2.1.41, 3.2.1.58, 3.2.1.75, 3.2.1.78, 3.2.1.101, 3.2.1.109, 3.2.1.110, 3.2.1.112
- 3.4.11 e.g., 3.4.11.1
- 3.4.21 e.g., 3.4.21.62
- 3.4.24 e.
- infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–12, 17–24, 34–45, 48–54, 61, 80–81, 83–88, 91, and enzymatically active fragments/mutants/variants thereof.
- infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as one or more cellulases, one or more lyases and one or more pectinases; as one or more cellulases, one or more hemicellulases and one or more xylanases; two or more cellulases; two or more glucanases; two or more pectinases; one or more glucanses and one or more xylanases; one or more peptidases and one or more proteases.
- Downy mildew infestations/infections such as those mediated by Bremia (e.g., B.
- Hyaloperonospora e.g., H. arabidopsidis, H. parasitica
- Peronospora e.g., P. belbahrii, P. destructor, P. effusa, P. farinose, P. fulva, P. lotorum, P. manshurica, P. parasitica, P. potentillae, P. rubi, P. schachtii, P. sparsa, P. tabacina, P. trifolii, P. viciae
- Peronosclerospora Plasmopara (e.g., P. halstedii, P.
- compositions of the present disclosure including, but not limited to, proteins exhibiting one or more activities belonging to EC 3.2.1. (e.g., 3.2.1.8, 3.2.1.78) and/or 3.4.21 (e.g., 3.4.21.19, 3.4.21.62) (and corresponding formulations, polynucleotides and organisms).
- infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 48–53, 80–87, and enzymatically active fragments/mutants /variants thereof.
- Powdery mildew infestations/infections such as those mediated by Blumeria (e.g., B. graminis), Erysiphe (e.g., E. cichoracearum, E. necator), Golovinomyces, Leveillula (e.g., L. taurica), Microsphaera (e.g., M. diffusa), Oidium, Phyllactinia, Podosphaera (e.g., P.
- Blumeria e.g., B. graminis
- Erysiphe e.g., E. cichoracearum, E. necator
- Golovinomyces e.g., Leveillula (e.g., L.
- aphanis, P. leucotricha, P. pannosa, P. xanthii), Sphaerotheca and Uncinula may be prevented, treated, suppressed and/or eliminated with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 1.1.3 (e.g., 1.1.3.4), EC 1.11.1 (e.g., 1.11.1.6), 3.2.1 (e.g., 3.2.1.8, 3.2.15) and/or 3.4.21 (and corresponding formulations, polynucleotides and organisms).
- infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–5, 10–12, 48–53, 80– 81, and enzymatically active fragments/mutants /variants thereof.
- infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as two or more pectinases.
- Mold infestations/infections such as those mediated by Botrytis (e.g., B. cinerea, B. elliptica), Penicillium (e.g., P. digitatum), Phytophthora (e.g., P. capsici, P.
- cinnamomi, P. ramorum, P. sojae may be prevented, treated, suppressed and/or eliminated with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 1.1.3 (e.g., 1.1.3.4), EC 1.1.99 (e.g., 1.1.99.18), 1.10.3 (e.g., 1.10.3.2), 1.11.1 (e.g., 1.11.1.6, 1.11.1.7), EC 1.14.99 (e.g., 1.14.99.56), EC 3.1.1 (e.g., 3.1.1.3, 3.1.1.5, 3.1.1.32), 3.2.1 (e.g., 3.2.1.1, 3.2.1.3, 3.2.1.4, 3.2.1.5, 3.2.1.6, 3.2.1.8, 3.2.1.11, 3.2.1.15, 3.2.1.17, 3.2.1.21, 3.2.1.24, 3.2.1.39, 3.2.1.41, 3.2.1.59, 3.2.1.75, 3.2.1.78, 3.2.1.
- infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–15, 17–24, 34–46, 48–54, 57–64, 68–69, 76–81, 83–88, 91, 45906, 72144, and enzymatically active fragments/mutants /variants thereof.
- infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as two or more cellulases; two or more pectinases; one or more cellulases, one or more hemicellulases and one or more xylanases; one or more peptidases and one or more proteases; one or more amylases, one or more glucanases and one or more bacillolysins; ; one or more cellulases, one or more hemicellulases and one or more xylanases; two or more peptidases; one or more glucanses and one or more xylanases; one or more peptidases and one or more proteases; one or more cellulases, one or more glucosidases and one or more xylanases; one or more cellulases, one or more furanosidases and one or more xylana
- Crown/fruit/root/stem rot infestations/infections such as those mediated by Colletotrichum, Fusarium (e.g., F. solani, F. virguliforme), Phytophthora (e.g., P. capsica, P. cinnamomi, P. nicotianae, P. parasitica, P. sojae), Pythium (e.g., P. graminicola, P. ultimum), Saprolegnia (e.g., S.
- Fusarium e.g., F. solani, F. virguliforme
- Phytophthora e.g., P. capsica, P. cinnamomi, P. nicotianae, P. parasitica, P. sojae
- Pythium e.g., P. graminicola, P. ultimum
- Saprolegnia e.g., S.
- EC 1.1.3 e.g., 1.1.3.4
- EC 1.1.99 e.g., 1.1.99.18
- 1.11.1 e.g., 1.11.1.6
- 3.2.1 e.g., 3.2.1.6, 3.2.1.8, 3.2.1.11, 3.2.1.39, 3.2.1.58, 3.2.1.75, 3.2.1.109, 3.2.1.110, 3.2.1.111
- 3.4.21 e.g., 3.4.21.19
- infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–13, 24, 34–41, 46, 48–54, 61, 78, 80–88, and enzymatically active fragments/mutants/variants thereof.
- infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as two or more cellulases; two or more pectinases; two or more glucanases; two or more peptidases; one or more amylases, one or more glucanases and one or more bacillolysins; one or more cellulases, one or more lyases and one or more pectinases; one or more cellulases, one or more hemicellulases and one or more xylanases; one or more glucanses and one or more xylanases; one or more peptidases and one or more proteases.
- enzymes such as two or more cellulases; two or more pectinases; two or more glucanases; two or more peptidases; one or more amylases, one or more glucanases and one or more bacillolysins; one or more
- Rust infestations/infections such as those mediated by Albugo (e.g., A. candida, A. occidentalis), Hemileia (e.g., H. coffeicola, H. vastatrix), Melamspora (e.g., M. lini), Phakopsora (e.g., P. meibomiae, P. pachyrhizi), Puccinia (e.g., P. asparagi, P. cacahata, P. graminis, P. kuehnii, P. melanocephala, P. porri, P. punctiformis, P. recondita, P. schedonnardii, P. sessilis, P.
- Albugo e.g., A. candida, A. occidentalis
- Hemileia e.g., H. coffeicola, H. vastatrix
- Melamspora e.g., M. lini
- sorghi, P. striiformis, P. tritici, P. triticina) and Uromyces may be prevented and/or treated with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 1.1.3 (e.g., 1.1.3.4), 1.10.3 (e.g., 1.10.3.2), 3.1.1 (e.g., 3.1.1.5), 3.2.1 (e.g., 3.2.1.1, 3.2.1.3, 3.2.1.4, 3.2.1.5, 3.2.1.6, 3.2.1.8, 3.2.1.15, 3.2.1.41, 3.2.1.58, 3.2.1.78), 3.4.11 (e.g., 3.4.11.1), 3.4.21 (e.g., 3.4.21.19, 3.4.21.62) and/or 3.4.24 (e.g., 3.4.24.28) (and corresponding formulations, polynucleotides and organisms).
- infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–5, 9, 24, 34–46, 48–53, 61, 68, 80–88, 72144, and enzymatically active fragments/mutants /variants thereof.
- infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as two or more glucanases; one or more peptidases and one or more proteases; and one or more amylases, one or more glucanases and one or more bacillolysins Wilt infestations/infections, such as those mediated by Fusarium (e.g., F. oxysporum,), Phytophthora (e.g., P. capsici, P. infestans, P.
- Fusarium e.g., F. oxysporum,
- Phytophthora e.g., P. capsici, P. infestans, P.
- ramorum may be prevented, treated, suppressed and/or eliminated with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 1.1.3 (e.g., 1.1.3.4), EC 1.1.99 (e.g., 1.1.99.18), 1.10.3 (e.g., 1.10.3.2), 1.11.1 (e.g., 1.11.1.6), 3.1.1 (e.g., 3.1.1.5), 3.2.1 (e.g., 3.2.1.1, 3.2.1.3, 3.2.1.4, 3.2.1.5, 3.2.1.6, 3.2.1.8, 3.2.1.11, 3.2.1.15, 3.2.1.39, 3.2.1.41, 3.2.1.58, 3.2.1.75, 3.2.1.78, 3.2.1.111), 3.4.11 (e.g., 3.4.11.1), 3.4.21 (e.g., 3.4.21.19, 3.4.21.62) and/or 3.4.24 (e.g., 3.4.24.28) (and corresponding formulations, polynu
- infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–15, 17–24, 34–46, 48–55, 57, 68, 80–88, 72144, and enzymatically active fragments/mutants/variants thereof.
- infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as two or more cellulases; two or more pectinases; two or more glucanases; two or more peptidases; two or more pectinases; one or more cellulases, one or more hemicellulases and one or more xylanases; one or more glucanases and one or more xylanases; one or more amylases, one or more glucanases and one or more xylanases.
- enzymes such as two or more cellulases; two or more pectinases; two or more glucanases; two or more peptidases; two or more pectinases; one or more cellulases, one or more hemicellulases and one or more xylanases; one or more glucanases and one or more xylanases; one or more amylase
- compositions of the present disclosure are useful for preventing, treating, suppressing, eliminating and/or reducing the severity of gastropod infestations by, for example, reducing attraction of a gastropod to a surface, inhibiting inhabitation by a gastropod, inhibiting feeding of a gastropod, inhibiting the growth of a gastropod, inhibiting the reproduction and/or proliferation of a gastropod, degrading on one or more structural components of a gastropod, killing a gastropod, and/or reducing one or more symptoms of a gastropod infestation.
- such inhibition is complete or substantially complete, such that the gastropod fails to inhabit/feed/grow/reproduce/proliferate at a rate effective to initiate and/or sustain an appreciable infestation.
- spraying a plant with an enzyme of the present disclosure may reduce the attractiveness of the plant to a gastropod, reduce a gastropod's desire/ability to inhabit the plant, inhibit a gastropod's desire/ability to feed on the plant, inhibiting the growth of a gastropod after it inhabits/feeds on the plant, inhibit the reproduction and/or proliferation of a gastropod on/in the plant, degrade one or more structural components of a gastropod on/in the plant, and/or kill a gastropod, thereby reducing one or more symptoms of infestation and/or enhancing one or more characteristics of growth and/or yield in the plant, as compared to an untreated control plant.
- compositions of the present disclosure may be used to prevent, treat, suppress, eliminate and/or reduce the severity of infestations of/by myriad gastropods, including, but not limited to, slugs and snails.
- compositions of the present disclosure are useful for preventing, treating, suppressing, eliminating and/or reducing the severity of insect infestations by, for example, reducing attraction of an insect to a surface, inhibiting entry of an insect into a material, inhibiting inhabitation by an insect, inhibiting feeding of an insect, inhibiting production of one or more amino acids, degrading one or more amino acids, preventing an insect from utilizing one or more essential amino acids, producing ammonia in the gut of an insect, inhibiting the growth of an insect, inhibiting the reproduction and/or proliferation of an insect, degrading on one or more structural components of an insect (e.g.
- procuticle components such as chitin, and epicuticle components, such as lipoproteins, hydrocarbons, polyphenols and esters of fatty acids and alcohols
- killing an insect and/or reducing one or more symptoms of an insect infestation.
- inhibition is complete or substantially complete, such that the insect fails to inhabit/feed/grow/reproduce/proliferate at a rate effective to initiate and/or sustain an appreciable infestation.
- spraying a plant with an enzyme of the present disclosure may reduce the attractiveness of the plant to an insect, reduce an insect's desire/ability to inhabit the plant, inhibit an insect's desire/ability to feed on the plant, inhibit production of one or more amino acids, degrade one or more amino acids, prevent an insect from utilizing one or more essential amino acids, produce ammonia in the gut of an insect, inhibit the growth of an insect after it inhabits/feeds on the plant, inhibit the reproduction and/or proliferation of an insect on/in the plant, degrade one or more structural components of an insect (e.g.
- compositions of the present disclosure may be used to prevent and/or treat infestations of myriad insects, including, but not limited to, Coleoptera, Dermaptera, Diptera, Hemiptera, Homoptera, Hymenoptera, Lepidoptera, Orthoptera and Thysanoptera, such as aphids, armyworms, beetles, bollworms, bugs, caterpillars, cutworms, flies, moths and thrips.
- enzymes of the present disclosure are used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation of by one or more Acalymma, Acanthaoscelides (e.g., A.
- Anasa e.g., A. tristis
- Anastrepha e.g., A. ludens
- Anoplophora e.g., A. glabripennis
- Anthonomus e.g., A. eugenii
- Acyrthosiphon e.g., A. pisum
- Aphis e.g., A. gossypii
- Aulacorthum e.g., A. solani
- Bactrocera e.g. ⁇ B. dosalis
- Bemisia e.g., B. argentifolii, B. tabaci
- Brevicoryne e.g., B.
- brassicae Bruchidius (e.g., B. atrolineatus), Bruchus (e.g., B. atomarius, B. dentipes, B. lentis, B. pisorum and/or B. rufipes), Callosobruchus (e.g., C. chinensis, C. maculatus, C. rhodesianus, C. subinnotatus, C. theobromae), Caryedon (e.g., C. serratus), Cassadinae, Ceratitis (e.g., C. capitata), Chrysomelinae, Circulifer (e.g., C.
- E. tenellus Criocerinae, Cryptocephalinae, Cryptolestes (e.g., C. ferrugineus, C. pusillis, C. pussilloides), Cylas (e.g., C. formicarius), Delia (e.g., D. antiqua), Diabrotica, Diaphania (e.g., D. nitidalis), Diaphorina (e.g., D. citri), Donaciinae, Ephestia (e.g, E. cautella, E. elutella, E., keuhniella), Epilachna (e.g., E. varivestris), Epiphyas (e.g., E.
- euphorbiae Manducca
- Melanoprus e.g., M. bivitattus, M. differntialis, M. femurrubrum
- Melittia e.g., M. cucurbitae
- Myzus e.g., M. persicae
- Nezara e.g., N. viridula
- Orzaephilus e.g., O. merator, O. surinamensis
- Ostrinia e.g., O. nubilalis
- Phthorimaea e.g., P. operculella
- Pieris e.g., P. rapae
- Plodia e.g., P.
- interpunctella Plutella (e.g., P. xylostella), Popillia (e.g., P. japonica), Prostephanus (e.g., P. truncates), Psila, Rhizopertha (e.g., R. dominica), Rhopalosiphum (e.g., R. maidis), Sagrinae, Solenopsis (e.g., S. Invicta), Spilopyrinae, Sitophilus (e.g., S. granaries, S. oryzae and/or S. zeamais), Sitotroga (e.g., S. cerealella), Spodoptera (e.g., S.
- frugiperda frugiperda
- Stegobium e.g., S. paniceum
- Synetinae Tenebrio (e.g., T. malens and/or T. molitor), Thrips (e.g., T. tabaci),
- Trialeurodes e.g., T. vaporariorum
- Tribolium e.g., T. castaneum and/or T. confusum
- Trichoplusia e.g., T. ni
- Trogoderma e.g., T. granarium
- Trogossitidae e.g., T. mauritanicus
- compositions of the present disclosure may be particularly useful for preventing, treating, suppressing, eliminating and/or reducing the severity of infestations/infections of/by leaf-eating insects, such as aphids, beetles, grasshoppers, leaf-eating larvae, locusts, thrips and weevils.
- Leaf-eating insect infestations/infections may be prevented, treated, suppressed and/or eliminated with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 2.3.2 (e.g., 2.3.2.2), EC 3.1.1 (e.g., EC 3.1.1.3, EC 3.1.1.74), EC 3.2.1 (e.g., EC 3.2.1.24, EC 3.2.1.130, EC 3.2.1.163, EC 3.2.1.198), EC 3.5.1 (e.g., EC 3.5.1.1, EC 3.5.1.2, EC 3.5.1.33, EC 3.5.1.35) and EC 3.5.4 (e.g., EC 3.5.4.1, EC 3.5.4.2, EC 3.5.4.3, EC 3.5.4.4) (and corresponding formulations, polynucleotides and organisms).
- EC 2.3.2 e.g., 2.3.2.2
- EC 3.1.1 e.g., EC
- infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 16, 17–23, 27–31, 58, 76–77, 79, 89–90, 72147, 72149 and enzymatically active fragments/mutants/variants thereof.
- infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as two or more amidases; two or more aminoacyltransferases; two or more asparaginases; two or more cutinases; two or more glutaminases; two or more mannanases; two or more mannosidases; two or more triacylglycerol lipases; one amidase and one aminoacyltransferase.
- enzymes such as two or more amidases; two or more aminoacyltransferases; two or more asparaginases; two or more cutinases; two or more glutaminases; two or more mannanases; two or more mannosidases; two or more triacylglycerol lipases; one amidase and one aminoacyltransferase.
- compositions of the present disclosure are useful for preventing, treating, suppressing, eliminating and/or reducing the severity of nematode infestations/infections by, for example, inhibiting adhesion of a nematode to a surface, inhibiting entry of a nematode into a material, inhibiting habitation by a nematode, inhibiting production of one or more amino acids, degrading one or more amino acids, preventing a nematode from utilizing one or more essential amino acids, inhibiting the growth of a nematode, inhibiting the reproduction and/or proliferation of a nematode, degrading on one or more structural components of a nematode (e.g.
- cuticle components such as collagens, cuticlins, glycoproteins and lipids
- killing a nematode and/or reducing one or more symptoms of a nematode infestation/infection.
- inhibition is complete or substantially complete, such that the nematode fails to inhabit/feed/grow/reproduce/proliferate at a rate effective to initiate and/or sustain an appreciable infestation/infection.
- spraying a plant with an enzyme of the present disclosure may inhibit a nematode's ability to adhere to the surface of a plant, inhibit a nematode's ability to enter into the plant, inhibit a nematode's ability to inhabit the plant, inhibit growth of a nematode on/in the plant, inhibit the reproduction and/or proliferation of a nematode on/in the plant, degrade one or more structural components of a nematode (e.g., one or more collagens, one or more cuticlins, one or more glycoproteins and/or one or more lipids) on/in the plant, and/or kill a nematode, thereby reducing one or more symptoms of infestation and/or enhancing one or more characteristics of growth and/or yield in the plant, as compared to an untreated control plant.
- a nematode's ability to adhere to the surface of a plant may inhibit a nematode's ability to enter into the plant, inhibit a
- compositions of the present disclosure may be used to prevent, treat, suppress, eliminate and/or reduce the severity of infestations/infections of/by myriad phytopathogenic nematodes, including, but not limited to, root-knot nematodes, cyst nematodes, burrowing nematodes, root lesion nematodes, wilt nematodes and reniform nematodes.
- enzymes of the present disclosure are used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part by one or more Meloidogyne (e.g., M. arenaria, M. graminicola, M. hapla, M. incognita, M.
- Globodera e.g., G. pallida, G. rostochiensis
- Heterodera e.g., H. avenae, H. filipjevi, H. glycines, H. schachtii
- Pratylenchus e.g., P. penetrans, P. thornei, P. neglectus, P. zae, P. vulnus, P. coffeae
- Radopholus e.g., R. similis
- Ditylenchus e.g., D. dipsaci, D. angustus, D. desctructor, D. africanus, D. myceliophagus, D.
- Bursaphelenchus e.g., B. xylophilus, B. mucronatus
- Rotylenchus e.g., R. reniformis, R. parvus
- Xiphinema e.g., X. index, X. italiae, X. viuttenezi, X. diversicaudatun
- Nacobbus e.g., N. aberrans
- compositions of the present disclosure e.g., proteins, formulations, polynucleotides and organisms of the present disclosure
- methods of using compositions of the present disclosure for a) preventing, treating, suppressing and/or eliminating infestations/infections of/by various pests, including, but not limited to, phytopathogenic pests, such as acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa, viruses and weeds; b) treating surfaces/substances that are susceptible to infestation/infection by pests; c) cleansing surfaces/substances that are infested/infected by pests; d) reducing one
- a protein that exhibits one or more oxidoreductase activities belonging to EC 1 for example, one or more oxidase activities belonging to EC 1.1.3 (e.g., glucose oxidase activity belonging to EC 1.1.3.4, hexose oxidase activity belonging to EC 3.1.1.5, galactose oxidase activity belonging to EC 1.1.3.9), EC 1.1.99 (e.g., cellobiose oxidase activity belonging to EC 1.1.99.18), EC 1.4.3 (e.g., D-aspartate oxidase activity belonging to EC 1.4.3.1, L-amino acid oxidase activity belonging to EC 1.4.3.2, D-amino acid oxidase activity belonging to EC 1.4.3.3, D-glutamate oxidase activity belonging to EC 1.4.3.7, L-glutamate oxidase activity belonging to EC 1.4.3.11,
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 1–15; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89,
- a protein exhibiting activity belonging to EC 1.1 for example, a protein exhibiting activity belonging to EC 1.1.3 (e.g., EC 1.1.3.4) or EC 1.1.99 (e.g., EC 1.1.99.18)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Blumeria (e.g., B. graminis), Botrytis (e.g., B. cinerea), Fusarium (e.g., F. graminearum, F. oxysporum, F.
- Blumeria e.g., B. graminis
- Botrytis e.g., B. cinerea
- Fusarium e.g., F. graminearum, F. oxysporum, F.
- virguliforme e.g., M. grisea, M. oryzae
- Penicillium e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum
- Phakopsora e.g., P. pachyrhizi
- Phytophthora e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P. sojae
- Puccinia e.g., P. striiformis
- Zymoseptoria e.g., Z. tritici
- an oxidoreductase optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 1–8, (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations/infections.
- a protein exhibiting activity belonging to belonging to EC 1.10 for example, a protein exhibiting activity belonging to EC 1.10.3 (e.g., EC 1.10.3.2)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Botrytis (e.g., B. cinerea), Fusarium (e.g., F. graminearum, F. oxysporum, F. virguliforme), Phakopsora (e.g., P. pachyrhizi), Phytophthora (e.g., P. capsici, P.
- Botrytis e.g., B. cinerea
- Fusarium e.g., F. graminearum, F. oxysporum, F. virguliforme
- Phakopsora e.g., P. pachyrh
- a oxidase optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 9, (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part
- a protein exhibiting activity belonging to EC 1.11 for example, a protein exhibiting activity belonging to EC 1.11.1 (e.g., EC 1.11.1.6 and EC 1.11.1.7)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Blumeria (e.g., B. graminis), Botrytis (e.g., B. cinerea), Fusarium (e.g., F. graminearum, F. oxysporum, F. virguliforme), Magnaporthe (e.g., M. grisea, M.
- Blumeria e.g., B. graminis
- Botrytis e.g., B. cinerea
- Fusarium e.g., F. graminearum, F. oxysporum, F. virguliforme
- Penicillium e.g., P. digitatum
- Phakopsora e.g., P. pachyrhizi
- Phytophthora e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P. sojae
- Puccinia e.g., P. striiformis
- Zymoseptoria e.g., Z. tritici
- a peroxidase optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 10–13, (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations/infections.
- a protein exhibiting activity belonging to EC 1.14 for example, a protein exhibiting activity belonging to EC 1.14.99 (e.g., EC 1.14.99.56)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Botrytis (e.g., B. cinerea), Fusarium (e.g., F. graminearum, F. oxysporum, F. virguliforme), Magnaporthe (e.g., M. grisea, M. oryzae), Penicillium (e.g., P. digitatum, P.
- Botrytis e.g., B. cinerea
- Fusarium e.g., F. graminearum, F. oxysporum, F. virguliforme
- Magnaporthe e.g., M. grisea,
- a oxygenase optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 14–15, (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations/infections.
- a protein that exhibits one or more transferase activities belonging to EC 2 for example, one or more aminoacyltransferase activities belonging to EC 2.3.2 (e.g., D-glutamyltransferase activity belonging to EC 2.3.2.1, gamma-glutamyltransferase activity belong to EC 2.3.2.2, aspartyltransferase activity belonging to EC 2.3.2.7, protein-glutamine gamma-glutamyltransferase activity belonging to EC 2.3.2.13, D-alanine gamma-glutamyl transferase activity belonging to EC 2.3.2.14)—or a corresponding formulation, polynucleotide, or organism, optionally a protein comprising, consisting essentially of, or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 16; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
- a protein exhibiting activity belonging to EC 2.3 for example, a protein exhibiting activity belonging to EC 2.3.2 (e.g., EC 2.3.2.2)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation of a plant or plant part of/by one or more leaf-eating insects.
- an aminoacyltransferase optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 16 (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations.
- a protein that exhibits one or more hydrolase activities belonging to EC 3 for example, one or more esterase activities belonging to EC 3.1.1 (e.g., triacylglycerol lipase activity belong to EC 3.1.1.3, phospholipase A 2 activity belonging to EC 3.1.1.4, lysophospholipase activity belonging to 3.1.1.5, pectinesterase activity belonging to 3.1.1.11, phospholipase A 1 activity belonging to 3.1.1.32, lipoprotein lipase activity belonging to EC 3.1.1.34, cutinase activity belonging to 3.1.1.74), EC 3.1.3 (e.g., alkaline phosphatase activity belonging to EC 3.1.3.1, acid phosphatase activity belonging to EC 3.1.3.2, 3-phytase activity belonging to EC 3.1.3.8, glucose-6-phosphatase activity belonging to EC 3.1.3.9, glucose-1-phosphatase activity belonging to EC 3.1.3.10, fructo
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 17–90, 45906, 72144, 72147 and 72149; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85,
- a protein exhibiting activity belonging to EC 3.1 for example, a protein exhibiting activity belonging to EC 3.1.1 (e.g., EC 3.1.1.3, EC 3.1.1.5, EC 3.1.1.11, and EC 3.1.1.74) and 3.1.4 (e.g., EC 3.1.4.3 and EC 3.1.4.11)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Botrytis (e.g., B. cinerea), Fusarium (e.g., F. graminearum, F. oxysporum, F.
- Botrytis e.g., B. cinerea
- Fusarium e.g., F. graminearum, F. oxysporum, F.
- virguliforme e.g., M. grisea, M. oryzae
- Penicillium e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum
- Phakopsora e.g., P. pachyrhizi
- Phytophthora e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P. sojae
- Zymoseptoria e.g., Z. tritici
- insects e.g., Z. tritici
- a protein exhibiting activity belonging to EC 3.2 for example, a protein exhibiting activity belonging to EC 3.2.1 (e.g., EC 3.2.1.1, EC 3.2.1.3, EC 3.2.1.4, EC 3.2.1.6, EC 3.2.1.7, EC 3.2.1.8, EC 3.2.1.11, EC 3.2.1.15, EC 3.2.1.17, EC 3.2.1.21, EC 3.2.1.24, EC 3.2.1.39, EC 3.2.1.41, EC 3.2.1.55, EC 3.2.1.58, EC 3.2.1.59, EC 3.2.1.73, EC 3.2.1.75, EC 3.2.1.78, EC 3.2.1.101, EC 3.2.1.109, EC 3.2.1.130, EC 3.2.1.133, EC 3.2.1.163 and EC 3.2.1.198)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection
- Botrytis e.g., B. cinerea
- Fusarium e.g., F. graminearum, F. oxysporum, F. virguliforme
- Magnaporthe e.g., M. grisea, M. oryzae
- Penicillium e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum
- Phakopsora e.g., P. pachyrhizi
- Phytophthora e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P.
- Pseudoperonospora e.g., P. cubensis
- Puccinia e.g., P. striiformis
- Zymoseptoria e.g., Z. tritici
- a glycosylase optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 34–79, 45906 and 72144, (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations/infections.
- a protein exhibiting activity belonging to belonging to EC 3.4 for example, a protein exhibiting activity belonging to EC 3.4.11 (e.g., EC 3.4.11.1), EC 3.4.21 (e.g., EC 3.4.21.19, EC 3.4.21.62) and EC 3.4.24 (e.g., EC 3.4.24.28)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Blumeria (e.g., B. graminis), Botrytis (e.g., B. cinerea), Fusarium (e.g., F.
- Blumeria e.g., B. graminis
- Botrytis e.g., B. cinerea
- Fusarium e.g., F.
- P. graminearum F. oxysporum, F. virguliforme
- Magnaporthe e.g., M. grisea, M. oryzae
- Penicillium e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum
- Phakopsora e.g., P. pachyrhizi
- Phytophthora e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P. sojae
- Pseudoperonospora e.g., P.
- a peptidase optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 80–88, (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent
- a protein exhibiting activity belonging to EC 3.5 for example, a protein exhibiting activity belonging to EC 3.5.1 (e.g., EC 3.5.1.1 and EC 3.5.1.2)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Blumeria (e.g., B. graminis), Botrytis (e.g., B. cinerea), Penicillium (e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum) and insects.
- Blumeria e.g., B. graminis
- Botrytis e.g., B. cinerea
- Penicillium e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum
- a protein that exhibits one or more lyase activities belonging to EC 4 for example, one or more carboxy-lyase activities belonging to EC 4.1.1 (e.g., aspartate 1-decarboxylase activity belonging to EC 4.1.1.11, aspartate 4-decarboxylase activity belonging to EC 4.1.1.12, valine decarboxylase activity belonging to EC 4.1.1.14, glutamate decarboxylase activity belonging to EC 4.1.1.15, lysine decarboxylase activity belonging to EC 4.1.1.18, arginine decarboxylase activity belonging to EC 4.1.1.19, histidine decarboxylase activity belonging to EC 4.1.1.22, tyrosine decarboxylase activity belonging to EC 4.1.1.25, phenylalanine decarboxylase activity belonging to EC 4.1.1.53, methionine decarboxylase activity belonging to EC 4.1.1.57, L-tryptophan decarboxylase activity belonging to
- the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 91; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90
- a protein exhibiting activity belonging to belonging to EC 4.2 for example, a protein exhibiting activity belonging to EC 4.2.2 (e.g., EC 4.2.2.2, 4.2.2.10)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Botrytis (e.g., B. cinerea), Fusarium (e.g., F. graminearum, F. oxysporum, F. virguliforme), Penicillium (e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P.
- Botrytis e.g., B. cinerea
- Fusarium e.g., F. graminearum, F. oxysporum, F. virguliforme
- Penicillium e.g., P. digitatum
- Puccinia e.g., P. striiformis
- Phytophthora e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P. sojae
- Puccinia e.g., P. striiformis
- Zymoseptoria e.g., Z. tritici
- a carbon-oxygen lyase optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 55 and 91, (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations/infections.
- the protein comprises, consists essentially of, or consists of a wild-type polypeptide.
- the protein comprises, consists essentially of, or consists of a wild-type polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof.
- the protein comprises, consists essentially of, or consists of a variant polypeptide.
- the protein comprises, consists essentially of, or consists of a variant polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof.
- the protein comprises, consists essentially of or consists of a catalytic domain, a binding module and a linker between said catalytic domain and said binder module. In some embodiments, the protein comprises two or more catalytic domains. In some embodiments, the protein comprises two or more binding modules.
- the protein is a fusion protein comprising a first polypeptide and a second polypeptide, said second polypeptide being distinct from said first polypeptide, wherein said first polypeptide is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69
- the present disclosure encompasses methods of using one or more compositions of the present disclosure for enhancing the environments in which plants are grown by, for example, changing the pH of the environment, increasing the availability of nutrients, stimulating beneficial microorganisms and/or suppressing/eliminating harmful microorganisms.
- the present disclosure encompasses methods of using one or more compositions of the present disclosure for improving plant growth, development and/or yield characteristics by, for example, increasing nutrient availability, increasing nutrient uptake, improving nutrient uptake efficiency, improving water use efficiency, stimulating the production of plant growth promoters, stimulating plant defense mechanisms, and/or preventing, treating, suppressing, eliminating and/or reducing the severity of pest infestations/infections.
- the present disclosure encompasses methods of using one or more compositions of the present disclosure for increasing the availability of one or more nutrients by, for example, fixing atmospheric nitrogen, retaining nitrogen in different oxidation stages, solubilizing phosphate, releasing organic acids, and/or solubilizing micronutrients.
- introducing an enzyme of the present disclosure into soil in the vicinity of a plant may increase the bioavailability of one or more vitamins, macrominerals, micronutrients, organic acids and/or trace minerals, as compared to a control soil lacking said enzyme.
- Nitrogen bioavailability may be increased with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 1.18.6 (e.g., EC 1.18.6.1), EC 3.1.1 (e.g., EC 3.1.1.4, 3.1.1.32) and EC 3.1.4 (e.g., EC 3.1.4.3, EC 3.1.4.4, EC 3.1.4.11) (and corresponding formulations, polynucleotides and organisms).
- nitrogen bioavailability is increased using one or more of SEQ ID NO(s): 26 and 32–33, and enzymatically active fragments/mutants/variants thereof.
- Phosphate bioavailability may be increased with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 3.1.3 (e.g., EC 3.1.3.1, EC 3.1.3.2, EC 3.1.3.26), 3.1.4 (e.g., EC 3.1.4.3, EC 3.1.4.4, EC 3.1.4.11) and 3.1.21 (e.g., EC 3.1.21.1) (and corresponding formulations, polynucleotides and organisms).
- phosphate bioavailability is increased using one or more of SEQ ID NO(s): 32–33, and enzymatically active fragments/mutants/variants thereof.
- the present disclosure encompasses methods of using one or more compositions of the present disclosure for prolonging the shelf-life of harvested plants or plant parts by, for example, treating (e.g., coating) harvested plants and plant parts directly and/or treating post-harvest transport/storage containers. See generally, e.g., US 2019/159470; US 2020/022719; US 2020/352183; US 2011/244095; FR 3038495; WO 2022/049139.
- the present disclosure encompasses methods of using one or more compositions of the present disclosure for reducing the need for chemical pesticides by, for example, reducing chemical pesticide-induced phytotoxicity, pest resistance, etc.
- compositions of the present disclosure may be applied to / used to treat any plant type, including, but not limited to, row crops and vegetables.
- compositions of the present disclosure are formulated for the treatment of one or more plants selected from the families Amaranthaceae (e.g., chard, spinach, sugar beet, quinoa), Asteraceae (e.g., artichoke, asters, chamomile, chicory, chrysanthemums, dahlias, daisies, echinacea, goldenrod, guayule, lettuce, marigolds, safflower, sunflowers, zinnias), Brassicaceae (e.g., arugula, broccoli, bok choy, Brussels sprouts, cabbage, cauliflower, canola, collard greens, daikon, garden cress, horseradish, kale, mustard, radish, rapeseed, rutabaga, turnip, wasabi, water
- Non-limiting examples of plants that may be treated with compositions of the present disclosure include plants sold under the ACCELERON®, AGRIPRO®, AGRISURE®, AGROESTE®, AGVENTURE®, ALFOREXTM, ASGROW®, AQUAMAX®, BOLLGARD IITM, BOLLGARDTM 3, BREVANTTM, CHANNELTM, CONFIDORTM, CORTEVA AGRISCIENCETM, CORVUSTM, CREDENZ®, CROPSTARTM, DAIRYLANDTM, DEKALB®, DELTAPINETM, DERUITERTM, DROUGHTGARD®, ENLIST E3®, ENOGEN®, FIBERMAX®, GAUCHOTM, GENUITY®, GOLDENHARVEST®, HOEGEMEYERTM, INTACTA RR2 PROTM, INVIGOR®, LIBERTY LINK®, NEXGROW®, NK®, NUTECH SEED®, OPTIMUM®, PHYTOGEN®,
- compositions of the present disclosure may be applied to any part/portion of a plant.
- the compositions are applied to plant propagation materials (e.g., cuttings, rhizomes, seeds and tubers).
- the compositions are applied to the roots of a plant.
- the compositions are applied to the foliage of a plant.
- the compositions are applied to both the roots and the foliage of a plant.
- the compositions are applied to plant propagation materials and to the plants that grow from said plant propagation materials.
- Compositions of the present disclosure may be applied to any plant growth medium, including, but not limited to, soil.
- compositions of the present disclosure may be applied to plants, plant parts and/or plant growth media in any suitable manner, including, but not limited to, on-seed application, in-furrow application and foliar application.
- Compositions of the present disclosure may be applied using any suitable method(s), including, but not limited to, coating, dripping, dusting, encapsulating, fogging, immersing, spraying, and soaking.
- Batch systems in which predetermined batch sizes of material and composition are delivered into a mixer, may be employed.
- Continuous treatment systems which are calibrated to apply composition at a predefined rate in proportion to a continuous flow of material, may also be employed.
- compositions of the present disclosure are applied directly to plant propagation material (e.g., seeds).
- plant propagation materials are soaked in a composition of the present disclosure for at least 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.25, 1.5, 1.75, 2, 3, 4, 5, 6, 9, 12, 15, 18, 21, 24, 36, 48 hours.
- plant propagation materials are coated with the compositions.
- Plant propagation materials may be coated with one or more additional layers (e.g., one or more protective layers that serve to enhance the stability and/or activity of an enzyme/organism of the present disclosure and/or one or more sequestration layers comprising substances that may reduce the stability and/or activity of an enzyme/organism of the present disclosure if included in the same layer as the enzyme/organism of the present disclosure).
- the coating comprises, consists essentially of, or consists of a composition of the present disclosure and a drying powder.
- compositions of the present disclosure are applied directly to a plant growth medium (e.g., a soil).
- the compositions are applied in the vicinity of a plant propagation material (e.g., a seed).
- the compositions are applied to the root zone of a plant.
- the compositions are applied using a drip irrigation system.
- compositions of the present disclosure are applied directly to plants.
- compositions are fogged, misted, sprayed and/or sprinkled onto the plant(s) to be treated (e.g., foliar sprays).
- compositions of the present disclosure are applied to harvested plants and/or plant parts. Individual components of the compositions (e.g., proteins of the present disclosure and chemical pesticides) may be applied separately or together.
- compositions of the present disclosure may be incorporated into integrated pest management strategies (e.g., a formulation comprising one or more proteins of the present disclosure may be applied to an orchard/vineyard as part of an integrated pest management strategy that includes separate applications of 2, 3, 4, 5 or more distinct pesticides in a rotation designed to reduce/prevent chemical pesticide-induced phytotoxicity and/or pest resistance).
- integrated pest management strategies e.g., a formulation comprising one or more proteins of the present disclosure may be applied to an orchard/vineyard as part of an integrated pest management strategy that includes separate applications of 2, 3, 4, 5 or more distinct pesticides in a rotation designed to reduce/prevent chemical pesticide-induced phytotoxicity and/or pest resistance.
- compositions of the present disclosure are freeze- spray- or spray-freeze-dried and then applied to plants/plant parts.
- a formulation comprising and enzyme/organism of the present disclosure and one or more stabilizing components is freeze- spray- or spray-freeze-dried, mixed with a drying powder (e.g., a drying powder comprising calcium stearate, attapulgite clay, montmorillonite clay, graphite, magnesium stearate, silica (e.g., fumed silica, hydrophobically-coated silica and/or precipitated silica) and/or talc), then coated on seed that was been pre-treated with one or more adhesives (e.g., an adhesive composition comprising one or more maltodextrins, one or more mono-, di- or oligosaccharides, one or more peptones, etc.), one or more pesticides and/or one or more plant signal molecules (e.g., one or more LCOs).
- a drying powder e.g., a drying powder comprising calcium stearate, attapulgite clay, montmorillonit
- compositions of the present disclosure may be applied to plant growth media (e.g., soil), plants, plant parts and agricultural/floricultural/horticultural/silvicultural apparatuses/facilities at any time, including, but not limited to, prior to planting, at the time of planting, after planting, prior to germination, at the time of germination, after germination, prior to seedling emergence, at the time of seedling emergence, after seedling emergence, prior to the vegetative stage, during the vegetative stage, after the vegetative stage, prior to the reproductive stage, during the reproductive stage, after the reproductive stage, prior to flowering, at the time of flowering, after flowering, prior to fruiting, at the time of fruiting, after fruiting, prior to ripening, at the time of ripening, after ripening, prior to harvest, at the time of harvest, and after harvesting.
- compositions of the present disclosure may be used to extend the shelf-life of harvested products by preventing, treating, suppressing, eliminating and/or reducing the severity of infestations/infections of/by acarids, bacteria, fungi, insects, oomycetes and protozoa for many weeks/months post-harvest.
- compositions of the present disclosure are applied to plant growth media prior to introducing a plant into the plant growth media (e.g., prior to planting seed).
- compositions of the present disclosure are applied to plant growth media concurrently with the introduction of a plant into the plant growth media (e.g., at the time of planting).
- compositions of the present disclosure are applied to plant growth media after introducing a plant into the plant growth media (e.g., by drip irrigation following planting).
- compositions of the present disclosure are applied to plant propagation materials (e.g., seeds) about/at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, 84, 88, 92, 96, 100, 104 weeks prior to planting.
- compositions of the present disclosure are applied to plant propagation materials (e.g., seeds) at the time of planting.
- compositions of the present disclosure are applied to plant propagation materials (e.g., seeds) after planting but before germination. In some embodiments, compositions of the present disclosure are applied to plants following emergence. In some embodiments, compositions of the present disclosure are applied to a plant or plant part pre- harvest (i.e., within 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or more days before the plant or plant part is (to be) harvested). In some embodiments, compositions of the present disclosure are applied to a plant or plant part post- harvest (i.e., after the plant or plant part has been harvested). In some embodiments, compositions of the present disclosure are applied to a harvested plant or plant part at a processing/shipping facility.
- compositions of the present disclosure are applied to a processed plant product. In some embodiments, compositions of the present disclosure are applied to an agricultural, floricultural, horticultural and/or silvicultural apparatus/facility prior to contacting a plant or plant part with or introducing a plant or plant part into said apparatus/facility. In some embodiments, compositions of the present disclosure are applied to an agricultural, floricultural, horticultural and/or silvicultural apparatus/facility concurrently with contacting a plant or plant part with or introducing a plant or plant part into said apparatus/facility.
- compositions of the present disclosure are applied to an agricultural, floricultural, horticultural and/or silvicultural apparatus/facility after contacting a plant or plant part with or introducing a plant or plant part into said apparatus/facility.
- Compositions of the present disclosure may be applied to plants, plant parts and/or plant growth media in any suitable amount(s)/concentration(s).
- compositions of the present disclosure comprise one or more proteins of the present disclosure in an amount ranging from about 0.001 to about 100 milligrams per gram and/or milliliter of composition.
- compositions of the present disclosure may comprise about/at least 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100 milligrams of protein per gram and/or milliliter of composition.
- compositions of the present disclosure comprise about/at least 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, or 0.5 milligrams of protein per gram and/or milliliter of composition.
- one or more proteins of the present disclosure comprise about 0.00000001 to about 95% (by weight) of the composition.
- one or more proteins of the present disclosure comprise about/at least 1 x 10 -15 , 1 x 10 -14 , 1 x 10 -13 , 1 x 10 -12 , 1 x 10 -11 , 1 x 10 -10 , 1 x 10 -9 , 1 x 10 -8 , 1 x 10 -7 , 1 x 10 -6 , 1 x 10 -5 , 1 x 10 -4 , 1 x 10 -3 , 1 x 10 -2 , 1 x 10 -1 , 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95% or more (
- the composition is applied at a rate that is equivalent to about 1 x 10 1 to about 1 x 10 15 enzyme units (at optimum conditions) of each protein of the present disclosure per kilogram of plant propagation material.
- compositions of the present disclosure are applied in an amount sufficient to ensure the plant propagation materials are coated with about/at least 1 x 10 1 , 1 x 10 2 , 1 x 10 3 , 1 x 10 4 , 1 x 10 5 , 1 x 10 6 , 1 x 10 7 , 1 x 10 8 , 1 x 10 9 , 1 x 10 10 , 1 x 10 11 , 1 x 10 12 , 1 x 10 13 , 1 x 10 14 or 1 x 10 15 enzyme units (at optimum conditions) of each protein of the present disclosure per kilogram of plant propagation material.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure that an average of about/at least 1 x 10 4 , 1 x 10 5 , 1 x 10 6 , 1 x 10 7 , 1 x 10 8 , 1 x 10 9 , 1 x 10 10 , 1 x 10 11 , or 1 x 10 12 enzyme units (at optimum conditions) of each protein of the present disclosure is applied to each seed.
- the composition is applied at a rate that is equivalent to about 1 x 10 1 to about 1 x 10 15 enzyme units (at optimum conditions) of each protein of the present disclosure per plant.
- compositions of the present disclosure are applied in an amount sufficient to ensure each plant is treated with about/at least 1 x 10 1 , 1 x 10 2 , 1 x 10 3 , 1 x 10 4 , 1 x 10 5 , 1 x 10 6 , 1 x 10 7 , 1 x 10 8 , 1 x 10 9 , 1 x 10 10 , 1 x 10 11 , 1 x 10 12 , 1 x 10 13 , 1 x 10 14 or 1 x 10 15 enzyme units (at optimum conditions) of each protein of the present disclosure.
- compositions of the present disclosure are applied in an amount sufficient to ensure that an average of about/at least 1 x 10 4 , 1 x 10 5 , 1 x 10 6 , 1 x 10 7 , 1 x 10 8 , 1 x 10 9 , 1 x 10 10 , 1 x 10 11 , or 1 x 10 12 enzyme units (at optimum conditions) of each protein of the present disclosure is applied to each plant.
- the composition is applied at a rate that is equivalent to about 1 x 10 1 to about 1 x 10 15 enzyme units (at optimum conditions) of each protein of the present disclosure per hectare/acre of treated crops.
- compositions of the present disclosure are applied in an amount sufficient to ensure each hectare/acre of treated crops is treated with about/at least 1 x 10 1 , 1 x 10 2 , 1 x 10 3 , 1 x 10 4 , 1 x 10 5 , 1 x 10 6 , 1 x 10 7 , 1 x 10 8 , 1 x 10 9 , 1 x 10 10 , 1 x 10 11 , 1 x 10 12 , 1 x 10 13 , 1 x 10 14 or 1 x 10 15 enzyme units (at optimum conditions) of each protein of the present disclosure.
- compositions of the present disclosure are applied in an amount sufficient to ensure that an average of about/at least 1 x 10 4 , 1 x 10 5 , 1 x 10 6 , 1 x 10 7 , 1 x 10 8 , 1 x 10 9 , 1 x 10 10 , 1 x 10 11 , or 1 x 10 12 enzyme units (at optimum conditions) of each protein of the present disclosure is applied to each hectare/acre of treated crops.
- the composition is applied at a rate that is equivalent to about 1 x 10 1 to about 1 x 10 15 enzyme units (at optimum conditions) of each protein of the present disclosure per hectare/acre of plant growth media.
- compositions of the present disclosure are applied in an amount sufficient to ensure each hectare/acre of plant growth media is treated with about/at least 1 x 10 1 , 1 x 10 2 , 1 x 10 3 , 1 x 10 4 , 1 x 10 5 , 1 x 10 6 , 1 x 10 7 , 1 x 10 8 , 1 x 10 9 , 1 x 10 10 , 1 x 10 11 , 1 x 10 12 , 1 x 10 13 , 1 x 10 14 or 1 x 10 15 enzyme units (at optimum conditions) of each protein of the present disclosure.
- compositions of the present disclosure are are applied in an amount sufficient to ensure that an average of about/at least 1 x 10 4 , 1 x 10 5 , 1 x 10 6 , 1 x 10 7 , 1 x 10 8 , 1 x 10 9 , 1 x 10 10 , 1 x 10 11 , or 1 x 10 12 enzyme units (at optimum conditions) of each protein of the present disclosure is applied to each hectare/acre of plant growth media.
- the composition is applied at a rate that is equivalent to about 1 x 10 1 to about 1 x 10 15 enzyme units (at optimum conditions) of each protein of the present disclosure per square inch/foot of surface area on an agricultural/floricultural/horticultural/silvicultural apparatus/facility.
- compositions of the present disclosure are applied in an amount sufficient to ensure each square inch/foot is treated with about/at least 1 x 10 1 , 1 x 10 2 , 1 x 10 3 , 1 x 10 4 , 1 x 10 5 , 1 x 10 6 , 1 x 10 7 , 1 x 10 8 , 1 x 10 9 , 1 x 10 10 , 1 x 10 11 , 1 x 10 12 , 1 x 10 13 , 1 x 10 14 or 1 x 10 15 enzyme units (at optimum conditions) of each protein of the present disclosure.
- compositions of the present disclosure are are applied in an amount sufficient to ensure that an average of about/at least 1 x 104 , 1 x 10 5 , 1 x 10 6 , 1 x 10 7 , 1 x 10 8 , 1 x 10 9 , 1 x 10 10 , 1 x 10 11 , or 1 x 10 12 enzyme units (at optimum conditions) of each protein of the present disclosure is applied to each square inch/foot.
- the composition is applied at a rate that is equivalent to about 0.001 to about 100 milligrams of protein of the present disclosure per kilogram of plant propagation material.
- compositions of the present disclosure are applied in an amount sufficient to ensure the plant propagation materials are coated with about/at least 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100 milligrams of protein of the present disclosure per kilogram of plant propagation material.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, or 0.5 milligrams of protein of the present disclosure is applied to each seed.
- the composition is applied at a rate that is equivalent to about 0.001 to about 100 milligrams of protein of the present disclosure per plant.
- compositions of the present disclosure are applied in an amount sufficient to ensure each plant is treated with about/at least 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100 milligrams of protein of the present disclosure.
- compositions of the present disclosure are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, or 0.5 milligrams of protein of the present disclosure are applied to each plant.
- the composition is applied at a rate that is equivalent to about 0.001 to about 100 milligrams of protein of the present disclosure per hectare/acre of treated crops.
- compositions of the present disclosure are applied in an amount sufficient to ensure each hectare/acre of treated crops is treated with about/at least 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100 milligrams of protein of the present disclosure.
- compositions of the present disclosure are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, or 0.5 milligrams of protein of the present disclosure are applied to each hectare/acre of treated crops.
- the composition is applied at a rate that is equivalent to about 0.001 to about 100 milligrams of protein of the present disclosure per hectare/acre of plant growth media.
- compositions of the present disclosure are applied in an amount sufficient to ensure each hectare/acre of plant growth media is treated with about/at least 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100 milligrams of protein of the present disclosure.
- compositions of the present disclosure are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, or 0.5 milligrams of protein of the present disclosure are applied to each hectare/acre of plant growth media.
- compositions of the present disclosure are applied at a rate of about 0.05 to about 100 milliliters and/or grams of composition per kilogram of plant propagation material.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant propagation materials are coated with about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 milliliters and/or grams of compositions per kilogram of plant propagation material.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75 or 5 milliliters and/or grams of composition is applied to each seed.
- compositions of the present disclosure are applied at a rate of about 0.5 to about 100 milliliters and/or grams of composition per plant.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure each plant is treated with about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 milliliters and/or grams of composition.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75 or 5 milliliters and/or grams of composition is applied to each plant.
- compositions of the present disclosure are applied at a rate of about 0.5 to about 100 milliliters and/or grams of composition per hectare/acre of treated crops.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure each hectare/acre of treated crops is treated with about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 milliliters and/or grams of composition.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75 or 5 milliliters and/or grams of composition is applied to each hectare/acre of treated crops.
- compositions of the present disclosure are applied at a rate of about 0.5 to about 100 milliliters and/or grams of composition per hectare/acre of plant growth media.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure each hectare/acre of plant growth media is treated with about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 milliliters and/or grams of composition.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75 or 5 milliliters and/or grams of composition is applied to each hectare/acre of plant growth media.
- compositions of the present disclosure are applied at a rate of about 0.5 to about 100 milliliters and/or grams of composition per square inch/foot of surface area on an agricultural/floricultural/horticultural/silvicultural apparatus/facility.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure each square inch/foot is treated with about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 milliliters and/or grams of composition.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75 or 5 milliliters and/or grams of composition is applied to each square inch/foot.
- compositions of the present disclosure are applied at a rate sufficient to prevent, treat, suppress and/or eliminate one or more pest infestations/infections.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to prevent, treat, suppress and/or eliminate infestation/infection by 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or more phytopathogenic pests.
- compositions of the present disclosure are applied at a rate sufficient to reduce one or more aspects of disease severity.
- compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to reduce one or more aspects of disease severity by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100%, as compared to an untreated control.
- compositions of the present disclosure are applied at a rate sufficient to enhance nutrient availability, uptake and/or accumulation.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to enhance the availability, uptake and/or accumulation of one or more nutrients, optionally one or more of boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc availability, uptake and/or accumulation, by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200% or more, as compared to an untreated control.
- compositions of the present disclosure are applied at a rate sufficient to enhance one or more plant growth and/or development characteristics.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to enhance one or more plant growth and/or development characteristics, optionally biomass, carbohydrate biosynthesis, chlorophyll content, cold tolerance, drought tolerance, height, leaf length, leaf mass, leaf number, leaf surface area, leaf volume, nutrient uptake (e.g., calcium, magnesium, nitrogen, phosphorous and/or potassium uptake), rate(s) of photosynthesis, root area, root diameter, root length, root mass, root nodulation (e.g., nodule mass, nodule number, nodule volume), root number, root surface area, root volume, salt tolerance, seed germination, seedling emergence, shoot diameter, shoot length, shoot mass, shoot number,
- compositions of the present disclosure are applied at a rate sufficient to enhance one or more plant yield characteristics.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to enhance one or more plant yield characteristics, optionally biomass; bushels per acre; grain weight per plot (GWTPP); nutritional content; percentage of plants in a given area (e.g., plot) that fail to produce grain; yield at standard moisture percentage (YSMP), such as grain yield at standard moisture percentage (GYSMP); yield per plot (YPP), such as grain weight per plot (GWTPP); and yield reduction (YRED), by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200% or
- compositions of the present disclosure are applied at a rate sufficient to reduce the need for exogenous fertilizer.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to reduce the amount(s) of exogenous fertilizer, optionally exogenous boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc, needed to achieve a desired result by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100%, as compared to an untreated control.
- compositions of the present disclosure are applied at a rate sufficient to enhance the efficacy of a biological pesticide.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to enhance the efficacy of a biological pesticide by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200% or more, as compared to an untreated control.
- compositions of the present disclosure are applied at a rate sufficient to enhance the efficacy of a chemical pesticide.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to enhance the efficacy of a chemiical pesticide by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200% or more, as compared to an untreated control.
- compositions of the present disclosure are applied at a rate sufficient to reduce one or more aspects of pesticide-induced pest resistance.
- one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to reduce one or more aspects of pesticide-induced pest resistance by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100%, as compared to an untreated control.
- compositions of the present disclosure are applied at a rate sufficient to reduce one or more aspects of pesticide-induced phytotoxicity.
- compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to reduce one or more aspects of pesticide-induced phytotoxicity by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100%, as compared to an untreated control.
- compositions of the present disclosure are applied at a rate sufficient to delay ripening of a harvest plant or plant part.
- compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to delay ripening of a harvest plant or plant part by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100%, as compared to an untreated control.
- compositions of the present disclosure are applied at a rate sufficient to hasten ripening of a harvest plant or plant part.
- compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to hasten ripening of a harvest plant or plant part by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100%, as compared to an untreated control.
- compositions of the present disclosure are applied at a rate sufficient to extend the shelf-life of a harvested plant or plant part.
- compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to extend the shelf-life of a harvested plant or plant part by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200% or more, as compared to an untreated control.
- the present disclosure extends to plant growth media, plants, plant parts and agricultural/floricultural/horticultural/silvicultural apparatuses/facilities that have been treated with a composition of the present disclosure (e.g., plant propagation materials coated with a formulation comprising one or more enzymes of the present disclosure, plants sprayed with a formulation comprising one or more enzymes of the present disclosure, harvested plant parts coated with a formulation comprising one or more enzymes of the present disclosure), to plants grown from plant propagation materials that were treated with a composition of the present disclosure, to plant parts harvested from plants that have been treated with a composition of the present disclosure, to plant parts harvested from plants grown from plant propagation materials that were treated with a composition of the present disclosure, to crops comprising a plurality of plants that were treated with a composition of the present disclosure, to crops comprising a plurality of plants grown from plant propagation materials that were treated with a composition of the present disclosure, to crops treated with a composition of the present disclosure, to processed products derived from plants that were treated with
- the present disclosure encompasses coated plant propagation materials comprising, consisting essentially of, or consisting of a plant propagation material and a coating that covers at least a portion of the outer surface of the plant propagation material, said coating comprising, consisting essentially of, or consisting of one or more compositions of the present disclosure.
- the coating comprises two, three, four, five or more layers.
- the coating comprises an inner layer that contains one or more proteins of the present disclosure and one or more outer layers free or substantially free of proteins of the present disclosure.
- the coating comprises an inner layer that is a composition of the present disclosure and an outer layer that is equivalent to a composition of the present disclosure except that it does not contain proteins of the present disclosure.
- the coating comprises, consists essentially of, or consists of a composition of the present disclosure and a drying powder. Drying powders may be applied in any suitable amount(s)/concentration(s). The absolute value of the amount/concentration that is/are sufficient to cause the desired effect(s) may be affected by factors such as the type, size and volume of material to which the composition will be applied, the type(s) of proteins in the composition, the number of proteins in the composition, the stability of the proteins in the composition and storage conditions (e.g., temperature, relative humidity, duration). Those skilled in the art will understand how to select an effective amount/concentration using routine dose-response experiments.
- the drying powder is applied in an amount ranging from about 0.5 to about 10 grams of drying powder per kilogram of plant propagation material.
- drying powder e.g., drying powder comprising magnesium stearate, magnesium sulfate, powdered milk, silica, soy lecithin and/or talc
- drying powder comprising magnesium stearate, magnesium sulfate, powdered milk, silica, soy lecithin and/or talc
- a drying powder comprising calcium stearate, attapulgite clay, montmorillonite clay, graphite, magnesium stearate, silica (e.g., fumed silica, hydrophobically-coated silica and/or precipitated silica) and/or talc is applied to seeds coated with a composition of the present disclosure at a rate of about 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, or 3 grams per kilogram of seed. In some embodiments, the coating completely covers the outer surface of the plant propagation material.
- the average thickness of the coating is at least 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.1, 3.2, 3.3, 3.4, 3.5, 4, 4.5, 5 ⁇ m or more. In some embodiments, the average thickness of the coating is about 1.5 to about 3.0 ⁇ m.
- kits comprising, consisting essentially of, or consisting of one or more plants and/or plant parts (e.g., coated plant propagation materials) that have been treated with the compositions of the present disclosure and a container housing the treated plant(s) and/or plant part(s).
- the kit further comprises one or more oxygen scavengers, such as activated carbon, ascorbic acid, iron powder, mixtures of ferrous carbonate and metal halide catalysts, sodium chloride and/or sodium hydrogen carbonate.
- the container may comprise any suitable material(s), including, but not limited to, materials that reduce the amount of light, moisture and/or oxygen that contact the coated plant propagation material when the container is sealed.
- the container comprises, consists essentially of, or consists of a material having light permeability of less than about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70 or 75%.
- the container comprises, consists essentially of, or consists of a material having an oxygen transmission rate of less than about 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 125, 150, 175, 200, 225, 250, 275, 300, 325, 350, 375, 400, 425, 450, 475, or 500 cm 3 /m 2 ⁇ day (as measured in accordance with ASTM D3985).
- the container reduces the amount of ambient light that reaches said coated plant propagation material by about 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100% when sealed.
- the container reduces the amount of ambient moisture that reaches said plant propagation material by about 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100% when sealed. In some embodiments, the container reduces the amount of ambient oxygen that reaches said plant propagation material by about 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100% when sealed. In some embodiments, kits of the present disclosure comprise 1, 2, 3, 4, 5 or more additional containers.
- the additional containers may comprise any suitable component(s) or composition(s), including, but not limited to, agriculturally beneficial microorganisms, biostimulants, drying agents, nutrients, oxidation control components and pesticides. Examples of agriculturally beneficial microorganisms, biostimulants, drying agents, nutrients, oxidation control components and pesticides that may be included in the additional containers are described above.
- proteins of the present disclosure may be formulated into compositions comprising a variety of components, such as adhesives (stickers), chemical actives, dispersants (spreaders), drying agents, emulsifiers, microbes, nutrients, pest attractants and feeding stimulants, pH control components, postharvest treatments, rain fasteners, rhealogical agents, safeners, stabilizers, UV protectants and wetting agents. It is to be understood that compositions and methods of the present disclosure may likewise be used in combination with such components as separate and distinct compositions (as part of an integrated pest management strategy, for example).
- compositions and methods of the present disclosure may be combined with known compositions and methods, such as fertilization compositions/methods, inoculant compositions/methods, pesticide compositions/methods, and post-harvest compositions/methods.
- compositions and methods of the present disclosure are used as part of an Integrated Pest Management program/strategy.
- one or more proteins, organisms and/or formulations of the present disclosure is/are applied to a plant, plant part or plant growth medium as part of an Integrated Pest Management program/strategy comprising one or more biological pesticides and/or one or more chemical pesticides.
- compositions and methods of the present disclosure are not limited to agicultural/floricultural/horticultural/silvicultural uses.
- the same activities that make enzymes, formulations, nucleic acids and organisms of the present disclosure useful for preventing, treating, suppressing and/or eliminating infestations/infections of/by phytopathogenic pests likewise render them useful for preventing/treating/suppressing/eliminating/reducing the detrimental effects of infestations/infections of/by arachnids, bacteria, fungi, insects, oomycetes, protozoa and viruses in and on myriad surfaces/substances, such as food storage containers, animal bedding/feed, clothing, hard surfaces, medical instruments, etc.
- compositions and methods of the present disclosure may be modified for use in any other industry or endeavor in which such prevention/treatment/suppression/elimination/reduction may be of benefit.
- the present disclosure extends to animal feed compositions comprising, consisting essentially of or consisting of a food component and an enzyme component, said enzyme component comprising, consisting essentially of, or consisting of one or more compositions of the present disclosure.
- Animal feed compositions of the present disclosure may comprise any suitable food component, including, but not limited to, fodder (e.g., grains, hay, legumes, silage and/or straw) and forage (e.g., grass).
- Animal feed compositions of the present disclosure may be fed to any suitable animal, including, but not limited to, farm animals, zoo animals, laboratory animals and/or companion animals.
- the animal feed composition is formulated to meet the dietary needs of birds (e.g., chickens, ducks, quails and/or turkeys), bovids (e.g., antelopes, bison, cattle, gazelles, goats, impala, oxen, sheep and/or wildebeests), canines, cervids (e.g., caribou, deer, elk and/or moose), equines (e.g., donkeys, horses and/or zebras), felines, fish, pigs, rabbits, rodents (e.g., guinea pigs, hamsters, mice and/or rats) and the like.
- birds e.g., chickens, ducks, quails and/or turkeys
- bovids e.g.,
- composition of the present disclosure e.g., a protein or formulation of the present disclosure
- a composition of the present disclosure for any one, two, three, four, five, six, seven, eight, nine, ten or more of the following: 1) preventing, treating, suppressing and/or eliminating infestation/infection of a surface/substance of/by one or more pests, optionally one or more acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa and/or viruses; 2) preventing, treating, suppressing and/or eliminating infestation/infection of a plant, plant part, plant growth medium or agricultural/floricultural/horticultural/silvicultural apparatus/facility (e.g., an apparatus/facility for planting, irrigating, fertilizing, growing, monitoring, testing, harvesting, processing, packaging and/or storing a plant or plant part) of/by one or
- the composition comprises, consists essentially of or consists of an enzyme 2) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1 3) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.1 4) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.1.3 5) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.1.3.4 6) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.1.99 7) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.1.99.18 8) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4 9) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3 10) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3 10) the composition comprises, consists essentially of or essentially of or EC 1.4.3 10) the composition comprises, consists
- EXAMPLES The following examples are provided to illustrate certain embodiments and are not to be construed as limiting the inventive concepts described in the present disclosure. Enzyme treatments are described in the corresponding Figures with reference to the predominant enzyme(s) comprised therein. It is to be understood that enzyme treatments may possess other enzymatic activities not expressly disclosed in the corresponding Figures. For example, an enzyme treatment having a predominant beta-glucanase activity may exhibit lesser side activities, such as cellulase activity and/or xylanase activity.
- Leaf discs were painted with enzyme solutions comprising 1 mg enzyme protein per mL in a 10 mM buffer solution (sodium acetate pH 5, potassium phosphate pH 6, potassium phosphate pH 7, or potassium phosphate pH 8), with or without 0.1% w/v surfactant (BREAK-THRU ® S 301 or SILWET TM L-77), or with a corresponding control solution comprising no enzyme, and then air dried. Six replicates were made for each condition.
- GFP-transformed Fusarium graminearum strain PH-1 was grown on potato dextrose agar for seven days at 21°C under a regime of 12 h dark and 12 h combined UVA and UVC light to induce sporulation. 2) A working spore suspension was created by adding approx.
- the centers of the leaves were wounded with a scalpel by gently scraping the epidermal layer of the leaves.
- Wounded leaves were painted with enzyme solutions comprising 1 mg enzyme protein per mL in a 10mM buffer solution (sodium acetate pH 5, potassium phosphate pH 6, potassium phosphate pH 7, or potassium phosphate pH 8), with or without 0.1% w/v surfactant (BREAK-THRU ® S 301 or SILWET TM L-77), or with a corresponding control solution comprising no enzyme, and then air dried.
- enzyme solutions comprising 1 mg enzyme protein per mL in a 10mM buffer solution (sodium acetate pH 5, potassium phosphate pH 6, potassium phosphate pH 7, or potassium phosphate pH 8), with or without 0.1% w/v surfactant (BREAK-THRU ® S 301 or SILWET TM L-77), or with a corresponding control solution comprising no enzyme, and then air dried.
- 6 replicates were made for each condition.
- each leaf was inoculated with a 10 ⁇ l droplet of the Fusarium graminearum PH-1 spore suspension or with a corresponding solution comprising no Fusarium graminearum spores.
- Plates were sealed with parafilm and incubated at 18°C under a 16-hour light / 8-hour dark cycle.
- Disease progression was monitored through multispectral imaging and visual inspection. Multispectral images were taken at start of experiment (T 0 ) and after incubation for 24, 48, 72 and 96 hours. Fv/Fm, ChlIdx and cGFP were evaluated from the spectral images. See Table 2.
- Detached leaves were treated with buffered enzyme solutions and subsequently inoculated with Phakopsora pachyrhizi. The leaves were incubated in clear plastic clamshell containers for two weeks and evaluated for severity of ASR (lesion and pustule counts). Efficacy was evaluated in two separate experiments conducted at the University of Florida. Procedures 1) ASR-susceptible soybean plants (Williams 82) were grown in a greenhouse to growth stage V2.5, at which point fully expanded trifoliate leaves were excised and used in the detach leaf assays described below. 2) Detached leaves were placed, top (adaxial) side up, into clamshell incubation containers lined with moistened paper towels. Two leaves (six leaflets) were placed in each container.
- Each DLA experiment was repeated as two blocks (six leaflets per treatment in each block) for a total of four trifoliate leaves (12 leaflets) per treatment.
- Incubation containers were kept at room temperature, 21° C ⁇ 1°, under 12-24 hours of natural and fluorescent light per day. 3)
- leaves were sprayed with enzyme solutions comprising 0.5 mg enzyme protein per mL in a 0.1x PBS buffer (pH 7.3), with or without 0.1% TWEEN® 20, or with a corresponding control solution comprising no enzyme.
- the treatments were sprayed on the top side of the soybean leaves up to the point just before runoff, which was approximately 0.6 mL per leaf. Separate, 2 fl.
- oz hand-pump sprayers (HydiorTM) were used to make each application. 4) On Day 2 of the assays, leaves were inoculated with a suspension of soybean rust spores collected on the day of the inoculation. The top side of each leaf was sprayed with 0.6 mL of a Phakopsora pachyrhizi spore suspension (in water with 0.1% TWEEN). For the first experimental replicate, naturally occurring Phakopsora pachyrhizi spores were isolated directly from wild kudzu and suspended (1.62 x 10 5 spores per mL).
- spores derived from the Phakopsora pachyrhizi strain were cultured on Williams 82 soybeans, then isolated and suspended (1.75 x 10 6 spores per mL). 5) Leaves were maintained at room temperature and moisture levels were maintained as needed. 6) Leaves were examined using a dissecting microscope. The underside (abaxial side) of each leaflet was examined, where pustules (uredinia) develop. A 1.0 or 0.4 sq cm circle was placed on the leaflet and the number of ASR pustules and or lesions found within the circle were counted. Both sides of the leaflet (divided by the midvein) were counted and recorded for a total of two counts/leaflet.
- the counting circle was placed to avoid any areas of the leaflet with decaying tissue.
- a rating of leaflet decay (as % affected area) was also performed for each leaflet.
- sampling and rating of leaves occurred from days 15 to 18 days post-infection.
- sampling and rating was conducted from days 12 to 16 days post-infection.
- Results Enzymes were evaluated for efficacy against Phakopsora pachyrhizi as described above. Results are presented in Fig.5 as the mean number of combined lesions and pustules from experimental replicates 1 and 2.
- Example 6 Effective Control of Late Blight Principle Evaluated the efficacy of enzyme solutions for control of late blight on tomato and potato leaf discs.
- Leaf discs were treated with enzyme and then inoculated with Phytophthora infestans US 23. Disease was assessed up to six days post-inoculation. Experiments were conducted by Novozymes Biologicals, Salem, VA. Procedures 1) Blight-susceptible tomato and potato plants were grown in a greenhouse for approximately three weeks. Leaves were detached from the mid-region of each plant, and leaf discs were excised using a cork bore (diameter 14 mm) and randomized amongst treatments. 2) One leaf disc was placed, adaxial side up, in each well of a 24-well microtiter plate comprising solidified 0.5% Butterfield's Buffer agar (5 g agar per liter of Butterfield's Buffer).
- Leaf discs were treated with enzymes in Butterfield's Buffer (8.3 mM phosphate, pH 7.2) or potassium phosphate buffer (0.05 M, pH 7.88 or pH 8), with or without 0.1% w/v surfactant (BREAK-THRU ® SP 133 or SILWET TM L-77), or with a corresponding control solution comprising no enzyme, and then air dried.
- Enzyme solutions were applied using two different methods: A) 50 ⁇ L was pipetted onto the adaxial surface of leaf disc, spreading with sterile inoculation loop as necessary; B) enzyme solution was sprayed onto the adaxial surface of leaf disc using an atomizer spray bottle, two pumps each, which adequately covered the surface without pooling.
- Results for pipette-treated tomato leaf discs treated are presented in Fig.6A as mean percent disease.
- Results for spray-treated tomato leaf discs are presentd in Fig.6B as (-) no disease reduction, (+) mild disease reduction, (++) moderate disease reduction or (+++) extreme disease reduction and in Fig.6C as mean percent disease.
- Results for spray-treated potato leaf discs are presented in Fig.6D as mean percent healthy.
- Example 7 Effective Control of Downy Mildew Principle Evaluated the efficacy of enzyme solutions for control of downy mildew on cucumber leaf discs. Leaf discs were treated with buffered enzyme solutions and subsequently inoculated with Pseudoperonospora cubensis.
- Leaf discs were treated with enzymes in a buffer solution—20 mM sodium acetate, pH 5; 1M potassium phosphate, pH 7; or 20 mM TRIS, pH 8), with or without surfactant (SAFER® insecticidal soap or TWEEN® 20), or with a corresponding control solution comprising no enzyme, and then air dried. Six replicates were made for each condition. Enzyme treatments were applied by pipetting 15 ⁇ L of the treatment solution onto center of the abaxial surface of the leaf disc.
- a buffer solution 20 mM sodium acetate, pH 5; 1M potassium phosphate, pH 7; or 20 mM TRIS, pH 8
- SAFER® insecticidal soap or TWEEN® 20 surfactant
- Plants were sprayed with an enzyme solution comprising 0.1% w/v surfactant (BREAK-THRU ® S 301, SILWET TM L-77, or TWEEN® 20) in a 10 mM buffer (sodium acetate, pH 5; potassium phosphate, pH 6; potassium phosphate, pH 7; or potassium phosphate, pH 8), or with a corresponding control solution comprising no enzyme and/or buffer, using a cabin sprayer (volume – 600 mL; 150 L/ha, 3.6 km/hour, yellow nozzles 0.2). Six replicates were made for each condition.
- an enzyme solution comprising 0.1% w/v surfactant (BREAK-THRU ® S 301, SILWET TM L-77, or TWEEN® 20) in a 10 mM buffer (sodium acetate, pH 5; potassium phosphate, pH 6; potassium phosphate, pH 7; or potassium phosphate, pH 8), or with a corresponding control solution comprising no enzyme
- Example 9 Effective Fungal Growth Inhibition Principle Evaluated the efficacy of enzyme solutions for inhibiting fungal growth using high-throughput imaging. Serial dilutions were used to determine the minimum inhibitory concentration (MIC 50 ) for each enzyme against four fungal phytopathogens: Botrytis cinerea, Fusarium graminearum, Fusarium virguliforme, and Zymoseptoria tritici. Procedures 1) Enzyme dilution series ranging from 0.0078 to 0.5 mg/mL were added in quadruplicate to 384-well imaging plates. Plates were centrifuged for two minutes at 2500 rpm to ensure all enzyme samples were at the bottom of the wells.
- MIC 50 minimum inhibitory concentration
- Sterile growth medium comprised one part Potato Dexrtrose Broth and nine parts M9 minimal medium (200 mL M9 salt solution (64.0 g Na 2 HPO 4 2H 2 O, 15 g KH 2 PO 4 , 2.5 g NaCl, 5.0 g NH 4 Cl ad 1 L distilled water), 2 mL 1 M MgSO 4 , 20 mL 20% glucose, 100 ⁇ l 1 M CaCl 2 in 1 L distilled water). 3) Plates were sealed with BREATHE-EASY® sealing membrane (SIGMA-ALDRICH® catalog no. Z380059) and placed in a lidded plastic container with a wet paper towel.
- M9 salt solution 64.0 g Na 2 HPO 4 2H 2 O, 15 g KH 2 PO 4 , 2.5 g NaCl, 5.0 g NH 4 Cl ad 1 L distilled water
- 2 mL 1 M MgSO 4 20 mL 20% glucose, 100 ⁇ l 1 M CaCl 2 in 1 L
- Results are presented in Fig. 9 as the minimum inhibitory concentration (MIC 50 ) for average hyphal branch length and total mycelium area (i.e., the enzyme concentration required to inhibit average hyphal branch length/total mycelium area to 50% or less as compared to that of corresponding untreated control). Data are presented as averages of quadruplicate samples.
- MIC 50 minimum inhibitory concentration
- Example 10 Effective Fungal Growth Inhibition Principle Evaluated the efficacy of enzyme solutions for inhibiting fungal growth using Radial Diffusion Assays (RDA), which consisted of plating a fungal pathogen in potato dextrose agar (PDA) in sufficient amount to obtain a homogeneous mat of mycelium, allowing the mycelium mat to dry, and then adding a 5 ⁇ L drop of enzyme solution. Growth inhibition was scored as the presence/absence of an inhibition- or stress-zone created by the enzyme after incubation of the assay plates at 26 o C up to 15 days.
- RDA Radial Diffusion Assays
- Procedures 1 Plates comprising potato dextrose agar were inoculated with a fungal phytopathogen—Botrytis cinerea ATCC56594, Fusarium graminearum Schwabe ATCC 36885, Magnaporthe grisea, Penicillium digitatum CBS658.68, Penicillium expansum DSM1282, Penicillium italicum, Phytophthora infestans, or Zymoseptoria tritici GPD-GFPB3 (Rohel et al., MOL.
- PLANT MICROBE INTERACT.14(2):156– 63 (Feb.2001))—by adding a droplet of fungal suspension and spreading the droplet “pprox.”y across the surface of the medium using glass beads. 2) After the plates were dry, test plates were treated with an enzyme solution, with or without buffer (potassium phosphate, pH 6; potassium phosphate, pH 7; or potassium phosphate, pH 8), and with or without surfactant (SILWET TM L-77). Tests were conducted in duplicate. An untreated control plate was kept for each fungal phytopathogen. 3) Plates were incubated at 26° C and assessed daily for 15 days.
- Results Enzymes were evaluated for efficacy against Botrytis cinerea, Fusarium graminerum, Magnaporthe grisea, Penicillium digitatum, Penicillium expansum, Penicillium italicum, Phytophthora infestans and Zymoseptoria tritici as described above. Results are presented in Fig.10A and Fig.10B as (-) no growth inhibition, (+) visible stress reaction and/or mild growth inhibition, (++) moderate growth inhibition or (+++) extreme growth inhibition.
- Example 11 Effective Control of Leaf-Eating Insects Principle Evaluated the efficacy of enzyme solutions for inhibiting growth / development of leaf-eating insects.
- Leaf discs were treated with buffered enzyme solutions and subsequently exposed to 2 nd instar cabbage looper larvae. The relative growth rate of each larvae was determined after two days of feeding. Procedures 1) Leaves were detached from Chinese cabbage plants (var. Minuet) and leaf discs were excised using a #12 cork borer. Only one disc was punched from each leaf. All leaf discs were kept in a water bath until use. 2) One leaf disc was placed in each well of a 12-well plate comprising solidified 1% water agar.
- Leaf discs were painted with enzyme solutions comprising 1 mg enzyme protein per mL in a phosphate buffer solution (0.163 g K 2 HPO 4 and 0.09g of KH 2 PO 4 in 100 mL distilled water) comprising 0.05% SILWET TM L-77, or with a corresponding control solution comprising no enzyme, and then air dried. Twelve replicates were made for each condition. 4) After drying, one 2 nd instar cabbage looper larva that had been weighed to the nearest tenth of a milligram was added to each leaf disc. 5) Cabbage loopers were reweighed after two days.
- Example 13 Effective Control of Gray Mold Principle Evaluated the efficacy of enzyme solutions for control of gray mold on grapes.
- Harvested grapes were surface sterilized, inoculated with Botrytis cinerea, wounded, and then treated with buffered enzyme solution. Disease severity was assessed after 14 days. Experiments were conducted by Novozymes Biologicals (Salem, VA). Procedures 1. Table grapes were cut into bunches containing 6 grapes. Bunches were washed for five minutes in tap water, two minutes in a 10% bleach solution, and one minute in DI water. Grapes were then allowed to dry for approximately 1-hour. 2.
- a 10 ⁇ l droplet of Botrytis cinerea conidia suspension (1.5 x 10 6 conidia per ml water) was pipetted onto the surface of each grape.
- the inoculum was dried for approximately 1-hour. 3.
- the skin of each grape was then gently punctured at the site of dried inoculum using a sterile dissecting needle.
- Grapes were treated with enzyme solutions comprising 2.5 mg enzyme protein per mL in a 0.05 M buffer solution (sodium acetate pH 5, potassium phosphate pH 7, or potassium phosphate pH 8). Enzyme treatments were applied via atomizer sprayer, adequately covering the fruit surface with no pooling. 5.
- Enzyme treatments were dried onto the fruit for approximately three hours. Each grape bunch was stored in an individual plastic container with lid. 6.
- Grapes were incubated at 20°C in the dark for a 14-day period. Disease progression was monitored for 14-days and expressed as a percentage of lesion area to total grape area on a 2D plane. Results Enzymes were evaluated for efficacy against Botrytis cinerea as described above. Results are presented in Fig. 13 as mean percent disease. A minimum three experimental repeats with six replicates were completed for each treatment.
- Example 14 Effective Control of Head Blight Principle Evaluated the efficacy of enzyme solutions for control of Fusarium head blight on wheat plants. Plants were treated with enzyme solution and subsequently inoculated with GFP-transformed Fusarium graminearum. Pathogen biomass was quantified via GFP, and plant health parameters were collected up to 14 days post- inoculation.
- GFP-transformed Fusarium graminearum strain PH-1 was grown on potato dextrose agar for seven days at 21°C under a regime of 12 h dark and 12 h combined UVA and UVC light to induce sporulation.
- a working spore suspension was created by adding “pprox.. 20 mL of phosphate buffered saline containing 0.01% TWEEN® 80, pH 7.2–7.4, to the petri dish, agitating the mycelium with a spatula, separating spores from mycelium using a sterile filter, and then diluting to a concentration of 0.5 x 10 6 spores per mL.
- Infected plants and uninoculated control plants were grown under controlled greenhouse conditions (T day 21 °C, T night 16 °C, 60 % relative humidity), except that infected plants were kept at 100% relative humidity during the first 48 hours post-inoculation. Infected plants were grown in a quarantine compartment to prevent infection of uninoculated control plants. 7) Disease progression was monitored through visual inspection and multispectral imaging. Fv/Fm, ChlIdx and cGFP were evaluated from the multispectral images. See Table 2. Mean Fv/Fm, ChlIdx and cGFP values for untreated, inoculated control plants were used as a reference (100%) to evaluate the Fv/Fm, ChlIdx and cGFP values for treated leaves.
- Results Enzymes were evaluated for efficacy against Fusarium graminearum as described above. Results are presented in Fig.14A (four days post-inoculation) and Fig.14B (twelve and thirteen days post-inoculation) as percentage increase of the spectral parameters (Fv/Fm, ChlIdx and cGFP) as compared to a corresponding untreated, inoculated controls.
- Example 15 Effective Control of Yellow Rust Principle Evaluated the efficacy of enzyme solutions for control of yellow rust on winter wheat plants. Plants were treated with buffered enzyme solution and subsequently inoculated with Puccinia striiformis.
- Percent leaf area attacked was assessed fifteen days post-inoculation and again with two- or three-day intervals until the full effects were seen. For scoring the standard EPPO scales were used. Experiments were conducted by ⁇ rhus University, Flakkebjerg, Denmark. Procedures 1) Winter wheat kernels (var. Morocco) were sown 10 seeds/plants per pot in 0.5 L pots and allowed to germinate and grow in a greenhouse for approximately two weeks until reaching the two-leaf crop growth stage (BBCH12).
- Example 16 Degradation of Fungal Cell Wall Components Principle Evaluated the efficacy of enzyme solutions for degradation of fungal cell wall components.
- Fungal mycelium were isolated and treated with buffered enzyme solution.
- a reducing end assay was used to analyze cell wall degradation.
- Procedures 1) Shake flasks comprising sterile YP media with 2% glucose were inoculated with a fungal phytopathogen—Botrytis cinerea ATCC56594, Fusarium graminerum Schwabe ATCC 36885, Penicillium digitatum CBS658.68, Penicillium expansum DSM1282, Penicillium italicum, Phytophthora infestans, Pyricularia grisea, or Zymoseptoria tritici—and incubated for seven days at 26 °C with shaking.
- a standard curve is prepared by plotting the absorbance of glucose standards (0.0125 to 0.25 mg/mL) against the glucose concentration and the number of reducing ends are calculated as glucose equivalents from the standard curve. The results are given as mg glucose equivalents per gram of crude cell wall material (mg Glc/g CW). Results Enzymes were evaluated for efficacy against Botrytis cinerea, Fusarium graminerum, Penicillium digitatum, Penicillium expansum, Penicillium italicum, Phytophthora infestans, Pyricularia grisea and Zymoseptoria tritici as described above. Results are presented in Fig. 16 as mg glucose equivalents per gram of crude cell wall material (mg Glc/g CW).
- Example 17 Effective Fungal Germination Inhibition Principle Evaluated the efficacy of enzyme solutions for inhibiting fungal germination. Serial dilutions were used to determine the minimum enzyme concentration required to prevent germination of Botrytis cinerea and Penicillium expansum spores. Procedures 1) Enzyme dilution series ranging from 0.002 to 2 mg/mL in 100 ⁇ L 10 mM buffer solution (sodium citrate pH 3, sodium citrate pH 4, sodium citrate pH 5, potassium phosphate pH 6, potassium phosphate pH 7, or potassium phosphate pH 8) were added in triplicate to 96-well imaging plates, alongside corresponding control solutions comprising no enzyme.
- Untreated control solutions exhibiting (substantially) complete germination were used as positive controls.
- Washed and replated fungal spore suspensions were reimaged after 24 hours and 48 hours at 25 °C to determine which enzyme treatments allowed / prevented germination even after washout.
- Results Enzymes were evaluated for efficacy against Botrytis cinerea and Penicillium expansum as described above. Results are presented in Fig. 17 as the minimum enzyme concentration that completely prevent fungal spore germination after 24 hours with enzyme, 24 hours after enzyme washout, and 48 hours after enzyme washout. Data are presented as averages of triplicate samples.
- Example 18 Effective Fungal Growth Inhibition Principle Evaluated the efficacy of enzyme solutions for inhibiting fungal growth using high-throughput imaging. Serial dilutions were used to determine the minimum inhibitory concentration (MIC 50 ) of enzyme needed to inhibit growth of Botrytis cinerea. Procedures 1) Enzyme dilution series ranging from 0.0078 to 0.5 mg/mL were added in quadruplicate to 384-well imaging plates.
- a serial dilution of fludioxonil (SCHOLAR® SC; Syngenta Crop Protection, LLC (Greensboro, NC)) was included as a positive control. Plates were centrifuged for two minutes at 2500 rpm to ensure all enzyme samples were at the bottom of the wells. 2) Fungal spore suspensions comprising 2–2.5 x 10 4 spores of Botrytis cinerea per mL of sterile growth medium were added to the wells.
- Sterile growth medium comprised one part Potato Dexrtrose Broth and nine parts M9 minimal medium (200 mL M9 salt solution (64.0 g Na 2 HPO 4 2H 2 O, 15 g KH 2 PO 4 , 2.5 g NaCl, 5.0 g NH 4 Cl ad 1 L distilled water), 2 mL 1 M MgSO 4 , 20 mL 20% glucose, 100 ⁇ l 1 M CaCl 2 in 1 L distilled water). 3) Plates were sealed with BREATHE-EASY® sealing membrane (SIGMA-ALDRICH® catalog no. Z380059) and placed in a lidded plastic container with a wet paper towel.
- M9 salt solution 64.0 g Na 2 HPO 4 2H 2 O, 15 g KH 2 PO 4 , 2.5 g NaCl, 5.0 g NH 4 Cl ad 1 L distilled water
- 2 mL 1 M MgSO 4 20 mL 20% glucose, 100 ⁇ l 1 M CaCl 2 in 1 L
- Example 19 Effective Fungal Growth Inhibition Principle Evaluated the efficacy of enzyme solutions for inhibiting germ tube elongation in Botrytis cinerea and Penicillium expansum using high-throughput imaging. Procedures 1) Fungal spore suspensions comprising 5 x 10 4 spores per mL of sterile growth medium (Potato Dextrose Broth) were added to 384-well imaging plates.
Abstract
The present disclosure provides proteins useful for preventing, treating, suppressing and/or eliminating infestations and infections of plants by various phytopathogenic pests, as well as formulations comprising such proteins, polynucleotides encoding such proteins, organisms expressing such proteins, and methods of using such proteins, formulations, polynucleotides and organisms in agriculture and other fields of endeavor.
Description
COMPOSITIONS AND METHODS FOR PREVENTING, TREATING, SUPRESSING AND/OR ELIMINATING PHYTOPATHOGENIC INFESTATIONS AND INFECTIONS RELATED APPLICATIONS The claims priority to International Patent Application No. PCT/US2022/073761, filed July 15, 2022, and published as WO 2023/288,294 on January 19, 2023, and to U.S. Provisional Application Nos.63/342,064, filed May 14, 2022, and 63/476,590, filed December 21, 2022, the disclosure of each of which is incorporated herein by reference in its entirety. REFERENCE TO A SEQUENCE LISTING The application contains a Sequence Listing in computer readable form. The name of the file containing the Sequence Listing is SQ.XML, which was created on May 12, 2023, and contains 89,744,839 bytes. The computer readable form is incorporated herein by reference. BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a table showing significant results of efficacy testing of various enzyme treatments against Blumeria graminis. Results are presented as percent disease control relative to an untreated, uninoculated control (none – uninoculated control) and an untreated, inoculated control (none – inoculated control) at two timepoints / disease pressures. 100 % control means no disease was detected in the treatment and 0 % control means disease was at the same level as the untreated, inoculated control comparator. Fig. 2 is a table showing significant results of efficacy testing of various enzyme treatments against Botrytis cinerea. Results are presented as percentage increase of the spectral parameters (Fv/Fm, ChlIdx and mARI) and the percentage of water-soaked lesions (%WSL) as compared to the untreated, inoculated control (none – inoculated control). Fig. 3 is a table showing significant results of efficacy testing of various enzyme treatments against Fusarium graminearum. Results are presented as percentage increase of the spectral parameters (Fv/Fm, ChlIdx and cGFP) as compared to the untreated, inoculated control (none – inoculated control) after 72 hours. Fig. 4 is a table showing significant results of efficacy testing of various enzyme treatments against Magnaporthe grisea. Results are presented as the half maximal effective concentration for absorbance at 612 nm (Abs EC50; indicator of mycelia growth inhibition) and half maximal effective concentration for fluorescence after reaction with Resazurin (ex 570 nm – em 585 nm) (Fluorescence EC50; indicator of cell viability). Fig.5 is a table showing significant results of efficacy testing of various enzyme treatments against Phakopsora pachyrhizi. Results are presented as the mean number of combined Phakopsora pachyrhizi lesions and pustules. Fig.6A, Fig.6B, Fig.6C and Fig.6D are tables showing significant results of efficacy testing of various
enzyme treatments against Phytophthora infestans. Results for pipette-treated tomato leaf discs treated are presented in Fig. 6A as mean percent disease. Results for spray-treated tomato leaf discs are presented in Fig. 6B as (-) no disease reduction, (+) mild disease reduction, (++) moderate disease reduction or (+++) extreme disease reduction and in Fig. 6C as mean percent disease. Results for spray-treated potato leaf discs are presented in Fig.6D as mean percent healthy. Fig. 7 is a table showing significant results of efficacy testing of various enzyme treatments against Pseudoperonospora cubensis. Results are presented as (-) no disease reduction, (+) mild disease reduction, (++) moderate disease reduction or (+++) extreme disease reduction. Fig. 8A and Fig. 8B are tables showing significant results of efficacy testing of various enzyme treatments against Zymoseptoria tritici. Results are presented as percent disease control relative to untreated, inoculated control at various timepoints / disease pressures. 100 % control means no disease was detected in the treatment and 0 % control means disease was at the same level as the untreated, inoculated control comparator (none – inoculated control). Fig. 9 is a table showing significant results of efficacy testing of various enzyme treatments against Botrytis cinerea, Fusarium graminearum, Fusarium virguliforme, and Zymoseptoria tritici. Results are presented as the minimum inhibitory concentration (MIC50) for average hyphal branch length and mycelial area (i.e., the minimum enzyme concentration required to inhibit average hyphal branch length / total mycelium area to 50% or less of the corresponding untreated control). Fig. 10A and Fig. 10B are tables showing significant results of efficacy testing of various enzyme treatments against Botrytis cinerea, Fusarium graminerum, Magnaporthe grisea, Penicillium digitatum, Penicillium expansum, Penicillium italicum, Phytophthora infestans and Zymoseptoria tritici. Results are presented as (-) no growth inhibition, (+) visible stress reaction and/or mild growth inhibition, (++) moderate growth inhibition or (+++) extreme growth inhibition. Fig. 11 is a table showing significant results of efficacy testing of various enzyme treatments against leaf-eating insect larvae. Results are presented as relative growth rates of the larvae after two days of feeding on treated leaf discs. Fig. 12 is a table showing significant results of efficacy testing of various enzyme treatments against leaf-eating insect larvae. Results are presented as relative growth rates of the larvae after two days of feeding on treated leaf discs. Fig. 13 is a table showing significant results of efficacy testing of various enzyme treatments against gray mold (Botrytis cinerea). Results are presented as percent disease. Fig. 14A and Fig. 14B are tables showing significant results of efficacy testing of various enzyme treatments against Fusarium graminearum. Results are presented as percentage increase of the spectral parameters (Fv/Fm, ChlIdx and cGFP) as compared to corresponding untreated, inoculated controls (none – inoculated control; none- inoculated Silwet™ control; none – inoculated pH 6 buffer control; none – inoculated pH 7 buffer control; none – inoculated pH 8 buffer control).
Fig. 15A and Fig. 15B are tables showing significant results of efficacy testing of various enzyme treatments against Puccinia striiformis. Results are presented as area under the disease progress curve. Fig.16 is a table showing results of significant results of efficacy testing of various enzyme treatments against Botrytis cinerea, Fusarium graminerum, Penicillium digitatum, Penicillium expansum, Penicillium italicum, Phytophthora infestans, Pyricularia grisea and Zymoseptoria tritici. Results are presented as the amount of oligosaccharides solubilized after hydrolysis of crude cell wall preparations ( mg glucose equivalents per gram of crude cell wall material (mg Glc/g CW)) Fig. 17 is a table showing significant results of efficacy testing of various enzyme treatments against Botrytis cinerea and Penicillium expansum. Results are presented as minimum enzyme concentrations necessary to prevent spore germination in the presence of enzyme, 24 hours after enzyme washout, or 48 hours after enzyme washout. Fig.18 is a table showing significant results of efficacy testing of various enzyme treatments against Botrytis cinerea. Results are presented as the minimum inhibitory concentration (MIC50) for average total mycelial area (i.e., the minimum enzyme concentration required to inhibit average total mycelium area to 50% or less of the corresponding untreated control). Fig. 19 is a table showing significant results of efficacy testing of various enzyme treatments against Botrytis cinerea and Penicillium expansum. Results are presented as percent inhibition of germ tube elongation as compared to the corresponding buffer control solution. DETAILED DESCRIPTION This description is not intended to be a detailed catalog of all the different ways in which the inventive concepts disclosed herein may be implemented or of all the features that may be added thereto. For example, features illustrated with respect to one embodiment may be incorporated into other embodiments and features illustrated with respect to a particular embodiment may be deleted from that embodiment. In addition, numerous variations and additions to the various embodiments suggested herein, which do not depart from the instant inventions, will be apparent to those skilled in the art in light of the instant disclosure. Hence, the following description is intended to illustrate some embodiments of the instant inventions and not to exhaustively specify all permutations, combinations and variations thereof. The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the instant inventions. Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the inventions belong. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the specification and relevant art and should not be interpreted in an idealized or overly formal sense unless expressly so defined herein. For the sake of brevity and/or clarity, well-known functions or constructions may not be described in detail.
As used herein, the singular forms “a,” “an,” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. As used herein, “additive,” when referring to effects of combinations within a composition means that the effects of the combinations are generally about the same as the sum of effects of the individual components of the combination alone. The combination of individual components producing this effect may be called an additive combination. As used herein, the terms “agricultural, floricultural, horticultural and/or silvicultural apparatus/facility” and “agricultural/floricultural/horticultural/silvicultural apparatus/facility” refer to an apparatus or facility utilized in one or more aspects of the plant propagation, cultivation and/or harvesting, including, but not limited to, breeding, planting, irrigating, fertilizing, growing, monitoring, testing, pruning, harvesting, processing, packaging and/or storing plants and plant parts. Exemplary apparatuses and facilities include cultivators, seed containers, seeders, planting pots, hydroponic growth systems, growth chambers, greenhouses, broadcasters, fertilization drills, fertilizer spreaders, irrigation systems, harvesting apparatuses, postharvest storage containers, postharvest treatment chambers, and postharvest shipping containers. As used herein, the term “agriculturally acceptable carrier” refers to a substance or composition that can be used to deliver a beneficial agent to a plant, plant part or plant growth medium (e.g., soil) without causing/having an unduly adverse effect on plant growth, development and/or yield. As used herein, the term “foliar-compatible carrier” refers to a material that can be foliarly applied to a plant or plant part without causing/having an unduly adverse effect on the plant, plant part, plant growth, plant health, or the like. As used herein, the term “seed-compatible carrier” refers to a material that can be applied to a seed without causing/having an unduly adverse effect on the seed, the plant that grows from the seed, seed germination, or the like. As used herein, the term “soil-compatible carrier” refers to a material that can be added to a soil without causing/having an unduly adverse effect on plant growth, soil structure, soil drainage, or the like. As used herein, the term “and/or” is intended to include any and all combinations of one or more of the associated listed items, as well as the lack of combinations when interpreted in the alternative (“or”). Thus, the phrase “A, B and/or C” is to be interpreted as “A, A and B, A and B and C, A and C, B, B and C, or C.” As used herein, “antagonistic,” when referring to effects of combinations within a composition means that the effects of the combinations are generally less than the sum of effects of the individual components of the combination alone. These compositions may be called antagonistic combinations. As used herein, the term “aqueous” refers to a composition that contains more than a trace amount of water (i.e., more than 0.5% water by weight, based upon the total weight of the composition). As used herein, the terms “associated with,” in association with” and “associated therewith,” when used in reference to a relationship between a composition of the present disclosure and a plant or plant part, refer to at least a juxtaposition or close proximity of the composition and the plant or plant part. Such a juxtaposition or close proximity may be achieved by contacting or applying the composition directly to the plant or plant part and/or by applying the composition to the plant growth medium (e.g., soil) in which the plant or plant part will
be grown (or is currently being grown). According to some embodiments, the composition is applied as a coating to the outer surface of the plant or plant part. According to some embodiments, the composition is applied to soil at, near or surrounding the site in which the plant or plant part will be grown (or is currently being grown). As used herein, the term “beneficial agent” may refer to any agent having at least one agriculturally/floriculturally/horticulturally/silviculturally beneficial property (e.g., an ability to fix atmospheric nitrogen, an ability to solubilize phosphate, an ability to produce one or more agriculturally/floriculturally/horticulturally/silviculturally beneficial small molecules, such as plant signal molecules, an ability to stimulate one or more plant defense systems, and ability to produce one or more phytoprotective agents, such as pesticidal toxins). As used herein, the term “biostimulant” refers to an agent or combination of agents the application of which enhances one or more metabolic and/or physiological processes of a plant or plant part (e.g., carbohydrate biosynthesis, ion uptake, nucleic acid uptake, nutrient delivery, photosynthesis and/or respiration). As used herein, the term “binding module” refers to the region of an enzyme that mediates binding to the enzyme to a substrate. As used herein, the term “catalytic domain” refers to the region of an enzyme containing the catalytic machinery of the enzyme. As used herein, the term “cDNA” refers to a DNA molecule that can be prepared by reverse transcription from a mature, spliced, mRNA molecule obtained from a eukaryotic or prokaryotic cell. cDNAs lack intron sequences that may be present in the corresponding genomic DNA. The initial, primary RNA transcript is a precursor to mRNA that is processed through a series of steps, including splicing, before appearing as mature spliced mRNA. As used herein, the term “coding sequence” refers to a polynucleotide that directly specifies the amino acid sequence of a polypeptide. The boundaries of the coding sequence are generally determined by an open reading frame, which begins with a start codon, such as ATG, GTG, or TTG, and ends with a stop codon, such as TAA, TAG, or TGA. The coding sequence may be a genomic DNA, cDNA, synthetic DNA, or a combination thereof. As used herein, the terms “colony forming unit” and “cfu” refer to a microbial cell/spore capable of propagating on or in a suitable growth medium or substrate (e.g., a soil) when conditions (e.g., temperature, moisture, nutrient availability, pH, etc.) are favorable for germination and/or microbial growth. As used herein, the term “consists essentially of,” when used in reference to compositions and methods of the present disclosure, means that the compositions/methods may contain additional components/steps so long as the additional components/steps do not materially alter the composition/method. The term “materially alter,” as applied to a composition/method of the present disclosure, refers to an increase or decrease in the effectiveness of the composition/method of at least 20%. For example, a component added to a composition of the present disclosure may be deemed to “materially alter” the composition if it increases or decreases the
composition's ability to inhibit the growth of a target phytopathogen by at least 20%. As used herein, the term “control sequences” refers to nucleic acid sequences involved in regulation of expression of a polynucleotide in a specific organism or in vitro. Each control sequence may be native (i.e., from the same gene) or heterologous (i.e., from a different gene) to the polynucleotide encoding the polypeptide, and native or heterologous to each other. Such control sequences include, but are not limited to leader, polyadenylation, prepropeptide, propeptide, signal peptide, promoter, terminator, enhancer, and transcription or translation initiator and terminator sequences. At a minimum, the control sequences include a promoter, and transcriptional and translational stop signals. The control sequences may be provided with linkers for the purpose of introducing specific restriction sites facilitating ligation of the control sequences with the coding region of the polynucleotide encoding a polypeptide. As used herein, the term “derived from,” when used in reference to a relationship between an organism and a protein and/or polynucleotide, means that the protein and/or polynucleotide is naturally occurring in said organism. As used herein, the term “diazotroph” refers to an organism capable of converting atmospheric nitrogen (N2) into a form that may be utilized by a plant or plant part (e.g., ammonia (NH3), ammonium (NH4+), etc.). As used herein, the term “dispersant” refers to an agent or combination of agents the application of which reduces the cohesiveness of like particles, the surface tension of a liquid, the interfacial tension between two liquids and/or the interfacial tension between or a liquid and a solid. As used herein, the terms “effective amount,” “effective concentration” and “effective amount/concentration” refer to an amount or concentration that is sufficient to cause a desired effect (e.g. ¸ inhibiting plant disease, enhancing plant yield). The absolute value of the amount/concentration that is sufficient to cause the desired effect may be affected by factors such as the type and magnitude of effect desired, the type, size and volume of material to which the composition will be applied, the type(s) of enzymes in the composition, the amount(s) of enzyme(s) in the composition, the stability of the enzyme(s) in the composition and the storage conditions (e.g., temperature, relative humidity, duration). Those skilled in the art will understand how to select an effective amount/concentration using routine dose-response experiments. In some examples, an effective amount of a substance when used alone may be different than an effective amount of the same substance when used as part of a combination. As used herein, the term “endogenous gene” refers to a gene consisting of an endogenous polynucleotide. As used herein, the term “endogenous polynucleotide” refers to a polynucleotide that is native to the referenced host cell. As used herein, the terms “enhanced growth” and “enhanced plant growth” refer to an improvement in one or more characteristics of plant growth and/or development as compared to one or more control plants (e.g., a plant germinated from an untreated seed or an untreated plant). Exemplary plant growth/development characteristics include, but are not limited to, biomass, carbohydrate biosynthesis, chlorophyll content, cold
tolerance, drought tolerance, height, leaf length, leaf mass, leaf number, leaf surface area, leaf volume, nutrient uptake (e.g., calcium, magnesium, nitrogen, phosphorous and/or potassium uptake), rate(s) of photosynthesis, root area, root diameter, root length, root mass, root nodulation (e.g., nodule mass, nodule number, nodule volume), root number, root surface area, root volume, salt tolerance, seed germination, seedling emergence, shoot diameter, shoot length, shoot mass, shoot number, shoot surface area, shoot volume, spread, stomatal conductance and survival rate. As used herein, the terms “enhanced stability” and “enhanced enzyme stability” refer to an improvement in one or more characteristics of enzyme stability as compared to one or more controls (e.g., a control composition that is identical to a composition of the present disclosure except that it lacks one or more of the components found in the composition of the present disclosure). Exemplary enzyme stability characteristics include, but are not limited to, maintenance of enzymatic activity after being applied to a plant or plant part and/or stored for a defined period of time and the ability to cause a desired effect (e.g., reduced phytopathogenicity of a target pest) after being applied to a plant or plant part and/or stored for a defined period of time. As used herein, the terms “enhanced yield” and “enhanced plant yield” refer to an improvement in one or more characteristics of plant yield as compared to one or more control plants (e.g., a control plant germinated from an untreated seed). Exemplary plant yield characteristics include, but are not limited to, biomass; bushels per acre; grain weight per plot (GWTPP); nutritional content; percentage of plants in a given area (e.g., plot) that fail to produce grain; yield at standard moisture percentage (YSMP), such as grain yield at standard moisture percentage (GYSMP); yield per plot (YPP), such as grain weight per plot (GWTPP); and yield reduction (YRED). As used herein, the term “expression” refers to any step involved in the production of a polypeptide including, but not limited to, transcription, post-transcriptional modification, translation, post-translational modification, and secretion. Expression can be measured—for example, to detect increased expression—by techniques known in the art, such as measuring levels of mRNA and/or translated polypeptide. As used herein, the term “expression vector” refers to a linear or circular DNA construct comprising a DNA sequence encoding a polypeptide, which coding sequence is operably linked to a suitable control sequence capable of effecting expression of the DNA in a suitable host. Such control sequences may include a promoter to effect transcription, an optional operator sequence to control transcription, a sequence encoding suitable ribosome binding sites on the mRNA, enhancers and sequences which control termination of transcription and translation. As used herein, the term “extension” refers to an addition of one or more amino acids to the amino and/or carboxyl terminus of a polypeptide. As used herein, the term “foliage” refers to those portions of a plant that normally grow above the ground, including, but not limited to, leaves, stalks, stems, flowers, fruiting bodies and fruits. As used herein, the terms “foliar application” and “foliarly applied” refer to the application of one or
more active ingredients to the foliage of a plant (e.g., to the leaves of the plant). Application may be affected by any suitable means, including, but not limited to, spraying/fogging the plant with a composition comprising the active ingredient(s). In some embodiments, the active ingredient(s) is/are applied to the leaves, stems and/or stalk of the plant and not to the flowers, fruiting bodies or fruits of the plant. As used herein, the term “fragment” refers to a polypeptide having one or more amino acids absent from the amino and/or carboxyl terminus of the mature polypeptide. As used herein, the term “fusion protein” refers to a polypeptide in which one polypeptide is fused at the N-terminus and/or the C-terminus of a polypeptide of the present disclosure. A fusion protein is produced by fusing a polynucleotide encoding another polypeptide to a polynucleotide of the present disclosure, or by fusing two or more polynucleotides of the present disclosure together. Techniques for producing fusion proteins are known in the art and include ligating the coding sequences encoding the polypeptides so that they are in frame and that expression of the fusion protein is under control of the same promoter(s) and terminator. Fusion proteins may also be constructed using intein technology in which fusion proteins are created post- translationally (Cooper et al., 1993, EMBO J. 12: 2575-2583; Dawson et al., 1994, Science 266: 776-779). A fusion protein can further comprise a cleavage site between the two polypeptides. Upon secretion of the fusion protein, the site is cleaved releasing the two polypeptides. Examples of cleavage sites include, but are not limited to, the sites disclosed in Martin et al., 2003, J. Ind. Microbiol. Biotechnol.3: 568-576; Svetina et al., 2000, J. Biotechnol. 76: 245-251; Rasmussen-Wilson et al., 1997, Appl. Environ. Microbiol. 63: 3488-3493; Ward et al., 1995, Biotechnology 13: 498-503; and Contreras et al., 1991, Biotechnology 9: 378-381; Eaton et al., 1986, Biochemistry 25: 505-512; Collins-Racie et al., 1995, Biotechnology 13: 982-987; Carter et al., 1989, Proteins: Structure, Function, and Genetics 6: 240-248; and Stevens, 2003, Drug Discovery World 4: 35-48. As used herein, the term “heterologous,” when used to describe the relationship between a polynucleotide or polypeptide and a host cell, refers to a polynucleotide or polypeptide that does not naturally occur in the host cell. For the purposes of the present disclosure, extraneous copies of polynucleotides that are otherwise native to the referenced host cell are deemed heterologous polynucleotides. As used herein, the term “heterologous,” when used to describe the relationship between a polynucleotide or polypeptide and a control sequence (e.g., a promoter sequence), refers to a polynucleotide or polypeptide is not naturally associated with the control sequence (i.e., the control sequence is from a gene other than the gene encoding the mature polypeptide). As used herein, the terms “host strain” and “host cell” refer to an organism into which an expression vector, phage, virus, or other DNA construct, including a polynucleotide encoding a polypeptide of interest (e.g., an amylase) has been introduced. Exemplary host strains are microorganism cells (e.g., bacteria, filamentous fungi, and yeast) and plant cells capable of expressing a protein of interest. The term “host cell” includes protoplasts created from cells. As used herein, the terms “inoculant composition” and “inoculum” refer to a composition comprising microbial cells and/or spores, said cells/spores being capable of propagating/germinating on or in a suitable
growth medium or substrate (e.g., a soil) when conditions (e.g., temperature, moisture, nutrient availability, pH, etc.) are favorable for germination and/or microbial growth. As used herein, the term “introduced,” when used to describe the insertion of a nucleic acid sequence into a cell, encompasses “transfection”, “transformation” or “transduction,” as known in the art. As used herein, the term “isolated” refers to a polypeptide, nucleic acid, cell, or other specified material or component that has been separated from at least one other material or component, including but not limited to, other proteins, nucleic acids, cells, etc. An isolated polypeptide, nucleic acid, cell or other material is thus in a form that does not occur in nature. An isolated polypeptide includes, but is not limited to, a culture broth containing the secreted polypeptide expressed in a host cell. As used herein, the term “isomer” includes all stereoisomers of the compounds and/or molecules to which it refers, including enantiomers and diastereomers, as well as all conformers, roatmers and tautomers, unless otherwise indicated. Compounds and/or molecules disclosed herein include all enantiomers in either substantially pure levorotatory or dextrorotatory form, or in a racemic mixture, or in any ratio of enantiomers. Where embodiments disclose a (D)-enantiomer, that embodiment also includes the (L)-enantiomer; where embodiments disclose a (L)-enantiomer, that embodiment also includes the (D)-enantiomer. Where embodiments disclose a (+)-enantiomer, that embodiment also includes the (-)-enantiomer; where embodiments disclose a (-)-enantiomer, that embodiment also includes the (+)-enantiomer. Where embodiments disclose a (S)-enantiomer, that embodiment also includes the (R)-enantiomer; where embodiments disclose a (R)- enantiomer, that embodiment also includes the (S)-enantiomer. Embodiments are intended to include any diastereomers of the compounds and/or molecules referred to herein in diastereomerically pure form and in the form of mixtures in all ratios. Unless stereochemistry is explicitly indicated in a chemical structure or chemical name, the chemical structure or chemical name is intended to embrace all possible stereoisomers, conformers, rotamers and tautomers of compounds and/or molecules depicted. As used herein, the term “mature polypeptide” refers to a polypeptide in its mature form following N-terminal and/or C-terminal processing (e.g., removal of signal peptide). As used herein, the term “mature polypeptide coding sequence” refers to a polynucleotide that encodes a mature polypeptide. As used herein, the term “modified microbial strain” refers to a microbial strain that is modified from a strain isolated from nature. Modified microbial strains may be produced by any suitable method(s), including, but not limited to, chemical or other form of induced mutation to a polynucleotide within any genome within the strain; the insertion or deletion of one or more nucleotides within any genome within the strain, or combinations thereof; an inversion of at least one segment of DNA within any genome within the strain; a rearrangement of any genome within the strain; generalized or specific transduction of homozygous or heterozygous polynucleotide segments into any genome within the strain; introduction of one or more phage into any genome of the strain; transformation of any strain resulting in the introduction into the strain of stably replicating autonomous extrachromosomal DNA; any change to any genome or to the total DNA composition
within the strain isolated from nature as a result of conjugation with any different microbial strain; and any combination of the foregoing. The term modified microbial strains includes a strain with (a) one of more heterologous nucleotide sequences, (b) one or more non-naturally occurring copies of a nucleotide sequence isolated from nature (i.e., additional copies of a gene that naturally occurs in the microbial strain from which the modified microbial strain was derived), (c) a lack of one or more nucleotide sequences that would otherwise be present in the natural reference strain by for example deleting nucleotide sequence, and (d) added extrachromosomal DNA. In some embodiments, modified microbial strains comprise a combination of two or more nucleotide sequences (e.g., two or more naturally occurring genes that do not naturally occur in the same microbial strain) or comprise a nucleotide sequence isolated from nature at a locus that is different from the natural locus. As used herein, the term “native” refers to a polynucleotide or polypeptide naturally occurring in a host cell. As used herein, the term “naturally occurring” refers to anything (e.g., proteins, amino acids, or nucleic acid sequences) that is found in nature. Conversely, the term “non-naturally occurring” refers to anything that is not found in nature (e.g., recombinant nucleic acids and protein sequences produced in a laboratory, modification of a wild-type sequence, formulations comprising one or more synthetic components, formulations comprising an artificial combination of otherwise naturally occurring components). As used herein, the term “non-aqueous” refers to a composition that comprises no more than a trace amount of water (i.e., no more than 0.5% water by weight, based upon the total weight of the composition). As used herein, the term “nutrient” refers to a compound or element useful for nourishing a plant (e.g., vitamins, macrominerals, micronutrients, trace minerals, organic acids, etc. that are necessary for plant growth and/or development). As used herein, the term “obtained from,” when used in reference to a relationship between an organism and a protein, means that the protein is expressed in the organism, whether from a naturally occurring polynucleotide therein or from a heterologous polynucleotide that was introduced into the organism. As used herein, the term “polynucleotide” encompasses DNA, RNA, heteroduplexes, and synthetic molecules capable of encoding a polypeptide. Polynucleotides may be single-stranded or double-stranded and may comprise chemical modifications. The terms “nucleic acid” and “polynucleotide” are used interchangeably. Because the genetic code is degenerate, more than one codon may be used to encode a particular amino acid, and the present compositions and methods encompass nucleotide sequences that encode a particular amino acid sequence. Unless otherwise indicated, nucleic acid sequences are presented in 5'-to-3' orientation. As used herein, the term “nucleic acid construct” refers to a polynucleotide, either single- or double- stranded, which is isolated from a naturally occurring gene or is modified to contain segments of nucleic acids in a manner that would not otherwise exist in nature or which is synthetic, and which comprises one or more control sequences operably linked to the nucleic acid sequence. As used herein, the term “operably linked” means that specified components are in a relationship
(including but not limited to juxtaposition) permitting them to function in an intended manner. For example, a regulatory sequence is operably linked to a coding sequence such that expression of the coding sequence is under control of the regulatory sequence. As used herein, the term “phosphate-solubilizing microorganism” refers to a microorganism capable of converting insoluble phosphate into a soluble form of phosphate. As used herein, the term “phytopathogenic pest” includes any organism or virus that negatively affects a plant, including, but not limited to, organisms and viruses that spread disease, damage host plants and/or compete for soil nutrients. The term “phytopathogenic pest” encompasses organisms and viruses that are known to associate with plants and to cause a detrimental effect on the plant's health and/or vigor. Phytopathogenic pests include, but are not limited to, arachnids (e.g., mites, ticks, spiders, etc.), bacteria, fungi, gastropods (e.g., slugs, snails, etc.), invasive plants (e.g., weeds), insects (e.g., white flies, thrips, weevils, etc.), nematodes (e.g., root-knot nematode, soybean cyst nematode, etc.), rodents and viruses (e.g., tobacco mosaic virus (TMV), tomato spotted wilt virus (TSWV), cauliflower mosaic virus (CaMV), etc.). As used herein, the term “plant” includes all plant populations, including, but not limited to, agricultural, floricultural, horticultural and silvicultural plants. The term “plant” encompasses plants obtained by conventional plant breeding and optimization methods (e.g., marker-assisted selection) and plants obtained by genetic engineering, including cultivars protectable and not protectable by plant breeders' rights. As used herein, the term “plant cell” refers to a cell of an intact plant, a cell taken from a plant, or a cell derived from a cell taken from a plant. Thus, the term “plant cell” includes cells within seeds, suspension cultures, embryos, meristematic regions, callus tissue, leaves, shoots, gametophytes, sporophytes, pollen and microspores. As used herein, the term “plant growth regulator” refers to an agent or combination of agents the application of which accelerates or retards the growth/maturation rate of a plant through direct physiological action on the plant or which otherwise alters the behavior of a plant through direct physiological action on the plant. “Plant growth regulator” shall not be interpreted to include any agent or combination of agents excluded from the definition of “plant regulator” that is set forth section 2(v) of the Federal Insecticide, Fungicide, and Rodenticide Act (7 U.S.C. § 136(v)). Thus, “plant growth regulator” does not encompass microorganisms applied to a plant, plant part or plant growth medium for the purpose of enhancing the availability and/or uptake of nutrients, nutrients necessary to normal plant growth, soil amendments applied for the purpose of improving soil characteristics favorable for plant growth or vitamin hormone products as defined by 40 C.F.R. § 152.6(f). As used herein, the term “plant part” refers to any part of a plant, including cells and tissues derived from plants. Thus, the term “plant part” may refer to any of plant components or organs (e.g., leaves, stems, roots, etc.), plant tissues, plant cells and seeds. Examples of plant parts, include, but are not limited to, anthers, embryos, flowers, fruits, fruiting bodies, leaves, ovules, pollen, rhizomes, roots, seeds, shoots, stems and tubers, as well as scions, rootstocks, protoplasts, calli and the like. As used herein, the term “plant propagation material” refers to a plant part from which a whole plant
can be generated. Examples of plant propagation materials include, but are not limited to, cuttings (e.g., leaves, stems), rhizomes, seeds, tubers and cells/tissues that can be cultured into a whole plant. As used herein, the term “protein” is not meant to refer to a specific amino acid chain length and encompasses peptides, oligopeptides and polypeptides. It is to be understood that the term “protein” also encompasses two or more polypeptides combined to form an encoded product, as well as hybrid polypeptides and fusion proteins. As used herein, the term “purified” refers to a polynucleotide, protein or cell that is substantially free from other components as determined by analytical techniques well known in the art (e.g., a purified polynucleotide or protein may form a discrete band in an electrophoretic gel, chromatographic eluate, and/or a media subjected to density gradient centrifugation). A purified polynucleotide or protein is at least about 50% pure, usually at least about 60%, about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, about 99%, about 99.5%, about 99.6%, about 99.7%, about 99.8% or more pure (e.g., percent by weight or on a molar basis). In a related sense, a composition is enriched for a molecule when there is a substantial increase in the concentration of the molecule after application of a purification or enrichment technique. The term “enriched” refers to a compound, polynucleotide, protein, cell, nucleic acid, amino acid, or other specified material or component that is present in a composition at a relative or absolute concentration that is higher than a starting composition. ln one aspect, the term “purified” as used herein refers to the protein or cell being essentially free from components (especially insoluble components) from the production organism. In other aspects. the term “purified” refers to the protein being essentially free of insoluble components (especially insoluble components) from the native organism from which it is obtained. In one aspect, the protein is separated from some of the soluble components of the organism and culture medium from which it is recovered. The protein may be purified (i.e., separated) by one or more of the unit operations filtration, precipitation, or chromatography. Accordingly, the protein may be purified such that only minor amounts of other proteins, in particular, other proteins, are present. The term “purified” as used herein may refer to removal of other components, particularly other proteins and most particularly other enzymes present in the cell of origin of the protein. The protein may be “substantially pure”, i.e., free from other components from the organism in which it is produced, e.g., a host organism for recombinantly produced protein. In one aspect, the protein is at least 40% pure by weight of the total protein material present in the preparation. In one aspect, the protein is at least 50%, 60%, 70%, 80% or 90% pure by weight of the total protein material present in the preparation. As used herein. a “substantially pure protein” may denote a protein preparation that contains at most 10%, preferably at most 8%, more preferably at most 6%, more preferably at most 5%, more preferably at most 4%, more preferably at most 3%, even more preferably at most 2%, most preferably at most 1%, and even most preferably at most 0.5% by weight of other protein material with which the protein is natively or recombinantly associated. It is, therefore, preferred that the substantially pure protein is at least 92% pure, preferably at least 94% pure, more preferably at least 95% pure, more preferably at least 96% pure, more preferably at least 97% pure,
more preferably at least 98% pure, even more preferably at least 99% pure, most preferably at least 99.5% pure by weight of the total protein material present in the preparation. Proteins of the present disclosure are preferably in a substantially pure form (i.e., the preparations are essentially free of other protein material). This can be accomplished, for example by preparing the protein by well-known recombinant methods or by classical purification methods. As used herein, the term “recombinant” is used in its conventional meaning to refer to the manipulation, e.g., cutting and rejoining, of nucleic acid sequences to form constellations different from those found in nature. The term recombinant refers to a cell, nucleic acid, protein or vector that has been modified from its native state. Thus, for example, recombinant cells express genes that are not found within the native (non-recombinant) form of the cell, or express native genes at different levels or under different conditions than found in nature. The term “recombinant” is synonymous with “genetically modified” and “transgenic”. As used herein, the terms “recover” and “recovery” refer to the removal of a protein from at least one fermentation broth component selected from the list of a cell, a nucleic acid, or other specified material, e.g., recovery of the protein from the whole fermentation broth, or from the cell-free fermentation broth, by protein crystal harvest, by filtration, e.g. depth filtration (by use of filter aids or packed filter medias, cloth filtration in chamber filters, rotary-drum filtration, drum filtration, rotary vacuum-drum filters, candle filters, horizontal leaf filters or similar, using sheed or pad filtration in framed or modular setups) or membrane filtration (using sheet filtration, module filtration, candle filtration, microfiltration, ultrafiltration in either cross flow, dynamic cross flow or dead end operation), or by centrifugation (using decanter centrifuges, disc stack centrifuges, hyrdo cyclones or similar), or by precipitating the protein and using relevant solid-liquid separation methods to harvest the protein from the broth media by use of classification separation by particle sizes. Recovery encompasses isolation and/or purification of the protein. As used herein, the relatedness between two amino acid sequences or between two nucleotide sequences is described by the parameter “sequence identity”. For purposes of the present disclosure, the sequence identity between two amino acid sequences is determined as the output of “longest identity” using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48: 443-453) as implemented in the Needle program of the EMBOSS package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends Genet.16: 276- 277), preferably version 6.6.0 or later. The parameters used are a gap open penalty of 10, a gap extension penalty of 0.5, and the EBLOSUM62 (EMBOSS version of BLOSUM62) substitution matrix. In order for the Needle program to report the longest identity, the -nobrief option must be specified in the command line. The output of Needle labeled “longest identity” is calculated as follows: (Identical Residues x 100)/(Length of Alignment – Total Number of Gaps in Alignment) For purposes of the present disclosure, the sequence identity between two polynucleotide sequences is determined as the output of “longest identity” using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, supra) as implemented in the Needle program of the EMBOSS package (EMBOSS: The
European Molecular Biology Open Software Suite, Rice et al., 2000, supra), preferably version 6.6.0 or later. The parameters used are a gap open penalty of 10, a gap extension penalty of 0.5, and the EDNAFULL (EMBOSS version of NCBI NUC4.4) substitution matrix. In order for the Needle program to report the longest identity, the nobrief option must be specified in the command line. The output of Needle labeled “longest identity” is calculated as follows: (Identical Deoxyribonucleotides x 100)/(Length of Alignment – Total Number of Gaps in Alignment). As used herein, the term “signal peptide” refers to a sequence of amino acids attached to the N-terminal portion of a protein, which facilitates the secretion of the protein outside the cell. The mature form of an extracellular protein lacks the signal peptide, which is cleaved off during the secretion process. As used herein, the terms “stabilizing compound” and “stabilizer” refer to an agent or combination of agents the application of which enhances the stability of an enzyme. As used herein, the term “subsequence” refers to a polynucleotide having one or more nucleotides absent from the 5' and/or 3' end of a mature protein coding sequence; wherein the subsequence encodes a fragment having enzymatic activity. As used herein, the term “variant” refers to a protein comprising a man-made mutation, i.e., a substitution, insertion (including extension), and/or deletion (e.g., truncation), at one or more positions. A substitution means replacement of the amino acid occupying a position with a different amino acid; a deletion means removal of the amino acid occupying a position; and an insertion means adding 1-5 amino acids (e.g., 1-3 amino acids, in particular, 1 amino acid) adjacent to and immediately following the amino acid occupying a position. As used herein, the term “wild-type” in reference to an amino acid sequence or nucleic acid sequence means that the amino acid sequence or nucleic acid sequence is a native or naturally occurring sequence. While certain aspects of the present disclosure will hereinafter be described with reference to embodiments thereof, it will be understood by those of ordinary skill in the art that various changes in form and details may be made therein without departing from the spirit and scope of the present disclosure as defined by the claims. All publications, patent applications, patents and other references mentioned herein are incorporated by reference in their entirety, except insofar as they contradict any disclosure expressly set forth herein. The present disclosure provides proteins useful for a) preventing, treating, suppressing and/or eliminating infestations/infections of/by myriad pests, including, but not limited to, phytopathogenic pests, such as arachnids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa, viruses and weeds; b) treating surfaces/substances that are susceptible to infestation/infection; c) cleansing infested/infected surfaces/substances; d) reducing disease severity in plants and plant parts affected directly or indirectly by phytopathogenic pests; e) enhancing plant growth environments; f) improving nutrient availability in plant
growth media; g) reducing the amount(s) of exogenous fertilizer needed to achieve a desired result; h) improving plant growth, development and yield characteristics; i) prolonging the shelf-life of harvested plants and plant parts; j) delaying the ripening of plants and plant parts; k) hastening the ripening of plants and plant parts; l) improving the efficacy of biological/chemical pesticides; m) preventing, treating, suppressing and/or eliminating pesticide-induced resistance/phytotoxicity, as well as polynucleotides encoding such proteins, organisms expressing such proteins, formulations comprising such proteins, polynucleotides and organisms, and methods of using such proteins, polynucleotides, organisms and formulations in agriculture and other fields of endeavor. As those skilled in the art will appreciate, proteins, polynucleotides and organisms of the present disclosure may be used (and may be formulated for use) at any time(s) throughout the agricultural, floricultural, horticultural, and silvicultural processes, such as prior to planting, at the time of planting, after planting, prior to germination, after germination, prior to seedling emergence, at the time of seedling emergence, after seedling emergence, prior to the vegetative stage, during the vegetative stage, after the vegetative stage, prior to the reproductive stage, during the reproductive stage, after the reproductive stage, prior to flowering, at the time of flowering, after flowering, prior to fruiting, at the time of fruiting, after fruiting, prior to ripening, at the time of ripening, after ripening, prior to harvest, at the time of harvest, after harvesting, prior to transport/storage, at the time of transport/storage, and/or after transport/storage. Accordingly, proteins of the present disclosure may be formulated for any suitable method of application, including, but not limited to, on-seed application, in-furrow application, foliar application, preharvest application, and postharvest application. As those skilled in the art will further appreciate, proteins, polynucleotides, organisms and formulations of the present disclosure may affect the desired outcome(s)—including prevention, treatment, suppression and/or elimination of infestations/infections—without being toxic. As will be explained in further detail below, compositions of the present disclosure may exert their effects through various non-lethal means, such as reducing the attraction of a pest to a treated surface by degrading a food source, for example. Moreover, in many instances, otherwise toxic proteins of the present disclosure may be used in non-lethal doses to enhance the efficacy of and/or expand the target pest range of various chemical pesticides and biological pesticides. Finally, those skilled in the art will appreciate that proteins, polynucleotides, organisms and formulations of the present disclosure may be used in combination to achieve the desire outcome(s). The present disclosure thus extends to formulations comprising two or more proteins of the present disclosure, to hybrid proteins comprising two or more distinct catalytic domains, to fusion proteins comprising two or more enzymatic polypeptides, etc. Although certain combinations will be described in detail below, it is to be understood that the present disclosure is not limited to those combinations but extends to all possible combinations of proteins, formulations, polynucleotides, and organisms described herein. In some embodiments, proteins of the present disclosure exhibit one or more catalytic activities
belonging to Enzyme Commission classification number 1 (EC 1). For example, in some embodiments, proteins of the present disclosure exhibit glucose oxidase, cellobiose dehydrogenase, amino acid oxidase, laccase, catalase, peroxidase and/or oxygenase activity useful for a) preventing/treating/suppressing/eliminating/reducing the detrimental effects of infestations/infections of/by various pests, including, but not limited to, phytopathogenic pests, such as acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa, viruses and weeds; b) reducing one or more aspects of disease severity in plants affected by one or more phytopathogenic pests; c) pretreating surfaces/substances that are susceptible to infestation/infection by pests; d) cleaning surfaces/substances that are infested/infected by pests; e) enhancing the environments in which plants are grown by; f) improving nutrient availability in plant growth media; g) reducing the amounts of exogenous fertilizer needed to achieve a desired result; h) improving plant growth, development, and yield characteristics; i) prolonging the shelf-life of harvested plants and plant parts; j) delaying/hastening the ripening of a plant or plant part; k) improving the efficacy of chemical pesticides; and/or l) reducing chemical-pesticide-induced resistance/phytotoxicity. In some embodiments, proteins of the present disclosure exhibit one or more oxidoreductase activities belonging to EC 1 and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 1–15 and 183–2755. In some embodiments, proteins of the present disclosure exhibit one or more oxidoreductase activities belonging to EC 1.1, such as oxidase activities belonging to EC 1.1.3 (e.g., glucose oxidase activity belonging to EC 1.1.3.4, hexose oxidase activity belonging to EC 3.1.1.5, galactose oxidase activity belonging to EC 1.1.3.9) and/or EC 1.1.99 (e.g., cellobiose oxidase activity belonging to EC 1.1.99.18), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one, two, three, four, five or more of the amino acid sequences set forth herein as SEQ ID NO(s): 1–8. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 1–5; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 1–5; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 92–96 or the cDNA sequence thereof;
d) a polypeptide derived from any one of SEQ ID NO(s): 1–5 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 1–5 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has glucose oxidase activity belonging to EC 1.1.3.4. Examples of proteins that exhibit glucose oxidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 1–5 are set forth herein as SEQ ID NOs: 183–2205. In some such embodiments, the protein is derived from Aspergillus (e.g., A.. chevalieri, A. cristatus, A. flavus, A. niger, A. niveoglaucus, A. nomiae, A. oryzae., A. terreus, A. tubingensis), Beauveria (e.g., B. bassiana), Escherichia (e.g., E. coli), Komagataella (e.g., K. pastoris), Penicillium (e.g., P. adametzii, P. amagasakiense, P. chrysogenum, P. decumbens, P. expansum, P. polonicum, P. viridicatum), or Talaromyces (e.g., T. bacillisporus, T. flavus, T. stipitatus, T. variabilis). For example, in some embodiments, the protein is a native Aspergillus (e.g., A. chevalieri, A. cristatus, A. flavus, A. niger, A. niveoglaucus, A. nomiae, A. oryzae., A. terreus, A. tubingensis), Beauveria (e.g., B. bassiana), Escherichia (e.g., E. coli), Komagataella (e.g., K. pastoris), Penicillium (e.g., P. adametzii, P. amagasakiense, P. chrysogenum, P. decumbens, P. expansum, P. polonicum, P. viridicatum), or Talaromyces (e.g., T. bacillisporus, T. flavus, T. stipitatus, T. variabilis) glucose oxidase or is a functional fragment/mutant/variant of a native Aspergillus (e.g., A.. chevalieri, A. cristatus, A. flavus, A. niger, A. niveoglaucus, A. nomiae, A. oryzae., A. terreus, A. tubingensis), Beauveria (e.g., B. bassiana), Escherichia (e.g., E. coli), Komagataella (e.g., K. pastoris), Penicillium (e.g., P. adametzii, P. amagasakiense, P. chrysogenum, P. decumbens, P. expansum, P. polonicum, P. viridicatum), or Talaromyces (e.g., T. bacillisporus, T. flavus, T. stipitatus, T. variabilis) glucose oxidase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 6–8; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 6–8; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 97–99 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 6–8 by substitution, deletion, or insertion of one or more amino acids;
e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 6–8 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has cellobiose oxidase activity belonging to EC 1.1.99.18. Examples of proteins that exhibit cellobiose oxidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 6–8 are set forth herein as SEQ ID NOs: 2206–2217. In some such embodiments, the protein is derived from Chaetomium, Humicola, Microdochium, Myceliophthora, Myriococcum, Neurospora or Remersonia. For example, in some embodiments, the protein is a native Chaetomium, Humicola, Microdochium, Myceliophthora, Myriococcum, Neurospora or Remersonia cellobiose oxidase or is a functional fragment/mutant/variant of a native Chaetomium, Humicola, Microdochium, Myceliophthora, Myriococcum, Neurospora or Remersonia cellobiose oxidase. Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more oxidoreductase activities belonging to EC 1.1. See, e.g., CN101348794-A; CN101348795-A; CN102517304-A; CN103275942-A; CN103525778-A; CN103614350- A; CN103981159-A; CN104312989-A; CN104711273-A; CN104711274-A; CN105002147-A; CN105420252-A; CN105746635-A; CN105950577-A; CN105950578-A; CN106119219-A; CN107012130- A; CN107988177-A; CN108003244-A; CN108004256-A; CN108118036-A; CN108118037-A; CN108118038-A; CN108251389-A; CN108251390-A; CN108251391-A; CN108251392-A; CN108374001- A; CN108893453-A; CN109207446-A; CN109321586-A; CN109423483-A; CN109666657-A; CN110577939-A; CN110592034-A; CN110628738-A; CN110885801-A; CN111004786-A; CN112143717- A; CN112760299-A; CN112877306-A; CN113061189-A; CN113403290-A; CN113528476-A; CN113862233-A; CN114058637-A; CN114181916-A; CN114395540-A; CN114395541-A; CN114736879- A; CN114736880-A; CN114736881-A; CN115029327-A; CN115029328-A; CN115612628-A; CN1229139- A; EP1892529-A1; EP2415863-A1; EP2562250-A1; EP2796547-A1; EP3572503-A1; EP3984368-A1; FR2979918-A1; JP2011139677-A; JP2012157315-A; JP2015002686-A; JP2018198581-A; US10233430-B1; US2004053425-A1; US2022283151-A1; WO2010039840-A1; WO2010053161-A1; WO2010121933-A1; WO2010135499-A1; WO2011068050-A1; WO2012068236-A2; WO2013026575-A2; WO2013159005-A2; WO2013181760-A1; WO2014000746-A1; WO2014013073-A1; WO2014081700-A1; WO2014114810-A1; WO2014173822-A2; WO2015109405-A1; WO2016026842-A1; WO2016031611-A1; WO2016090472-A1; WO2016090473-A1; WO2016050905-A1; WO2018039802-A1; WO2019110497-A1; WO2020125700-A1; WO2020239064-A1; WO2020254336-A1; WO2022138668-A1; WO2022256274-A1; WO2023004432-A2; WO2023288294-A1; WO8912675-A; WO9521924-A1. In some embodiments, proteins of the present disclosure exhibit one or more oxidoreductase activities belonging to EC 1.4, such as oxidase activities belonging to EC 1.4.3 (e.g., D-aspartate oxidase activity
belonging to EC 1.4.3.1, L-amino acid oxidase activity belonging to EC 1.4.3.2, D-amino acid oxidase activity belonging to EC 1.4.3.3, D-glutamate oxidase activity belonging to EC 1.4.3.7, L-glutamate oxidase activity belonging to EC 1.4.3.11, cyclohexylamine oxidase activity belonging to EC 1.4.3.12, protein-lysine 6-oxidase activity belonging to EC 1.4.3.13, L-lysine oxidase activity belonging to EC 1.4.3.14, D- glutamate(D-aspartate) oxidase activity belonging to EC 1.4.3.15, L-aspartate oxidase activity belonging to EC 1.4.3.16, glycine oxidase activity belonging to EC 1.4.3.19, L-lysine 6-oxidase activity belonging to EC 1.4.3.20, L-arginine oxidase activity belonging to EC 1.4.3.25). In some embodiments, proteins of the present disclosure exhibit one or more oxidase activities belonging to EC 1.10, such as activities belonging to EC 1.10.3 (e.g., laccase activity belonging to EC 1.10.3.2), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to the amino acid sequence set forth herein as SEQ ID NO: 9. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 9; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 9; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 100 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 9 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 9 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has laccase activity belonging to EC 1.10.3.2. Examples of proteins that exhibit laccase activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 9 are set forth herein as SEQ ID NOs: 2218–2251. In some such embodiments, the protein is derived from Chaetomium, Chrysocorona, Melanocarpus, Myceliophthoora, Myriococcum, or Thermothelomyces. For example, in some embodiments, the protein is a native Chaetomium, Chrysocorona, Melanocarpus, Myceliophthoora, Myriococcum, or Thermothelomyces
laccase or is a functional fragment/mutant/variant of a native Chaetomium, Chrysocorona, Melanocarpus, Myceliophthoora, Myriococcum, or Thermothelomyces laccase. Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more oxidase activities belonging to EC 1.10. See, e.g., EP3444323-A1; IN9601521-I4; US2008148432-A1; US2009155415-A1; US2012227131-A1; US2022298533-A1; US6060442-A; WO2009075860-A2; WO2012068236-A2; WO2013181760-A1; WO2014081700-A1; WO2015109405-A1; WO2016029107-A1; WO2016090059-A1; WO2016090474-A1; WO2017089304-A1; WO2022029293-A1; WO2022270590-A1; WO2023288294-A1; WO9838286-A1. In some embodiments, enzymes of the present disclosure exhibit peroxidase activity belonging to EC 1.11, such as peroxidase activity belonging to EC 1.11.1 (e.g., catalase activity belonging to EC 1.11.1.6, peroxidase activity belonging to EC 1.11.1.7, lignin peroxidase activity belonging to EC 1.11.1.14), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 10–13. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 10–12; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 10–12; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 101–103 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 10–12 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 10–12 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has catalase activity belonging to EC 1.11.1.6. Examples of proteins that exhibit catalase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 10–12 are set forth herein as SEQ ID NOs: 2252–2296. In some such embodiments, the protein is derived from Aspergillus, Myceliophthora, Penicillium,
Rasamsonia, Talaromyces or Thermoascus. For example, in some embodiments, the protein is a native Aspergillus, Myceliophthora, Penicillium, Rasamsonia, Talaromyces or Thermoascus catalase or is a functional fragment/mutant/variant of a native Aspergillus, Myceliophthora, Penicillium, Rasamsonia, Talaromyces or Thermoascus catalase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 13; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 13; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 104 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 13 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 13 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has peroxidase activity belonging to EC 1.11.1.7. Examples of proteins that exhibit peroxidase activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 13 are set forth herein as SEQ ID NOs: 2297–2381. In some such embodiments, the protein is derived from Arthromyces or Coprinopsis. For example, in some embodiments, the protein is a native A Arthromyces or Coprinopsis peroxidase or is a functional fragment/mutant/variant of a native Arthromyces or Coprinopsis peroxidase. Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more peroxidase activities belonging to EC 1.11. See, e.g., CN105441400- A; CN108070574-A; CN112522227-A; EP2295582-A2; EP486067-A2; JP2007143405-A; JP2010044058-A; KR2011013726-A; US2005108791-A1; US2007118916-A1; US2008148432-A1; US2013074202-A1; US2020306342-A1; WO2004108765-A2; WO2006114616-A1; WO2007020428-A1; WO2007044043-A2; WO2009104622-A1; WO2010027755-A1; WO2011068297-A1; WO2012068236-A2; WO2012072777-A1; WO2012130120-A1; WO2013091547-A1; WO2014018368-A2; WO2014081700-A1; WO2014202616-A2; WO2015048332-A2; WO2015182941-A1; WO2017040907-A1; WO2018089391-A1; WO2020200321-A1; WO2020200322-A1; WO2022074170-A1; WO2022251056-A1; WO2023002065-A2; WO2023019266-A2;
WO9317721-A1; WO9318166-A2; WO9510602-A1; WO9515391-A2; WO9810060-A1; WO9835026-A1. In some embodiments, proteins of the present disclosure exhibit one or more oxygenase activities belonging to EC 1.14, such as oxygenase activities belonging to EC 1.14.16 (e.g., phenylalanine 4- monooxygenase activity belonging to EC 1.14.16.1, tyrosine 3-monooxygenase activity belonging to EC 1.14.16.2, tryptophan 5-monooxygenase activity belonging to EC 1.14.16.4, phenylalanine 3-monooxygenase activity belonging to EC 1.14.16.7), EC 1.14.18 (e.g., tyrosinase activity belonging to EC 1.14.18.1) and/or EC 1.14.99 (e.g., lytic chitin monooxygenase activity belonging to EC 1.14.99.53, lytic cellulose monooxygenase activity belonging to EC 1.14.99.54, lytic starch monooxygenase activity belonging to EC 1.14.99.55, lytic cellulose monooxygenase activity belonging to EC 1.14.99.56, lytic cellulose monooxygenase activity belonging to EC 1.14.99.56), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 14–15. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 14–15; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 14–15; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 105–106 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 14–15 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 14–15 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has lytic cellulose monooxygenase activity belonging to EC 1.14.99.56. Examples of proteins that exhibit lytic cellulose monooxygenase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 14–15 are set forth herein as SEQ ID NOs: 2382–2755. In some such embodiments, the protein is derived from Penicillium, Rasamsonia, or Thermoascus. For example, in some embodiments, the protein is a native Penicillium, Rasamsonia, or Thermoascus monooxygenase or is a functional fragment/mutant/variant of a native Penicillium, Rasamsonia, or
Thermoascus monooxygenase. Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more oxygenase activities belonging to EC 1.14. See, e.g., CN103232949-A; CN103255072-A; CN106544329-A; CN109554355-A; CN110093326-A; JP2016039821-A; US2008299613- A1; US2011099671-A1; US2014075603-A1; US2018019412-A1; US2019153414-A1; WO2011080267-A2; WO2011121768-A1; WO2011153516-A2; WO2012000892-A1; WO2012021394-A1; WO2012021395-A1; WO2012044835-A1; WO2012044836-A1; WO2012068509-A1; WO2012089023-A1; WO2013028915-A2; WO2013036898-A2; WO2013110242-A1; WO2013119302-A2; WO2014085251-A1; WO2014093835-A1; WO2014138983-A1; WO2014140165-A1; WO2014202616-A2; WO2014202711-A1; WO2015105835-A1; WO2015187935-A1; WO2016045569-A1; WO2016090473-A1; WO2016145358-A1; WO2017070219-A1; WO2018019948-A1; WO2018106656-A1; WO2018142002-A1; WO2019005755-A1; WO2019083831-A1; WO2019229228-A1. In some embodiments, proteins of the present disclosure exhibit one or more catalytic activities belonging to Enzyme Commission classification number 2 (EC 2). For example, in some embodiments, proteins of the present disclosure exhibit aminoacyltransferase activity useful for a) preventing/treating/ suppressing/eliminating/reducing the detrimental effects of infestations/infections of/by various pests, including, but not limited to, phytopathogenic pests, such as acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa, viruses and weeds; b) reducing one or more aspects of disease severity in plants affected by one or more phytopathogenic pests; c) pretreating surfaces/substances that are susceptible to infestation/infection by pests; d) cleaning surfaces/substances that are infested/infected by pests; e) enhancing the environments in which plants are grown by; f) improving nutrient availability in plant growth media; g) reducing the amounts of exogenous fertilizer needed to achieve a desired result; h) improving plant growth, development, and yield characteristics; i) prolonging the shelf-life of harvested plants and plant parts; j) delaying/hastening the ripening of a plant or plant part; k) improving the efficacy of chemical pesticides; and/or l) reducing chemical-pesticide-induced resistance/phytotoxicity. In some embodiments, proteins of the present disclosure exhibit transferase activity belonging to EC 2 and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 16 and 2756–2769. In some embodiments, proteins of the present disclosure exhibit one or more acyltransferase activities belonging to EC 2.3, such as aminoacyl transferase activities belonging to EC 2.3.2 (e.g., D-glutamyl transferase activity belonging to EC 2.3.2.1, gamma-glutamyl transferase activity belong to EC 2.3.2.2, aspartyl transferase activity belonging to EC 2.3.2.7, protein-glutamine gamma-glutamyl transferase activity belonging to EC 2.3.2.13, D-alanine gamma-glutamyl transferase activity belonging to EC 2.3.2.14), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61,
62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequence set forth herein as SEQ ID NO: 16. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 16; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 16; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 107 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 16 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 16 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has gamma-glutamyl transferase activity belonging to EC 2.3.2.2. Examples of proteins that exhibit gamma-glutamyl transferase activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 16 are set forth herein as SEQ ID NOs: 2756–2769. In some such embodiments, the protein is derived from Bacillus. For example, in some embodiments, the protein is a native Bacillus gamma-glutamyl transferase or is a fragment/mutant/variant of a native Bacillus gamma-glutamyl transferase. Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more acyltransferase activities belonging to EC 2.3. See, e.g., CN107828754-A; CN108611333-A; CN108929866-A; CN112111468-A; CN114806988-A; EP441353-A; KR1814024-B1; WO2003087149-A2; WO2005075652-A1; WO2014081884-A1; WO2015048332-A2; WO2018234382-A1. In some embodiments, proteins of the present disclosure exhibit one or more catalytic activities belonging to Enzyme Commission classification number 3 (EC 3). For example, in some embodiments, proteins of the present disclosure exhibit lipase, triacylglycerol lipase, pectinesterase, phospholipase, lysophospholipase, cutinase, amylase, glucosidase, galactosidase, cellulase, glucanase, xylanase, ceramidase, dextranase, chitinase, chitosanase, galacturonase, fucosidase, lysozymes, xylosidase, lucosidass, pullulanase,
mannosidase, amidase, aminidase, maltohydrolases, cellobiosidase, pectinase, mannanase, aminopeptidase, serine peptidase and/or metallopeptidase, asparaginase and/or glutaminase activity useful for a) prevent- ing/treating/suppressing/eliminat-ing/reducing the detrimental effects of infestations/infections of/by various pests, including, but not limited to, phytopathogenic pests, such as acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa, viruses and weeds; b) reducing one or more aspects of disease severity in plants affected by one or more phytopathogenic pests; c) pretreating surfaces/substances that are susceptible to infestation/infection by pests; d) cleaning surfaces/substances that are infested/infected by pests; e) enhancing the environments in which plants are grown by; f) improving nutrient availability in plant growth media; g) reducing the amounts of exogenous fertilizer needed to achieve a desired result; h) improving plant growth, development, and yield characteristics; i) prolonging the shelf-life of harvested plants and plant parts; j) delaying/hastening the ripening of a plant or plant part; k) improving the efficacy of chemical pesticides; and/or l) reducing chemical-pesticide-induced resistance/phytotoxicity. In some embodiments, proteins of the present disclosure exhibit esterase activity belonging to EC 3 and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 17–90 and 2770–72141. In some embodiments, proteins of the present disclosure exhibit one or more esterase activities belonging to EC 3.1, such as lipase activities belonging to EC 3.1.1 (e.g., triacylglycerol lipase activity belong to EC 3.1.1.3, phospholipase A2 activity belonging to EC 3.1.1.4, lysophospholipase activity belonging to 3.1.1.5, pectinesterase activity belonging to 3.1.1.11, phospholipase A1 activity belonging to 3.1.1.32, lipoprotein lipase activity belonging to EC 3.1.1.34, cutinase activity belonging to 3.1.1.74), phosphatase activities belonging to EC 3.1.3 (e.g., alkaline phosphatase activity belonging to EC 3.1.3.1, acid phosphatase activity belonging to EC 3.1.3.2, 3-phytase activity belonging to EC 3.1.3.8, glucose-6-phosphatase activity belonging to EC 3.1.3.9, glucose-1-phosphatase activity belonging to EC 3.1.3.10, fructose-biphosphatase activity belonging to EC 3.1.3.11, sugar-phosphatase activity belonging to EC 3.1.3.23, 4-phytase activity belonging to EC 3.1.3.26, fructose-2,6-biphosphate 2-phosphatase activity belonging to EC3.1.3.46, fructose- 2,6-biphosphate 6-phosphatase activity belonging to EC 3.1.3.54, 5-phytase activity belonging to EC 3.1.3.72, lipid-phosphate phosphatase activity belonging to EC 3.1.3.76), and/or hydrolase activities belonging to EC 3.1.4 (e.g., phospholipase C activity belonging to 3.1.4.3, phospholipase D activity belonging to EC 3.1.4.4, phoshoinositide phospholipase C activity belonging to 3.1.4.11), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 17–33, 72147 and 72149. In some embodiments, the protein is selected from the group consisting of:
a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 17–22; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 17–22; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 108–113 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 17–22 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 17–22 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has triacylglycerol lipase activity belonging to EC 3.1.1.3. Examples of proteins that exhibit triacylglycerol lipase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 17–22 are set forth herein as SEQ ID NOs: 2778–10223. In some embodiments, the protein is derived from Aspergillus, Bacillus, Cryphonectria, Fusarium, Haloquadratum, Humicola, Penicillium, Scytalidium, Talaromyces, Thermomyces or Thermus. For example, in some embodiments, the protein is a native Aspergillus, Bacillus, Cryphonectria, Fusarium, Haloquadratum, Humicola, Penicillium, Scytalidium, Talaromyces, Thermomyces or Thermus triacylglycerol lipase or is a fragment/mutant/variant of a native Aspergillus, Bacillus, Cryphonectria, Fusarium, Haloquadratum, Humicola, Penicillium, Scytalidium, Talaromyces, Thermomyces or Thermus triacylglycerol lipase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 23; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 23; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 114 or the cDNA sequence thereof;
d) a polypeptide derived from any one of SEQ ID NO(s): 23 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 23 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has triacylglycerol lipase activity belonging to EC 3.1.1.3 and/or phospholipase A1 activity belonging to EC 3.1.1.32. Examples of proteins that exhibit triacylglycerol lipase activity and/or phospholipase A1 activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 23 are set forth herein as SEQ ID NOs: 10243–15978. In some embodiments, the protein is derived from Aspergillus, Bacillus, Fusarium, Struthio, Talaromyces or Thermomyces. For example, in some embodiments, the protein is a native Aspergillus, Bacillus, Fusarium, Struthio, Talaromyces or Thermomyces triacylglycerol lipase or is a fragment/mutant/variant of a native Aspergillus, Bacillus, Fusarium, Struthio, Talaromyces or Thermomyces triacylglycerol lipase. In some embodiments, the protein is derived from Aspergillus, Bacillus, Fusarium, Struthio, Talaromyces or Thermomyces. For example, in some embodiments, the protein is a native Aspergillus, Bacillus, Fusarium, Struthio, Talaromyces or Thermomyces phospholipase A1 or is a fragment/mutant/variant of a native Aspergillus, Bacillus, Fusarium, Struthio, Talaromyces or Thermomyces phospholipase A1. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 24; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 24; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 115 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 24 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 24 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and
g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has lysophospholipase activity belonging to EC 3.1.1.5. Examples of proteins that exhibit lysophospholipase activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 24 are set forth herein as SEQ ID NOs: 15979–15981. In some embodiments, the protein is derived from Aspergillus. For example, in some embodiments, the protein is a native Aspergillus lysophospholipase or is a fragment/mutant/variant of a native Aspergillus lysophospholipase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 25; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 25; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 116 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 25 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 25 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has pectinesterase activity belonging to EC 3.1.1.11. Examples of proteins that exhibit pectinesterase activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 25 are set forth herein as SEQ ID NOs: 2770–2777. In some embodiments, the protein is derived from Aspergillus. For example, in some embodiments, the protein is a native Aspergillus pectinesterase or is a fragment/mutant/variant of a native Aspergillus pectinesterase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 26; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence
identity to a mature polypeptide of any one of SEQ ID NO(s): 26; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 117 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 26 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 26 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has phospholipase A1 activity belonging to EC 3.1.1.32. Examples of proteins that exhibit phospholipase A1 activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 26 are set forth herein as SEQ ID NOs: 10224–10242. In some embodiments, the protein is derived from Evansstolkia. For example, in some embodiments, the protein is a native Evansstolkia phospholipase A1 or is a fragment/mutant/variant of a native Evansstolkia phospholipase A1. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 27–31, 72147 and 72149; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 27–31, 72147 and 72149; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 118–122, 72148 and 72150 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 27–31, 72147 and 72149by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 27–31, 72147 and 72149by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has cutinase activity belonging to EC 3.1.1.74. Examples of proteins that exhibit
cutinase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 27–31, 72147 and 72149are set forth herein as SEQ ID NOs: 15982–16004. In some embodiments, the protein is derived from Acrophialophora, Ascomycota, Chaetomium, Humicola, Hypocrea, Myceliophthora, Myriococcum, Pyrenophora, Thermochaetoides or Trichoderma. For example, in some embodiments, the protein is a native Acrophialophora, Ascomycota, Chaetomium, Humicola, Hypocrea, Myceliophthora, Myriococcum, Pyrenophora, Thermochaetoides or Trichoderma cutinase or is a fragment/mutant/variant of a native Acrophialophora, Ascomycota, Chaetomium, Humicola, Hypocrea, Myceliophthora, Myriococcum, Pyrenophora, Thermochaetoides or Trichoderma cutinase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 32; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 32; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 123 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 32 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 32 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has phospholipase C activity belonging to EC 3.1.4.3. Examples of proteins that exhibit phospholipase C activity and have an amino acid sequence that is at least 70% identical to SEQ ID NO: 32 are set forth herein as SEQ ID NOs: 16396–16412. In some embodiments, the protein is derived from Pseudomonas. For example, in some embodiments, the protein is a native Pseudomonas phospholipase C or is a fragment/mutant/variant of a native Pseudomonas phospholipase C. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 33; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75,
76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 33; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 124 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 33 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 33 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has phosphoinositide phospholipase C activity belonging to EC 3.1.4.11. Examples of proteins that exhibit phosphoinositide phospholipase C activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 33 are set forth herein as SEQ ID NOs: 16005–16395. In some embodiments, the protein is derived from Bacillus, Komagataella or Lysinibacillus. For example, in some embodiments, the protein is a native Bacillus, Komagataella or Lysinibacillus phosphoinositide phospholipase C or is a fragment/mutant/variant of a native Bacillus, Komagataella or Lysinibacillus phosphoinositide phospholipase C. Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more esterase activities belong to EC 3.1. See, e.g., CA2715086-A1; CN102604913-A; CN103045559-A; CN103243038-A; CN103555600-A; CN103865896-A; CN103981160- A; CN104293744-A; CN104878033-A; CN105087614-A; CN106591258-A; CN106632683-A; CN106635846-A; CN106676084-A; CN106884030-A; CN107151660-A; CN107488644-A; CN107488645- A; CN107488646-A; CN107488647-A; CN107488648-A; CN107815460-A; CN108118039-A; CN108239626-A; CN108239627-A; CN108277212-A; CN108315312-A; CN108359655-A; CN108913675- A; CN109321546-A; CN109468301-A; CN109776686-A; CN109929821-A; CN110129301-A; CN110760531-A; CN111378583-A; CN112175976-A; CN112574974-A; CN112592907-A; CN112608912- A; CN113025595-A; CN113025596-A; CN113122520-A; CN113215130-A; CN113338044-A; CN113736817-A; CN113755509-A; CN113846074-A; CN114317490-A; CN114621941-A; CN115521925- A; CN115717134-A; DE102016204813-A1; EP2145904-A1; EP2623586-; 2; EP305216-A; EP3091080-A1; EP3101108-A1; EP3101109-A1; EP3284811-A1; EP3287513-A1; EP3301145-A1; EP3301147-A1; EP3301156-A1; EP3301161-A1; EP3301162-A1; EP3301163-A1; EP3301165-A1; EP3301166-A1; EP3301169-A1; JP09249891-A; JP09249893-A; JP2019165727-A; US2005287250-A1; US2007173430-A1; US2009162480-A1; US2009217463-A1; US2009217464-A1; US2009221033-A1; US2009221034-A1; US2011312057-A1; US2013316458-A1; US2018094228-A1; US2019093054-A1; US2020306342-A1;
US2021015105-A1; US2022177812-A1; US9102933-B1; WO2000060063-A1; WO200011211-A1; WO200034450-A1; WO200127251-A1; WO200192502-A1; WO200255679-A2; WO200262973-A2; WO200266622-A2; WO200295127-A2; WO2003060112-A1; WO2003089620-A2; WO2004099400-A2; WO2004111216-A2; WO2005032496-A2; WO2005086900-A2; WO2006084470-A2; WO2006136159-A2; WO2006136160-A2; WO2007080197-A2; WO2007087243-A2; WO2007087318-A2; WO2007087319-A2; WO2007087508-A2; WO2008073169-A2; WO2008079685-A2; WO2008122640-A2; WO2009071550-A1; WO2009083607-A1; WO2009108941-A2; WO2009133177-A1; WO2011046812-A1; WO2011046815-A1; WO2012027282-A2; WO2012078741-A2; WO2012129548-A2; WO2012173658-A1; WO2013098205-A2; WO2013113622-A1; WO2013149858-A1; WO2013171072-A1; WO2013181760-A1; WO2014055778-A2; WO2014059360-A1; WO2014059541-A1; WO2014081700-A1; WO2014081884-A1; WO2014147219-A1; WO2014162001-A1; WO2014184164-A1; WO2014186464-A1; WO2015010009-A2; WO2015017045-A1; WO2015048332-A2; WO2015067161-A1; WO2015085920-A1; WO2015109405-A1; WO2015110058-A1; WO2015110562-A1; WO2015140275-A1; WO2015144780-A2; WO2015173426-A1; WO2016050661-A1; WO2016087401-A1; WO2016090472-A1; WO2016090473-A1; WO2016090474-A1; WO2016091870-A1; WO2016102356-A1; WO2016107567-A1; WO2016109758-A2; WO2016164596-A2; WO2017001673-A1; WO2017005640-A1; WO2017015233-A1; WO2017093318-A1; WO2017101801-A1; WO2017161091-A1; WO2017182666-A1; WO2018001959-A1; WO2018015295-A1; WO2018127486-A1; WO2018171552-A1; WO2018188667-A1; WO2019014118-A1; WO2019060574-A1; WO2019063499-A1; WO2019110462-A1; WO2019137289-A1; WO2019154951-A1; WO2019154952-A1; WO2019154954-A1; WO2019154955-A1; WO2019215078-A1; WO2019236717-A1; WO2020014407-A1; WO2020046613-A1; WO2020076697-A1; WO2020088393-A1; WO2020103861-A1; WO2020135657-A1; WO2020135658-A1; WO2020173817-A1; WO2020190782-A1; WO2021037878-A1; WO2021119304-A1; WO2021170799-A1; WO2021239267-A1; WO2022063699-A1; WO2022090361-A2; WO2022103725-A1; WO2022173694-A1; WO2023032952-A1; WO2023288294-A1; WO9205249-A; WO9219726-A1; WO9425575-A1; WO9425577-A1; WO9522615- A1; WO9613580-A1; WO9704079-A1; WO9707202-A1; WO9707205-A1; WO9707206-A1. In some embodiments, proteins of the present disclosure exhibit one or more glycosylase activities belonging to EC 3.2, such as glycosidase activities belonging to EC 3.2.1 (e.g., alpha-amylase activity belong to EC 3.2.1.1, beta-amylase activity belong to EC 3.2.1.2, glucan 1,4-alpha-glucosidase activity belong to 3.2.1.3, cellulase activity belong to 3.2.1.4, endo-1,3(4)-beta-glucanase activity belong to 3.2.1.6, inulinase activity belong to 3.2.1.7, endo-1,4-beta-xylanase activity belong to 3.2.1.8, oligo-1,6-glucosidase activity belong to 3.2.1.10, dextranase activity belong to 3.2.1.11, chitinase activity belong to 3.2.1.14, endo- polygalacturonase (pectinase) activity belong to 3.2.1.15, lysozyme activity belong to 3.2.1.17, alpha- glucosidase activity belong to 3.2.1.20, beta-glucosidase activity belong to 3.2.1.21, alpha-galactosidase activity belong to 3.2.1.22, beta-galactosidase activity belong to 3.2.1.23, alpha-mannosidase activity belong to 3.2.1.24, beta-mannosidase activity belong to 3.2.1.25, beta-fructofuranosidase activity belong to 3.2.1.26, alpha,alpha-trehalase activity belong to 3.2.1.28, endo-1,3-beta-xylanase activity belong to 3.2.1.32, amylo-
1,6-glucosidase activity belonging to EC3.2.1.33, xylan 1,4-beta-xylosidase activity belong to 3.2.1.37, glucan endo-1,3-beta-D-glucosidase activity belong to 3.2.1.39, pullulanase activity belong to 3.2.1.41, alpha- L-arabinofuranosidase activity belong to 3.2.1.55, glucan 1,3-beta-glucosidase activity belong to 3.2.1.58, glucan endo-1,3-alpha-glucosidase activity belong to 3.2.1.59, glucan 1,6-alpha-glucosidase activity belonging to EC 3.2.1.70, glucan endo-1,2-beta-glucosidase activity belonging to EC 3.2.1.71, xylan 1,3-beta- xylosidase activity belonging to EC 3.2.1.72, licheninase activity belong to 3.2.1.73, glucan 1,4-beta- glucosidase activity belonging to EC 3.2.1.74, glucan endo-1,6-beta-glucosidase activity belong to 3.2.1.75, mannan 1,2-(1,3)-alpha-mannosidase activity belonging to EC 3.2.1.77, mannan endo-1,4-β-mannosidase activity belonging to 3.2.1.78, glucan 1,3-alpha-glucosidase activity belonging to EC 3.2.1.84, cellulose 1,4- beta-cellobiosidase activity belong to 3.2.1.91, peptidoglycan beta-N-acetylmuramidase activity belonging to EC 3.2.1.92, endo-alpha-N-acetylgalactosaminidase activity belong to 3.2.1.97, mannan 1,4-mannobiosidase activity belonging to EC 3.2.1.100, mannan endo-1,6-alpha-mannosidase activity belong to 3.2.1.101, endogalactosaminidase activity belong to 3.2.1.109, 1,3-alpha-L-fucosidase activity belong to 3.2.1.111, 2- deoxyglucosidase activity belong to 3.2.1.112, glycoprotein endo-alpha-1,2-mannosidase activity belonging to EC 3.2.1.130, chitosanase activity belong to 3.2.1.132, glucan 1,4-alpha-maltohydrolase activity belong to 3.2.1.133, mannan exo-1,2-1,6-alpha-mannosidase activity belonging to EC 3.2.1.137, 1,6-alpha-D- mannosidase activity belonging to 3.2.1.163, 1,4-beta-cellobiosidase activity belonging to 3.2.1.176, galactan endo-beta-1,3-galactanase activity belonging to EC 3.2.1.181, alpha-mannan endo-1,2-alpha-mannanase activity belonging to EC 3.2.1.198, exo-chitinase activity belonging to EC 3.2.1.200, exo-chitinase activity belonging to EC 3.2.1.201), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 34–80, 45906 and 72144. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 34–40; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 34–40; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 125–131 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 34–40 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 34–40 by
substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has alpha-amylase activity belonging to EC 3.2.1.1. Examples of proteins that exhibit alpha-amylase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 34–40 are set forth herein as SEQ ID NOs: 16413–45041. In some embodiments, the protein is derived from Alicyclobacillus, Alkalihalobacillus, Anoxybacillus, Aspergillus, Bacillus, Cytophaga, Exiguobacterium, Geobacillus, Hamigera, Homo sapiens, Jeotgalibacillus, Neosartorya, Penicillium, Priestia, Pyrococcus, Rasamsonia, Sutcliffiella or Thermoascus. For example, in some embodiments, the protein is a native Alicyclobacillus, Alkalihalobacillus, Anoxybacillus, Aspergillus, Bacillus, Cytophaga, Exiguobacterium, Geobacillus, Hamigera, Homo sapiens, Jeotgalibacillus, Neosartorya, Penicillium, Priestia, Pyrococcus, Rasamsonia, Sutcliffiella or Thermoascus alpha-amylase or is a fragment/mutant/variant of a native Alicyclobacillus, Alkalihalobacillus, Anoxybacillus, Aspergillus, Bacillus, Cytophaga, Exiguobacterium, Geobacillus, Hamigera, Homo sapiens, Jeotgalibacillus, Neosartorya, Penicillium, Priestia, Pyrococcus, Rasamsonia, Sutcliffiella or Thermoascus alpha-amylase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 41–42; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 41–42; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 132–133 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 41–42 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 41–42 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has glucan 1,4-alpha-glucosidase activity belonging to EC 3.2.1.3. Examples of proteins that exhibit glucan 1,4-alpha-glucosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 41–42 are set forth herein as SEQ ID NOs: 45756–45904.
In some embodiments, the protein is derived from Aspergillus, Bos, Elaphocordyceps, Fusarium, Penicillium, Rasamsonia or Saccharomycopsis. For example, in some embodiments, the protein is a native Aspergillus, Bos, Elaphocordyceps, Fusarium, Penicillium, Rasamsonia or Saccharomycopsis glucan 1,4- alpha-glucosidase or is a fragment/mutant/variant of a native Aspergillus, Bos, Elaphocordyceps, Fusarium, Penicillium, Rasamsonia or Saccharomycopsis glucan 1,4-alpha-glucosidase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 43–45; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 43–45; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 134–136 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 43–45 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 43–45 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has cellulase activity belonging to EC 3.2.1.4. Examples of proteins that exhibit cellulase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 43–45 are set forth herein as SEQ ID NOs: 45913–48750. In some embodiments, the protein is derived from Acremonium, Alteromonas, Ascomycota, Aspergillus, Bacillus, Chaetomium, Clonostachys, Corynascus, Cylindrocarpon, Escherichia, Fusarium, Humicola, Madurella, Melanocarpus, Myceliophthora, Neurospora, Podospora, Remersonia, Scytalidium, Sordaria, Staphylotrichum, Thermocarpiscus, Thermochaetoides, Thermothielavioides, Thielavia, Trichocladium, Trichothecium or Triticum. For example, in some embodiments, the protein is a native Acremonium, Alteromonas, Ascomycota, Aspergillus, Bacillus, Chaetomium, Clonostachys, Corynascus, Cylindrocarpon, Escherichia, Fusarium, Humicola, Madurella, Melanocarpus, Myceliophthora, Neurospora, Podospora, Remersonia, Scytalidium, Sordaria, Staphylotrichum, Thermocarpiscus, Thermochaetoides, Thermothielavioides, Thielavia, Trichocladium, Trichothecium or Triticum cellulase or is a fragment/mutant/variant of a native Acremonium, Alteromonas, Ascomycota, Aspergillus, Bacillus, Chaetomium, Clonostachys, Corynascus, Cylindrocarpon, Escherichia, Fusarium, Humicola, Madurella,
Melanocarpus, Myceliophthora, Neurospora, Podospora, Remersonia, Scytalidium, Sordaria, Staphylotrichum, Thermocarpiscus, Thermochaetoides, Thermothielavioides, Thielavia, Trichocladium, Trichothecium or Triticum cellulase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 46; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 46; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 137 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 46 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 46 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has endo-1,3(4)-beta-glucanase activity belonging to EC 3.2.1.6. Examples of proteins that exhibit endo-1,3(4)-beta-glucanase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 46 are set forth herein as SEQ ID NOs: 49229–49346. In some embodiments, the protein is derived from Bacillus, Bispora, Hordeum or Paenibacillus. For example, in some embodiments, the protein is a native Bacillus, Bispora, Hordeum or Paenibacillus endo- 1,3(4)-beta-glucanase or is a fragment/mutant/variant of a native Bacillus, Bispora, Hordeum or Paenibacillus endo-1,3(4)-beta-glucanase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 47; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 47; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97,
98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 138 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 47 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 47 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has inulinase activity belonging to EC 3.2.1.7. Examples of proteins that exhibit inulinase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 47 are set forth herein as SEQ ID NOs: 49347–49419. In some embodiments, the protein is derived from Aspergillus, Penicillium, Pseudomonas or Talaromyces. For example, in some embodiments, the protein is a native Aspergillus, Penicillium, Pseudomonas or Talaromyces inulinase or is a fragment/mutant/variant of a native Aspergillus, Penicillium, Pseudomonas or Talaromyces inulinase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 48–53; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 48–53; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 139–144 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 48–53 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 48–53 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has endo-1,4-beta-xylanase activity belonging to EC 3.2.1.8. Examples of proteins that exhibit endo-1,4-beta-xylanase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 48–53 are set forth herein as SEQ ID NOs: 49453–49912. In some embodiments, the protein is derived from Anaerocellum, Aspergillus, Bacillus,
Caldicellulosiruptor, Clostridium, Dicytoglomus, Evansstolkia, Hordeum, Lactobacillus, Malbranchea, Neosartorya, Nicotiana, Paecilomyces, Paenibacillus, Penicillium, Pyrococcus, Rasamsonia, Saccharomyces, Talaromyces, Thermoclostridium, Thermomyces, Thermus or Viridiplantae. For example, in some embodiments, the protein is a native Anaerocellum, Aspergillus, Bacillus, Caldicellulosiruptor, Clostridium, Dicytoglomus, Evansstolkia, Hordeum, Lactobacillus, Malbranchea, Neosartorya, Nicotiana, Paecilomyces, Paenibacillus, Penicillium, Pyrococcus, Rasamsonia, Saccharomyces, Talaromyces, Thermoclostridium, Thermomyces, Thermus or Viridiplantae endo-1,4-beta-xylanase or is a fragment/mutant/variant of a native Anaerocellum, Aspergillus, Bacillus, Caldicellulosiruptor, Clostridium, Dicytoglomus, Evansstolkia, Hordeum, Lactobacillus, Malbranchea, Neosartorya, Nicotiana, Paecilomyces, Paenibacillus, Penicillium, Pyrococcus, Rasamsonia, Saccharomyces, Talaromyces, Thermoclostridium, Thermomyces, Thermus or Viridiplantae endo-1,4-beta-xylanase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 54; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 54; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 145 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 54 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 54 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has dextranase activity belonging to EC 3.2.1.11. Examples of proteins that exhibit dextranase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 54 are set forth herein as SEQ ID NOs: 45063–45071. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 56; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75,
76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 56; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 147 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 56 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 56 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has lysozyme activity belonging to EC 3.2.1.17. Examples of proteins that exhibit lysozyme activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 56 are set forth herein as SEQ ID NOs: 45443–45456. In some embodiments, the protein is derived from Clonostachys or Sodiomyces. For example, in some embodiments, the protein is a native Clonostachys or Sodiomyces lysozyme or is a fragment/mutant/variant of a native Clonostachys or Sodiomyces lysozyme. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 57; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 57; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 148 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 57 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 57 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has beta-glucosidase activity belonging to EC 3.2.1.21. Examples of proteins that
exhibit beta-glucosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 57 are set forth herein as SEQ ID NOs: 45457–45754. In some embodiments, the protein is derived from Aspergillus, Coccidioides, Evansstolkia, Neosartorya, Penicillium, Rasamsonia, Schizosaccharomyces or Thermoascus. For example, in some embodiments, the protein is a native Aspergillus, Coccidioides, Evansstolkia, Neosartorya, Penicillium, Rasamsonia, Schizosaccharomyces or Thermoascus beta-glucosidase or is a fragment/mutant/variant of a native Aspergillus, Coccidioides, Evansstolkia, Neosartorya, Penicillium, Rasamsonia, Schizosaccharomyces or Thermoascus beta-glucosidase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 58; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 58; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 149 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 58 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 58 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has alpha-mannosidase activity belonging to EC 3.2.1.24. Examples of proteins that exhibit alpha-mannosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 58 are set forth herein as SEQ ID NOs: 45755. In some embodiments, the protein is derived from Neobacillus. For example, in some embodiments, the protein is a native Neobacillus alpha-mannosidase or is a fragment/mutant/variant of a native Neobacillus alpha-mannosidase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 59–60 and 45906; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75,
76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 59–60 and 45906; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 150–151 and 72146 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 59–60 and 45906by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 59–60 and 45906by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has glucan endo-1,3-beta-D-glucosidase activity belonging to EC 3.2.1.39. Examples of proteins that exhibit glucan endo-1,3-beta-D-glucosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 59–60 and 45906 are set forth herein as SEQ ID NOs: 45905–45912. In some embodiments, the protein is derived from Trichoderma. For example, in some embodiments, the protein is a native Trichoderma glucan endo-1,3-beta-D-glucosidase or is a fragment/mutant/variant of a native Trichoderma glucan endo-1,3-beta-D-glucosidase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 61; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 61; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 152 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 61 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 61 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through f) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and
g) a fragment of the polypeptide of any one of a) through g) wherein the polypeptide has pullulanase activity belonging to EC 3.2.1.41. Examples of proteins that exhibit pullulanase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 61 are set forth herein as SEQ ID NOs: 48751–49148. In some embodiments, the protein is derived from Bacillus, Geobacillus or Pulluanibacillus. For example, in some embodiments, the protein is a native Bacillus, Geobacillus or Pulluanibacillus pullulanase or is a fragment/mutant/variant of a native Bacillus, Geobacillus or Pulluanibacillus pullulanase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 62; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 62; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 153 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 62 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 62 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has alpha-L-arabinofuranosidase activity belonging to EC 3.2.1.55. Examples of proteins that exhibit alpha-L-arabinofuranosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 62 are set forth herein as SEQ ID NOs: 49149–49209. In some embodiments, the protein is derived from Acremonium, ACrophialophora, Actinomadura, Actinoplanes, Aspergillus, Aureobasidium, Chaetomium, Gliomastix, Humicola, Hypocrea, Microdochium, Myceliophthora, Oculimacula, Penicillium, Streptomyces, Streptosporangium, Talaromyces, Thielavia, Trichoderma or Xylanibacterium. For example, in some embodiments, the protein is a native Acremonium, ACrophialophora, Actinomadura, Actinoplanes, Aspergillus, Aureobasidium, Chaetomium, Gliomastix, Humicola, Hypocrea, Microdochium, Myceliophthora, Oculimacula, Penicillium, Streptomyces, Streptosporangium, Talaromyces, Thielavia, Trichoderma or Xylanibacterium alpha-L-arabinofuranosidase or is a fragment/mutant/variant of a native Acremonium, ACrophialophora, Actinomadura, Actinoplanes, Aspergillus, Aureobasidium, Chaetomium, Gliomastix, Humicola, Hypocrea, Microdochium, Myceliophthora,
Oculimacula, Penicillium, Streptomyces, Streptosporangium, Talaromyces, Thielavia, Trichoderma or Xylanibacterium alpha-L-arabinofuranosidase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 63–64; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 63–64; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 154–155 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 63–64 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 63–64 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has glucan endo-1,3-alpha-glucosidase activity belonging to EC 3.2.1.59. Examples of proteins that exhibit glucan endo-1,3-alpha-glucosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 63–64 are set forth herein as SEQ ID NOs: 49210–49228. In some embodiments, the protein is derived from Clonostachys, Hypocrea, Myceliophthora or Trichoderma. For example, in some embodiments, the protein is a native Clonostachys, Hypocrea, Myceliophthora or Trichoderma glucan endo-1,3-alpha-glucosidase or is a fragment/mutant/variant of a native Clonostachys, Hypocrea, Myceliophthora or Trichoderma glucan endo-1,3-alpha-glucosidase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 65; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 65; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 156 or the cDNA sequence thereof;
d) a polypeptide derived from any one of SEQ ID NO(s): 65 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 65 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has licheninase activity belonging to EC 3.2.1.73. Examples of proteins that exhibit licheninase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 65 are set forth herein as SEQ ID NOs: 49420–49446. In some embodiments, the protein is derived from Bacillus or Salipaludibacillus. For example, in some embodiments, the protein is a native Bacillus or Salipaludibacillus licheninase or is a fragment/mutant/variant of a native Bacillus or Salipaludibacillus licheninase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 66–67; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 66–67; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 157–158 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 66–67 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 66–67 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has glucan endo-1,6-beta-glucosidase activity belonging to EC 3.2.1.75. Examples of proteins that exhibit glucan endo-1,6-beta-glucosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 66–67 are set forth herein as SEQ ID NOs: 49447–49451. In some embodiments, the protein is derived from Trichoderma. For example, in some embodiments, the protein is a native Trichoderma glucan endo-1,6-beta-glucosidase or is a fragment/mutant/variant of a native Trichoderma glucan endo-1,6-beta-glucosidase.
In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 68 and 72144; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 68 and 72144; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 159 and 72145 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 68 and 72144 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 68 and 72144 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has mannan endo-1,4-beta-mannosidase activity belonging to EC 3.2.1.78. Examples of proteins that exhibit mannan endo-1,4-beta-mannosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 68 and 72144 are set forth herein as SEQ ID NOs: 49452. In some embodiments, the protein is derived from Alkalihalobacillus. For example, in some embodiments, the protein is a native Alkalihalobacillus mannan endo-1,4-beta-mannosidase or is a fragment/mutant/variant of a native Alkalihalobacillus mannan endo-1,4-beta-mannosidase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 69; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 69; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 160 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 69 by substitution, deletion, or insertion of
one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 69 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has mannan endo-1,6-alpha-mannosidase activity belonging to EC 3.2.1.101. Examples of proteins that exhibit mannan endo-1,6-alpha-mannosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 69 are set forth herein as SEQ ID NOs: 45042. In some embodiments, the protein is derived from Talaromyces. For example, in some embodiments, the protein is a native Talaromyces mannan endo-1,6-alpha-mannosidase or is a fragment/mutant/variant of a native Talaromyces mannan endo-1,6-alpha-mannosidase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 70–75; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 70–75; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 161–166 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 70–75 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 70–75 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has endogalactosaminidase activity belonging to EC 3.2.1.109. Examples of proteins that exhibit endogalactosaminidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 70–75 are set forth herein as SEQ ID NOs: 45043–45062. In some embodiments, the protein is derived from Bjerkandera, Diaporthe, Fusarium, Neonectria, Ostropa, Pseudoplectania, Stenocarpella or Urunula. For example, in some embodiments, the protein is a native Bjerkandera, Diaporthe, Fusarium, Neonectria, Ostropa, Pseudoplectania, Stenocarpella or Urunula
endogalactosaminidase or is a fragment/mutant/variant of a native Bjerkandera, Diaporthe, Fusarium, Neonectria, Ostropa, Pseudoplectania, Stenocarpella or Urunula endogalactosaminidase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 76–77; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 76–77; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 167–168 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 76–77 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 76–77 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has glycoprotein endo-alpha-1,2-mannosidase activity belonging to EC 3.2.1.130 and/or alpha-mannan endo-1,2-alpha-mannanase activity belonging to EC 3.2.1.198. In some embodiments, the protein is derived from Chryseobacterium or Lysobacter. For example, in some embodiments, the protein is a native Chryseobacterium or Lysobacter glycoprotein endo-alpha-1,2- mannosidase or is a fragment/mutant/variant of a native Chryseobacterium or Lysobacter glycoprotein endo- alpha-1,2-mannosidase. Similarly, in some embodiments, the protein is a native Chryseobacterium or Lysobacter alpha-mannan endo-1,2-alpha-mannanase or is a fragment/mutant/variant of a native Chryseobacterium or Lysobacter alpha-mannan endo-1,2-alpha-mannanase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 78; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 78; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97,
98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 169 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 78 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 78 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has glucan 1,4-alpha-maltohydrase activity belonging to EC 3.2.1.133. Examples of proteins that exhibit glucan 1,4-alpha-maltohydrase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 78 are set forth herein as SEQ ID NOs: 45072–45408. In some embodiments, the protein is derived from Alicyclobacillus, Bacillus, Effusibacillus or Geobacillus. For example, in some embodiments, the protein is a native Alicyclobacillus, Bacillus, Effusibacillus or Geobacillus glucan 1,4-alpha-maltohydrase or is a fragment/mutant/variant of a native Alicyclobacillus, Bacillus, Effusibacillus or Geobacillus glucan 1,4-alpha-maltohydrase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 79; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 79; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 170 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 79 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 79 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has 1,6-alpha-D-mannosidase activity belonging to EC 3.2.1.163. Examples of proteins that exhibit 1,6-alpha-D-mannosidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 79 are set forth herein as SEQ ID NOs: 45437–45442. In some embodiments, the protein is derived from Aspergillus, Evansstolkia, Penicillium,
Rasamsonia, Talaromyces or Thermomyces. For example, in some embodiments, the protein is a native Aspergillus, Evansstolkia, Penicillium, Rasamsonia, Talaromyces or Thermomyces 1,6-alpha-D-mannosidase or is a fragment/mutant/variant of a native Aspergillus, Evansstolkia, Penicillium, Rasamsonia, Talaromyces or Thermomyces 1,6-alpha-D-mannosidase. Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more glycosylase activities belong to EC 3.2. See, e.g., AU2016101771-A4; AU2017203481-A1; BY20193-C1; CN101134949-A; CN101139556-A; CN101173226-A; CN101298604-A; CN101457230-A; CN101492661-A; CN101659948-A; CN101824401-A; CN101870956-A; CN101899458- A; CN101962633-A; CN102021191-A; CN102477437-A; CN102477438-A; CN102492707-A; CN102703480-A; CN102796751-A; CN102827821-A; CN102851266-A; CN102994475-A; CN103060290- A; CN103184163-A; CN103194419-A; CN103343111-A; CN103525793-A; CN103555751-A; CN103789285-A; CN103805579-A; CN103834606-A; CN103966188-A; CN104130988-A; CN104293748- A; CN104313000-A; CN104450650-A; CN104450651-A; CN104480087-A; CN104498456-A; CN104561060-A; CN104789543-A; CN104862290-A; CN104928270-A; CN105039288-A; CN105062991- A; CN105155324-A; CN105176947-A; CN105177084-A; CN105441415-A; CN105623937-A; CN105671019-A; CN105671022-A; CN105695435-A; CN105734034-A; CN105802940-A; CN105802943- A; CN105886520-A; CN105907775-A; CN105969783-A; CN106084016-A; CN106148235-A; CN106190934-A; CN106754825-A; CN106754826-A; CN106801046-A; CN106929495-A; CN107022588- A; CN107058264-A; CN107236692-A; CN107312763-A; CN107326020-A; CN107475219-A; CN107513527-A; CN107586767-A; CN107603965-A; CN108102934-A; CN108588056-A; CN108611339- A; CN108623652-A; CN108795781-A; CN108823186-A; CN108841809-A; CN109022396-A; CN109055439-A; CN109207458-A; CN109234339-A; CN109321552-A; CN109370973-A; CN109439607- A; CN109439641-A; CN109486689-A; CN109486791-A; CN109777795-A; CN109810961-A; CN109825466-A; CN109897842-A; CN110066777-A; CN110157688-A; CN110229800-A; CN110343687- A; CN110423737-A; CN110495549-A; CN110592051-A; CN110628748-A; CN110699337-A; CN110713999-A; CN110724645-A; CN110724646-A; CN110951628-A; CN111454929-A; CN111500558- A; CN111518792-A; CN111621490-A; CN111793613-A; CN111826377-A; CN112063678-A; CN112342208-A; CN112522238-A; CN112552382-A; CN112680433-A; CN112795554-A; CN112795555- A; CN113151327-A; CN113234705-A; CN113584075-A; CN113667662-A; CN113717864-A; CN113817709-A; CN113881654-A; CN114350637-A; CN114369588-A; CN114457056-A; CN114606216- A; CN114686386-A; CN114752583-A; CN114790451-A; CN115029334-A; CN115074345-A; CN115125226-A; CN115197924-A; CN115247165-A; CN115478061-A; CN115703996-A; CN115704017- A; CN115704018-A; CN115704019-A; CN1465699-A; CN1594542-A; CN1834249-A; DD272102-A; DE102004047777-A1; DE102005062984-A1; DE102014018149-A1; DE102014212640-A1; DE102014212643-A1; DE102014225472-1; DE102014225473-A1; DE102020205400-A1; DE10309803-A1; EP1764411-A1; EP208491-; EP2100948-A1; EP2100950-A1; EP2116136-A1; EP2166092-A1; EP2292773-
A1; EP2295582-A2; EP2298904-A1; EP2314698-A1; EP2357220-A1; EP2404928-A1; EP2404930-A1; EP2486799-A1; EP2540825-A2; EP2551335-A1; EP260160-; EP285123-A; EP2993230-A1; EP3034592- A1; EP3121270-A2; EP3228703-A1; EP3241890-A1; EP3241891-A1; EP3301154-A1; EP3330349-A1; EP3339422-A1; EP3428260-A2; EP3485734-A1; EP3502242-A1; EP3502243-A1; EP3653705-A1; EP3653706-A1; EP3730595-A2; EP4001389-A1; EP4047088-A1; EP409299-A; EP495257-1; EP540784- A1; EP605040-A1; EP633311-A1; EP683228-A2; EP828002-A2; FR2665178-A; FR2676456-A1; GB2479462-A; IN194800-B; IN201811045754-A; IN9700577-I1; IN9702287-I4; JP04058889-A; JP07059574-A; JP2000135093-A; JP2000245466-A; JP2004313022-A; JP2005171409-A; JP2011167076-A; JP2011223962-A; JP2016015894-A; JP2019146520-A; JP2020065514-A; JP2020184937-A; JP62104580-A; KR2001027418-A; KR2004006812-A; KR2011017208-A; KR2011106174-A; KR2012140565-A; KR2013112172-A; KR834708-B1; NZ524303-A; RU2574206-C1; TR201404579-A; TW200811294-A; US10563185-B1; US2004191864-A1; US2005108791-A1; US2005196853-A1; US2005214410-A1; US2006246566-A1; US2007044171-A1; US2007244020-A1; US2008044858-A1; US2008148432-A1; US2009111155-A1; US2009117642-A1; US2009158452-A1; US2009181874-A1; US2009203109-A1; US2009209026-A1; US2009238923-A1; US2009252828-A1; US2010021587-A1; US2010124769-A1; US2010204080-A1; US2010323448-A1; US2011039751-A1; US2011099671-A1; US2011195481-A1; US2011252501-A1; US2011269210-A1; US2011287516-A1; US2012156734-A1; US2012252095-A1; US2013011882-A1; US2013074202-A1; US2013252850-A1; US2013269061-A1; US2014017737-A1; US2014127753-A1; US2014256018-A1; US2015064766-A1; US2015299720-A1; US2015337329-A1; US2016032267-A1; US2017247730-A1; US2017342433-A1; US2018010111-A1; US2018155744-A1; US2018163191-A1; US2018216039-A1; US2018258442-A1; US2019194634-A1; US2019359961-A1; US2019360012-A1; US2020181593-A1; US2020270593-A1; US2020306342-A1; US2020339917-A1; US2021122998-A1; US2021163995-A1; US2021230644-A1; US2021254115-A1; US2021292688-A1; US2021317431-A1; US2022154236-A1; US2022204956-A1; US2022347262-A1; US2023002748-A1; US5824532-A; US5849549-A; US6682923-B1; US6887986-B1; US7504490-B1; US8409836-B2; WO200001796-A2; WO200029560-A1; WO200034452-A1; WO200043504-A1; WO200060058-A2; WO200060059-A2; WO200109294-A1; WO200116349-A1; WO200136586-A2; WO200142433-A2; WO200147956-A2; WO200151620-A2; WO200159141-A2; WO200164852-A1; WO200183559-A2; WO200188107-A2; WO200210355-A2; WO200212511-A1; WO200240997-A2; WO200268589-A2; WO200268597-A2; WO2003012071-A2; WO2003014358-A2; WO2003016535-A2; WO2003018766-A2; WO2003089614-A2; WO2004080923-A2; WO2004081171-A2; WO2004091544-A2; WO2004113551-A1; WO2005001036-A2; WO2005001064-A2; WO2005003311-A2; WO2005019443-A2; WO2005045018-A1; WO2005052148-A2; WO2005054475-A1; WO2005056787-A1; WO2005073368-A1; WO2005096804-A2; WO2005108537-A1; WO2005111203-A2; WO2005113785-A2; WO2005117756-A2; WO2006002643-A2; WO2006012899-A1; WO2006012902-A2; WO2006031554-A2; WO2006037483-A2; WO2006066594-A2; WO2006066596-A2; WO2006069290-A2; WO2006117432-A1; WO2006136159-A2; WO2006136160-A2;
WO2007028088-A2; WO2007071820-A1; WO2007113292-A2; WO2007146944-A2; WO2007149699-A2; WO2008000632-A1; WO2008006881-A1; WO2008015861-A1; WO2008024372-A2; WO2008057637-A2; WO2008080093-A2; WO2008112459-A2; WO2008148845-A2; WO2008153805-A2; WO2008153934-A2; WO2008153935-A2; WO2009026397-A2; WO2009037279-A1; WO2009061379-A2; WO2009062942-A2; WO2009071550-A1; WO2009074650-A2; WO2009075682-A1; WO2009076655-A2; WO2009098229-A2; WO2009100102-A2; WO2009100138-A2; WO2009100990-A1; WO2009108941-A2; WO2009112992-A1; WO2009126773-A1; WO2009133096-A2; WO2009134670-A2; WO2009149130-A2; WO2009149271-A2; WO2009149395-A2; WO2009158694-A1; WO2009158716-A1; WO2010022518-A1; WO2010027857-A2; WO2010036515-A1; WO2010036970-A2; WO2010072224-A1; WO2010072225-A1; WO2010074999-A1; WO2010102982-A1; WO2010104675-A1; WO2010115021-A2; WO2010115156-A2; WO2010121933-A1; WO2010132157-A2; WO2010135836-A1; WO2010138754-A1; WO2010148148-A2; WO2011020852-A1; WO2011041391-A1; WO2011048852-A1; WO2011057101-A1; WO2011057140-A1; WO2011057159-A1; WO2011057163-A2; WO2011066187-A1; WO2011076123-A1; WO2011076897-A1; WO2011080352-A1; WO2011080353-A1; WO2011080354-A1; WO2011082425-A2; WO2011082429-A1; WO2011127820-A1; WO2011128712-A1; WO2011153516-A2; WO2012013197-A2; WO2012016960-A1; WO2012021399-A1; WO2012021400-A1; WO2012021883-A2; WO2012027282-A2; WO2012027374-A2; WO2012027395-A2; WO2012044835-A1; WO2012044836-A1; WO2012044915-A2; WO2012088303-A2; WO2012088467-A2; WO2012089024-A1; WO2012101206-A2; WO2012106824-A1; WO2012122308-A2; WO2012125865-A1; WO2012125925-A2; WO2012127001-A1; WO2012128260-A1; WO2012129697-A1; WO2012129699-A1; WO2012134626-A2; WO2012159007-A1; WO2013001078-A1; WO2013001087-A2; WO2013023938-A1; WO2013029496-A1; WO2013034106-A1; WO2013039776-A1; WO2013055676-A1; WO2013057141-A2; WO2013057143-A2; WO2013063460-A2; WO2013074956-A2; WO2013076253-A1; WO2013082486-A1; WO2013089889-A2; WO2013096294-A1; WO2013115305-A1; WO2013148993-A1; WO2013160316-A1; WO2013181760-A1; WO2013182671-A1; WO2013184577-A1; WO2014007921-A1; WO2014013073-A1; WO2014013074-A1; WO2014019219-A1; WO2014029808-A1; WO2014055778-A2; WO2014055782-A1; WO2014059541-A1; WO2014060380-A1; WO2014068109-A2; WO2014070841-A1; WO2014081700-A1; WO2014081884-A1; WO2014085439-A1; WO2014093123-A1; WO2014099416-A1; WO2014099653-A1; WO2014101753-A1; WO2014106593-A1; WO2014124927-A2; WO2014131842-A1; WO2014138672-A1; WO2014138983-A1; WO2014140165-A1; WO2014151805-A2; WO2014152878-A2; WO2014161987-A1; WO2014162001-A1; WO2014164777-A1; WO2014164800-A1; WO2014164834-A1; WO2014169101-A1; WO2014169129-A1; WO2014176311-A1; WO2014182990-A1; WO2014183920-A1; WO2014183921-A1; WO2014195356-A2; WO2014197296-A1; WO2014202616-A2; WO2014202622-A2; WO2014209800-A1; WO2015007639-A1; WO2015035914-A1; WO2015042064-A1; WO2015044448-A1; WO2015048332-A2; WO2015048340-A2; WO2015048342-A2; WO2015050723-A1; WO2015058700-A1; WO2015065871-A1; WO2015066492-A1; WO2015077126-A1; WO2015079063-A1; WO2015091959-A2; WO2015091990-A1; WO2015094809-A1; WO2015105835-A1; WO2015109405-A1; WO2015110473-A2; WO2015118123-A1;
WO2015143144-A1; WO2015143324-A1; WO2015144782-A1; WO2015144824-A1; WO2015150457-A1; WO2015157656-A1; WO2015162038-A1; WO2015187697-A2; WO2015189370-A1; WO2015189371-A1; WO2015189372-A1; WO2015200659-A1; WO2016020478-A1; WO2016029107-A1; WO2016030448-A1; WO2016036648-A1; WO2016036834-A1; WO2016040464-A1; WO2016062875-A2; WO2016066896-A1; WO2016079110-A2; WO2016079305-A1; WO2016087327-A1; WO2016087445-A1; WO2016090472-A1; WO2016090473-A1; WO2016090474-A1; WO2016095856-A1; WO2016100837-A1; WO2016109758-A2; WO2016117549-A1; WO2016124651-A1; WO2016126294-A1; WO2016145350-A1; WO2016153924-A1; WO2016167235-A1; WO2016180748-A1; WO2016180749-A1; WO2016180792-A1; WO2016196202-A1; WO2016203064-A2; WO2016206621-A1; WO2016208492-A1; WO2016210238-A1; WO2017010833-A1; WO2017014974-A1; WO2017019490-A1; WO2017029238-A2; WO2017083226-A1; WO2017084560-A1; WO2017088820-A1; WO2017097861-A1; WO2017097866-A1; WO2017097896-A1; WO2017097897-A1; WO2017106676-A1; WO2017112540-A1; WO2017112631-A1; WO2017112643-A1; WO2017114891-A1; WO2017129754-A1; WO2017144008-A1; WO2017147690-A1; WO2017152169-A1; WO2017161091-A1; WO2017186928-A1; WO2017191109-A1; WO2017191160-A1; WO2017194487-A1; WO2017205337-A1; WO2017217453-A1; WO2017220422-A1; WO2018002261-A1; WO2018015303-A1; WO2018027131-A1; WO2018053220-A1; WO2018075430-A1; WO2018085524-A2; WO2018094181-A1; WO2018098124-A1; WO2018098381-A1; WO2018102348-A1; WO2018106656-A1; WO2018112123-A1; WO2018127486-A1; WO2018161899-A1; WO2018165594-A1; WO2018167669-A1; WO2018167670-A1; WO2018184004-A1; WO2018185048-A1; WO2018204483-A2; WO2018209345-A1; WO2018219854-A1; WO2018224544-A1; WO2019014118-A1; WO2019036721-A2; WO2019042971-A1; WO2019063543-A1; WO2019068850-A1; WO2019083831-A1; WO2019099235-A1; WO2019110538-A1; WO2019113413-A1; WO2019113415-A1; WO2019121930-A1; WO2019121937-A1; WO2019137289-A1; WO2019161227-A1; WO2019163886-A1; WO2019193102-A1; WO2019201725-A1; WO2019201783-A1; WO2019201785-A1; WO2019228448-A1; WO2019229228-A1; WO2020002574-A1; WO2020007875-A1; WO2020023411-A1; WO2020028443-A1; WO2020053276-A1; WO2020058228-A1; WO2020070199-A1; WO2020076697-A1; WO2020077331-A2; WO2020086430-A2; WO2020088393-A1; WO2020096905-A1; WO2020096907-A1; WO2020106600-A1; WO2020114965-A1; WO2020123463-A1; WO2020127775-A1; WO2020131691-A2; WO2020154387-A1; WO2020156903-A1; WO2020169840-A1; WO2020174070-A1; WO2020187883-A1; WO2020188095-A1; WO2020193532-A1; WO2020193534-A2; WO2020193535-A2; WO2020201403-A1; WO2020208056-A1; WO2020260223-A1; WO2020264552-A1; WO2021025872-A1; WO2021026201-A1; WO2021032881-A1; WO2021055395-A1; WO2021058022-A1; WO2021080948-A2; WO2021099457-A1; WO2021119304-A1; WO2021123184-A2; WO2021127319-A1; WO2021130167-A1; WO2021133658-A1; WO2021133701-A1; WO2021144342-A1; WO2021148364-A1; WO2021152120-A1; WO2021152123-A1; WO2021163030-A2; WO2021163036-A1; WO2021202479-A1; WO2021204838-A1; WO2021212095-A1; WO2021214059-A1; WO2021231621-A1; WO2021231623-A1; WO2021236715-A1; WO2021248045-A2; WO2022014428-A1; WO2022020665-A2; WO2022043273-A2; WO2022043745-A1; WO2022044629-A1; WO2022047264-A1;
WO2022071451-A1; WO2022074037-A2; WO2022089571-A1; WO2022171780-A2; WO2022173694-A1; WO2022175435-A1; WO2022214457-A1; WO2022214459-A1; WO2022225696-A2; WO2022226376-A2; WO2022261003-A1; WO2022268885-A1; WO2023002065-A2; WO2023023642-A2; WO2023274282-A1; WO2023288294-A1; WO8402921-A; WO9009436-A; WO9100353-A; WO9117244-A; WO9203540-A; WO9218688-A1; WO9219726-A1; WO9402597-A1; WO9407998-A1; WO9418314-A1; WO9502675-A1; WO9518219-A1; WO9524471-A1; WO9526397-A1; WO9534662-A1; WO9535382-A2; WO9605295-A2; WO9617994-A1; WO9623873-A1; WO9623874-A1; WO9629397-A1; WO9630481-A1; WO9639528-A2; WO9714804-A1; WO9728256-A1; WO9743409-A2; WO9743424-A1; WO9803639-A1; WO9804663-A1; WO9811239-A1; WO9812307-A1; WO9816633-A1; WO9818437-A1; WO9826078-A1; WO9844126-A1; WO9909183-A1; WO9919467-A1; WO9923211-A1; WO9929876-A2; WO9945124-A2; WO9946399-A1; WO9957256-A1; WO9957260-A1. In some embodiments, proteins of the present disclosure exhibit one or more peptidase activities belonging to EC 3.4, such as aminopeptidase activities belonging to EC 3.4.11, serine endopeptidase activities belonging to EC 3.4.21 (e.g., chymotrypsin activity belonging to EC 3.4.21.1, trypsin activity belonging to EC 3.4.21.4, alpha-lytic endopeptidase activity belonging to EC 3.4.21.12, glutamyl endopeptidase activity belonging to EC 3.4.21.19, cucumisin activity belonging to EC 3.4.21.25, chymase activity belonging to EC 3.4.21.39, lysyl endopeptidase activity belonging to EC 3.4.21.50, leucyl endopeptidase activity belonging to EC 3.4.21.57, subtilisin activity belonging to 3.4.21.62), cysteine endopeptidase activities belonging to 3.4.22 (e.g., papain activity belonging to EC 3.4.22.2, actinidain activity belonging to EC 3.4.22.14, caricain activity belonging to EC 3.4.22.30, ananain activity belonging to EC 3.4.22.31, bromelain activity belonging to EC 3.4.22.32, bromelain activity belonging to EC 3.4.22.33, legumain activity belonging to EC 3.4.22.34, zingipain activity belonging to EC 3.4.22.67), aspartic endopeptidase activities belonging to EC 3.4.23 (e.g., phytepsin activity belonging to EC 3.4.23.40), and/or metalloendopeptidase activities belonging to EC 3.4.24 (e.g., bacillolysin activity belonging to EC 3.4.24.28), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 80–88. In some embodiments, proteins of the present disclosure exhibit serine endoprotease activity belonging to EC 3.4.21 and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 80–86. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 80–81;
b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 80–81; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 171–172 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 80–81 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 80–81 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has serine endopeptidase activity belonging to EC 3.4.21. Examples of proteins that exhibit serine endopeptidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 80–81 are set forth herein as SEQ ID NOs: 49913–50777. In some embodiments, the protein is derived from Cinereomyces, Dichomitus, Ganoderma, Grifola, Lenzites, Meripilus, Neolentinus, Nocardiopsis, Polyporus or Trametes. For example, in some embodiments, the protein is a native Cinereomyces, Dichomitus, Ganoderma, Grifola, Lenzites, Meripilus, Neolentinus, Nocardiopsis, Polyporus or Trametes serine endopeptidase or is a fragment/mutant/variant of a native Cinereomyces, Dichomitus, Ganoderma, Grifola, Lenzites, Meripilus, Neolentinus, Nocardiopsis, Polyporus or Trametes serine endopeptidase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 82; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 82; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 173 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 82 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 82 by substitution, deletion, or insertion of one or more amino acids;
f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has glutamyl endopeptidase activity belonging to EC 3.4.21.19. Examples of proteins that exhibit glutamyl endopeptidase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 82 are set forth herein as SEQ ID NOs: 50778–50953. In some embodiments, the protein is derived from Bacillus. For example, in some embodiments, the protein is a native Bacillus glutamyl endopeptidase or is a fragment/mutant/variant of a native Bacillus glutamyl endopeptidase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 83–87; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 83–87; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SQ ID NO(s): 174–178 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 83–87 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 83–87 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has subtilisin activity belonging to EC 3.4.21.62. Examples of proteins that exhibit subtilisin activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 83–87 are set forth herein as SEQ ID NOs: 50954–70838. In some embodiments, the protein is derived from Alkalihalobacillus, Aspergillus, Bacillus, Brevia, Geomicrobium, Homo, Hordeum, Lederbergia, Saccharomyces, Shouchella or Thermus. For example, in some embodiments, the protein is a native Alkalihalobacillus, Aspergillus, Bacillus, Brevia, Geomicrobium, Homo, Hordeum, Lederbergia, Saccharomyces, Shouchella or Thermus subtilisin or is a fragment/mutant/variant of a native Alkalihalobacillus, Aspergillus, Bacillus, Brevia, Geomicrobium, Homo, Hordeum, Lederbergia, Saccharomyces, Shouchella or Thermus subtilisin. In some embodiments, the protein is selected from the group consisting of:
a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 88; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 88; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 179 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 88 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 88 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has bacillolycin activity belonging to EC 3.4.24.28. Examples of proteins that exhibit bacillolycin activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 88 are set forth herein as SEQ ID NOs: 70839–71903. In some embodiments, the protein is derived from Bacillus. For example, in some embodiments, the protein is a native Bacillus bacillolycin or is a fragment/mutant/variant of a native Bacillus bacillolycin. Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more peptidase activities belong to EC 3.4. See, e.g., CA2829859-A1; CN102676561-A; CN102703482-A; CN103013960-A; CN103243081-A; CN103255156-A; CN103602653- A; CN104232610-A; CN105132397-A; CN105176951-A; CN106350530-; CN106801048-A; CN107384897- A; CN107828765-A; CN107937372-A; CN107937374-A; CN108004220-; CN108359659-A; CN108384771- A; CN108570461-A; CN108570462-A; CN109456957-A; CN109593746-; CN110746494-A; CN110777136- A; CN110819612-A; CN110862979-A; CN110923221-A; CN110923222-; CN111004794-A; CN111334494- A; CN111575265-A; CN111893126-A; CN111909979-A; CN112301023-; CN112458072-A; CN112501149- A; CN112574978-A; CN112662652-A; CN112662653-A; CN113528493-; CN113699138-A; CN113832130- A; CN113832131-A; CN113862244-A; CN114107266-A; CN114317502-; CN114540330-A; CN114561375- A; CN114574469-A; CN114591935-A; CN114774396-A; CN114806990-; CN114836408-A; CN114908074- A; CN114958897-A; CN115029337-A; CN115074347-A; CN115247166-; CN1361279-A; CN1814746-A; CN1814755-A; CN1995343-A; DE102006022224-A1; DE102007044415-1; DE102007049830-A1; DE102007051092-A1; DE102008059446-A1; DE102008059447-A1; DE102009029513-A1; DE102010028951-A1; DE102011005354-A1; DE102011118032-A1; DE102012215642-A1;
DE102012220101-A1; DE102013219467-A1; DE102013221206-A1; DE102014212643-A1; DE102014224825-A1; DE102014226681-A1; DE102015223270-A1; DE102016204814-A1; DE102016204815-A1; DE102016208463-A1; DE102016210628-A1; DE102017215628-A1; DE102017215629-A1; DE102017215631-A1; DE102017223275-A1; DE102018004206-A1; DE102018004207-A1; DE102019111047-A1; DE102019111057-A1; DE102019111075-A1; DE102019210806-A1; DE102020105720-A1; DE102020105721-A1; DE102020205381-A1; DE102020205400-A1; DE10260903-A1; DE19530816-A1; DE3821491-A; DE4224125-A1; DE4411223- A1; EP1160327-A2; EP133756-A; EP2100948-A1; EP2607468-A1; EP3106508-A1; EP3275988-A1; EP3301155-A1; EP3309244-A1; EP3323875-A1; EP3339423-A1; EP3660146-A1; EP3660151-A1; EP398539-A; EP405901-A; EP405902-A; EP415296-A; EP416967-A; EP430637-A; EP443476-A; EP482879-A; EP516200-A1; EP571049-A1; EP687733-A1; JP01137972-A; JP02076586-A; JP11137282-A; JP2004043660-A; JP2004313043-A; JP2008022828-A; JP2011234685-A; JP2016121081-A; JP2017079639- A; JP2022045888-A; US2004091474-A1; US2004197894-A1; US2004223962-A1; US2009087888-A1; US2012067373-A1; US2013123162-A1; US2015125925-A1; US2016032267-A1; US2019185788-A1; US2019185789-A1; US2020306342-A1; US2021122997-A1; US2022098524-A1; US4980288-A; US5260207-A; US5316935-A; US5316941-A; US5371008-A; US5472855-A; US5652136-A; US5677272- A; US5679630-A; US5719021-A; US6017871-A; US6271012-1; US6312936-B1; US6440717-B1; WO200022103-A1; WO200024924-A2; WO200037599-A1; WO200037621-A1; WO200037622-A1; WO200037623-A1; WO200037624-A1; WO200037625-A1; WO200037626-A1; WO200037627-A1; WO200071683-A1; WO200071684-A1; WO200071685-A1; WO200071686-A1; WO200071687-A1; WO200071688-A1; WO200071689-A1; WO200071690-A1; WO200071691-A1; WO200116285-A2; WO200168821-A2; WO200175087-A2; WO200183559-A2; WO200210183-A1; WO200216547-A2; WO200218588-A1; WO200222796-A1; WO200231133-A1; WO200240997-A2; WO200277289-A1; WO200288340-A2; WO2003038082-A2; WO2003054184-A1; WO2003054185-A1; WO2003055974-A2; WO2003057713-A2; WO2003062381-A2; WO2003093453-A2; WO2004003186-A2; WO2004016752-A2; WO2004042049-A1; WO2004064744-A2; WO2004099401-A1; WO2004111219-A1; WO2005024002-A1; WO2005035747-A1; WO2005078074-A2; WO2005079826-A1; WO2005095592-A2; WO2005115445-A1; WO2005118793-A2; WO2005123911-A2; WO2005123914-A1; WO2005124012-A1; WO2006088325-A1; WO2006136159-A2; WO2006136160-A2; WO2007006305-A1; WO2007019858-A2; WO2007044993-A2; WO2007080197-A2; WO2007122175-A1; WO2008010925-A2; WO2008112258-A2; WO2008141281-A1; WO2008153934-A2; WO2008153935-A2; WO2009005647-A2; WO2009021867-A2; WO2009058518-A1; WO2009071550-A1; WO2009074650-A2; WO2009149144-A2; WO2009149145-A2; WO2009149200-A2; WO2010056640-A2; WO2010056653-A2; WO2010056671-A1; WO2010078462-A1; WO2010123754-A1; WO2011014278-A1; WO2011036263-A1; WO2011072099-A2; WO2011072117-A1; WO2011091370-A1; WO2011110625-A1; WO2011130076-A1; WO2011130222-A2; WO2011140316-A1; WO2011140364-A1; WO2012080202-A1; WO2012151480-A2; WO2012151534-A1; WO2013086219-A1; WO2013092635-A1;
WO2013110766-A1; WO2013159032-A1; WO2014037438-A1; WO2014055778-A2; WO2014055782-A1; WO2014081884-A1; WO2014194034-A2; WO2014207228-A1; WO2015038792-A1; WO2015048332-A2; WO2015048339-A2; WO2015065871-A1; WO2015089441-A1; WO2015089447-A1; WO2015143360-A2; WO2015144932-A1; WO2015144936-A1; WO2015185689-A1; WO2016040464-A1; WO2016046234-A2; WO2016069552-A1; WO2016069557-A1; WO2016069563-A1; WO2016069569-A2; WO2016097405-A1; WO2016145428-A1; WO2016164096-A1; WO2016174234-A2; WO2016180928-A1; WO2016183509-A1; WO2016203064-A2; WO2016205710-A1; WO2016205755-A1; WO2017006266-A1; WO2017050291-A1; WO2017081274-A1; WO2017089093-A1; WO2017089366-A1; WO2017089456-A1; WO2017106676-A1; WO2017177153-A1; WO2017189720-A1; WO2017192692-A1; WO2017210295-A1; WO2017219011-A1; WO2018015303-A1; WO2018015304-A1; WO2018118917-A1; WO2018118950-A1; WO2018161899-A1; WO2018188667-A1; WO2018222990-A1; WO2019048486-A1; WO2019048495-A1; WO2019108599-A1; WO2019180111-A1; WO2019238761-A1; WO2019245704-A1; WO2019245705-A1; WO2019245838-A1; WO2019245839-A1; WO2020002255-A1; WO2020007863-A1; WO2020023411-A1; WO2020076697-A1; WO2020112599-A1; WO2020114968-A1; WO2020156419-A1; WO2020169564-A1; WO2020176443-A1; WO2020188095-A1; WO2020200198-A1; WO2020201403-A1; WO2020207944-A1; WO2020243738-A1; WO2021013685-A1; WO2021013686-A1; WO2021025872-A1; WO2021030400-A1; WO2021080948-A2; WO2021119304-A1; WO2021122120-A2; WO2021130167-A1; WO2021133701-A1; WO2021148364-A1; WO2021209548-A1; WO2021230359-A1; WO2021231621-A1; WO2021231623-A1; WO2021248045-A2; WO2022043547-A1; WO2022043563-A1; WO2022043745-A1; WO2022106400-A1; WO2022129166-A1; WO2022171120-A1; WO2022171667-A1; WO2022175263-A2; WO2022225696-A2; WO2022226158-A2; WO2022261003-A1; WO2023288294-A1; WO8807581-A; WO9102792-A; WO9106637-A; WO9211348- A1; WO9211357-A1; WO9221760-A1; WO9307276-A1; WO9402618-A1; WO9418329-A2; WO9423053- A1; WO9507991-A2; WO9510591-A1; WO9510615-A1; WO9523221-A1; WO9523614-A1; WO9530011- A2; WO9628557-A2; WO9628566-A2; WO9634935-A2; WO9634946-A1; WO9820115-A1; WO9830682- A1; WO9855634-A1; WO9920770-A2; WO9927082-A1; WO9967370-A1. In some embodiments, proteins of the present disclosure exhibit one or more hydrolase activities belonging to EC 3.5, such as amidohydrolase and amidase activities belonging to EC 3.5.1 (e.g., asparaginase activity belong to EC 3.5.1.1, glutaminase activity belonging to 3.5.1.2, amidase activity belonging to 3.5.1.4, urease activity belonging to 3.5.1.5, biotinidase activity belonging to 3.5.1.12, nicotinamidase activity belonging to 3.5.1.19, N-acetylglucosamine deacetylase activity belonging to EC 3.5.1.33, D-glutaminase activity belonging to 3.5.1.35, glutamin-(asparagin-)ase activity belonging to 3.5.1.38, chitin deacetylase activity belonging to 3.5.1.41, peptidyl-glutaminase activity belonging to 3.5.1.43, protein-glutamine glutaminase activity belonging to 3.5.1.44, pentanamidase activity belonging to 3.5.1.50, peptidoglycan-N- acetylglucosamine deacetylase activity belonging to EC 3.5.1.104) aminidase and deiminase activities belonging to EC 3.5.3 (e.g., arginase activity belonging to EC 3.5.3.1, arginine deiminase activity belonging to EC 3.5.3.6, D-arginase activity belonging to EC 3.5.3.10, protein-arginine deiminase activity belonging to
EC 3.5.3.15), and/or deaminase activities belonging to EC 3.5.4 (e.g., cytosine deaminase activity belonging to EC 3.5.4.1, adenine deaminase activity belonging to EC 3.5.4.2, guanine deaminase activity belonging to EC 3.5.4.3, adenosine deaminase activity belonging to EC 3.5.4.4), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 89–90. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 89–90; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 89–90; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 180–181 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 89–90 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 89–90 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has asparaginase activity belonging to EC 3.5.1.1. Examples of proteins that exhibit asparaginase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 89–90 are set forth herein as SEQ ID NOs: 71904–72141. In some embodiments, the protein is derived from Aspergillus. For example, in some embodiments, the protein is a native Aspergillus asparaginase or is a fragment/mutant/variant of a native Aspergillus asparaginase. Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more hydrolase activities belong to EC 3.5. See, e.g., CN109486689-A; EP2295582-A2; US7504490-B1; WO2004032648-A1; WO2008110513-A1; WO2008128974-A1; WO2008128975-A1; WO2011134916-A1; WO2012068047-A2; WO2014027062-A1; WO2014027063-A1; WO2014147189-A1. In some embodiments, proteins of the present disclosure exhibit one or more lyase activities belonging to Enzyme Commission classification number 4 (EC 4). For example, in some embodiments,
proteins of the present disclosure exhibit lyase activity useful for a) preventing/treating/suppressing/eliminat- ing/reducing the detrimental effects of infestations/infections of/by various pests, including, but not limited to, phytopathogenic pests, such as acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa, viruses and weeds; b) reducing one or more aspects of disease severity in plants affected by one or more phytopathogenic pests; c) pretreating surfaces/substances that are susceptible to infestation/infection by pests; d) cleaning surfaces/substances that are infested/infected by pests; e) enhancing the environments in which plants are grown by; f) improving nutrient availability in plant growth media; g) reducing the amounts of exogenous fertilizer needed to achieve a desired result; h) improving plant growth, development, and yield characteristics; i) prolonging the shelf-life of harvested plants and plant parts; j) delaying/hastening the ripening of a plant or plant part; k) improving the efficacy of chemical pesticides; and/or l) reducing chemical-pesticide-induced resistance/phytotoxicity. In some embodiments, proteins of the present disclosure exhibit one or more carbon-carbon lyase activities belonging to EC 4.1, such as carboxy-lyase activities belonging to EC 4.1.1 (e.g., aspartate 1- decarboxylase activity belonging to EC 4.1.1.11, aspartate 4-decarboxylase activity belonging to EC 4.1.1.12, valine decarboxylase activity belonging to EC 4.1.1.14, glutamate decarboxylase activity belonging to EC 4.1.1.15, lysine decarboxylase activity belonging to EC 4.1.1.18, arginine decarboxylase activity belonging to EC 4.1.1.19, histidine decarboxylase activity belonging to EC 4.1.1.22, tyrosine decarboxylase activity belonging to EC 4.1.1.25, phenylalanine decarboxylase activity belonging to EC 4.1.1.53, methionine decarboxylase activity belonging to EC 4.1.1.57, L-tryptophan decarboxylase activity belonging to EC 4.1.1.105) and/or carbon-carbon lyase activities belonging to EC 4.1.99 (e.g., tryptophanase activity belonging to EC 4.1.99.1, tyrosine phenol-lyase activity belonging to EC 4.1.99.2). Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more carbon-carbon lyase activities belong to EC 4.1. In some embodiments, proteins of the present disclosure exhibit one or more carbon-oxygen lyase activities belonging to EC 4.2, such as polysaccharide lyase activities belonging to EC 4.2.2 (e.g., pectate lyase activity belong to EC 4.2.2.2, pectin lyase activity belonging to EC 4.2.2.10, glucan lyase activity belonging to EC 4.2.2.13, gellan lyase activity belonging to EC 4.2.2.25, oligo-alginase lyase activity belonging to EC 4.2.2.26, pectin monosaccharide-lyase activity belonging to EC 4.2.2.27), and, optionally, comprise, consist essentially of, or consist of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to the amino acid sequence set forth herein as SEQ ID NO(s): 91 and 55. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 91;
b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 91; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 182 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 91 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 91 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has pectate lyase activity belonging to EC 4.2.2.2. Examples of proteins that exhibit pectate lyase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 91 are set forth herein as SEQ ID NOs: 72142–72143. In some embodiments, the protein is derived from Bacillus. For example, in some embodiments, the protein is a native Bacillus pectate lyase or is a fragment/mutant/variant of a native Bacillus pectate lyase. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 55; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 55; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 146 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 55 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 55 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide has pectin lyase activity belonging to EC 4.2.2.10. Examples of proteins that exhibit
pectin lyase activity and have an amino acid sequence that is at least 70% identical to one or more of SEQ ID NOs: 55 are set forth herein as SEQ ID NOs: 45409–45436. In some embodiments, the protein is derived from Aspergillus, Botrytis, Neosartorya, Penicillium or Pseudomyllocerus. For example, in some embodiments, the protein is a native Aspergillus, Botrytis, Neosartorya, Penicillium or Pseudomyllocerus pectin lyase or is a fragment/mutant/variant of a native Aspergillus, Botrytis, Neosartorya, Penicillium or Pseudomyllocerus pectin lyase. Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more carbon-oxygen lyase activities belong to EC 4.2. See, e.g., US2015045535-A1; WO9927083-A1. In some embodiments, proteins of the present disclosure exhibit one or more carbon-nitrogen lyase activities belonging to EC 4.3, such as ammonia-lyase activities belonging to EC 4.3.1 (e.g., aspartate ammonia-lyase activity belonging to EC 4.3.1.1, histidine ammonia-lyase activity belong to EC 4.3.1.3, L- serine ammonia-lyase activity belonging to EC 4.3.1.17, D-serine ammonia-lyase activity belonging to EC 4.3.1.18, threonine ammonia-lyase activity belonging to EC 4.3.1.19, tyrosine ammonia-lyase activity belonging to EC 4.3.1.23, phenylalanine ammonia-lyase activity belonging to EC 4.3.1.24, phenylalanine/tyrosine ammonia-lyase activity belonging to EC 4.3.1.25, L-lysine cyclodeaminase activity belonging to EC 4.3.1.28, L-tryptophan ammonia-lyase activity belonging to EC 4.3.1.31). Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more carbon-nitrogen lyase activities belong to EC 4.3. In some embodiments, proteins of the present disclosure exhibit one or more carbon-sulfur lyase activities belonging to 4.4, such as carbon-sulfur lyase activities belonging to EC 4.4.1 (e.g., cysteine lyase activity belonging to EC 4.4.1.10, methionine gamma-lyase activity belonging to EC 4.4.1.11, L-cysteine desulfidase activity belonging to EC 4.4.1.28, L-cysteine beta-lyase activity belonging to EC 4.4.1.35). Those skilled in the art will understand how to identify, isolate, characterize, produce, recover and formulate proteins having one or more carbon-sulfur lyase activities belong to EC 4.4. In some embodiments, the protein comprises, consists essentially of, or consists of a wild-type polypeptide. For example, in some embodiments, the protein comprises, consists essentially of, or consists of a wild-type polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof. In some embodiments, the protein comprises, consists essentially of, or consists of a variant polypeptide. For example, in some embodiments, the protein comprises, consists essentially of, or consists of a variant polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof.
In some embodiments, the protein comprises, consists essentially of or consists of a catalytic domain, a binding module and a linker between said catalytic domain and said binder module. The present disclosure extends to proteins capable of exhibiting two, three, four, five or more distinct catalytic activities, including, but not limited to, proteins that inherently exhibit two or more distinct catalytic activities and fusion proteins comprising two or more polypeptides that exhibit distinct catalytic activities. In some embodiments, the protein is a hybrid protein. In some embodiments, the protein comprises two or more catalytic domains. In some embodiments, the protein comprises two or more binding modules. In some embodiments, the protein is a fusion protein (e.g., a fusion protein comprising a first polypeptide having a first enzymatic activity and a second polypeptide having a second enzymatic activity). In some embodiments, the protein is a fusion protein comprising a first polypeptide and a second polypeptide, said second polypeptide being distinct from said first polypeptide, wherein said first polypeptide is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f), and, optionally, wherein said second polypeptide is selected from the group consisting of: h) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; i) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence
identity to a mature polypeptide of any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; j) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA sequence thereof; k) a polypeptide derived from any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; l) a polypeptide derived from a mature polypeptide any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; m) a polypeptide derived from the polypeptide of any one of h) through l) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and n) a fragment of the polypeptide of any one of h) through m). In preferred embodiments, proteins of the present disclosure comprise, consist essentially of or consist of the amino acid sequence of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof. In preferred embodiments, proteins of the present disclosure are encoded by a polynucleotide that comprises, consists essentially of or consists of one of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA thereof. In some embodiments, proteins of the present disclosure comprise, consist essentially of or consist of a fragment of one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof. For example, the protein may be a fragment of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof, said fragment comprising at least 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99 % of the amino acids found in the original protein. As noted above, in some embodiments, proteins of the present disclosure comprise, consist essentially of or consist of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof with an N-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), a C-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more substitutions), one or more insertions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more insertions), and/or one or more deletions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more deletions). The amino acid changes may be of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of 1-30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino-terminal methionine residue; a small linker peptide of up to 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding module.
Essential amino acids in a polypeptide can be identified according to procedures known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (Cunningham and Wells, 1989, Science 244: 1081-1085). In the latter technique, single alanine mutations are introduced at every residue in the molecule, and the resultant molecules are evaluated for catalytic activity to identify amino acid residues that are critical to the activity of the molecule. See also, Hilton et al., 1996, J. Biol. Chem.271: 4699-4708. The active site of the enzyme or other biological interaction can also be determined by physical analysis of structure, as determined by such techniques as nuclear magnetic resonance, crystallography, electron diffraction, or photoaffinity labeling, in conjunction with mutation of putative contact site amino acids. See, for example, de Vos et al., 1992, Science 255: 306-312; Smith et al., 1992, J. Mol. Biol.224: 899-904; Wlodaver et al., 1992, FEBS Lett. 309: 59-64. The identity of essential amino acids can also be inferred from an alignment with a related polypeptide, and/or be inferred from sequence homology and conserved catalytic machinery with a related polypeptide or within a polypeptide or protein family with polypeptides/proteins descending from a common ancestor, typically having similar three-dimensional structures, functions, and significant sequence similarity. Additionally or alternatively, protein structure prediction tools can be used for protein structure modelling to identify essential amino acids and/or active sites of polypeptides. See, for example, Jumper et al., 2021, “Highly accurate protein structure prediction with AlphaFold”, Nature 596: 583-589. Single or multiple amino acid substitutions, deletions, and/or insertions can be made and tested using known methods of mutagenesis, recombination, and/or shuffling, followed by a relevant screening procedure, such as those disclosed by Reidhaar-Olson and Sauer, 1988, Science 241: 53-57; Bowie and Sauer, 1989, Proc. Natl. Acad. Sci. USA 86: 2152-2156; WO 95/17413; or WO 95/22625. Other methods that can be used include error-prone PCR, phage display (e.g., Lowman et al., 1991, Biochemistry 30: 10832-10837; US 5,223,409; WO 92/06204), and region-directed mutagenesis (Derbyshire et al., 1986, Gene 46: 145; Ner et al., 1988, DNA 7: 127). Mutagenesis/shuffling methods can be combined with high-throughput, automated screening methods to detect activity of cloned, mutagenized polypeptides expressed by host cells (Ness et al., 1999, Nature Biotechnology 17: 893-896). Mutagenized DNA molecules that encode active polypeptides can be recovered from the host cells and rapidly sequenced using standard methods in the art. These methods allow the rapid determination of the importance of individual amino acid residues in a polypeptide. Table 1 provides a non-exhaustive list of proteins useful in compositions and methods of the present disclosure. TABLE 1. Exemplary proteins of the present disclosure
Proteins of the present disclosure may be derived from microorganisms of any genus. In some embodiments, the protein is derived from and/or obtained from a Gram-negative bacterium, such as Campylobacter, Chryseobacterium (e.g., C. viscerum), Dicytoglomus (e.g., D. thermophilum), Escherichia (e.g., E. coli), Flavobacterium, Fusobacterium, Helicobacter, Ilyobacter, Lysobacter (e.g., L. gummosus), Neisseria, Pseudomonas, Salmonella or Ureaplasma. In some embodiments, the protein is derived from a Gram-positive bacterium, such as Alkalihalobacillus (e.g., A. akibai, A. clausii), Bacillus (e.g., B. agaradhaerens, B. alkalophilus, B. amyloliquefaciens, B. brevis, B. circulans, B. clausii, B. coagulans, B. deramificans, B. firmus, B. lautus, B. lentus, B. licheniformis, B. megaterium, B. pumilus, B. stearothermophilus, B. subtilis, B. thuringiensis), Clostridium, Effusibacillus (e.g., E. pohliae), Enterococcus, Geobacillus (e.g., G. stearothermophilus), Lactobacillus, Lactococcus, Lederbergia (e.g., L. lenta), Neobacillus (e.g., N. novalis), Nocardiopsis, Oceanobacillus (e.g., O. barbara), Staphylococcus, Streptococcus (e.g., S. equisimilis, S. pyogenes, S. uberis, and S. equi subsp. Zooepidemicus) or Streptomyces (e.g., S. achromogenes, S. avermitilis, S. coelicolor, S. griseus, S. lividans), Sutcliffiella (e.g., S. halmapala). In some embodiments, the protein is derived from a fungus, such as Acremonium, Acrophialophora (e.g., A. fusispora), Aspergillus (e.g., A. aculeatus, A. awamori, A. chevalieri, A. foetidus, A. fumigatus, A. japonicus, A. nidulans, A. niger, A. niveoglaucus, A. oryzae, A. tubingensis), Aureobasidium, Bjerkandera (e.g., B. adusta, B. fumosa), Ceriporiopsis (e.g., C. aneirina, C. caregiea, C. gilvescens, C. pannocinta, C. rivulosa, Ceriporiopsis subrufa, C. subvermispora), Chaetomium (e.g., C. erraticum, C. globosum), Chrysosporium (e.g., C. inops, C. keratinophilum, C. lucknowense, C. merdarium, C. pannicola, C. queenslandicum, C. tropicum, C. zonatum), Colletotrichum (e.g., C. graminicola), Coprinopsis (e.g., C. cinereus), Coprinus (e.g., C. cinereus), Coriolus (e.g., C. hirsutus), Cryphonectria (e.g., C. parasitica), Cryptococcus, Evansstolkia (e.g., E. leycettana), Filibasidium, Fusarium (e.g., F. bactridioides, F. cerealis, F. crookwellense, F. culmorum, F. graminearum, F. graminum, F. heterosporum, F. longipes, F. negundi, F. oxysporum, F. reticulatum, F. roseum, F. sambucinum, F. sarcochroum, F. solani, F. sporotrichioides, F. sulphureum, F. torulosum, F. trichothecioides, F. venenatum), Humicola (e.g., H. insolens, H. lanuginosa), Magnaporthe, Microdochium (e.g., M. nivale), Mucor (e.g., M. miehei), Myceliophthora (e.g., M. thermophila), Neocallimastix, Neurospora (e.g., Neurospora crassa), Ostropa (e.g., O. barbara), Paecilomyces, Penicillium (e.g., P. emersonii, P. purpurogenum, P. thomii, P. viridicatum), Phanerochaete (e.g., P. chrysosporium), Phlebia (e.g., Phlebia radiata), Piromyces, Pleurotus (e.g., Pleurotus eryngii), Pseudoplectania (e.g., P. vogesiaca), Schizophyllum, Sodiomyces (e.g., S.
alcalophilus), Stenocarpella (e.g., S. maydis), Talaromyces (e.g., T. bacillisporus, T. emersonii, T. pinophilus), Thermoascus (e.g., T. aurantiacus), Themochaetoides (e.g., T. thermophila), Thermomyces (e.g., T. lanuginosus), Thermothielavioides (e.g., T. terrestris), Thermothelomyces (e.g., T. thermophilus), Thielavia (e.g., T. terrestris), Tolypocladium, Trametes (e.g., T. hirsuta, T. villosa, T. versicolor), Trichoderma (e.g., T. atroviride, T. harzianum, T. koningii, T. longibrachiatum, T. reesei, T. viride), Trichophaea (e.g., T. saccata), or Urnula (e.g., U. criterium). In some embodiments, the protein is derived from a yeast, such as Candida, Hansenula, Komagataella (e.g., K. phaffii), Kluyveromyces (e.g., Kluyveromyces lactis), Pichia (e.g., P. pastoris), Saccharomyces (e.g., S. carlsbergensis, S. cerevisiae, S. diastaticus, S. douglasii, S. kluyveri, S. norbensis, S. oviformis), Schizosaccharomyces, or Yarrowia (e.g., Yarrowia lipolytica). It will be understood that for the aforementioned species, the disclosure encompasses both the perfect and imperfect states, and other taxonomic equivalents, e.g., anamorphs, regardless of the species name by which they are known. Those skilled in the art will readily recognize the identity of appropriate equivalents. The proteins may be identified and derived from other sources including microorganisms isolated from nature (e.g., soil, composts, water, etc.) or DNA samples obtained directly from natural materials (e.g., soil, composts, water, etc.) using the above-mentioned probes. Techniques for isolating microorganisms and DNA directly from natural habitats are well known in the art. A polynucleotide encoding the protein may then be obtained by similarly screening a genomic DNA or cDNA library of another microorganism or mixed DNA sample. Once a polynucleotide encoding a protein has been detected with the probe(s), the polynucleotide can be isolated or cloned by utilizing techniques that are known to those of ordinary skill in the art (see, e.g., Davis et al., 2012, Basic Methods in Molecular Biology, Elsevier). Proteins of the present disclosure may likewise be derived from plants of any genus. In some embodiments, the protein is derived from a plant selected from the families Amaranthaceae (e.g., chard, spinach, sugar beet, quinoa), Asteraceae (e.g., artichoke, asters, chamomile, chicory, chrysanthemums, dahlias, daisies, echinacea, goldenrod, guayule, lettuce, marigolds, safflower, sunflowers, zinnias), Brassicaceae (e.g., arugula, broccoli, bok choy, Brussels sprouts, cabbage, cauliflower, canola, collard greens, daikon, garden cress, horseradish, kale, mustard, radish, rapeseed, rutabaga, turnip, wasabi, watercress, Arabidopsis thaliana), Caricaceae (e.g., papaya), Cucurbitaceae (e.g., cantaloupe, cucumber, honeydew, melon, pumpkin, squash (e.g., acorn squash, butternut squash, summer squash), watermelon, zucchini), Fabaceae (e.g., alfalfa, beans, carob, clover, guar, lentils, mesquite, peas, peanuts, soybeans, tamarind, tragacanth, vetch), Malvaceae (e.g., cacao, cotton, durian, hibiscus, kenaf, kola, okra), Poaceae (e.g., bamboo, barley, corn, fonio, lawn grass (e.g., Bahia grass, Bermudagrass, bluegrass, Buffalograss, Centipede grass, Fescue, or Zoysia), millet, oats, ornamental grasses, rice, rye, sorghum, sugar cane, triticale, wheat and other cereal crops, Polygonaceae (e.g., buckwheat), Rosaceae (e.g., almonds, apples, apricots, blackberry, blueberry, cherries, peaches, plums, quinces, raspberries, roses, strawberries), Solanaceae (e.g., bell peppers, chili peppers, eggplant, petunia, potato, tobacco, tomato) and Vitaceae (e.g., grape).
Proteins of the present disclosure may be produced by and obtained from using any suitable method(s), including, but not limited to, shake flask cultivation and large-scale fermentation (including continuous, batch, fed-batch, solid-state and/or microcarrier-based fermentation) methods. The present disclosure extends to methods of producing a protein of the present disclosure, comprising (a) cultivating a cell, which in its wild-type form produces the protein, under conditions conducive for production of the protein; and optionally, (b) recovering the protein. The present disclosure also extends to methods of producing a protein of the present disclosure, comprising (a) cultivating a recombinant host cell of the present disclosure under conditions conducive for production of the protein; and optionally, (b) recovering the protein. In some embodiments, the protein is produced by and obtained from a Gram-negative bacterium, such as Campylobacter, Chryseobacterium (e.g., C. viscerum), Dicytoglomus (e.g., D. thermophilum), Escherichia (e.g., E. coli), Flavobacterium, Fusobacterium, Helicobacter, Ilyobacter, Lysobacter (e.g., L. gummosus), Neisseria, Pseudomonas, Salmonella or Ureaplasma. In some embodiments, the protein is produced by and obtained from a Gram-positive bacterium, such as Alkalihalobacillus (e.g., A. akibai, A. clausii), Bacillus (e.g., B. agaradhaerens, B. alkalophilus, B. amyloliquefaciens, B. brevis, B. circulans, B. clausii, B. coagulans, B. deramificans, B. firmus, B. lautus, B. lentus, B. licheniformis, B. megaterium, B. pumilus, B. stearothermophilus, B. subtilis, B. thuringiensis), Clostridium, Effusibacillus (e.g., E. pohliae), Enterococcus, Geobacillus (e.g., G. stearothermophilus), Lactobacillus, Lactococcus, Lederbergia (e.g., L. lenta), Neobacillus (e.g., N. novalis), Nocardiopsis, Oceanobacillus (e.g., O. barbara), Staphylococcus, Streptococcus (e.g., S. equisimilis, S. pyogenes, S. uberis, and S. equi subsp. Zooepidemicus) or Streptomyces (e.g., S. achromogenes, S. avermitilis, S. coelicolor, S. griseus, S. lividans), Sutcliffiella (e.g., S. halmapala). In some embodiments, the protein is produced by and obtained from a fungal cell, such as Acremonium, Acrophialophora (e.g., A. fusispora), Aspergillus (e.g., A. aculeatus, A. awamori, A. chevalieri, A. foetidus, A. fumigatus, A. japonicus, A. nidulans, A. niger, A. niveoglaucus, A. oryzae, A. tubingensis), Aureobasidium, Bjerkandera (e.g., B. adusta, B. fumosa), Ceriporiopsis (e.g., C. aneirina, C. caregiea, C. gilvescens, C. pannocinta, C. rivulosa, Ceriporiopsis subrufa, C. subvermispora), Chaetomium (e.g., C. erraticum, C. globosum), Chrysosporium (e.g., C. inops, C. keratinophilum, C. lucknowense, C. merdarium, C. pannicola, C. queenslandicum, C. tropicum, C. zonatum), Colletotrichum (e.g., C. graminicola), Coprinopsis (e.g., C. cinereus), Coprinus (e.g., C. cinereus), Coriolus (e.g., C. hirsutus), Cryphonectria (e.g., C. parasitica), Cryptococcus, Evansstolkia (e.g., E. leycettana), Filibasidium, Fusarium (e.g., F. bactridioides, F. cerealis, F. crookwellense, F. culmorum, F. graminearum, F. graminum, F. heterosporum, F. longipes, F. negundi, F. oxysporum, F. reticulatum, F. roseum, F. sambucinum, F. sarcochroum, F. solani, F. sporotrichioides, F. sulphureum, F. torulosum, F. trichothecioides, F. venenatum), Humicola (e.g., H. insolens, H. lanuginosa), Magnaporthe, Microdochium (e.g., M. nivale), Mucor (e.g., M. miehei), Myceliophthora (e.g., M. thermophila), Neocallimastix, Neurospora (e.g., Neurospora crassa), Ostropa (e.g., O. barbara), Paecilomyces, Penicillium
(e.g., P. emersonii, P. purpurogenum, P. thomii, P. viridicatum), Phanerochaete (e.g., P. chrysosporium), Phlebia (e.g., Phlebia radiata), Piromyces, Pleurotus (e.g., Pleurotus eryngii), Pseudoplectania (e.g., P. vogesiaca), Schizophyllum, Sodiomyces (e.g., S. alcalophilus), Stenocarpella (e.g., S. maydis), Talaromyces (e.g., T. bacillisporus, T. emersonii, T. pinophilus), Thermoascus (e.g., T. aurantiacus), Themochaetoides (e.g., T. thermophila), Thermomyces (e.g., T. lanuginosus), Thermothielavioides (e.g., T. terrestris), Thermothelomyces (e.g., T. thermophilus), Thielavia (e.g., T. terrestris), Tolypocladium, Trametes (e.g., T. hirsuta, T. villosa, T. versicolor), Trichoderma (e.g., T. atroviride, T. harzianum, T. koningii, T. longibrachiatum, T. reesei, T. viride), Trichophaea (e.g., T. saccata), or Urnula (e.g., U. criterium). In some embodiments, the protein is produced by and obtained from a yeast cell, such as Candida, Hansenula, Komagataella (e.g., K. phaffii), Kluyveromyces (e.g., K. lactis), Pichia (e.g., P. pastoris), Saccharomyces (e.g., S. carlsbergensis, S. cerevisiae, S. diastaticus, S. douglasii, S. kluyveri, S. norbensis, S. oviformis), Schizosaccharomyces, or Yarrowia (e.g., Y. lipolytica). In some embodiments, the protein is produced by and obtained from a plant cell selected from the families Amaranthaceae (e.g., chard, spinach, sugar beet, quinoa), Asteraceae (e.g., artichoke, asters, chamomile, chicory, chrysanthemums, dahlias, daisies, echinacea, goldenrod, guayule, lettuce, marigolds, safflower, sunflowers, zinnias), Brassicaceae (e.g., arugula, broccoli, bok choy, Brussels sprouts, cabbage, cauliflower, canola, collard greens, daikon, garden cress, horseradish, kale, mustard, radish, rapeseed, rutabaga, turnip, wasabi, watercress, Arabidopsis thaliana), Caricaceae (e.g., papaya), Cucurbitaceae (e.g., cantaloupe, cucumber, honeydew, melon, pumpkin, squash (e.g., acorn squash, butternut squash, summer squash), watermelon, zucchini), Fabaceae (e.g., alfalfa, beans, carob, clover, guar, lentils, mesquite, peas, peanuts, soybeans, tamarind, tragacanth, vetch), Malvaceae (e.g., cacao, cotton, durian, hibiscus, kenaf, kola, okra), Poaceae (e.g., bamboo, barley, corn, fonio, lawn grass (e.g., Bahia grass, Bermudagrass, bluegrass, Buffalograss, Centipede grass, Fescue, or Zoysia), millet, oats, ornamental grasses, rice, rye, sorghum, sugar cane, triticale, wheat and other cereal crops, Polygonaceae (e.g., buckwheat), Rosaceae (e.g., almonds, apples, apricots, blackberry, blueberry, cherries, peaches, plums, quinces, raspberries, roses, strawberries), Solanaceae (e.g., bell peppers, chili peppers, eggplant, petunia, potato, tobacco, tomato) and Vitaceae (e.g., grape). Cells may be cultivated in a nutrient medium suitable for production of the protein using methods known in the art. For example, the cell may be cultivated by shake flask cultivation, or small-scale or large- scale fermentation (including continuous, batch, fed-batch, or solid-state, and/or microcarrier-based fermentations) in laboratory or industrial fermentors in a suitable medium and under conditions allowing the protein to be expressed and/or isolated. Suitable media are available from commercial suppliers or may be prepared according to published compositions (e.g., in catalogues of the American Type Culture Collection). If the protein is secreted into the nutrient medium, the protein can be recovered directly from the medium. If the protein is not secreted, it can be recovered from cell lysates. The protein may be detected using methods known in the art that are specific for the protein, including, but not limited to, the use of specific antibodies, formation of an enzyme product, disappearance of an enzyme
substrate, or an assay determining the relative or specific activity of the protein. The protein may be recovered from the medium using methods known in the art, including, but not limited to, collection, centrifugation, filtration, extraction, spray-drying, evaporation, or precipitation. In one aspect, a whole fermentation broth comprising the protein is recovered. In another aspect, a cell-free fermentation broth comprising the protein is recovered. In some embodiments, the protein is secreted extracellularly. In some embodiments, the protein is isolated. In some embodiments, the protein is purified. The protein may be purified by a variety of procedures known in the art to obtain substantially pure proteins and/or protein fragments (see, e.g., Wingfield, 2015, Current Protocols in Protein Science; 80(1): 6.1.1-6.1.35; Labrou, 2014, Protein Downstream Processing, 1129: 3-10). In an alternative aspect, the protein is not recovered. The present disclosure also provides cells that naturally express native proteins of the present disclosure and cells that have been engineered to express heterologous proteins of the present disclosure (e.g., recombinant host cells comprising a polynucleotide of the present disclosure operably linked to one or more control sequences that direct the production of a protein of the present disclosure), as well as tools and methods for producing such recombinant host cells, including polynucleotides encoding proteins of the present disclosure and nucleic acid constructs comprising such polynucleotides. In some embodiments, the cell is a Gram-negative bacterium, such as Campylobacter, Chryseobacterium (e.g., C. viscerum), Dicytoglomus (e.g., D. thermophilum), Escherichia (e.g., E. coli), Flavobacterium, Fusobacterium, Helicobacter, Ilyobacter, Lysobacter (e.g., L. gummosus), Neisseria, Pseudomonas, Salmonella or Ureaplasma. In some embodiments, the cell is a Gram-positive bacterium, such as Alkalihalobacillus (e.g., A. akibai, A. clausii), Bacillus (e.g., B. agaradhaerens, B. alkalophilus, B. amyloliquefaciens, B. brevis, B. circulans, B. clausii, B. coagulans, B. deramificans, B. firmus, B. lautus, B. lentus, B. licheniformis, B. megaterium, B. pumilus, B. stearothermophilus, B. subtilis, B. thuringiensis), Clostridium, Effusibacillus (e.g., E. pohliae), Enterococcus, Geobacillus (e.g., G. stearothermophilus), Lactobacillus, Lactococcus, Lederbergia (e.g., L. lenta), Neobacillus (e.g., N. novalis), Nocardiopsis, Oceanobacillus (e.g., O. barbara), Staphylococcus, Streptococcus (e.g., S. equisimilis, S. pyogenes, S. uberis, and S. equi subsp. Zooepidemicus) or Streptomyces (e.g., S. achromogenes, S. avermitilis, S. coelicolor, S. griseus, S. lividans), Sutcliffiella (e.g., S. halmapala). In some embodiments, the cell is a fungal cell, such as Acremonium, Acrophialophora (e.g., A. fusispora), Aspergillus (e.g., A. aculeatus, A. awamori, A. chevalieri, A. foetidus, A. fumigatus, A. japonicus, A. nidulans, A. niger, A. niveoglaucus, A. oryzae, A. tubingensis), Aureobasidium, Bjerkandera (e.g., B. adusta, B. fumosa), Ceriporiopsis (e.g., C. aneirina, C. caregiea, C. gilvescens, C. pannocinta, C. rivulosa, Ceriporiopsis subrufa, C. subvermispora), Chaetomium (e.g., C. erraticum, C. globosum), Chrysosporium
(e.g., C. inops, C. keratinophilum, C. lucknowense, C. merdarium, C. pannicola, C. queenslandicum, C. tropicum, C. zonatum), Colletotrichum (e.g., C. graminicola), Coprinopsis (e.g., C. cinereus), Coprinus (e.g., C. cinereus), Coriolus (e.g., C. hirsutus), Cryphonectria (e.g., C. parasitica), Cryptococcus, Evansstolkia (e.g., E. leycettana), Filibasidium, Fusarium (e.g., F. bactridioides, F. cerealis, F. crookwellense, F. culmorum, F. graminearum, F. graminum, F. heterosporum, F. longipes, F. negundi, F. oxysporum, F. reticulatum, F. roseum, F. sambucinum, F. sarcochroum, F. solani, F. sporotrichioides, F. sulphureum, F. torulosum, F. trichothecioides, F. venenatum), Humicola (e.g., H. insolens, H. lanuginosa), Magnaporthe, Microdochium (e.g., M. nivale), Mucor (e.g., M. miehei), Myceliophthora (e.g., M. thermophila), Neocallimastix, Neurospora (e.g., Neurospora crassa), Ostropa (e.g., O. barbara), Paecilomyces, Penicillium (e.g., P. emersonii, P. purpurogenum, P. thomii, P. viridicatum), Phanerochaete (e.g., P. chrysosporium), Phlebia (e.g., Phlebia radiata), Piromyces, Pleurotus (e.g., Pleurotus eryngii), Pseudoplectania (e.g., P. vogesiaca), Schizophyllum, Sodiomyces (e.g., S. alcalophilus), Stenocarpella (e.g., S. maydis), Talaromyces (e.g., T. bacillisporus, T. emersonii, T. pinophilus), Thermoascus (e.g., T. aurantiacus), Themochaetoides (e.g., T. thermophila), Thermomyces (e.g., T. lanuginosus), Thermothielavioides (e.g., T. terrestris), Thermothelomyces (e.g., T. thermophilus), Thielavia (e.g., T. terrestris), Tolypocladium, Trametes (e.g., T. hirsuta, T. villosa, T. versicolor), Trichoderma (e.g., T. atroviride, T. harzianum, T. koningii, T. longibrachiatum, T. reesei, T. viride), Trichophaea (e.g., T. saccata), or Urnula (e.g., U. criterium). In some embodiments, the cell is a yeast cell, such as Candida, Hansenula, Komagataella (e.g., K. phaffii), Kluyveromyces (e.g., Kluyveromyces lactis), Pichia (e.g., P. pastoris), Saccharomyces (e.g., S. carlsbergensis, S. cerevisiae, S. diastaticus, S. douglasii, S. kluyveri, S. norbensis, S. oviformis), Schizosaccharomyces, or Yarrowia (e.g., Yarrowia lipolytica). In some embodiments, the cell is a plant cell, optionally a plant cell selected from the families Amaranthaceae (e.g., chard, spinach, sugar beet, quinoa), Asteraceae (e.g., artichoke, asters, chamomile, chicory, chrysanthemums, dahlias, daisies, echinacea, goldenrod, guayule, lettuce, marigolds, safflower, sunflowers, zinnias), Brassicaceae (e.g., arugula, broccoli, bok choy, Brussels sprouts, cabbage, cauliflower, canola, collard greens, daikon, garden cress, horseradish, kale, mustard, radish, rapeseed, rutabaga, turnip, wasabi, watercress, Arabidopsis thaliana), Caricaceae (e.g., papaya), Cucurbitaceae (e.g., cantaloupe, cucumber, honeydew, melon, pumpkin, squash (e.g., acorn squash, butternut squash, summer squash), watermelon, zucchini), Fabaceae (e.g., alfalfa, beans, carob, clover, guar, lentils, mesquite, peas, peanuts, soybeans, tamarind, tragacanth, vetch), Malvaceae (e.g., cacao, cotton, durian, hibiscus, kenaf, kola, okra), Poaceae (e.g., bamboo, barley, corn, fonio, lawn grass (e.g., Bahia grass, Bermudagrass, bluegrass, Buffalograss, Centipede grass, Fescue, or Zoysia), millet, oats, ornamental grasses, rice, rye, sorghum, sugar cane, triticale, wheat and other cereal crops, Polygonaceae (e.g., buckwheat), Rosaceae (e.g., almonds, apples, apricots, blackberry, blueberry, cherries, peaches, plums, quinces, raspberries, roses, strawberries), Solanaceae (e.g., bell peppers, chili peppers, eggplant, petunia, potato, tobacco, tomato) and Vitaceae (e.g., grape).
In some embodiments, the cell expresses: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and/or g) a fragment of the polypeptide of any one of a) through f). In preferred embodiments, the cell expresses a polypeptide that comprises, consists essentially of or consists of the amino acid sequence of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof. In some embodiments, the cell expresses a polypeptide that comprises, consists essentially of or consists of a fragment of one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof. For example, the microorganism may express a fragment of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof, said fragment comprising at least 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99 % of the amino acids found in the original protein. In some embodiments, the cell expresses a polypeptide that comprises, consists essentially of or consists of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof with an N-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), a C-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more substitutions), one or more insertions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more insertions), and/or one or more deletions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more deletions). The amino acid changes may be of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of 1-30 amino acids;
small amino- or carboxyl-terminal extensions, such as an amino-terminal methionine residue; a small linker peptide of up to 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding module. In some embodiments, the cell comprises a homologous or heterologous nucleic acid sequence that is at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the nucleic acid sequences set forth herein as SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA sequence thereof. In preferred embodiments, the cell comprises a polynucleotide encodes a polypeptide that comprises, consists essentially of or consists of the amino acid sequence of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof. In some embodiments, the cell comprises a polynucleotide that comprises, consists essentially of or consists of a nucleic acid sequence encoding a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149. In some embodiments, the cell comprises a polynucleotide that comprises, consists essentially of or consists of a nucleic acid sequence encoding a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149. In preferred embodiments, the cell comprises a polynucleotide that comprises, consists essentially of or consists of the nucleic acid sequence of any one of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or a cDNA sequence thereof. In some embodiments, the cell comprises a polynucleotide that encodes a polypeptide that comprises, consists essentially of or consists of a fragment of one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof. For example, the microorganism comprises a polynucleotide that encodes a fragment of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof, said fragment comprising at least 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99 % of the amino acids found in the original protein. In some embodiments, the cell comprises a polynucleotide that encodes a polypeptide that comprises, consists essentially of or consists of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof with an N-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), a C-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more substitutions),
one or more insertions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more insertions), and/or one or more deletions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more deletions). The amino acid changes may be of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of 1-30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino- terminal methionine residue; a small linker peptide of up to 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding module. The present disclosure thus encompasses plants and plant parts expressing one or more proteins of the present disclosure, including plants and plant parts that have been engineered to (over)express one or more proteins of the present disclosure, as well as methods producing proteins of the present disclosure comprising cultivating a (transgenic) plant or a plant part comprising a polynucleotide that encodes the protein under conditions conducive for production of the protein, and, optionally, recovering the protein. In alternative embodiments, such plants may be used as is to enhance one or more food/feed characteristics (e.g., improve nutritional value, palatability and/or rheological properties, destroy an antinutritive factor, etc.). In some embodiments, the plant expresses: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and/or g) a fragment of the polypeptide of any one of a) through f). In preferred embodiments, the plant expresses a polypeptide that comprises, consists essentially of or consists of the amino acid sequence of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof.
In some embodiments, the plant expresses a polypeptide that comprises, consists essentially of or consists of a fragment of one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof. For example, the microorganism may express a fragment of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof, said fragment comprising at least 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99 % of the amino acids found in the original protein. In some embodiments, the plant expresses a polypeptide that comprises, consists essentially of or consists of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof with an N-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), a C-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more substitutions), one or more insertions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more insertions), and/or one or more deletions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more deletions). The amino acid changes may be of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of 1-30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino-terminal methionine residue; a small linker peptide of up to 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding module. In some embodiments, the plant comprises a homologous or heterologous nucleic acid sequence that is at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the nucleic acid sequences set forth herein as SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA sequence thereof. In preferred embodiments, the plant comprises a polynucleotide encodes a polypeptide that comprises, consists essentially of or consists of the amino acid sequence of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof. In some embodiments, the plant comprises a polynucleotide that comprises, consists essentially of or consists of a nucleic acid sequence encoding a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149. In some embodiments, the plant comprises a polynucleotide that comprises, consists essentially of or consists of a nucleic acid sequence encoding a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149.
In preferred embodiments, the plant comprises a polynucleotide that comprises, consists essentially of or consists of the nucleic acid sequence of any one of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or a cDNA sequence thereof. In some embodiments, the plant comprises a polynucleotide that encodes a polypeptide that comprises, consists essentially of or consists of a fragment of one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof. For example, the microorganism comprises a polynucleotide that encodes a fragment of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof, said fragment comprising at least 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99 % of the amino acids found in the original protein. In some embodiments, the plant comprises a polynucleotide that encodes a polypeptide that comprises, consists essentially of or consists of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof with an N-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), a C-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more substitutions), one or more insertions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more insertions), and/or one or more deletions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more deletions). The amino acid changes may be of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of 1-30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino- terminal methionine residue; a small linker peptide of up to 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding module. Also included within the scope of the present disclosure are the progeny of such plants, plant parts, and plant cells. As noted above, the present disclosure extends to tools and methods for producing such recombinant host cells that express one or more proteins of the present disclosure, including polynucleotides encoding proteins of the present disclosure and nucleic acid constructs comprising such polynucleotides. The present disclosure provides polynucleotides encoding proteins of the present disclosure, including, but not limited to, nucleic acid constructs and recombinant expression vectors that encode one or more enzymes of the present disclosure, as well as methods of producing such polynucleotides. The polynucleotide may be a genomic DNA, a cDNA, a synthetic DNA, a synthetic RNA, a mRNA, or a combination thereof. The polynucleotide may be cloned from any suitable genus, species or strain. In some embodiments, the protein is cloned from a Gram-negative bacterium, such as Campylobacter, Chryseobacterium (e.g., C. viscerum), Dicytoglomus (e.g., D. thermophilum), Escherichia (e.g., E. coli),
Flavobacterium, Fusobacterium, Helicobacter, Ilyobacter, Lysobacter (e.g., L. gummosus), Neisseria, Pseudomonas, Salmonella or Ureaplasma. In some embodiments, the polynucleotide is cloned from a Gram-positive bacterium, such as Alkalihalobacillus (e.g., A. akibai, A. clausii), Bacillus (e.g., B. agaradhaerens, B. alkalophilus, B. amyloliquefaciens, B. brevis, B. circulans, B. clausii, B. coagulans, B. deramificans, B. firmus, B. lautus, B. lentus, B. licheniformis, B. megaterium, B. pumilus, B. stearothermophilus, B. subtilis, B. thuringiensis), Clostridium, Effusibacillus (e.g., E. pohliae), Enterococcus, Geobacillus (e.g., G. stearothermophilus), Lactobacillus, Lactococcus, Lederbergia (e.g., L. lenta), Neobacillus (e.g., N. novalis), Nocardiopsis, Oceanobacillus (e.g., O. barbara), Staphylococcus, Streptococcus (e.g., S. equisimilis, S. pyogenes, S. uberis, and S. equi subsp. Zooepidemicus) or Streptomyces (e.g., S. achromogenes, S. avermitilis, S. coelicolor, S. griseus, S. lividans), Sutcliffiella (e.g., S. halmapala). In some embodiments, the polynucleotide is cloned from a fungus, such as Acremonium, Acrophialophora (e.g., A. fusispora), Aspergillus (e.g., A. aculeatus, A. awamori, A. chevalieri, A. foetidus, A. fumigatus, A. japonicus, A. nidulans, A. niger, A. niveoglaucus, A. oryzae, A. tubingensis), Aureobasidium, Bjerkandera (e.g., B. adusta, B. fumosa), Ceriporiopsis (e.g., C. aneirina, C. caregiea, C. gilvescens, C. pannocinta, C. rivulosa, Ceriporiopsis subrufa, C. subvermispora), Chaetomium (e.g., C. erraticum, C. globosum), Chrysosporium (e.g., C. inops, C. keratinophilum, C. lucknowense, C. merdarium, C. pannicola, C. queenslandicum, C. tropicum, C. zonatum), Colletotrichum (e.g., C. graminicola), Coprinopsis (e.g., C. cinereus), Coprinus (e.g., C. cinereus), Coriolus (e.g., C. hirsutus), Cryphonectria (e.g., C. parasitica), Cryptococcus, Evansstolkia (e.g., E. leycettana), Filibasidium, Fusarium (e.g., F. bactridioides, F. cerealis, F. crookwellense, F. culmorum, F. graminearum, F. graminum, F. heterosporum, F. longipes, F. negundi, F. oxysporum, F. reticulatum, F. roseum, F. sambucinum, F. sarcochroum, F. solani, F. sporotrichioides, F. sulphureum, F. torulosum, F. trichothecioides, F. venenatum), Humicola (e.g., H. insolens, H. lanuginosa), Magnaporthe, Microdochium (e.g., M. nivale), Mucor (e.g., M. miehei), Myceliophthora (e.g., M. thermophila), Neocallimastix, Neurospora (e.g., Neurospora crassa), Ostropa (e.g., O. barbara), Paecilomyces, Penicillium (e.g., P. emersonii, P. purpurogenum, P. thomii, P. viridicatum), Phanerochaete (e.g., P. chrysosporium), Phlebia (e.g., Phlebia radiata), Piromyces, Pleurotus (e.g., Pleurotus eryngii), Pseudoplectania (e.g., P. vogesiaca), Schizophyllum, Sodiomyces (e.g., S. alcalophilus), Stenocarpella (e.g., S. maydis), Talaromyces (e.g., T. bacillisporus, T. emersonii, T. pinophilus), Thermoascus (e.g., T. aurantiacus), Themochaetoides (e.g., T. thermophila), Thermomyces (e.g., T. lanuginosus), Thermothielavioides (e.g., T. terrestris), Thermothelomyces (e.g., T. thermophilus), Thielavia (e.g., T. terrestris), Tolypocladium, Trametes (e.g., T. hirsuta, T. villosa, T. versicolor), Trichoderma (e.g., T. atroviride, T. harzianum, T. koningii, T. longibrachiatum, T. reesei, T. viride), Trichophaea (e.g., T. saccata), or Urnula (e.g., U. criterium). In some embodiments, the polynucleotide is cloned from a yeast, such as Candida, Hansenula, Komagataella (e.g., K. phaffii), Kluyveromyces (e.g., K. lactis), Pichia (e.g., P. pastoris), Saccharomyces (e.g., S. carlsbergensis, S. cerevisiae, S. diastaticus, S. douglasii, S. kluyveri, S. norbensis, S. oviformis),
Schizosaccharomyces, or Yarrowia (e.g., Y. lipolytica). In some embodiments, the polynucleotide is cloned from a plant cell selected from the families Amaranthaceae (e.g., chard, spinach, sugar beet, quinoa), Asteraceae (e.g., artichoke, asters, chamomile, chicory, chrysanthemums, dahlias, daisies, echinacea, goldenrod, guayule, lettuce, marigolds, safflower, sunflowers, zinnias), Brassicaceae (e.g., arugula, broccoli, bok choy, Brussels sprouts, cabbage, cauliflower, canola, collard greens, daikon, garden cress, horseradish, kale, mustard, radish, rapeseed, rutabaga, turnip, wasabi, watercress, Arabidopsis thaliana), Caricaceae (e.g., papaya), Cucurbitaceae (e.g., cantaloupe, cucumber, honeydew, melon, pumpkin, squash (e.g., acorn squash, butternut squash, summer squash), watermelon, zucchini), Fabaceae (e.g., alfalfa, beans, carob, clover, guar, lentils, mesquite, peas, peanuts, soybeans, tamarind, tragacanth, vetch), Malvaceae (e.g., cacao, cotton, durian, hibiscus, kenaf, kola, okra), Poaceae (e.g., bamboo, barley, corn, fonio, lawn grass (e.g., Bahia grass, Bermudagrass, bluegrass, Buffalograss, Centipede grass, Fescue, or Zoysia), millet, oats, ornamental grasses, rice, rye, sorghum, sugar cane, triticale, wheat and other cereal crops, Polygonaceae (e.g., buckwheat), Rosaceae (e.g., almonds, apples, apricots, blackberry, blueberry, cherries, peaches, plums, quinces, raspberries, roses, strawberries), Solanaceae (e.g., bell peppers, chili peppers, eggplant, petunia, potato, tobacco, tomato) and Vitaceae (e.g., grape). In some embodiments, the polynucleotide encodes: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; c) a polypeptide derived from any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C-terminal end has been extended by the addition of one or more amino acids; and/or g) a fragment of the polypeptide of any one of a) through f). In preferred embodiments, the polynucleotide encodes a polypeptide that comprises, consists essentially of or consists of the amino acid sequence of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof. In some embodiments, the polynucleotide comprises, consists essentially of or consists of a nucleic acid sequence having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any
one or more of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA sequence thereof; In preferred embodiments, the polynucleotide comprises, consists essentially of or consists of the nucleic acid sequence of any one of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or a cDNA sequence thereof. In some embodiments, the polynucleotide encodes a polypeptide that comprises, consists essentially of or consists of a fragment of one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof. For example, the polynucleotide may encode a fragment of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature peptide thereof, said fragment comprising at least 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98 or 99 % of the amino acids found in the original protein. In some embodiments, polynucleotides of the present disclosure encode a polypeptide that comprises, consists essentially of or consists of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof with an N-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), a C-terminal extension of one or more amino acids (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more amino acids), one or more substitutions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more substitutions), one or more insertions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more insertions), and/or one or more deletions (e.g., 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 or more deletions). The amino acid changes may be of a minor nature, that is conservative amino acid substitutions or insertions that do not significantly affect the folding and/or activity of the protein; small deletions, typically of 1-30 amino acids; small amino- or carboxyl-terminal extensions, such as an amino- terminal methionine residue; a small linker peptide of up to 20-25 residues; or a small extension that facilitates purification by changing net charge or another function, such as a poly-histidine tract, an antigenic epitope or a binding module. Polynucleotides of the present disclosure may be mutated by introduction of nucleotide substitutions that do not result in a change in the amino acid sequence of the protein, but which correspond to the codon usage of the host organism intended for production of the enzyme, or by introduction of nucleotide substitutions that may give rise to a different amino acid sequence. For a general description of nucleotide substitution, see, e.g., Ford et al., 1991, Protein Expression and Purification 2: 95-107. In an aspect, the polynucleotide is isolated. In another aspect, the polynucleotide is purified. The present disclosure also provides nucleic acid constructs comprising a polynucleotide of the present disclosure, wherein the polynucleotide is operably linked to one or more control sequences that direct the expression of the coding sequence in a suitable host cell under conditions compatible with the control sequences. The polynucleotide may be manipulated in a variety of ways to provide for expression of the protein. Manipulation of the polynucleotide prior to its insertion into a vector may be desirable or necessary depending on the expression vector. Techniques for modifying polynucleotides utilizing recombinant DNA methods are
well known in the art. The control sequence may be a promoter, a polynucleotide that is recognized by a host cell for expression of a polynucleotide encoding a protein of the present disclosure. The promoter contains transcriptional control sequences that mediate the expression of the protein. The promoter may be any polynucleotide that shows transcriptional activity in the host cell including mutant, truncated, and hybrid promoters, and may be obtained from genes encoding extracellular or intracellular proteins either homologous or heterologous to the host cell. Examples of suitable promoters for directing transcription of the polynucleotide of the present disclosure in a bacterial host cell are described in Sambrook et al., 1989, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Lab., NY, Davis et al., 2012, supra, and Song et al., 2016, PLOS One 11(7): e0158447. Examples of suitable promoters for directing transcription of the polynucleotide of the present disclosure in a filamentous fungal host cell are promoters obtained from Aspergillus, Fusarium, Rhizomucor and Trichoderma cells, such as the promoters described in Mukherjee et al., 2013, “Trichoderma: Biology and Applications”, and by Schmoll and Dattenböck, 2016, “Gene Expression Systems in Fungi: Advancements and Applications”, Fungal Biology. For expression in a yeast host, examples of useful promoters are described by Smolke et al., 2018, “Synthetic Biology: Parts, Devices and Applications” (Chapter 6: Constitutive and Regulated Promoters in Yeast: How to Design and Make Use of Promoters in S. cerevisiae), and by Schmoll and Dattenböck, 2016, “Gene Expression Systems in Fungi: Advancements and Applications”, Fungal Biology. The control sequence may also be a transcription terminator, which is recognized by a host cell to terminate transcription. The terminator is operably linked to the 3’-terminus of the polynucleotide encoding the protein. Any terminator that is functional in the host cell may be used in the present disclosure. Preferred terminators for bacterial host cells may be obtained from the genes for Bacillus clausii alkaline protease (aprH), Bacillus licheniformis alpha-amylase (amyL), and Escherichia coli ribosomal RNA (rrnB). Preferred terminators for filamentous fungal host cells may be obtained from Aspergillus or Trichoderma species, such as obtained from the genes for Aspergillus niger glucoamylase, Trichoderma reesei beta-glucosidase, Trichoderma reesei cellobiohydrolase I, and Trichoderma reesei endoglucanase I, such as the terminators described in Mukherjee et al., 2013, “Trichoderma: Biology and Applications”, and by Schmoll and Dattenböck, 2016, “Gene Expression Systems in Fungi: Advancements and Applications”, Fungal Biology. Preferred terminators for yeast host cells may be obtained from the genes for Saccharomyces cerevisiae enolase, Saccharomyces cerevisiae cytochrome C (CYC1), and Saccharomyces cerevisiae glyceraldehyde- 3-phosphate dehydrogenase. Other useful terminators for yeast host cells are described by Romanos et al., 1992, Yeast 8: 423-488. The control sequence may also be an mRNA stabilizer region downstream of a promoter and upstream
of the coding sequence of a gene which increases expression of the gene. Examples of suitable mRNA stabilizer regions are obtained from a Bacillus thuringiensis cryIIIA gene (WO 94/25612) and a Bacillus subtilis SP82 gene (Hue et al., 1995, J. Bacteriol.177: 3465-3471). Examples of mRNA stabilizer regions for fungal cells are described in Geisberg et al., 2014, Cell 156(4): 812-824, and in Morozov et al., 2006, Eukaryotic Cell 5(11): 1838-1846. The control sequence may also be a leader, a non-translated region of an mRNA that is important for translation by the host cell. The leader is operably linked to the 5’-terminus of the polynucleotide encoding the protein. Any leader that is functional in the host cell may be used. Suitable leaders for bacterial host cells are described by Hambraeus et al., 2000, Microbiology 146(12): 3051-3059, and by Kaberdin and Bläsi, 2006, FEMS Microbiol. Rev.30(6): 967-979. Preferred leaders for filamentous fungal host cells may be obtained from the genes for Aspergillus oryzae TAKA amylase and Aspergillus nidulans triose phosphate isomerase. Suitable leaders for yeast host cells may be obtained from the genes for Saccharomyces cerevisiae enolase (ENO-1), Saccharomyces cerevisiae 3-phosphoglycerate kinase, Saccharomyces cerevisiae alpha- factor, and Saccharomyces cerevisiae alcohol dehydrogenase/glyceraldehyde-3-phosphate dehydrogenase (ADH2/GAP). The control sequence may also be a polyadenylation sequence, a sequence operably linked to the 3’-terminus of the polynucleotide which, when transcribed, is recognized by the host cell as a signal to add polyadenosine residues to transcribed mRNA. Any polyadenylation sequence that is functional in the host cell may be used. Preferred polyadenylation sequences for filamentous fungal host cells are obtained from the genes for Aspergillus nidulans anthranilate synthase, Aspergillus niger glucoamylase, Aspergillus niger alpha- glucosidase, Aspergillus oryzae TAKA amylase, and Fusarium oxysporum trypsin-like protease. Useful polyadenylation sequences for yeast host cells are described by Guo and Sherman, 1995, Mol. Cellular Biol.15: 5983-5990. The control sequence may also be a signal peptide coding region that encodes a signal peptide linked to the N-terminus of a protein and directs the protein into the cell’s secretory pathway. The 5’-end of the coding sequence of the polynucleotide may inherently contain a signal peptide coding sequence naturally linked in translation reading frame with the segment of the coding sequence that encodes the protein. Alternatively, the 5’-end of the coding sequence may contain a signal peptide coding sequence that is heterologous to the coding sequence. A heterologous signal peptide coding sequence may be required where the coding sequence does not naturally contain a signal peptide coding sequence. Alternatively, a heterologous signal peptide coding sequence may simply replace the natural signal peptide coding sequence to enhance secretion of the protein. Any signal peptide coding sequence that directs the expressed protein into the secretory pathway of a host cell may be used. Effective signal peptide coding sequences for bacterial host cells are the signal peptide coding
sequences obtained from the genes for Bacillus NCIB 11837 maltogenic amylase, Bacillus licheniformis subtilisin, Bacillus licheniformis beta-lactamase, Bacillus stearothermophilus alpha-amylase, Bacillus stearothermophilus neutral proteases (nprT, nprS, nprM), and Bacillus subtilis prsA. Further signal peptides are described by Freudl, 2018, Microbial Cell Factories 17: 52. Effective signal peptide coding sequences for filamentous fungal host cells are the signal peptide coding sequences obtained from the genes for Aspergillus niger neutral amylase, Aspergillus niger glucoamylase, Aspergillus oryzae TAKA amylase, Humicola insolens cellulase, Humicola insolens endoglucanase V, Humicola lanuginosa lipase, and Rhizomucor miehei aspartic proteinase, such as the signal peptide described by Xu et al., 2018, Biotechnology Letters 40: 949-955 Useful signal peptides for yeast host cells are obtained from the genes for Saccharomyces cerevisiae alpha-factor and Saccharomyces cerevisiae invertase. Other useful signal peptide coding sequences are described by Romanos et al., 1992, supra. The control sequence may also be a propeptide coding sequence that encodes a propeptide positioned at the N-terminus of a protein. The resultant protein is known as a proenzyme or proprotein (or a zymogen in some cases). A proprotein is generally inactive and can be converted to an active protein by catalytic or autocatalytic cleavage of the propeptide from the proprotein. The propeptide coding sequence may be obtained from the genes for Bacillus subtilis alkaline protease (aprE), Bacillus subtilis neutral protease (nprT), Myceliophthora thermophila laccase (WO 95/33836), Rhizomucor miehei aspartic proteinase, and Saccharomyces cerevisiae alpha-factor. Where both signal peptide and propeptide sequences are present, the propeptide sequence is positioned next to the N-terminus of a protein and the signal peptide sequence is positioned next to the N-terminus of the propeptide sequence. Additionally or alternatively, when both signal peptide and propeptide sequences are present, the protein may comprise only a part of the signal peptide sequence and/or only a part of the propeptide sequence. Alternatively, the final or isolated protein may comprise a mixture of mature proteins and proteins which comprise, either partly or in full length, a propeptide sequence and/or a signal peptide sequence. It may also be desirable to add regulatory sequences that regulate expression of the protein relative to the growth of the host cell. Examples of regulatory sequences are those that cause expression of the gene to be turned on or off in response to a chemical or physical stimulus, including the presence of a regulatory compound. Regulatory sequences in prokaryotic systems include the lac, tac, and trp operator systems. In yeast, the ADH2 system or GAL1 system may be used. In filamentous fungi, the Aspergillus niger glucoamylase promoter, Aspergillus oryzae TAKA alpha-amylase promoter, and Aspergillus oryzae glucoamylase promoter, Trichoderma reesei cellobiohydrolase I promoter, and Trichoderma reesei cellobiohydrolase II promoter may be used. Other examples of regulatory sequences are those that allow for gene amplification. In fungal systems, these regulatory sequences include the dihydrofolate reductase gene that is amplified in the presence of methotrexate, and the metallothionein genes that are amplified with heavy metals. The control sequence may also be a transcription factor, a polynucleotide encoding a polynucleotide-
specific DNA-binding protein that controls the rate of the transcription of genetic information from DNA to mRNA by binding to a specific polynucleotide sequence. The transcription factor may function alone and/or together with one or more other proteins or transcription factors in a complex by promoting or blocking the recruitment of RNA polymerase. Transcription factors are characterized by comprising at least one DNA- binding domain which often attaches to a specific DNA sequence adjacent to the genetic elements which are regulated by the transcription factor. The transcription factor may regulate the expression of a protein of interest either directly, i.e., by activating the transcription of the gene encoding the protein of interest by binding to its promoter, or indirectly, i.e., by activating the transcription of a further transcription factor which regulates the transcription of the gene encoding the protein of interest, such as by binding to the promoter of the further transcription factor. Suitable transcription factors for fungal host cells are described in WO 2017/144177. Suitable transcription factors for prokaryotic host cells are described in Seshasayee et al., 2011, Subcellular Biochemistry 52: 7-23, as well in Balleza et al., 2009, FEMS Microbiol. Rev.33(1): 133-151. The present disclosure also provides recombinant expression vectors comprising a polynucleotide of the present disclosure, a promoter, and transcriptional and translational stop signals. The various nucleotide and control sequences may be joined together to produce a recombinant expression vector that may include one or more convenient restriction sites to allow for insertion or substitution of the polynucleotide encoding the protein at such sites. Alternatively, the polynucleotide may be expressed by inserting the polynucleotide or a nucleic acid construct comprising the polynucleotide into an appropriate vector for expression. In creating the expression vector, the coding sequence is located in the vector so that the coding sequence is operably linked with the appropriate control sequences for expression. The recombinant expression vector may be any vector (e.g., a plasmid or virus) that can be conveniently subjected to recombinant DNA procedures and can bring about expression of the polynucleotide. The choice of the vector will typically depend on the compatibility of the vector with the host cell into which the vector is to be introduced. The vector may be a linear or closed circular plasmid. The vector may be an autonomously replicating vector, i.e., a vector that exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g., a plasmid, an extrachromosomal element, a minichromosome, or an artificial chromosome. The vector may contain any means for assuring self-replication. Alternatively, the vector may be one that, when introduced into the host cell, is integrated into the genome and replicated together with the chromosome(s) into which it has been integrated. Furthermore, a single vector or plasmid or two or more vectors or plasmids that together contain the total DNA to be introduced into the genome of the host cell, or a transposon, may be used. The vector preferably contains one or more selectable markers that permit easy selection of transformed, transfected, transduced, or the like cells. A selectable marker is a gene the product of which provides for biocide or viral resistance, resistance to heavy metals, prototrophy to auxotrophs, and the like. The vector preferably contains at least one element that permits integration of the vector into the host cell's genome or autonomous replication of the vector in the cell independent of the genome.
For integration into the host cell genome, the vector may rely on the polynucleotide’s sequence encoding the protein or any other element of the vector for integration into the genome by homologous recombination, such as homology-directed repair (HDR), or non-homologous recombination, such as non- homologous end-joining (NHEJ). For autonomous replication, the vector may further comprise an origin of replication enabling the vector to replicate autonomously in the host cell in question. The origin of replication may be any plasmid replicator mediating autonomous replication that functions in a cell. The term “origin of replication” or “plasmid replicator” means a polynucleotide that enables a plasmid or vector to replicate in vivo. More than one copy of a polynucleotide of the present disclosure may be inserted into a host cell to increase production of a protein. For example, 2 or 3 or 4 or 5 or more copies are inserted into a host cell. An increase in the copy number of the polynucleotide can be obtained by integrating at least one additional copy of the sequence into the host cell genome or by including an amplifiable selectable marker gene with the polynucleotide where cells containing amplified copies of the selectable marker gene, and thereby additional copies of the polynucleotide, can be selected for by cultivating the cells in the presence of the appropriate selectable agent. The present disclosure also provides methods for producing recombinant host cells comprising a polynucleotide of the present disclosure operably linked to one or more control sequences that direct the production of a protein of the present disclosure. A construct or vector comprising a polynucleotide is introduced into a host cell so that the construct or vector is maintained as a chromosomal integrant or as a self-replicating extra-chromosomal vector as described earlier. The choice of a host cell will to a large extent depend upon the gene encoding the protein and its source. The protein can be native or heterologous to the recombinant host cell. Also, at least one of the one or more control sequences can be heterologous to the polynucleotide encoding the protein. The recombinant host cell may comprise a single copy, or at least two copies, e.g., three, four, five, or more copies of the polynucleotide of the present disclosure. The host cell may be any cell useful in the recombinant production of a protein of the present disclosure, including, not limited to, prokaryotic cells, fungal cells and plant cells, as described above. In an aspect, the host cell is isolated. In another aspect, the host cell is purified. In some embodiments, the host cell is a Gram-negative bacterium, such as Campylobacter, Chryseobacterium (e.g., C. viscerum), Dicytoglomus (e.g., D. thermophilum), Escherichia (e.g., E. coli), Flavobacterium, Fusobacterium, Helicobacter, Ilyobacter, Lysobacter (e.g., L. gummosus), Neisseria, Pseudomonas, Salmonella or Ureaplasma. In some embodiments, the host cell is a Gram-positive bacterium, such as Alkalihalobacillus (e.g., A. akibai, A. clausii), Bacillus (e.g., B. agaradhaerens, B. alkalophilus, B. amyloliquefaciens, B. brevis, B. circulans, B. clausii, B. coagulans, B. deramificans, B. firmus, B. lautus, B. lentus, B. licheniformis, B.
megaterium, B. pumilus, B. stearothermophilus, B. subtilis, B. thuringiensis), Clostridium, Effusibacillus (e.g., E. pohliae), Enterococcus, Geobacillus (e.g., G. stearothermophilus), Lactobacillus, Lactococcus, Lederbergia (e.g., L. lenta), Neobacillus (e.g., N. novalis), Nocardiopsis, Oceanobacillus (e.g., O. barbara), Staphylococcus, Streptococcus (e.g., S. equisimilis, S. pyogenes, S. uberis, and S. equi subsp. Zooepidemicus) or Streptomyces (e.g., S. achromogenes, S. avermitilis, S. coelicolor, S. griseus, S. lividans), Sutcliffiella (e.g., S. halmapala). Methods for introducing DNA into prokaryotic host cells are well-known in the art, and any suitable method can be used including but not limited to protoplast transformation, competent cell transformation, electroporation, conjugation, transduction, with DNA introduced as linearized or as circular polynucleotide. Persons skilled in the art will be readily able to identify a suitable method for introducing DNA into a given prokaryotic cell depending, e.g., on the genus. Methods for introducing DNA into prokaryotic host cells are for example described in Heinze et al., 2018, BMC Microbiology 18:56, Burke et al., 2001, Proc. Natl. Acad. Sci. USA 98: 6289-6294, Choi et al., 2006, J. Microbiol. Methods 64: 391-397, and Donald et al., 2013, J. Bacteriol.195(11): 2612-2620. In some embodiments, the host cell is a fungal cell, such as Acremonium, Acrophialophora (e.g., A. fusispora), Aspergillus (e.g., A. aculeatus, A. awamori, A. chevalieri, A. foetidus, A. fumigatus, A. japonicus, A. nidulans, A. niger, A. niveoglaucus, A. oryzae, A. tubingensis), Aureobasidium, Bjerkandera (e.g., B. adusta, B. fumosa), Ceriporiopsis (e.g., C. aneirina, C. caregiea, C. gilvescens, C. pannocinta, C. rivulosa, Ceriporiopsis subrufa, C. subvermispora), Chaetomium (e.g., C. erraticum, C. globosum), Chrysosporium (e.g., C. inops, C. keratinophilum, C. lucknowense, C. merdarium, C. pannicola, C. queenslandicum, C. tropicum, C. zonatum), Colletotrichum (e.g., C. graminicola), Coprinopsis (e.g., C. cinereus), Coprinus (e.g., C. cinereus), Coriolus (e.g., C. hirsutus), Cryphonectria (e.g., C. parasitica), Cryptococcus, Evansstolkia (e.g., E. leycettana), Filibasidium, Fusarium (e.g., F. bactridioides, F. cerealis, F. crookwellense, F. culmorum, F. graminearum, F. graminum, F. heterosporum, F. longipes, F. negundi, F. oxysporum, F. reticulatum, F. roseum, F. sambucinum, F. sarcochroum, F. solani, F. sporotrichioides, F. sulphureum, F. torulosum, F. trichothecioides, F. venenatum), Humicola (e.g., H. insolens, H. lanuginosa), Magnaporthe, Microdochium (e.g., M. nivale), Mucor (e.g., M. miehei), Myceliophthora (e.g., M. thermophila), Neocallimastix, Neurospora (e.g., Neurospora crassa), Ostropa (e.g., O. barbara), Paecilomyces, Penicillium (e.g., P. emersonii, P. purpurogenum, P. thomii, P. viridicatum), Phanerochaete (e.g., P. chrysosporium), Phlebia (e.g., Phlebia radiata), Piromyces, Pleurotus (e.g., Pleurotus eryngii), Pseudoplectania (e.g., P. vogesiaca), Schizophyllum, Sodiomyces (e.g., S. alcalophilus), Stenocarpella (e.g., S. maydis), Talaromyces (e.g., T. bacillisporus, T. emersonii, T. pinophilus), Thermoascus (e.g., T. aurantiacus), Themochaetoides (e.g., T. thermophila), Thermomyces (e.g., T. lanuginosus), Thermothielavioides (e.g., T. terrestris), Thermothelomyces (e.g., T. thermophilus), Thielavia (e.g., T. terrestris), Tolypocladium, Trametes (e.g., T. hirsuta, T. villosa, T. versicolor), Trichoderma (e.g., T. atroviride, T. harzianum, T. koningii, T. longibrachiatum, T. reesei, T. viride), Trichophaea (e.g., T. saccata), or Urnula (e.g., U. criterium).
In some embodiments, the host cell is a yeast cell, such as Candida, Hansenula, Komagataella (e.g., K. phaffii), Kluyveromyces (e.g., Kluyveromyces lactis), Pichia (e.g., P. pastoris), Saccharomyces (e.g., S. carlsbergensis, S. cerevisiae, S. diastaticus, S. douglasii, S. kluyveri, S. norbensis, S. oviformis), Schizosaccharomyces, or Yarrowia (e.g., Yarrowia lipolytica). Fungal cells may be transformed by a process involving protoplast-mediated transformation, Agrobacterium-mediated transformation, electroporation, biolistic method and shock-wave-mediated transformation as reviewed by Li et al., 2017, Microbial Cell Factories 16: 168 and procedures described in EP 238023, Yelton et al., 1984, Proc. Natl. Acad. Sci. USA 81: 1470-1474, Christensen et al., 1988, Bio/Technology 6: 1419-1422, and Lubertozzi and Keasling, 2009, Biotechn. Advances 27: 53-75. However, any method known in the art for introducing DNA into a fungal host cell can be used, and the DNA can be introduced as linearized or as circular polynucleotide. In some embodiments, the host cell is a plant cell, optionally a plant cell selected from the families Amaranthaceae (e.g., chard, spinach, sugar beet, quinoa), Asteraceae (e.g., artichoke, asters, chamomile, chicory, chrysanthemums, dahlias, daisies, echinacea, goldenrod, guayule, lettuce, marigolds, safflower, sunflowers, zinnias), Brassicaceae (e.g., arugula, broccoli, bok choy, Brussels sprouts, cabbage, cauliflower, canola, collard greens, daikon, garden cress, horseradish, kale, mustard, radish, rapeseed, rutabaga, turnip, wasabi, watercress, Arabidopsis thaliana), Caricaceae (e.g., papaya), Cucurbitaceae (e.g., cantaloupe, cucumber, honeydew, melon, pumpkin, squash (e.g., acorn squash, butternut squash, summer squash), watermelon, zucchini), Fabaceae (e.g., alfalfa, beans, carob, clover, guar, lentils, mesquite, peas, peanuts, soybeans, tamarind, tragacanth, vetch), Malvaceae (e.g., cacao, cotton, durian, hibiscus, kenaf, kola, okra), Poaceae (e.g., bamboo, barley, corn, fonio, lawn grass (e.g., Bahia grass, Bermudagrass, bluegrass, Buffalograss, Centipede grass, Fescue, or Zoysia), millet, oats, ornamental grasses, rice, rye, sorghum, sugar cane, triticale, wheat and other cereal crops, Polygonaceae (e.g., buckwheat), Rosaceae (e.g., almonds, apples, apricots, blackberry, blueberry, cherries, peaches, plums, quinces, raspberries, roses, strawberries), Solanaceae (e.g., bell peppers, chili peppers, eggplant, petunia, potato, tobacco, tomato) and Vitaceae (e.g., grape). Transgenic plants and plant cells expressing the protein may be constructed in accordance with methods known in the art. In short, the plant or plant cell is constructed by incorporating one or more expression constructs encoding the protein into the plant host genome or chloroplast genome and propagating the resulting modified plant or plant cell into a transgenic plant or plant cell. In an embodiment, a plant cell does not belong to plant varieties. The expression construct is conveniently a nucleic acid construct that comprises a polynucleotide encoding a protein, wherein the polynucleotide is operably linked with appropriate regulatory sequences required for expression of the polynucleotide in the plant or plant part of choice. Furthermore, the expression construct may comprise a selectable marker useful for identifying plant cells into which the expression construct has been integrated and DNA sequences necessary for introduction of the construct into the plant in question
(the latter depends on the DNA introduction method to be used). The choice of regulatory sequences, such as promoter and terminator sequences and optionally signal or transit sequences, is determined, for example, on the basis of when, where, and how the protein is desired to be expressed (Sticklen, 2008, Nature Reviews 9: 433-443). For instance, the expression of the gene encoding a protein may be constitutive or inducible, or may be developmental, stage or tissue specific, and the gene product may be targeted to a specific tissue or plant part such as seeds or leaves. Regulatory sequences are, for example, described by Tague et al., 1988, Plant Physiology 86: 506. For constitutive expression, the 35S-CaMV, the maize ubiquitin 1, or the rice actin 1 promoter may be used (Franck et al., 1980, Cell 21: 285-294; Christensen et al., 1992, Plant Mol. Biol. 18: 675-689; Zhang et al., 1991, Plant Cell 3: 1155-1165). Organ-specific promoters may be, for example, a promoter from storage sink tissues such as seeds, potato tubers, and fruits (Edwards and Coruzzi, 1990, Ann. Rev. Genet.24: 275-303), or from metabolic sink tissues such as meristems (Ito et al., 1994, Plant Mol. Biol.24: 863-878), a seed specific promoter such as the glutelin, prolamin, globulin, or albumin promoter from rice (Wu et al., 1998, Plant Cell Physiol. 39: 885-889), a Vicia faba promoter from the legumin B4 and the unknown seed protein gene from Vicia faba (Conrad et al., 1998, J. Plant Physiol.152: 708-711), a promoter from a seed oil body protein (Chen et al., 1998, Plant Cell Physiol. 39: 935-941), the storage protein napA promoter from Brassica napus, or any other seed specific promoter known in the art, e.g., as described in WO 91/14772. Furthermore, the promoter may be a leaf specific promoter such as the rbcs promoter from rice or tomato (Kyozuka et al., 1993, Plant Physiol.102: 991-1000), the chlorella virus adenine methyltransferase gene promoter (Mitra and Higgins, 1994, Plant Mol. Biol.26: 85-93), the aldP gene promoter from rice (Kagaya et al., 1995, Mol. Gen. Genet.248: 668- 674), or a wound inducible promoter such as the potato pin2 promoter (Xu et al., 1993, Plant Mol. Biol. 22: 573-588). Likewise, the promoter may be induced by abiotic treatments such as temperature, drought, or alterations in salinity or induced by exogenously applied substances that activate the promoter, e.g., ethanol, oestrogens, plant hormones such as ethylene, abscisic acid, and gibberellic acid, and heavy metals. A promoter enhancer element may also be used to achieve higher expression of a protein in the plant. For instance, the promoter enhancer element may be an intron that is placed between the promoter and the polynucleotide encoding a protein. For instance, Xu et al., 1993, supra, disclose the use of the first intron of the rice actin 1 gene to enhance expression. The selectable marker gene and any other parts of the expression construct may be chosen from those available in the art. The nucleic acid construct is incorporated into the plant genome according to conventional techniques known in the art, including Agrobacterium-mediated transformation, virus-mediated transformation, microinjection, particle bombardment, biolistic transformation, and electroporation (Gasser et al., 1990, Science 244: 1293; Potrykus, 1990, Bio/Technology 8: 535; Shimamoto et al., 1989, Nature 338: 274). Agrobacterium tumefaciens-mediated gene transfer is a method for generating transgenic dicots (for a review, see Hooykas and Schilperoort, 1992, Plant Mol. Biol. 19: 15-38) and for transforming monocots,
although other transformation methods may be used for these plants. A method for generating transgenic monocots is particle bombardment (microscopic gold or tungsten particles coated with the transforming DNA) of embryonic calli or developing embryos (Christou, 1992, Plant J.2: 275-281; Shimamoto, 1994, Curr. Opin. Biotechnol. 5: 158-162; Vasil et al., 1992, Bio/Technology 10: 667-674). An alternative method for transformation of monocots is based on protoplast transformation as described by Omirulleh et al., 1993, Plant Mol. Biol. 21: 415-428. Additional transformation methods include those described in U.S. Patent Nos. 6,395,966 and 7,151,204 (both of which are herein incorporated by reference in their entirety). Following transformation, the transformants having incorporated the expression construct are selected and regenerated into whole plants according to methods well known in the art. Often the transformation procedure is designed for the selective elimination of selection genes either during regeneration or in the following generations by using, for example, co-transformation with two separate T-DNA constructs or site- specific excision of the selection gene by a specific recombinase. In addition to direct transformation of a particular plant genotype with a construct of the present disclosure, transgenic plants may be made by crossing a plant having the construct to a second plant lacking the construct. For example, a construct encoding a protein can be introduced into a particular plant variety by crossing, without the need for ever directly transforming a plant of that given variety. Therefore, the present disclosure encompasses not only a plant directly regenerated from cells which have been transformed in accordance with the present disclosure, but also the progeny of such plants. As used herein, progeny may refer to the offspring of any generation of a parent plant prepared in accordance with the present disclosure. Such progeny may include a DNA construct prepared in accordance with the present disclosure. Crossing results in the introduction of a transgene into a plant line by cross pollinating a starting line with a donor plant line. Non- limiting examples of such steps are described in U.S. Patent No.7,151,204. Plants may be generated through a process of backcross conversion. For example, plants include plants referred to as a backcross converted genotype, line, inbred, or hybrid. Genetic markers may be used to assist in the introgression of one or more transgenes of the disclosure from one genetic background into another. Marker assisted selection offers advantages relative to conventional breeding in that it can be used to avoid errors caused by phenotypic variations. Further, genetic markers may provide data regarding the relative degree of elite germplasm in the individual progeny of a particular cross. For example, when a plant with a desired trait which otherwise has a non-agronomically desirable genetic background is crossed to an elite parent, genetic markers may be used to select progeny which not only possess the trait of interest, but also have a relatively large proportion of the desired germplasm. In this way, the number of generations required to introgress one or more traits into a particular genetic background is minimized. The present disclosure encompasses methods of producing a mutant of a parent cell, which comprises disrupting or deleting a polynucleotide, or a portion thereof, encoding a protein of the present disclosure, which results in the mutant cell producing less of the protein than the parent cell when cultivated under the same conditions.
The mutant cell may be constructed by reducing or eliminating expression of the polynucleotide using methods well known in the art, for example, one or more nucleotide insertions, one or more gene disruptions, one or more nucleotide replacements, or one or more nucleotide deletions. The polynucleotide to be modified or inactivated may be, for example, the coding region or a part thereof essential for activity, or a regulatory or control element required for expression of the coding region, e.g., a functional part of a promoter sequence, and/or a regulatory or control element required for the transcription or translation of the polynucleotide. Other control sequences for possible modification include, but are not limited to, a leader, polyadenylation sequence, propeptide sequence, signal peptide sequence, transcription terminator, and transcriptional activator. Modification or inactivation of the polynucleotide may be performed by subjecting the parent cell to mutagenesis and selecting for mutant cells in which expression of the polynucleotide has been reduced or eliminated. The mutagenesis, which may be specific or random, may be performed, for example, by use of a suitable physical or chemical mutagenizing agent, by use of a suitable oligonucleotide, or by subjecting the DNA sequence to PCR generated mutagenesis. Furthermore, the mutagenesis may be performed by use of any combination of these mutagenizing agents. Examples of a physical or chemical mutagenizing agent include ultraviolet (UV) irradiation, hydroxylamine, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), O-methyl hydroxylamine, nitrous acid, ethyl methane sulphonate (EMS), sodium bisulphite, formic acid, and nucleotide analogues (see J. L. Bose, Springer Protocols 2016, Methods in Molecular Biology, The Genetic Manipulation of Staphylococci). Additionally or alternatively, nucleotides may be inserted or removed so as to result in the introduction of a stop codon, the removal of the start codon, or a change in the open reading frame. Such modification or inactivation may be accomplished by site-directed mutagenesis or PCR generated mutagenesis in accordance with methods known in the art, or by targeted gene editing using one or more nucleases, e.g., zinc-finger nucleases or CRISPR-associated nucleases. Additionally or alternatively, the modification or inactivation may be achieved by gene silencing, genetic repression, genetic activation, and/or post-translational mutagenesis, e.g., by methods employing non-coding RNA, RNAi, siRNA, miRNA, ribozymes, catalytically inactive nucleases, CRISPRi, nucleotide methylation, and/or histone acetylation. The modification may be transient and/or reversible, irreversible and/or stable, or the modification may be dependent on chemical inducers or dependent on cultivation conditions, such as the cultivation temperature. The modification may be performed in vivo, i.e., directly on the cell expressing the polynucleotide to be modified, or the modification be performed in vitro. An example of a convenient way to eliminate or reduce expression of a polynucleotide is based on techniques of gene replacement, gene deletion, or gene disruption. For example, in the gene disruption method, a nucleic acid sequence corresponding to the endogenous polynucleotide is mutagenized in vitro to produce a defective nucleic acid sequence that is then transformed into the parent cell to produce a defective gene. By homologous recombination, the defective nucleic acid sequence replaces the endogenous polynucleotide. It may
be desirable that the defective polynucleotide also encodes a marker that may be used for selection of transformants in which the polynucleotide has been modified or destroyed. In an aspect, the polynucleotide is disrupted with a selectable marker such as those described herein. The present disclosure further relates to a mutant cell of a parent cell that comprises a disruption or deletion of a polynucleotide encoding a protein or a control sequence thereof or a silenced gene encoding the protein, which results in the mutant cell producing less of the protein or no protein compared to the parent cell. Protein-deficient mutant cells are useful as host cells for expression of native and heterologous proteins. Therefore, the present disclosure further relates to methods of producing a native or heterologous protein, comprising (a) cultivating a protein-deficient mutant cell under conditions conducive for production of a desired protein (e.g., a protein of the present disclosure); and (b) recovering the desired protein. The term “heterologous proteins” means proteins that are not native to the host cell, e.g., a variant of a native protein. The host cell may comprise more than one copy of a polynucleotide encoding a desired native or heterologous protein. In some embodiments, the present disclosure relates to a protein product essentially free from [enzyme] activity that is produced by a method of the present disclosure. Proteins, polynucleotides and organisms of the present disclosure may be incorporated into any suitable formulation(s), including, but not limited to, formulations comprising one or more seed-compatible carriers, soil-compatible carriers, foliar-compatible carriers, preharvest carriers, and/or postharvest carriers. Selection of appropriate carrier materials will depend on the intended application(s) and the protein(s) to be included in the formulation, as well as any other components that may be present in and/or added to the formulation. In some embodiments, the carrier is a liquid, a gel, a slurry, or a solid. In some embodiments, the carrier consists essentially of or consists of one or more protein-stabilizing compounds. The present disclosure encompasses granules/particles comprising one or more proteins of the disclosure. In an embodiment, the granule comprises a core, and optionally one or more coatings (outer layers) surrounding the core. The core may have a diameter, measured as equivalent spherical diameter (volume based average particle size), of 20-2000 µm, particularly 50-1500 µm, 100-1500 µm or 250-1200 µm. The core diameter, measured as equivalent spherical diameter, can be determined using laser diffraction, such as using a Malvern Mastersizer and/or the method described under ISO13320 (2020). In an embodiment, the core comprises one or more proteins of the present disclosure. The core may include additional materials such as fillers, fiber materials (cellulose or synthetic fibers), stabilizing agents, solubilizing agents, suspension agents, viscosity regulating agents, light spheres, plasticizers, salts, lubricants and fragrances. The core may include a binder, such as synthetic polymer, wax, fat, or carbohydrate. The core may include a salt of a multivalent cation, a reducing agent, an antioxidant, a peroxide decomposing catalyst and/or an acidic buffer component, typically as a homogenous blend. The core may include an inert particle with the protein absorbed into it, or applied onto the surface, e.g.,
by fluid bed coating. The core may have a diameter of 20-2000 µm, particularly 50-1500 µm, 100-1500 µm or 250-1200 µm. The core may be surrounded by at least one coating, e.g., to improve the storage stability, to reduce dust formation during handling, or for coloring the granule. The optional coating(s) may include a salt coating, or other suitable coating materials, such as polyethylene glycol (PEG), methyl hydroxy-propyl cellulose (MHPC) and polyvinyl alcohol (PVA). The coating may be applied in an amount of at least 0.1% by weight of the core, e.g., at least 0.5%, at least 1%, at least 5%, at least 10%, or at least 15%. The amount may be at most 100%, 70%, 50%, 40% or 30%. The coating is preferably at least 0.1 µm thick, particularly at least 0.5 µm, at least 1 µm or at least 5 µm. In some embodiments, the thickness of the coating is below 100 µm, such as below 60 µm, or below 40 µm. The coating should encapsulate the core unit by forming a substantially continuous layer. A substantially continuous layer is to be understood as a coating having few or no holes, so that the core unit has few or no uncoated areas. The layer or coating should, in particular, be homogeneous in thickness. The coating can further contain other materials as known in the art, e.g., fillers, antisticking agents, pigments, dyes, plasticizers and/or binders, such as titanium dioxide, kaolin, calcium carbonate or talc. A salt coating may comprise at least 60% by weight of a salt, e.g., at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95% or at least 99% by weight. To provide acceptable protection, the salt coating is preferably at least 0.1 µm thick, e.g., at least 0.5 µm, at least 1 µm, at least 2 µm, at least 4 µm, at least 5 µm, or at least 8 µm. In a particular embodiment, the thickness of the salt coating is below 100 µm, such as below 60 µm, or below 40 µm. The salt may be added from a salt solution where the salt is completely dissolved or from a salt suspension wherein the fine particles are less than 50 µm, such as less than 10 µm or less than 5 μm. The salt coating may comprise a single salt or a mixture of two or more salts. The salt may be water soluble, in particular, having a solubility at least 0.1 g in 100 g of water at 20°C, preferably at least 0.5 g per 100 g water, e.g., at least 1 g per 100 g water, e.g., at least 5 g per 100 g water. The salt may be an inorganic salt, e.g., salts of sulfate, sulfite, phosphate, phosphonate, nitrate, chloride or carbonate or salts of simple organic acids (less than 10 carbon atoms, e.g., 6 or less carbon atoms) such as citrate, malonate or acetate. Examples of cations in these salts are alkali or earth alkali metal ions, the ammonium ion or metal ions of the first transition series, such as sodium, potassium, magnesium, calcium, zinc or aluminum. Examples of anions include chloride, bromide, iodide, sulfate, sulfite, bisulfite, thiosulfate, phosphate, monobasic phosphate, dibasic phosphate, hypophosphite, dihydrogen pyrophosphate, tetraborate, borate, carbonate, bicarbonate, metasilicate, citrate, malate, maleate, malonate, succinate, lactate, formate, acetate, butyrate, propionate, benzoate, tartrate, ascorbate or gluconate. In particular, alkali- or earth alkali metal salts of sulfate, sulfite, phosphate, phosphonate, nitrate, chloride or carbonate or salts of simple organic acids such as citrate, malonate or acetate may be used.
The salt in the coating may have a constant humidity at 20°C above 60%, particularly above 70%, above 80% or above 85%, or it may be another hydrate form of such a salt (e.g., anhydrate). The salt coating may be as described in WO 00/01793 or WO 2006/034710. Specific examples of suitable salts are NaCl (CH20°C=76%), Na2CO3 (CH20°C=92%), NaNO3 (CH20°C=73%), Na2HPO4 (CH20°C=95%), Na3PO4 (CH25°C=92%), NH4Cl (CH20°C = 79.5%), (NH4)2HPO4 (CH20°C = 93,0%), NH4H2PO4 (CH20°C = 93.1%), (NH4)2SO4 (CH20°C=81.1%), KCl (CH20°C=85%), K2HPO4 (CH20°C=92%), KH2PO4 (CH20°C=96.5%), KNO3 (CH20°C=93.5%), Na2SO4 (CH20°C=93%), K2SO4 (CH20°C=98%), KHSO4 (CH20°C=86%), MgSO4 (CH20°C=90%), ZnSO4 (CH20°C=90%) and sodium citrate (CH25°C=86%). Other examples include NaH2PO4, (NH4)H2PO4, CuSO4, Mg(NO3)2 and magnesium acetate. The salt may be in anhydrous form, or it may be a hydrated salt, i.e., a crystalline salt hydrate with bound water(s) of crystallization, such as described in WO 99/32595. Specific examples include anhydrous sodium sulfate (Na2SO4), anhydrous magnesium sulfate (MgSO4), magnesium sulfate heptahydrate (MgSO4 .7H2O), zinc sulfate heptahydrate (ZnSO4 .7H2O), sodium phosphate dibasic heptahydrate (Na2HPO4 .7H2O), magnesium nitrate hexahydrate (Mg(NO3)2(6H2O)), sodium citrate dihydrate and magnesium acetate tetrahydrate. Preferably the salt is applied as a solution of the salt, e.g., using a fluid bed. The coating materials can be waxy coating materials and film-forming coating materials. Examples of waxy coating materials are poly(ethylene oxide) products (polyethyleneglycol, PEG) with mean molar weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids. Examples of film- forming coating materials suitable for application by fluid bed techniques are given in GB 1483591. The granule may optionally have one or more additional coatings. Examples of suitable coating materials are polyethylene glycol (PEG), methyl hydroxy-propyl cellulose (MHPC) and polyvinyl alcohol (PVA). Examples of enzyme granules with multiple coatings are described in WO 93/07263 and WO 97/23606. The core can be prepared by granulating a blend of the ingredients, e.g., by a method comprising granulation techniques such as crystallization, precipitation, pan-coating, fluid bed coating, fluid bed agglomeration, rotary atomization, extrusion, prilling, spheronization, size reduction methods, drum granulation, and/or high shear granulation. Methods for preparing the core can be found in the Handbook of Powder Technology; Particle size enlargement by C. E. Capes; Vol. 1; 1980; Elsevier. Preparation methods include known feed and granule formulation technologies, e.g., (a) Spray dried products, wherein a liquid protein-containing solution is atomized in a spray drying tower to form small droplets which during their way down the drying tower dry to form a protein-containing particulate material. Exceedingly small particles can be produced this way (Michael S. Showell (editor); Powdered detergents; Surfactant Science Series; 1998; Vol.71; pages 140-142; Marcel Dekker).
(b) Layered products, wherein the protein is coated as a layer around a pre-formed inert core particle, wherein a protein-containing solution is atomized, typically in a fluid bed apparatus wherein the pre-formed core particles are fluidized, and the protein-containing solution adheres to the core particles and dries up to leave a layer of dry protein on the surface of the core particle. Particles of a desired size can be obtained this way if a useful core particle of the desired size can be found. This type of product is described in, e.g., WO 97/23606. (c) Absorbed core particles, wherein rather than coating the protein as a layer around the core, the protein is absorbed onto and/or into the surface of the core. Such a process is described in WO 97/39116. (d) Extrusion or pelletized products, wherein a protein-containing paste is pressed to pellets or under pressure is extruded through a small opening and cut into particles which are subsequently dried. Such particles usually have a considerable size because of the material in which the extrusion opening is made (usually a plate with bore holes) sets a limit on the allowable pressure drop over the extrusion opening. Also, extremely high extrusion pressures when using a small opening increase heat generation in the protein paste, which is harmful to the protein (Michael S. Showell (editor); Powdered detergents; Surfactant Science Series; 1998; Vol. 71; pages 140-142; Marcel Dekker). (e) Prilled products, wherein a protein-containing powder is suspended in molten wax and the suspension is sprayed, e.g., through a rotating disk atomizer, into a cooling chamber where the droplets quickly solidify (Michael S. Showell (editor); Powdered detergents; Surfactant Science Series; 1998; Vol. 71; pages 140-142; Marcel Dekker). The product obtained is one wherein the protein is uniformLy distributed throughout an inert material instead of being concentrated on its surface. US 4,016,040 and US 4,713,245 describe this technique. (f) Mixer granulation products, wherein a protein-containing liquid is added to a dry powder composition of conventional granulating components. The liquid and the powder in a suitable proportion are mixed and as the moisture of the liquid is absorbed in the dry powder, the components of the dry powder will start to adhere and agglomerate and particles will build up, forming granulates comprising the protein. Such a process is described in US 4,106,991, EP 170360, EP 304332, EP 304331, WO 90/09440 and WO 90/09428. In a particular aspect of this process, various high-shear mixers can be used as granulators. Granulates consisting of protein, fillers and binders etc. are mixed with cellulose fibers to reinforce the particles to produce a so-called T-granulate. Reinforced particles, are more robust, and release less enzymatic dust. (g) Size reduction, wherein the cores are produced by milling or crushing of larger particles, pellets, tablets, briquettes etc. containing the protein. The wanted core particle fraction is obtained by sieving the milled or crushed product. Over and undersized particles can be recycled. Size reduction is described in Martin Rhodes (editor); Principles of Powder Technology; 1990; Chapter 10; John Wiley & Sons. (h) Fluid bed granulation. Fluid bed granulation involves suspending particulates in an air stream and spraying a liquid onto the fluidized particles via nozzles. Particles hit by spray droplets get wetted and become tacky. The tacky particles collide with other particles and adhere to them to form a granule.
(i) The cores may be subjected to drying, such as in a fluid bed drier. Other known methods for drying granules in the feed or enzyme industry can be used by the skilled person. The drying preferably takes place at a product temperature of from 25 to 90°C. For some proteins, it is important the cores comprising the protein contain a low amount of water before coating with the salt. If water sensitive proteins are coated with a salt before excessive water is removed, the excessive water will be trapped within the core and may affect the activity of the protein negatively. After drying, the cores preferably contain 0.1-10% w/w water. Non-dusting granulates may be produced, e.g., as disclosed in US 4,106,991 and US 4,661,452 and may optionally be coated by methods known in the art. The granulate may further comprise one or more additional enzymes, e.g., hydrolase, isomerase, ligase, lyase, oxidoreductase, and transferase. The one or more additional enzymes are preferably selected from the group consisting of acetylxylan esterase, acylglycerol lipase, amylase, alpha-amylase, beta-amylase, arabinofuranosidase, cellobiohydrolases, cellulase, feruloyl esterase, galactanase, alpha-galactosidase, beta- galactosidase, beta-glucanase, beta-glucosidase, lysophospholipase, lysozyme, alpha-mannosidase, beta- mannosidase (mannanase), phytase, phospholipase A1, phospholipase A2, phospholipase D, protease, pullulanase, pectin esterase, triacylglycerol lipase, xylanase, beta-xylosidase or any combination thereof. Each enzyme will then be present in more granules securing a more uniform distribution of the enzymes, and also reduces the physical segregation of different enzymes due to different particle sizes. Methods for producing multi-enzyme co-granulates is disclosed in the ip.com disclosure IPCOM000200739D. Another example of formulation of proteins by the use of co-granulates is disclosed in WO 2013/188331. The present disclosure also relates to protected proteins prepared according to the method(s) disclosed in EP 238216. The present disclosure likewise encompasses liquid formulations comprising one or more proteins of the disclosure. The formulation may comprise an enzyme stabilizer (examples of which include polyols such as propylene glycol or glycerol, sugar or sugar alcohol, lactic acid, reversible protease inhibitor, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid). In some embodiments, filler(s) or carrier material(s) are included to increase the volume of such formulation. Suitable filler or carrier materials include, but are not limited to, various salts of sulfate, carbonate and silicate as well as talc, clay and the like. Suitable filler or carrier materials for liquid formulation include, but are not limited to, water or low molecular weight primary and secondary alcohols including polyols and diols. Examples of such alcohols include, but are not limited to, methanol, ethanol, propanol and isopropanol. In some embodiments, the formulation contain from about 5% to about 90% of such materials. In an aspect, the liquid formulation comprises 20-80% w/w of polyol. In one embodiment, the liquid formulation comprises 0.001-2% w/w preservative. In another embodiment, the disclosure relates to liquid formulations comprising:
(A) 0.001-25% w/w of one or more proteins of the present disclosure; (B) 20-80% w/w of polyol; (C) optionally 0.001-2% w/w preservative; and (D) water. In another embodiment, the disclosure relates to liquid formulations comprising: (A) 0.001-25% w/w one or more proteins of the present disclosure; (B) 0.001-2% w/w preservative; (C) optionally 20-80% w/w of polyol; and (D) water. In another embodiment, the liquid formulation comprises one or more formulating agents, such as a formulating agent selected from the group consisting of polyol, sodium chloride, sodium benzoate, potassium sorbate, sodium sulfate, potassium sulfate, magnesium sulfate, sodium thiosulfate, calcium carbonate, sodium citrate, dextrin, glucose, sucrose, sorbitol, lactose, starch, PVA, acetate and phosphate, preferably selected from the group consisting of sodium sulfate, dextrin, cellulose, sodium thiosulfate, kaolin and calcium carbonate. In one embodiment, the polyols is selected from the group consisting of glycerol, sorbitol, propylene glycol (MPG), ethylene glycol, diethylene glycol, triethylene glycol, 1,2-propylene glycol or 1,3-propylene glycol, dipropylene glycol, polyethylene glycol (PEG) having an average molecular weight below about 600 and polypropylene glycol (PPG) having an average molecular weight below about 600, more preferably selected from the group consisting of glycerol, sorbitol and propylene glycol (MPG) or any combination thereof. In another embodiment, the liquid formulation comprises 20-80% polyol (i.e., total amount of polyol), e.g., 25-75% polyol, 30-70% polyol, 35-65% polyol, or 40-60% polyol. In one embodiment, the liquid formulation comprises 20-80% polyol, e.g., 25-75% polyol, 30-70% polyol, 35-65% polyol, or 40-60% polyol, wherein the polyol is selected from the group consisting of glycerol, sorbitol, propylene glycol (MPG), ethylene glycol, diethylene glycol, triethylene glycol, 1,2-propylene glycol or 1,3-propylene glycol, dipropylene glycol, polyethylene glycol (PEG) having an average molecular weight below about 600 and polypropylene glycol (PPG) having an average molecular weight below about 600. In one embodiment, the liquid formulation comprises 20-80% polyol (i.e., total amount of polyol), e.g., 25-75% polyol, 30-70% polyol, 35-65% polyol, or 40-60% polyol, wherein the polyol is selected from the group consisting of glycerol, sorbitol and propylene glycol (MPG). In another embodiment, the preservative is selected from the group consisting of sodium sorbate, potassium sorbate, sodium benzoate and potassium benzoate or any combination thereof. In one embodiment, the liquid formulation comprises 0.02-1.5% w/w preservative, e.g., 0.05-1% w/w preservative or 0.1-0.5% w/w preservative. In one embodiment, the liquid formulation comprises 0.001-2% w/w preservative (i.e., total amount of preservative), e.g., 0.02-1.5% w/w preservative, 0.05-1% w/w preservative, or 0.1-0.5% w/w preservative, wherein the preservative is selected from the group consisting of sodium sorbate, potassium sorbate, sodium benzoate and potassium benzoate or any combination thereof.
It is to be understood that formulations of the present disclosure may comprise combinations of the enzymes, including, but not limited to combinations of enzymes expressly disclosed herein and combinations with enzymes that are not expressly disclosed herein. In some embodiments, formulations of the present disclosure comprise 2, 3, 4, 5, 6, 7, 8, 9, 10 or more proteins of the present disclosure. For example, in some embodiments, formulations of the present disclosure comprise 2, 3, 4, 5, 6, 7, 8, 9, 10 or more of the polypeptides set forth herein as SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149, a mature polypeptide thereof, or a functional fragment/mutant/variant thereof. In some embodiments, formulations of the present disclosure comprise two or more distinct amylases, cellulases, glucanases, hemicellulases, lipases, mannanases, oxidases, pectinases, peptidases, proteases and/or xylanases. In some embodiments, formulations of the present disclosure comprise at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof) and at least one xylanase (e.g., an endo-1,4-beta-xylanase, such as any one of SEQ ID NOs: 48–53 or a functional fragment/mutant/variant thereof). In some embodiments, formulations of the present disclosure comprise at least one arabanase, at least one cellulase, at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof) and at least one xylanase (e.g., an endo-1,4-beta-xylanase, such as any one of SEQ ID NOs: 48–53 or a functional fragment/mutant/variant thereof). In some embodiments, formulations of the present disclosure comprise at least one glucanase (e.g., glucan 1,4-alpha-glucosidase), at least one lipase (e.g., a lysophospholipase, such as SEQ ID NO: 24 or a functional fragment/mutant/variant thereof) and at least one pullulanase (e.g., SEQ ID NO: 61 or a functional fragment/mutant/variant thereof). In some embodiments, formulations of the present disclosure comprise at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof) and at least one pectinase. In some embodiments, formulations of the present disclosure comprise at least one catalase (e.g., any one of SEQ ID NOs: 11–12 or a functional fragment/mutant/variant thereof) and at least one glucose oxidase (e.g., any one of SEQ ID NOs: 1–5 or a functional fragment/mutant/variant thereof). In some embodiments, formulations of the present disclosure comprise at least one amylase (e.g., any one of SEQ ID NOs: 34–40 or a functional fragment/mutant/variant thereof), at least one chitinase, and at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof). In some embodiments, formulations of the present disclosure comprise at least one amylase (e.g., any one of SEQ ID NOs: 34–40 or a functional fragment/mutant/variant thereof), at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof), and at least one bacillolycin (e.g., SEQ ID NO: 88 or a functional fragment/mutant/variant thereof).
In some embodiments, formulations of the present disclosure comprise at least one cellulase (e.g., any one of SEQ ID NOs: 43–45 or a functional fragment/mutant/variant thereof), at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof), at least one pectinase and at least one pectin lyase (e.g., SEQ ID NO: 88 or a functional fragment/mutant/variant thereof). In some embodiments, formulations of the present disclosure comprise at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof), at least one oxygenase (e.g., a lytic cellulose monooxygenase, such as any one of SEQ ID NOs: 14–15 or a functional fragment/mutant/variant thereof) and at least one xylanase (e.g., an endo-1,4-beta-xylanase, such as any one of SEQ ID NOs: 48–53 or a functional fragment/mutant/variant thereof). In some embodiments, formulations of the present disclosure comprise at least one cellulase(e.g., any one of SEQ ID NOs: 43–45 or a functional fragment/mutant/variant thereof), at least one furanosidase (e.g., an arabinofuranosidase, such as SEQ ID NO: 62 or a functional fragment/mutant/variant thereof) and at least one xylanase (e.g., an endo-1,4-beta-xylanase, such as any one of SEQ ID NOs: 48–53 or a functional fragment/mutant/variant thereof). In some embodiments, formulations of the present disclosure comprise at least one subtilisin (e.g., any one of SEQ ID NOs: 83–87 or a functional fragment/mutant/variant thereof), and at least one bacillolysin (e.g., SEQ ID NO: 88 or a functional fragment/mutant/variant thereof). In some embodiments, formulations of the present disclosure comprise at least one catalase (e.g., any one of SEQ ID NOs: 11–12 or a functional fragment/mutant/variant thereof) and at least one peptidase (e.g., a bacillolysin, SEQ ID NO: 88 or a functional fragment/mutant/variant thereof; a serine endopeptidase, such as any one of SEQ ID NOs: 80–81 or a functional fragment/mutant/variant thereof). In some embodiments, formulations of the present disclosure comprise at least one catalase (e.g., any one of SEQ ID NOs: 11–12 or a functional fragment/mutant/variant thereof), at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof) and at least one xylanase (e.g., an endo-1,4-beta-xylanase, such as any one of SEQ ID NOs: 48–53 or a functional fragment/mutant/variant thereof). In some embodiments, formulations of the present disclosure comprise at least one peptidase (e.g., a bacillolysin, SEQ ID NO: 88 or a functional fragment/mutant/variant thereof; a serine endopeptidase, such as any one of SEQ ID NOs: 80–81 or a functional fragment/mutant/variant thereof), at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof) and at least one xylanase (e.g., an endo-1,4-beta-xylanase, such as any one of SEQ ID NOs: 48–53 or a functional fragment/mutant/variant thereof). In some embodiments, formulations of the present disclosure comprise at least one amylase (e.g., any one of SEQ ID NOs: 34–40 or a functional fragment/mutant/variant thereof), at least one glucanase (e.g., an endo-1,3(4)-beta-glucanase, such as SEQ ID NO: 46 or a functional fragment/mutant/variant thereof) and at
least one peptidase (e.g., a bacillolysin, SEQ ID NO: 88 or a functional fragment/mutant/variant thereof; a serine endopeptidase, such as any one of SEQ ID NOs: 80–81 or a functional fragment/mutant/variant thereof). In some embodiments, formulations of the present disclosure comprise a fermentation broth that comprises 2, 3, 4, 5, 6, 7, 8, 9, 10 or more enzymes. In some embodiments, formulations of the present disclosure comprise a fermentation broth that comprises 2, 3, 4, 5, 6, 7, 8, 9, 10 or more proteins of the present disclosure (2, 3, 4, 5, 6, 7, 8, 9, 10 or more of SEQ ID NOs: 1–91, 45906, 72144, 72147 and 72149 or functional fragments/mutants/variants thereof). Formulations of the present disclosure may comprise myriad components, including, but not limited to, adhesives (stickers), biological actives, chemical actives, dispersants (spreaders), drying agents, emulsifiers, nutrients, pest attractants and feeding stimulants, pH control components, postharvest treatments, preservatives, rain fasteners, rhealogical agents, safeners, stabilizers, UV protectants and/or wetting agents. Examples of actives that may be included in formulations of the present disclosure include, but not are not limited to, acaracides and miticides (e.g., carvacrol, sanguinarine, azobenzene, benzoximate, benzyl benzoate, bromopropylate, chlorbenside, chlorfenethol, chlorfenson, chlorfensulphide, chlorobenzilate, chloropropylate, cyflumetofen, DDT, dicofol, diphenyl sulfone, dofenapyn, fenson, fentrifanil, fluorbenside, genit, hexachlorophene, phenproxide, proclonol, tetradifon, tetrasul, benomyl, carbanolate, carbaryl, carbofuran, methiocarb, metolcarb, promacyl, propoxur, aldicarb, butocarboxim, oxamyl, thiocarboxime, thiofanox, bifenazate, binapacryl, dinex, dinobuton, dinocap-4, dinocap-6, dinocton, dinopenton, dinosulfon, dinoterbon, DNOC, amitraz, chlordimeform, chloromebuform, formetanate, formparanate, medimeform, semiamitraz, afoxolaner, fluralaner, sarolaner, tetranactin ◦avermectin acaricides, abamectin, doramectin, eprinomectin, ivermectin, selamectin, milbemectin, milbemycin oxime, moxidectin,, clofentezine, cyromazine, diflovidazin, dofenapyn, fluazuron, flubenzimine, flucycloxuron, flufenoxuron, hexythiazox, bromocyclen, camphechlor, DDT, dienochlor, endosulfan, lindane, chlorfenvinphos, crotoxyphos, dichlorvos, heptenophos, mevinphos, monocrotophos, naled, TEPP, tetrachlorvinphos, amidithion, amiton, azinphos-ethyl, azinphos-methyl, azothoate, benoxafos, bromophos, bromophos-ethyl, carbophenothion, chlorpyrifos, chlorthiophos, coumaphos, cyanthoate, demeton-O, demeton-S, demeton-O-methyl, demeton-S-methyl, demeton-S-methylsulphon, dialifos, diazinon, dimethoate, dioxathion, disulfoton, endothion, ethion, ethoate-methyl, formothion, malathion, mecarbam, methacrifos, omethoate, oxydeprofos, oxydisulfoton, parathion, phenkapton, phorate, phosalone, phosmet, phostin, phoxim, pirimiphos-methyl, prothidathion, prothoate, pyrimitate, quinalphos, quintiofos, sophamide, sulfotep, thiometon, triazophos, trifenofos, vamidothion, trichlorfon, isocarbophos, methamidophos, propetamphos, dimefox, mipafox, schradan,, azocyclotin, cyhexatin, fenbutatin oxide, phostin, dichlofluanid, dialifos, phosmet, cyenopyrafen, fenpyroximate, pyflubumide, tebufenpyrad, acetoprole, fipronil, vaniliprole,, acrinathrin, bifenthrin, brofluthrinate, cyhalothrin, alpha-cypermethrin, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, permethrin, halfenprox,, pyrimidifen, chlorfenapyr, sanguinarine, chinomethionat, thioquinox, bifujunzhi, fluacrypyrim, flufenoxystrobin, pyriminostrobin,, aramite, propargite, spirodiclofen, clofentezine, diflovidazin, flubenzimine, hexythiazox, fenothiocarb, chloromethiuron,
diafenthiuron, acequinocyl, amidoflumet, arsenous oxide, clenpirin, closantel, crotamiton, cycloprate, cymiazole, disulfiram, etoxazole, fenazaflor, fenazaquin, fluenetil, mesulfen, MNAF, nifluridide, nikkomycins, pyridaben, sulfiram, sulfluramid, sulfur, thuringiensin, triarathene, and combinations thereof); fungicides (e.g., strobilurins, such as azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyribencarb, trifloxystrobin, 2-[2-(2,5-dimethyl-phenoxymethyl)-phenyl]-3- methoxy-acrylic acid methyl ester and 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneaminooxymethyl)- phenyl)-2-methoxyimino-N-methyl-acetamide; carboxamides, such as carboxanilides (e.g., benalaxyl, benalaxyl-M, benodanil, bixafen, boscalid, carboxin, fenfuram, fenhexamid, flutolanil, fluxapyroxad, furametpyr, isopyrazam, isotianil, kiralaxyl, mepronil, metalaxyl, metalaxyl-M (mefenoxam), ofurace, oxadixyl, oxycarboxin, penflufen, penthiopyrad, sedaxane, tecloftalam, thifluzamide, tiadinil, 2-amino-4-methyl- thiazole-5-carboxanilide, N-(4'-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyra- zole-4- carboxamide, N-(2-(1,3,3-trimethylbutyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide), carboxylic morpholides (e.g., dimethomorph, flumorph, pyrimorph), benzoic acid amides (e.g., flumetover, fluopicolide, fluopyram, zoxamide), carpropamid, dicyclomet, mandiproamid, oxytetracyclin, silthiofam and N-(6-methoxy-pyridin-3-yl) cyclopropanecarboxylic acid amide; azoles, such as triazoles (e.g., azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, oxpoconazole, paclobutrazole, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole) and imidazoles (e.g., cyazofamid, imazalil, pefurazoate, prochloraz, triflumizol); heterocyclic compounds, such as pyridines (e.g., fluazinam, pyrifenox (cf.D1b), 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]- pyridine, 3-[5-(4-methyl-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine), pyrimidines (e.g., bupirimate, cyprodinil, diflumetorim, fenarimol, ferimzone, mepanipyrim, nitrapyrin, nuarimol, pyrimethanil), piperazines (e.g., triforine), pirroles (e.g., fenpiclonil, fludioxonil), morpholines (e.g., aldimorph, dodemorph, dodemorph- acetate, fenpropimorph, tridemorph), piperidines (e.g., fenpropidin), dicarboximides (e.g., fluoroimid, iprodione, procymidone, vinclozolin), non-aromatic 5-membered heterocycles (e.g., famoxadone, fenamidone, flutianil, octhilinone, probenazole, 5-amino-2-isopropyl-3-oxo-4-ortho-tolyl-2,3-dihydro-pyrazole-1- carbothioic acid S-allyl ester), acibenzolar-S-methyl, ametoctradin, amisulbrom, anilazin, blasticidin-S, captafol, captan, chinomethionat, dazomet, debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate, fenoxanil, Folpet, oxolinic acid, piperalin, proquinazid, pyroquilon, quinoxyfen, triazoxide, tricyclazole, 2- butoxy-6-iodo-3-propylchromen-4-one, 5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H- benzoimidazole and 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo-[1,5- a]pyrimidine; benzimidazoles, such as carbendazim; and other active substances, such as guanidines (e.g., guanidine, dodine, dodine free base, guazatine, guazatine-acetate, iminoctadine), iminoctadine-triacetate and iminoctadine-tris(albesilate); antibiotics (e.g., kasugamycin, kasugamycin hydrochloride-hydrate, streptomycin,
polyoxine and validamycin A); nitrophenyl derivates (e.g., binapacryl, dicloran, dinobuton, dinocap, nitrothal- isopropyl, tecnazen); organometal compounds (e.g., fentin salts, such as fentin-acetate, fentin chloride, fentin hydroxide); sulfur-containing heterocyclyl compounds (e.g., dithianon, isoprothiolane); organophosphorus compounds (e.g., edifenphos, fosetyl, fosetyl-aluminum, iprobenfos, phosphorus acid and its salts, pyrazophos, tolclofos-methyl); organochlorine compounds (e.g., chlorothalonil, dichlofluanid, dichlorophen, flusulfamide, hexachlorobenzene, pencycuron, pentachlorphenole and its salts, phthalide, quintozene, thiophanate-methyl, thiophanate, tolylfluanid, N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide), inorganic active substances (e.g., Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, phosphite salt, sulfur, zinc sulfate), natamycin, and combinations thereof); gastropodicides (e.g., methiocarb, metaldehyde, carbaryl, spinosad, copper sulfate in combination with lime, boric acid, iron phosphate, and combinations thereof); herbicides (e.g., 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4,5- trichlorophenoxyacetic acid (2,4,5-T), ametryn, amicarbazone, aminocyclopyrachlor, acetochlor, acifluorfen, alachlor, atrazine, azafenidin, bentazon, benzofenap, bifenox, bromacil, bromoxynil, butachlor, butafenacil, butroxydim, carfentrazone-ethyl, chlorimuron, chlorotoluro, clethodim, clodinafop, clomazone, cyanazine, cycloxydim, cyhalofop, desmedipham, desmetryn, dicamba, diclofop, dimefuron, diuron, dithiopyr, fenoxaprop, fluazifop, fluazifop-P, fluometuron, flufenpyr-ethyl, flumiclorac-pentyl, flumioxazin, fluoroglycofen, fluthiacet- methyl, fomesafe, fomesafen, glyphosate, glufosinate, haloxyfop, hexazinone, imazamox, imazaquin, imazethapyr, ioxynil, isoproturon, isoxaflutole, lactofen, linuron, mecoprop, mecoprop-P, mesotrion, metamitron, metazochlor, methibenzuron , metolachlor (and S-metolachlor ), metoxuron, metribuzin, monolinuron, oxadiargyl, oxadiazon, oxyfluorfen, phenmedipham, pretilachlor, profoxydim, prometon, prometry, propachlor, propanil , propaquizafop, propisochlor, pyraflufen-ethyl, pyrazon, pyrazolynate, pyrazoxyfen, pyridate, quizalofop, quizalofop-P (e.g., quizalofop-ethyl, quizalofop-P-ethyl, clodinafop- propargyl, cyhalofop-butyl, diclofop- methyl, fenoxaprop-P-ethyl, fluazifop-P-butyl, haloxyfop-methyl, haloxyfop-R-methyl), saflufenacil, sethoxydim, siduron, simazine, simetryn, sulcotrione, sulfentrazone, tebuthiuron, tembotrione, tepraloxydim, terbacil, terbumeton, terbuthylazine, thaxtomin (e.g., the thaxtomins described in US Patent No.: 7,989,393), thenylchlor, tralkoxydim, triclopyr, trietazine, tropramezone, salts and esters thereof; racemic mixtures and resolved isomers thereof and combinations thereof); and insecticides and nematicides (e.g., antibiotic insecticides such as allosamidin and thuringiensin; macrocyclic lactone insecticides such as spinosad, spinetoram, and other spinosyns including the 21-butenyl spinosyns and their derivatives; avermectin insecticides such as abamectin, doramectin, emamectin, eprinomectin, ivermectin and selamectin; milbemycin insecticides such as lepimectin, milbemectin, milbemycin oxime and moxidectin; arsenical insecticides such as calcium arsenate, copper acetoarsenite, copper arsenate, lead arsenate, potassium arsenite and sodium arsenite; other biological insecticides, plant incorporated protectant insecticides such as Cry1Ab, Cry1Ac, Cry1F, Cry1A.105, Cry2Ab2, Cry3A, mir Cry3A, Cry3Bb1, Cry34, Cry35, and VIP3A; botanical insecticides such as anabasine, azadirachtin, d-limonene, nicotine, pyrethrins, cinerins, cinerin I, cinerin II, jasmolin I, jasmolin II, pyrethrin I, pyrethrin II, quassia, rotenone, ryania and sabadilla; carbamate insecticides
such as bendiocarb and carbaryl; benzofuranyl methylcarbamate insecticides such as benfuracarb, carbofuran, carbosulfan, decarbofuran and furathiocarb; dimethylcarbamate insecticides dimitan, dimetilan, hyquincarb and pirimicarb; oxime carbamate insecticides such as alanycarb, aldicarb, aldoxycarb, butocarboxim, butoxycarboxim, methomyl, nitrilacarb, oxamyl, tazimcarb, thiocarboxime, thiodicarb and thiofanox; phenyl methylcarbamate insecticides such as allyxycarb, aminocarb, bufencarb, butacarb, carbanolate, cloethocarb, dicresyl, dioxacarb, EMPC, ethiofencarb, fenethacarb, fenobucarb, isoprocarb, methiocarb, metolcarb, mexacarbate, promacyl, promecarb, propoxur, trimethacarb, XMC and xylylcarb; dinitrophenol insecticides such as dinex, dinoprop, dinosam and DNOC; fluorine insecticides such as barium hexafluorosilicate, cryolite, sodium fluoride, sodium hexafluorosilicate and sulfluramid; formamidine insecticides such as amitraz, chlordimeform, formetanate and formparanate; fumigant insecticides such as acrylonitrile, carbon disulfide, carbon tetrachloride, chloroform, chloropicrin, para-dichlorobenzene, 1,2-dichloropropane, ethyl formate, ethylene dibromide, ethylene dichloride, ethylene oxide, hydrogen cyanide, iodomethane, methyl bromide, methylchloroform, methylene chloride, naphthalene, phosphine, sulfuryl fluoride and tetrachloroethane; inorganic insecticides such as borax, calcium polysulfide, copper oleate, mercurous chloride, potassium thiocyanate and sodium thiocyanate; chitin synthesis inhibitors such as bistrifluoron, buprofezin, chlorfluazuron, cyromazine, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, penfluoron, teflubenzuron and triflumuron; juvenile hormone mimics such as epofenonane, fenoxycarb, hydroprene, kinoprene, methoprene, pyriproxyfen and triprene; juvenile hormones such as juvenile hormone I, juvenile hormone II and juvenile hormone III; moulting hormone agonists such as chromafenozide, halofenozide, methoxyfenozide and tebufenozide; moulting hormones such as .alpha.-ecdysone and ecdysterone; moulting inhibitors such as diofenolan; precocenes such as precocene I, precocene II and precocene III; unclassified insect growth regulators such as dicyclanil; nereistoxin analogue insecticides such as bensultap, cartap, thiocyclam and thiosultap; nicotinoid insecticides such as flonicamid; nitroguanidine insecticides such as clothianidin, dinotefuran, imidacloprid and thiamethoxam; nitromethylene insecticides such as nitenpyram and nithiazine; pyridylmethylamine insecticides such as acetamiprid, imidacloprid, nitenpyram and thiacloprid; organochlorine insecticides such as bromo-DDT, camphechlor, DDT, pp'-DDT, ethyl-DDD, HCH, gamma-HCH, lindane, methoxychlor, pentachlorophenol and TDE; cyclodiene insecticides such as aldrin, bromocyclen, chlorbicyclen, chlordane, chlordecone, dieldrin, dilor, endosulfan, endrin, HEOD, heptachlor, HHDN, isobenzan, isodrin, kelevan and mirex; organophosphate insecticides such as bromfenvinfos, chlorfenvinphos, crotoxyphos, dichlorvos, dicrotophos, dimethylvinphos, fospirate, heptenophos, methocrotophos, mevinphos, monocrotophos, naled, naftalofos, phosphamidon, propaphos, TEPP and tetrachlorvinphos; organothiophosphate insecticides such as dioxabenzofos, fosmethilan and phenthoate; aliphatic organothiophosphate insecticides such as acethion, amiton, cadusafos, chlorethoxyfos, chlormephos, demephion, demephion-O, demephion-S, demeton, demeton-O, demeton-S, demeton-methyl, demeton-O- methyl, demeton-S-methyl, demeton-S-methylsulphon, disulfoton, ethion, ethoprophos, IPSP, isothioate, malathion, methacrifos, oxydemeton-methyl, oxydeprofos, oxydisulfoton, phorate, sulfotep, terbufos and
thiometon; aliphatic amide organothiophosphate insecticides such as amidithion, cyanthoate, dimethoate, ethoate-methyl, formothion, mecarbam, omethoate, prothoate, sophamide and vamidothion; oxime organothiophosphate insecticides such as chlorphoxim, phoxim and phoxim-methyl; heterocyclic organothiophosphate insecticides such as azamethiphos, coumaphos, coumithoate, dioxathion, endothion, menazon, morphothion, phosalone, pyraclofos, pyridaphenthion and quinothion; benzothiopyran organothiophosphate insecticides such as dithicrofos and thicrofos; benzotriazine organothiophosphate insecticides such as azinphos-ethyl and azinphos-methyl; isoindole organothiophosphate insecticides such as dialifos and phosmet; isoxazole organothiophosphate insecticides such as isoxathion and zolaprofos; pyrazolopyrimidine organothiophosphate insecticides such as chlorprazophos and pyrazophos; pyridine organothiophosphate insecticides such as chlorpyrifos and chlorpyrifos-methyl; pyrimidine organothiophosphate insecticides such as butathiofos, diazinon, etrimfos, lirimfos, pirimiphos-ethyl, pirimiphos-methyl, primidophos, pyrimitate and tebupirimfos; quinoxaline organothiophosphate insecticides such as quinalphos and quinalphos-methyl; thiadiazole organothiophosphate insecticides such as athidathion, lythidathion, methidathion and prothidathion; triazole organothiophosphate insecticides such as isazofos and triazophos; phenyl organothiophosphate insecticides such as azothoate, bromophos, bromophos-ethyl, carbophenothion, chlorthiophos, cyanophos, cythioate, dicapthon, dichlofenthion, etaphos, famphur, fenchlorphos, fenitrothion fensulfothion, fenthion, fenthion-ethyl, heterophos, jodfenphos, mesulfenfos, parathion, parathion-methyl, phenkapton, phosnichlor, profenofos, prothiofos, sulprofos, temephos, trichlormetaphos-3 and trifenofos; phosphonate insecticides such as butonate and trichlorfon; phosphonothioate insecticides such as mecarphon; phenyl ethylphosphonothioate insecticides such as fonofos and trichloronat; phenyl phenylphosphonothioate insecticides such as cyanofenphos, EPN and leptophos; phosphoramidate insecticides such as crufomate, fenamiphos, fosthietan, imicyafos, mephosfolan, phosfolan and pirimetaphos; phosphoramidothioate insecticides such as acephate, isocarbophos, isofenphos, methamidophos and propetamphos; phosphorodiamide insecticides such as dimefox, mazidox, mipafox and schradan; oxadiazine insecticides such as indoxacarb; phthalimide insecticides such as dialifos, phosmet and tetramethrin; pyrazole insecticides such as acetoprole, ethiprole, fipronil, pyrafluprole, pyriprole, tebufenpyrad, tolfenpyrad and vaniliprole; pyrethroid ester insecticides such as acrinathrin, allethrin, bioallethrin, barthrin, bifenthrin, bioethanomethrin, cyclethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta- cypermethrin, cyphenothrin, deltamethrin, dimefluthrin, dimethrin, empenthrin, fenfluthrin, fenpirithrin, fenpropathrin, fenvalerate, esfenvalerate, flucythrinate, fluvalinate, tau-fluvalinate, furethrin, imiprothrin, metofluthrin, permethrin, biopermethrin, transpermethrin, phenothrin, prallethrin, profluthrin, pyresmethrin, resmethrin, biopermethrin, cismethrin, tefluthrin, terallethrin, tetramethrin, tralomethrin and transfluthrin; pyrethroid ether insecticides such as etofenprox, flufenprox, halfenprox, protrifenbute and silafluofen; pyrimidinamine insecticides such as flufenerim and pyrimidifen; pyrrole insecticides such as chlorfenapyr; tetronic acid insecticides such as spirodiclofen, spiromesifen and spirotetramat; thiourea insecticides such as
diafenthiuron; urea insecticides such as flucofuron and sulcofuron; and unclassified insecticides such as AKD- 3088, chlorantraniliprole, closantel, crotamiton, cyflumetofen, E2Y45, EXD, fenazaflor, fenazaquin, fenoxacrim, fenpyroximate, FKI-1033, flubendiamide, HGW86, hydramethylnon, IKI-2002, isoprothiolane, malonoben, metaflumizone, metoxadiazone, nifluridide, NNI-9850, NNI-0101, pymetrozine, pyridaben, pyridalyl, pyrifluquinazon, Qcide, rafoxanide, Rynaxypyr.TM., SYJ-159, triarathene and triazamate, and combinations thereof). Non-limiting examples of actives that may be incorporated into formulations of the present disclosure—or into which proteins and other compositions of the present disclosure may be incorporated— include, but are not limited to, commercial products sold under the tradenames ABACUS®, ACROBAT®, ACRONIS®, ADHERE®, ADMIRAL®, AGCELENCE®, AGMUSA®, ALLEGRO®, ALITE 27®, ALTREVIN®, AMP®, AMPLEXUS®, AMPLO®, ARMEZON®, ARESENAL®, ASSIST®, ATECTRA®, ATIVUM®, AUMENAX®, AURA®, BASAGRAN®, BELLIS®, BEYOND®, BLAVITY®, BLITZ®, BOMVORO®, BRIO®, CABRIO®, CARAMBA®, CADRE®, CANTUS®, CAPACITY®, CARAMBA®, CAURIFIX®, CEPTIVA®, CEYVA®, CHOPPER®, CLARITY®, CLEARFIELD®, CLEARPATH®, CLEARSOL®, COLLIS®, COMET®, CONTAIN®, CONVEY®, COPEO®, CREDENZ®, CUPRODUL®, CYCOCEL®, DASH®, DELAN®, DISTINCT®, DORMEX®, DUETT®, DURAVEL®, ENDURA®, ENGENIA®, ENTIGRIS®, EXTREME®, F 500®, FACET®, FASTAC®, FENDONA®, FIBERMAX®, FINALE®, FORUM®, GELFIX®, GESTUS®, GLYTOL®, GRANOURO®, GREEN LAWNGER®, HEADLINE®, HEAT®, HERBADOX®, HI-LIGHT®, HICOAT®, HIDROCUP®, HISTICK®, ILEVO®, IMUNIT®, INITIUM®, INTERFIELD®, KIFIX®, KIXOR®, KUMULUS®, LACTOSILO®, LAWNGER®, LIBERTY®, LIBERTYLINK®, LIDERO®, LUPRO-GRAIN®, MEES®, MERIVON®, MUNEO®, NEALTA®, NEPAXIR®, NEWPATH®, NEXICOR®, NODULATOR®, NOMOLT®, OBVIUS®, ONDUTY®, ONLY®, OPERA®, OPTILL®, ORKESTRA®, ORQUESTA®, OUTLOOK®, PENDULUM®, PIRATE®, PIVOT®, PIX®, PLATEAU®, POAST®, POLYACER®, POLYRAM®, PONCHO®, PREMIS®, PRIAXOR®, PRISTINE®, PROVISIA®, PROVYSOL®, PROWL®, PURSUTI®, RAK®, RAPTOR®, REGENT®, RELENYA®, RELY®, RENESTRA®, REVYSOL®, REVYTEK®, RHIZO-FLO®, SEFINA®, SELTIMA®, SEPIRET®, SERIFEL®, SHARPEN®, SISTEMA®, SISTIVA®, SOYTECH®, SPHAEREX®, SPOT®, STAMINA®, STANDAK®, STATUS®, STORM®, STROBY®, SUNFIRE®, SYSTIVA®, TACAZO®, TAJ®, TERAXXA®, TREEVIX®, TUIT®, TUTOR®, TWINLINK®, VABORO®, VALEOS®, VARISTO®, VAULT®, VELTYMA®, VERDICT®, VERISMO®, VERSATILIS®, VERSYS®, VIVANDO®, VOTIVO®, XANTHION®, XEMIUM®, ZAMPOR®, ZIDUA® and ZYNION® from BASF (Ludwigshafen, Germany); CORVUS®, POWERMAX®, DELARO®, PROSARO®, BAYTHROID®, SIVANTO®, FINISH®, GINSTAR®, ACCELERON®, RAXIL®, AERIS®, EVERGOL®, TRILEX®, ALLEGIANCE®, BUTEO, EMESTO®, GAUCHO® and THIRAM® from Bayer Crop Science (Creve Coeur, MO, USA); AGREE®, AGRIPHAGE™, AGSIL®, ANCORA, AZATIN®, BOTANIGARD®, BOTEGHA®, BUG-N-SLUGGO®, CARB-O-NATOR®, CRYMAX®, CUEVA®, CYD-X®, DEFGUARD®, DELIVER®,
DES-X®, DOUBLE NICKEL®, FIREFIGHTER™, GEMSTAR®, GROTTO®, HOMEPLATE®, JAVELIN®, KALMOR®, KOCIDE®, LIFEGARD®, MADEX®, MELOCON®, MYCOTROL®, NEEMIX®, OSO™, PFR-97™, SEDUCE™, SIL-MATRIX®, SLUGGO®, SOILGARD®, THURICIDE®, TRIACT®, TRIATHLON® and TRILOGY® from Certis (Columbia, MD); ABUNDIT®, ACCENT®, AFFORIA®, APROACH®, BASIS®, BEXFOND®, BLACKHAWK®, CANOPY®, CINCH®, CLINHER®, CURTAIL®, CURZATE®, DELEGATE®, RAINSHIELD®, DITHANE®, FEXAPAN®, VAPORGRIP®, LANNATE®, TANOS®, DURANGO®, DMA®, ELEVORE®, EMBED®, ENABLE®, ENLIST DUO®, ENLIST ONE®, ENLITE®, ENTRUST®, ENVIVE®, EVERPLEX®, FONTELIS®, FULTIME®, GOLDSKY®, GRANDSTAND®, GRANITE®, GRASP®, HEARKEN®, INDAR®, NXTGEN®, INSTINCT®, INTREPID 2F®, INTREPID EDGE®, KERB®, KEYSTONE®, KYBER®, LEADOFF®, LOYANT®, MATRIX®, N-SERVE®, NOVIXID®, OPENSKY®, PERFECTMATCH®, PINDAR®, PIXXARO®, POWERFLEX®, QUELEX®, RADIANT®, RALLY®, REALM®, REBELEX®, RESICORE®, RESOLVE®, REVULIN®, REZUVANT®, RIDGEBACK®, SEQUOIA®, SIMPLICITY®, SONIC®, STARANE®, STEADFAST®, STINGER®, STRONGARM®, SUCCESS®, SURESTART®, SURPASS®, SURVEIL®, SYNCHRONY®, TARZEC®, TRANSFORM®, TRELLIS®, TRIVENCE®, UTRISHA®, VERTISAN®, VYDATE®, WIDEARMATCH®, WIDEMATCH® and ZEST® from Corteva Agroscience (Indianapolis, IN, USA); BIO-SAVE® from Decco U.S. Post-Harvest, Inc. (Monrovia, CA, USA); ACCUDO®, AFFINITY®, AGILITY®, AIM®, ALLY®, ALTACOR®, ANTHEM®, ATHENA®, AUTHORITY®, AVAUNT®, BELEAF®, BRIGADE®, CADET®, CAPTURE®, CARBINE®, COMMAND®, CORAGEN®, DISPLAY®, ELEVEST®, ETHOS®, EXIREL®, EXPRESS®, FINESSE®, FIRSTSHOT®, FURAGRO®, GLADIATOR®, HARMONY®, HERO®, LUCENTO®, MARVEL®, MUSTANG®, OBEY®, PANOFLEX®, PRESENCE®, PREVATHON®, QUARTZO®, RHYME®, ROVRAL®, SEAMAC®, SHARK®, SOLIDA®, SPARTAN®, STEWARD®, TEMITRY®, TERRA®, TOPGUARD®, UPBEET®, VANTACOR®, VERIMARK®, XYWAY®, ZEUS® and ZIRONAR® from FMC Corporation (Philadelphia, PA, USA); PENTIA®, ABAMEX®, AGRI TIN®, CHAMP®, CHIPTOX®, GIN OUT®, KAISO®, MEPEX®, NUPRID®, RAPPORT®, TERMINATE®, THISTROL®, ULTRA FLOURISH®, GOAL®, GOALTENDER®, GRAPPLE®, TUSCANY®, CHAMPION++, AGRI-MYCIN®, PHOSTROL®, BLIGHTBAN®, CHEETAH®, MYCOSHIELD®, RITEWAY®, TAZER®, MYSTIC®, CUPROXAT® and TYPY® from Nufarm Limited (Victoria, Australia); BIOSPECTRA®, PACRITE®, EFOG®, SHIELD-BRITE®, FUNGAFLOR®, PENBOTEC, and SOPP from Pace International (Wapato, WA, USA); ACTARA®, ACTELLIC®, ACTIGARD®, ACURON™, ADVION®, AFLAGUARD®, AGRIPRO®, ALTO®, ALUMNI®, AMISTAR®, APIRO®, APRON®, AVICTA®, AWARD®, AXIAL™, AXORIS®, BANNER®, BANVEL®, BARRICADE®, BEACON®, BICEP II MAGNUM®, BION®, BONZI®, BOUNDARY®, BOXER®, BRAVO®, C. C. BENOIST®, CADENCE®, CALARIS®, CALLISTO®, CAMIX®, CAPTORA®, CASPER®, CELEST®, CHAIRMAN®, CHESS®, CITATION®, CLARIVA®, COLZOR®, CRUISER®, CULTAR®, CURACON®, DACONIL®, DISCOVER®, DIVIDEND®, DUAL®,
DUAXO®, DURIVO®, DYNASTY®, EDDUS®, ELATIS®, ELUMIS®, ENDEAVOR®, ENVOKE®, EPERON®, EPIVO®, ERIJAN®, FARMORE®, FLAGSHIP®, FLEX®, FLEXSTAR®, FLORIPRO SERVICES®, FOLIO®, FORCE®, FORTENZA®, FUSIFLEX®, FUSILADE®, GESAGARD®, GESAPAX®, GESAPRIM®, GOLD®, GOLDEN HARVEST®, GRADUATE®, GRADUATEA+®, GRAMOXONE®, HALEX®, HERITAGE®, HILLESHOG®, HORIZON®, HYVIDO®, INSEGAR®, ISABION®, KARATE ZEON®, LENTAGRAN®, LISTEGO®, LOGRAN®, LUMAX®, MAAG®, MATCH®, MAXIM®, MAXX®, MENTOR®, MERTECT®, MILAGRO®, MINECTO®, MIRAVIS®, MODDUS®, NEMATHORIN®, NK®, ORDRAM®, ORONDIS®, PALISADE®, PEAK®, PEGASUS®, PIRIMOR®, POLO®, PREFIX®, PRIMO®, PROCLAIM®, QUANTIS®, REFLECT®, REFLEX®, REGLONE®, RESOLVA®, REVUS®, RIFIT®, ROGERS®, S&G®, SAKALIA®, SALTRO®, SCHOLAR®, SCIMITAR®, SCORE®, SEGURIS®, SEQUESTRENE®, SETOFF®, SOFIT®, SOLVIGO®, STADIUM®, SUPREN®, SWITCH®, SYMETRA®, SYNGENTA®, TAEGRO®, TAVIUM®, TERVIGO®, TILT®, TIMOREX®, TOPIK®, TOPREX®, TRIGARD®, TRIMMIT®, TOUCHDOWN®, UNIX®, VAYANTIS®, VERTIMAC®, VIBRANCE®, WEATHER STIK®, from Syngenta Crop Protection (Basel, Switzerland); and ASULOX®, BALISTIK®, BEETUP®, BELLMAC®, BETASANA®, BETTIX®, BUGUIS®, CENTURION®, CLIOPHAR®, COLZAMID®, CORZAL®, DEFIANT®, DEVRINOL®, MINSTREL®, AFFIX®, AXIDOR®, BUZZ®, MIMIX®, DIOZINOS®, DIPROSPERO®, EVITO®, MANZATE®, MICROTHIOL®, NAUTILE®, PENNCOZEB®, PROMESS®, PROPLANT®, PROXANIL®, PYRUS®, SACRON®, SYLLIT®, TEBUZOL®, THIOPRON®, TOKYO®, UNIZEB®, VACCIPLANT®, VIDEO®, ZOXIS®, CYTHRIN®, DIMILIN®, FORESTER®, FUMICYP®, TALISMA®, B-NINE®, FAZOR®, GYRO®, HIMALAYA®, ICENI®, TRINEXIS®, IODUS®, AUDIT®, BASAGRAN®, BATLIUM®, BOYCOTT®, BROADLOOM®, COYOTE®, COLLIDE®, DUET®, ETHOTRON®, EVEREST®, IMIFLEX®, LIFELINE®, METRICOR®, MOCCASIN®, MOTIF®, PRE-PARE®, SATELLITE®, SHADOW®, SHUTDOWN®, STAM®, SUPERWHAM! ®, SUPREMACY®, TRICOR®, TRIZENTA®, CUPROFIX®, DEXTER®, ELEVATE®, ELIXIR®, FORTIX®, FROGHORN®, METEOR®, MICROTHI®, ORANIL®, PH-D®, PROCURE®, RANCOVA®, TEPERA®, TERRAGUARD®, TERRAMASTER®, TERRAZOLE®, TOPSIN®, TRIONIC®, ZIRAM®, ZOLERA®, ADIOS®, GOLDWING®, OFF-SHOOT-T®, PACZOL®, ROYAL®, ROYALTAC®, ACENTHRIN®, ACEPHATE®, ACRAMITE®, ADEPT®, ARGYLE®, ASSAIL®, BANTER®, BIFENTURE®, BIOMITE®, COMITE®, DIMILIN®, ENKOUNTER®, INTRUDER®, KANEMITE®, LAMBDA-CY®, MICROMITE®, OMITE®, PEDESTAL®, PERM-UP®, RIMON®, STRAFER®, TURNSTYLE®, UP-CYDE®, VENDEX®, VIGILANT®, ZYLO®, ATTENDANT®, BEAN GUARD®, ALLEGIANCE®, BELMONT®, ENHANCE®, GRAINGUARD®, MESH®, PRO-GRO®, RANCONA®, STARTUP®, THIRAM®, VITAFLO®, VITAVAX®, MAGNAPHOS®, WEEVIL-CIDE®, AQUASTRIKE®, AQUATHOL®, PEGASUS, GOLIATH, POACONSTRICTOR, RAVEN, T-BIRD, UP-END®, UP-START®, ETHEPHON PEGASUS, GOLIATH, POACONSTRICTOR, RAVEN, T-BIRD, UP-END®, UP-START®, ZEBA® and
FLORAMITE® from UPL Limited (Mumbai, Maharashtra, India). Formulations of the present disclosure may comprise any suitable combination of actives and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned actives. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned actives are expressly excluded from formulations of the present disclosure. Examples of adhesives (stickers) that may be included in formulations of the present disclosure include, but not are not limited to, disaccharides (e.g. maltose, sucrose, trehalose), gums (e.g., cellulose gum, guar gum, gum arabic, gum combretum, xantham gum), maltodextrins (e.g., maltodextrins having a DEV of about 10 to about 20), monosaccharides, oils (e.g., mineral oil, olive oil, peanut oil, soybean oil and/or sunflower oil), and oligosaccharides. See generally, e.g., POWERBLOX™ (Dow, Midland, MI, USA), such as POWERBLOX™ ADJ-65 and POWERBLOX™ ADJ-65; EP0 0245970; US 5496568; WO 2008/144024; WO 2009/135049; WO 2011/126832; WO 2017/083049; WO 2020/225276; WO 2021/055316; WO 2022/096688; WO 2022/096691; WO 2022/096692; WO 2022/096693; WO 2022/096694; WO/2022/096695; WO 2022/096696. Formulations of the present disclosure may comprise any suitable combination of adhesives (stickers) and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned adhesives (stickers). Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned adhesives (stickers) are expressly excluded from formulations of the present disclosure. Examples of dispersants (spreaders) that may be included in formulations of the present disclosure include, but not are not limited to, anionic surfactants, cationic surfactants and non-ionic surfactants. See generally, e.g., EP 0245970; US 5496568; WO 2008/144024; WO 2009/135049; WO 2011/126832; WO 2017/083049; WO 2020/225276; WO 2021/055316; WO 2022/096688; WO 2022/096691; WO 2022/096692; WO 2022/096693; WO 2022/096694; WO/2022/096695; WO 2022/096696. In some embodiments, formulations of the present disclosure comprise one or more anionic surfactants. For example, in some embodiments, formulations of the present disclosure comprise one or more anionic surfactants selected from the group consisting of alkyl carboxylates (e.g., sodium stearate), alkyl sulfates (e.g., alkyl lauryl sulfate, sodium lauryl sulfate), alkyl ether sulfates, alkyl amido ether sulfates, alkyl aryl polyether sulfates, alkyl aryl sulfates, alkyl aryl sulfonates, alkyl sulfonates, alkyl amide sulfonates, alkyl aryl sulfonates, alkyl benzene sulfonates, alkyl diphenyloxide sulfonate, alpha-olefin sulfonates, alkyl naphthalene sulfonates, paraffin sulfonates, alkyl sulfosuccinates, alkyl ether sulfosuccinates, alkylamide sulfosuccinates, alkyl sulfosuccinamates, alkyl sulfoacetates, alkyl phosphates, alkyl ether phosphates, acyl sarconsinates, acyl isethionates, N-acyl taurates, N-acyl-N-alkyltaurates, benzene sulfonates, cumene sulfonates, dioctyl sodium sulfosuccinate, ethoxylated sulfosuccinates, lignin sulfonates, linear alkylbenzene sulfonates, monoglyceride sulfates, perfluorobutanesulfonate, perfluorooctanesulfonate, phosphate ester, styrene acrylic polymers, toluene sulfonates and xylene sulfonates. In some embodiments, formulations of the present disclosure comprise one or more cationic surfactants.
For example, in some embodiments, formulations of the present disclosure comprise one or more cationic surfactants selected from the group consisting of alkyltrimethylammonium salts (e.g., cetyl trimethylammonium bromide, cetyl trimethylammonium chloride), cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, 5-Bromo-5-nitro-1,3-dioxane, dimethyldioctadecylammonium chloride, cetrimonium bromide, dioctadecyldimethylammonium bromide and/or octenidine dihydrochloride. In some embodiments, formulations of the present disclosure comprise one or more nonionic surfactants. For example, in some embodiments, formulations of the present disclosure comprise one or more nonionic surfactants selected from the group consisting of alcohol ethoxylates (e.g., TERGITOL™ 15-S surfactants (The Dow Chemical Company, Midland, MI), such as TERGITOL™15-S-9, alkanolamides, alkanolamine condensates, carboxylic acid esters, cetostearyl alcohol, cetyl alcohol, cocamide DEA, dodecyldimethylamine oxides, ethanolamides, ethoxylates of glycerol ester and glycol esters, ethylene oxide polymers, ethylene oxide-propylene oxide copolymers, glucoside alkyl ethers, glycerol alkyl ethers, glycerol esters, glycol alkyl ethers (e.g., polyoxyethylene glycol alkyl ethers, polyoxypropylene glycol alkyl ethers), glycol alkylphenol ethers (e.g., polyoxyethylene glycol alkylphenol ethers,), glycol esters, monolaurin, pentaethylene glycol monododecyl ethers, poloxamer, polyamines, polyglycerol polyricinoleate, polysorbate, polyoxyethylenated fatty acids, polyoxyethylenated mercaptans, polyoxyethylenated polyoxyproylene glycols, polyoxyethylene glycol sorbitan alkyl esters, polyethylene glycol-polypropylene glycol copolymers, polyoxyethylene glycol octylphenol ethers, polyvinyl pynolidones, sugar-based alkyl polyglycosides, sulfoanylamides, sorbitan fatty acid alcohol ethoxylates, sorbitan fatty acid ester ethoxylates, sorbitan fatty acid ester and/or tertiary acetylenic glycols. In some embodiments, formulations of the present disclosure comprise one or more zwitterionic surfactants. For example, in some embodiments, formulations of the present disclosure comprise one or more zwitterionic surfactants selected from the group consisting of 3-[(3-cholamidopropyl)dimethylammonio]-1- propanesulfonate, cocamidopropyl betaine, cocamidopropyl hydroxysultaine, phosphatidylserine, phosphatidylethanolamine, phosphatidylcholine and/or one or more sphingomyelins. In some embodiments, formulations of the present disclosure comprise one or more soaps and/or organosilicone surfactants. Non-limiting examples of dispersants that may be incorporated into formulations of the present disclosure—or into which proteins and other compositions of the present disclosure may be incorporated— include ATLOX™ (e.g., 4916, 4991; Croda International PLC, Edison, NJ), ATLOX METASPERSE™ (Croda International PLC, Edison, NJ), BIO-SOFT® (e.g., N series, such as N1-3, N1-7, N1-5, N1-9, N23-3, N2.3-6.5, N25-3, N25-7, N25-9, N91-2.5, N91-6, N91-8; Stepan Company, Northfield, IL), MAKON® nonionic surfactants (e.g., DA-4, DA-6 and DA-9; Stepan Company, Northfield, IL), MORWET® powders (Akzo Nobel Surface Chemistry LLC, Chicago, IL), MULTIWET™ surfactants (e.g., MO-85P-PW-(AP); Croda International PLC, Edison, NJ), SAFER® soaps (Woodstream Corporation, Inc., Lancaster, PA), SILWET® surfactants (Momentive Performance Materials, Inc., Niskayuna, NY), SPAN™ surfactants (e.g., 20, 40, 60,
65, 80 and 85; Croda Inc., Edison NJ), TAMOL™ dispersants (The Dow Chemical Company, Midland, MI ), TERGITOL™ surfactants (e.g., TMN-6 and TMN-100X; The Dow Chemical Company, Midland, MI), TERSPERSE surfactants (e.g., 2001, 2020, 2100, 2105, 2158, 2700, 4894 and 4896; Hunstman Corp., The Woodlands, TX), TRITON™ surfactants (e.g., X-100; The Dow Chemical Company, Midland, MI), TWEEN® surfactants (e.g., TWEEN® 20 (polyoxyethylenesorbitan monolaurate), 21, 22, 23, 28, 40, 60, 61, 65, 80, 81 and 85; Croda International PLC, Edison, NJ) and combinations thereof. Additional examples of dispersants may be found in BAIRD & ZUBLENA.1993. SOIL FACTS: USING WETTING AGENTS (NONIONIC SURFACTANTS) ON SOIL (North Carolina Cooperative Extension Service Publication AG-439-25) (1993); BURGES, FORMULATION OF MICROBIAL BIOPESTICIDES: BENEFICIAL MICROORGANISMS, NEMATODES AND SEED TREATMENTS (Springer Science & Business Media) (2012); MCCARTY, WETTING AGENTS (Clemson University Cooperative Extension Service Publication) (2001). Formulations of the present disclosure may comprise any suitable combination of dispersants (spreaders) and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned dispersants (spreaders). Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned dispersants (spreaders) are expressly excluded from formulations of the present disclosure. Examples of drying agents that may be included in formulations of the present disclosure include, but not are not limited to, calcium stearate, clay (e.g., attapulgite clay, montmorillonite clay), graphite, magnesium stearate, magnesium sulfate, powdered milk, silica (e.g., fumed silica, hydrophobically-coated silica, precipitated silica), soy lecithin and talc. Additional examples of drying agents may be found in Burges, Formulation of Microbial Biopesticides: Beneficial Microorganisms, Nematodes and Seed Treatments (Springer Science & Business Media) (2012). Non-limiting examples of drying agents that may be incorporated into formulations of the present disclosure—or into which proteins and other compositions of the present disclosure may be incorporated— include, but are not limited to, commercial products sold under the tradenames AEROSIL® and SIPERNAT® from Evonik Corporation (Parsippany, NJ), BENTOLITE® from BYK-Chemie GmbH (Wesel, Germany), and INCOTEC® from INCOTEC Inc. (Salinas, CA). Formulations of the present disclosure may comprise any suitable combination of drying agents and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned drying agents. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned drying agents are expressly excluded from formulations of the present disclosure. Examples of microbes that may be included in formulations of the present disclosure include, but not are not limited to, diazotrophs, phosphate-solubilizing microorganisms and biopesticides. See generally, e.g., WO 92/08355; US 2003/082164; US 2008/320615; US 2016/345588; US 2018/168168; US 2005/187107; US 2006/258534; US 2018/279624; US 10820594; US 2019/014786; US 10874109; US 10856552; US 2019/014787; US 11076603; US 2020/093125; US 2020/085065; US 2020/000098; US 2019/345572; US
2020/263734; WO 2021/101949; WO 2021/101937; WO 2016/201284; WO 2018/186307; WO 2007/142543; WO 2017/205800; WO 2015/003908; WO 2021/018321; WO 2003/016510; WO 2016/044542; WO 92/11856. In some embodiments, formulations of the present disclosure comprise one or more of the following: Azospirillum brasilense Ab-V5, Azospirillum brasilense Ab-V6, Azospirillum brasilense INTA Az-39, Bacillus amyloliquefaciens D747, Bacillus amyloliquefaciens NRRL B-50349, Bacillus amyloliquefaciens TJ1000, Bacillus amyloliquefaciens FZB24, Bacillus amyloliquefaciens FZB42, Bacillus amyloliquefaciens IN937a, Bacillus amyloliquefaciens IT-45, Bacillus amyloliquefaciens TJ1000, Bacillus amyloliquefaciens MBI600, Bacillus amyloliquefaciens BS27 (deposited as NRRL B-5015), Bacillus amyloliquefaciens BS2084 (deposited as NRRL B-50013), Bacillus amyloliquefaciens 15AP4 (deposited as ATCC PTA-6507), Bacillus amyloliquefaciens 3AP4 (deposited as ATCC PTA-6506), Bacillus amyloliquefaciens LSSA01 (deposited as NRRL B-50104), Bacillus amyloliquefaciens ABP278 (deposited as NRRL B-50634), Bacillus amyloliquefaciens 1013 (deposited as NRRL B-50509), Bacillus amyloliquefaciens 918 (deposited as NRRL B-50508), Bacillus amyloliquefaciens 22CP1 (deposited as ATCC PTA-6508) and Bacillus amyloliquefaciens BS18 (deposited as NRRL B-50633), Bacillus amyloliquefaciens SB3778, Bacillus cereus I-1562, Bacillus firmus I-1582, Bacillus lichenformis BA842 (deposited as NRRL B-50516), Bacillus lichenformis BL21 (deposited as NRRL B-50134), Bacillus megaterium NRRL B-67352, Bacillus megaterium NRRL B-67357, Bacillus megaterium NRRL B-67521, Bacillus megaterium NRRL B-67522, Bacillus megaterium NRRL B- 67533, Bacillus megaterium NRRL B-67534, Bacillus megaterium NRRL B-67525, Bacillus megaterium NRRL B-67526, Bacillus megaterium NRRL B-67527, Bacillus megaterium NRRL B-67528, Bacillus megaterium NRRL B-67529, Bacillus megaterium NRRL B-67530, Bacillus mycoides NRRL B-21664, Bacillus pumilus NRRL B-30087, Bacillus pumilus NRRL B 21662, Bacillus pumilus NRRL B-30087, Bacillus pumilus ATCC 55608, Bacillus pumilus ATCC 55609, Bacillus pumilus GB34, Bacillus pumilus KFP9F, Bacillus pumilus QST 2808, Bacillus sp. AQ175 (deposited as ATCC 55608), Bacillus sp. AQ177 (deposited as ATCC 55609), Bacillus subtilis AQ713 (deposited as NRRL B-21661), Bacillus subtilis AQ743 (deposited as NRRL B-21665), Bacillus subtilis ATCC 55078, Bacillus subtilis ATCC 55079, Bacillus subtilis MBI 600, Bacillus subtilis NRRL B-21661, Bacillus subtilis NRRL B-21665, Bacillus subtilis CX-9060, Bacillus subtilis GB03, Bacillus subtilis GB07, Bacillus subtilis QST-713, Bacillus subtilis FZB24, Bacillus subtilis D747, Bacillus subtilis 3BP5 (deposited as NRRL B-50510), Bacillus thuringiensis AQ52 (deposited as NRRL B- 21619), Bacillus thuringiensis ATCC 13367, Bacillus thuringiensis GC-91, Bacillus thuringiensis NRRL B- 21619, Bacillus thuringiensis ABTS-1857, Bacillus thuringiensis SAN 401 I, Bacillus thuringiensis ABG-6305, Bacillus thuringiensis ABG-6346, Bacillus thuringiensis AM65-52, Bacillus thuringiensis SA-12, Bacillus thuringiensis SB4, Bacillus thuringiensis ABTS-351, Bacillus thuringiensis HD-1, Bacillus thuringiensis EG 2348, Bacillus thuringiensis EG 7826, Bacillus thuringiensis EG 7841, Bacillus thuringiensis DSM 2803, Bacillus thuringiensis NB-125, Bacillus thuringiensis NB-176, Bradyrhizobium spp. 8A57, Bradyrhizobium elkanii SEMIA 501, Bradyrhizobium elkanii SEMIA 587, Bradyrhizobium elkanii SEMIA 5019, Bradyrhizobium japonicum 61A227, Bradyrhizobium japonicum 61A228, Bradyrhizobium japonicum 61A273,
Bradyrhizobium japonicum E-109, Bradyrhizobium japonicum NRRL B-50586 (also deposited as NRRL B- 59565), Bradyrhizobium japonicum NRRL B-50587 (also deposited as NRRL B-59566), Bradyrhizobium japonicum NRRL B-50588 (also deposited as NRRL B-59567), Bradyrhizobium japonicum NRRL B-50589 (also deposited as NRRL B-59568), Bradyrhizobium japonicum NRRL B-50590 (also deposited as NRRL B- 59569), Bradyrhizobium japonicum NRRL B-50591 (also deposited as NRRL B-59570), Bradyrhizobium japonicum NRRL B-50592 (also deposited as NRRL B-59571), Bradyrhizobium japonicum NRRL B-50593 (also deposited as NRRL B-59572), Bradyrhizobium japonicum NRRL B-50594 (also deposited as NRRL B- 50493), Bradyrhizobium japonicum NRRL B-50608, Bradyrhizobium japonicum NRRL B-50609, Bradyrhizobium japonicum NRRL B-50610, Bradyrhizobium japonicum NRRL B-50611, Bradyrhizobium japonicum NRRL B-50612, Bradyrhizobium japonicum NRRL B-50726, Bradyrhizobium japonicum NRRL B-50727, Bradyrhizobium japonicum NRRL B-50728, Bradyrhizobium japonicum NRRL B-50729, Bradyrhizobium japonicum NRRL B-50730, Bradyrhizobium japonicum SEMIA 566, Bradyrhizobium japonicum SEMIA 5079, Bradyrhizobium japonicum SEMIA 5080, Bradyrhizobium japonicum USDA 6, Bradyrhizobium japonicum USDA 110, Bradyrhizobium japonicum USDA 122, Bradyrhizobium japonicum USDA 123, Bradyrhizobium japonicum USDA 127, Bradyrhizobium japonicum USDA 129, Bradyrhizobium japonicum USDA 532C, Erwinia billingiae NRRL B-67766, Gliocladium virens ATCC 52045, Gliocladium virens GL-21, Glomus intraradices RTI-801, Lysinibacillus sphaericus NRRL B-67350, Lysinibacillus sphaericus NRRL B-67351, Lysinibacillus sphaericus NRRL B-67486, Metarhizium anisopliae F52, Paenibacillus graminis NRRL B-68249, Paenibacillus kribbensis NRRL B-68250, Paenibacillus peoriae NRRL B-67884, Paenibacillus peoriae NRRL B-67885, Paenibacillus sonchi NRRL B-68251, Penicillium bilaiae ATCC 18309, Penicillium bilaiae ATCC 20851, Penicillium bilaiae ATCC 22348, Penicillium bilaiae NRRL 50162, Penicillium bilaiae NRRL 50169, Penicillium bilaiae NRRL 50776, Penicillium bilaiae NRRL 50777, Penicillium bilaiae NRRL 50778, Penicillium bilaiae NRRL 50777, Penicillium bilaiae NRRL 50778, Penicillium bilaiae NRRL 50779, Penicillium bilaiae NRRL 50780, Penicillium bilaiae NRRL 50781, Penicillium bilaiae NRRL 50782, Penicillium bilaiae NRRL 50783, Penicillium bilaiae NRRL 50784, Penicillium bilaiae NRRL 50785, Penicillium bilaiae NRRL 50786, Penicillium bilaiae NRRL 50787, Penicillium bilaiae NRRL 50788, Penicillium bilaiae NRRL 67154, Penicillium bilaiae NRRL 67155, Penicillium bilaiae NRRL 67156, Penicillium bilaiae NRRL 67157, Penicillium bilaiae NRRL 67158, Penicillium bilaiae NRRL 67159, Penicillium bilaiae RS7B-SD1, Penicillium brevicompactum AgRF18, Penicillium canescens ATCC 10419, Penicillium expansum ATCC 24692, Penicillium expansum YT02, Penicillium fellatanum ATCC 48694, Penicillium gaestrivorus NRRL 50170 , Penicillium glabrum DAOM 239074, Penicillium glabrum CBS 229.28, Penicillium janthinellum ATCC 10455, Penicillium lanosocoeruleum ATCC 48919, Penicillium radicum ATCC 201836, Penicillium radicum FRR 4717, Penicillium radicum FRR 4719, Penicillium radicum N93/47267, Penicillium raistrickii ATCC 10490, Pseudomonas jessenii PS06, Pseudomonas koreensis NRRL B-67883, Rhizobium leguminosarum SO12A-2 (IDAC 080305-01), Sinorhizobium fredii CCBAU114, Sinorhizobium fredii USDA 205, Streptomyces sp.
NRRL B-30145, Streptomyces sp. M1064, Streptomyces WYE 53, Streptomyces glabus NRRL 30232, Streptomyces lydicus WYEC 108 (deposited as ATCC 55445), Streptomyces violaceusniger YCED 9, Trichoderma asperellum SKT-1, Trichoderma asperellum ICC 012, Trichoderma atroviride LC52, Trichoderma atroviride CNCM 1-1237, Trichoderma fertile JM41R, Trichoderma gamsii ICC 080, Trichoderma hamatum ATCC 52198, Trichoderma harzianum ATCC 52445, Trichoderma harzianum KRL- AG2, Trichoderma harzianum T-22, Trichoderma harzianum TH-35, Trichoderma harzianum T-39, Trichoderma harzianum ICC012, Trichoderma reesi ATCC 28217, Trichoderma virens ATCC 58678, Trichoderma virens GI-3, Trichoderma virens GI-21, Trichoderma virens GL-21, Trichoderma virens G-41, Trichoderma viridae ATCC 52440, Trichoderma viridae ICC080, Trichoderma viride TV1, Yersinia entomophaga MH96, Yersinia entomophaga NRRL B-67598, Yersinia entomophaga NRRL B-67599, Yersinia entomophaga NRRL B-67600 and Yersinia entomophaga NRRL B-67601. Non-limiting examples of microbial compositions that may be incorporated into formulations of the present disclosure—or into which proteins and other compositions of the present disclosure may be incorporated—include, but are not limited to, commercial products sold under the tradenames SERIFEL® from BASF (Ludwigshafen, Germany); VOTIVO® from Bayer Crop Science (Creve Coeur, MO, USA); AGREE®, AGRIPHAGE™, AGSIL®, ANCORA, AZATIN®, BOTANIGARD®, BOTEGHA®, BUG-N-SLUGGO®, CARB-O-NATOR®, CRYMAX®, CUEVA®, CYD-X®, DEFGUARD®, DELIVER®, DES-X®, DOUBLE NICKEL®, FIREFIGHTER™, GEMSTAR®, GROTTO®, HOMEPLATE®, JAVELIN®, KALMOR®, KOCIDE®, LIFEGARD®, MADEX®, MELOCON®, MYCOTROL®, NEEMIX®, OSO™, PFR-97™, SEDUCE™, SIL-MATRIX®, SLUGGO®, SOILGARD®, THURICIDE®, TRIACT®, TRIATHLON® and TRILOGY® from Certis (Columbia, MD); BEXFOND™ and HEARKEN® from Corteva Agroscience (Indianapolis, IN, USA); ACCUDO®, FURAGRO®, PRESENCE®, QUARTZO®, SEAMAC® and ZIRONAR® from FMC Corporation (Philadelphia, PA, USA); B.SUB™, BAM™, BIO-N™, BIO-P™, BIO- PLEX™, MICRO-FORCE™, MYCO-FORCE™, PLATFORM™, ROOT-GUARD™, and TRICHO- SHIELD™ from Nutri-Tech Solutions Pty Ltd. (Yandina, Queensland, Australia); PROVEN® and RETURN® from Pivot Bio (Berkeley, CA); ACTINOVATE®, AZOMAX®, B300®, BIONIQ®, CELL-TECH®, CTS- 500®, GLYCIMAX®, JUMPSTART®, MYCOPLEX®, NITRAGIN®, OPTIMIZE®, QUICKROOTS®, RHIZOMAX®, RHIZOMYCO®, TAEGRO® and TAGTEAM® from Novozymes. Formulations of the present disclosure may comprise any suitable combination of microbial compositions and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned microbial compositions. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned microbial compositions are expressly excluded from formulations of the present disclosure. Examples of nutrients that may be included in formulations of the present disclosure include, but not are not limited to, organic acids (e.g., acetic acid, citric acid, lactic acid, malic acid, taurine, etc.), macrominerals (e.g., phosphorous, calcium, magnesium, potassium, sodium, iron, etc.), trace minerals (e.g., boron, cobalt,
chloride, chromium, copper, fluoride, iodine, manganese, molybdenum, selenium, zinc, etc.), vitamins, (e.g., vitamin A, vitamin B complex (i.e., vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B7, vitamin B8, vitamin B9, vitamin B12, choline) vitamin C, vitamin D, vitamin E, vitamin K, carotenoids (α- carotene, β-carotene, cryptoxanthin, lutein, lycopene, zeaxanthin, etc.), and combinations thereof. See also, generally, e.g., US 2014/235447; WO 2022/029224; WO 2022/029221; WO 2021/255118; WO 2021/247915; US 2021/300837; US 2020/148605; US 2012/247164; US 2016/355443; US 2020/055794; US 2011/154873; US 2006/243009; US 2017/088474. Formulations of the present disclosure may comprise any suitable combination of nutrients and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned nutrients. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned nutrients are expressly excluded from formulations of the present disclosure. Examples of pest attractants and feeding stimulants that may be included in formulations of the present disclosure include, but not are not limited to, brevicomin, ceralure, codlelure, cue-lure, disparlure, dominicalure, eugenol, frontalin, gossyplure, grandlure, hexalure, ipsdienol, ipsenol, japonilure, latitlure, lineatin, litlure, looplure, medlure, megatomic acid, methyl eugenol, moguchun, α-multistriatin, muscalure, orfalure, oryctalure, ostramone, rescalure, siglure, sulcatol, trimedlure, trunc-call, and combinations thereof. See generally, e.g., WO 00/28824; US 5607684; US 4510133; US 5290556; US 60774634; US 6773727; WO 2022/051661; EP 0563963; WO 2013/164384; WO 2003/020030; US 8420070; US 5401506; WO 92/11856. Formulations of the present disclosure may comprise any suitable combination of pest attractants and/or feeding stimulants and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned pest attractants and/or feeding stimulants. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned pest attractants and/or feeding stimulants are expressly excluded from formulations of the present disclosure. Examples of pH control components that may be included in formulations of the present disclosure include phosphate and other salts capable of buffering at the desired pH, and having an aqueous solubility of more than 1% w/w. A preferred pH control component is a phosphate buffer containing the ionic species HPO4 2- and H2PO4-. A pH control component may be a single ionic species that can maintain a constant pH but only provide a buffering effect towards either acidification or basification. An example of such, is HPO42- which can ensure an alkaline pH (of approximately 9) and provide a buffering effect against acidification. This may be beneficial in an agricultural setting to keep the pH constant at an alkaline pH, as most environmental factors will cause acidification of the droplet and deposit. In preferred embodiments, the pH control component does not significantly change pH (+/- 0.5 pH units) or change in a desired direction upon drying when the solvent evaporates from the droplet on the leaf surface. Some buffers will, upon drying, change pH as a result of differences in solubility of the buffer components. As an example, the pH of a sodium phosphate buffer constituting of Na2HPO4 and NaH2PO4 can
reduce to pH 4 or lower upon drying since the dibasic form (Na2HPO4) will crystallize to a larger degree. On the contrary, the pH of a potassium phosphate buffer constituting of K2HPO4 and KH2PO4 will approach pH 9 upon drying since the monobasic form (KH2PO4) has the lowest solubility (Sarciaux 1999). A pH control component is most effective (highest buffer capacity) when the pKa is close to the desired pH of the composition. This will reduce the amount of buffer needed to maintain a desired pH. In an embodiment, the buffer includes salts having a neutral/alkaline pKa, such as a pKa in the range of 6.5 to 10. As a rule of thumb, a pH control component can be used to control the pH of a solution at a pH +/- 1 pH-unit from its pKa value. pH control components with a pKa value above 6.5 are useful for controlling the pH at 7.5 or above. Examples of suitable pH control component includes, but are not limited to: Sodium/potassium phosphate (pKa1 2.12, pKa2 7.21, pKa312.67), sodium/potassium carbonate (pKa1 6.37, pKa2 10.32), 2-amino-2-(hydroxymethyl)-1,3-propanediol (TRIS) (pKa 8.1), [Bis(2- hydroxyethyl)amino]acetic acid (Bicine) (pKa 8.35), N-[tris(hydroxymethyl)methyl]glycine (Tricine) (pKa 8.15), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pKa1 3.0, pKa2 7.5), N- [tris(hydroxymethyl)methyl]- 2-aminoethanesulfonic acid (TES) (pKa 7.55), 3-(N-morpholino)propanesulfonic acid (MOPS) (pKa 7.2), tris(hydroxymethyl)methylamino]propanesulfonic acid (TAPS) (pKa 8.44), N- [tris(hydroxymethyl)methyl]-3-amino-2-hydroxypropanesulfonic acid (TAPSO) (pKa 7.6), glycylglycine (pKa13.14 pKa28.17), 2-(N-cyclohexylamino)ethanesulfonic acid (CHES) (pKa 9.3), sodium/potassium borate (pKa19.24, pKa212.4, pKa313.3), 2-amino-2-methyl-1,3-propanediol (ammediol) (pKa 8.8), triethanol amine (pKa 7.74), 2-amino-2-methyl-1-propanol (pKa 9.7), glycine (pKa12.34, pKa29.6), histidine (pKa11.82, pKa2 6.00, pKa39.17), and other amino acid buffers. Non-preferred pH control components include, but are not limited to, pH control components with an unfavorable pKa (pKa <6.5 for an enzyme that requires an alkaline pH), volatile pH control component, pH control component that display significant phytotoxicity (this may sometimes include the above-mentioned “suitable” pH control components, as phytotoxicity is depended on buffer concentration, pH and target crop), and pH control components that are unwanted in the environment and therefore regulated by authorities (this may sometimes include the above-mentioned “suitable” pH control component, as regulations varies throughout the world). In some embodiments, formulations of the present disclosure comprise one or more pH control components in an amount of about/at least 0.01–10 % w/w, preferably about/at least 0.05–5 % w/w. In some embodiments, formulations of the present disclosure can maintain an alkaline pH. pH control components may be used to obtain such formulations. For example, in some preferred embodiments, formulations of the present disclosure comprise one or more pH control components selected to provide a composition having an alkaline pH within the operable pH range(s) of each enzyme in the formulation, most preferably within +/- 1 pH-unit from the optimal pH value of each enzyme in the formulation. Thus, in some embodiments, formulations of the present disclosure comprise a pH control component, such as a buffer, where
an 1% w/w aqueous solution of the pH control component (buffer) has an alkaline pH in which each enzymne in the formulation is operable. In some embodiments, formulations of the present disclosure can maintain an acidic pH. pH control components may be used to obtain such formulations. For example, in some preferred embodiments, formulations of the present disclosure comprise one or more pH control components selected to provide a composition having an acidic pH within the operable pH range(s) of each enzyme in the formulation, most preferably within +/- 1 pH-unit from the optimal pH value of each enzyme in the formulation. Thus, in some embodiments, formulations of the present disclosure comprise a pH control component, such as a buffer, where an 1% w/w aqueous solution of the pH control component (buffer) has an acidic pH in which each enzyme in the formulation is operable. Formulations of the present disclosure may comprise any suitable combination of pH control components and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned pH control components. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned pH control components are expressly excluded from formulations of the present disclosure. Examples of postharvest treatments that may be included in formulations of the present disclosure include, but not are not limited to, essential oils, ethylene biosynthesis inhibitors (e.g., cyclopropenes), pesticides and waxes. See generally, e.g., WO 00/10386; WO 01/43548; US 2002/058592; US 2002/061822; US 2002/043730; US 2002/198107; US 2004/072694; US 2003/100450; US 2004/077502; US 2005/043179; US 2005/250649; US 2005/261131; US 2005/261132; US 2005/288189; CA 2512254; CA 2512256; US 2007/117720; US 2007/265166; US 2008/113867; US 2010/144533; US 2008/206823; US 2009/035380; US2009/077684; US 2009/118492; US 2009/230350; US 2010/047408; US 2011/321191; US 2011/034335; US 2011/014334; US 2012/272572; US 2012/282380; US2011/293801; US2012/004108; US2013/065764; US2012/258220; US2012/142534; US 2014/127309; US 2013/004634; US 2014/011679; US 2015/208679; WO 2014/120715; WO 2015/175157; WO 2017/180695; US 2014/080710; US 2015/237877; US 2015/272115; US 2016/000072; US 2015/366189; US 2014/242235; US 2014/271758; US 2016/066568; US 2016/095311; US 2015/018430; US 2015/087520; US 2015/231588; US 2015/366230; US 2016/235070; US 2016/324147; US 2017/251673; US 2017/251662; US 2017/251669; US 2017/265462; US 2017/318804; US 2018/139975; US 2018/356384; US 2021/102245; US 2021/238201; WO 2022/094214; EP 2468107; ES 2439616; WO 2014/128321; WO 2018/116027; WO 2018/128807; WO 2019/058211; WO 2020/157714; US 2009/253578; US 2009/253579; US 2004/146617; US 2022/087261; WO 2020/016728; US 2010/173773; US 2010/292080; US 5858436; EP 0972450; US 6221414; US 6723364; WO 00/49880; US 6403139; US 2005/129662; US 2006/228458; US 2005/137090; US 2006/276336; US 2008/175926; US 2008/016766; US 2008/145499; US 2010/092631; US 2010/081636; US 2011/003694; US 2011/008475; US 2010/298147; US 2013/072383; US 2013/156835; US 2013/266670; US 2013/236562; US 2013/178489; US 2014/187570; US 2013/306158; US 2013/341809; US 2016/330987; WO 2017/001502; US 2019/159469; WO 2017/220581; US 2020/060300; US
2020/221719; WO 2020/016154; WO 2020/225066; WO 2021/233900; WO 2005/058014. Non-limiting examples of postharvest treatment compositions that may be incorporated into formulations of the present disclosure—or into which proteins and other compositions of the present disclosure may be incorporated—include commercial products sold under the tradenames ACTISEAL™, ACTISEAL™, CONTORL-TEC™, ETHYLBLOC, FRESHCLOUD™, FRESHSTART, HARVISTA™, SMARTCITRUS, SMARTFRESH™, TEYCER, VITAFRESH from AgroFresh, Inc. (Philadelphia, PA, USA); CERAXEL®, CERASULFUR®, CERAQUINT®, ELIM®, MUSACARE® and CERAFRUTA from CERADIS Crop Protection (Ceradis B.V., Netherlands); APL-LUSTR®, APL-BRITE, BIO-SAVE®, CITRUBLUSH, CITRUS BRITE, CITRUS FIX™, CITRUS LUSTR®, DECCO and DECCONATUR™ from Decco U.S. Post-Harvest, Inc. (Monrovia, CA, USA); SEMPERFRESH, LUSTRE DRY, NATURAL SHINE®, PACRITE®, PRIMAFRESH®, SHIELD-BRITE®, EFOG® and XEDAQUIN from Pace International (Wapato, WA, USA); ALUMNI®, CHAIRMAN®, GRADUATE®, GRADUATEA+®, MENTOR®, MERTECT®, SCHOLAR® and STADIUM® from Syngenta Crop Protection (Basel, Switzerland); and MAGNAPHOS, QUICKPHLO-R, QUICKPHOS from UPL Limited (Mumbai, Maharashtra, India). It is to be understood that many of the compounds described above as “chemical actives” and “chemical active compositions” may be applied to plants and plant parts both preharvest and postharvest and may therefore also be considered “postharvest treatments” and “postharvest treatment compositions.” Formulations of the present disclosure may comprise any suitable combination of postharvest treatment compositions and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned postharvest treatment compositions. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned v are expressly excluded from formulations of the present disclosure. Examples of preservatives that may be included in formulations of the present disclosure include, but are not limited to, benzoates (e.g., sodium benzoate), benzoic acid, methyl paraben, phenoxy ethanol, proprionates (e.g., ammonium proprionate, calcium proprionate, sodium proprionate), proprionic acid, sorbates (e.g., potassium sorbate, sodium sorbate), and 1,2-benzisothiazolin-3-one (PROXEL®; Basel, Switzerland). Formulations of the present disclosure may comprise any suitable combination of preservatives and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned preservatives. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned preservatives are expressly excluded from formulations of the present disclosure. Examples of rain fasteners that may be included in formulations of the present disclosure include, but not are not limited to, organo-modified siloxanes (organosiloxanes), such as trisiloxanes and polysiloxanes. See generally EP 0245970; US 5496568; WO 2008/144024; WO 2009/135049; WO 2011/126832; WO 2017/083049; WO 2020/225276; WO 2021/055316; WO 2022/096688; WO 2022/096691; WO 2022/096692; WO 2022/096693; WO 2022/096694; WO/2022/096695; WO 2022/096696. In some embodiments, formulations of the present disclosure comprise one or more organo-modified
siloxanes having the general molecular structure of Formula 1:
in which R1 represents identical or different from each other hydrocarbon substituents of 1-10 carbons or hydrogen, preferred are methyl, ethyl, propyl and phenyl substituents, particularly preferred are methyl substituents; R2 represents identical or different from each other polyether substituents of the general Formula II: -R3O[CH2CH2O]C[CH2CH(CH3)O]D[CHR4CHR4O]ER5 wherein R3 represents identical or different from each other hydrocarbon moieties of 1-8 carbons, which optionally is interrupted by oxygen atoms. Preferred is linear hydrocarbons of 2-4 carbons, particularly preferred is -CH2-CH2-CH2- R4 represents identical or different from each other hydrocarbon substituents of 1-12 carbons or hydrogen, preferred is methyl, ethyl, phenyl or hydrogen substituents R5 represents identical or different from each other hydrocarbon substituents of 1-16 carbons, which optionally contains urethane, carbonyl or carboxylic acid functionality, or hydrogen. Methyl or hydrogen substituents are preferred, with hydrogen being most preferred. A is 0-200, preferably 0-1, more preferably 0. B is 0-200, preferably 0.5-2, more preferably 1. In preferred embodiments, A+B > 0. C is 0- 60, preferably 1-15. D is 0-60, preferably 0-10. E is 0-20, preferably 0-10, more preferably 0. In preferred embodiments, C+D+E > 0. A trisiloxane may be defined as a molecule of the general Formula I with A = 0 and B = 1, whereas a polysiloxane is a molecule of the general formula I with A + B >1 and A >1. Examples of commercially available organo-modified siloxanes include, but are not limited to SILWET™ surfactants (Momentive Performance Materials, Inc., Niskayuna, NY), such as SILWET™ L-77 (polyalkyleneoxide modified heptamethyltrisiloxane), SILWET™ HS-312, SILWET™ 408, SILWET™ 618, SILWET™ 625, SILWET™ 636, SILWET™ 641, SILWET™ 806, SILWET™ DA-40, SILWET™ DRS-60, SILWET™ ECO, SILWET™ HS-604, SILWET™ STIK 2 and SILWET™) and BREAK-THRU® surfactants (Evonik Operations Gmbh, Essen, Germany), such as BREAK-THRU® S 200, BREAK-THRU® S 233, BREAK- THRU® S 240, BREAK-THRU® S 255, BREAK-THRU® S 279, BREAK-THRU® S 301 (polyether trisolxane), BREAK-THRU® SD 260, BREAK-THRU® SF 420, BREAK-THRU® SP 133 (polyglycerol esters and fatty acid esters), BREAK-THRU® UNION, BREAK-THRU® VIBRANT). In some embodiments,
formulations of the present disclosure comprise one or more organo-modified siloxanes in an amount of about/at least 0.001-50% w/w, preferably about/at least 0.005-25% w/w. Formulations of the present disclosure may comprise any suitable combination of rain fasteners and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned rain fasteners. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned rain fasteners are expressly excluded from formulations of the present disclosure. Examples of suitable stabilizers include, but not are not limited to, boric acid, boric acid derivatives, inorganic salts, lactic acid, polyols, sugars, sugar alcohols and reversible protease inhibitors. See generally, e.g., WO 2007/113241; WO 01/04279; WO 2013/004636; WO 95/02046; WO 2009/118375; WO 2020/115179; WO 96/41859; WO 2007/025549; WO 96/23062; WO 2018/130654; WO 96/22366; WO 92/17571; WO 2017/044473; WO 2017/044545, WO 2017/116837, WO 2017/116846, WO 2017/210163, WO 2017/210166, WO 2018/118740, WO 2018/175681, WO 2018/183491, WO 2018/218008, WO 2018/218016; WO 2018/218035. Formulations of the present disclosure may comprise any suitable combination of stabilizers and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned stabilizers. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned stabilizers are expressly excluded from formulations of the present disclosure. Examples of suitable UV protectants include, but not are not limited to, aromatic amino acids (e.g., tryptophan, tyrosine), carotenoids, cinnamates, lignosulfonates (e.g., calcium lignosulfonate, sodium lignosulfonate), melanins, mycosporines, polyphenols and/or salicylates). Non-limiting examples of UV protectants include Borregaard LignoTech™ lignosulfonates (e.g., Borresperse 3A, Borresperse CA, Borresperse NA, Marasperse AG, Norlig A, Norlig 11D, Ufoxane 3A, Ultrazine NA, Vanisperse CB; Borregaard Lignotech, Sarpsborg, Norway) and combinations thereof. Additional examples of UV protectants may be found in BURGES, FORMULATION OF MICROBIAL BIOPESTICIDES: BENEFICIAL MICROORGANISMS, NEMATODES AND SEED TREATMENTS (Springer Science & Business Media) (2012). Formulations of the present disclosure may comprise any suitable combination of UV protectants and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned UV protectants. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned UV protectants are expressly excluded from formulations of the present disclosure. Examples of suitable wetting agents include, but are not limited to, naphthalene sulfonates, such as alkyl naphthalene sulfonates (e.g., sodium alkyl naphthalene sulfonate), isopropyl naphthalene sulfonates (e.g., sodium isopropyl naphthalene sulfonate) and butyl naphthalene sulfonates (e.g., sodium n-butyl naphthalene sulfonate). Formulations of the present disclosure may comprise any suitable combination of wetting agents and may therefore comprise two, three, four, five, six, seven, eight, nine, ten or more of the aforementioned wetting agents. Conversely, in some embodiments, one, two, three, four, five, six, seven, eight, nine, ten or more of the
aforementioned wetting agents are expressly excluded from formulations of the present disclosure. As will be understood by those skilled in the art, compositions of the present disclosure have many uses, including, but not limited to a) preventing, treating, suppressing and/or eliminating infestations/infections of/by myriad pests, including, but not limited to, phytopathogenic pests, such as arachnids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa, viruses and weeds; b) treating surfaces/substances that are susceptible to infestation/infection; c) cleansing infested/infected surfaces/substances; d) reducing disease severity in plants and plant parts affected directly or indirectly by phytopathogenic pests; e) enhancing plant growth environments; f) improving nutrient availability/uptake/accumulation; g) reducing the amount(s) of exogenous fertilizer needed to achieve a desired result; h) improving plant growth, development and yield characteristics; i) prolonging the shelf-life of harvested plants and plant parts; j) delaying the ripening of plants and plant parts; k) hastening the ripening of plants and plant parts; l) improving the efficacy of biological/chemical pesticides; m) preventing, treating, suppressing and/or eliminating pesticide-induced resistance/phytotoxicity. Compositions of the present disclosure may be particularly useful for protecting plants from environmental pathogens. In some embodiments, compositions of the present disclosure are useful for preventing, treating, suppressing, eliminating and/or reducing the severity of acarid infestations by, for example, reducing attraction of an acarid to a surface, inhibiting entry of an acarid into a material, inhibiting inhabitation by an acarid, inhibiting feeding of an acarid, inhibiting amino acid production, degrading one or more amino acids, preventing an acarid from utilizing one or more essential amino acids, producing ammonia in the gut of an acarid, inhibiting the growth of an acarid, inhibiting the reproduction and/or proliferation of an acarid, degrading on one or more structural components of an acarid (e.g. procuticle components, such as chitin, and epicuticle components, such as lipoproteins, hydrocarbons, polyphenols and esters of fatty acids and alcohols), killing an acarid, and/or reducing one or more symptoms of an acarid infestation. In some embodiments, such inhibition is complete or substantially complete, such that the acarid fails to inhabit/feed/grow/reproduce/proliferate at a rate effective to initiate and/or sustain an appreciable infestation. For example, spraying a plant with an enzyme of the present disclosure may reduce the attractiveness of the plant to an acarid, reduce an acarid's desire/ability to inhabit the plant, inhibit an acarid's desire/ability to feed on the plant, inhibit production of one or more amino acids, degrade one or more amino acids, prevent an acarid from utilizing one or more essential amino acids, produce ammonia in the gut of an acarid, inhibiting the growth of an acarid after it inhabits/feeds on the plant, inhibit the reproduction and/or proliferation of an acarid on/in the plant, degrade one or more structural components of an acarid (e.g. one or more chitins, one or more lipoproteins and/or one or more long chain hydrocarbons) on/in the plant, and/or kill an acarid on/in the plant, thereby reducing one or more symptoms of infestation and/or enhancing one or more characteristics of growth and/or yield in the plant, as compared to an untreated control plant. Compositions of the present disclosure may be used to prevent, treat, suppress, eliminate and/or reduce
the severity of infestations of/by myriad acarids, including, but not limited to, herbivorous acarids, such as broad mites, bulb mites, cyclamen mites, earth mites, eriophyid mites, Lewis mites, russet mites, rust mites, and spider mites. In some embodiments, enzymes of the present disclosure are used to prevent and/or treat an infestation of a plant or plant part by one or more Auculops, (e.g., A. lycopersici), Calacarus (e.g., C. flagelliseta), Eutetranychus (e.g., E. lewesi), Halotydeus (e.g., H. destructor), Polyphagotarsonemus (e.g., P. latus), Rhizoglyphus, Tarsonemus (e.g., T. pallidus), and/or Tetranychus (e.g., T. cinnabarinus, T. evansi, T. ludeni, T. urticae). In some embodiments, compositions of the present disclosure are useful for preventing, treating, suppressing, eliminating and/or reducing the severity of bacterial infestations/infections by, for example, inhibiting adhesion of a bacterium to a surface, inhibiting entry of a bacterium into a material, inhibiting habitation by a bacterium, inhibiting the growth of a bacterium, inhibiting the reproduction and/or proliferation of a bacterium, degrading on one or more structural components of a bacterium (e.g. cell wall components, such as peptidoglycans and lipopolysaccharides), killing a bacterium, and/or reducing one or more symptoms of a bacterial infestation/infection. In some embodiments, such inhibition is complete or substantially complete, such that the bacterium fails to inhabit/feed/grow/reproduce/proliferate at a rate effective to initiate and/or sustain an appreciable infestation/infection. For example, spraying a plant with an enzyme of the present disclosure may inhibit a bacterium's ability to adhere to the surface of a plant, inhibit a bacterium's ability to enter into the plant, inhibit a bacterium's ability to inhabit the plant, inhibit growth of a bacterium on/in the plant, inhibit the reproduction and/or proliferation of a bacterium on/in the plant, degrade one or more structural components of a bacterium (e.g. one or more peptidoglycans and/or one or more lipopolysaccharides) on/in the plant, and/or kill a bacterium, thereby reducing one or more symptoms of infestation and/or enhancing one or more characteristics of growth and/or yield in the plant, as compared to an untreated control plant. Compositions of the present disclosure may be used to prevent, treat, suppress, eliminate and/or reduce the severity of infestations/infections of/by myriad phytopathogenic bacteria, including, but not limited to, phytopathogenic Erwiniaceae and Xanthomonadales. In some embodiments, enzymes of the present disclosure are used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part by one or more Agrobacterium (e.g., A. rhizogenes, A. tumefaciens, A. vitis), Burkholderia (e.g., B. gladioli), Clostridium, Dickeya (e.g., D. dadantii, D. solani), Erwinia (e.g., E. amylovora, E. aphidicola, E. carotovora, E. chrysanthemi, E. papayae, E. persicina, E. psidii, E. pyrifoliae, E. rhapontici, E. tracheiphila), Pectobacterium (e.g., P. atrosepticum, P. carotovorum), Pseudomonas (e.g., P. agarici, P. amygdali, P. avellanae,P. cannabina, P. caricapapayae, P. cichorii, P. coronafaciens, P. costantinii, P. ficuserectae, P. fuscovaginae, P. helianthin, P. meliae, P. savastanoi, P. syringae, P. tolaasii, P. tomato, P. turbinellae, P. viridiflava), Ralstonia (e.g., R. solanacearum), Xanthomonas (e.g., X. alfalfae, X. ampelina, X. arboricola, X. axonopodia, X. boreopolis, X. badrii, X. bromi, X. campestris, X. cassavae, X. citri, X. cucrurbitae, X. cyanopsidis, X. cynarae, X.euvesicatoria , X. frageriae, X.gardneri, X. holcicola, X. hortorum, X. hyacinthi, X. maliensis, X. malvacearum, X. manihotis, X. melonis, X. oryzae, X. papavericola, X. perforans, X. phaseoli, X.
pisi, X. populi, X. sacchari, X. theicola, X. translucens, X. vasicola, X. vesicatoria), and/or Xylella (e.g., X. fastidiosa). In some embodiments, compositions of the present disclosure are useful for preventing, treating, suppressing, eliminating and/or reducing the severity of fungal infestations/infections by, for example, inhibiting adhesion of a fungus to a surface, inhibiting entry of a fungus into a material, inhibiting habitation by a fungus, inhibiting production of one or more amino acids, degrading one or more amino acids, inhibiting the growth of a fungus, inhibiting the reproduction and/or proliferation of a fungus, degrading on one or more structural components of a fungus (e.g. cell wall components, such as chitins, glucans and mannans, and cell membrane components, such as ergosterols), killing a fungus, and/or reducing one or more symptoms of a fungal infestation/infection. In some embodiments, such inhibition is complete or substantially complete, such that the fungus fails to inhabit/feed/grow/reproduce/proliferate at a rate effective to initiate and/or sustain an appreciable infestation/infection. For example, spraying a plant with an enzyme of the present disclosure may inhibit a fungus' ability to adhere to the surface of a plant, inhibit a fungus' ability to enter into the plant, inhibit a fungus' ability to inhabit the plant, inhibit the ability of a fungus to produce one or more amino acids, degrade one or more amino acids, inhibit growth of a fungus on/in the plant, inhibit the reproduction and/or proliferation of a fungus on/in the plant, degrade one or more structural components of a fungus (e.g. one or more chitins, one or more glucans and/or one or more mannans) on/in the plant, and/or kill a fungus, thereby reducing one or more symptoms of infestation and/or enhancing one or more characteristics of growth and/or yield in the plant, as compared to an untreated control plant. Compositions of the present disclosure may be used to prevent, treat, suppress, eliminate and/or reduce the severity of infestations/infections of/by myriad phytopathogenic fungi, including, but not limited to, phytopathogenic Ascomycetes, Basidiomycetes, Chytridiomycota, Deueromycota, Peronosporomycota, Plasmodiophoromycota and Zygomycota, such as blasts, blights, bunts, galls, mildews, molds, rots, rusts, scabs, smuts and wilts. In some embodiments, enzymes of the present disclosure are used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part by one or more Aecidium (e.g., A. aechmantherae, A. amaryllidis, A. breyniae, A. campanulastri, A. cannabis, A. cantensis, A. capsicum, A. foeniculi, A. narcissi), Alternaria (e.g. ¸ A. alternata, A. alternantherae, A. arachidis, A. arborescens, A. arbusti, A. blumeae, A. brassicae, A. brassicicola, A. burnsii. A. carotiincultae, A. carthami, A. celosiae, A. cinerariae, A. citri, A. conjuncta, A. cucumerina, A. dauci, A. dianthi, A. dianthicola, A. eichhorniae, A. euphorbiicola, A. gaisen, A. helianthi, A. helianthicola, A. hungarica, A. infectoria, A. japonica, A. leucanthemi, A. linicola, A. longipes, A. mali, A. molesta, A. padwickii, A. panax, A. perpunctulata, A. patroselini, A. porri, A. quericola, A. radicina, A. raphani, A. saponariae, A. selini, A. senecionis, A. smyrnii, A. solani, A. sonchi, A. tenuissima, A. triticina, A. ventricosa, A. zinniae), Ascochyta (e.g., A. asparagina, A. bohemica, A., caricae, A. doronici, A. fabae, A. gossypii, A. graminea, A. hordei, A. humuli, A. medicaginicola, A. pinodes, A. pisi, A. prasadii, A. rabiei, A. rhei, A. sorghi, A. sorghinia, A. spinaciae, A. tarda, A. tritici, A. viciae, A. vindobonensis), Ascospora (e.g., A. ruborum), Aspergillus (e.g., A. aculeatus, A. candidus, A. clavatus, A. fisherianus, A. flavus,
A. fumigatus, A. niger, A. parasiticus, A. restrictus, A. sojae, A. solani), Asteroma (e.g., A. caryae), Austropuccinia (e.g., A. psidii), Bipolaris (e.g., B. cactivora, B. cookei, B. incurvata, B. sacchari, B. sorghicola, B. sorokiniana, B. zeae), Blumeria (e.g., B. graminis), Boeremia (e.g., B. lycopersici), Botrytis (e.g., B. allii, B. anthophila, B. cinerea, B. citricola, B. citrina, B. elliptica, B. fabae, B. fabiopsis, B. galanthina, B. gladioli, B. gossypina, B. hormini, B. hyacinthi, B. isabellina, B. latebricola, B. liliorum, B. limacidae, B. luteobrunnea, B. lutescens, B. mali, B. monilioides, B. narcissicola, B. necans, B. paeoniae, B. peronosporoides, B. pistiae, B. platensis, B. pruinosa, B. pseudocinerea, B. pyramidalis, B. rivoltae, B. rosea, B. rubescens, B. rudiculoides, B. sekimotoi, B. septospora, B. setuligera, B. sinoallii, B. sonchina, B. splendida, B. squamosa, B. taxi, B. terrestris, B. tracheiphila, B. trifolii, B. tulipae, B. viciae-hirsutae, B. yuae), Calonectria (e.g., C. ilicicola, C. indusiate, C. kyotensis, C. pteridis, C. pyrochroa, C. quinqueseptata), Camarotella (e.g., C. acrocomiae, C. costaricensis), Candida (e.g., C. albicans), Capnodium (e.g., C. theae), Cephalosporium (e.g., C. gramineum), Ceratocystis (e.g., C. fimbriata), Ceratobasidium (e.g., C. cereale), Cercoseptoria (e.g., C. ocellata), Cercospora (e.g., C. angreci, C. apii, C. apiicola, C. arachidicola, C. asparagi, C. atrofiliformis, C. beticola, C. bolleana, C. brachypus, C. brassicola, C. brunkii, C. canescens, C. cannabis, C. cantuariensis, C. capsici, C. caribaea, C. carotae, C. circumscissa, C. citrulline, C. clemensiae, C. coffeicola, C. coryli, C. corylina, C. eleusine, C. fragariae, C. fuchsiae, C. fusca, C. fusimaculans, C. gerberae, C. halstedii, C. handelii, C. hayi, C. hydrangeae, C. kaki, C. kikuchii, C. lentis, C. liquidambraris, C. longipes, C. longissima, C. malloti, C. mamaonis, C. mangiferae, C. medicaginis, C. melongenae, C. minima, C. minuta, C. musae, C. nicotianae, C. odontoglossi, C. oryzae, C. papayae, C. penniseti, C. personata, C. piaropi, C. pisa-sativae, C. platanicola, C. puderii, C. pulcherrima, C. rhapidicola, C. rosicola, C. rubrotincta, C. sojina, C. solani, C. solani-tuberosi, C. sorghi, C. theae, C. tuberculans, C. vexans, C. vicosae, C. zeae-maydis, C. zebrina, C. zonata), Cercosporella (e.g., C. rubi), Choanephora (e.g., C. cucurbitarum), Cladosporium (e.g., C. arthropodii, C. brassicae, C. brassicola, C. chrysanthemi, C. citri, C. cladosporioides, C. cucumerinum, C. fulvum, C. gossypiicola, C. herbarum, C. hydrangeae, C. leguminicola, C. musae, C. oncobae, C. orchidis, C. pisi, C. rhododendri, C. salinae, C. spharospermum, C. sorghi, C. syringae, C. syringicola, C. yuccae, C. zeae), Claviceps (e.g., C. africana, C. fusiformis, C. paspali, C. purpurea, C. sorghi, C. zizaniae), Clitocybe (e.g., C. parasitica), Coccidioides (e.g., C. immitus), Cochliobolus (e.g., C. carbonum, C. cymbopogonis, C. hawaiiensis, C. heterostrophus, C. lunatus, C. miyabeanus, C. ravenelii, C. sativus, C. setariae, C. spicifer, C. stenospilus, C. tuberculatus, C. victoriae), Coleosporium (e.g., C. helianthi, C. ipomoeae, C. madiae, C. pacificum, C. tussilaginis), Colletotrichum (e.g., C. acutatum, C. agaves, C. arachidis, C. boninense, C. brasiliense, C. brassicola, C. brevisporum, C. cacao, C. capsici, C. caudatum, C. cereale, C. citri, C. citricola, C. coccodes, C. coffeanum, C. crassipes, C. curcumae, C. dematium, C. derridis, C. destructivum, C. fioriniae, C. fragariae, C. fructi, C. fruticola, C. fructivorum, C. gloeosporioides, C. glycines, C. graminicola, C. gossypii, C. hanaui, C. higginsianum, C. jacksonii, C. kahawae, C. lentis, C. limonicola, C. lindemuthianum, C. lini, C. lupini, C. mangenotii, C. melonis, C. miscanthi, C. musae, C. nicholsonii, C. nigrum, C. orbiculare, C. orchidis, C. paspali, C. pisi, C. pisicola, C. radicis, C. roseum, C. serranegrense, C. sojae, C. spinaceae, C. sublineolum, C.
sublineola, C. tabacum, C. trichellum, C. trifolii, C. truncatum, C. zoysiae), Coniella, Coniothecium (e.g., C. chomatosporum), Coniothyrium (e.g., C. henriquesii, C. rosarum, C. wernsdorffiae), Coprinopsis (e.g., C. psychromorbida), Cordana (e.g., C. johnstonii, C. musae), Corticum (e.g., C. theae), Cryphonectria (e.g., C. parasitica), Cylindrocarpon (e.g., C. ianthothele, C. magnusianum, C. musae), Cylindrocladiella (e.g., C. camelliae, C. parva), Cylindrocladium (e.g., C. lanceolatum, C. peruvianum), Cylindrosporium (e.g., C. cannabinum, C. juglandis, C. rubi), Cymadothea (e.g., C. trifolii), Cytospora (e.g, C. palmarum, C. personata, C. sacchari, C. sacculus, C. terebinthi), Cytosporina (e.g., C. ludibunda), Diaporthe (e.g., D. arctii, D. asparagi, D. capsici, D. citri, D. coffeae, D. dulcamarae, D. eres, D. helianthi, D. lagunensis, D. lokoyae, D. melonis, D. musae, D. orthoceras, D. perniciosa, D. phaseolorum, D. rudis, D. tanakae, D. viticola), Diplodia (e.g., D. gossypina), Dreschlera (e.g., D. avenacea, D. campanulata, D. dematioidea, D. gigantea, D. glycines, D. graminea, D. hawaiiensis, D. musae, D. poae, D. teres, D. wirreganensis), Eremothcium (formerly Nematospora) (e.g., E. gossypii), Erysiphe (e.g., E. betae, E. cichoracearum, E. communis, E. cruciferarum, E. flexuosa, E. heraclei, E. necator, E. pisi, E. polygoni, E. robiniae, E. syringae), Exserohilum (e.g., E. oryzicola, E. oryzinum), Fusarium (e.g., F. affine, F. arthrosporioides, F. avenaceum, F. circinatum, F. crookwellense, F. culmorum, F. fujikuroi, F. graminearum, F. incarnatum, F. langsethiae, F. mangiferae, F. merismoides, F. moniliforme, F. oxysporum, F. pallidoroseum, F. poae, F. proliferatum, F. redolens, F. roseum, F. sacchari, F. solani, F. sporotrichioides, F. sterilihyphosum, F. subglutinans, F. sulphureum, F. tricinctum, F. verticillioides, F. virguliforme), Gaeumannomyces (e.g., G. graminis), Geotrichum (e.g., G. candidum), Gibberella (e.g., G. fujikuroi, G. pulicaris, G. stilboides, G. tricincta, G. xylarioides, G. zeae), Gilbertella (e.g., G. persicaria), Glomerella (e.g., G. cingulata), Gymnosporangium (e.g., G. juniperi-virginianae), Helminthosporium (e.g., H. oryzae, H. solani), Hemileia (e.g., H. coffeicola, H. vastatrix), Laetisaria (e.g., L. fuciformis), Leptosphaeria (e.g., L. acuta, L. asparagi, L. cannabina, L. coffaeicida, L. coniothyrium, L. glyceriae, L. gossypii, L. grisea, L. korrae, L. longispora, L. maculans, L. maydis, L. musae, L. oryzicola, L. oryzina, L. pini, L. platanicola, L. pratensis, L. raphani, L. saccharicola, L. solani, L. solanicola, L. trifolii, L. viciae, L. woroninii, L. zeae, L. zeae-maydis), Macrophomina (e.g., M. phaseolina), Magnaporthe (e.g., M. grisea, M. oryzae, M. poae), Melamspora (e.g., M. lini), Microdochium (e.g., M. nivale), Monilinia (e.g., M. fructicola), Mucor (e.g., M. piriformis), Mycosphaerella (e.g., M. fijiensis, M. graminicola, M. tassiana, M. zeae-maydis), Neofabraea (e.g., N. malicorticus), Ophiostoma (e.g., O. novo-ulmi, O. ulmi), Paracoccidioides (e.g., P. braziliensis), Penicillium (e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum), Phakopsora (e.g., P. gossypii, P. meibomiae, P. pachyrhizi), Phialophora (e.g., P. gregata), Phoma (e.g., P. glycinicola), Phomopsis (e.g., P. asparagi, P. coffeae, P. logicolla, P. mangiferae, P. obscurans, P. perseae, P. purnorum, P. sojae, P. sclerotioides, P. tanakae, P. theae, P. vitcola), Phymatotrichopsis (e.g., P. omnivora), Physalospora (e.g., P. obtusa), Phytomyxea, Pneumocystis (e.g., P. carinii), Podosphaera (e.g., P. oxyacanthae), Pseudocercosporella, Puccinia (e.g. , P. asparagi, P. cacahata, P. coronata, P. graminis, P. kuehnii, P. melanocephala, P. porri, P. punctiformis, P. recondita, P. schedonnardii, P. sessilis, P. sorghi, P. striiformis, P. tritici, P. triticina), Pyrenophora (e.g., P. tritici-repentis), Pyricularia (e.g., P. grisea), Rhizoctonia (e.g., R.
cerealis, R. solani), Rhizopus (e.g., R. nigricans, R. stolonifer), Rhynchosporium, Sclerotinia (e.g., S. borealis, S. bulborum, S. homoeocarpa, S. libertiana, S. minor, S. ricini, S. sclerotiorum, S. spermophila, S. trifoliorum), Sclerotium (e.g., S. rolfsii), Scopulariopsis (e.g., S. brevicaulis), Septoria (e.g., S. apiicola, S. aciculosa, S. ampelina, S. avenae, S. azalea, S. bataticola, S. campanulae, S. caryae, S. citri, S. cucurbitacearum, S. cytisi, S. dianthi, S. eumusae, fragariae, S. fragariaecola, S. glycines, S. helianthin, S. humuli, S. hydrangea, S. lactucae, S. lycopersici, S. malagutii, S. menthae, S. musiva, S. ostryae, S. passerinii, S. pisi, S. pistaciae, S. platanifolia, S. rhododendri, S. secais, S. selenophomoides), Sporisorium (e.g., S. scitamineum), Synchytrium (e.g., S. endobioticum), Taphrina (e.g., T, deformans), Thielaviopsis (e.g., T. basicola, T. ceremica), Tilletia (e.g., T. barclayana, T. caries, T. controversa, T. foetida, T. indica, T. laevis, T. tritici), Typhula (e.g., T. incarnata, T. ishikariensis), Uncinula, Urocystis (e.g., U. agropyri), Uromyces (e.g., U. melanocephala), Ustilago (e.g., U. esculenta, U. maydis, U. nuda, U. scitaminea, U. striiformis, U. tritici, U. virens), Venturia, Verticillium (e.g., V. alfalfae, V. dahliae, V. isaacii, V. longisporum, V. theobromae, V. zaregamsianum), Waitea (e.g., W. circinata) and/or Zymoseptoria (e.g., Z. tritici). Additional examples of fungi that may be targeted using proteins, formulations, polynucleotides and organisms of the present disclosure may be found in Bradley, Managing Diseases, in Illinois Agronomy Handbook (2008). In some embodiments, compositions of the present disclosure are useful for preventing, treating, suppressing, eliminating and/or reducing the severity of oomycete infestations/infections by, for example, inhibiting adhesion of an oomycete to a surface, inhibiting entry of an oomycete into a material, inhibiting habitation by an oomycete, inhibiting production of one or more amino acids, degrading one or more amino acids, inhibiting the growth of an oomycete, inhibiting the reproduction and/or proliferation of an oomycete, degrading on one or more structural components of an oomycete (e.g. cell wall components, such as celluloses and other beta-glucans), killing an oomycete, and/or reducing one or more symptoms of an oomycete infestation/infection. In some embodiments, such inhibition is complete or substantially complete, such that the oomycete fails to inhabit/feed/grow/reproduce/proliferate at a rate effective to initiate and/or sustain an appreciable infestation/infection. For example, spraying a plant with an enzyme of the present disclosure may inhibit an oomycete's ability to adhere to the surface of a plant, inhibit an oomycete's ability to enter into the plant, inhibit an oomycete's ability to inhabit the plant, inhibit production of one or more amino acids, degrade one or more amino acids, inhibit growth of an oomycete on/in the plant, inhibit the reproduction and/or proliferation of an oomycete on/in the plant, degrade one or more structural components of an oomycete (e.g. one or more beta-glucans) on/in the plant, and/or kill an oomycete, thereby reducing one or more symptoms of infestation and/or enhancing one or more characteristics of growth and/or yield in the plant, as compared to an untreated control plant. Compositions of the present disclosure may be used to prevent and/or treat infestations/infections of myriad phytopathogenic oomycetes, including, but not limited to, phytopathogenic Albuginaceae, Peronosporaceae and Pythiaceae, such as blights, mildews, molds, root rots and rusts In some embodiments, proteins of the present disclosure are used to prevent, treat, suppress, eliminate and/or reduce the severity of an
infestation/infection of a plant or plant part by one or more Achlya, Albugo (e.g., A. candida), Aphanomyces (e.g., A. cochlioides, A. euteiches, A. invadans, A. iridis, A. raphani), Bremia (e.g., B. lactucae), Hyaloperonospora (e.g., H. arabidopsidis), Peronospora (e.g., P. belbahrii, P. destructor, P. effusa, P. farinose, P. fulva, P. lotorum, P. manshurica, P. parasitica, P. potentillae, P. rubi, P. schachtii, P. sparsa, P. tabacina, P. trifolii, P. viciae), Phytophthora (e.g., P. agathidicia, P. boehmeriae, P. cactorum, P. cambivora, P. capsica, P. cinnamomi, P. citricola, P. citrophthora, P. cryptogea, P. drechsleri, P. erythroseptica, P. fragariae, P. heveae, P. infestans, P. kernoviae, P. lateralis, P. megakaryam P. megasperma, P. nicotianae, P. palmivora, P. parasitica, P. ramorum, P. sojae, P. syringae), Plasmopara (e.g., P. halstedii, P. viticola), Pseudeoperonospora (e.g., P. cubensis, P. humuli), Pseudosclerospora (e.g., P. philippinesis, P. sacchari, P. sorghi), Pythium (e.g., P. acanthicum, P. aphanidermatum, P. aristosporum, P. arrhenomanes, P. butleri, P. chondricola, P. citrinum, P. cucurbitacearum, P. debaryanum, P. delicense, P. emineosum, P. graminicola, P. heterothallicum, P. hypogynum, P. insidiosum, P. irregulare, P. iwayamae, P. middletonii, P. myriotylum, P. okanoganense, P. oopapillum, P. paddicum, P. paroecandrum, P. perniciosum, P. porphyrae, P. rostratum, P. scleroteichum, P. spinosum, P. splendens, P. sulcatum, P. tardicrescens, P. tracheiphilum, P. ultimum, P. violae, P. volutum), Saprolegnia (e.g., S. parasitica), Sclerophthora (e.g., S. macrospora, S. rayssiae) and/or Sclerospora (e.g., S. graminicola). Additional examples of fungi that may be targeted using proteins, formulations, polynucleotides and organisms of the present disclosure may be found in Bradley, Managing Diseases, in ILLINOIS AGRONOMY HANDBOOK (2008). Compositions of the present disclosure may be particularly useful for preventing, treating, suppressing, eliminating and/or reducing the severity of infestations/infections of/by phytopathogenic fungi and oomycetes, such as Albugo (e.g., A. candida, A. occidentalis), Alternaria (e.g. ¸A. alternata, A. alternantherae, A. arachidis, A. arborescens, A. arbusti, A. blumeae, A. brassicae, A. brassicicola, A. burnsii. A. carotiincultae, A. carthami, A. celosiae, A. cinerariae, A. citri, A. conjuncta, A. cucumerina, A. dauci, A. dianthi, A. dianthicola, A. eichhorniae, A. euphorbiicola, A. gaisen, A. helianthi, A. helianthicola, A. hungarica, A. infectoria, A. japonica, A. leucanthemi, A. linicola, A. longipes, A. mali, A. molesta, A. padwickii, A. panax, A. perpunctulata, A. patroselini, A. porri, A. quericola, A. radicina, A. raphani, A. saponariae, A. selini, A. senecionis, A. smyrnii, A. solani, A. sonchi, A. tenuissima, A. triticina, A. ventricosa, A. zinniae), Blumeria (e.g., B. graminis), Botrytis (e.g., B. aclada, B. allii, B. cinerea, B. elliptica, B. fabae, B. squamosa), Ceratocystis (e.g., C. fimbriata), Colletotrichum, Diplodia (e.g., D. gossypina), Erwinia (e.g., E. amylovora, E. aphidicola, E. carotovora, E. chrysanthemi, E. papayae, E. persicina, E. psidii, E. pyrifoliae, E. rhapontici, E. tracheiphila), Fusarium (e.g., F. graminearum, F. oxysporum, F. solani, F. virguliforme), Geotrichum (e.g., G. candidum), Gibberella (e.g., G. fujikuroi, G. pulicaris, G. zeae), Gilbertella (e.g., G. persicaria), Glomerella (e.g., G. cingulata), Hyaloperonospora (e.g., H. arabidopsidis), Macrophomina (e.g., M. phaseolina), Magnaporthe (e.g., M. grisea, M. oryzae), Melampsora (e.g., M. lini), Monilinia (e.g., M. fructicola), Mucor (e.g., M. piriformis), Mycosphaerella (e.g., M. graminícola), Neofabraea (e.g., N. malicorticus), Penicillium (e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum), Phakopsora (e.g., P. pachyrhizi), Physalospora (e.g., P.
obtusa), Phytophthora (e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P. sojae), Plasmopara (e.g., P. vitícola), Pseudoperonospora (e.g., P. cubensis), Puccinia (e.g. , P. asparagi, P. cacahata, P. graminis, P. kuehnii, P. melanocephala, P. porri, P. punctiformis, P. recondita, P. schedonnardii, P. sessilis, P. sorghi, P. striiformis, P. tritici, P. triticina), Pythium (e.g., P. butleri, P. ultimum), Rhizoctonia (e.g., R. solani), Rhizopus (e.g., R. nigricans, R. stolonifer), Sclerotinia (e.g., S. borealis, S. bulborum, S. homoeocarpa, S. libertiana, S. minor, S. ricini, S. sclerotiorum, S. spermophila, S. trifoliorum), Septoria (e.g., S. cucurbitacearum, S. glycines, S. lycospersici), Ustilago (e.g., U. esculenta, U. maydis, U. nuda), Zymoseptoria (e.g., Z. tritici). Blast infestations/infections, such as those mediated by Magnaporthe (e.g., M. grisea, M. oryzae), may be prevented, treated, suppressed and/or eliminated with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 1.1.3 (e.g., 1.1.3.4), EC 1.1.99 (e.g., 1.1.99.18), 1.11.1 (e.g., 1.11.1.6), 3.1.1 (e.g., 3.1.1.3), 3.2.1 (e.g., 3.2.1.1, 3.2.1.4, 3.2.1.6, 3.2.1.8, 3.2.1.21), 3.4.11 and/or 3.4.21 (and corresponding formulations, polynucleotides and organisms). In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–8, 10–12, 14–15, 17–23, 34–40, 43–46, 48–53, 57, and enzymatically active fragments/mutants/variants thereof. In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as one or more cellulases, one or more hemicellulases and one or more xylanases; one or more peptidases and one or more proteases; one or more cellulases, one or more glucosidases and one or more xylanases. Blight infestations/infections, such as those mediated by Alternaria (e.g. ¸A. alternata, A. carotiincultae, A. panax, A. petroselini, A. solani, A. triticina), Colletotrichum, Fusarium (e.g., F. graminearum), Gibberella (e.g., G. zeae), Phytophthora (e.g., P. capsici, P. infestans, P. ramorum), may be prevented, treated, suppressed and/or eliminated with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 1.1.3 (e.g., 1.1.3.4), EC 1.1.99 (e.g., 1.1.99.18),1.10.3 (e.g., 1.10.3.2), 1.11.1 (e.g., 1.11.1.6), 3.1.1 (e.g., 3.1.1.5), 3.2.1 (e.g., 3.2.1.1, 3.2.1.3, 3.2.1.4, 3.2.1.5, 3.2.1.6, 3.2.1.8, 3.2.1.11, 3.2.1.15, 3.2.1.39, 3.2.1.41, 3.2.1.58, 3.2.1.75, 3.2.1.78, 3.2.1.111), 3.4.11 (e.g., 3.4.11.1), 3.4.21 (e.g., 3.4.21.19, 3.4.21.62), 3.4.24 (e.g., 3.4.24.28) and/or 4.2.2 (e.g., 4.2.2.2) (and corresponding formulations, polynucleotides and organisms). In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–15, 17–25, 34–55, 57, 61, 65, 68, 80–88, 91, 72144, and enzymatically active fragments/mutants/variants thereof. In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as two or more cellulases; two or more pectinases; two or more glucanases; two or more peptidases; two or more pectinases; one or more cellulases, one or more hemicellulases and one or more xylanases; one or more glucanses and one or more xylanases; one or more amylases, one or more glucanases and one or more xylanases. Blotch infestations/infections, such as those mediated by Mycosphaerella (e.g., M. graminícola) and Zymoseptoria (e.g., Z. tritici) may be prevented, treated, suppressed and/or eliminated with myriad
compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 1.1.3 (e.g., 1.1.3.4), EC 1.1.99 (e.g., 1.1.99.18), 1.10.3 (e.g., 1.10.3.2), 1.11.1 (e.g., 1.11.1.6), 3.1.1 (e.g., 3.1.1.5), 3.2.1 (e.g., 3.2.1.1, 3.2.1.3, 3.2.1.6, 3.2.1.8, 3.2.1.11, 3.2.1.15, 3.2.1.39, 3.2.1.41, 3.2.1.58, 3.2.1.75, 3.2.1.78, 3.2.1.101, 3.2.1.109, 3.2.1.110, 3.2.1.112), 3.4.11 (e.g., 3.4.11.1), 3.4.21 (e.g., 3.4.21.62), 3.4.24 (e.g., 3.4.24.28) and/or 4.2.2 (e.g., 4.2.2.2) (and corresponding formulations, polynucleotides and organisms). In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–12, 17–24, 34–45, 48–54, 61, 80–81, 83–88, 91, and enzymatically active fragments/mutants/variants thereof. In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as one or more cellulases, one or more lyases and one or more pectinases; as one or more cellulases, one or more hemicellulases and one or more xylanases; two or more cellulases; two or more glucanases; two or more pectinases; one or more glucanses and one or more xylanases; one or more peptidases and one or more proteases. Downy mildew infestations/infections, such as those mediated by Bremia (e.g., B. lactucae), Hyaloperonospora (e.g., H. arabidopsidis, H. parasitica), Peronospora (e.g., P. belbahrii, P. destructor, P. effusa, P. farinose, P. fulva, P. lotorum, P. manshurica, P. parasitica, P. potentillae, P. rubi, P. schachtii, P. sparsa, P. tabacina, P. trifolii, P. viciae), Peronosclerospora, Plasmopara (e.g., P. halstedii, P. viticola) and Pseudoperonospora (e.g., P. cubensis, P. humuli), may be prevented, treated, suppressed and/or eliminated with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 3.2.1. (e.g., 3.2.1.8, 3.2.1.78) and/or 3.4.21 (e.g., 3.4.21.19, 3.4.21.62) (and corresponding formulations, polynucleotides and organisms). In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 48–53, 80–87, and enzymatically active fragments/mutants /variants thereof. Powdery mildew infestations/infections, such as those mediated by Blumeria (e.g., B. graminis), Erysiphe (e.g., E. cichoracearum, E. necator), Golovinomyces, Leveillula (e.g., L. taurica), Microsphaera (e.g., M. diffusa), Oidium, Phyllactinia, Podosphaera (e.g., P. aphanis, P. leucotricha, P. pannosa, P. xanthii), Sphaerotheca and Uncinula, may be prevented, treated, suppressed and/or eliminated with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 1.1.3 (e.g., 1.1.3.4), EC 1.11.1 (e.g., 1.11.1.6), 3.2.1 (e.g., 3.2.1.8, 3.2.15) and/or 3.4.21 (and corresponding formulations, polynucleotides and organisms). In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–5, 10–12, 48–53, 80– 81, and enzymatically active fragments/mutants /variants thereof. In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as two or more pectinases. Mold infestations/infections, such as those mediated by Botrytis (e.g., B. cinerea, B. elliptica), Penicillium (e.g., P. digitatum), Phytophthora (e.g., P. capsici, P. cinnamomi, P. ramorum, P. sojae), may be prevented, treated, suppressed and/or eliminated with myriad compositions of the present disclosure, including,
but not limited to, proteins exhibiting one or more activities belonging to EC 1.1.3 (e.g., 1.1.3.4), EC 1.1.99 (e.g., 1.1.99.18), 1.10.3 (e.g., 1.10.3.2), 1.11.1 (e.g., 1.11.1.6, 1.11.1.7), EC 1.14.99 (e.g., 1.14.99.56), EC 3.1.1 (e.g., 3.1.1.3, 3.1.1.5, 3.1.1.32), 3.2.1 (e.g., 3.2.1.1, 3.2.1.3, 3.2.1.4, 3.2.1.5, 3.2.1.6, 3.2.1.8, 3.2.1.11, 3.2.1.15, 3.2.1.17, 3.2.1.21, 3.2.1.24, 3.2.1.39, 3.2.1.41, 3.2.1.59, 3.2.1.75, 3.2.1.78, 3.2.1.101, 3.2.1.109, 3.2.1.110, 3.2.1.111, 3.2.1.112, 3.2.1.130, 3.2.1.133, 3.2.1.163, 3.2.1.198), 3.4.11 (e.g., 3.4.11.1), 3.4.21 (e.g., 3.4.21.62), 3.4.24 (e.g., 3.4.24.28) and/or 4.2.2 (e.g., 4.2.2.2) (and corresponding formulations, polynucleotides and organisms). In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–15, 17–24, 34–46, 48–54, 57–64, 68–69, 76–81, 83–88, 91, 45906, 72144, and enzymatically active fragments/mutants /variants thereof. In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as two or more cellulases; two or more pectinases; one or more cellulases, one or more hemicellulases and one or more xylanases; one or more peptidases and one or more proteases; one or more amylases, one or more glucanases and one or more bacillolysins; ; one or more cellulases, one or more hemicellulases and one or more xylanases; two or more peptidases; one or more glucanses and one or more xylanases; one or more peptidases and one or more proteases; one or more cellulases, one or more glucosidases and one or more xylanases; one or more cellulases, one or more furanosidases and one or more xylanases. Crown/fruit/root/stem rot infestations/infections, such as those mediated by Colletotrichum, Fusarium (e.g., F. solani, F. virguliforme), Phytophthora (e.g., P. capsica, P. cinnamomi, P. nicotianae, P. parasitica, P. sojae), Pythium (e.g., P. graminicola, P. ultimum), Saprolegnia (e.g., S. parasitica), may be prevented, treated, suppressed and/or eliminated with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 1.1.3 (e.g., 1.1.3.4), EC 1.1.99 (e.g., 1.1.99.18), 1.11.1 (e.g., 1.11.1.6), 3.2.1 (e.g., 3.2.1.6, 3.2.1.8, 3.2.1.11, 3.2.1.39, 3.2.1.58, 3.2.1.75, 3.2.1.109, 3.2.1.110, 3.2.1.111) and/or 3.4.21 (e.g., 3.4.21.19) (and corresponding formulations, polynucleotides and organisms). In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–13, 24, 34–41, 46, 48–54, 61, 78, 80–88, and enzymatically active fragments/mutants/variants thereof. In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as two or more cellulases; two or more pectinases; two or more glucanases; two or more peptidases; one or more amylases, one or more glucanases and one or more bacillolysins; one or more cellulases, one or more lyases and one or more pectinases; one or more cellulases, one or more hemicellulases and one or more xylanases; one or more glucanses and one or more xylanases; one or more peptidases and one or more proteases. Rust infestations/infections, such as those mediated by Albugo (e.g., A. candida, A. occidentalis), Hemileia (e.g., H. coffeicola, H. vastatrix), Melamspora (e.g., M. lini), Phakopsora (e.g., P. meibomiae, P. pachyrhizi), Puccinia (e.g., P. asparagi, P. cacahata, P. graminis, P. kuehnii, P. melanocephala, P. porri, P. punctiformis, P. recondita, P. schedonnardii, P. sessilis, P. sorghi, P. striiformis, P. tritici, P. triticina) and Uromyces (e.g., U. appendiculatus), may be prevented and/or treated with myriad compositions of the present
disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 1.1.3 (e.g., 1.1.3.4), 1.10.3 (e.g., 1.10.3.2), 3.1.1 (e.g., 3.1.1.5), 3.2.1 (e.g., 3.2.1.1, 3.2.1.3, 3.2.1.4, 3.2.1.5, 3.2.1.6, 3.2.1.8, 3.2.1.15, 3.2.1.41, 3.2.1.58, 3.2.1.78), 3.4.11 (e.g., 3.4.11.1), 3.4.21 (e.g., 3.4.21.19, 3.4.21.62) and/or 3.4.24 (e.g., 3.4.24.28) (and corresponding formulations, polynucleotides and organisms). In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–5, 9, 24, 34–46, 48–53, 61, 68, 80–88, 72144, and enzymatically active fragments/mutants /variants thereof. In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as two or more glucanases; one or more peptidases and one or more proteases; and one or more amylases, one or more glucanases and one or more bacillolysins Wilt infestations/infections, such as those mediated by Fusarium (e.g., F. oxysporum,), Phytophthora (e.g., P. capsici, P. infestans, P. ramorum), may be prevented, treated, suppressed and/or eliminated with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 1.1.3 (e.g., 1.1.3.4), EC 1.1.99 (e.g., 1.1.99.18), 1.10.3 (e.g., 1.10.3.2), 1.11.1 (e.g., 1.11.1.6), 3.1.1 (e.g., 3.1.1.5), 3.2.1 (e.g., 3.2.1.1, 3.2.1.3, 3.2.1.4, 3.2.1.5, 3.2.1.6, 3.2.1.8, 3.2.1.11, 3.2.1.15, 3.2.1.39, 3.2.1.41, 3.2.1.58, 3.2.1.75, 3.2.1.78, 3.2.1.111), 3.4.11 (e.g., 3.4.11.1), 3.4.21 (e.g., 3.4.21.19, 3.4.21.62) and/or 3.4.24 (e.g., 3.4.24.28) (and corresponding formulations, polynucleotides and organisms). In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 1–15, 17–24, 34–46, 48–55, 57, 68, 80–88, 72144, and enzymatically active fragments/mutants/variants thereof. In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as two or more cellulases; two or more pectinases; two or more glucanases; two or more peptidases; two or more pectinases; one or more cellulases, one or more hemicellulases and one or more xylanases; one or more glucanases and one or more xylanases; one or more amylases, one or more glucanases and one or more xylanases. In some embodiments, compositions of the present disclosure are useful for preventing, treating, suppressing, eliminating and/or reducing the severity of gastropod infestations by, for example, reducing attraction of a gastropod to a surface, inhibiting inhabitation by a gastropod, inhibiting feeding of a gastropod, inhibiting the growth of a gastropod, inhibiting the reproduction and/or proliferation of a gastropod, degrading on one or more structural components of a gastropod, killing a gastropod, and/or reducing one or more symptoms of a gastropod infestation. In some embodiments, such inhibition is complete or substantially complete, such that the gastropod fails to inhabit/feed/grow/reproduce/proliferate at a rate effective to initiate and/or sustain an appreciable infestation. For example, spraying a plant with an enzyme of the present disclosure may reduce the attractiveness of the plant to a gastropod, reduce a gastropod's desire/ability to inhabit the plant, inhibit a gastropod's desire/ability to feed on the plant, inhibiting the growth of a gastropod after it inhabits/feeds on the plant, inhibit the reproduction and/or proliferation of a gastropod on/in the plant, degrade one or more structural components of a gastropod on/in the plant, and/or kill a gastropod, thereby reducing one or more symptoms of infestation and/or enhancing one or more characteristics of growth and/or yield in the plant, as
compared to an untreated control plant. Compositions of the present disclosure may be used to prevent, treat, suppress, eliminate and/or reduce the severity of infestations of/by myriad gastropods, including, but not limited to, slugs and snails. In some embodiments, compositions of the present disclosure are useful for preventing, treating, suppressing, eliminating and/or reducing the severity of insect infestations by, for example, reducing attraction of an insect to a surface, inhibiting entry of an insect into a material, inhibiting inhabitation by an insect, inhibiting feeding of an insect, inhibiting production of one or more amino acids, degrading one or more amino acids, preventing an insect from utilizing one or more essential amino acids, producing ammonia in the gut of an insect, inhibiting the growth of an insect, inhibiting the reproduction and/or proliferation of an insect, degrading on one or more structural components of an insect (e.g. procuticle components, such as chitin, and epicuticle components, such as lipoproteins, hydrocarbons, polyphenols and esters of fatty acids and alcohols), killing an insect, and/or reducing one or more symptoms of an insect infestation. In some embodiments, such inhibition is complete or substantially complete, such that the insect fails to inhabit/feed/grow/reproduce/proliferate at a rate effective to initiate and/or sustain an appreciable infestation. For example, spraying a plant with an enzyme of the present disclosure may reduce the attractiveness of the plant to an insect, reduce an insect's desire/ability to inhabit the plant, inhibit an insect's desire/ability to feed on the plant, inhibit production of one or more amino acids, degrade one or more amino acids, prevent an insect from utilizing one or more essential amino acids, produce ammonia in the gut of an insect, inhibit the growth of an insect after it inhabits/feeds on the plant, inhibit the reproduction and/or proliferation of an insect on/in the plant, degrade one or more structural components of an insect (e.g. one or more chitins, one or more lipoproteins and/or one or more long chain hydrocarbons) on/in the plant, and/or kill an insect, thereby reducing one or more symptoms of infestation and/or enhancing one or more characteristics of growth and/or yield in the plant, as compared to an untreated control plant. Compositions of the present disclosure may be used to prevent and/or treat infestations of myriad insects, including, but not limited to, Coleoptera, Dermaptera, Diptera, Hemiptera, Homoptera, Hymenoptera, Lepidoptera, Orthoptera and Thysanoptera, such as aphids, armyworms, beetles, bollworms, bugs, caterpillars, cutworms, flies, moths and thrips. In some embodiments, enzymes of the present disclosure are used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation of by one or more Acalymma, Acanthaoscelides (e.g., A. obtectus, ), Anasa (e.g., A. tristis), Anastrepha (e.g., A. ludens), Anoplophora (e.g., A. glabripennis), Anthonomus (e.g., A. eugenii), Acyrthosiphon (e.g., A. pisum), Aphis (e.g., A. gossypii), Aulacorthum (e.g., A. solani), Bactrocera (e.g. ¸ B. dosalis), Bemisia (e.g., B. argentifolii, B. tabaci), Brevicoryne (e.g., B. brassicae), Bruchidius (e.g., B. atrolineatus), Bruchus (e.g., B. atomarius, B. dentipes, B. lentis, B. pisorum and/or B. rufipes), Callosobruchus (e.g., C. chinensis, C. maculatus, C. rhodesianus, C. subinnotatus, C. theobromae), Caryedon (e.g., C. serratus), Cassadinae, Ceratitis (e.g., C. capitata), Chrysomelinae, Circulifer (e.g., C. tenellus), Criocerinae, Cryptocephalinae, Cryptolestes (e.g., C. ferrugineus, C. pusillis, C. pussilloides), Cylas (e.g., C. formicarius), Delia (e.g., D. antiqua), Diabrotica, Diaphania (e.g.,
D. nitidalis), Diaphorina (e.g., D. citri), Donaciinae, Ephestia (e.g, E. cautella, E. elutella, E., keuhniella), Epilachna (e.g., E. varivestris), Epiphyas (e.g., E. postvittana), Eumolpinae, Galerucinae, Helicoverpa (e.g., H. zea), Heteroligus (e.g., H. meles), Iobesia (e.g., I. botrana), Lamprosomatinae, Lasioderma (e.g., L. serricorne), Leptinotarsa (e.g., L. decemLineata), Leptoglossus, Liriomyza (e.g., L. trifolii), Macrosiphoniella (e.g., M. sanborni), Macrosiphum (e.g., M. euphorbiae), Manducca, Melanoprus (e.g., M. bivitattus, M. differntialis, M. femurrubrum),, Melittia (e.g., M. cucurbitae), Myzus (e.g., M. persicae), Nezara (e.g., N. viridula), Orzaephilus (e.g., O. merator, O. surinamensis), Ostrinia (e.g., O. nubilalis), Phthorimaea (e.g., P. operculella), Pieris (e.g., P. rapae), Plodia (e.g., P. interpunctella), Plutella (e.g., P. xylostella), Popillia (e.g., P. japonica), Prostephanus (e.g., P. truncates), Psila, Rhizopertha (e.g., R. dominica), Rhopalosiphum (e.g., R. maidis), Sagrinae, Solenopsis (e.g., S. Invicta), Spilopyrinae, Sitophilus (e.g., S. granaries, S. oryzae and/or S. zeamais), Sitotroga (e.g., S. cerealella), Spodoptera (e.g., S. frugiperda), Stegobium (e.g., S. paniceum), Synetinae, Tenebrio (e.g., T. malens and/or T. molitor), Thrips (e.g., T. tabaci), Trialeurodes (e.g., T. vaporariorum), Tribolium (e.g., T. castaneum and/or T. confusum), Trichoplusia (e.g., T. ni), Trogoderma (e.g., T. granarium) and/or Trogossitidae (e.g., T. mauritanicus). Additional species of insects that may be targeted using enzymes, formulations, polynucleotides and organisms of the present disclosure may be found in CAPINERA, HANDBOOK OF VEGETABLE PESTS (2001) and Steffey and Gray, Managing Insect Pests, in ILLINOIS AGRONOMY HANDBOOK (2008). Compositions of the present disclosure may be particularly useful for preventing, treating, suppressing, eliminating and/or reducing the severity of infestations/infections of/by leaf-eating insects, such as aphids, beetles, grasshoppers, leaf-eating larvae, locusts, thrips and weevils. Leaf-eating insect infestations/infections, such as those mediated by leaf-eating larvae, may be prevented, treated, suppressed and/or eliminated with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 2.3.2 (e.g., 2.3.2.2), EC 3.1.1 (e.g., EC 3.1.1.3, EC 3.1.1.74), EC 3.2.1 (e.g., EC 3.2.1.24, EC 3.2.1.130, EC 3.2.1.163, EC 3.2.1.198), EC 3.5.1 (e.g., EC 3.5.1.1, EC 3.5.1.2, EC 3.5.1.33, EC 3.5.1.35) and EC 3.5.4 (e.g., EC 3.5.4.1, EC 3.5.4.2, EC 3.5.4.3, EC 3.5.4.4) (and corresponding formulations, polynucleotides and organisms). In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using one or more of SEQ ID NO(s): 16, 17–23, 27–31, 58, 76–77, 79, 89–90, 72147, 72149 and enzymatically active fragments/mutants/variants thereof. In some embodiments, such infestations/infections may be prevented, treated, suppressed and/or eliminated using a combination of enzymes, such as two or more amidases; two or more aminoacyltransferases; two or more asparaginases; two or more cutinases; two or more glutaminases; two or more mannanases; two or more mannosidases; two or more triacylglycerol lipases; one amidase and one aminoacyltransferase. In some embodiments, compositions of the present disclosure are useful for preventing, treating, suppressing, eliminating and/or reducing the severity of nematode infestations/infections by, for example, inhibiting adhesion of a nematode to a surface, inhibiting entry of a nematode into a material, inhibiting
habitation by a nematode, inhibiting production of one or more amino acids, degrading one or more amino acids, preventing a nematode from utilizing one or more essential amino acids, inhibiting the growth of a nematode, inhibiting the reproduction and/or proliferation of a nematode, degrading on one or more structural components of a nematode (e.g. cuticle components, such as collagens, cuticlins, glycoproteins and lipids), killing a nematode, and/or reducing one or more symptoms of a nematode infestation/infection. In some embodiments, such inhibition is complete or substantially complete, such that the nematode fails to inhabit/feed/grow/reproduce/proliferate at a rate effective to initiate and/or sustain an appreciable infestation/infection. For example, spraying a plant with an enzyme of the present disclosure may inhibit a nematode's ability to adhere to the surface of a plant, inhibit a nematode's ability to enter into the plant, inhibit a nematode's ability to inhabit the plant, inhibit growth of a nematode on/in the plant, inhibit the reproduction and/or proliferation of a nematode on/in the plant, degrade one or more structural components of a nematode (e.g., one or more collagens, one or more cuticlins, one or more glycoproteins and/or one or more lipids) on/in the plant, and/or kill a nematode, thereby reducing one or more symptoms of infestation and/or enhancing one or more characteristics of growth and/or yield in the plant, as compared to an untreated control plant. Compositions of the present disclosure may be used to prevent, treat, suppress, eliminate and/or reduce the severity of infestations/infections of/by myriad phytopathogenic nematodes, including, but not limited to, root-knot nematodes, cyst nematodes, burrowing nematodes, root lesion nematodes, wilt nematodes and reniform nematodes. In some embodiments, enzymes of the present disclosure are used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part by one or more Meloidogyne (e.g., M. arenaria, M. graminicola, M. hapla, M. incognita, M. javanica), Globodera (e.g., G. pallida, G. rostochiensis), Heterodera (e.g., H. avenae, H. filipjevi, H. glycines, H. schachtii), Pratylenchus (e.g., P. penetrans, P. thornei, P. neglectus, P. zae, P. vulnus, P. coffeae), Radopholus (e.g., R. similis), Ditylenchus (e.g., D. dipsaci, D. angustus, D. desctructor, D. africanus, D. myceliophagus, D. gigas), Bursaphelenchus (e.g., B. xylophilus, B. mucronatus), Rotylenchus (e.g., R. reniformis, R. parvus), Xiphinema (e.g., X. index, X. italiae, X. viuttenezi, X. diversicaudatun), and/or Nacobbus (e.g., N. aberrans). Additional examples of nematodes that may be targeted by enzymes, formulations, polynucleotides and organisms of the present disclosure may be found in CAPINERA, HANDBOOK OF VEGETABLE PESTS (2001) and Niblack, Nematodes, in ILLINOIS AGRONOMY HANDBOOK (2008) The present disclosure thus extends to methods of using compositions of the present disclosure (e.g., proteins, formulations, polynucleotides and organisms of the present disclosure) for a) preventing, treating, suppressing and/or eliminating infestations/infections of/by various pests, including, but not limited to, phytopathogenic pests, such as acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa, viruses and weeds; b) treating surfaces/substances that are susceptible to infestation/infection by pests; c) cleansing surfaces/substances that are infested/infected by pests; d) reducing one or more aspects of disease severity in plants and plant parts affected directly or indirectly by one or more phytopathogenic pests; e) enhancing the environments in which plants are grown; f) improving nutrient availability in plant growth media,
optionally boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc availability; g) improving nutrient uptake and/or accumulation by a plant or plant part, optionally boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc uptake/accumulation; h) reducing the amounts of exogenous fertilizer needed to achieve a desired result (e.g., the amount of exogenous nitrogen and/or phosphorous required to produce X kilograms of harvested plant material on a given parcel of land); i) improving one or more characteristics of plant growth and/or development; j) improving one or more characteristics of plant yield; k) prolonging the shelf-life of harvested plants and plant parts; l) delaying the ripening of a plant or plant part; m) hastening the ripening of a plant or plant part; n) improving the efficacy of one or more biological pesticides; o) preventing, treating, suppressing and/or eliminating biological-pesticide-induced pest resistance; p) preventing, treating, suppressing and/or eliminating biological-pesticide-induced phytotoxicity; q) improving the efficacy of one or more chemical pesticides; r) preventing, treating, suppressing and/or eliminating chemical-pesticide-induced pest resistance; and/or s) preventing, treating, suppressing and/or eliminating chemical-pesticide-induced phytotoxicity. In some embodiments, a protein that exhibits one or more oxidoreductase activities belonging to EC 1—for example, one or more oxidase activities belonging to EC 1.1.3 (e.g., glucose oxidase activity belonging to EC 1.1.3.4, hexose oxidase activity belonging to EC 3.1.1.5, galactose oxidase activity belonging to EC 1.1.3.9), EC 1.1.99 (e.g., cellobiose oxidase activity belonging to EC 1.1.99.18), EC 1.4.3 (e.g., D-aspartate oxidase activity belonging to EC 1.4.3.1, L-amino acid oxidase activity belonging to EC 1.4.3.2, D-amino acid oxidase activity belonging to EC 1.4.3.3, D-glutamate oxidase activity belonging to EC 1.4.3.7, L-glutamate oxidase activity belonging to EC 1.4.3.11, cyclohexylamine oxidase activity belonging to EC 1.4.3.12, protein- lysine 6-oxidase activity belonging to EC 1.4.3.13, L-lysine oxidase activity belonging to EC 1.4.3.14, D- glutamate(D-aspartate) oxidase activity belonging to EC 1.4.3.15, L-aspartate oxidase activity belonging to EC 1.4.3.16, glycine oxidase activity belonging to EC 1.4.3.19, L-lysine 6-oxidase activity belonging to EC 1.4.3.20, L-arginine oxidase activity belonging to EC 1.4.3.25), EC 1.10.3 (e.g., laccase activity belonging to EC 1.10.3.2), EC 1.11.1 (e.g., catalase activity belonging to EC 1.11.1.6, peroxidase activity belonging to EC 1.11.1.7, lignin peroxidase activity belonging to EC 1.11.1.14), EC 1.14.16 (e.g., phenylalanine 4- monooxygenase activity belonging to EC 1.14.16.1, tyrosine 3-monooxygenase activity belonging to EC 1.14.16.2, tryptophan 5-monooxygenase activity belonging to EC 1.14.16.4, phenylalanine 3-monooxygenase activity belonging to EC 1.14.16.7), EC 1.14.18 (e.g., tyrosinase activity belonging to EC 1.14.18.1) and/or EC 1.14.99 (e.g., lytic chitin monooxygenase activity belonging to EC 1.14.99.53, lytic cellulose monooxygenase activity belonging to EC 1.14.99.54, lytic starch monooxygenase activity belonging to EC 1.14.99.55, lytic cellulose monooxygenase activity belonging to EC 1.14.99.56, lytic cellulose monooxygenase activity belonging to EC 1.14.99.56)—or a corresponding formulation, polynucleotide, or organism, optionally a protein comprising, consisting essentially of, or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89,
90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 1–15 or a functional fragment/mutant/variant thereof (or a corresponding formulation, polynucleotide, or organism) is applied to a plant growth medium, plant, plant part (e.g., a seed), or agricultural/floricultural//horticultural/silvicultural apparatus/facility (e.g., an apparatus/facility for planting, irrigating, fertilizing, growing, monitoring, testing, harvesting, processing, packaging and/or storing a plant or plant part, such as a cultivator, seed container, seeder, planting pot, hydroponic growth system, growth chamber, greenhouse, laboratory, broadcaster, fertilization drill, fertilizer spreader, irrigation system, harvesting apparatus, postharvest storage container, postharvest treatment chamber, or postharvest shipping container) in an amount/concentration effective to a) prevent, treat, suppress and/or eliminate infestation/infection of said plant growth medium, plant, plant part or agricultural/floricultural/horticultural/silvicultural apparatus/facility o/by one or more phytopathogenic pests; b) cleanse said plant growth medium, plant, plant part, or agricultural/floricultural/horticultural/silvicultural apparatus/facility of one or more pest(s); c) prevent, treat, suppress and/or eliminate infestation/infection of a plant grown in said plant growth medium; d) reduce one or more aspects of disease severity in a plant grown in said plant growth medium; e) reduce one or more aspects of disease severity in said plant or plant part; f) prevent, treat, suppress and/or eliminate infestation/infection of a plant or plant part grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; g) reduce one or more aspects of disease severity in a plant or plant part grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; h) enhance one or more growth and/or development characteristics of a plant grown in said plant growth medium; i) enhance one or more growth and/or development characteristics of said plant or plant part; j) enhance one or more growth and/or development characteristics of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; k) enhance one or more yield characteristics of a plant grown in said plant growth medium; l) enhance one or more yield characteristics in said plant or plant part; m) enhance one or more yield characteristics of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; n) enhance the availability of one or more nutrients in said plant growth medium for uptake and/or accumulation by a plant grown therein, optionally boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc; o) enhance uptake and/or accumulation of one or more nutrients by said plant or plant part, optionally boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc; p) reduce the amount(s) of exogenous fertilizer needed to achieve a desired result (e.g., the amount of exogenous nitrogen and/or phosphorous required to produce X kilograms of harvested plant material); q) prolong the shelf-life of a plant grown in said plant growth medium; r) prolong the shelf-life of said plant or plant part; s) prolong the shelf-life of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; t) delay the ripening of a plant grown in said plant growth medium; u) delay the ripening of said plant or plant part; v) delay the ripening of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; w) hasten
the ripening of a plant grown in said plant growth medium; x) hastening the ripening of a plant or plant part; y) hasten the ripening of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; z) improve the efficacy of a biological pesticide that is applied to said plant, plant part, plant growth medium or agricultural/floricultural/horticultural/silvicultural apparatus/facility prior to, concurrently with, or after application of said protein (or corresponding formulation, polynucleotide, or organism); aa) prevent, treat, suppress and/or eliminate biological-pesticide-induced pest resistance of a plant grown in said plant growth medium; bb) prevent, treat, suppress and/or eliminate biological-pesticide-induced pest resistance of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; cc) improve the efficacy of a chemical pesticide that is applied to said plant, plant part, plant growth medium or agricultural/floricultural/horticultural/silvicultural apparatus/facility prior to, concurrently with, or after application of said protein (or corresponding formulation, polynucleotide, or organism); dd) prevent, treat, suppress and/or eliminate chemical-pesticide-induced pest resistance of a plant grown in said plant growth medium; and/or ee) prevent, treat, suppress and/or eliminate chemical-pesticide-induced pest resistance of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 1–15; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 1–15; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 92–106 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 1–15 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 1–15 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide exhibits one or more oxidoreductase activities. In some embodiments, a protein exhibiting activity belonging to EC 1.1—for example, a protein exhibiting activity belonging to EC 1.1.3 (e.g., EC 1.1.3.4) or EC 1.1.99 (e.g., EC 1.1.99.18)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Blumeria (e.g., B.
graminis), Botrytis (e.g., B. cinerea), Fusarium (e.g., F. graminearum, F. oxysporum, F. virguliforme), Magnaporthe (e.g., M. grisea, M. oryzae), Penicillium (e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum), Phakopsora (e.g., P. pachyrhizi), Phytophthora (e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P. sojae), Puccinia (e.g., P. striiformis) and Zymoseptoria (e.g., Z. tritici). For example, an oxidoreductase, optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 1–8, (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations/infections. In some embodiments, a protein exhibiting activity belonging to belonging to EC 1.10—for example, a protein exhibiting activity belonging to EC 1.10.3 (e.g., EC 1.10.3.2)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Botrytis (e.g., B. cinerea), Fusarium (e.g., F. graminearum, F. oxysporum, F. virguliforme), Phakopsora (e.g., P. pachyrhizi), Phytophthora (e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P. sojae) and Zymoseptoria (e.g., Z. tritici). For example, a oxidase, optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 9, (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations/infections. In some embodiments, a protein exhibiting activity belonging to EC 1.11—for example, a protein exhibiting activity belonging to EC 1.11.1 (e.g., EC 1.11.1.6 and EC 1.11.1.7)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Blumeria (e.g., B. graminis), Botrytis (e.g., B. cinerea), Fusarium (e.g., F. graminearum, F. oxysporum, F. virguliforme), Magnaporthe (e.g., M. grisea, M. oryzae), Penicillium (e.g., P. digitatum), Phakopsora (e.g., P. pachyrhizi), Phytophthora (e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P. sojae), Puccinia (e.g., P. striiformis) and Zymoseptoria (e.g., Z. tritici). For example, a peroxidase, optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 10–13, (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations/infections. In some embodiments, a protein exhibiting activity belonging to EC 1.14—for example, a protein
exhibiting activity belonging to EC 1.14.99 (e.g., EC 1.14.99.56)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Botrytis (e.g., B. cinerea), Fusarium (e.g., F. graminearum, F. oxysporum, F. virguliforme), Magnaporthe (e.g., M. grisea, M. oryzae), Penicillium (e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum), Phakopsora (e.g., P. pachyrhizi), Phytophthora (e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P. sojae) and Zymoseptoria (e.g., Z. tritici). For example, a oxygenase, optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 14–15, (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations/infections. In some embodiments, a protein that exhibits one or more transferase activities belonging to EC 2—for example, one or more aminoacyltransferase activities belonging to EC 2.3.2 (e.g., D-glutamyltransferase activity belonging to EC 2.3.2.1, gamma-glutamyltransferase activity belong to EC 2.3.2.2, aspartyltransferase activity belonging to EC 2.3.2.7, protein-glutamine gamma-glutamyltransferase activity belonging to EC 2.3.2.13, D-alanine gamma-glutamyl transferase activity belonging to EC 2.3.2.14)—or a corresponding formulation, polynucleotide, or organism, optionally a protein comprising, consisting essentially of, or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 16 or a functional fragment/mutant/variant thereof (or a corresponding formulation, polynucleotide, or organism) is applied to a plant growth medium, plant, plant part (e.g., a seed), or agricultural/floricultural/horticultural/silvicultural apparatus/facility (e.g., an apparatus/facility for planting, irrigating, fertilizing, growing, monitoring, testing, harvesting, processing, packaging and/or storing a plant or plant part, such as a cultivator, seed container, seeder, planting pot, hydroponic growth system, growth chamber, greenhouse, laboratory, broadcaster, fertilization drill, fertilizer spreader, irrigation system, harvesting apparatus, postharvest storage container, postharvest treatment chamber, or postharvest shipping container) in an amount/concentration effective to a) prevent, treat, suppress and/or eliminate infestation/infection of said plant growth medium, plant, plant part or agricultural/floricultural/horticultural/silvicultural apparatus/facility o/by one or more phytopathogenic pests; b) cleanse said plant growth medium, plant, plant part, or agricultural/floricultural/horticultural/silvicultural apparatus/facility of one or more pest(s); c) prevent, treat, suppress and/or eliminate infestation/infection of a plant grown in said plant growth medium; d) reduce one or more aspects of disease severity in a plant grown in said plant growth medium; e) reduce one or more aspects of disease severity in said plant or plant part; f) prevent, treat, suppress and/or eliminate infestation/infection of a plant or plant part grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; g) reduce one or more aspects of disease
severity in a plant or plant part grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; h) enhance one or more growth and/or development characteristics of a plant grown in said plant growth medium; i) enhance one or more growth and/or development characteristics of said plant or plant part; j) enhance one or more growth and/or development characteristics of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; k) enhance one or more yield characteristics of a plant grown in said plant growth medium; l) enhance one or more yield characteristics in said plant or plant part; m) enhance one or more yield characteristics of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; n) enhance the availability of one or more nutrients in said plant growth medium for uptake and/or accumulation by a plant grown therein, optionally boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc; o) enhance uptake and/or accumulation of one or more nutrients by said plant or plant part, optionally boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc; p) reduce the amount(s) of exogenous fertilizer needed to achieve a desired result (e.g., the amount of exogenous nitrogen and/or phosphorous required to produce X kilograms of harvested plant material); q) prolong the shelf-life of a plant grown in said plant growth medium; r) prolong the shelf-life of said plant or plant part; s) prolong the shelf-life of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; t) delay the ripening of a plant grown in said plant growth medium; u) delay the ripening of said plant or plant part; v) delay the ripening of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; w) hasten the ripening of a plant grown in said plant growth medium; x) hastening the ripening of a plant or plant part; y) hasten the ripening of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; z) improve the efficacy of a biological pesticide that is applied to said plant, plant part, plant growth medium or agricultural/floricultural/horticultural/silvicultural apparatus/facility prior to, concurrently with, or after application of said protein (or corresponding formulation, polynucleotide, or organism); aa) prevent, treat, suppress and/or eliminate biological-pesticide-induced pest resistance of a plant grown in said plant growth medium; bb) prevent, treat, suppress and/or eliminate biological-pesticide-induced pest resistance of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; cc) improve the efficacy of a chemical pesticide that is applied to said plant, plant part, plant growth medium or agricultural/floricultural/horticultural/silvicultural apparatus/facility prior to, concurrently with, or after application of said protein (or corresponding formulation, polynucleotide, or organism); dd) prevent, treat, suppress and/or eliminate chemical-pesticide-induced pest resistance of a plant grown in said plant growth medium; and/or ee) prevent, treat, suppress and/or eliminate chemical-pesticide-induced pest resistance of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity
to one or more of SEQ ID NO(s): 16; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 16; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 107 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 16 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 16 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide exhibits one or more transferase activities. In some embodiments, a protein exhibiting activity belonging to EC 2.3—for example, a protein exhibiting activity belonging to EC 2.3.2 (e.g., EC 2.3.2.2)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation of a plant or plant part of/by one or more leaf-eating insects. For example, an aminoacyltransferase, optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 16 (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations. In some embodiments, a protein that exhibits one or more hydrolase activities belonging to EC 3—for example, one or more esterase activities belonging to EC 3.1.1 (e.g., triacylglycerol lipase activity belong to EC 3.1.1.3, phospholipase A2 activity belonging to EC 3.1.1.4, lysophospholipase activity belonging to 3.1.1.5, pectinesterase activity belonging to 3.1.1.11, phospholipase A1 activity belonging to 3.1.1.32, lipoprotein lipase activity belonging to EC 3.1.1.34, cutinase activity belonging to 3.1.1.74), EC 3.1.3 (e.g., alkaline phosphatase activity belonging to EC 3.1.3.1, acid phosphatase activity belonging to EC 3.1.3.2, 3-phytase activity belonging to EC 3.1.3.8, glucose-6-phosphatase activity belonging to EC 3.1.3.9, glucose-1-phosphatase activity belonging to EC 3.1.3.10, fructose-biphosphatase activity belonging to EC 3.1.3.11, sugar-phosphatase activity belonging to EC 3.1.3.23, 4-phytase activity belonging to EC 3.1.3.26, fructose-2,6-biphosphate 2-phosphatase activity belonging to EC3.1.3.46, fructose-2,6-biphosphate 6-phosphatase activity belonging to EC 3.1.3.54, 5- phytase activity belonging to EC 3.1.3.72, lipid-phosphate phosphatase activity belonging to EC 3.1.3.76), and/or EC 3.1.4 (e.g., phospholipase C activity belonging to 3.1.4.3, phospholipase D activity belonging to EC
3.1.4.4, phoshoinositide phospholipase C activity belonging to 3.1.4.11),one or more glycosylase activities belonging to EC 3.2 (e.g., alpha-amylase activity belong to EC 3.2.1.1, beta-amylase activity belong to EC 3.2.1.2, glucan 1,4-alpha-glucosidase activity belong to 3.2.1.3, cellulase activity belong to 3.2.1.4, endo- 1,3(4)-beta-glucanase activity belong to 3.2.1.6, inulinase activity belong to 3.2.1.7, endo-1,4-beta-xylanase activity belong to 3.2.1.8, oligo-1,6-glucosidase activity belong to 3.2.1.10, dextranase activity belong to 3.2.1.11, chitinase activity belong to 3.2.1.14, endo-polygalacturonase (pectinase) activity belong to 3.2.1.15, lysozyme activity belong to 3.2.1.17, alpha-glucosidase activity belong to 3.2.1.20, beta-glucosidase activity belong to 3.2.1.21, alpha-galactosidase activity belong to 3.2.1.22, beta-galactosidase activity belong to 3.2.1.23, alpha-mannosidase activity belong to 3.2.1.24, beta-mannosidase activity belong to 3.2.1.25, beta- fructofuranosidase activity belong to 3.2.1.26, alpha,alpha-trehalase activity belong to 3.2.1.28, endo-1,3-beta- xylanase activity belong to 3.2.1.32, amylo-1,6-glucosidase activity belonging to EC3.2.1.33, xylan 1,4-beta- xylosidase activity belong to 3.2.1.37, glucan endo-1,3-beta-D-glucosidase activity belong to 3.2.1.39, pullulanase activity belong to 3.2.1.41, alpha-L-arabinofuranosidase activity belong to 3.2.1.55, glucan 1,3- beta-glucosidase activity belong to 3.2.1.58, glucan endo-1,3-alpha-glucosidase activity belong to 3.2.1.59, glucan 1,6-alpha-glucosidase activity belonging to EC 3.2.1.70, glucan endo-1,2-beta-glucosidase activity belonging to EC 3.2.1.71, xylan 1,3-beta-xylosidase activity belonging to EC 3.2.1.72, licheninase activity belong to 3.2.1.73, glucan 1,4-beta-glucosidase activity belonging to EC 3.2.1.74, glucan endo-1,6-beta- glucosidase activity belong to 3.2.1.75, mannan 1,2-(1,3)-alpha-mannosidase activity belonging to EC 3.2.1.77, mannan endo-1,4-β-mannosidase activity belonging to 3.2.1.78, glucan 1,3-alpha-glucosidase activity belonging to EC 3.2.1.84, cellulose 1,4-beta-cellobiosidase activity belong to 3.2.1.91, peptidoglycan beta-N- acetylmuramidase activity belonging to EC 3.2.1.92, endo-alpha-N-acetylgalactosaminidase activity belong to 3.2.1.97, mannan 1,4-mannobiosidase activity belonging to EC 3.2.1.100, mannan endo-1,6-alpha-mannosidase activity belong to 3.2.1.101, endogalactosaminidase activity belong to 3.2.1.109, 1,3-alpha-L-fucosidase activity belong to 3.2.1.111, 2-deoxyglucosidase activity belong to 3.2.1.112, glycoprotein endo-alpha-1,2- mannosidase activity belonging to EC 3.2.1.130, chitosanase activity belong to 3.2.1.132, glucan 1,4-alpha- maltohydrolase activity belong to 3.2.1.133, mannan exo-1,2-1,6-alpha-mannosidase activity belonging to EC 3.2.1.137, 1,6-alpha-D-mannosidase activity belonging to 3.2.1.163, 1,4-beta-cellobiosidase activity belonging to 3.2.1.176, galactan endo-beta-1,3-galactanase activity belonging to EC 3.2.1.181, alpha-mannan endo-1,2- alpha-mannanase activity belonging to EC 3.2.1.198, exo-chitinase activity belonging to EC 3.2.1.200, exo- chitinase activity belonging to EC 3.2.1.201), one or more aminopeptidase activities belonging to EC 3.4.11, one or more serine endopeptidase activities belonging to EC 3.4.21 (e.g., chymotrypsin activity belonging to EC 3.4.21.1, trypsin activity belonging to EC 3.4.21.4, alpha-lytic endopeptidase activity belonging to EC 3.4.21.12, glutamyl endopeptidase activity belonging to EC 3.4.21.19, cucumisin activity belonging to EC 3.4.21.25, chymase activity belonging to EC 3.4.21.39, lysyl endopeptidase activity belonging to EC 3.4.21.50, leucyl endopeptidase activity belonging to EC 3.4.21.57, subtilisin activity belonging to 3.4.21.62), one or more cysteine endopeptidase activities belonging to 3.4.22 (e.g., papain activity belonging to EC 3.4.22.2, actinidain
activity belonging to EC 3.4.22.14, caricain activity belonging to EC 3.4.22.30, ananain activity belonging to EC 3.4.22.31, bromelain activity belonging to EC 3.4.22.32, bromelain activity belonging to EC 3.4.22.33, legumain activity belonging to EC 3.4.22.34, zingipain activity belonging to EC 3.4.22.67), one or more aspartic endopeptidase activities belonging to EC 3.4.23 (e.g., phytepsin activity belonging to EC 3.4.23.40), one or more metalloendopeptidase activities belonging to EC 3.4.24 (e.g., bacillolysin activity belonging to EC 3.4.24.28), one or more amidohydrolase and amidase activities belonging to EC 3.5.1 (e.g., asparaginase activity belong to EC 3.5.1.1, glutaminase activity belonging to 3.5.1.2, amidase activity belonging to 3.5.1.4, urease activity belonging to 3.5.1.5, biotinidase activity belonging to 3.5.1.12, nicotinamidase activity belonging to 3.5.1.19, N-acetylglucosamine deacetylase activity belonging to EC 3.5.1.33, D-glutaminase activity belonging to 3.5.1.35, glutamin-(asparagin-)ase activity belonging to 3.5.1.38, chitin deacetylase activity belonging to 3.5.1.41, peptidyl-glutaminase activity belonging to 3.5.1.43, protein-glutamine glutaminase activity belonging to 3.5.1.44, pentanamidase activity belonging to 3.5.1.50, peptidoglycan-N- acetylglucosamine deacetylase activity belonging to EC 3.5.1.104), one or more aminidase/deiminase activities belonging to EC 3.5.3 (e.g., arginase activity belonging to EC 3.5.3.1, arginine deiminase activity belonging to EC 3.5.3.6, D-arginase activity belonging to EC 3.5.3.10, protein-arginine deiminase activity belonging to EC 3.5.3.15), and/or one or more deaminase activities belonging to EC 3.5.4 (e.g., cytosine deaminase activity belonging to EC 3.5.4.1, adenine deaminase activity belonging to EC 3.5.4.2, guanine deaminase activity belonging to EC 3.5.4.3, adenosine deaminase activity belonging to EC 3.5.4.4)—or a corresponding formulation, polynucleotide, or organism, optionally a protein comprising, consisting essentially of, or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 17–90, 45906, 72144, 72147 and 72149 or a functional fragment/mutant/variant thereof (or a corresponding formulation, polynucleotide, or organism) is applied to a plant growth medium, plant, plant part (e.g., a seed), or agricultural/floricultural/horticultural/silvicultural apparatus/facility (e.g., an apparatus/facility for planting, irrigating, fertilizing, growing, monitoring, testing, harvesting, processing, packaging and/or storing a plant or plant part, such as a cultivator, seed container, seeder, planting pot, hydroponic growth system, growth chamber, greenhouse, laboratory, broadcaster, fertilization drill, fertilizer spreader, irrigation system, harvesting apparatus, postharvest storage container, postharvest treatment chamber, or postharvest shipping container) in an amount/concentration effective to a) prevent, treat, suppress and/or eliminate infestation/infection of said plant growth medium, plant, plant part or agricultural/floricultural/horticultural/silvicultural apparatus/facility o/by one or more phytopathogenic pests; b) cleanse said plant growth medium, plant, plant part, or agricultural/floricultural/horticultural/silvicultural apparatus/facility of one or more pest(s); c) prevent, treat, suppress and/or eliminate infestation/infection of a plant grown in said plant growth medium; d) reduce one or more aspects of disease severity in a plant grown in said plant growth medium; e) reduce one or more aspects of disease severity in said plant or plant part; f) prevent, treat, suppress and/or eliminate infestation/infection of
a plant or plant part grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; g) reduce one or more aspects of disease severity in a plant or plant part grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; h) enhance one or more growth and/or development characteristics of a plant grown in said plant growth medium; i) enhance one or more growth and/or development characteristics of said plant or plant part; j) enhance one or more growth and/or development characteristics of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; k) enhance one or more yield characteristics of a plant grown in said plant growth medium; l) enhance one or more yield characteristics in said plant or plant part; m) enhance one or more yield characteristics of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; n) enhance the availability of one or more nutrients in said plant growth medium for uptake and/or accumulation by a plant grown therein, optionally boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc; o) enhance uptake and/or accumulation of one or more nutrients by said plant or plant part, optionally boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc; p) reduce the amount(s) of exogenous fertilizer needed to achieve a desired result (e.g., the amount of exogenous nitrogen and/or phosphorous required to produce X kilograms of harvested plant material); q) prolong the shelf-life of a plant grown in said plant growth medium; r) prolong the shelf-life of said plant or plant part; s) prolong the shelf-life of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; t) delay the ripening of a plant grown in said plant growth medium; u) delay the ripening of said plant or plant part; v) delay the ripening of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; w) hasten the ripening of a plant grown in said plant growth medium; x) hastening the ripening of a plant or plant part; y) hasten the ripening of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; z) improve the efficacy of a biological pesticide that is applied to said plant, plant part, plant growth medium or agricultural/floricultural/horticultural/silvicultural apparatus/facility prior to, concurrently with, or after application of said protein (or corresponding formulation, polynucleotide, or organism); aa) prevent, treat, suppress and/or eliminate biological-pesticide-induced pest resistance of a plant grown in said plant growth medium; bb) prevent, treat, suppress and/or eliminate biological-pesticide-induced pest resistance of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; cc) improve the efficacy of a chemical pesticide that is applied to said plant, plant part, plant growth medium or agricultural/floricultural/horticultural/silvicultural apparatus/facility prior to, concurrently with, or after application of said protein (or corresponding formulation, polynucleotide, or organism); dd) prevent, treat, suppress and/or eliminate chemical-pesticide-induced pest resistance of a plant grown in said plant growth medium; and/or ee) prevent, treat, suppress and/or eliminate chemical-pesticide-induced pest resistance of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility. In some embodiments, the protein is selected from the group consisting of:
a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 17–90, 45906, 72144, 72147 and 72149; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 17–90, 45906, 72144, 72147 and 72149; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 108–181, 72145–72146, 72148 and 72150 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 17–90, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 17–90, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide exhibits one or more hydrolase activities. In some embodiments, a protein exhibiting activity belonging to EC 3.1—for example, a protein exhibiting activity belonging to EC 3.1.1 (e.g., EC 3.1.1.3, EC 3.1.1.5, EC 3.1.1.11, and EC 3.1.1.74) and 3.1.4 (e.g., EC 3.1.4.3 and EC 3.1.4.11)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Botrytis (e.g., B. cinerea), Fusarium (e.g., F. graminearum, F. oxysporum, F. virguliforme), Magnaporthe (e.g., M. grisea, M. oryzae), Penicillium (e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum), Phakopsora (e.g., P. pachyrhizi), Phytophthora (e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P. sojae), Zymoseptoria (e.g., Z. tritici) and insects. For example, a hydrolase, optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 17–33, 72147 and 72149 (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations/infections. In some embodiments, a protein exhibiting activity belonging to EC 3.2—for example, a protein exhibiting activity belonging to EC 3.2.1 (e.g., EC 3.2.1.1, EC 3.2.1.3, EC 3.2.1.4, EC 3.2.1.6, EC 3.2.1.7, EC 3.2.1.8, EC 3.2.1.11, EC 3.2.1.15, EC 3.2.1.17, EC 3.2.1.21, EC 3.2.1.24, EC 3.2.1.39, EC 3.2.1.41, EC 3.2.1.55, EC 3.2.1.58, EC 3.2.1.59, EC 3.2.1.73, EC 3.2.1.75, EC 3.2.1.78, EC 3.2.1.101, EC 3.2.1.109, EC 3.2.1.130,
EC 3.2.1.133, EC 3.2.1.163 and EC 3.2.1.198)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Blumeria (e.g., B. graminis), Botrytis (e.g., B. cinerea), Fusarium (e.g., F. graminearum, F. oxysporum, F. virguliforme), Magnaporthe (e.g., M. grisea, M. oryzae), Penicillium (e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum), Phakopsora (e.g., P. pachyrhizi), Phytophthora (e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P. sojae), Pseudoperonospora (e.g., P. cubensis), Puccinia (e.g., P. striiformis), Zymoseptoria (e.g., Z. tritici) and insects. For example, a glycosylase, optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 34–79, 45906 and 72144, (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations/infections. In some embodiments, a protein exhibiting activity belonging to belonging to EC 3.4—for example, a protein exhibiting activity belonging to EC 3.4.11 (e.g., EC 3.4.11.1), EC 3.4.21 (e.g., EC 3.4.21.19, EC 3.4.21.62) and EC 3.4.24 (e.g., EC 3.4.24.28)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Blumeria (e.g., B. graminis), Botrytis (e.g., B. cinerea), Fusarium (e.g., F. graminearum, F. oxysporum, F. virguliforme), Magnaporthe (e.g., M. grisea, M. oryzae), Penicillium (e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum), Phakopsora (e.g., P. pachyrhizi), Phytophthora (e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P. sojae), Pseudoperonospora (e.g., P. cubensis), Puccinia (e.g., P. striiformis), Zymoseptoria (e.g., Z. tritici) and insects. For example, a peptidase, optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 80–88, (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations/infections. In some embodiments, a protein exhibiting activity belonging to EC 3.5—for example, a protein exhibiting activity belonging to EC 3.5.1 (e.g., EC 3.5.1.1 and EC 3.5.1.2)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Blumeria (e.g., B. graminis), Botrytis (e.g., B. cinerea), Penicillium (e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum) and insects. For example, a hydrolase, optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of
the amino acid sequences set forth herein as SEQ ID NO(s): 89–90 (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations/infections. In some embodiments, a protein that exhibits one or more lyase activities belonging to EC 4—for example, one or more carboxy-lyase activities belonging to EC 4.1.1 (e.g., aspartate 1-decarboxylase activity belonging to EC 4.1.1.11, aspartate 4-decarboxylase activity belonging to EC 4.1.1.12, valine decarboxylase activity belonging to EC 4.1.1.14, glutamate decarboxylase activity belonging to EC 4.1.1.15, lysine decarboxylase activity belonging to EC 4.1.1.18, arginine decarboxylase activity belonging to EC 4.1.1.19, histidine decarboxylase activity belonging to EC 4.1.1.22, tyrosine decarboxylase activity belonging to EC 4.1.1.25, phenylalanine decarboxylase activity belonging to EC 4.1.1.53, methionine decarboxylase activity belonging to EC 4.1.1.57, L-tryptophan decarboxylase activity belonging to EC 4.1.1.105), one or more carbon- carbon lyase activities belonging to EC 4.1.99 (e.g., tryptophanase activity belonging to EC EC 4.1.99.1, tyrosine phenol-lyase activity belonging to EC 4.1.99.2), one or more ammonia-lyase activities belonging to EC 4.3.1 (e.g., aspartate ammonia-lyase activity belonging to EC 4.3.1.1, histidine ammonia-lyase activity belong to EC 4.3.1.3, L-serine ammonia-lyase activity belonging to EC 4.3.1.17, D-serine ammonia-lyase activity belonging to EC 4.3.1.18, threonine ammonia-lyase activity belonging to EC 4.3.1.19, tyrosine ammonia-lyase activity belonging to EC 4.3.1.23, phenylalanine ammonia-lyase activity belonging to EC 4.3.1.24, phenylalanine/tyrosine ammonia-lyase activity belonging to EC 4.3.1.25, L-lysine cyclodeaminase activity belonging to EC 4.3.1.28, L-tryptophan ammonia-lyase activity belonging to EC 4.3.1.31), and/or one or more -sulfur lyase activities belonging to EC 4.4.1 (e.g., cysteine lyase activity belonging to EC 4.4.1.10, methionine gamma-lyase activity belonging to EC 4.4.1.11, L-cysteine desulfidase activity belonging to EC 4.4.1.28, L-cysteine beta-lyase activity belonging to EC 4.4.1.35)—or a corresponding formulation, polynucleotide, or organism, optionally a protein comprising, consisting essentially of, or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 55 and 91 or a functional fragment/mutant/variant thereof (or a corresponding formulation, polynucleotide, or organism) is applied to a plant growth medium, plant, plant part (e.g., a seed), or agricultural/floricultural/horticultural/silvicultural apparatus/facility (e.g., an apparatus/facility for planting, irrigating, fertilizing, growing, monitoring, testing, harvesting, processing, packaging and/or storing a plant or plant part, such as a cultivator, seed container, seeder, planting pot, hydroponic growth system, growth chamber, greenhouse, laboratory, broadcaster, fertilization drill, fertilizer spreader, irrigation system, harvesting apparatus, postharvest storage container, postharvest treatment chamber, or postharvest shipping container) in an amount/concentration effective to a) prevent, treat, suppress and/or eliminate infestation/infection of said plant growth medium, plant, plant part or agricultural/floricultural/horticultural/silvicultural apparatus/facility o/by one or more phytopathogenic pests; b) cleanse said plant growth medium, plant, plant part, or agricultural/floricultural/horticultural/silvicultural
apparatus/facility of one or more pest(s); c) prevent, treat, suppress and/or eliminate infestation/infection of a plant grown in said plant growth medium; d) reduce one or more aspects of disease severity in a plant grown in said plant growth medium; e) reduce one or more aspects of disease severity in said plant or plant part; f) prevent, treat, suppress and/or eliminate infestation/infection of a plant or plant part grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; g) reduce one or more aspects of disease severity in a plant or plant part grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; h) enhance one or more growth and/or development characteristics of a plant grown in said plant growth medium; i) enhance one or more growth and/or development characteristics of said plant or plant part; j) enhance one or more growth and/or development characteristics of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; k) enhance one or more yield characteristics of a plant grown in said plant growth medium; l) enhance one or more yield characteristics in said plant or plant part; m) enhance one or more yield characteristics of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; n) enhance the availability of one or more nutrients in said plant growth medium for uptake and/or accumulation by a plant grown therein, optionally boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc; o) enhance uptake and/or accumulation of one or more nutrients by said plant or plant part, optionally boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc; p) reduce the amount(s) of exogenous fertilizer needed to achieve a desired result (e.g., the amount of exogenous nitrogen and/or phosphorous required to produce X kilograms of harvested plant material); q) prolong the shelf-life of a plant grown in said plant growth medium; r) prolong the shelf-life of said plant or plant part; s) prolong the shelf-life of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; t) delay the ripening of a plant grown in said plant growth medium; u) delay the ripening of said plant or plant part; v) delay the ripening of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; w) hasten the ripening of a plant grown in said plant growth medium; x) hastening the ripening of a plant or plant part; y) hasten the ripening of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; z) improve the efficacy of a biological pesticide that is applied to said plant, plant part, plant growth medium or agricultural/floricultural/horticultural/silvicultural apparatus/facility prior to, concurrently with, or after application of said protein (or corresponding formulation, polynucleotide, or organism); aa) prevent, treat, suppress and/or eliminate biological-pesticide-induced pest resistance of a plant grown in said plant growth medium; bb) prevent, treat, suppress and/or eliminate biological-pesticide-induced pest resistance of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility; cc) improve the efficacy of a chemical pesticide that is applied to said plant, plant part, plant growth medium or agricultural/floricultural/horticultural/silvicultural apparatus/facility prior to, concurrently with, or after application of said protein (or corresponding formulation, polynucleotide, or organism); dd) prevent, treat, suppress and/or eliminate chemical-pesticide-induced pest resistance of a plant grown in said plant growth
medium; and/or ee) prevent, treat, suppress and/or eliminate chemical-pesticide-induced pest resistance of a plant grown in or contacted by said agricultural/floricultural/horticultural/silvicultural apparatus/facility. In some embodiments, the protein is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 91; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 91; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 182 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 91 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 91 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f) wherein the polypeptide exhibits one or more lyase activities. In some embodiments, a protein exhibiting activity belonging to belonging to EC 4.2—for example, a protein exhibiting activity belonging to EC 4.2.2 (e.g., EC 4.2.2.2, 4.2.2.10)—or a corresponding formulation, polynucleotide, or organism is used to prevent, treat, suppress, eliminate and/or reduce the severity of an infestation/infection of a plant or plant part of/by one or more Botrytis (e.g., B. cinerea), Fusarium (e.g., F. graminearum, F. oxysporum, F. virguliforme), Penicillium (e.g., P. digitatum, P. expansum, P. italicum, P. rugulosum, P. verrucosum), Puccinia (e.g., P. striiformis), Phytophthora (e.g., P. capsici, P. cinnamomi, P. infestans, P. parasitica, P. ramorum, P. sojae), Puccinia (e.g., P. striiformis), Zymoseptoria (e.g., Z. tritici) and insects. For example, a carbon-oxygen lyase, optionally a protein comprising, consisting essentially of or consisting of an amino acid sequence that is about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % identical to one or more of the amino acid sequences set forth herein as SEQ ID NO(s): 55 and 91, (or a corresponding formulation, polynucleotide, or organism) may be applied to a plant or plant part to prevent, treat, suppress, eliminate and/or reducing the severity of such infestations/infections. In some embodiments, the protein comprises, consists essentially of, or consists of a wild-type polypeptide. For example, in some embodiments, the protein comprises, consists essentially of, or consists of a wild-type polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77,
78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof. In some embodiments, the protein comprises, consists essentially of, or consists of a variant polypeptide. For example, in some embodiments, the protein comprises, consists essentially of, or consists of a variant polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof. In some embodiments, the protein comprises, consists essentially of or consists of a catalytic domain, a binding module and a linker between said catalytic domain and said binder module. In some embodiments, the protein comprises two or more catalytic domains. In some embodiments, the protein comprises two or more binding modules. In some embodiments, the protein is a fusion protein comprising a first polypeptide and a second polypeptide, said second polypeptide being distinct from said first polypeptide, wherein said first polypeptide is selected from the group consisting of: a) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; b) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; c) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA sequence thereof; d) a polypeptide derived from any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; e) a polypeptide derived from a mature polypeptide any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; f) a polypeptide derived from the polypeptide of any one of a) through e) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and g) a fragment of the polypeptide of any one of a) through f), and, optionally, wherein said second polypeptide is selected from the group consisting of: h) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; i) a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76,
77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149; j) a polypeptide encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA sequence thereof; k) a polypeptide derived from any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; l) a polypeptide derived from a mature polypeptide any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids; m) a polypeptide derived from the polypeptide of any one of h) through l) wherein the N- and/or C- terminal end has been extended by the addition of one or more amino acids; and n) a fragment of the polypeptide of any one of h) through m). The present disclosure encompasses methods of using one or more compositions of the present disclosure for enhancing the environments in which plants are grown by, for example, changing the pH of the environment, increasing the availability of nutrients, stimulating beneficial microorganisms and/or suppressing/eliminating harmful microorganisms. The present disclosure encompasses methods of using one or more compositions of the present disclosure for improving plant growth, development and/or yield characteristics by, for example, increasing nutrient availability, increasing nutrient uptake, improving nutrient uptake efficiency, improving water use efficiency, stimulating the production of plant growth promoters, stimulating plant defense mechanisms, and/or preventing, treating, suppressing, eliminating and/or reducing the severity of pest infestations/infections. The present disclosure encompasses methods of using one or more compositions of the present disclosure for increasing the availability of one or more nutrients by, for example, fixing atmospheric nitrogen, retaining nitrogen in different oxidation stages, solubilizing phosphate, releasing organic acids, and/or solubilizing micronutrients. For example, introducing an enzyme of the present disclosure into soil in the vicinity of a plant may increase the bioavailability of one or more vitamins, macrominerals, micronutrients, organic acids and/or trace minerals, as compared to a control soil lacking said enzyme. Nitrogen bioavailability may be increased with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 1.18.6 (e.g., EC 1.18.6.1), EC 3.1.1 (e.g., EC 3.1.1.4, 3.1.1.32) and EC 3.1.4 (e.g., EC 3.1.4.3, EC 3.1.4.4, EC 3.1.4.11) (and corresponding formulations, polynucleotides and organisms). In some embodiments, nitrogen bioavailability is increased using one or more of SEQ ID NO(s): 26 and 32–33, and enzymatically active fragments/mutants/variants thereof. Phosphate bioavailability may be increased with myriad compositions of the present disclosure, including, but not limited to, proteins exhibiting one or more activities belonging to EC 3.1.3 (e.g., EC 3.1.3.1,
EC 3.1.3.2, EC 3.1.3.26), 3.1.4 (e.g., EC 3.1.4.3, EC 3.1.4.4, EC 3.1.4.11) and 3.1.21 (e.g., EC 3.1.21.1) (and corresponding formulations, polynucleotides and organisms). In some embodiments, phosphate bioavailability is increased using one or more of SEQ ID NO(s): 32–33, and enzymatically active fragments/mutants/variants thereof. The present disclosure encompasses methods of using one or more compositions of the present disclosure for prolonging the shelf-life of harvested plants or plant parts by, for example, treating (e.g., coating) harvested plants and plant parts directly and/or treating post-harvest transport/storage containers. See generally, e.g., US 2019/159470; US 2020/022719; US 2020/352183; US 2011/244095; FR 3038495; WO 2022/049139. The present disclosure encompasses methods of using one or more compositions of the present disclosure for reducing the need for chemical pesticides by, for example, reducing chemical pesticide-induced phytotoxicity, pest resistance, etc. Compositions of the present disclosure may be applied to / used to treat any plant type, including, but not limited to, row crops and vegetables. In some embodiments, compositions of the present disclosure are formulated for the treatment of one or more plants selected from the families Amaranthaceae (e.g., chard, spinach, sugar beet, quinoa), Asteraceae (e.g., artichoke, asters, chamomile, chicory, chrysanthemums, dahlias, daisies, echinacea, goldenrod, guayule, lettuce, marigolds, safflower, sunflowers, zinnias), Brassicaceae (e.g., arugula, broccoli, bok choy, Brussels sprouts, cabbage, cauliflower, canola, collard greens, daikon, garden cress, horseradish, kale, mustard, radish, rapeseed, rutabaga, turnip, wasabi, watercress, Arabidopsis thaliana), Caricaceae (e.g., papaya), Cucurbitaceae (e.g., cantaloupe, cucumber, honeydew, melon, pumpkin, squash (e.g., acorn squash, butternut squash, summer squash), watermelon, zucchini), Fabaceae (e.g., alfalfa, beans, carob, clover, guar, lentils, mesquite, peas, peanuts, soybeans, tamarind, tragacanth, vetch), Malvaceae (e.g., cacao, cotton, durian, hibiscus, kenaf, kola, okra), Poaceae (e.g., bamboo, barley, corn, fonio, lawn grass (e.g., Bahia grass, Bermudagrass, bluegrass, Buffalograss, Centipede grass, Fescue, or Zoysia), millet, oats, ornamental grasses, rice, rye, sorghum, sugar cane, triticale, wheat and other cereal crops, Polygonaceae (e.g., buckwheat), Rosaceae (e.g., almonds, apples, apricots, blackberry, blueberry, cherries, peaches, plums, quinces, raspberries, roses, strawberries), Solanaceae (e.g., bell peppers, chili peppers, eggplant, petunia, potato, tobacco, tomato) and Vitaceae (e.g., grape). Non-limiting examples of plants that may be treated with compositions of the present disclosure include plants sold under the ACCELERON®, AGRIPRO®, AGRISURE®, AGROESTE®, AGVENTURE®, ALFOREX™, ASGROW®, AQUAMAX®, BOLLGARD II™, BOLLGARD™ 3, BREVANT™, CHANNEL™, CONFIDOR™, CORTEVA AGRISCIENCE™, CORVUS™, CREDENZ®, CROPSTAR™, DAIRYLAND™, DEKALB®, DELTAPINE™, DERUITER™, DROUGHTGARD®, ENLIST E3®, ENOGEN®, FIBERMAX®, GAUCHO™, GENUITY®, GOLDENHARVEST®, HOEGEMEYER™, INTACTA RR2 PRO™, INVIGOR®, LIBERTY LINK®, NEXGROW®, NK®, NUTECH SEED®, OPTIMUM®, PHYTOGEN®, PIONEER®, QROME®, RIB COMPLETE®, ROUNDUP READY®, ROUNDUP READY 2 YIELD®, ROUNDUP READY 2 XTEND®, SEMETES AGROCERES™,
SEMINIS™, SMARTSTAX®, STONEVILLE®, SYNGENTA®, TRUFLEX™, VT DOUBLE PRO®, VT TRIPLE PRO®, YIELDGARD®, YIELDGARD VT ROOTWORM/RR2®, YIELDGARD VT TRIPLE® and/or XTENDFLEX™ tradenames. Compositions of the present disclosure may be applied to any part/portion of a plant. In some embodiments, the compositions are applied to plant propagation materials (e.g., cuttings, rhizomes, seeds and tubers). In some embodiments, the compositions are applied to the roots of a plant. In some embodiments, the compositions are applied to the foliage of a plant. In some embodiments, the compositions are applied to both the roots and the foliage of a plant. In some embodiments, the compositions are applied to plant propagation materials and to the plants that grow from said plant propagation materials. Compositions of the present disclosure may be applied to any plant growth medium, including, but not limited to, soil. Compositions of the present disclosure may be applied to plants, plant parts and/or plant growth media in any suitable manner, including, but not limited to, on-seed application, in-furrow application and foliar application. Compositions of the present disclosure may be applied using any suitable method(s), including, but not limited to, coating, dripping, dusting, encapsulating, fogging, immersing, spraying, and soaking. Batch systems, in which predetermined batch sizes of material and composition are delivered into a mixer, may be employed. Continuous treatment systems, which are calibrated to apply composition at a predefined rate in proportion to a continuous flow of material, may also be employed. In some embodiments, compositions of the present disclosure are applied directly to plant propagation material (e.g., seeds). According to some embodiments, plant propagation materials are soaked in a composition of the present disclosure for at least 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.25, 1.5, 1.75, 2, 3, 4, 5, 6, 9, 12, 15, 18, 21, 24, 36, 48 hours. According to some embodiments, plant propagation materials are coated with the compositions. Plant propagation materials may be coated with one or more additional layers (e.g., one or more protective layers that serve to enhance the stability and/or activity of an enzyme/organism of the present disclosure and/or one or more sequestration layers comprising substances that may reduce the stability and/or activity of an enzyme/organism of the present disclosure if included in the same layer as the enzyme/organism of the present disclosure). In some embodiments, the coating comprises, consists essentially of, or consists of a composition of the present disclosure and a drying powder. In some embodiments, compositions of the present disclosure are applied directly to a plant growth medium (e.g., a soil). According to some embodiments, the compositions are applied in the vicinity of a plant propagation material (e.g., a seed). According to some embodiments, the compositions are applied to the root zone of a plant. According to some embodiments, the compositions are applied using a drip irrigation system. In some embodiments, compositions of the present disclosure are applied directly to plants. According to some embodiments, the compositions are fogged, misted, sprayed and/or sprinkled onto the plant(s) to be treated (e.g., foliar sprays).
In some embodiments, compositions of the present disclosure are applied to harvested plants and/or plant parts. Individual components of the compositions (e.g., proteins of the present disclosure and chemical pesticides) may be applied separately or together. For example, in some embodiments, compositions of the present disclosure may be incorporated into integrated pest management strategies (e.g., a formulation comprising one or more proteins of the present disclosure may be applied to an orchard/vineyard as part of an integrated pest management strategy that includes separate applications of 2, 3, 4, 5 or more distinct pesticides in a rotation designed to reduce/prevent chemical pesticide-induced phytotoxicity and/or pest resistance). In some embodiments, compositions of the present disclosure are freeze- spray- or spray-freeze-dried and then applied to plants/plant parts. For examples, in some embodiments, a formulation comprising and enzyme/organism of the present disclosure and one or more stabilizing components (e.g., one or more maltodextrins having a DEV of about 15 to about 20) is freeze- spray- or spray-freeze-dried, mixed with a drying powder (e.g., a drying powder comprising calcium stearate, attapulgite clay, montmorillonite clay, graphite, magnesium stearate, silica (e.g., fumed silica, hydrophobically-coated silica and/or precipitated silica) and/or talc), then coated on seed that was been pre-treated with one or more adhesives (e.g., an adhesive composition comprising one or more maltodextrins, one or more mono-, di- or oligosaccharides, one or more peptones, etc.), one or more pesticides and/or one or more plant signal molecules (e.g., one or more LCOs). See, generally, e.g., US 11472981; US 2020/0085065; US 10820594. Compositions of the present disclosure may be applied to plant growth media (e.g., soil), plants, plant parts and agricultural/floricultural/horticultural/silvicultural apparatuses/facilities at any time, including, but not limited to, prior to planting, at the time of planting, after planting, prior to germination, at the time of germination, after germination, prior to seedling emergence, at the time of seedling emergence, after seedling emergence, prior to the vegetative stage, during the vegetative stage, after the vegetative stage, prior to the reproductive stage, during the reproductive stage, after the reproductive stage, prior to flowering, at the time of flowering, after flowering, prior to fruiting, at the time of fruiting, after fruiting, prior to ripening, at the time of ripening, after ripening, prior to harvest, at the time of harvest, and after harvesting. Indeed, compositions of the present disclosure may be used to extend the shelf-life of harvested products by preventing, treating, suppressing, eliminating and/or reducing the severity of infestations/infections of/by acarids, bacteria, fungi, insects, oomycetes and protozoa for many weeks/months post-harvest. In some embodiments, compositions of the present disclosure are applied to plant growth media prior to introducing a plant into the plant growth media (e.g., prior to planting seed). In some embodiments, compositions of the present disclosure are applied to plant growth media concurrently with the introduction of a plant into the plant growth media (e.g., at the time of planting). In some embodiments, compositions of the present disclosure are applied to plant growth media after introducing a plant into the plant growth media (e.g., by drip irrigation following planting). In some embodiments, compositions of the present disclosure are applied to plant propagation materials
(e.g., seeds) about/at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 28, 32, 36, 40, 44, 48, 52, 56, 60, 64, 68, 72, 76, 80, 84, 88, 92, 96, 100, 104 weeks prior to planting. In some embodiments, compositions of the present disclosure are applied to plant propagation materials (e.g., seeds) at the time of planting. In some embodiments, compositions of the present disclosure are applied to plant propagation materials (e.g., seeds) after planting but before germination. In some embodiments, compositions of the present disclosure are applied to plants following emergence. In some embodiments, compositions of the present disclosure are applied to a plant or plant part pre- harvest (i.e., within 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or more days before the plant or plant part is (to be) harvested). In some embodiments, compositions of the present disclosure are applied to a plant or plant part post- harvest (i.e., after the plant or plant part has been harvested). In some embodiments, compositions of the present disclosure are applied to a harvested plant or plant part at a processing/shipping facility. In some embodiments, compositions of the present disclosure are applied to a processed plant product. In some embodiments, compositions of the present disclosure are applied to an agricultural, floricultural, horticultural and/or silvicultural apparatus/facility prior to contacting a plant or plant part with or introducing a plant or plant part into said apparatus/facility. In some embodiments, compositions of the present disclosure are applied to an agricultural, floricultural, horticultural and/or silvicultural apparatus/facility concurrently with contacting a plant or plant part with or introducing a plant or plant part into said apparatus/facility. In some embodiments, compositions of the present disclosure are applied to an agricultural, floricultural, horticultural and/or silvicultural apparatus/facility after contacting a plant or plant part with or introducing a plant or plant part into said apparatus/facility. Compositions of the present disclosure may be applied to plants, plant parts and/or plant growth media in any suitable amount(s)/concentration(s). In some embodiments, compositions of the present disclosure comprise one or more proteins of the present disclosure in an amount ranging from about 0.001 to about 100 milligrams per gram and/or milliliter of composition. For example, compositions of the present disclosure may comprise about/at least 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100 milligrams of protein per gram and/or milliliter of composition. In some embodiments, compositions of the present disclosure comprise about/at least 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, or 0.5 milligrams of protein
per gram and/or milliliter of composition. In some embodiments, one or more proteins of the present disclosure comprise about 0.00000001 to about 95% (by weight) of the composition. In some embodiments, one or more proteins of the present disclosure comprise about/at least 1 x 10-15, 1 x 10-14, 1 x 10-13, 1 x 10-12, 1 x 10-11, 1 x 10-10, 1 x 10-9, 1 x 10-8, 1 x 10-7, 1 x 10-6, 1 x 10-5, 1 x 10-4, 1 x 10-3, 1 x 10-2, 1 x 10-1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95% or more (by weight) of the composition. In some embodiments, the composition is applied at a rate that is equivalent to about 1 x 101 to about 1 x 1015 enzyme units (at optimum conditions) of each protein of the present disclosure per kilogram of plant propagation material. According to some embodiments, compositions of the present disclosure are applied in an amount sufficient to ensure the plant propagation materials are coated with about/at least 1 x 101, 1 x 102, 1 x 103, 1 x 104, 1 x 105, 1 x 106, 1 x 107, 1 x 108, 1 x 109, 1 x 1010, 1 x 1011, 1 x 1012, 1 x 1013, 1 x 1014 or 1 x 1015 enzyme units (at optimum conditions) of each protein of the present disclosure per kilogram of plant propagation material. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure that an average of about/at least 1 x 104, 1 x 105, 1 x 106, 1 x 107, 1 x 108, 1 x 109, 1 x 1010, 1 x 1011, or 1 x 1012 enzyme units (at optimum conditions) of each protein of the present disclosure is applied to each seed. In some embodiments, the composition is applied at a rate that is equivalent to about 1 x 101 to about 1 x 1015 enzyme units (at optimum conditions) of each protein of the present disclosure per plant. According to some embodiments, compositions of the present disclosure are applied in an amount sufficient to ensure each plant is treated with about/at least 1 x 101, 1 x 102, 1 x 103, 1 x 104, 1 x 105, 1 x 106, 1 x 107, 1 x 108, 1 x 109, 1 x 1010, 1 x 1011, 1 x 1012, 1 x 1013, 1 x 1014 or 1 x 1015 enzyme units (at optimum conditions) of each protein of the present disclosure. According to some embodiments, compositions of the present disclosure are applied in an amount sufficient to ensure that an average of about/at least 1 x 104, 1 x 105, 1 x 106, 1 x 107, 1 x 108, 1 x 109, 1 x 1010, 1 x 1011, or 1 x 1012 enzyme units (at optimum conditions) of each protein of the present disclosure is applied to each plant. In some embodiments, the composition is applied at a rate that is equivalent to about 1 x 101 to about 1 x 1015 enzyme units (at optimum conditions) of each protein of the present disclosure per hectare/acre of treated crops. According to some embodiments, compositions of the present disclosure are applied in an amount sufficient to ensure each hectare/acre of treated crops is treated with about/at least 1 x 101, 1 x 102, 1 x 103, 1 x 104, 1 x 105, 1 x 106, 1 x 107, 1 x 108, 1 x 109, 1 x 1010, 1 x 1011, 1 x 1012, 1 x 1013, 1 x 1014 or 1 x 1015 enzyme units (at optimum conditions) of each protein of the present disclosure. According to some embodiments, compositions of the present disclosure are applied in an amount sufficient to ensure that an average of about/at least 1 x 104, 1 x 105, 1 x 106, 1 x 107, 1 x 108, 1 x 109, 1 x 1010, 1 x 1011, or 1 x 1012 enzyme units (at optimum conditions) of each protein of the present disclosure is applied to each hectare/acre of treated crops.
In some embodiments, the composition is applied at a rate that is equivalent to about 1 x 101 to about 1 x 1015 enzyme units (at optimum conditions) of each protein of the present disclosure per hectare/acre of plant growth media. According to some embodiments, compositions of the present disclosure are applied in an amount sufficient to ensure each hectare/acre of plant growth media is treated with about/at least 1 x 101, 1 x 102, 1 x 103, 1 x 104, 1 x 105, 1 x 106, 1 x 107, 1 x 108, 1 x 109, 1 x 1010, 1 x 1011, 1 x 1012, 1 x 1013, 1 x 1014 or 1 x 1015 enzyme units (at optimum conditions) of each protein of the present disclosure. According to some embodiments, compositions of the present disclosure are are applied in an amount sufficient to ensure that an average of about/at least 1 x 104, 1 x 105, 1 x 106, 1 x 107, 1 x 108, 1 x 109, 1 x 1010, 1 x 1011, or 1 x 1012 enzyme units (at optimum conditions) of each protein of the present disclosure is applied to each hectare/acre of plant growth media. In some embodiments, the composition is applied at a rate that is equivalent to about 1 x 101 to about 1 x 1015 enzyme units (at optimum conditions) of each protein of the present disclosure per square inch/foot of surface area on an agricultural/floricultural/horticultural/silvicultural apparatus/facility. According to some embodiments, compositions of the present disclosure are applied in an amount sufficient to ensure each square inch/foot is treated with about/at least 1 x 101, 1 x 102, 1 x 103, 1 x 104, 1 x 105, 1 x 106, 1 x 107, 1 x 108, 1 x 109, 1 x 1010, 1 x 1011, 1 x 1012, 1 x 1013, 1 x 1014 or 1 x 1015 enzyme units (at optimum conditions) of each protein of the present disclosure. According to some embodiments, compositions of the present disclosure are are applied in an amount sufficient to ensure that an average of about/at least 1 x 104 , 1 x 10 5 , 1 x 10 6 , 1 x 10 7 , 1 x 108, 1 x 109, 1 x 1010, 1 x 1011, or 1 x 1012 enzyme units (at optimum conditions) of each protein of the present disclosure is applied to each square inch/foot. In some embodiments, the composition is applied at a rate that is equivalent to about 0.001 to about 100 milligrams of protein of the present disclosure per kilogram of plant propagation material. According to some embodiments, compositions of the present disclosure are applied in an amount sufficient to ensure the plant propagation materials are coated with about/at least 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100 milligrams of protein of the present disclosure per kilogram of plant propagation material. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, or 0.5 milligrams of protein of the present disclosure is applied to each seed. In some embodiments, the composition is applied at a rate that is equivalent to about 0.001 to about 100 milligrams of protein of the present disclosure per plant. According to some embodiments, compositions of the present disclosure are applied in an amount sufficient to ensure each plant is treated with about/at least 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2,
2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100 milligrams of protein of the present disclosure. According to some embodiments, compositions of the present disclosure are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, or 0.5 milligrams of protein of the present disclosure are applied to each plant. In some embodiments, the composition is applied at a rate that is equivalent to about 0.001 to about 100 milligrams of protein of the present disclosure per hectare/acre of treated crops. According to some embodiments, compositions of the present disclosure are applied in an amount sufficient to ensure each hectare/acre of treated crops is treated with about/at least 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100 milligrams of protein of the present disclosure. According to some embodiments, compositions of the present disclosure are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, or 0.5 milligrams of protein of the present disclosure are applied to each hectare/acre of treated crops. In some embodiments, the composition is applied at a rate that is equivalent to about 0.001 to about 100 milligrams of protein of the present disclosure per hectare/acre of plant growth media. According to some embodiments, compositions of the present disclosure are applied in an amount sufficient to ensure each hectare/acre of plant growth media is treated with about/at least 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100 milligrams of protein of the present disclosure. According to some embodiments, compositions of the present disclosure are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.4, 0.45, or 0.5 milligrams of protein of the present disclosure are applied to each hectare/acre of plant growth media. In some embodiments, compositions of the present disclosure are applied at a rate of about 0.05 to about 100 milliliters and/or grams of composition per kilogram of plant propagation material. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant propagation materials are coated with about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 milliliters and/or grams of compositions per kilogram of plant propagation material. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5,
0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75 or 5 milliliters and/or grams of composition is applied to each seed. In some embodiments, compositions of the present disclosure are applied at a rate of about 0.5 to about 100 milliliters and/or grams of composition per plant. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure each plant is treated with about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 milliliters and/or grams of composition. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75 or 5 milliliters and/or grams of composition is applied to each plant. In some embodiments, compositions of the present disclosure are applied at a rate of about 0.5 to about 100 milliliters and/or grams of composition per hectare/acre of treated crops. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure each hectare/acre of treated crops is treated with about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 milliliters and/or grams of composition. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75 or 5 milliliters and/or grams of composition is applied to each hectare/acre of treated crops. In some embodiments, compositions of the present disclosure are applied at a rate of about 0.5 to about 100 milliliters and/or grams of composition per hectare/acre of plant growth media. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure each hectare/acre of plant growth media is treated with about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 milliliters and/or grams of composition. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75 or 5 milliliters and/or grams of composition is applied to each
hectare/acre of plant growth media. In some embodiments, compositions of the present disclosure are applied at a rate of about 0.5 to about 100 milliliters and/or grams of composition per square inch/foot of surface area on an agricultural/floricultural/horticultural/silvicultural apparatus/facility. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure each square inch/foot is treated with about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10, 20, 30, 40, 50, 60, 70, 80, 90 or 100 milliliters and/or grams of composition. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure that an average of about/at least 0.05, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.2.5, 0.275, 0.3, 0.325, 0.35, 0.375, 0.4, 0.425, 0.45, 0.475, 0.5, 0.55, 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, 0.9, 0.95, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75 or 5 milliliters and/or grams of composition is applied to each square inch/foot. In some embodiments, compositions of the present disclosure are applied at a rate sufficient to prevent, treat, suppress and/or eliminate one or more pest infestations/infections. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to prevent, treat, suppress and/or eliminate infestation/infection by 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or more phytopathogenic pests. In some embodiments, compositions of the present disclosure are applied at a rate sufficient to reduce one or more aspects of disease severity. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to reduce one or more aspects of disease severity by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100%, as compared to an untreated control. In some embodiments, compositions of the present disclosure are applied at a rate sufficient to enhance nutrient availability, uptake and/or accumulation. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to enhance the availability, uptake and/or accumulation of one or more nutrients, optionally one or more of boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc availability, uptake and/or accumulation, by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200% or more, as compared to an untreated control. In some embodiments, compositions of the present disclosure are applied at a rate sufficient to enhance one or more plant growth and/or development characteristics. According to some embodiments, one or more
compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to enhance one or more plant growth and/or development characteristics, optionally biomass, carbohydrate biosynthesis, chlorophyll content, cold tolerance, drought tolerance, height, leaf length, leaf mass, leaf number, leaf surface area, leaf volume, nutrient uptake (e.g., calcium, magnesium, nitrogen, phosphorous and/or potassium uptake), rate(s) of photosynthesis, root area, root diameter, root length, root mass, root nodulation (e.g., nodule mass, nodule number, nodule volume), root number, root surface area, root volume, salt tolerance, seed germination, seedling emergence, shoot diameter, shoot length, shoot mass, shoot number, shoot surface area, shoot volume, spread, stomatal conductance and/or survival rate , by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200% or more, as compared to an untreated control. In some embodiments, compositions of the present disclosure are applied at a rate sufficient to enhance one or more plant yield characteristics. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to enhance one or more plant yield characteristics, optionally biomass; bushels per acre; grain weight per plot (GWTPP); nutritional content; percentage of plants in a given area (e.g., plot) that fail to produce grain; yield at standard moisture percentage (YSMP), such as grain yield at standard moisture percentage (GYSMP); yield per plot (YPP), such as grain weight per plot (GWTPP); and yield reduction (YRED), by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200% or more, as compared to an untreated control. In some embodiments, compositions of the present disclosure are applied at a rate sufficient to reduce the need for exogenous fertilizer. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to reduce the amount(s) of exogenous fertilizer, optionally exogenous boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc, needed to achieve a desired result by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100%, as compared to an untreated control. In some embodiments, compositions of the present disclosure are applied at a rate sufficient to enhance the efficacy of a biological pesticide. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to enhance the efficacy of a biological pesticide by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200% or more, as compared to an untreated control.
In some embodiments, compositions of the present disclosure are applied at a rate sufficient to enhance the efficacy of a chemical pesticide. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to enhance the efficacy of a chemiical pesticide by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200% or more, as compared to an untreated control. In some embodiments, compositions of the present disclosure are applied at a rate sufficient to reduce one or more aspects of pesticide-induced pest resistance. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to reduce one or more aspects of pesticide-induced pest resistance by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100%, as compared to an untreated control. In some embodiments, compositions of the present disclosure are applied at a rate sufficient to reduce one or more aspects of pesticide-induced phytotoxicity. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to reduce one or more aspects of pesticide-induced phytotoxicity by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100%, as compared to an untreated control. In some embodiments, compositions of the present disclosure are applied at a rate sufficient to delay ripening of a harvest plant or plant part. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to delay ripening of a harvest plant or plant part by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100%, as compared to an untreated control. In some embodiments, compositions of the present disclosure are applied at a rate sufficient to hasten ripening of a harvest plant or plant part. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to hasten ripening of a harvest plant or plant part by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100%, as compared to an untreated control. In some embodiments, compositions of the present disclosure are applied at a rate sufficient to extend the shelf-life of a harvested plant or plant part. According to some embodiments, one or more compositions of the present disclosure is/are applied in an amount sufficient to ensure the plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility is treated with an amount sufficient to extend the shelf-life of a harvested plant or plant part by about/at least 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55,
60, 65, 70, 75, 80, 85, 90, 95, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200% or more, as compared to an untreated control. The present disclosure extends to plant growth media, plants, plant parts and agricultural/floricultural/horticultural/silvicultural apparatuses/facilities that have been treated with a composition of the present disclosure (e.g., plant propagation materials coated with a formulation comprising one or more enzymes of the present disclosure, plants sprayed with a formulation comprising one or more enzymes of the present disclosure, harvested plant parts coated with a formulation comprising one or more enzymes of the present disclosure), to plants grown from plant propagation materials that were treated with a composition of the present disclosure, to plant parts harvested from plants that have been treated with a composition of the present disclosure, to plant parts harvested from plants grown from plant propagation materials that were treated with a composition of the present disclosure, to crops comprising a plurality of plants that were treated with a composition of the present disclosure, to crops comprising a plurality of plants grown from plant propagation materials that were treated with a composition of the present disclosure, to crops treated with a composition of the present disclosure, to processed products derived from plants that were treated with a composition of the present disclosure, to processed products derived from plants grown from plant parts that were treated with a composition of the present disclosure, and to processed products treated with a composition of the present disclosure. The present disclosure encompasses coated plant propagation materials comprising, consisting essentially of, or consisting of a plant propagation material and a coating that covers at least a portion of the outer surface of the plant propagation material, said coating comprising, consisting essentially of, or consisting of one or more compositions of the present disclosure. In some embodiments, the coating comprises two, three, four, five or more layers. According to some embodiments, the coating comprises an inner layer that contains one or more proteins of the present disclosure and one or more outer layers free or substantially free of proteins of the present disclosure. In some embodiments, the coating comprises an inner layer that is a composition of the present disclosure and an outer layer that is equivalent to a composition of the present disclosure except that it does not contain proteins of the present disclosure. In some embodiments, the coating comprises, consists essentially of, or consists of a composition of the present disclosure and a drying powder. Drying powders may be applied in any suitable amount(s)/concentration(s). The absolute value of the amount/concentration that is/are sufficient to cause the desired effect(s) may be affected by factors such as the type, size and volume of material to which the composition will be applied, the type(s) of proteins in the composition, the number of proteins in the composition, the stability of the proteins in the composition and storage conditions (e.g., temperature, relative humidity, duration). Those skilled in the art will understand how to select an effective amount/concentration using routine dose-response experiments. Guidance for the selection of appropriate amounts/concentrations can be found, for example, in International Patent Application Nos. PCT/US2016/050529 and PCT/US2016/050647
and U.S. Provisional Patent Application Nos. 62/296,798; 62/271,857; 62/347,773; 62/343,217; 62/296,784; 62/271,873; 62/347,785; 62/347,794; and 62/347,805. In some embodiments, the drying powder is applied in an amount ranging from about 0.5 to about 10 grams of drying powder per kilogram of plant propagation material. For example, in some embodiments, about 0.5, 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, 3, 3.25, 3.5, 3.75, 4, 4.25, 4.5, 4.75, 5, 5.5, 6, 6.5, 7, 7.5, 8, 8.5, 9, 9.5, 10 grams or more of drying powder (e.g., drying powder comprising magnesium stearate, magnesium sulfate, powdered milk, silica, soy lecithin and/or talc) is applied per kilogram of seed. In some embodiments, a drying powder comprising calcium stearate, attapulgite clay, montmorillonite clay, graphite, magnesium stearate, silica (e.g., fumed silica, hydrophobically-coated silica and/or precipitated silica) and/or talc is applied to seeds coated with a composition of the present disclosure at a rate of about 1, 1.25, 1.5, 1.75, 2, 2.25, 2.5, 2.75, or 3 grams per kilogram of seed. In some embodiments, the coating completely covers the outer surface of the plant propagation material. In some embodiments, the average thickness of the coating is at least 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.1, 3.2, 3.3, 3.4, 3.5, 4, 4.5, 5 µm or more. In some embodiments, the average thickness of the coating is about 1.5 to about 3.0 µm. The present disclosure extends to kits comprising, consisting essentially of, or consisting of one or more plants and/or plant parts (e.g., coated plant propagation materials) that have been treated with the compositions of the present disclosure and a container housing the treated plant(s) and/or plant part(s). In some embodiments, the kit further comprises one or more oxygen scavengers, such as activated carbon, ascorbic acid, iron powder, mixtures of ferrous carbonate and metal halide catalysts, sodium chloride and/or sodium hydrogen carbonate. The container may comprise any suitable material(s), including, but not limited to, materials that reduce the amount of light, moisture and/or oxygen that contact the coated plant propagation material when the container is sealed. In some embodiments, the container comprises, consists essentially of, or consists of a material having light permeability of less than about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70 or 75%. In some embodiments, the container comprises, consists essentially of, or consists of a material having an oxygen transmission rate of less than about 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 60, 70, 80, 90, 100, 125, 150, 175, 200, 225, 250, 275, 300, 325, 350, 375, 400, 425, 450, 475, or 500 cm3/m2·day (as measured in accordance with ASTM D3985). In some embodiments, the container reduces the amount of ambient light that reaches said coated plant propagation material by about 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100% when sealed. In some embodiments, the container reduces the amount of ambient moisture that reaches said plant propagation material by about 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100% when sealed. In some embodiments, the container reduces the amount of ambient oxygen that reaches said plant propagation material by about 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95 or 100% when sealed.
In some embodiments, kits of the present disclosure comprise 1, 2, 3, 4, 5 or more additional containers. The additional containers may comprise any suitable component(s) or composition(s), including, but not limited to, agriculturally beneficial microorganisms, biostimulants, drying agents, nutrients, oxidation control components and pesticides. Examples of agriculturally beneficial microorganisms, biostimulants, drying agents, nutrients, oxidation control components and pesticides that may be included in the additional containers are described above. As noted above, proteins of the present disclosure may be formulated into compositions comprising a variety of components, such as adhesives (stickers), chemical actives, dispersants (spreaders), drying agents, emulsifiers, microbes, nutrients, pest attractants and feeding stimulants, pH control components, postharvest treatments, rain fasteners, rhealogical agents, safeners, stabilizers, UV protectants and wetting agents. It is to be understood that compositions and methods of the present disclosure may likewise be used in combination with such components as separate and distinct compositions (as part of an integrated pest management strategy, for example). It is to be understood that compositions and methods of the present disclosure may be combined with known compositions and methods, such as fertilization compositions/methods, inoculant compositions/methods, pesticide compositions/methods, and post-harvest compositions/methods. In some instances, compositions and methods of the present disclosure are used as part of an Integrated Pest Management program/strategy. According to some embodiments, one or more proteins, organisms and/or formulations of the present disclosure is/are applied to a plant, plant part or plant growth medium as part of an Integrated Pest Management program/strategy comprising one or more biological pesticides and/or one or more chemical pesticides. It is to be understood that compositions and methods of the present disclosure are not limited to agicultural/floricultural/horticultural/silvicultural uses. The same activities that make enzymes, formulations, nucleic acids and organisms of the present disclosure useful for preventing, treating, suppressing and/or eliminating infestations/infections of/by phytopathogenic pests likewise render them useful for preventing/treating/suppressing/eliminating/reducing the detrimental effects of infestations/infections of/by arachnids, bacteria, fungi, insects, oomycetes, protozoa and viruses in and on myriad surfaces/substances, such as food storage containers, animal bedding/feed, clothing, hard surfaces, medical instruments, etc. Thus, it is to be understood that compositions and methods of the present disclosure may be modified for use in any other industry or endeavor in which such prevention/treatment/suppression/elimination/reduction may be of benefit. For example, in some embodiments, the present disclosure extends to animal feed compositions comprising, consisting essentially of or consisting of a food component and an enzyme component, said enzyme component comprising, consisting essentially of, or consisting of one or more compositions of the present disclosure. Animal feed compositions of the present disclosure may comprise any suitable food component, including, but not limited to, fodder (e.g., grains, hay, legumes, silage and/or straw) and forage (e.g., grass).
Animal feed compositions of the present disclosure may be fed to any suitable animal, including, but not limited to, farm animals, zoo animals, laboratory animals and/or companion animals. In some embodiments, the animal feed composition is formulated to meet the dietary needs of birds (e.g., chickens, ducks, quails and/or turkeys), bovids (e.g., antelopes, bison, cattle, gazelles, goats, impala, oxen, sheep and/or wildebeests), canines, cervids (e.g., caribou, deer, elk and/or moose), equines (e.g., donkeys, horses and/or zebras), felines, fish, pigs, rabbits, rodents (e.g., guinea pigs, hamsters, mice and/or rats) and the like. The following is a non-exhaustive listing of concepts and embodiments encompassed by the present disclosure: Use of a composition of the present disclosure (e.g., a protein or formulation of the present disclosure) for any one, two, three, four, five, six, seven, eight, nine, ten or more of the following: 1) preventing, treating, suppressing and/or eliminating infestation/infection of a surface/substance of/by one or more pests, optionally one or more acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa and/or viruses; 2) preventing, treating, suppressing and/or eliminating infestation/infection of a plant, plant part, plant growth medium or agricultural/floricultural/horticultural/silvicultural apparatus/facility (e.g., an apparatus/facility for planting, irrigating, fertilizing, growing, monitoring, testing, harvesting, processing, packaging and/or storing a plant or plant part) of/by one or more phytopathogenic pests, optionally one or more arachnids, bacteria, fungi, gastropods, insects, nematodes, oomycetes protozoa, viruses and/or weeds; 3) reducing one or more aspects of disease severity in a plant or plant part affected by one or more phytopathogenic pests, optionally one or more arachnids, bacteria, fungi, gastropods, insects, nematodes, oomycetes protozoa, viruses and/or weeds; 4) reducing one or more aspects of disease severity in a plant or plant part grown in a plant growth medium that is infested/infected by/with one or more phytopathogenic pests, optionally one or more arachnids, bacteria, fungi, gastropods, insects, nematodes, oomycetes protozoa, viruses and/or weeds; 5) reducing one or more aspects of disease severity in a plant or plant part grown in or contacted by agricultural/floricultural/horticultural/silvicultural apparatus/facility that is infested/infected by/with one or more phytopathogenic pests, optionally one or more arachnids, bacteria, fungi, gastropods, insects, nematodes, oomycetes protozoa, viruses and/or weeds; 6) treating a surface/substance that is susceptible to infestation/infection by one or more pests, optionally one or more acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa and/or viruses; 7) cleaning a surface/substance that is infested/infected by one or more pests, optionally one or more acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa and/or viruses; 8) treating (e.g., coating, dipping, drenching, fogging, misting, soaking, spraying) a plant or plant part; 9) treating (e.g., drenching, fogging, misting, spraying) a plant growth medium;
10) treating (e.g., coating, dipping, drenching, fogging, irrigating, misting, soaking, spraying) an agricultural/floricultural/horticultural/silvicultural apparatus/facility, optionally an apparatus/facility for planting, irrigating, fertilizing, growing, monitoring, testing, harvesting, processing, packaging and/or storing a plant or plant part; 11) improving one or more soil characteristics; 12) improving nutrient availability/uptake/accumulation, optionally boron, calcium, carbon, copper, iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc availability/uptake/accumulation; 13) improving one or more characteristics of plant growth and/or development; 14) reducing the need for exogenous fertilize; 15) reducing the amount(s) of exogenous fertilizer needed to achieve desired result; 16) improving one or more characteristics of plant yield; 17) prolonging the shelf-life of a harvested plant or plant part; 18) delaying the ripening of a harvested plant or plant part; 19) hastening the ripening of a harvested plant or plant part; 20) improving the efficacy of a chemical pesticide, optionally an acaricide, bactericide, fungicide, gastropodicide, herbicide, insecticide, nematicide, oomyceticide, protozoacide or viricide; 21) improving the efficacy of a biological pesticide, optionally an acaricide, bactericide, fungicide, gastropodicide, herbicide, insecticide, nematicide, oomyceticide, protozoacide or viricide; 22) improving the efficacy of a preharvest treatment; 23) improving the efficacy of a postharvest treatment; 24) preventing, treating, suppressing and/or eliminating chemical pesticide-induced pest resistance and/or phytotoxicity; 25) preventing, treating, suppressing and/or eliminating biological pesticide-induced pest resistance and/or phytotoxicity; 26) inclusion as part of an Integrated Pest Management program/strategy, optionally an Integrated Pest Management program/strategy comprising one or more chemical pesticides. Any of the foregoing uses in which any one, two, three, four, five, six, seven, eight, nine, ten or more of the following is true: 1) the composition comprises, consists essentially of or consists of an enzyme 2) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1 3) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.1 4) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.1.3 5) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.1.3.4 6) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.1.99
7) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.1.99.18 8) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4 9) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3 10) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3.1 11) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3.2 12) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3.3 13) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3.7 14) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3.11 15) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3.12 16) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3.13 17) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3.14 18) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3.15 19) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3.16 20) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3.19 21) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3.20 22) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.4.3.25 23) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.10 24) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.10.3 25) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.10.3.2 26) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.11 27) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.11.1 28) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.11.1.6 29) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.11.1.7 30) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.14 31) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.14.18 32) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.14.18.1 33) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.14.99 34) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 1.14.99.56 35) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 2 36) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 2.3 37) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 2.3.2 38) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 2.3.2.2 39) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3 40) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.1 41) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.1.1 42) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.1.1.3
43) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.1.1.5 44) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.1.1.11 45) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.1.1.32 46) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.1.1.74 47) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.1.4 48) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.1.4.3 49) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.1.4.11 50) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2 51) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1 52) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.1 53) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.2 54) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.3 55) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.4 56) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.5 57) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.6 58) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.7 59) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.8 60) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.10 61) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.11 62) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.14 63) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.15 64) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.17 65) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.20 66) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.21 67) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.22 68) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.23 69) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.24 70) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.25 71) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.26 72) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.28 73) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.32 74) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.37 75) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.39 76) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.41 77) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.55 78) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.58
79) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.59 80) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.73 81) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.75 82) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.78 83) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.91 84) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.92 85) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.97 86) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.101 87) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.109 88) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.111 89) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.112 90) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.125 91) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.130 92) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.132 93) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.133 94) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.163 95) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.176 96) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.2.1.198 97) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.4 98) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.4.11 99) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.4.11.1 100) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.4.21 101) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.4.21.19 102) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.4.21.62 103) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.4.24 104) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.4.24.28 105) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5 106) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1 107) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1.1 108) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1.2 109) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1.4 110) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1.5 111) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1.12 112) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1.19 113) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1.33 114) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1.35
115) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1.38 116) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1.41 117) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1.43 118) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1.44 119) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1.50 120) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 3.5.1.104 121) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4 122) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.2 123) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.2.2 124) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.2.2.2 125) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.2.2.10 126) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.2.2.13 127) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.2.2.25 128) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.2.2.26 129) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.2.2.27 130) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.3 131) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.3.1 132) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.3.1.1 133) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.3.1.3 134) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.3.1.17 135) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.3.1.18 136) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.3.1.19 137) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.3.1.23 138) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.3.1.24 139) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.3.1.25 140) the composition comprises, consists essentially of or consists of an enzyme belonging to EC 4.3.1.31 141) the composition comprises, consists essentially of or consists of one or more polypeptides having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof 142) the composition comprises, consists essentially of or consists of one or more polypeptides encoded by a polynucleotide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA sequence thereof 143) the composition comprises, consists essentially of or consists of one or more polypeptides derived from
any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids 144) the composition comprises, consists essentially of or consists of one or more polypeptides derived from a mature polypeptide of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids 145) the composition comprises, consists essentially of or consists of one or more polypeptides derived from any one of 71) through 74) wherein the N- and/or C-terminal end has been extended by the addition of one or more amino acids 146) the composition comprises, consists essentially of or consists of a fragment of any one of 71) through 75) 147) the composition comprises, consists essentially of or consists of an enzymatically active fragment/mutant/variant of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof 148) the composition comprises a fusion protein, optionally a fusion protein comprising a first polypeptide and a second polypeptide wherein at least one of said first and second polypeptides is a protein of the present disclosure 149) the composition comprises 2, 3, 4, 5, 6, 7, 8, 9, 10 or more proteins of the present disclosure or enzymatically active fragments/mutations/variants thereof 150) the composition is an aqueous enzyme solution, optionally an aqueous enzyme solution comprising, consisting essentially of or consisting of water, one or more proteins of the present disclosure and one or more preservatives (e.g., potassium sorbate, sodium benzoate, 1,2-benzisothiazolin-3-one) and/or stabilizers (e.g., glycerol, potassium chloride, propylene glycol, sodium chloride, sorbitol) 151) the composition comprises an agriculturally acceptable carrier 152) the composition comprises a seed-compatible carrier 153) the composition comprises a foliar-compatible carrier 154) the composition comprises a soil-compatible carrier 155) the composition comprises one or more adhesives (stickers), optionally one or more disaccharides (e.g., sucrose), gums and/or maltodextrins 156) the composition comprises one or more beneficial agents 157) the composition comprises one or more microorganisms 158) the composition comprises one or more diazotrophs 159) the composition comprises one or more phosphate-solubilizing microorganisms 160) the composition comprises one or more bacteria, optionally one or more Alkalihalobacillus, Azospirillum, Bacillus, Bradyrhizobium, Campylobacter, Chryseobacterium, Clostridium, Dicytoglomus, Effusibacillus, Enterococcus, Erwinia, Escherichia, Flavobacterium, Fusobacterium, Geobacillus, Helicobacter, Ilyobacter, Lactobacillus, Lactococcus, Lederbergia, Lysinibacillus, Lysobacter, Neisseria, Neobacillus, Nocardiopsis, Oceanobacillus, Paenibacillus, Pseudomonas, Rhizobium, Salmonella,
Sinorhizobium, Staphylococcus, Streptococcus, Streptomyces, Sutcliffiella, Ureaplasma and/or Yersinia 161) the composition comprises one or more fungi, optionally one or more Acremonium, Acrophialophora, Aspergillus, Aureobasidium, Bjerkandera, Ceriporiopsis, Chaetomium, Chrysosporium, Colletotrichum, Coprinopsis, Coprinus, Coriolus, Cryphonectria, Cryptococcus, Evansstolkia, Filibasidium, Fusarium, Gliocladium, Glomus, Humicola, Magnaporthe, Metarhizium, Microdochium, Mucor, Myceliophthora, Neocallimastix, Neurospora, Ostropa, Paecilomyces, Penicillium, Phlebia, Piromyces, Pleurotus, Pseudoplectania, Schizophyllum, Sodiomyces, Stenocarpella, Talaromyces, Thermoascus, Themochaetoides, Thermomyces, Thermothielavioides, Thermothelomyces, Thielavia, Tolypocladium, Trametes, Trichoderma, Trichophaea and/or Urnula 162) the composition comprises one or more yeast, optionally one or more Candida, Hansenula, Komagataella, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces and/or Yarrowia 163) the composition comprises one or more plant cells, optionally one or more Amaranthaceae, Asteraceae, Brassicaceae, Caricaceae, Cucurbitaceae, Fabaceae, Malvaceae, Poaceae, Polygonaceae, Rosaceae, Solanaceae and/or Vitaceae cells 164) the composition comprises one or more biological pesticides, optionally one or more biological acaricides, biological bactericides, biological fungicides, biological gastropodicides, biological herbicides, biological insecticides, biological miticides, biological nematicides, biological oomyceticides and/or biological protozoacides 165) the composition comprises one or more chemical pesticides, optionally one or more chemical acaricides, chemical bactericides, chemical fungicides, chemical gastropodicides, chemical herbicides, chemical insecticides, chemical miticides, chemical nematicides, chemical oomyceticides and/or chemical protozoacides 166) the composition comprises one or more microbial pesticides, optionally one or more microbial acaricides, microbial bactericides, one or more microbial fungicides, microbial gastropodicides, microbial herbicides, microbial insecticides, microbial miticides, microbial nematicides, microbial oomyceticides and/or microbial protozoacides 167) the composition comprises one or more dispersants, optionally one or more alcohol ethoxylates and/or polyvinylpyrrolidones 168) the composition comprises one or more drying agents 169) the composition comprises one or more nutrients, optionally one or more organic acids (e.g., acetic acid, citric acid, lactic acid, malic acid, taurine, etc.), macrominerals (e.g., phosphorous, calcium, magnesium, potassium, sodium, iron, etc.), trace minerals (e.g., boron, cobalt, chloride, chromium, copper, fluoride, iodine, manganese, molybdenum, selenium, zinc, etc.), and/or vitamins (e.g., vitamin A, vitamin B complex (i.e., vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B7, vitamin B8, vitamin B9, vitamin B12, choline) vitamin C, vitamin D, vitamin E, vitamin K, carotenoids (α-carotene, β-carotene, cryptoxanthin, lutein, lycopene, zeaxanthin, etc.)
170) the composition comprises one or more pest attractants 171) the composition comprises one or more pest feeding stimulants 172) the composition comprises one or more pH control components 173) the composition has a pH within the operable range for each enzyme therein 174) the composition has a pH within +/- 1 pH-unit of the optimal pH for at least one enzyme therein 175) the composition has a pH within +/- 1 pH-unit of the optimal pH for each enzyme therein 176) the composition has a pH of about 2.5 to about 7 177) the composition has a pH of about 2.5 to about 6.5 178) the composition has a pH of about 2.5 to about 6 179) the composition has a pH of about 2.5 to about 5.5 180) the composition has a pH of about 2.5 to about 5 181) the composition has a pH of about 2.5 to about 4.5 182) the composition has a pH of about 2.5 to about 4 183) the composition has a pH of about 2.5 to about 3.5 184) the composition has a pH of about 2.5 to about 3 185) the composition has a pH of about 3 to about 7 186) the composition has a pH of about 3 to about 6.5 187) the composition has a pH of about 3 to about 6 188) the composition has a pH of about 3 to about 5.5 189) the composition has a pH of about 3 to about 5 190) the composition has a pH of about 3 to about 4.5 191) the composition has a pH of about 3 to about 4 192) the composition has a pH of about 3 to about 3.5 193) the composition has a pH of about 3.5 to about 7 194) the composition has a pH of about 3.5 to about 6.5 195) the composition has a pH of about 3.5 to about 6 196) the composition has a pH of about 3.5 to about 5.5 197) the composition has a pH of about 3.5 to about 5 198) the composition has a pH of about 3.5 to about 4.5 199) the composition has a pH of about 3.5 to about 4 200) the composition has a pH of about 4 to about 7 201) the composition has a pH of about 4 to about 6.5 202) the composition has a pH of about 4 to about 6 203) the composition has a pH of about 4 to about 5.5 204) the composition has a pH of about 4 to about 5 205) the composition has a pH of about 4 to about 4.5
206) the composition has a pH of about 4.5 to about 8.5 207) the composition has a pH of about 4.5 to about 8 208) the composition has a pH of about 4.5 to about 7.5 209) the composition has a pH of about 4.5 to about 7 210) the composition has a pH of about 4.5 to about 6.5 211) the composition has a pH of about 4.5 to about 6 212) the composition has a pH of about 4.5 to about 5.5 213) the composition has a pH of about 4.5 to about 5 214) the composition has a pH of about 5 to about 9 215) the composition has a pH of about 5 to about 8.5 216) the composition has a pH of about 5 to about 8 217) the composition has a pH of about 5 to about 7.5 218) the composition has a pH of about 5 to about 7 219) the composition has a pH of about 5 to about 6.5 220) the composition has a pH of about 5 to about 6 221) the composition has a pH of about 5 to about 5.5 222) the composition has a pH of about 5.5 to about 8.5 223) the composition has a pH of about 5.5 to about 8 224) the composition has a pH of about 5.5 to about 7.5 225) the composition has a pH of about 5.5 to about 7 226) the composition has a pH of about 5.5 to about 6.5 227) the composition has a pH of about 5.5 to about 6 228) the composition has a pH of about 6 to about 11 229) the composition has a pH of about 6 to about 10.5 230) the composition has a pH of about 6 to about 10 231) the composition has a pH of about 6 to about 9.5 232) the composition has a pH of about 6 to about 9 233) the composition has a pH of about 6 to about 8.5 234) the composition has a pH of about 6 to about 8 235) the composition has a pH of about 6 to about 7.5 236) the composition has a pH of about 6 to about 7 237) the composition has a pH of about 6 to about 6.5 238) the composition has a pH of about 6.5 to about 11 239) the composition has a pH of about 6.5 to about 10.5 240) the composition has a pH of about 6.5 to about 10 241) the composition has a pH of about 6.5 to about 9.5
242) the composition has a pH of about 6.5 to about 9 243) the composition has a pH of about 6.5 to about 8.5 244) the composition has a pH of about 6.5 to about 8 245) the composition has a pH of about 6.5 to about 7.5 246) the composition has a pH of about 6.5 to about 7 247) the composition has a pH of about 7 to about 11 248) the composition has a pH of about 7 to about 10.5 249) the composition has a pH of about 7 to about 10 250) the composition has a pH of about 7 to about 9.5 251) the composition has a pH of about 7 to about 9 252) the composition has a pH of about 7 to about 8.5 253) the composition has a pH of about 7 to about 8 254) the composition has a pH of about 7 to about 7.5 255) the composition has a pH of about 7.5 to about 11 256) the composition has a pH of about 7.5 to about 10.5 257) the composition has a pH of about 7.5 to about 10 258) the composition has a pH of about 7.5 to about 9.5 259) the composition has a pH of about 7.5 to about 9 260) the composition has a pH of about 7.5 to about 8.5 261) the composition has a pH of about 7.5 to about 8 262) the composition has a pH of about 8 to about 11 263) the composition has a pH of about 8 to about 10.5 264) the composition has a pH of about 8 to about 10 265) the composition has a pH of about 8 to about 9.5 266) the composition has a pH of about 8 to about 9 267) the composition has a pH of about 8 to about 8.5 268) the composition has a pH of about 8.5 to about 11 269) the composition has a pH of about 8.5 to about 10.5 270) the composition has a pH of about 8.5 to about 10 271) the composition has a pH of about 8.5 to about 9.5 272) the composition has a pH of about 8.5 to about 9 273) the composition has a pH of less than 4 274) the composition has a pH of more than 4 275) the composition has a pH of less than 5 276) the composition has a pH of more than 5 277) the composition has a pH of less than 6
278) the composition has a pH of more than 6 279) the composition has a pH of less than 6.5 280) the composition has a pH of more than 6.5 281) the composition has a pH of less than 7 282) the composition has a pH of more than 7 283) the composition has a pH of less than 7.5 284) the composition has a pH of more than 7.5 285) the composition has a pH of less than 8 286) the composition has a pH of more than 8 287) the composition has a pH of less than 9 288) the composition has a pH of more than 9 289) the composition comprises one or more postharvest treatments 290) the composition comprises one or more essential oils 291) the composition comprises one or more ethylene biosynthesis inhibitors 292) the composition comprises one or more cyclopropenes 293) the composition comprises one or more waxes 294) the composition comprises one or more preservatives 295) the composition comprises one or more benzoates (e.g., sodium benzoate) 296) the composition comprises benzoic acid 297) the composition comprises methyl paraben 298) the composition comprises phenoxy ethanol 299) the composition comprises one or more proprionates (e.g., ammonium proprionate, calcium proprionate, sodium proprionate) 300) the composition comprises proprionic acid 301) the composition comprises one or more sorbates (e.g., potassium sorbate, sodium sorbate) 302) the composition comprises 1,2-benzisothiazolin-3-one (PROXEL®; Basel, Switzerland) 303) the composition comprises one or more rain fasteners 304) the composition comprises one or more organo-modified siloxanes 305) the composition comprises one or more trisiloxanes 306) the composition comprises one or more polysiloxanes 307) the composition comprises one or more rhealogical agents 308) the composition comprises one or more safeners 309) the composition comprises one or more stabilizers, optionally one or more boric acid derivatives, inorganic salts, lactic acid, polyols, sugars, sugar alcohols and/or reversible protease inhibitors 310) the composition comprises boric acid 311) the composition comprises glycerol
312) the composition comprises one or more UV protectants, optionally one or more aromatic amino acids, carotenoids, cinnamates, lignosulfonates, melanins, mycosporines, polyphenols and/or salicylates 313) the composition comprises one or more wetting agents, optionally one or more naphthalene sulfonates 314) the composition is applied in a pesticidally effective amount 315) the composition is applied in an acaricidally effective amount 316) the composition is applied in a bactericidally effective amount 317) the composition is applied in a fungicidally effective amount 318) the composition is applied in a gastropodicidally effective amount 319) the composition is applied in an herbicidally effective amount 320) the composition is applied in an insecticidally effective amount 321) the composition is applied in an miticidally effective amount 322) the composition is applied in a nematicidally effective amount 323) the composition is applied in an oomyceticidally effective amount 324) the composition is applied in a protozoacidally effective amount 325) the composition is applied in a pesticidally ineffective amount (e.g., as an adjuvant) 326) the composition is applied in an acaricidally ineffective amount (e.g., as an adjuvant) 327) the composition is applied in a bactericidally ineffective amount (e.g., as an adjuvant) 328) the composition is applied in a fungicidally ineffective amount (e.g., as an adjuvant) 329) the composition is applied in a gastropodicidally ineffective amount (e.g., as an adjuvant) 330) the composition is applied in a herbicidially ineffective amount (e.g., as an adjuvant) 331) the composition is applied in an insecticidally ineffective amount (e.g., as an adjuvant) 332) the composition is applied in an miticidally ineffective amount (e.g., as an adjuvant) 333) the composition is applied in a nematicidally ineffective amount (e.g., as an adjuvant) 334) the composition is applied in an oomyceticidally ineffective amount (e.g., as an adjuvant) 335) the composition is applied in a protozoacidally ineffective amount (e.g., as an adjuvant) 336) the composition is applied prior to planting 337) the composition is applied at the time of planting 338) the composition is applied after planting 339) the composition is applied prior to germination 340) the composition is applied at the time of germination 341) the composition is applied after germination 342) the composition is applied prior to seedling emergence 343) the composition is applied at the time of seedling emergence 344) the composition is applied after seeding emergence 345) the composition is applied prior to vegetative stage 346) the composition is applied during vegetative stage
347) the composition is applied after vegetative stage 348) the composition is applied prior to reproductive stage 349) the composition is applied during reproductive stage 350) the composition is applied after reproductive stage 351) the composition is applied prior to flowering 352) the composition is applied at the time of flowering 353) the composition is applied after flowering 354) the composition is applied prior to fruiting 355) the composition is applied at the time of fruiting 356) the composition is applied after fruiting 357) the composition is applied prior to ripening 358) the composition is applied at the time of ripening 359) the composition is applied after ripening 360) the composition is applied prior to pruning 361) the composition is applied at the time of pruning 362) the composition is applied after pruning 363) the composition is applied prior to harvest 364) the composition is applied at the time of harvest 365) the composition is applied after harvest 366) the composition is applied prior to storage and/or transport 367) the composition is applied at the time of storage and/or transport 368) the composition is applied after storage and/or transport 369) the composition is used in combination with one or more adhesives 370) the composition is used in combination with one or more beneficial agents 371) the composition is used in combination with one or more microorganisms 372) the composition is used in combination with one or more diazotrophs 373) the composition is used in combination with one or more phosphate-solubilizing microorganisms 374) the composition is used in combination with one or more bacteria, optionally one or more Alkalihalobacillus, Azospirillum, Bacillus, Bradyrhizobium, Campylobacter, Chryseobacterium, Clostridium, Dicytoglomus, Effusibacillus, Enterococcus, Erwinia, Escherichia, Flavobacterium, Fusobacterium, Geobacillus, Helicobacter, Ilyobacter, Lactobacillus, Lactococcus, Lederbergia, Lysinibacillus, Lysobacter, Neisseria, Neobacillus, Nocardiopsis, Oceanobacillus, Paenibacillus, Pseudomonas, Rhizobium, Salmonella, Sinorhizobium, Staphylococcus, Streptococcus, Streptomyces, Sutcliffiella, Ureaplasma and/or Yersinia 375) the composition is used in combination with one or more fungi, optionally one or more Acremonium, Acrophialophora, Aspergillus, Aureobasidium, Bjerkandera, Ceriporiopsis, Chaetomium,
Chrysosporium, Colletotrichum, Coprinopsis, Coprinus, Coriolus, Cryphonectria, Cryptococcus, Evansstolkia, Filibasidium, Fusarium, Gliocladium, Glomus, Humicola, Magnaporthe, Metarhizium, Microdochium, Mucor, Myceliophthora, Neocallimastix, Neurospora, Ostropa, Paecilomyces, Penicillium, Phlebia, Piromyces, Pleurotus, Pseudoplectania, Schizophyllum, Sodiomyces, Stenocarpella, Talaromyces, Thermoascus, Themochaetoides, Thermomyces, Thermothielavioides, Thermothelomyces, Thielavia, Tolypocladium, Trametes, Trichoderma, Trichophaea and/or Urnula 376) the composition is used in combination with one or more yeast, optionally one or more Candida, Hansenula, Komagataella, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces and/or Yarrowia 377) the composition is used in combination with one or more biological pesticides, optionally one or more biological acaricides, biological bactericides, biological fungicides, biological gastropodicides, biological herbicides, biological insecticides, biological miticides, biological nematicides, biological oomyceticides and/or biological protozoacides 378) the composition is used in combination with one or more chemical pesticides, optionally one or more chemical acaricides, chemical bactericides, chemical fungicides, chemical gastropodicides, chemical herbicides, chemical insecticides, chemical miticides, chemical nematicides, chemical oomyceticides and/or chemical protozoacides 379) the composition is used in combination with one or more microbial pesticides, optionally one or more microbial acaricides, microbial bactericides, one or more microbial fungicides, microbial gastropodicides, microbial herbicides, microbial insecticides, microbial miticides, microbial nematicides, microbial oomyceticides and/or microbial protozoacides 380) the composition is used in combination with one or more pest attractants 381) the composition is used in combination with one or more pest feeding stimulants 382) the composition is used in combination with one or more plant growth regulators 383) the composition is used in combination with one or more rain fasteners 384) the composition is used in combination with one or more organo-modified siloxanes 385) the composition is used in combination with one or more trisiloxanes 386) the composition is used in combination with one or more polysiloxanes 387) the composition is used in combination with one or more preharvest treatments 388) the composition is used in combination with one or more postharvest treatments 389) the composition is used in combination with one or more essential oils 390) the composition is used in combination with one or more ethylene biosynthesis inhibitors 391) the composition is used in combination with one or more cyclopropenes 392) the composition is used in combination with one or more waxes 393) the composition is used in combination with one or more stabilizers, optionally one or more boric acid derivatives, inorganic salts, lactic acid, polyols, sugars, sugar alcohols and/or reversible protease
inhibitors 394) the composition is used in combination with one or more UV protectants, optionally one or more aromatic amino acids, carotenoids, cinnamates, lignosulfonates, melanins, mycosporines, polyphenols and/or salicylates 395) the composition is used in combination with one or more wetting agents, optionally one or more naphthalene sulfonates Transgenic microorganisms, plants or plant parts for which any one, two, three, four, five, six, seven, eight, nine, ten or more of the following are true: 1) comprises one or more polynucleotides encoding a polypeptide having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof 2) comprises one or more polynucleotides having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to any one or more of SEQ ID NO(s): 92–182, 72145–72146, 72148 and 72150 or the cDNA sequence thereof 3) expresses one or more polypeptides having about/at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 or a mature polypeptide thereof 4) comprises one or more polynucleotides encoding a polypeptide derived from any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids 5) expresses one or more polypeptides derived from any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids 6) comprises one or more polynucleotides encoding a polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids 7) expresses one or more polypeptides derived from a mature polypeptide of any one of SEQ ID NO(s): 1– 91, 45906, 72144, 72147 and 72149 by substitution, deletion, or insertion of one or more amino acids 8) comprises one or more polynucleotides encoding a polypeptide derived from any one of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 above wherein the N- and/or C-terminal end has been extended by the addition of one or more amino acids 9) expresses one or more polypeptides derived from any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 wherein the N- and/or C-terminal end has been extended by the addition of one or more amino acids
10) comprises one or more polynucleotides encoding an enzymatically active fragment of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 11) expresses an enzymatically active fragment of any one SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 12) expresses an enzymatically active a fusion protein comprising a first polypeptide and a second polypeptide wherein at least one of said first and second polypeptides is a protein of the present disclosure. EXAMPLES The following examples are provided to illustrate certain embodiments and are not to be construed as limiting the inventive concepts described in the present disclosure. Enzyme treatments are described in the corresponding Figures with reference to the predominant enzyme(s) comprised therein. It is to be understood that enzyme treatments may possess other enzymatic activities not expressly disclosed in the corresponding Figures. For example, an enzyme treatment having a predominant beta-glucanase activity may exhibit lesser side activities, such as cellulase activity and/or xylanase activity. Example 1 Effective Control of Powdery Mildew Principle Tested the efficacy of enzyme solutions for control of powdery mildew on wheat plants. Plants were sprayed with buffered enzyme solutions and subsequently inoculated with Blumeria graminis. Percent leaf area attacked was assessed nine days post-inoculation and again with two-day intervals until the full effects were seen. For scoring the standard EPPO scales (PP2/.10 (1)) were used. Experiments were conducted by Århus University, Flakkebjerg, Denmark. Procedures 1) Powdery mildew-susceptible wheat plants (var. Anja) were grown in a greenhouse for approximately two weeks until reaching the two-leaf crop growth stage (BBCH12). 2) Plants were then sprayed with an enzyme solution comprising 0.1% TWEEN® 20, or a control solution comprising 0.1% TWEEN® 20 with no enzyme added, using a cabin sprayer (volume 600 mL; 150 L/ha, 3.6 km/hour, yellow nozzles 0.2). Six replicates were made for each condition. 3) 24 hours after the initial spray application, the plants were sprayed with a Blumeria graminis spore suspension. 4) After Blumeria graminis inoculation, the plants were kept under high relative humidity for 24 hours to ensure infection before being placed under normal greenhouse conditions.
5) Percent leaf area attacked by powdery mildew was determined nine days after inoculation and again every two days until the full effects were found. For scoring, the standard EPPO scale was used (EPPO standards: Guidelines on good plant protection practice. Wheat. PP 2/10(1)). Results Enzymes were evaluated for efficacy against Blumeria graminis as described above. Results are presented in Fig. 1 as percent disease control relative to an untreated, uninoculated control and an untreated, inoculated control at two timepoints / disease pressures.100 % control means no disease was detected in the treatment and 0 % control means disease was at the same level as the untreated, inoculated control comparator. Example 2 Effective Control of Gray Mold Principle Evaluated the efficacy of enzyme solutions for control of gray mold on tomato leaf discs. Leaf discs were painted with buffered enzyme solutions and subsequently inoculated with Botrytis cinerea. After incubation for 24-96 hours, selected plant health parameters were evaluated using multispectral analysis. Testing was conducted at Ghent University (Ghent, Belgium). Procedures 1) Tomato plants were grown in potting soil for 28 days. Leaf discs (diameter 20 mm) were cut from the 4th composite leaves using a cork bore. Only one disc was punched from each leaf. All leaf discs were kept in a water bath until use. 2) One leaf disc was placed in each well of a 24-well microtiter plate. 3) Leaf discs were painted with enzyme solutions comprising 1 mg enzyme protein per mL in a 10 mM buffer solution (sodium acetate pH 5, potassium phosphate pH 6, potassium phosphate pH 7, or potassium phosphate pH 8), with or without 0.1% w/v surfactant (BREAK-THRU® S 301 or SILWETTM L-77), or with a corresponding control solution comprising no enzyme, and then air dried. Six replicates were made for each condition. 4) After drying, discs were inoculated with two 5 µL drops of Botrytis cinerea spore suspension (106 spores per mL in 10 mM glucose, 0.067 mM K-phosphate buffer, pH 5) or with a corresponding solution comprising no Botrytis cinerea spores. 5) Disease progression was monitored through multispectral imaging and visual inspection for water- soaked lesions. Multispectral images were taken at the start of the experiment (T0) and after incubation for 24, 48, 72 and 96 hours. Fv/Fm, ChlIdx and mARI were evaluated from the spectral images. See
Table 2. Mean Fv/Fm, ChlIdx and mARI values for leaves at T0 were used as a reference (100%) to evaluate the Fv/Fm, ChlIdx and mARI values for treated leaves. TABLE 2. Multispectral imaging parameters
Results Enzymes were evaluated for efficacy against Botrytis cinerea as described above. Results are presented in Fig. 2 as percentage increase of the spectral parameters (Fv/Fm, ChlIdx and mARI) and the percentage of water- soaked lesions (%WSL) as compared to the untreated, inoculated control. Example 3 Effective Control of Head Blight Principle Evaluated the efficacy of enzyme solutions for control of Fusarium head blight on detached wheat leaves. Detached leaves were treated with enzyme solution and subsequently inoculated with GFP-transformed Fusarium graminearum. Pathogen biomass was quantified via GFP, and plant health parameters were collected up to 96 hours post-inoculation. Testing was conducted at Ghent University (Ghent, Belgium).
Procedures 1) GFP-transformed Fusarium graminearum strain PH-1 was grown on potato dextrose agar for seven days at 21°C under a regime of 12 h dark and 12 h combined UVA and UVC light to induce sporulation. 2) A working spore suspension was created by adding approx. 20 mL of phosphate buffered saline containing 0.01% TWEEN® 80, pH 7.2–7.4, to the petri dish, agitating the mycelium with a spatula, separating spores from mycelium using a sterile filter, and then diluting to a concentration of 0.5 x 106 spores per mL. 3) Wheat plants were grown in potting soil for 10 days, after which leaves (approx.6 cm) were detached and used in the bioassays described below. 4) Detached leaves (leaf tops) were placed on their abaxial surface in rectangular petri dishes containing 0.5% (w/v) water agar supplemented with 40 mg benzimidazole per mL. The centers of the leaves were wounded with a scalpel by gently scraping the epidermal layer of the leaves. 5) Wounded leaves were painted with enzyme solutions comprising 1 mg enzyme protein per mL in a 10mM buffer solution (sodium acetate pH 5, potassium phosphate pH 6, potassium phosphate pH 7, or potassium phosphate pH 8), with or without 0.1% w/v surfactant (BREAK-THRU® S 301 or SILWETTM L-77), or with a corresponding control solution comprising no enzyme, and then air dried. Six replicates were made for each condition. 6) After drying, each leaf was inoculated with a 10 µl droplet of the Fusarium graminearum PH-1 spore suspension or with a corresponding solution comprising no Fusarium graminearum spores. 7) Plates were sealed with parafilm and incubated at 18°C under a 16-hour light / 8-hour dark cycle. 8) Disease progression was monitored through multispectral imaging and visual inspection. Multispectral images were taken at start of experiment (T0) and after incubation for 24, 48, 72 and 96 hours. Fv/Fm, ChlIdx and cGFP were evaluated from the spectral images. See Table 2. Mean Fv/Fm, ChlIdx and cGFP values for leaves at T0 were used as a reference (100%) to evaluate the Fv/Fm, ChlIdx and cGFP values for treated leaves. Results Enzymes were evaluated for efficacy against Fusarium graminearum as described above. Results are presented in Fig. 3A as percentage increase of the spectral parameters (Fv/Fm, ChlIdx and cGFP) as compared to the untreated, inoculated control after 72 hours.
Example 4 Effective Control of Rice Blast Principle Evaluated the efficacy of enzyme solutions for control of Magnaporthe grisea using high-throughput imaging. Serial dilutions were used to determine the half maximal effective concentration (EC50) for two distinct indicators of fungal inhibition: absorbance at 612 nm (indicator of mycelia growth inhibition) and fluorescence after reaction with Resazurin (ex 570 nm – em 585 nm; indicator of cell viability). Experiments were conducted by Fundación Medina, Centro de Exelencia en Investigación de Medicamentos Innovadores en Andalucía (Granada, Spain). Procedures 1) Starting with 10 mg/mL enzyme stock solutions, a 1:2 dilution series of each enzyme was prepared (1x, 0.5x, 0.25x, 0.05x, 0.025x, 0.0125x, 0.00625x and 0.00325x) in 1/10 PBS buffer in 96 well plates, obtaining eight doses ranging from 10 mg/mL to 0.03125 mg/mL. 2) Final enzyme test concentrations ranging from 3.91 to 500 µg/mL were obtained by adding 5 µL of each enzyme dose to 95 µL of Magnaporthe grisea CF-105765 conidia suspension in triplicate. 3) 10 µL of 500 µg/mL Amphotericin B in 90 µL conidia suspension was used as a positive control (assay final concentration of 50 µg/mL) and 10 µL 20% DMSO in 90 µL conidia suspension was used as a negative control (assay final concentration of 2%). All assay plates included quadruplicates of both the positive and the negative control. Furthermore, all assay plates also included an Amphotericin B standard curve consisting of a 1:2 serial dilution ranging from 50 µg/mL to 0.390625 µg/mL. 4) Assay plates were incubated for 24h at __° C. 5) Absorbance at 612 nm was measured before (T0) and after the 24h incubation period (Tf) using a spectrophotometer. 6) Resazurin was then added to each reaction well (0.002% per well) and fluorescence at ex. 570 nm – em.585 nm measured using a spectrophotometer after 2 h incubation at __° C. The percent of inhibition (%INH) based on absorbance (Abs) was calculated following the formula:
where: X = Abs value of enzyme candidate Inhibitor = 100 % of inhibition (Amphotericin B at 50 µg/mL) Neutral = 0 % of inhibition (DMSO at 2%) T0: Abs at time zero
TF: Abs after incubation time – final Abs 7) The % of inhibition based on fluorescence was calculated following the formula:
where:
Inhibitor = Fluorescence intensity of 100 % of Amphotericin B at 50 µg/mL Neutral = Fluorescence intensity of vehicle X = Fluorescence intensity of enzyme candidate Results Enzymes were evaluated for efficacy against Magnaporthe grisea as described above. Data were normalized to two controls, a 100% inhibition control (50 µg/m Lamphotericin B) and a 0% inhibition control (2% dimethylsulfoxide). Results are presented in Fig. 4 as the half maximal effective concentration (EC50) for absorbance at 612 nm (indicator of mycelia growth inhibition) and fluorescence after reaction with Resazurin (ex 570 nm – em 585 nm; indicator of cell viability). Data are presented as averages of triplicate samples. Example 5 Effective Control of Asian Soybean Rust Principle Evaluated the efficacy of enzyme solutions for control of Asian soybean rust on detached soybean leaves. Detached leaves were treated with buffered enzyme solutions and subsequently inoculated with Phakopsora pachyrhizi. The leaves were incubated in clear plastic clamshell containers for two weeks and evaluated for severity of ASR (lesion and pustule counts). Efficacy was evaluated in two separate experiments conducted at the University of Florida. Procedures 1) ASR-susceptible soybean plants (Williams 82) were grown in a greenhouse to growth stage V2.5, at which point fully expanded trifoliate leaves were excised and used in the detach leaf assays described below. 2) Detached leaves were placed, top (adaxial) side up, into clamshell incubation containers lined with moistened paper towels. Two leaves (six leaflets) were placed in each container. Each DLA experiment was repeated as two blocks (six leaflets per treatment in each block) for a total of four
trifoliate leaves (12 leaflets) per treatment. Incubation containers were kept at room temperature, 21° C ± 1°, under 12-24 hours of natural and fluorescent light per day. 3) On Day 1 of the assays, leaves were sprayed with enzyme solutions comprising 0.5 mg enzyme protein per mL in a 0.1x PBS buffer (pH 7.3), with or without 0.1% TWEEN® 20, or with a corresponding control solution comprising no enzyme. The treatments were sprayed on the top side of the soybean leaves up to the point just before runoff, which was approximately 0.6 mL per leaf. Separate, 2 fl. oz hand-pump sprayers (Hydior™) were used to make each application. 4) On Day 2 of the assays, leaves were inoculated with a suspension of soybean rust spores collected on the day of the inoculation. The top side of each leaf was sprayed with 0.6 mL of a Phakopsora pachyrhizi spore suspension (in water with 0.1% TWEEN). For the first experimental replicate, naturally occurring Phakopsora pachyrhizi spores were isolated directly from wild kudzu and suspended (1.62 x 105 spores per mL). For the second experimental replicate, spores derived from the Phakopsora pachyrhizi strain were cultured on Williams 82 soybeans, then isolated and suspended (1.75 x 106 spores per mL). 5) Leaves were maintained at room temperature and moisture levels were maintained as needed. 6) Leaves were examined using a dissecting microscope. The underside (abaxial side) of each leaflet was examined, where pustules (uredinia) develop. A 1.0 or 0.4 sq cm circle was placed on the leaflet and the number of ASR pustules and or lesions found within the circle were counted. Both sides of the leaflet (divided by the midvein) were counted and recorded for a total of two counts/leaflet. The counting circle was placed to avoid any areas of the leaflet with decaying tissue. A rating of leaflet decay (as % affected area) was also performed for each leaflet. For the first experimental replicate, sampling and rating of leaves occurred from days 15 to 18 days post-infection. For the second experimental replicate, sampling and rating was conducted from days 12 to 16 days post-infection. Results Enzymes were evaluated for efficacy against Phakopsora pachyrhizi as described above. Results are presented in Fig.5 as the mean number of combined lesions and pustules from experimental replicates 1 and 2. Example 6 Effective Control of Late Blight Principle Evaluated the efficacy of enzyme solutions for control of late blight on tomato and potato leaf discs. Leaf discs were treated with enzyme and then inoculated with Phytophthora infestans US 23. Disease was assessed up to six days post-inoculation. Experiments were conducted by Novozymes Biologicals, Salem, VA.
Procedures 1) Blight-susceptible tomato and potato plants were grown in a greenhouse for approximately three weeks. Leaves were detached from the mid-region of each plant, and leaf discs were excised using a cork bore (diameter 14 mm) and randomized amongst treatments. 2) One leaf disc was placed, adaxial side up, in each well of a 24-well microtiter plate comprising solidified 0.5% Butterfield's Buffer agar (5 g agar per liter of Butterfield's Buffer). 3) Leaf discs were treated with enzymes in Butterfield's Buffer (8.3 mM phosphate, pH 7.2) or potassium phosphate buffer (0.05 M, pH 7.88 or pH 8), with or without 0.1% w/v surfactant (BREAK-THRU® SP 133 or SILWETTM L-77), or with a corresponding control solution comprising no enzyme, and then air dried. Enzyme solutions were applied using two different methods: A) 50 µL was pipetted onto the adaxial surface of leaf disc, spreading with sterile inoculation loop as necessary; B) enzyme solution was sprayed onto the adaxial surface of leaf disc using an atomizer spray bottle, two pumps each, which adequately covered the surface without pooling. 4) After drying, discs were inoculated with 10 µL of Phytophthora infestans isolate US 23 spore suspension (1 x 105 spores per mL in distilled water) or sterile water comprising no Phytophthora infestans spores. 5) Plates were sealed with parafilm and incubated at 18°C under a 16-hour light / 8-hour dark cycle. 6) Images of the leaf disk plates were captured and analyzed for disease at 6 days post-infection. Results Enzymes were evaluated for efficacy against Phytophthora infestans as described above. A minimum two experimental repeats with four replicates were completed for each treatment. Results for pipette-treated tomato leaf discs treated are presented in Fig.6A as mean percent disease. Results for spray-treated tomato leaf discs are presentd in Fig.6B as (-) no disease reduction, (+) mild disease reduction, (++) moderate disease reduction or (+++) extreme disease reduction and in Fig.6C as mean percent disease. Results for spray-treated potato leaf discs are presented in Fig.6D as mean percent healthy. Example 7 Effective Control of Downy Mildew Principle Evaluated the efficacy of enzyme solutions for control of downy mildew on cucumber leaf discs. Leaf discs were treated with buffered enzyme solutions and subsequently inoculated with Pseudoperonospora cubensis. Plates of inoculated leaf discs were incubated and assessed for disease severity after five days.
Procedures 1) Downy mildew-susceptible cucumber plants were grown in a greenhouse for approximately four weeks. Leaves were detached from the mid-region of each plant, and leaf discs were excised using a cork bore (diameter 8 mm). 2) One leaf disc was placed, abaxial side up, in each well of a 48-well microtiter plate comprising solidified 1% water agar. 3) Leaf discs were treated with enzymes in a buffer solution—20 mM sodium acetate, pH 5; 1M potassium phosphate, pH 7; or 20 mM TRIS, pH 8), with or without surfactant (SAFER® insecticidal soap or TWEEN® 20), or with a corresponding control solution comprising no enzyme, and then air dried. Six replicates were made for each condition. Enzyme treatments were applied by pipetting 15 µL of the treatment solution onto center of the abaxial surface of the leaf disc. 4) After drying, discs were inoculated with 10 µL of Pseudoperonospora cubensis spore suspension (1–3 x 105 spores per mL in distilled water) or sterile water comprising no Pseudoperonospora cubensis spores. 5) Plates were sealed with parafilm and incubated at 18°C under a 16-hour light / 8-hour dark cycle. 6) Images of the leaf disk plates were captured and analyzed for disease five days post-infection. Results Enzymes were evaluated for efficacy against Pseudoperonospora cubensis as described above. Results are presented in Fig.7 as (-) no disease reduction, (+) mild disease reduction, (++) moderate disease reduction or (+++) extreme disease reduction. A minimum six replicates were completed for each treatment. Example 8 Effective Control of Septoria Tritici Blotch Principle Evaluated the efficacy of enzyme solutions for control of Septoria tritici blotch (STB) on wheat plants. A winter wheat cultivar (var. Hereford) growing in 1 L pots was first sprayed with enzyme and after 24 hours sprayed with a spore suspension of Zymoseptoria tritici. Percent leaf area attacked was assessed 14 days after inoculation and again with 3 days interval until the full effects were found. For scoring the standard EPPO scales were used (EPPO standards: Guidelines on good plant protection practice. Wheat. PP 2/10(1)). Experiments were conducted by Aarhus University, Flakkebjerg, Denmark. Procedures 1) STB-susceptible wheat plants (var. Hereford) were grown in a greenhouse for approximately two weeks until reaching the two-leaf crop growth stage (BBCH12).
2) Plants were sprayed with an enzyme solution comprising 0.1% w/v surfactant (BREAK-THRU® S 301, SILWETTM L-77, or TWEEN® 20) in a 10 mM buffer (sodium acetate, pH 5; potassium phosphate, pH 6; potassium phosphate, pH 7; or potassium phosphate, pH 8), or with a corresponding control solution comprising no enzyme and/or buffer, using a cabin sprayer (volume – 600 mL; 150 L/ha, 3.6 km/hour, yellow nozzles 0.2). Six replicates were made for each condition. 3) 24 hours after the initial spray application, the plants were sprayed with a Zymoseptoria tritici spore suspension (2 x 106 spores per mL in 0.1% TWEEN® 20). Two distinct Zymoseptoria tritici cultures were used: A) a culture comprising five isolates collected from naturally infected plant in Denmark in 2020 and B) a culture comprising five isolates collected from naturally infected plant in Denmark in 2021. 4) After Zymoseptoria tritici inoculation, the plants were kept under high relative humidity for 24 hours to ensure infection before being placed under normal greenhouse conditions. 5) Percent leaf area attacked by STB was determined 14 days after inoculation and again every three days until the full effects were found. For scoring, the standard EPPO scale was used (EPPO standards: Guidelines on good plant protection practice. Wheat. PP 2/10(1)). Results Enzymes were evaluated for efficacy on Zymoseptoria tritici infected winter wheat as described above using Inoculum A or Inoculum B. Results are presented in Fig.8A (2020 inoculum) and Fig.8B (2021 inoculum) as percent disease control relative to untreated, inoculated control at various timepoints / disease pressures.100 % control means no disease was detected in the treatment and 0 % control means disease was at the same level as the untreated, inoculated control comparator. Example 9 Effective Fungal Growth Inhibition Principle Evaluated the efficacy of enzyme solutions for inhibiting fungal growth using high-throughput imaging. Serial dilutions were used to determine the minimum inhibitory concentration (MIC50) for each enzyme against four fungal phytopathogens: Botrytis cinerea, Fusarium graminearum, Fusarium virguliforme, and Zymoseptoria tritici. Procedures 1) Enzyme dilution series ranging from 0.0078 to 0.5 mg/mL were added in quadruplicate to 384-well imaging plates. Plates were centrifuged for two minutes at 2500 rpm to ensure all enzyme samples were at the bottom of the wells.
2) Fungal spore suspensions comprising 2–2.5 x 104 spores per mL of sterile growth medium were added to the wells. Four fungal phytopathogens were analyzed: Botrytis cinerea, Fusarium graminearum, Fusarium virguliforme, and Zymoseptoria tritici. Sterile growth medium comprised one part Potato Dexrtrose Broth and nine parts M9 minimal medium (200 mL M9 salt solution (64.0 g Na2HPO42H2O, 15 g KH2PO4, 2.5 g NaCl, 5.0 g NH4Cl ad 1 L distilled water), 2 mL 1 M MgSO4, 20 mL 20% glucose, 100 µl 1 M CaCl2 in 1 L distilled water). 3) Plates were sealed with BREATHE-EASY® sealing membrane (SIGMA-ALDRICH® catalog no. Z380059) and placed in a lidded plastic container with a wet paper towel. 4) Following incubation at room temperature, 21° C ± 1°, for 48 hours, plates were imaged with a high- throughput microscope using a 10x objective, capturing four non-overlapping fields per well. 5) GE Developer software and proprietary, in-house scripts were used to determine total mycelium area, total counts, total end nodes, total hyphae length, average hyphal branch length, intensity levels, and total ungerminated spores. Results Enzymes were evaluated for efficacy against Botrytis cinerea, Fusarium graminearum, Fusarium virguliforme and Zymoseptoria tritici as described above. Data were normalized to two controls, a 100% inhibition control (cycloheximide) and a 0% inhibition control (1:9 Potato Dextrose Broth:M9; MILLIPORE® catalog no. P6685). Results are presented in Fig. 9 as the minimum inhibitory concentration (MIC50) for average hyphal branch length and total mycelium area (i.e., the enzyme concentration required to inhibit average hyphal branch length/total mycelium area to 50% or less as compared to that of corresponding untreated control). Data are presented as averages of quadruplicate samples. Example 10 Effective Fungal Growth Inhibition Principle Evaluated the efficacy of enzyme solutions for inhibiting fungal growth using Radial Diffusion Assays (RDA), which consisted of plating a fungal pathogen in potato dextrose agar (PDA) in sufficient amount to obtain a homogeneous mat of mycelium, allowing the mycelium mat to dry, and then adding a 5 µL drop of enzyme solution. Growth inhibition was scored as the presence/absence of an inhibition- or stress-zone created by the enzyme after incubation of the assay plates at 26oC up to 15 days. Procedures 1) Plates comprising potato dextrose agar were inoculated with a fungal phytopathogen—Botrytis cinerea ATCC56594, Fusarium graminearum Schwabe ATCC 36885, Magnaporthe grisea, Penicillium
digitatum CBS658.68, Penicillium expansum DSM1282, Penicillium italicum, Phytophthora infestans, or Zymoseptoria tritici GPD-GFPB3 (Rohel et al., MOL. PLANT MICROBE INTERACT.14(2):156– 63 (Feb.2001))—by adding a droplet of fungal suspension and spreading the droplet “pprox.”y across the surface of the medium using glass beads. 2) After the plates were dry, test plates were treated with an enzyme solution, with or without buffer (potassium phosphate, pH 6; potassium phosphate, pH 7; or potassium phosphate, pH 8), and with or without surfactant (SILWETTM L-77). Tests were conducted in duplicate. An untreated control plate was kept for each fungal phytopathogen. 3) Plates were incubated at 26° C and assessed daily for 15 days. Results Enzymes were evaluated for efficacy against Botrytis cinerea, Fusarium graminerum, Magnaporthe grisea, Penicillium digitatum, Penicillium expansum, Penicillium italicum, Phytophthora infestans and Zymoseptoria tritici as described above. Results are presented in Fig.10A and Fig.10B as (-) no growth inhibition, (+) visible stress reaction and/or mild growth inhibition, (++) moderate growth inhibition or (+++) extreme growth inhibition. Example 11 Effective Control of Leaf-Eating Insects Principle Evaluated the efficacy of enzyme solutions for inhibiting growth / development of leaf-eating insects. Leaf discs were treated with buffered enzyme solutions and subsequently exposed to 2nd instar cabbage looper larvae. The relative growth rate of each larvae was determined after two days of feeding. Procedures 1) Leaves were detached from Chinese cabbage plants (var. Minuet) and leaf discs were excised using a #12 cork borer. Only one disc was punched from each leaf. All leaf discs were kept in a water bath until use. 2) One leaf disc was placed in each well of a 12-well plate comprising solidified 1% water agar. 3) Leaf discs were painted with enzyme solutions comprising 1 mg enzyme protein per mL in a phosphate buffer solution (0.163 g K2HPO4 and 0.09g of KH2PO4 in 100 mL distilled water) comprising 0.05% SILWETTM L-77, or with a corresponding control solution comprising no enzyme, and then air dried. Twelve replicates were made for each condition. 4) After drying, one 2nd instar cabbage looper larva that had been weighed to the nearest tenth of a milligram was added to each leaf disc.
5) Cabbage loopers were reweighed after two days. 6) The growth rate of the cabbage loopers were determined using the following equation from Bouvaine et al., PLOS ONE 9(1):e86256 (2014): Relative Growth Rate (RGR) = [ ln (final weight / initial weight) ] / days Results Enzymes were evaluated for efficacy against leaf-eating insects as described above. Results are presented in Fig.11 as relative growth rates (RGR) after two days of feeding on treated leaf discs. Example 12 Effective Control of Leaf-Eating Insects Principle Evaluated the efficacy of enzyme solutions for inhibiting growth / development of leaf-eating insects was evaluated. Leaf discs were treated with buffered enzyme solutions and subsequently exposed to 2nd instar cabbage looper larvae. The relative growth rate of each larvae was determined after two days of feeding. Procedures 1) Leaves were detached from Chinese cabbage plants (var. Minuet) and leaf discs were excised using a #12 cork borer. Only one disc was punched from each leaf. All leaf discs were kept in a water bath until use. 2) One leaf disc was placed in each well of a 12-well plate comprising solidified 1% water agar. 3) Leaf discs were painted with enzyme solutions comprising 1 mg enzyme protein per mL in a phosphate buffer solution (0.163 g K2HPO4 and 0.09g of KH2PO4 in 100 mL distilled water) comprising 0.05% SILWETTM L-77, or with a corresponding control solution comprising no enzyme, and then air dried. Twelve replicates were made for each condition. 4) After drying, one 2nd instar cabbage looper larva that had been weighed to the nearest tenth of a milligram was added to each leaf disc. 5) Cabbage loopers were reweighed after two days. 6) The growth rate of the cabbage loopers were determined using the following equation from Bouvaine et al., PLOS ONE 9(1):e86256 (2014): Relative Growth Rate (RGR) = [ ln (final weight / initial weight) ] / days Results Enzymes were evaluated for efficacy against leaf-eating insects as described above. Results are presented in Fig.12 as relative growth rates (RGR) after two days of feeding on treated leaf discs.
Example 13 Effective Control of Gray Mold Principle Evaluated the efficacy of enzyme solutions for control of gray mold on grapes. Harvested grapes were surface sterilized, inoculated with Botrytis cinerea, wounded, and then treated with buffered enzyme solution. Disease severity was assessed after 14 days. Experiments were conducted by Novozymes Biologicals (Salem, VA). Procedures 1. Table grapes were cut into bunches containing 6 grapes. Bunches were washed for five minutes in tap water, two minutes in a 10% bleach solution, and one minute in DI water. Grapes were then allowed to dry for approximately 1-hour. 2. A 10 µl droplet of Botrytis cinerea conidia suspension (1.5 x 106 conidia per ml water) was pipetted onto the surface of each grape. The inoculum was dried for approximately 1-hour. 3. The skin of each grape was then gently punctured at the site of dried inoculum using a sterile dissecting needle. 4. Grapes were treated with enzyme solutions comprising 2.5 mg enzyme protein per mL in a 0.05 M buffer solution (sodium acetate pH 5, potassium phosphate pH 7, or potassium phosphate pH 8). Enzyme treatments were applied via atomizer sprayer, adequately covering the fruit surface with no pooling. 5. Enzyme treatments were dried onto the fruit for approximately three hours. Each grape bunch was stored in an individual plastic container with lid. 6. Grapes were incubated at 20°C in the dark for a 14-day period. Disease progression was monitored for 14-days and expressed as a percentage of lesion area to total grape area on a 2D plane. Results Enzymes were evaluated for efficacy against Botrytis cinerea as described above. Results are presented in Fig. 13 as mean percent disease. A minimum three experimental repeats with six replicates were completed for each treatment.
Example 14 Effective Control of Head Blight Principle Evaluated the efficacy of enzyme solutions for control of Fusarium head blight on wheat plants. Plants were treated with enzyme solution and subsequently inoculated with GFP-transformed Fusarium graminearum. Pathogen biomass was quantified via GFP, and plant health parameters were collected up to 14 days post- inoculation. Testing was conducted at Ghent University (Ghent, Belgium). Procedures 1) GFP-transformed Fusarium graminearum strain PH-1 was grown on potato dextrose agar for seven days at 21°C under a regime of 12 h dark and 12 h combined UVA and UVC light to induce sporulation. 2) A working spore suspension was created by adding “pprox.. 20 mL of phosphate buffered saline containing 0.01% TWEEN® 80, pH 7.2–7.4, to the petri dish, agitating the mycelium with a spatula, separating spores from mycelium using a sterile filter, and then diluting to a concentration of 0.5 x 106 spores per mL. 3) Wheat plants were grown in potting soil for three months under controlled greenhouse conditions (Tday 21 °C, Tnight 16 °C, 60 % relative humidity). Two separate pots, each containing approximately 10 wheat ears in anthesis, were selected for each treatment in the bioassays described below. 4) Plants were sprayed until runoff with enzyme solutions comprising 0.5 or 1 mg enzyme protein per mL in a 10mM buffer solution (sodium acetate pH 5, potassium phosphate pH 6, potassium phosphate pH 7, or potassium phosphate pH 8), with or without 0.05% w/v surfactant (SILWETTM L-77), or with a corresponding control solution comprising no enzyme, one day prior to inoculation with Fusarium graminearum PH-1 spore suspension. 5) Plants were double-inoculated with Fusarium graminearum PH-1: (i) six ears per plant were point- inoculated on one spikelet with a 10 µl droplet of the Fusarium graminearum PH-1 spore suspension or with a corresponding solution comprising no Fusarium graminearum spores, and (ii) plants were sprayed until runoff with the Fusarium graminearum PH-1 spore suspension or with a corresponding solution comprising no Fusarium graminearum spores. 6) Infected plants and uninoculated control plants were grown under controlled greenhouse conditions (Tday 21 °C, Tnight 16 °C, 60 % relative humidity), except that infected plants were kept at 100% relative humidity during the first 48 hours post-inoculation. Infected plants were grown in a quarantine compartment to prevent infection of uninoculated control plants. 7) Disease progression was monitored through visual inspection and multispectral imaging. Fv/Fm, ChlIdx and cGFP were evaluated from the multispectral images. See Table 2. Mean Fv/Fm, ChlIdx and
cGFP values for untreated, inoculated control plants were used as a reference (100%) to evaluate the Fv/Fm, ChlIdx and cGFP values for treated leaves. Results Enzymes were evaluated for efficacy against Fusarium graminearum as described above. Results are presented in Fig.14A (four days post-inoculation) and Fig.14B (twelve and thirteen days post-inoculation) as percentage increase of the spectral parameters (Fv/Fm, ChlIdx and cGFP) as compared to a corresponding untreated, inoculated controls. Example 15 Effective Control of Yellow Rust Principle Evaluated the efficacy of enzyme solutions for control of yellow rust on winter wheat plants. Plants were treated with buffered enzyme solution and subsequently inoculated with Puccinia striiformis. Percent leaf area attacked was assessed fifteen days post-inoculation and again with two- or three-day intervals until the full effects were seen. For scoring the standard EPPO scales were used. Experiments were conducted by Århus University, Flakkebjerg, Denmark. Procedures 1) Winter wheat kernels (var. Morocco) were sown 10 seeds/plants per pot in 0.5 L pots and allowed to germinate and grow in a greenhouse for approximately two weeks until reaching the two-leaf crop growth stage (BBCH12). 2) Plants were then sprayed with enzyme solution comprising 0.1 to 0.132 mg enzyme protein per mL in a 10 mM buffer solution (sodium acetate pH 5, potassium phosphate pH 6, potassium phosphate pH 7, or potassium phosphate pH 8) with 0.1% w/v surfactant (SILWETTM L-77), or with a corresponding control solution comprising no enzyme, using a cabin sprayer (volume 600 mL; 150 L/ha, 5.5 km/hour, yellow nozzles 0.2; 2.24 bar). Six replicates were made for each condition. 3) 24 hours after the initial spray application, the plants were sprayed with a Puccinia striiformis spore suspension (Puccinia striiformis f. sp. tritici Dk229/19). 4) After Puccinia striiformis inoculation, the plants were kept under high relative humidity for 24 hours at 10–12 °C to ensure infection before being placed under normal greenhouse conditions. 5) Percent leaf area attacked by yellow rust was determined fifteen days after inoculation and again every two to three days until the full effects were found. For scoring, the standard EPPO scale (EPPO standards: Guidelines on good plant protection practice. Wheat. PP/26 (4)) was used. The area under the disease progress curve was calculated to summarize effects across the performed assessments.
Results Enzymes were evaluated for efficacy against Puccinia striiformis as described above. Results are presented in Fig.15 as area under the disease progress curve. Example 16 Degradation of Fungal Cell Wall Components Principle Evaluated the efficacy of enzyme solutions for degradation of fungal cell wall components. Fungal mycelium were isolated and treated with buffered enzyme solution. A reducing end assay was used to analyze cell wall degradation. Procedures 1) Shake flasks comprising sterile YP media with 2% glucose were inoculated with a fungal phytopathogen—Botrytis cinerea ATCC56594, Fusarium graminerum Schwabe ATCC 36885, Penicillium digitatum CBS658.68, Penicillium expansum DSM1282, Penicillium italicum, Phytophthora infestans, Pyricularia grisea, or Zymoseptoria tritici—and incubated for seven days at 26 °C with shaking. 2) After incubation, mycelia were harvested by centrifugation (10 minutes, 3000 rpm). Supernatant was removed by decanting, and pellet was washed 3 times in 3 x 50 mL demineralized water. 3) After final wash, pellet was suspended in 5 mL demineralized water and homogenized in ball mill with 2 glass beads for 150 seconds at room temperature. 4) Homogenate was washed thoroughly in 50 mL centrifuge tube with 2 x 20 mL demineralized water 5) The washed pellet was freeze dried and the dried product homogenized in mortar and kept frozen until use. This material is the crude cell wall preparation. 6) For the hydrolysis, 250 µL of 20 mg/mL crude cell wall preparation suspended in phosphate buffer was mixed with 250 µL buffered enzyme solution (sodium acetate pH 5, potassium phosphate pH 6, potassium phosphate pH 7, or potassium phosphate pH 8), or with a corresponding solution comprising no enzyme, in 1.5 mL Eppendorf tube and incubated overnight at 40 °C with shaking. Enzymes were evaluated as duplicates. 7) After hydrolysis, the supernatant was isolated by centrifugation (5 minutes at 14000 rpm) and the amount of solubilized oligosaccharides were determined by measuring the reducing ends using the PAHBAH assay:
a. 20 µL supernatant from hydrolysis or 20 µL standard plus 80 µL demineralized water is mixed with 75 µL freshly prepared PAHBAH solution (15 mg/mL 4-hydroxybenzhydrazide in PAHBAH buffer (50 g/L K-Na-tartrate tetrahydrate + 20 g/L NaOH)) in a 96 well PCR plate. b. The plate is incubated for 10 minutes at 95 °C in PCR machine and then cooled down to room temperature. c. 100 µL is then transferred to new 96 well transparent microtiter plate and the absorbance is measured at 405 nm. d. A standard curve is prepared by plotting the absorbance of glucose standards (0.0125 to 0.25 mg/mL) against the glucose concentration and the number of reducing ends are calculated as glucose equivalents from the standard curve. The results are given as mg glucose equivalents per gram of crude cell wall material (mg Glc/g CW). Results Enzymes were evaluated for efficacy against Botrytis cinerea, Fusarium graminerum, Penicillium digitatum, Penicillium expansum, Penicillium italicum, Phytophthora infestans, Pyricularia grisea and Zymoseptoria tritici as described above. Results are presented in Fig. 16 as mg glucose equivalents per gram of crude cell wall material (mg Glc/g CW). Example 17 Effective Fungal Germination Inhibition Principle Evaluated the efficacy of enzyme solutions for inhibiting fungal germination. Serial dilutions were used to determine the minimum enzyme concentration required to prevent germination of Botrytis cinerea and Penicillium expansum spores. Procedures 1) Enzyme dilution series ranging from 0.002 to 2 mg/mL in 100 µL 10 mM buffer solution (sodium citrate pH 3, sodium citrate pH 4, sodium citrate pH 5, potassium phosphate pH 6, potassium phosphate pH 7, or potassium phosphate pH 8) were added in triplicate to 96-well imaging plates, alongside corresponding control solutions comprising no enzyme. 2) Fungal spore suspensions comprising 5 x 104 spores per mL of sterile growth medium (Potato Dextrose Broth) were added to the wells. Two fungal phytopathogens were analyzed: Botrytis cinerea and Penicillium expansum. 3) Plates were sealed with BREATHE-EASY® sealing membrane (SIGMA-ALDRICH® catalog no. Z380059) and placed in a 25 °C incubator until ready for imaging.
4) Following incubation at 25° C for 24 hours, plates were imaged using a high-throughput inverted microscope using a 10x objective. Images were visually analyzed to determine which enzyme treatments allowed / prevented spore germination. Untreated control solutions exhibiting (substantially) complete germination were used as positive controls. 5) After imaging, enzyme solutions were replaced with sterile PBS. Plates were centrifuged at 3000 rpm for ten minutes, supernatant was removed, and sterile PBS was added. Steps were repeated twice more to ensure thorough enzyme washout. 6) Washed fungal spore suspensions were replated in fresh 96-well imaging plates containing sterile growth medium (Potato Dextrose Broth) and incubated for up to 48 hours at 25 °C. 7) Washed and replated fungal spore suspensions were reimaged after 24 hours and 48 hours at 25 °C to determine which enzyme treatments allowed / prevented germination even after washout. Results Enzymes were evaluated for efficacy against Botrytis cinerea and Penicillium expansum as described above. Results are presented in Fig. 17 as the minimum enzyme concentration that completely prevent fungal spore germination after 24 hours with enzyme, 24 hours after enzyme washout, and 48 hours after enzyme washout. Data are presented as averages of triplicate samples. Example 18 Effective Fungal Growth Inhibition Principle Evaluated the efficacy of enzyme solutions for inhibiting fungal growth using high-throughput imaging. Serial dilutions were used to determine the minimum inhibitory concentration (MIC50) of enzyme needed to inhibit growth of Botrytis cinerea. Procedures 1) Enzyme dilution series ranging from 0.0078 to 0.5 mg/mL were added in quadruplicate to 384-well imaging plates. A serial dilution of fludioxonil (SCHOLAR® SC; Syngenta Crop Protection, LLC (Greensboro, NC)) was included as a positive control. Plates were centrifuged for two minutes at 2500 rpm to ensure all enzyme samples were at the bottom of the wells. 2) Fungal spore suspensions comprising 2–2.5 x 104 spores of Botrytis cinerea per mL of sterile growth medium were added to the wells. Sterile growth medium comprised one part Potato Dexrtrose Broth and nine parts M9 minimal medium (200 mL M9 salt solution (64.0 g Na2HPO42H2O, 15 g KH2PO4, 2.5 g NaCl, 5.0 g NH4Cl ad 1 L distilled water), 2 mL 1 M MgSO4, 20 mL 20% glucose, 100 µl 1 M CaCl2 in 1 L distilled water).
3) Plates were sealed with BREATHE-EASY® sealing membrane (SIGMA-ALDRICH® catalog no. Z380059) and placed in a lidded plastic container with a wet paper towel. 4) Following incubation at room temperature, 21° C ± 1°, for 48 hours, plates were imaged with a high- throughput microscope using a 10x objective, capturing four non-overlapping fields per well. 5) Proprietary, in-house scripts were used to quantify total mycelium area, average hyphal branch length, and total ungerminated spores. Results Enzymes were evaluated for efficacy against Botrytis cinerea as described above. Data were normalized to two controls, a 100% inhibition control (cycloheximide) and a 0% inhibition control (1:9 Potato Dextrose Broth:M9; MILLIPORE® catalog no. P6685). Results are presented in Fig. 18 as the minimum inhibitory concentration (MIC50) for average total mycelium area (i.e., the enzyme concentration required to inhibit mycelial area to 50% or less as compared to that of corresponding untreated control). Data are presented as averages of three biological replicates with quadruplicate technical replicates. Example 19 Effective Fungal Growth Inhibition Principle Evaluated the efficacy of enzyme solutions for inhibiting germ tube elongation in Botrytis cinerea and Penicillium expansum using high-throughput imaging. Procedures 1) Fungal spore suspensions comprising 5 x 104 spores per mL of sterile growth medium (Potato Dextrose Broth) were added to 384-well imaging plates. 2) Plates were sealed with BREATHE-EASY® sealing membrane (SIGMA-ALDRICH® catalog no. Z380059), centrifuged for one minute at 1000 rpm, and incubated at 18 °C for six hours. 3) Each well was treated with an enzyme solution comprising enzyme protein in 10mM buffer solution (sodium citrate pH 3, sodium citrate pH 4, sodium citrate pH 5, potassium phosphate pH 6, potassium phosphate pH 7, or potassium phosphate pH 8) to a final concentration of 2 mg per mL, or with a corresponding control solution comprising no enzyme. All treatments were performed in triplicate. 4) Plates were sealed with BREATHE-EASY® sealing membrane (SIGMA-ALDRICH® catalog no. Z380059), centrifuged for one minute at 1000 rpm, and incubated at 18 °C under ready for imaging. 5) Plates were imaged with a high-throughput microscope using a 20x objective, capturing four non- overlapping fields per well. 6) Proprietary, in-house scripts were used to quantify total hyphal area and germ tube length.
Results Enzymes were evaluated for efficacy against Botrytis cinerea and Penicillium expansum as described above. Results are presented in Fig.19 as percent inhibition of germ tube elongation as compared to the corresponding buffer control solution. Data are presented as averages of triplicate samples. Example 20 Exemplary Polypeptide Sequences of the Present Disclosure
KAQINSWEKVFGMEGWNWDNLLPYMNKVEASRPPNAAQIAAGHYFDPACHGVNGTVQVGPRDTG
Claims
THAT WHICH IS CLAIMED: 1. Use of an enzymatically active protein, a formulation comprising an enzymatically active protein, a polynucleotide encoding an enzymatically active protein, or an organism expressing an enzymatically active protein for: a. treating a surface/substance that is susceptible to infestation/infection by one or more pests, optionally one or more acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa and/or viruses; b. cleansing a surface/substance that is infested/infected by one or more pests, optionally one or more acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa and/or viruses; c. treating (e.g., coating, dipping, drenching, fogging, misting, soaking, spraying) a plant or plant part; d. treating (e.g., drenching, fogging, misting, spraying) a plant growth medium; e. treating (e.g., coating, dipping, drenching, fogging, irrigating, misting, soaking, spraying) a agricultural/floricultural/horticultural/silvicultural apparatus/facility, optionally an apparatus/facility for planting, irrigating, fertilizing, growing, monitoring, testing, pruning, harvesting, processing, packaging and/or storing a plant or plant part; f. preventing, treating, suppressing and/or eliminating infestation/infection of a surface/substance of/by one or more pests, optionally one or more acarids, bacteria, fungi, gastropods, insects, nematodes, oomycetes, protozoa and/or viruses; g. preventing, treating, suppressing and/or eliminating infestation/infection of a plant, plant part, plant growth medium or agricultural/floricultural/horticultural/silvicultural apparatus/facility of/by one or more phytopathogenic pests, optionally one or more arachnids, bacteria, fungi, gastropods, insects, nematodes, oomycetes protozoa, viruses and/or weeds; h. reducing one or more aspects of disease severity in a plant or plant part affected by one or more phytopathogenic pests, optionally one or more arachnids, bacteria, fungi, gastropods, insects, nematodes, oomycetes protozoa, viruses and/or weeds; i. reducing one or more aspects of disease severity in a plant or plant part grown in a plant growth medium that is infested/infected by/with one or more phytopathogenic pests, optionally one or more arachnids, bacteria, fungi, gastropods, insects, nematodes, oomycetes protozoa, viruses and/or weeds; j. reducing one or more aspects of disease severity in a plant or plant part grown in or contacted by an agricultural/floricultural/horticultural/silvicultural apparatus/facility that is infested/infected by/with one or more phytopathogenic pests, optionally one or more arachnids, bacteria, fungi, gastropods, insects, nematodes, oomycetes protozoa, viruses and/or weeds; k. improving one or more soil characteristics, optionally soil structure and/or drainage; l. improving nutrient availability/uptake/accumulation, optionally boron, calcium, carbon, copper,
iron, magnesium, manganese, molybdenum, nitrogen, phosphorous, potassium, sulfur and/or zinc availability/uptake/accumulation; m. improving one or more characteristics of plant growth and/or development; n. reducing the need for exogenous fertilize; o. reducing the amount(s) of exogenous fertilizer needed to achieve desired result; p. improving one or more characteristics of plant yield; q. prolonging the shelf-life of a harvested plant or plant part; r. delaying the ripening of a harvested plant or plant part; s. hastening the ripening of a harvested plant or plant part; t. improving the efficacy of a chemical pesticide, optionally an acaricide, bactericide, fungicide, gastropodicide, herbicide, insecticide, nematicide, oomyceticide, protozoacide or viricide; u. improving the efficacy of a biological pesticide, optionally an acaricide, bactericide, fungicide, gastropodicide, herbicide, insecticide, nematicide, oomyceticide, protozoacide or viricide; v. improving the efficacy of a preharvest treatment; w. improving the efficacy of a postharvest treatment; x. preventing, treating, suppressing and/or eliminating chemical pesticide-induced pest resistance and/or phytotoxicity; y. preventing, treating, suppressing and/or eliminating biological pesticide-induced pest resistance and/or phytotoxicity; and/or z. inclusion as part of an Integrated Pest Management program/strategy, optionally an Integrated Pest Management program/strategy comprising one or more chemical pesticides, said enzymatically active protein selected from the group consisting of: i. a polypeptide having glucose oxidase activity; ii. a polypeptide having glucose oxidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 1–5 and 183–2205; iii. a polypeptide having glucose oxidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 1–5 and 183–2205; iv. a polypeptide having glucose oxidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 92–96 or the cDNA sequence thereof; v. a polypeptide having cellobiose oxidase activity; vi. a polypeptide having cellobiose oxidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69,
70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 6–8 and 2206–2217; vii. a polypeptide having cellobiose oxidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 6– 8 and 2206–2217; viii. a polypeptide having cellobiose oxidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 97–99 or the cDNA sequence thereof; ix. a polypeptide having laccase activity; x. a polypeptide having laccase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 9 and 2218–2251; xi. a polypeptide laccase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 9 and 2218–2251; xii. a polypeptide having laccase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 100 or the cDNA sequence thereof; xiii. a polypeptide having catalase activity; xiv. a polypeptide having catalase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 10–12 and 2252–2296; xv. a polypeptide having catalase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 10–12 and 2252–2296; xvi. a polypeptide having catalase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 101–103 or the cDNA sequence thereof; xvii. a polypeptide having peroxidase activity;
xviii. a polypeptide having peroxidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 13 and 2297–2381; xix. a polypeptide having peroxidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 13 and 2297–2381; xx. a polypeptide having peroxidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 104 or the cDNA sequence thereof; xxi. a polypeptide having lytic cellulose monooxygenase activity; xxii. a polypeptide having lytic cellulose monooxygenase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 14–15 and 2382–2755; xxiii. a polypeptide having lytic cellulose monooxygenase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 14–15 and 2382–2755; xxiv. a polypeptide having lytic cellulose monooxygenase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 105–106 or the cDNA sequence thereof; xxv. a polypeptide having gamma-glutamyl transferase activity; xxvi. a polypeptide having gamma-glutamyl transferase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 16 and 2756–2769; xxvii. a polypeptide having gamma-glutamyl transferase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 16 and 2756–2769; xxviii. a polypeptide having gamma-glutamyl transferase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83,
84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 107 or the cDNA sequence thereof; xxix. a polypeptide having triacylglycerol lipase activity; xxx. a polypeptide having triacylglycerol lipase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 17–22 and 2778– 10223; xxxi. a polypeptide having triacylglycerol lipase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 17–22 and 2778–10223; xxxii. a polypeptide having triacylglycerol lipase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 108–113 or the cDNA sequence thereof; xxxiii. a polypeptide having triacylglycerol lipase and/or phospholipase A1 activity; xxxiv. a polypeptide having triacylglycerol lipase and/or phospholipase A1 activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 23 and 10243–15978; xxxv. a polypeptide having triacylglycerol lipase and/or phospholipase A1 activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 23 and 10243–15978; xxxvi. a polypeptide having triacylglycerol lipase and/or phospholipase A1 activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 114 or the cDNA sequence thereof; xxxvii. a polypeptide having lysophospholipase activity; xxxviii. a polypeptide having lysophospholipase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 24 and 15979–15981; xxxix. a polypeptide having lysophospholipase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 24 and 15979–15981;
xl. a polypeptide having lysophospholipase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 115 or the cDNA sequence thereof; xli. a polypeptide having pectinesterase activity; xlii. a polypeptide having pectinesterase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 25 and 2770–2777; xliii. a polypeptide having pectinesterase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 25 and 2770–2777; xliv. a polypeptide having pectinesterase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 116 or the cDNA sequence thereof; xlv. a polypeptide having phospholipase A 1 activity; xlvi. a polypeptide having phospholipase A1 activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 26 and 10224–10242; xlvii. a polypeptide having phospholipase A1 activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 26 and 10224–10242; xlviii. a polypeptide having phospholipase A1 activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 117 or the cDNA sequence thereof; xlix. a polypeptide having cutinase activity; l. a polypeptide having cutinase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 27–31 and 15982–16004; li. a polypeptide having cutinase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 27–31 and 15982–16004;
lii. a polypeptide having cutinase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 118–122 or the cDNA sequence thereof; liii. a polypeptide having phospholipase C activity; liv. a polypeptide having phospholipase C activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 32 and 16396–16412; lv. a polypeptide having phospholipase C activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 32 and 16396–16412; lvi. a polypeptide having phospholipase C activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 123 or the cDNA sequence thereof; lvii. a polypeptide having phosphoinositide phospholipase C activity; lviii. a polypeptide having phosphoinositide phospholipase C activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 33 and 16005–16395; lix. a polypeptide having phosphoinositide phospholipase C activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 33 and 16005–16395; lx. a polypeptide having phosphoinositide phospholipase C activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 124 or the cDNA sequence thereof; lxi. a polypeptide having amylase activity; lxii. a polypeptide having alpha-amylase activity; lxiii. a polypeptide having alpha-amylase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 34–40 and 16413–45041; lxiv. a polypeptide having alpha-amylase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96,
97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 34– 40 and 16413–45041; lxv. a polypeptide having alpha-amylase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 125–131 or the cDNA sequence thereof; lxvi. a polypeptide having beta-amylase activity; lxvii. a polypeptide having glucanase activity; lxviii. a polypeptide having alpha-glucanase activity; lxix. a polypeptide having beta-glucanase activity; lxx. a polypeptide having glucan 1,4-alpha-glucosidase activity; lxxi. a polypeptide having glucan 1,4-alpha-glucosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 41–42 and 45756–45904; lxxii. a polypeptide having glucan 1,4-alpha-glucosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 41–42 and 45756–45904; lxxiii. a polypeptide having glucan 1,4-alpha-glucosidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 132–133 or the cDNA sequence thereof; lxxiv. a polypeptide having cellulase activity; lxxv. a polypeptide having cellulase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 43–45 and 45913–48750; lxxvi. a polypeptide having cellulase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 43–45 and 45913–48750; lxxvii. a polypeptide having cellulase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 134–136 or the cDNA sequence thereof; lxxviii. a polypeptide having endo-1,3(4)-beta-glucanase activity;
lxxix. a polypeptide having endo-1,3(4)-beta-glucanase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 46 and 49229– 49346; lxxx. a polypeptide having endo-1,3(4)-beta-glucanase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 46 and 49229–49346; lxxxi. a polypeptide having endo-1,3(4)-beta-glucanase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 137 or the cDNA sequence thereof; lxxxii. a polypeptide having inulinase activity; lxxxiii. a polypeptide having inulinase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 47 and 49347–49419; lxxxiv. a polypeptide having inulinase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 47 and 49347–49419; lxxxv. a polypeptide having inulinase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 138 or the cDNA sequence thereof; lxxxvi. a polypeptide having endo-1,4-beta-xylanase activity; lxxxvii. a polypeptide having endo-1,4-beta-xylanase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 48–53 and 49453– 49912; lxxxviii. a polypeptide having endo-1,4-beta-xylanase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 48–53 and 49453–49912; lxxxix. a polypeptide having endo-1,4-beta-xylanase activity encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85,
86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 139–144 or the cDNA sequence thereof; xc. a polypeptide having dextranase activity; xci. a polypeptide having dextranase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 54 and 45063–45071; xcii. a polypeptide having dextranase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 54 and 45063–45071; xciii. a polypeptide having dextranase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 145 or the cDNA sequence thereof; xciv. a polypeptide having chitinase activity; xcv. a polypeptide having endo-polygalacturonase (pectinase) activity; xcvi. a polypeptide having lysozyme activity; xcvii. a polypeptide having lysozyme activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 56 and 45443–45456; xcviii. a polypeptide having lysozyme activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 56 and 45443–45456; xcix. a polypeptide having lysozyme activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 147 or the cDNA sequence thereof; c. a polypeptide having alpha-glucosidase activity; ci. a polypeptide having beta-glucosidase activity; cii. a polypeptide having beta-glucosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 57 and 45457–45754; ciii. a polypeptide having beta-glucosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95,
96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 57 and 45457–45754; civ. a polypeptide having beta-glucosidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 148 or the cDNA sequence thereof; cv. a polypeptide having alpha-galactosidase activity; cvi. a polypeptide having beta-galactosidase activity; cvii. a polypeptide having alpha-mannosidase activity; cviii. a polypeptide having alpha-mannosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 58 and 45755; cix. a polypeptide having alpha-mannosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 58 and 45755; cx. a polypeptide having alpha-mannosidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 149 or the cDNA sequence thereof; cxi. a polypeptide having beta-mannosidase activity; cxii. a polypeptide having endo-1,3-beta-xylanase activity; cxiii. a polypeptide having glucan endo-1,3-beta-D-glucosidase activity; cxiv. a polypeptide having glucan endo-1,3-beta-D-glucosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 59– 60 and 45905–45912; cxv. a polypeptide having glucan endo-1,3-beta-D-glucosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 59–60 and 45905–45912; cxvi. a polypeptide having glucan endo-1,3-beta-D-glucosidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 150–151 or the cDNA sequence thereof; cxvii. a polypeptide having pullulanase activity;
cxviii. a polypeptide having pullulanase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 61 and 48751–49148; cxix. a polypeptide having pullulanase activity having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 61 and 48751–49148; cxx. a polypeptide having pullulanase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 152 or the cDNA sequence thereof; cxxi. a polypeptide having alpha-L-arabinofuranosidase activity; cxxii. a polypeptide having alpha-L-arabinofuranosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 62 and 49149–49209; cxxiii. a polypeptide having alpha-L-arabinofuranosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 62 and 49149–49209; cxxiv. a polypeptide having alpha-L-arabinofuranosidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 153 or the cDNA sequence thereof; cxxv. a polypeptide having glucan 1,3-beta-glucosidase activity; cxxvi. a polypeptide having glucan endo-1,3-alpha-glucosidase activity; cxxvii. a polypeptide having glucan endo-1,3-alpha-glucosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 63–64 and 49210–49228; cxxviii. a polypeptide having glucan endo-1,3-alpha-glucosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 63–64 and 49210–49228; cxxix. a polypeptide having glucan endo-1,3-alpha-glucosidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81,
82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 154–155 or the cDNA sequence thereof; cxxx. a polypeptide having glucan 1,4-alpha-glucosidase acitivty cxxxi. a polypeptide having glucan 1,6-alpha-glucosidase activity; cxxxii. a polypeptide having glucan endo-1,2-beta-glucosidase activity; cxxxiii. a polypeptide having xylanase activity; cxxxiv. a polypeptide having licheninase activity; cxxxv. a polypeptide having licheninase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 65 and 49420–49446; cxxxvi. a polypeptide having licheninase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 65 and 49420–49446; cxxxvii. a polypeptide having licheninase activity encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 156 or the cDNA sequence thereof; cxxxviii. a polypeptide having glucan 1,4-beta-glucosidase activity; cxxxix. a polypeptide having glucan endo-1,6-beta-glucosidase activity; cxl. a polypeptide having glucan endo-1,6-beta-glucosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 66–67 and 49447–49451; cxli. a polypeptide having glucan endo-1,6-beta-glucosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 66–67 and 49447–49451; cxlii. a polypeptide having glucan endo-1,6-beta-glucosidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 157–158 or the cDNA sequence thereof; cxliii. a polypeptide having mannan 1,2-(1,3)-alpha-mannosidase activity; cxliv. a polypeptide having mannan endo-1,4-beta-mannosidase activity; cxlv. a polypeptide having mannan endo-1,4-beta-mannosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,
91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 68, 72144 and 49452; cxlvi. a polypeptide having mannan endo-1,4-beta-mannosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 68, 72144 and 49452; cxlvii. a polypeptide having mannan endo-1,4-beta-mannosidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 159 and 72145 or the cDNA sequence thereof; cxlviii. a polypeptide having glucan 1,3-alpha-glucosidase activity; cxlix. a polypeptide having cellulose 1,4-beta-cellobiosidase activity; cl. a polypeptide having mannan endo-1,6-alpha-mannosidase activity; cli. a polypeptide having mannan endo-1,6-alpha-mannosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 69 and 45042; clii. a polypeptide having mannan endo-1,6-alpha-mannosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 69 and 45042; cliii. a polypeptide having mannan endo-1,6-alpha-mannosidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 160 or the cDNA sequence thereof; cliv. a polypeptide having endogalactosaminidase activity; clv. a polypeptide having endogalactosaminidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 70–75 and 45043– 45062; clvi. a polypeptide having endogalactosaminidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 70–75 and 45043–45062; clvii. a polypeptide having endogalactosaminidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84,
85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 161–166 or the cDNA sequence thereof; clviii. a polypeptide having glycoprotein endo-alpha-1,2-mannosidase activity; clix. a polypeptide having glycoprotein endo-alpha-1,2-mannosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 76–77; clx. a polypeptide having glycoprotein endo-alpha-1,2-mannosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 76–77; clxi. a polypeptide having glycoprotein endo-alpha-1,2-mannosidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 167–168 or the cDNA sequence thereof; clxii. a polypeptide having chitosanase activity; clxiii. a polypeptide having glucan 1,4-alpha-maltohydrase activity; clxiv. a polypeptide having glucan 1,4-alpha-maltohydrase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 78 and 45072–45408; clxv. a polypeptide having glucan 1,4-alpha-maltohydrase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 78 and 45072–45408; clxvi. a polypeptide having glucan 1,4-alpha-maltohydrase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 169 or the cDNA sequence thereof; clxvii. a polypeptide having 1,6-alpha-D-mannosidase activity; clxviii. a polypeptide having 1,6-alpha-D-mannosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 79 and 45437– 45442; clxix. a polypeptide having 1,6-alpha-D-mannosidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93,
94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 79 and 45437–45442; clxx. a polypeptide having 1,6-alpha-D-mannosidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 170 or the cDNA sequence thereof; clxxi. a polypeptide having beta-1,2-mannosidase activity; clxxii. a polypeptide having aminopeptidase activity; clxxiii. a polypeptide having leucyl aminopeptidase activity; clxxiv. a polypeptide having alanyl aminopeptidase activity; clxxv. a polypeptide having cystinyl aminopeptidase activity; clxxvi. a polypeptide having tripeptide aminopeptidase activity; clxxvii. a polypeptide having prolyl aminopeptidase activity; clxxviii. a polypeptide having glutamyl aminopeptidase activity; clxxix. a polypeptide having cytosol aminopeptidase activity; clxxx. a polypeptide having tryptophanyl aminopeptidase activity; clxxxi. a polypeptide having methionyl aminopeptidase activity; clxxxii. a polypeptide having aspartyl aminopeptidase activity; clxxxiii. a polypeptide having carboxypeptidase activity; clxxxiv. a polypeptide having endopeptidase activity; clxxxv. a polypeptide having serine endopeptidase activity; clxxxvi. a polypeptide having serine endopeptidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 80–81 and 49913– 50777; clxxxvii. a polypeptide having serine endopeptidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 80–81 and 49913–50777; clxxxviii. a polypeptide having serine endopeptidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 171–172 or the cDNA sequence thereof; clxxxix. a polypeptide having glutamyl endopeptidase activity; cxc. a polypeptide having glutamyl endopeptidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93,
94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 82 and 50778– 50953; cxci. a polypeptide having glutamyl endopeptidase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 82 and 50778–50953; cxcii. a polypeptide having glutamyl endopeptidase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 173 or the cDNA sequence thereof; cxciii. a polypeptide having subtilisin activity; cxciv. a polypeptide having subtilisin activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 83–87 and 50954–70838; cxcv. a polypeptide having subtilisin activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 83–87 and 50954–70838; cxcvi. a polypeptide having subtilisin activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SQ ID NO(s): 174–178 or the cDNA sequence thereof; cxcvii. a polypeptide having bacillolycin activity; cxcviii. a polypeptide having bacillolycin activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 88 and 70839–71903; cxcix. a polypeptide having bacillolycin activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 88 and 70839–71903; cc. a polypeptide having bacillolycin activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 179 or the cDNA sequence thereof; cci. a polypeptide having asparaginase activity;
ccii. a polypeptide having asparaginase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 89–90 and 71904–72141; cciii. a polypeptide having asparaginase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 89– 90 and 71904–72141; cciv. a polypeptide having asparaginase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 180–181 or the cDNA sequence thereof; ccv. a polypeptide having glutaminase activity; ccvi. a polypeptide having amidase activity; ccvii. a polypeptide having urease activity; ccviii. a polypeptide having hydrolase activity; ccix. a polypeptide having deacetylase activity; ccx. a polypeptide having deaminase activity; ccxi. a polypeptide having pectate lyase activity; ccxii. a polypeptide having pectate lyase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 91and 72142–72143; ccxiii. a polypeptide having pectate lyase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 91 and 72142–72143; ccxiv. a polypeptide having pectate lyase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 182 or the cDNA sequence thereof; ccxv. a polypeptide having pectin lyase activity; ccxvi. a polypeptide having pectin lyase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 55 and 45409–45436; ccxvii. a polypeptide having pectin lyase activity and at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97,
98, 99 or 100 % sequence identity to a mature polypeptide of any one of SEQ ID NO(s): 55 and 45409–45436; ccxviii. a polypeptide having pectin lyase activity and encoded by a polynucleotide having at least 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100 % sequence identity to one or more of SEQ ID NO(s): 146 or the cDNA sequence thereof; ccxix. a polypeptide having glucan lyase activity; ccxx. a polypeptide having alpha-1,4-glucan lyase activity; ccxxi. an enzymatically active fragment/mutant/variant of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 and 183–72143 or a mature polypeptide thereof; ccxxii. an enzymatically active polypeptide derived from any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 and 183–72143 by substitution, deletion, or insertion of one or more amino acids; ccxxiii. an enzymatically active polypeptide derived from a mature polypeptide of any one of SEQ ID NO(s): 1–91, 45906, 72144, 72147 and 72149 and 183–72143 by substitution, deletion, or insertion of one or more amino acids; ccxxiv. an enzymatically active polypeptide derived from the polypeptide of any one of i) through ccxxiii) wherein the N- and/or C-terminal end has been extended by the addition of one or more amino acids; ccxxv. an enzymatically active fragment of the polypeptide of any one of i) through ccxxiv); and ccxxvi. fusion proteins comprising a first polypeptide having a first enzymatic activity and a second polypeptide having a second enzymatic activity, wherein at least one of said first polypeptide and said second polypeptide optionally comprises the polypeptide of any one of i) through ccxxv). 2. A method comprising applying an enzymatically active protein selected from the group consisting of i) through ccxxvi), as defined in claim 1 above, to a plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility. 3. A formulation comprising an enzymatically active protein selected from the group consisting of i) through ccxxvi), as defined in claim 1 above, in an agriculturally acceptable carrier. 4. A method comprising applying the formulation of claim 3 to a plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural apparatus/facility. 5. A method comprising applying a cell, optionally a recombinant host cell, that expresses an enzymatically active protein selected from the group consisting of i) through ccxxvi), as defined in claim 1 above, to a plant, plant part, plant growth medium and/or agricultural/floricultural/horticultural/silvicultural
apparatus/facility. 6. A plant or plant part comprising a heterologous polynucleotide that encodes an enzymatically active protein selected from the group consisting of i) through ccxxvi), as defined in claim 1 above. 7. A plant or plant part that expresses a heterologous enzymatically active protein selected from the group consisting of i) through ccxxvi), as defined in claim 1 above. 8. A method comprising introducing a plant or plant part comprising a heterologous polynucleotide that encodes an enzymatically active protein selected from the group consisting of i) through ccxxvi), as defined in claim 1 above, into a plant growth medium. 9. A method comprising introducing a plant or plant part that expresses a heterologous enzymatically active protein selected from the group consisting of i) through ccxxvi), as defined in claim 1 above, into a plant growth medium.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202263342064P | 2022-05-14 | 2022-05-14 | |
US63/342,064 | 2022-05-14 | ||
PCT/US2022/073761 WO2023288294A1 (en) | 2021-07-16 | 2022-07-15 | Compositions and methods for improving the rainfastness of proteins on plant surfaces |
USPCT/US2022/073761 | 2022-07-15 | ||
US202263476590P | 2022-12-21 | 2022-12-21 | |
US63/476,590 | 2022-12-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2023225459A2 true WO2023225459A2 (en) | 2023-11-23 |
WO2023225459A3 WO2023225459A3 (en) | 2024-02-22 |
Family
ID=88020892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2023/066918 WO2023225459A2 (en) | 2022-05-14 | 2023-05-12 | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023225459A2 (en) |
Citations (1597)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4016040A (en) | 1969-12-10 | 1977-04-05 | Colgate-Palmolive Company | Preparation of enzyme-containing beads |
GB1483591A (en) | 1973-07-23 | 1977-08-24 | Novo Industri As | Process for coating water soluble or water dispersible particles by means of the fluid bed technique |
US4106991A (en) | 1976-07-07 | 1978-08-15 | Novo Industri A/S | Enzyme granulate composition and process for forming enzyme granulates |
EP0000027A1 (en) | 1977-06-14 | 1978-12-20 | BASF Aktiengesellschaft | Process for the manufacture, according to the Levitherm process, of hard polyvinyl chloride films |
WO1984002921A2 (en) | 1983-01-28 | 1984-08-02 | Cetus Corp | Glucoamylase cdna |
EP0133756A2 (en) | 1983-07-06 | 1985-03-06 | Genex Corporation | Vector for expression of polypeptides |
US4510133A (en) | 1982-04-22 | 1985-04-09 | Imperial Chemical Industries Plc | Method for combating pests |
EP0170360A1 (en) | 1984-05-29 | 1986-02-05 | Novo Nordisk A/S | Enzyme containing granulates suitable for use as detergent additives |
EP0208491A2 (en) | 1985-07-03 | 1987-01-14 | Genencor International, Inc. | Hybrid polypeptides and process for their preparation |
JPS62104580A (en) | 1985-10-30 | 1987-05-15 | Kunio Yamane | Dna-expressing heat-resistant enzyme |
EP0238216A1 (en) | 1986-02-20 | 1987-09-23 | Albright & Wilson Limited | Protected enzyme systems |
EP0238023A2 (en) | 1986-03-17 | 1987-09-23 | Novo Nordisk A/S | Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus |
EP0245970A1 (en) | 1986-04-25 | 1987-11-19 | Rohm And Haas Company | Dithiocarbamate compostions having increased rain fastness |
US4713245A (en) | 1984-06-04 | 1987-12-15 | Mitsui Toatsu Chemicals, Incorporated | Granule containing physiologically-active substance, method for preparing same and use thereof |
EP0260160A1 (en) | 1986-06-10 | 1988-03-16 | Transgene S.A. | Block for the expression of amyloglucosidase in yeast, as well as yeasts containing it |
EP0285123A2 (en) | 1987-04-03 | 1988-10-05 | Stabra AG | A method for complete mutagenesis of nucleic acids |
WO1988007581A1 (en) | 1987-04-03 | 1988-10-06 | Amgen Inc. | Novel proteolytic enzymes |
EP0304331A2 (en) | 1987-08-21 | 1989-02-22 | Novo Nordisk A/S | Method for production of an enzyme granulate |
EP0304332A2 (en) | 1987-08-21 | 1989-02-22 | Novo Nordisk A/S | Enzyme containing granulate and method for production thereof |
EP0305216A1 (en) | 1987-08-28 | 1989-03-01 | Novo Nordisk A/S | Recombinant Humicola lipase and process for the production of recombinant humicola lipases |
JPH01137972A (en) | 1987-08-03 | 1989-05-30 | Ajinomoto Co Inc | Novel subtilisin |
DD272102A1 (en) | 1988-05-12 | 1989-09-27 | Akad Wissenschaften Ddr | PROCESS FOR PREPARING THERMOSTATIC BACILLUS BETA-1,3-1,4-GLUCANASE |
DE3821491A1 (en) | 1988-06-25 | 1989-12-28 | Henkel Kgaa | HYBRID PLASMIDE FOR THE PRODUCTION OF SUBTILISIN CARLSBERG IN BACILLUS |
WO1989012675A1 (en) | 1988-06-21 | 1989-12-28 | Chiron Corporation | Production of glucose oxidase in recombinant systems |
JPH0276586A (en) | 1988-09-12 | 1990-03-15 | Nippon Petrochem Co Ltd | Gene to code elastase |
WO1990009436A1 (en) | 1989-02-16 | 1990-08-23 | Carlsberg A/S | A THERMOSTABLE (1,3-1,4)-β-GLUCANASE |
WO1990009440A1 (en) | 1989-02-20 | 1990-08-23 | Novo Nordisk A/S | Enzyme containing granulate and method for production thereof |
WO1990009428A1 (en) | 1989-02-20 | 1990-08-23 | Novo Nordisk A/S | Detergent additive granulate and method for production thereof |
EP0398539A1 (en) | 1989-05-17 | 1990-11-22 | Amgen Inc. | Multiply mutated subtilisins |
US4980288A (en) | 1986-02-12 | 1990-12-25 | Genex Corporation | Subtilisin with increased thermal stability |
EP0405902A1 (en) | 1989-06-26 | 1991-01-02 | Unilever Plc | Enymatic detergent compositions |
EP0405901A1 (en) | 1989-06-26 | 1991-01-02 | Unilever Plc | Enzymatic detergent compositions |
WO1991000353A2 (en) | 1989-06-29 | 1991-01-10 | Gist-Brocades N.V. | MUTANT MICROBIAL α-AMYLASES WITH INCREASED THERMAL, ACID AND/OR ALKALINE STABILITY |
EP0409299A2 (en) | 1989-06-29 | 1991-01-23 | Gist-Brocades N.V. | Mutant enzyme having reduced stability under industrial application conditions |
EP0415296A2 (en) | 1989-08-31 | 1991-03-06 | Solvay Enzymes GmbH & Co. KG | High alkaline proteases |
WO1991002792A1 (en) | 1989-08-25 | 1991-03-07 | Henkel Research Corporation | Alkaline proteolytic enzyme and method of production |
EP0416967A1 (en) | 1989-08-11 | 1991-03-13 | Mitsubishi Gas Chemical Company, Inc. | Novel alkaline protease |
WO1991006637A1 (en) | 1989-10-31 | 1991-05-16 | Genencor International, Inc. | Subtilisin mutants |
EP0430637A1 (en) | 1989-11-27 | 1991-06-05 | NIHON CHEMICAL RESEARCH KABUSHIKI KAISHA also known as JAPAN CHEMICAL RESEARCH CO., LTD | Fibrinolytic protein and production method thereof |
EP0441353A2 (en) | 1990-02-07 | 1991-08-14 | Kyowa Hakko Kogyo Co., Ltd. | Process for the production of gamma-glutamyl transpeptidase |
EP0443476A2 (en) | 1990-02-23 | 1991-08-28 | ENIRICERCHE S.p.A. | Thermostable mutants of neutral protease and means for their preparation |
WO1991014772A1 (en) | 1990-03-23 | 1991-10-03 | Gist-Brocades N.V. | Production of enzymes in seeds and their use |
WO1991017244A1 (en) | 1990-05-09 | 1991-11-14 | Novo Nordisk A/S | An enzyme capable of degrading cellulose or hemicellulose |
JPH0476A (en) | 1990-04-17 | 1992-01-06 | Smc Corp | Valve |
FR2665178A1 (en) | 1990-07-30 | 1992-01-31 | Agronomique Inst Nat Rech | Heat-stable variants of the alpha-amylase of Bacillus licheniformis, process for their preparation and their use |
JPH0458889A (en) | 1990-06-25 | 1992-02-25 | Aizo Matsushiro | Alpha-1,3-glucanase gene |
WO1992003540A1 (en) | 1990-08-24 | 1992-03-05 | Novo Nordisk A/S | Enzymes with xylanolytic activity |
WO1992005249A1 (en) | 1990-09-13 | 1992-04-02 | Novo Nordisk A/S | Lipase variants |
WO1992006204A1 (en) | 1990-09-28 | 1992-04-16 | Ixsys, Inc. | Surface expression libraries of heteromeric receptors |
EP0482879A2 (en) | 1990-10-24 | 1992-04-29 | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. | Protease from Bacillus licheniformis |
EP0486067A2 (en) | 1990-11-16 | 1992-05-20 | Suntory Limited | Peroxidase gene of microbial origin |
WO1992008355A1 (en) | 1990-11-13 | 1992-05-29 | Liphatech, Inc. | Process for preparation of bacterial agricultural products |
WO1992011357A1 (en) | 1990-12-21 | 1992-07-09 | Novo Nordisk A/S | ENZYME MUTANTS HAVING A LOW DEGREE OF VARIATION OF THE MOLECULAR CHARGE OVER A pH RANGE |
WO1992011348A1 (en) | 1990-12-21 | 1992-07-09 | Unilever N.V. | Enzymes and enzymatic detergent compositions |
EP0495257A1 (en) | 1991-01-16 | 1992-07-22 | The Procter & Gamble Company | Compact detergent compositions with high activity cellulase |
WO1992011856A1 (en) | 1991-01-09 | 1992-07-23 | Wright James E | Biopesticide composition and process for insect pest control |
WO1992017571A1 (en) | 1991-03-27 | 1992-10-15 | Novo Nordisk A/S | Catalase, its production and use |
WO1992018688A1 (en) | 1991-04-22 | 1992-10-29 | Novo Nordisk A/S | Use of cellulase for pulp treatment |
WO1992019726A1 (en) | 1991-05-01 | 1992-11-12 | Novo Nordisk A/S | Stabilized enzymes |
FR2676456A1 (en) | 1991-05-13 | 1992-11-20 | Agronomique Inst Nat Rech | Thermostable variants of Bacillus licheniformis alpha -amylase, process for preparing them and their use |
EP0516200A1 (en) | 1991-05-01 | 1992-12-02 | Unilever N.V. | Detergent compositions containing stabilized enzymes |
WO1992021760A1 (en) | 1991-05-29 | 1992-12-10 | Cognis, Inc. | Mutant proteolytic enzymes from bacillus |
DE4224125A1 (en) | 1991-07-27 | 1993-01-28 | Solvay Enzymes Gmbh & Co Kg | METHOD FOR IMPROVING THE STABILITY OF ENZYMS AND STABILIZED ENZYMES |
WO1993007263A2 (en) | 1991-10-07 | 1993-04-15 | Genencor International, Inc. | Coated enzyme containing granule |
WO1993007276A1 (en) | 1991-10-08 | 1993-04-15 | Chemgen Corporation | A novel alkaline protease produced by a bacillus |
EP0540784A1 (en) | 1991-11-06 | 1993-05-12 | The Procter & Gamble Company | Dye transfer inhibiting compositions |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
EP0563963A1 (en) | 1992-04-02 | 1993-10-06 | AgriSense | Delivery system for insecticides |
US5260207A (en) | 1987-04-06 | 1993-11-09 | Enzon Labs Inc. | Engineering of electrostatic interactions at metal ion binding sites for the stabilization of proteins |
EP0571049A1 (en) | 1988-02-11 | 1993-11-24 | Genencor International, Inc. | Novel proteolytic enzymes and their use in detergents |
WO1994002618A1 (en) | 1992-07-17 | 1994-02-03 | Gist-Brocades N.V. | High alkaline serine proteases |
WO1994002597A1 (en) | 1992-07-23 | 1994-02-03 | Novo Nordisk A/S | MUTANT α-AMYLASE, DETERGENT, DISH WASHING AGENT, AND LIQUEFACTION AGENT |
US5290556A (en) | 1990-02-02 | 1994-03-01 | The United States Of America As Represented By The Secretary Of Agriculture | Plastic bait composition for attracting and killing crop pests |
WO1994007998A1 (en) | 1992-10-06 | 1994-04-14 | Novo Nordisk A/S | Cellulase variants |
US5316935A (en) | 1992-04-06 | 1994-05-31 | California Institute Of Technology | Subtilisin variants suitable for hydrolysis and synthesis in organic media |
US5316941A (en) | 1989-01-06 | 1994-05-31 | Genencor, Inc. | Non-human carbonyl hydrolase mutants, DNA sequences and vectors encoding same and hosts transformed with said vectors |
EP0605040A1 (en) | 1992-12-28 | 1994-07-06 | SOLVAY (Société Anonyme) | Pullulanase, micro-organisms producing the same, method for preparation thereof as well as its use |
WO1994018329A2 (en) | 1993-02-04 | 1994-08-18 | Genentech, Inc. | Serine protease variants having peptide ligase activity |
WO1994018314A1 (en) | 1993-02-11 | 1994-08-18 | Genencor International, Inc. | Oxidatively stable alpha-amylase |
WO1994023053A1 (en) | 1993-04-01 | 1994-10-13 | Novo Nordisk A/S | Protease variants |
WO1994025612A2 (en) | 1993-05-05 | 1994-11-10 | Institut Pasteur | Nucleotide sequences for the control of the expression of dna sequences in a cellular host |
WO1994025577A1 (en) | 1993-04-23 | 1994-11-10 | Novo Nordisk A/S | Lipase variants |
WO1994025575A1 (en) | 1993-04-30 | 1994-11-10 | Novo Nordisk A/S | An enzyme exhibiting pectin methylesterase activity |
US5371008A (en) | 1984-05-29 | 1994-12-06 | Genencor International, Inc. | Substrate assisted catalysis |
EP0633311A1 (en) | 1993-06-28 | 1995-01-11 | The Procter & Gamble Company | Hydrophobic amines for cellulase stabilization in liquid detergent compositions containing anionic surfactant and cellulase |
WO1995002046A1 (en) | 1993-07-09 | 1995-01-19 | Novo Nordisk A/S | Boronic acid or borinic acid derivatives as enzyme stabilizers |
WO1995002675A1 (en) | 1993-07-12 | 1995-01-26 | Novo Nordisk A/S | A detergent composition comprising two cellulase components |
JPH0759574A (en) | 1993-08-23 | 1995-03-07 | Mitsui Toatsu Chem Inc | Novel dna |
WO1995007991A2 (en) | 1993-09-15 | 1995-03-23 | The Procter & Gamble Company | Subtilisin bpn' variants with decreased adsorption and increased hydrolysis |
US5401506A (en) | 1990-12-07 | 1995-03-28 | Temple University | Stabilized insect nematode compositions |
WO1995010615A1 (en) | 1993-10-14 | 1995-04-20 | Genencor International, Inc. | Subtilisin variants |
WO1995010591A1 (en) | 1993-10-14 | 1995-04-20 | The Procter & Gamble Company | Protease-containing cleaning compositions |
WO1995017413A1 (en) | 1993-12-21 | 1995-06-29 | Evotec Biosystems Gmbh | Process for the evolutive design and synthesis of functional polymers based on designer elements and codes |
WO1995018219A1 (en) | 1993-12-24 | 1995-07-06 | Gist-Brocades N.V. | Alkali-tolerant xylanases |
WO1995021924A1 (en) | 1994-02-10 | 1995-08-17 | Commonwealth Scientific And Industrial Research Organisation | Expression of the glucose oxidase gene in transgenic organisms |
WO1995022625A1 (en) | 1994-02-17 | 1995-08-24 | Affymax Technologies N.V. | Dna mutagenesis by random fragmentation and reassembly |
WO1995022615A1 (en) | 1994-02-22 | 1995-08-24 | Novo Nordisk A/S | A method of preparing a variant of a lipolytic enzyme |
WO1995023221A1 (en) | 1994-02-24 | 1995-08-31 | Cognis, Inc. | Improved enzymes and detergents containing them |
WO1995023614A1 (en) | 1994-03-01 | 1995-09-08 | E.R. Squibb & Sons, Inc. | Enzymatic debridement compositions and methods |
WO1995024471A1 (en) | 1994-03-08 | 1995-09-14 | Novo Nordisk A/S | Novel alkaline cellulases |
DE4411223A1 (en) | 1994-03-31 | 1995-10-05 | Solvay Enzymes Gmbh & Co Kg | Use of alkaline proteases in commercial textile washing processes |
WO1995026397A1 (en) | 1994-03-29 | 1995-10-05 | Novo Nordisk A/S | Alkaline bacillus amylase |
WO1995030011A2 (en) | 1994-05-02 | 1995-11-09 | The Procter & Gamble Company | Subtilisin 309 variants having decreased adsorption and increased hydrolysis |
EP0683228A2 (en) | 1987-02-04 | 1995-11-22 | Ciba-Geigy Ag | Novel expression system |
US5472855A (en) | 1984-05-29 | 1995-12-05 | Genentech, Inc. | Substrate assisted catalysis |
WO1995033836A1 (en) | 1994-06-03 | 1995-12-14 | Novo Nordisk Biotech, Inc. | Phosphonyldipeptides useful in the treatment of cardiovascular diseases |
EP0687733A1 (en) | 1994-06-16 | 1995-12-20 | The Procter & Gamble Company | Detergent composition containing wool compatible high alkaline proteases |
WO1995034662A1 (en) | 1994-06-14 | 1995-12-21 | Gist-Brocades B.V. | Thermostable xylanases |
WO1995035382A2 (en) | 1994-06-17 | 1995-12-28 | Genecor International Inc. | NOVEL AMYLOLYTIC ENZYMES DERIVED FROM THE B. LICHENIFORMIS α-AMYLASE, HAVING IMPROVED CHARACTERISTICS |
WO1996005295A2 (en) | 1994-08-11 | 1996-02-22 | Genencor International, Inc. | An improved cleaning composition |
US5496568A (en) | 1995-06-26 | 1996-03-05 | Church & Dwight Co., Inc. | Fungal disease control in cultivated plants |
WO1996013580A1 (en) | 1994-10-26 | 1996-05-09 | Novo Nordisk A/S | An enzyme with lipolytic activity |
WO1996017994A1 (en) | 1994-12-05 | 1996-06-13 | Novo Nordisk A/S | A method of obtaining a cellulosic textile fabric with reduced tendency to pilling formation |
WO1996022366A1 (en) | 1995-01-19 | 1996-07-25 | Novo Nordisk A/S | Transglutaminases from oomycetes |
WO1996023062A1 (en) | 1995-01-26 | 1996-08-01 | Novo Nordisk A/S | Animal feed additives comprising xylanase |
WO1996023874A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | A method of designing alpha-amylase mutants with predetermined properties |
WO1996023873A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | Amylase variants |
WO1996028557A2 (en) | 1995-03-09 | 1996-09-19 | The Procter & Gamble Company | Subtilisin dy variants having decreased adsorption and increased hydrolysis |
WO1996028566A2 (en) | 1995-03-08 | 1996-09-19 | The Procter & Gamble Company | Subtilisin carlsberg variants having decreased adsorption and increased hydrolysis |
WO1996029397A1 (en) | 1995-03-17 | 1996-09-26 | Novo Nordisk A/S | Novel endoglucanases |
WO1996030481A1 (en) | 1995-03-24 | 1996-10-03 | Genencor International, Inc. | An improved laundry detergent composition comprising amylase |
WO1996034935A2 (en) | 1995-05-05 | 1996-11-07 | Unilever N.V. | Subtilisin variants |
WO1996034946A1 (en) | 1995-05-05 | 1996-11-07 | Novo Nordisk A/S | Protease variants and compositions |
WO1996039528A2 (en) | 1995-06-06 | 1996-12-12 | Genencor International, Inc. | MUTANT α-AMYLASE |
WO1996041859A1 (en) | 1995-06-13 | 1996-12-27 | Novo Nordisk A/S | 4-substituted-phenyl-boronic acids as enzyme stabilizers |
WO1997004079A1 (en) | 1995-07-14 | 1997-02-06 | Novo Nordisk A/S | A modified enzyme with lipolytic activity |
WO1997007205A1 (en) | 1995-08-11 | 1997-02-27 | Novo Nordisk A/S | Method for preparing polypeptide variants |
WO1997007202A1 (en) | 1995-08-11 | 1997-02-27 | Novo Nordisk A/S | Novel lipolytic enzymes |
DE19530816A1 (en) | 1995-08-23 | 1997-02-27 | Cognis Bio Umwelt | Use of mutant subtilisin protease in cosmetic products |
US5607684A (en) | 1991-10-31 | 1997-03-04 | Micro Flo Company | Manufacture of bait with hot melt binder |
WO1997014804A1 (en) | 1995-10-17 | 1997-04-24 | Röhn Enzyme Finland OY | Cellulases, the genes encoding them and uses thereof |
WO1997023606A1 (en) | 1995-12-22 | 1997-07-03 | Genencor International, Inc. | Enzyme containing coated granules |
WO1997028256A1 (en) | 1996-01-29 | 1997-08-07 | Novo Nordisk A/S | Process for desizing cellulosic fabric |
JPH09249891A (en) | 1996-03-15 | 1997-09-22 | Lion Corp | Detergent composition |
JPH09249893A (en) | 1996-03-15 | 1997-09-22 | Lion Corp | Detergent composition |
US5677272A (en) | 1993-10-14 | 1997-10-14 | The Procter & Gamble Company | Bleaching compositions comprising protease enzymes |
WO1997039116A1 (en) | 1996-04-12 | 1997-10-23 | Novo Nordisk A/S | Enzyme-containing granules and process for the production thereof |
WO1997043409A2 (en) | 1996-05-10 | 1997-11-20 | Novo Nordisk A/S | Method of providing novel dna sequences |
WO1997043424A1 (en) | 1996-05-14 | 1997-11-20 | Genencor International, Inc. | MODIFIED α-AMYLASES HAVING ALTERED CALCIUM BINDING PROPERTIES |
WO1998003639A1 (en) | 1996-07-24 | 1998-01-29 | Iowa State University Research Foundation, Inc. | PROTEIN ENGINEERING OF GLUCOAMYLASE TO INCREASE pH OPTIMUM, SUBSTRATE SPECIFICITY AND THERMOSTABILITY |
WO1998004663A1 (en) | 1996-07-30 | 1998-02-05 | The Procter & Gamble Company | Detergent composition comprising two cellulase components, with and without a cellulose-binding domain |
US5719021A (en) | 1989-05-02 | 1998-02-17 | University Of Medicine And Dentistry Of New Jersey | Protein activation |
EP0828002A2 (en) | 1996-09-09 | 1998-03-11 | National Research Council Of Canada | Modification of xylanase to improve thermophilicity, alkophilicity and thermostability |
WO1998011239A1 (en) | 1996-09-13 | 1998-03-19 | Meiji Seika Kaisha, Ltd. | REGULATORY SEQUENCE OF CELLULASE cbh1 GENES ORIGINATING IN TRICHODERMA VIRIDE AND SYSTEM FOR MASS-PRODUCING PROTEINS OR PEPTIDES THEREWITH |
WO1998012307A1 (en) | 1996-09-17 | 1998-03-26 | Novo Nordisk A/S | Cellulase variants |
WO1998016633A1 (en) | 1996-10-11 | 1998-04-23 | Novo Nordisk A/S | Alpha-amylase fused to cellulose binding domain, for starch degradation |
WO1998018437A1 (en) | 1996-10-25 | 1998-05-07 | Novo Nordisk A/S | An oral care product comprising a mutan binding domain |
WO1998020115A1 (en) | 1996-11-04 | 1998-05-14 | Novo Nordisk A/S | Subtilase variants and compositions |
WO1998026078A1 (en) | 1996-12-09 | 1998-06-18 | Genencor International, Inc. | H mutant alpha-amylase enzymes |
WO1998030682A1 (en) | 1997-01-10 | 1998-07-16 | Novo Nordisk A/S | Enzyme coupled with polymeric molecules for skin care |
WO1998038286A1 (en) | 1997-02-28 | 1998-09-03 | Novo Nordisk A/S | Laccase mutants |
WO1998044126A1 (en) | 1997-03-31 | 1998-10-08 | Kao Corporation | MUTATED α-AMYLASES |
WO1998055634A1 (en) | 1997-06-04 | 1998-12-10 | The Procter & Gamble Company | Protease enzymes for tough cleaning and/or spot and film reduction and compositions incorporating same |
US5858436A (en) | 1996-03-12 | 1999-01-12 | Xeda International | Process for the treatment of fruits and vegetables |
WO1999009183A1 (en) | 1997-08-19 | 1999-02-25 | Genencor International, Inc. | MUTANT α-AMYLASE COMPRISING MODIFICATION AT RESIDUES CORRESPONDING TO A210, H405 AND/OR T412 IN $i(BACILLUS LICHENIFORMIS) |
WO1999019467A1 (en) | 1997-10-13 | 1999-04-22 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
WO1999020770A2 (en) | 1997-10-23 | 1999-04-29 | Genencor International, Inc. | Multiply-substituted protease variants |
WO1999023211A1 (en) | 1997-10-30 | 1999-05-14 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
JPH11137282A (en) | 1997-09-04 | 1999-05-25 | Natl Sci Council | Variant subtilisin yab and its application |
WO1999027082A1 (en) | 1997-11-21 | 1999-06-03 | Novo Nordisk A/S | Protease variants and compositions |
WO1999027083A1 (en) | 1997-11-24 | 1999-06-03 | Novo Nordisk A/S | PECTIN DEGRADING ENZYMES FROM $i(BACILLUS LICHENIFORMIS) |
WO1999029876A2 (en) | 1997-12-09 | 1999-06-17 | Genencor International, Inc. | Mutant bacillus licheniformis alpha-amylase |
WO1999032595A1 (en) | 1997-12-20 | 1999-07-01 | Genencor International, Inc. | Granule with hydrated barrier material |
WO1999045124A2 (en) | 1998-03-04 | 1999-09-10 | Genencor International, Inc. | Modified forms of pullulanase |
WO1999046399A1 (en) | 1998-03-09 | 1999-09-16 | Novo Nordisk A/S | Enzymatic preparation of glucose syrup from starch |
CN1229139A (en) | 1999-01-28 | 1999-09-22 | 中国农业科学院生物技术研究中心 | Application of glucose oxidase gen to breeding disease-resistant transfer-gen |
WO1999057256A1 (en) | 1998-05-01 | 1999-11-11 | The Procter & Gamble Company | Laundry detergent and/or fabric care compositions comprising a modified cellulase |
WO1999067370A1 (en) | 1998-06-23 | 1999-12-29 | Novozymes A/S | A polypeptide-polymer conjugate |
WO2000001796A2 (en) | 1998-07-02 | 2000-01-13 | Novozymes A/S | Starch debranching enzymes |
WO2000001793A1 (en) | 1998-06-30 | 2000-01-13 | Novozymes A/S | A new improved enzyme containing granule |
EP0972450A1 (en) | 1998-07-13 | 2000-01-19 | Xeda International | Fruit and vegetable treatment process |
WO2000010386A1 (en) | 1998-08-20 | 2000-03-02 | Biotechnologies For Horticulture, Inc. | Plant ethylene response inhibition compounds and complexes |
WO2000011211A1 (en) | 1998-08-19 | 2000-03-02 | Novozymes A/S | Enzyme activity screen with substrate replacement |
WO2000022103A1 (en) | 1998-10-13 | 2000-04-20 | Novozymes A/S | A modified polypeptide with reduced immune response |
WO2000024924A2 (en) | 1998-10-23 | 2000-05-04 | The Procter & Gamble Company | Methods for screening protease variants for use in detergent compositions |
US6060442A (en) | 1998-02-24 | 2000-05-09 | Novo Nordisk A/S | Laccase mutants |
JP2000135093A (en) | 1998-08-24 | 2000-05-16 | Daiwa Kasei Kk | New amylase for baking and its gene |
WO2000028824A1 (en) | 1998-11-16 | 2000-05-25 | Aventis Cropscience S.A. | Compositions and methods for controlling insects |
WO2000029560A1 (en) | 1998-11-16 | 2000-05-25 | Novozymes A/S | α-AMYLASE VARIANTS |
CA2715086A1 (en) | 1998-11-27 | 2000-06-08 | Novozymes A/S | Lipolytic enzyme variants |
WO2000034450A1 (en) | 1998-12-04 | 2000-06-15 | Novozymes A/S | Cutinase variants |
WO2000034452A1 (en) | 1998-12-07 | 2000-06-15 | Novozymes A/S | Glucoamylases with n-terminal extensions |
WO2000037627A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
WO2000037621A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
WO2000037622A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
WO2000037625A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
WO2000037599A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in the active site loop region |
WO2000037626A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
WO2000037624A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
WO2000037623A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
WO2000043504A1 (en) | 1999-01-22 | 2000-07-27 | Iowa State University Research Foundation, Inc. | PROTEIN ENGINEERING OF GLUCOAMYLASE TO INCREASE pH OPTIMUM, SUBSTRATE SPECIFICITY AND THERMOSTABILITY |
WO2000049880A1 (en) | 1999-02-26 | 2000-08-31 | Xeda International | Treatment method for fruits and vegetables |
JP2000245466A (en) | 1999-02-25 | 2000-09-12 | Kao Corp | Mutant alpha-amylase |
WO2000060059A2 (en) | 1999-03-30 | 2000-10-12 | NovozymesA/S | Alpha-amylase variants |
WO2000060063A1 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Lipase variant |
WO2000060058A2 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
WO2000071684A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 131 and 132 |
WO2000071690A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 128 and 129 |
WO2000071688A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 126 and 127 |
WO2000071691A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 125 and 126 |
WO2000071683A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 130 and 131 |
WO2000071687A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 129 and 130 |
WO2000071686A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 97 and 98 |
WO2000071685A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 132 and 133 |
WO2000071689A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 127 and 128 |
WO2001004279A1 (en) | 1999-07-09 | 2001-01-18 | Novozymes A/S | A process for preparing an enzyme containing granule |
WO2001009294A1 (en) | 1999-07-31 | 2001-02-08 | Newbiotechnic, S.A. | Antifungic compositions and method for controlling fungi |
WO2001016285A2 (en) | 1999-08-31 | 2001-03-08 | Novozymes A/S | Novel proteases and variants thereof |
WO2001016349A1 (en) | 1999-09-01 | 2001-03-08 | Novozymes A/S | Method for production of maltose and/or enzymatically modified starch |
KR20010027418A (en) | 1999-09-09 | 2001-04-06 | 박종헌 | Crystals of maltogenic amylase comprising and structure thereof |
WO2001027251A1 (en) | 1999-10-14 | 2001-04-19 | Novozymes A/S | Lysophospholipase from aspergillus |
US6221414B1 (en) | 1998-09-02 | 2001-04-24 | Xeda International | Process for treating fruits and vegetables after harvesting, with purification of plant-protection products contaminated with aromatic primary amines |
WO2001036586A2 (en) | 1999-11-19 | 2001-05-25 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Aspegillus niger beta-glucosidase gene, protein and uses thereof |
WO2001042433A2 (en) | 1999-12-07 | 2001-06-14 | Danisco A/S | Talaromyces emersonii xylanase |
WO2001043548A1 (en) | 1999-12-17 | 2001-06-21 | Agrofresh Inc. | Synthesis methods, complexes and delivery methods for the safe and convenient storage, transport and application of compounds for inhibiting the ethylene response in plants |
WO2001047956A2 (en) | 1999-12-23 | 2001-07-05 | Genencor International, Inc. | Method for obtaining proteins having improved functional characteristics |
WO2001051620A2 (en) | 2000-01-12 | 2001-07-19 | Novozymes A/S | Pullulanase variants and methods for preparing such variants with predetermined properties |
US6271012B1 (en) | 1989-10-11 | 2001-08-07 | Genencor International, Inc. | Protease muteins and their use in detergents |
WO2001059141A2 (en) | 2000-02-10 | 2001-08-16 | Washington State University Research Foundation | Methods and compositions that utilize barley as a foodstuff for animals |
WO2001064852A1 (en) | 2000-03-03 | 2001-09-07 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
WO2001068821A2 (en) | 2000-03-14 | 2001-09-20 | Novozymes A/S | Novel subtilase enzymes having an improved wash performance on egg stains |
WO2001075087A2 (en) | 2000-04-03 | 2001-10-11 | Maxygen, Inc. | Subtilisin variants |
WO2001083559A2 (en) | 2000-04-28 | 2001-11-08 | Novozymes A/S | Production and use of protein variants having modified immunogenecity |
WO2001088107A2 (en) | 2000-05-12 | 2001-11-22 | Novozymes A/S | Alpha-amylase variants with altered 1,6-activity |
WO2001092502A1 (en) | 2000-06-02 | 2001-12-06 | Novozymes A/S | Cutinase variants |
WO2002010355A2 (en) | 2000-08-01 | 2002-02-07 | Novozymes A/S | Alpha-amylase mutants with altered stability |
WO2002010183A1 (en) | 2000-07-31 | 2002-02-07 | Menzel, Rolf | Compositions and methods for directed gene assembly |
WO2002012511A1 (en) | 2000-07-28 | 2002-02-14 | Consejo Superior De Investigaciones Científicas | Novel method for overproduction of lichenase in bacteria by isolating the genes directly from natural samples (lichenaturase) |
WO2002016547A2 (en) | 2000-08-21 | 2002-02-28 | Novozymes A/S | Subtilase enzymes |
WO2002018588A1 (en) | 2000-08-29 | 2002-03-07 | Novozymes A/S | Method for screening highly active proteases and inhibitors |
WO2002022796A1 (en) | 2000-09-11 | 2002-03-21 | University Of Maryland Biotechnology Institute | Calcium free subtilisin mutants |
US20020043730A1 (en) | 2000-09-29 | 2002-04-18 | Chong Joshua Anthony | Continuous process for the preparation of encapsulated cyclopropenes |
WO2002031133A1 (en) | 2000-10-13 | 2002-04-18 | Novozymes A/S | Subtilase variants |
US20020058592A1 (en) | 2000-09-28 | 2002-05-16 | Kostansek Edward Charles | Delivery system for cyclopropenes |
WO2002040997A2 (en) | 2000-10-02 | 2002-05-23 | Genencor International, Inc. | Production and use of proteins producing an altered immunogenic response |
US20020061822A1 (en) | 2000-09-29 | 2002-05-23 | Kostansek Edward Charles | Delivery systems for cyclopropenes requiring less water |
US6395966B1 (en) | 1990-08-09 | 2002-05-28 | Dekalb Genetics Corp. | Fertile transgenic maize plants containing a gene encoding the pat protein |
US6403139B1 (en) | 1999-03-03 | 2002-06-11 | Xeda International | Process for treating fruit and vegetables using tocopherols as antioxidants |
WO2002055679A2 (en) | 2001-01-10 | 2002-07-18 | Novozymes A/S | Thermostable lipolytic enzyme variant |
CN1361279A (en) | 2000-12-28 | 2002-07-31 | 福建福大百特科技发展有限公司 | Lichenized bacillus L-25 keratinase and its encoding DNA |
WO2002062973A2 (en) | 2001-02-07 | 2002-08-15 | Novozymes A/S | Lipase variants |
US6440717B1 (en) | 1993-09-15 | 2002-08-27 | The Procter & Gamble Company | BPN′ variants having decreased adsorption and increased hydrolysis |
WO2002066622A2 (en) | 2001-02-23 | 2002-08-29 | Novozymes A/S | Method of generating diversity into lipolytic enzymes and lipolytic enzyme genes |
WO2002068597A2 (en) | 2001-02-21 | 2002-09-06 | Diversa Corporation | Enzymes having alpha amylase activity and methods of use thereof |
WO2002077289A1 (en) | 2001-03-21 | 2002-10-03 | Hercules Incorporated | Methods for the synthesis of polynucleotides and combinatorial libraries of polynucleotides |
WO2002088340A2 (en) | 2001-05-02 | 2002-11-07 | Henkel Kommanditgesellschaft Auf Aktien | Alkaline protease variants and detergents and cleaning agents containing said alkaline protease variants |
WO2002095127A2 (en) | 2001-05-21 | 2002-11-28 | Novozymes A/S | Use of lipolytic enzymes for stickies control |
US20020198107A1 (en) | 2001-02-26 | 2002-12-26 | Kostansek Edward Charles | Delivery systems for cyclopropenes |
WO2003012071A2 (en) | 2001-08-03 | 2003-02-13 | Elitra Pharmaceuticals, Inc. | Nucleic acids of aspergillus fumigatus encoding industrial enzymes and methods of use |
WO2003014358A2 (en) | 2001-08-07 | 2003-02-20 | Henkel Kommanditgesellschaft Auf Aktien | Detergent and cleaning agent with hybrid alpha amylases |
WO2003016535A2 (en) | 2001-08-16 | 2003-02-27 | Dsm Ip Assets B.V. | Novel amylases and uses thereof |
WO2003016510A1 (en) | 2001-08-14 | 2003-02-27 | Pioneer Co., Ltd. | New biopesticide using gene from erwinia pyrifoliaewt#3, novel pathogen that affects asian pear trees |
WO2003018766A2 (en) | 2001-08-27 | 2003-03-06 | Syngenta Participations Ag | Self-processing plants and plant parts |
WO2003020030A1 (en) | 2001-09-03 | 2003-03-13 | The State Of Queensland Through Its Department Of Primary Industries | Synthetic fruitpiercing moth attractant |
US20030082164A1 (en) | 2001-06-22 | 2003-05-01 | Drahos David Joseph | Novel biofungicide |
WO2003038082A2 (en) | 2001-10-31 | 2003-05-08 | Henkel Kommanditgesellschaft Auf Aktien | Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants |
US20030100450A1 (en) | 2001-10-18 | 2003-05-29 | Kostansek Edward Charles | Delivery system for cyclopropenes |
WO2003054185A1 (en) | 2001-12-20 | 2003-07-03 | Henkel Kommanditgesellschaft Auf Aktien | Novel alkaline protease from bacillus gibsonii (dsm 14391) and washing and cleaning agents containing said novel alkaline protease |
WO2003054184A1 (en) | 2001-12-20 | 2003-07-03 | Henkel Kommanditgesellschaft Auf Aktien | Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
WO2003055974A2 (en) | 2001-12-22 | 2003-07-10 | Henkel Kommanditgesellschaft Auf Aktien | Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
WO2003057713A2 (en) | 2001-12-31 | 2003-07-17 | Genencor International, Inc. | Proteases producing an altered immunogenic response and methods of making and using the same |
WO2003060112A1 (en) | 2002-01-16 | 2003-07-24 | Novozymes A/S | Lipolytic enzyme variants and method for their production |
CA2829859A1 (en) | 2002-01-16 | 2003-07-31 | Genencor International, Inc. | Multiply-substituted protease variants |
WO2003062381A2 (en) | 2002-01-16 | 2003-07-31 | Genencor International, Inc. | Multiply-substituted protease variants |
WO2003087149A2 (en) | 2002-04-10 | 2003-10-23 | Novozymes A/S | Bacillus licheniformis mutant host cell |
WO2003089620A2 (en) | 2002-04-19 | 2003-10-30 | Diversa Corporation | Phospholipases, nucleic acids encoding them and methods for making and using them |
WO2003089614A2 (en) | 2002-04-18 | 2003-10-30 | Genencor International, Inc. | Production of functional antibodies in filamentous fungi |
WO2003093453A2 (en) | 2002-04-10 | 2003-11-13 | Novozymes A/S | Bacillus licheniformis mutant host cell |
CN1465699A (en) | 2002-06-12 | 2004-01-07 | 大连轻工业学院 | Gene engineering of producing fructose by inulase hydrolyzing helianthus tuberosus |
WO2004003186A2 (en) | 2002-06-26 | 2004-01-08 | Novozymes A/S | Subtilases and subtilase variants having altered immunogenicity |
KR20040006812A (en) | 2002-07-15 | 2004-01-24 | 주식회사 제노포커스 | Maltopentaose-producing amylase and process for producing maltopentaose |
US6682923B1 (en) | 1999-05-12 | 2004-01-27 | Xencor | Thermostable alkaliphilic xylanase |
JP2004043660A (en) | 2002-07-12 | 2004-02-12 | Toto Ltd | Enzymic depilatory and enzymic depilation method |
WO2004016752A2 (en) | 2002-08-14 | 2004-02-26 | The Regents Of The University Of California | Proteome-wide mapping of post-translational modifications using endonucleases |
US20040053425A1 (en) | 2002-04-19 | 2004-03-18 | Baylor College Of Medicine | Quantitative measurement of proteins using genetically-engineeredglucose oxidase fusion molecules |
US20040072694A1 (en) | 2002-02-25 | 2004-04-15 | Jacobson Richard Martin | Method to inhibit ethylene responses in plants |
US6723364B1 (en) | 1998-12-03 | 2004-04-20 | Xeda International | Fog treatment method using a liquid composition for treating fruits and vegetables and implementing device |
WO2004032648A1 (en) | 2002-10-11 | 2004-04-22 | Novozymes A/S | Method of preparing a heat-treated product |
US20040077502A1 (en) | 2002-08-06 | 2004-04-22 | Jacobson Richard Martin | Stable ethylene inhibiting compounds and methods for their preparation |
US20040091474A1 (en) | 2001-01-08 | 2004-05-13 | Health Protection Agency | Degradation and detection of TSE infectivity |
WO2004042049A1 (en) | 2002-10-24 | 2004-05-21 | Meiji Seika Kaisha, Ltd. | Method of degrading hardly degradable protein |
NZ524303A (en) | 1996-12-09 | 2004-06-25 | Genencor Int | Alpha amylase enzymes with increased stability |
DE10260903A1 (en) | 2002-12-20 | 2004-07-08 | Henkel Kgaa | New perhydrolases |
US20040146617A1 (en) | 1998-10-27 | 2004-07-29 | Schrader Lawrence E | Compositions and methods for suppressing cracking and water loss from cherries |
WO2004064744A2 (en) | 2003-01-16 | 2004-08-05 | Genencor International Inc. | Methods for site-directed mutagenesis and targeted randomization |
US6773727B1 (en) | 2001-08-13 | 2004-08-10 | The United States Of America As Represented By The Secretary Of Agriculture | Use of gossypol and related terpenes for control of urban and agricultural pests |
DE10309803A1 (en) | 2003-03-05 | 2004-09-23 | Henkel Kgaa | New alpha-amylase variants, useful in cleaning and washing compositions and for desizing cotton, have improved activity in alkaline media, also nucleic acid that encodes them |
WO2004081171A2 (en) | 2003-03-12 | 2004-09-23 | Danisco A/S | Variants of enzymes of the alpha-amylase family |
WO2004080923A2 (en) | 2003-03-10 | 2004-09-23 | Novozymes A/S | Alcohol product processes |
US20040191864A1 (en) | 2003-03-31 | 2004-09-30 | Novozymes Biotech, Inc. | Methods for producing biological substances in enzyme-deficient mutants of Aspergillus |
US20040197894A1 (en) | 2001-07-12 | 2004-10-07 | Fano Tina Sejersgard | Subtilase variants |
WO2004091544A2 (en) | 2003-03-06 | 2004-10-28 | Diversa Corporation | Amylases, nucleic acids encoding them and methods for making and using them |
US20040223962A1 (en) | 2003-05-07 | 2004-11-11 | Riordan Neil H. | Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism |
JP2004313043A (en) | 2003-04-14 | 2004-11-11 | Kao Corp | Alkali protease |
JP2004313022A (en) | 2003-04-11 | 2004-11-11 | Meiji Seika Kaisha Ltd | Endoglucanase mte1 and cellulase preparation containing the same |
WO2004099401A1 (en) | 2003-05-07 | 2004-11-18 | Novozymes A/S | Variant subtilisin enzymes (subtilases) |
WO2004099400A2 (en) | 2003-05-09 | 2004-11-18 | Novozymes A/S | Variant lipolytic ensymes |
WO2004108765A2 (en) | 2003-06-10 | 2004-12-16 | Ace Biosciences A/S | Extracellular aspergillus polypeptides |
WO2004111219A1 (en) | 2003-06-19 | 2004-12-23 | Novozymes A/S | Improved proteases and methods for producing them |
WO2004111216A2 (en) | 2003-06-19 | 2004-12-23 | Novozymes A/S | Phospholipase variants |
WO2004113551A1 (en) | 2003-06-25 | 2004-12-29 | Novozymes A/S | Process for the hydrolysis of starch |
WO2005001064A2 (en) | 2003-06-25 | 2005-01-06 | Novozymes A/S | Polypeptides having alpha-amylase activity and polypeptides encoding same |
WO2005001036A2 (en) | 2003-05-29 | 2005-01-06 | Genencor International, Inc. | Novel trichoderma genes |
WO2005003311A2 (en) | 2003-06-25 | 2005-01-13 | Novozymes A/S | Enzymes for starch processing |
US20050043179A1 (en) | 2003-08-21 | 2005-02-24 | Jacobson Richard Martin | Method to inhibit ethylene responses in plants |
WO2005019443A2 (en) | 2003-08-22 | 2005-03-03 | Novozymes A/S | Fungal alpha-amylase variants |
CN1594542A (en) | 2003-08-19 | 2005-03-16 | 中国农业科学院饲料研究所 | Aspergillus niger inulin endopeptidase gene and recombinant Pichia strain for expressing same |
WO2005024002A1 (en) | 2003-09-11 | 2005-03-17 | Novozymes A/S | Recombinant production of antimicrobial agents |
WO2005032496A2 (en) | 2003-03-07 | 2005-04-14 | Diversa Corporation | Hydrolases, nucleic acids encoding them and mehods for making and using them |
WO2005035747A1 (en) | 2003-10-10 | 2005-04-21 | Novozymes A/S | Protease variants |
US6887986B1 (en) | 1998-11-16 | 2005-05-03 | Novozymes A/S | α-amylase variants |
US20050108791A1 (en) | 2001-12-04 | 2005-05-19 | Edgerton Michael D. | Transgenic plants with improved phenotypes |
WO2005045018A1 (en) | 2003-10-28 | 2005-05-19 | Novozymes North America, Inc. | Hybrid enzymes |
WO2005052148A2 (en) | 2003-11-21 | 2005-06-09 | Genencor International, Inc. | Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates |
US20050129662A1 (en) | 2002-04-17 | 2005-06-16 | Paolo Lameri | Use of vegetable oil as an adjuvant for substances having a fungicide, bactericide, insecticide and herbicide activity |
WO2005054475A1 (en) | 2003-12-03 | 2005-06-16 | Meiji Seika Kaisha, Ltd. | Endoglucanase stce and cellulase preparation containing the same |
US20050137090A1 (en) | 2003-12-18 | 2005-06-23 | Alberto Sardo | Solutions of CIPC and of a terpene or of a terpene oil and their uses for the antigerminative treatment of bulbs or tubers |
WO2005056787A1 (en) | 2003-12-08 | 2005-06-23 | Meiji Seika Kaisha, Ltd. | Surfactant-tolerant cellulase and method of converting the same |
JP2005171409A (en) | 2003-12-10 | 2005-06-30 | Oji Paper Co Ltd | Method for improving pulp-bleaching ability of xylanase |
WO2005058014A1 (en) | 2003-12-16 | 2005-06-30 | Ultimate Nominees Pty Ltd | Fruit ripening method and liquid coating composition |
WO2005073368A1 (en) | 2004-01-30 | 2005-08-11 | Lifenza Co., Ltd. | Protein with activity of hydrolyzing dextran, starch, mutan, inulin and levan, gene encoding the same, cell expressing the same, and production method thereof |
WO2005075652A1 (en) | 2004-02-03 | 2005-08-18 | Kyoto University | Process for producing modified ϝ-glutamyltranspeptidase (modified ggt) having enhanced glutaryl-7-aminosephalosporanic acid (gl-7-aca) acylase activity |
WO2005078074A2 (en) | 2004-02-13 | 2005-08-25 | Novozymes A/S | Protease variants |
US20050187107A1 (en) | 2003-12-23 | 2005-08-25 | Nitragin, Inc. | Methods and compositions providing agronomically beneficial effects in legumes and non-legumes |
WO2005079826A1 (en) | 2004-02-24 | 2005-09-01 | Ajinomoto Co., Inc. | Soothing agent and food for treating fatigue |
WO2005086900A2 (en) | 2004-03-08 | 2005-09-22 | Diversa Corporation | Phospholipases, nucleic acids encoding them and methods for making and using them |
US20050214410A1 (en) | 2004-03-25 | 2005-09-29 | Iogen Bio-Products Corporation | Modified xylanases exhibiting improved expression |
WO2005095592A2 (en) | 2004-04-02 | 2005-10-13 | Novozymes A/S | Subtilase variants having altered immunogenicity |
WO2005096804A2 (en) | 2004-03-08 | 2005-10-20 | Syngenta Participations Ag | Self-processing plants and plant parts |
US20050250649A1 (en) | 2004-05-05 | 2005-11-10 | Jacobson Richard M | Humidity activated delivery systems for cyclopropenes |
WO2005108537A1 (en) | 2004-04-27 | 2005-11-17 | Henkel Kommanditgesellschaft Auf Aktien | DETERGENTS COMPRISING A RINSING SURFACTANT AND A SPECIAL α-AMYLASE |
US20050261131A1 (en) | 2004-05-19 | 2005-11-24 | Basel Richard M | Compositions with cyclopropenes and adjuvants |
WO2005111203A2 (en) | 2004-04-08 | 2005-11-24 | Genencor International, Inc. | MUTANT α ΑMYLASES |
US20050261132A1 (en) | 2004-05-19 | 2005-11-24 | Kostansek Edward C | Compositions with cyclopropenes and metal-complexing agents |
WO2005113785A2 (en) | 2004-05-13 | 2005-12-01 | Novozymes North America, Inc. | A process of producing a fermentation product |
WO2005115445A1 (en) | 2004-05-24 | 2005-12-08 | Novozymes A/S | Enzymes for pharmaceutical use |
WO2005117756A2 (en) | 2004-05-27 | 2005-12-15 | Genencor International, Inc. | Acid-stable alpha amylases having granular starch hydrolyzing activity and enzyme compositions |
WO2005118793A2 (en) | 2004-06-02 | 2005-12-15 | Henkel Kommanditgesellschaft Auf Aktien | Alkaline protease variants having improved performance and washing and cleaning agents containing said alkaline protease variants having improved performance |
WO2005124012A1 (en) | 2004-06-18 | 2005-12-29 | Henkel Kommanditgesellschaft Auf Aktien | New enzymatic bleaching system |
US20050287250A1 (en) | 1995-06-07 | 2005-12-29 | Danisco A/S | Method |
WO2005123911A2 (en) | 2004-06-21 | 2005-12-29 | Novozymes A/S | Proteases |
US20050288189A1 (en) | 2004-06-24 | 2005-12-29 | Jacobson Richard M | Method for treating plants or plant parts |
WO2005123914A1 (en) | 2004-06-21 | 2005-12-29 | Novozymes A/S | Improved methods of producing heterologous proteases |
WO2006002643A2 (en) | 2004-07-05 | 2006-01-12 | Novozymes A/S | Alpha-amylase variants with altered properties |
WO2006012902A2 (en) | 2004-08-02 | 2006-02-09 | Novozymes A/S | Creation of diversity in polypeptides |
WO2006012899A1 (en) | 2004-08-02 | 2006-02-09 | Novozymes A/S | Maltogenic alpha-amylase variants |
WO2006031554A2 (en) | 2004-09-10 | 2006-03-23 | Novozymes North America, Inc. | Methods for preventing, removing, reducing, or disrupting biofilm |
WO2006034710A1 (en) | 2004-09-27 | 2006-04-06 | Novozymes A/S | Enzyme granules |
WO2006037483A2 (en) | 2004-10-01 | 2006-04-13 | Henkel Kommanditgesellschaft Auf Aktien | Alpha-amylase variants stabilized against dimerization and/or multimerization, method for the production thereof, and detergents and cleansers containing these alpha-amylase variants |
WO2006069290A2 (en) | 2004-12-22 | 2006-06-29 | Novozymes A/S | Enzymes for starch processing |
WO2006066594A2 (en) | 2004-12-23 | 2006-06-29 | Novozymes A/S | Alpha-amylase variants |
WO2006066596A2 (en) | 2004-12-22 | 2006-06-29 | Novozymes A/S | Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate -binding module as second amino acid sequence |
CN1814746A (en) | 2005-01-31 | 2006-08-09 | 中国科学院微生物研究所 | Nattokinase and its coding gene and clone and expressing method |
WO2006084470A2 (en) | 2005-02-10 | 2006-08-17 | Novozymes A/S | Enzymatic enantioselective ester or amide hydrolysis or synthesis |
WO2006088325A1 (en) | 2005-02-18 | 2006-08-24 | Inha-Industry Partnership Institute | Bacillus sp. i-52, a detergent- and oxidant-stable haloalkalophilic protease therefrom, a gene encoding the same and a use thereof |
CN1834249A (en) | 2006-03-29 | 2006-09-20 | 浙江大学 | Fusion gene of beta-glucanase and xylanase, constitution method and application |
US20060228458A1 (en) | 2003-04-08 | 2006-10-12 | Alberto Sardo | Method for processing fruits and vegetables on the base of lecithin |
US20060246566A1 (en) | 2005-04-29 | 2006-11-02 | Ab Enzymes Gmbh | Novel cellulases and their uses |
US20060243009A1 (en) | 2005-02-23 | 2006-11-02 | Burnham Jeffrey C | Manufacturing of bioorganic-augmented high nitrogen-containing inorganic fertilizer |
WO2006114616A1 (en) | 2005-04-26 | 2006-11-02 | University Of Sussex | Engineered peroxidases with veratryl alcohol oxidase activity |
WO2006117432A1 (en) | 2005-04-29 | 2006-11-09 | Ab Enzymes Oy | Improved cellulases |
US20060258534A1 (en) | 2005-05-16 | 2006-11-16 | Hill James D | Rhizobium leguminosarum strain and use thereof as plant inoculant |
US20060276336A1 (en) | 2005-06-02 | 2006-12-07 | Alberto Sardo | Process for the anti-germination and/or biocide treatment of bulbs or tubers by means of CIPC and a terpene or terpene oil |
US7151204B2 (en) | 2001-01-09 | 2006-12-19 | Monsanto Technology Llc | Maize chloroplast aldolase promoter compositions and methods for use thereof |
WO2006136159A2 (en) | 2005-06-24 | 2006-12-28 | Novozymes A/S | Lipases for pharmaceutical use |
WO2006136160A2 (en) | 2005-06-24 | 2006-12-28 | Novozymes A/S | Proteases for pharmaceutical use |
CA2512256A1 (en) | 2005-07-15 | 2007-01-15 | Rohm And Haas Company | Compositions with cyclopropenes and adjuvants |
CA2512254A1 (en) | 2005-07-15 | 2007-01-15 | Rohm And Haas Company | Compositions with cyclopropenes and metal-complexing agents |
WO2007006305A1 (en) | 2005-07-08 | 2007-01-18 | Novozymes A/S | Subtilase variants |
WO2007019858A2 (en) | 2005-08-16 | 2007-02-22 | Novozymes A/S | Subtilases |
US20070044171A1 (en) | 2000-12-14 | 2007-02-22 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
WO2007020428A1 (en) | 2005-08-15 | 2007-02-22 | University Of Sussex | Novel peroxidases and uses |
WO2007028088A2 (en) | 2005-09-02 | 2007-03-08 | Novozymes North America, Inc. | Methods for enhancing the dewaterability of sludge with alpha-amylase treatment |
WO2007025549A1 (en) | 2005-09-02 | 2007-03-08 | Novozymes A/S | Stabilization of concentrated liquid enzyme additives |
EP1764411A1 (en) | 2005-07-26 | 2007-03-21 | Kao Corporation | Alkaline xylanase |
WO2007044043A2 (en) | 2004-12-21 | 2007-04-19 | Monsanto Technology, Llc | Transgenic plants with enhanced agronomic traits |
WO2007044993A2 (en) | 2005-10-12 | 2007-04-19 | Genencor International, Inc. | Use and production of storage-stable neutral metalloprotease |
US20070117720A1 (en) | 2005-11-18 | 2007-05-24 | Jacobson Richard M | Compositions with cyclopropenes |
US20070118916A1 (en) | 2005-10-14 | 2007-05-24 | Metanomics Gmbh | Process for the production of fine chemicals |
JP2007143405A (en) | 2005-11-24 | 2007-06-14 | Mitsubishi Gas Chem Co Inc | Catalase b gene and catalase b protein |
WO2007071820A1 (en) | 2005-12-22 | 2007-06-28 | Ab Enzymes Oy | Novel enzymes |
WO2007080197A2 (en) | 2006-01-16 | 2007-07-19 | Novozymes A/S | Immobilised enzymes |
US20070173430A1 (en) | 2006-01-23 | 2007-07-26 | The Procter & Gamble Company | Composition comprising a lipase and a bleach catalyst |
WO2007087319A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Detergent compositions |
WO2007087243A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Detergent compositions |
WO2007087318A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Detergent compositions |
WO2007087508A2 (en) | 2006-01-23 | 2007-08-02 | Novozymes A/S | Lipase variants |
WO2007113241A1 (en) | 2006-03-31 | 2007-10-11 | Novozymes A/S | A stabilized liquid enzyme composition |
WO2007113292A2 (en) | 2006-04-04 | 2007-10-11 | Novozymes A/S | Mashing process |
US20070244020A1 (en) | 2006-04-13 | 2007-10-18 | Ab Enzymes Oy | Enzyme fusion proteins and their use |
WO2007122175A1 (en) | 2006-04-20 | 2007-11-01 | Novozymes A/S | Savinase variants having an improved wash performance on egg stains |
US20070265166A1 (en) | 2006-05-15 | 2007-11-15 | Eduardo Jose Bardella | Contacting crop plants with compositions |
WO2007142543A2 (en) | 2006-06-08 | 2007-12-13 | Encoate Holdings Limited | Novel bacteria and uses thereof |
WO2007146944A2 (en) | 2006-06-16 | 2007-12-21 | Syngenta Participations Ag | Catalytically inactive proteins and method for recovery of enzymes from plant-derived materials |
WO2007149699A2 (en) | 2006-06-21 | 2007-12-27 | Novozymes North America, Inc. | Desizing and scouring process |
WO2008000632A1 (en) | 2006-06-29 | 2008-01-03 | Dsm Ip Assets B.V. | A method for achieving improved polypeptide expression |
WO2008006881A1 (en) | 2006-07-13 | 2008-01-17 | Dsm Ip Assets B.V. | Use of bacterial amylases in feed for bovine animals |
US20080016766A1 (en) | 2006-07-24 | 2008-01-24 | Alberto Sardo | Device for thermal nebulisation of a liquid composition for treating fruits or vegetables and corresponding use |
WO2008010925A2 (en) | 2006-07-18 | 2008-01-24 | Danisco Us, Inc., Genencor Division | Protease variants active over a broad temperature range |
JP2008022828A (en) | 2006-07-25 | 2008-02-07 | Kao Corp | Control of protease activation with surfactant |
WO2008015861A1 (en) | 2006-08-04 | 2008-02-07 | Amano Enzyme Inc. | Method for designing mutated enzyme, method for preparing the same and mutated enzyme |
EP1892529A1 (en) | 2006-08-23 | 2008-02-27 | Canon Kabushiki Kaisha | Enzyme electrode, enzyme electrode producing method, sensor and fuel cell each using enzyme electrode |
WO2008024372A2 (en) | 2006-08-23 | 2008-02-28 | Danisco Us, Inc., Genencor Division | Pullulanase variants with increased productivity |
TW200811294A (en) | 2006-08-25 | 2008-03-01 | Da Guang Biotechnology Co Ltd | A method of producing protein rich in functional peptide that may reduce triglycerides |
CN101134949A (en) | 2006-08-30 | 2008-03-05 | 中国农业科学院饲料研究所 | Beta-glucanase, encoding gene thereof, recombinant plasmid and bacterial strain and uses thereof |
CN101139556A (en) | 2007-08-21 | 2008-03-12 | 华东理工大学 | Highly effective production method for recombinant alpha-glucanase fusion protein and related expression carrier and bacterial strain |
CN101173226A (en) | 2007-10-22 | 2008-05-07 | 中国农业大学 | Pichia pastoris phaff recombined bacterium and uses thereof |
US20080113867A1 (en) | 2006-11-09 | 2008-05-15 | Edward Charles Kostansek | Cyclopropene compositions |
WO2008057637A2 (en) | 2006-07-21 | 2008-05-15 | Novozymes, Inc. | Methods of increasing secretion of polypeptides having biological activity |
KR100834708B1 (en) | 2007-02-01 | 2008-06-02 | 경북대학교 산학협력단 | Amylase gene isolated from Tricholoma matsutake and protein encoded thereby |
US20080145499A1 (en) | 2006-12-07 | 2008-06-19 | Alberto Sardo | Method for treating fruit or vegetables with phosphorous ions and corresponding compositions |
US20080148432A1 (en) | 2005-12-21 | 2008-06-19 | Mark Scott Abad | Transgenic plants with enhanced agronomic traits |
WO2008073169A2 (en) | 2006-08-31 | 2008-06-19 | The Trustees Of The University Of Pennsylvania | Methods, compositions and kits comprising attenuated anthrax vaccines and methods of delivery |
WO2008079685A2 (en) | 2006-12-21 | 2008-07-03 | Novozymes A/S | Lipase variants for pharmaceutical use |
WO2008080093A2 (en) | 2006-12-21 | 2008-07-03 | Verenium Corporation | Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
US20080175926A1 (en) | 2006-04-27 | 2008-07-24 | Gilbert Bompeix | Process for treating storage reservoirs contaminated with mycotoxins |
US20080206823A1 (en) | 2007-02-22 | 2008-08-28 | Richard Martin Jacobson | Method of making a complex |
WO2008110513A1 (en) | 2007-03-09 | 2008-09-18 | Novozymes A/S | Thermostable asparaginases |
WO2008112459A2 (en) | 2007-03-09 | 2008-09-18 | Danisco Us Inc., Genencor Division | Alkaliphilic bacillus species a-amylase variants, compositions comprising a-amylase variants, and methods of use |
WO2008112258A2 (en) | 2007-03-12 | 2008-09-18 | Danisco Us Inc. | Modified proteases |
WO2008122640A2 (en) | 2007-04-09 | 2008-10-16 | Novozymes A/S | An enzymatic treatment of skin and hide degreasing |
WO2008128974A1 (en) | 2007-04-20 | 2008-10-30 | Dsm Ip Assets B.V. | Asparaginase enzyme variants and uses thereof |
WO2008128975A1 (en) | 2007-04-20 | 2008-10-30 | Dsm Ip Assets B.V. | Novel asparaginases and uses thereof |
CN101298604A (en) | 2008-06-25 | 2008-11-05 | 天津科技大学 | High-temperature acid-resistant alpha-amylase mutant strain and construction method thereof |
WO2008141281A1 (en) | 2007-05-10 | 2008-11-20 | Danisco Us Inc., Genencor Division | A modified secretion system to increase expression of polypeptides in bacteria |
WO2008144024A2 (en) | 2007-05-18 | 2008-11-27 | Agion Technologies, Inc. | Disinfecting methods and compositions |
US20080299613A1 (en) | 2007-05-31 | 2008-12-04 | Novozymes, Inc. | Compositions for degrading cellulosic material |
WO2008148845A2 (en) | 2007-06-07 | 2008-12-11 | Novozymes A/S | Method of preparing a dough-based product |
WO2008153935A2 (en) | 2007-06-06 | 2008-12-18 | Danisco Us, Inc., Genencor Division | Methods for improving protein properties |
WO2008153805A2 (en) | 2007-05-30 | 2008-12-18 | Danisco Us, Inc., Genencor Division | Improved variants of the bacillus licheniformis alpha-amylase |
US20080320615A1 (en) | 2001-02-02 | 2008-12-25 | Johnson Thomas D | Plant seed assemblies comprising bacterial/fungal antagonists |
WO2009005647A2 (en) | 2007-06-27 | 2009-01-08 | Bioverdant, Inc. | Compounds and process to prepare chiral intermediates for synthesis of paroxetine |
CN101348794A (en) | 2007-07-19 | 2009-01-21 | 中国科学院武汉病毒研究所 | Encoding gene of high activity glucose oxidase, preparation and use thereof |
CN101348795A (en) | 2007-07-19 | 2009-01-21 | 中国科学院武汉病毒研究所 | Encoding gene of glucose oxidase, preparation and use thereof |
US20090035380A1 (en) | 2007-08-03 | 2009-02-05 | Edward Charles Kostansek | Oil formulations |
WO2009021867A2 (en) | 2007-08-10 | 2009-02-19 | Henkel Ag & Co. Kgaa | Agents containing proteases |
WO2009026397A2 (en) | 2007-08-20 | 2009-02-26 | Fraunhofer Usa, Inc. | Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods |
US7504490B1 (en) | 1998-10-16 | 2009-03-17 | Oscient Pharmaceuticals Corporation | Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics |
US20090077684A1 (en) | 2007-09-17 | 2009-03-19 | Rohm And Haas Company | Compositions and methods for the modification of physiological responses in plants |
WO2009037279A1 (en) | 2007-09-18 | 2009-03-26 | Basf Plant Science Gmbh | Plants with increased yield |
US20090087888A1 (en) | 2007-10-01 | 2009-04-02 | Subash Buddoo | Production of monatin stereoisomers |
US20090117642A1 (en) | 2007-11-05 | 2009-05-07 | Power Scott D | Alpha-amylase variants with altered properties |
US20090118492A1 (en) | 2007-11-06 | 2009-05-07 | Richard Martin Jacobson | Method for making inclusion complex |
WO2009058518A1 (en) | 2007-10-31 | 2009-05-07 | Danisco Us Inc., Genencor Division | Use and production of neutral metallproteases in a serine protease-free background |
WO2009062942A2 (en) | 2007-11-12 | 2009-05-22 | Novozymes A/S | Dual affinity polypeptides for purification |
WO2009071550A1 (en) | 2007-12-04 | 2009-06-11 | Novozymes A/S | Protease variants for pharmaceutical use |
CN101457230A (en) | 2008-12-08 | 2009-06-17 | 江南大学 | High efficiency preparation method of high temperature alpha-amylase and mutant thereof |
WO2009076655A2 (en) | 2007-12-13 | 2009-06-18 | University Of Washington | Synthetic enzymes derived from computational design |
WO2009075860A2 (en) | 2007-12-12 | 2009-06-18 | Monsanto Technology, Llc | Transgenic plants with enhanced agronomic traits |
WO2009075682A1 (en) | 2007-12-12 | 2009-06-18 | Novozymes A/S | Mashing process |
US20090158452A1 (en) | 2001-12-04 | 2009-06-18 | Johnson Richard G | Transgenic plants with enhanced agronomic traits |
US20090155415A1 (en) | 2007-12-14 | 2009-06-18 | Novozymes A/S | Laccase for detoxification of feed products |
WO2009074650A2 (en) | 2007-12-12 | 2009-06-18 | Novozymes A/S | Brewing process |
US20090162480A1 (en) | 2007-12-20 | 2009-06-25 | Novozymes A/S | Cutinase for detoxification of feed products |
WO2009083607A1 (en) | 2008-01-03 | 2009-07-09 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disorders |
US20090181874A1 (en) | 2008-01-11 | 2009-07-16 | Philip Frank Souter | Cleaning And/Or Treatment Compositions |
CN101492661A (en) | 2009-01-16 | 2009-07-29 | 江南大学 | Clone, expression of beta-glucosidase gene, and preparation for gentian oligose |
WO2009100102A2 (en) | 2008-02-04 | 2009-08-13 | Danisco Us Inc., Genencor Division | Ts23 alpha-amylase variants with altered properties |
WO2009100138A2 (en) | 2008-02-04 | 2009-08-13 | Danisco Us Inc., Genencor Division | Variants of bacillus stearothermophilus alpha-amylase and uses thereof |
WO2009100990A1 (en) | 2008-02-13 | 2009-08-20 | Dsm Ip Assets B.V. | Process for the production of a peptide |
WO2009104622A1 (en) | 2008-02-18 | 2009-08-27 | 明治製菓株式会社 | Thermotolerant catalase |
US20090217463A1 (en) | 2008-02-29 | 2009-09-03 | Philip Frank Souter | Detergent composition comprising lipase |
US20090217464A1 (en) | 2008-02-29 | 2009-09-03 | Philip Frank Souter | Detergent composition comprising lipase |
US20090221033A1 (en) | 2008-02-29 | 2009-09-03 | Novozymes A/S | Polypeptides Having Lipase Activity And Polynucleotides Encoding Same |
US20090221034A1 (en) | 2008-02-29 | 2009-09-03 | Novozymes A/S | Lipolytic Enzyme Variant With Improved Stability And Polynucleotides Encoding Same |
WO2009108941A2 (en) | 2008-02-29 | 2009-09-03 | University Of Central Florida Research Foundation, Inc. | Production and use of plant degrading materials |
EP2100948A1 (en) | 2008-03-14 | 2009-09-16 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
US20090230350A1 (en) | 2008-03-13 | 2009-09-17 | Richard Martin Jacobson | Cyclopropene complex compositions |
WO2009112992A1 (en) | 2008-03-14 | 2009-09-17 | The Procter & Gamble Company | Automatic detergent dishwashing composition |
US20090238923A1 (en) | 2007-11-05 | 2009-09-24 | Danisco Us Inc., Genencor Division | Variants of bacillus licheniformis alpha-amylase with increased thermostability and/or decreased calcium dependence |
WO2009118375A2 (en) | 2008-03-26 | 2009-10-01 | Novozymes A/S | Stabilized liquid enzyme compositions |
US20090253579A1 (en) | 2008-04-03 | 2009-10-08 | Heiman Daniel F | Methods of Applying Ethylene Biosynthesis Inhibitor Compositions by Thermal Fogging |
US20090253578A1 (en) | 2008-04-03 | 2009-10-08 | Heiman Daniel F | Ethylene Biosynthesis Inhibitor Compositions Suitable for Thermal Fogging Applications |
WO2009126773A1 (en) | 2008-04-11 | 2009-10-15 | Danisco Us Inc., Genencor Division | Alpha-glucanase and oral care composition containing the same |
WO2009135049A1 (en) | 2008-04-30 | 2009-11-05 | Novus International Inc. | Methods and compositions of plant micronutrients |
WO2009133096A2 (en) | 2008-04-29 | 2009-11-05 | Dsm Ip Assets B.V. | β-LACTAM PRODUCING STRAINS |
WO2009134670A2 (en) | 2008-04-30 | 2009-11-05 | Danisco Us Inc., Genencor Division | New chimeric alpha-amylase variants |
WO2009133177A1 (en) | 2008-04-30 | 2009-11-05 | Novozymes A/S | Isolated peptides having phospholipase inhibitory activity |
EP2116136A1 (en) | 2008-05-08 | 2009-11-11 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | Novel phytases |
WO2009149145A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc., Genencor Division | Compositions and methods comprising variant microbial proteases |
WO2009149395A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc., Genencor Division | Variant alpha-amylases from bacillus subtilis and methods of use, thereof |
WO2009149271A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc. | Production of glucose from starch using alpha-amylases from bacillus subtilis |
WO2009149130A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc. | Geobacillus stearothermophilus alpha-amylase (amys) variants with improved properties |
WO2009158716A1 (en) | 2008-06-28 | 2009-12-30 | The Donald Danforth Plant Science Center | Improved protein production and storage in plants |
EP2145904A1 (en) | 2008-07-18 | 2010-01-20 | Basf Se | Method for enzyme-catalysed hydrolysis of polyacrylic acid esters and esterases to be used |
US20100021587A1 (en) | 2007-11-05 | 2010-01-28 | Danisco Us Inc., Genencor Division | VARIANTS OF BACILLUS sp. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES |
JP2010044058A (en) | 2008-07-15 | 2010-02-25 | Kikkoman Corp | Enzyme immunoassay using enzyme labeled antibody |
US20100047408A1 (en) | 2008-08-25 | 2010-02-25 | Todd Bryan Edgington | Banana Treatments |
CN101659948A (en) | 2008-11-10 | 2010-03-03 | 中国农业大学 | Heat resistant xylanase as well as coding gene and application thereof |
WO2010022518A1 (en) | 2008-08-29 | 2010-03-04 | Iogen Energy Corporation | Modified beta-glucosidases with improved stability |
WO2010027755A1 (en) | 2008-08-27 | 2010-03-11 | The Procter & Gamble Company | Cleaning and/or treatment compositions |
WO2010027857A2 (en) | 2008-08-26 | 2010-03-11 | University Of Georgia Research Foundation, Inc. | Methods, microorganisms, and compositions for plant biomass processing |
EP2166092A1 (en) | 2008-09-18 | 2010-03-24 | The Procter and Gamble Company | Detergent composition |
US20100081636A1 (en) | 2007-03-30 | 2010-04-01 | Alberto Sardo | Method for the nematocidal treatment of plants using eugenol and/or lecithin(s) and/or derivatives thereof |
WO2010036970A2 (en) | 2008-09-25 | 2010-04-01 | Fraunhofer Usa, Inc. | Influenza vaccines, antigens, compositions, and methods |
WO2010036515A1 (en) | 2008-09-25 | 2010-04-01 | Danisco Us Inc. | Alpha-amylase blends and methods for using said blends |
WO2010039840A1 (en) | 2008-09-30 | 2010-04-08 | Novozymes, Inc. | Methods for producing polypeptides in enzyme-deficient mutants of fusarium venenatum |
US20100092631A1 (en) | 2007-02-16 | 2010-04-15 | Alberto Sardo | Combinations of abietic acid esters with one or mote terpenes and use thereof for coating fruit or vegetables |
WO2010053161A1 (en) | 2008-11-06 | 2010-05-14 | ユニチカ株式会社 | Modified flavin-adenine-dinucleotide-dependent glucose dehydrogenase |
WO2010056653A2 (en) | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Proteases comprising one or more combinable mutations |
WO2010056671A1 (en) | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Compositions and methods comprising a subtilisin variant |
US20100124769A1 (en) | 2008-11-18 | 2010-05-20 | Novozymes, Inc. | Methods and compositions for degrading cellulosic material |
WO2010056640A2 (en) | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Compositions and methods comprising serine protease variants |
US20100144533A1 (en) | 2007-01-17 | 2010-06-10 | Gretchen Baier | Delivery of ethylene blocking and/or promoting agents |
WO2010072225A1 (en) | 2008-12-23 | 2010-07-01 | Danisco A/S | Polypeptides with xylanase activity |
WO2010072224A1 (en) | 2008-12-23 | 2010-07-01 | Danisco A/S | Polypeptides with xylanase activity |
WO2010074999A1 (en) | 2008-12-15 | 2010-07-01 | Danisco Us Inc. | Hybrid alpha-amylases |
US20100173773A1 (en) | 2005-06-30 | 2010-07-08 | Syngenta Crop Protection, Inc. | Method of reducing mycotoxin contamination of the harvest |
WO2010078462A1 (en) | 2008-12-31 | 2010-07-08 | Solae, Llc | Protein hydrolysate compositions |
CN101824401A (en) | 2009-03-03 | 2010-09-08 | 福建福大百特科技发展有限公司 | Glucanase and coding nucleic acid and expression thereof |
WO2010104675A1 (en) | 2009-03-10 | 2010-09-16 | Danisco Us Inc. | Bacillus megaterium strain dsm90-related alpha-amylases, and methods of use, thereof |
WO2010102982A1 (en) | 2009-03-10 | 2010-09-16 | Dsm Ip Assets B.V. | Method for improving the yield of a polypeptide |
WO2010115156A2 (en) | 2009-04-03 | 2010-10-07 | Synthetic Genomics, Inc. | Endophytic fungus and uses therefor |
WO2010115021A2 (en) | 2009-04-01 | 2010-10-07 | Danisco Us Inc. | Compositions and methods comprising alpha-amylase variants with altered properties |
CN101870956A (en) | 2009-01-12 | 2010-10-27 | 北京挑战生物技术有限公司 | Cellulase-producing fungus agent and application thereof |
WO2010123754A1 (en) | 2009-04-24 | 2010-10-28 | Danisco Us Inc. | Proteases with modified pro regions |
WO2010121933A1 (en) | 2009-04-22 | 2010-10-28 | Dsm Ip Assets B.V. | Process for the production of a recombinant polypeptide of interest |
WO2010132157A2 (en) | 2009-05-11 | 2010-11-18 | Danisco Us Inc. | Improved production of maltotetraose syrup using a pseudomonas saccharophila maltotetraohydrolase variant and a debranching enzyme |
US20100292080A1 (en) | 2009-02-13 | 2010-11-18 | Bayer Cropscience Ag | Use of succinate dehydrogenase inhibitors for extending shelf life of fruits and vegetables |
US20100298147A1 (en) | 2009-05-19 | 2010-11-25 | Alberto Sardo | Concentrated formulations of cipc in a dialkylene glycol and uses thereof for the anti-germinating treatment of bulbs or tubers |
WO2010135499A1 (en) | 2009-05-21 | 2010-11-25 | Danisco Us Inc. | Dish detergent comprising bleaching enzymes |
CN101899458A (en) | 2009-12-24 | 2010-12-01 | 江南大学 | High-yield and temperature-resistant beta-dextranase pichia pastoris and construction thereof |
WO2010135836A1 (en) | 2009-05-29 | 2010-12-02 | Iogen Energy Corporation | Novel beta-glucosidase enzymes |
WO2010138754A1 (en) | 2009-05-29 | 2010-12-02 | Novozymes, Inc. | Methods for enhancing the degradation or conversion of cellulosic material |
WO2010148148A2 (en) | 2009-06-16 | 2010-12-23 | Codexis, Inc. | β-GLUCOSIDASE VARIANTS |
US20110003694A1 (en) | 2007-11-09 | 2011-01-06 | Zone Artisanale La Crau Route Nationale 7 | Use of solutions of mint oil or of l-carvone for the fungicidal and/or anti-germinating treatment of bulbs and/or tubers |
US20110008475A1 (en) | 2007-11-09 | 2011-01-13 | Alberto Sardo | Use of an emulsion of mint oil or of l-carvone for the fungicidal treatment of fruit, vegetables or plants |
US20110014334A1 (en) | 2009-07-14 | 2011-01-20 | Giovanni Regiroli | Treatment of Produce |
CN101962633A (en) | 2009-07-23 | 2011-02-02 | 福建福大百特科技发展有限公司 | Alpha-amylase, encoding gene and expression thereof |
WO2011014278A1 (en) | 2009-07-31 | 2011-02-03 | Danisco Us Inc. | Proteases with modified pre-pro regions |
US20110034335A1 (en) | 2009-08-06 | 2011-02-10 | James Daly | Treatment of Ornamental Plants |
KR20110013726A (en) | 2009-08-03 | 2011-02-10 | 한국화학연구원 | Thermostable coprinus cinereus peroxidase mutant protein |
KR20110017208A (en) | 2009-08-13 | 2011-02-21 | 한국생명공학연구원 | Novel bacillus sp. hy-20 strain isolated from apis melifera and xylanase produced from it |
WO2011020852A1 (en) | 2009-08-19 | 2011-02-24 | Danisco A/S | Variants of glucoamylase |
EP2292773A1 (en) | 2004-03-25 | 2011-03-09 | Monsanto Technology LLC | Genes and uses for plant improvement |
EP2295582A2 (en) | 2004-07-31 | 2011-03-16 | Monsanto Technology LLC | Genes and uses for plant improvement |
EP2298904A1 (en) | 2002-06-14 | 2011-03-23 | Verenium Corporation | Xylanases, nucleic acids encoding them and methods for making and using them |
WO2011036263A1 (en) | 2009-09-25 | 2011-03-31 | Novozymes A/S | Subtilase variants |
WO2011041391A1 (en) | 2009-09-29 | 2011-04-07 | Fraunhofer Usa, Inc. | Influenza hemagglutinin antibodies, compositions, and related methods |
CN102021191A (en) | 2009-12-24 | 2011-04-20 | 江南大学 | Method for evolving beta-glucanase in vitro |
WO2011046815A1 (en) | 2009-10-16 | 2011-04-21 | Bunge Oils, Inc. | Oil degumming methods |
WO2011046812A1 (en) | 2009-10-16 | 2011-04-21 | Verenium Corporation | Phospholipases, nucleic acids encoding them and methods for making and using them |
WO2011048852A1 (en) | 2009-10-19 | 2011-04-28 | バイオアイ株式会社 | Pectin lyase, pectin lyase gene, enzyme preparation, and method for production of single cells of plant tissue |
US20110099671A1 (en) | 2009-10-23 | 2011-04-28 | Novozymes, Inc. | Cellobiohydrolase variants and polynucleotides encoding same |
WO2011057140A1 (en) | 2009-11-06 | 2011-05-12 | Novozymes, Inc. | Compositions for saccharification of cellulosic material |
WO2011057163A2 (en) | 2009-11-06 | 2011-05-12 | Agrivida, Inc. | Intein-modified enzymes, their production and industrial applications |
WO2011057159A1 (en) | 2009-11-06 | 2011-05-12 | Agrivida, Inc. | Plants expressing cell wall degrading enzymes and expression vectors |
WO2011066187A1 (en) | 2009-11-25 | 2011-06-03 | Codexis, Inc. | Recombinant thermoascus aurantiacus beta-glucosidase variants for production of fermentable sugars from cellulosic biomass |
WO2011068297A1 (en) | 2009-12-01 | 2011-06-09 | Korea Research Institute Of Chemical Technology | Peroxidase variant having improved radical stability |
WO2011068050A1 (en) | 2009-12-05 | 2011-06-09 | 天野エンザイム株式会社 | Mutant enzyme and application thereof |
WO2011072099A2 (en) | 2009-12-09 | 2011-06-16 | Danisco Us Inc. | Compositions and methods comprising protease variants |
WO2011072117A1 (en) | 2009-12-09 | 2011-06-16 | The Procter & Gamble Company | Fabric and home care products |
WO2011076897A1 (en) | 2009-12-22 | 2011-06-30 | Novozymes A/S | Use of amylase variants at low temperature |
WO2011076123A1 (en) | 2009-12-22 | 2011-06-30 | Novozymes A/S | Compositions comprising boosting polypeptide and starch degrading enzyme and uses thereof |
US20110154873A1 (en) | 2009-12-30 | 2011-06-30 | Vitag Corporation | Bioorganically-augmented high value fertilizer |
WO2011080354A1 (en) | 2010-01-04 | 2011-07-07 | Novozymes A/S | Alpha-amylases |
WO2011080267A2 (en) | 2009-12-29 | 2011-07-07 | Novozymes A/S | Polypetides having detergency enhancing effect |
JP2011139677A (en) | 2010-01-08 | 2011-07-21 | Unitika Ltd | Modified flavine-adenine-dinucleotide-dependent glucose dehydrogenase |
WO2011091370A1 (en) | 2010-01-25 | 2011-07-28 | Allergan, Inc. | Methods of intracellular conversion of single-chain proteins into their di-chain form |
US7989393B2 (en) | 2007-04-09 | 2011-08-02 | Novosymes Biologicals, Inc. | Methods of controlling algae with thaxtomin and thaxtomin compositions |
US20110195481A1 (en) | 2010-02-10 | 2011-08-11 | Novozymes A/S | Variants And Compositions Comprising Variants With High Stability In Presence Of A Chelating Agent |
EP2357220A1 (en) | 2010-02-10 | 2011-08-17 | The Procter & Gamble Company | Cleaning composition comprising amylase variants with high stability in the presence of a chelating agent |
WO2011110625A1 (en) | 2010-03-11 | 2011-09-15 | Henkel Ag & Co. Kgaa | Performance-enhanced protease variant |
KR20110106174A (en) | 2010-03-22 | 2011-09-28 | 한국해양연구원 | Cold-active and thermostable cellulase gene |
US20110244095A1 (en) | 2008-09-22 | 2011-10-06 | Xeda International | Method for Coating Food Products |
WO2011121768A1 (en) | 2010-03-31 | 2011-10-06 | 明治製菓株式会社 | Novel cellulase gene |
GB2479462A (en) | 2010-04-09 | 2011-10-12 | Univ Exeter | Polysaccharide degrading enzymes from Coleoptera insects |
WO2011126832A2 (en) | 2010-03-30 | 2011-10-13 | University Of Central Florida Research Foundation, Inc. | Multifunctional silica-based compositions and gels, methods of making them, and methods of using them |
US20110252501A1 (en) | 2006-08-17 | 2011-10-13 | Monsanto Technology Llc | Transgenic plants with enhanced agronomic traits |
WO2011127820A1 (en) | 2010-04-14 | 2011-10-20 | Novozymes A/S | Processes for producing fermentation products |
WO2011130076A1 (en) | 2010-04-15 | 2011-10-20 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2011130222A2 (en) | 2010-04-15 | 2011-10-20 | Danisco Us Inc. | Compositions and methods comprising variant proteases |
WO2011128712A1 (en) | 2010-04-12 | 2011-10-20 | Stellenbosch University | Biofuel production |
WO2011134916A1 (en) | 2010-04-27 | 2011-11-03 | Dsm Ip Assets B.V. | Novel asparaginase enzyme |
JP2011223962A (en) | 2010-04-22 | 2011-11-10 | Osaka Prefecture Univ | New cellulase |
WO2011140364A1 (en) | 2010-05-06 | 2011-11-10 | Danisco Us Inc. | Compositions and methods comprising subtilisin variants |
JP2011234685A (en) | 2010-05-12 | 2011-11-24 | Kao Corp | Recombinant microorganism |
US20110293801A1 (en) | 2010-05-25 | 2011-12-01 | Deirdre Margaret Holcroft | Waxy Coatings on Plant Parts |
WO2011153516A2 (en) | 2010-06-03 | 2011-12-08 | Mascoma Corporation | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
US20110312057A1 (en) | 2010-06-21 | 2011-12-22 | Toyota Motor Engineering & Manufacturing North America, Inc. | Lipase-containing polymeric coatings for the facilitated removal of fingerprints |
US20110321191A1 (en) | 2009-03-05 | 2011-12-29 | Rosichan Jeffrey L | Control of targeted turnover of key ethylene hormone signaling pathway proteins to modulate ethylene sensitivity in plants |
WO2012000892A1 (en) | 2010-06-29 | 2012-01-05 | Dsm Ip Assets B.V. | Polypeptide having or assisting in carbohydrate material degrading activity and uses thereof |
US20120004108A1 (en) | 2010-07-02 | 2012-01-05 | Yueqian Zhen | Coated powder particles |
EP2404930A1 (en) | 2003-07-02 | 2012-01-11 | Verenium Corporation | Glucanases, nucleic acids encoding them and methods for making and using them |
US20120006737A1 (en) | 2006-06-20 | 2012-01-12 | Cummins Filtration Ip, Inc. | Replaceable filter elements including plural filter media and related filtration systems, techniques and methods |
WO2012013197A2 (en) | 2010-07-30 | 2012-02-02 | Aalborg Universitet | Aspergillus encoding beta-glucosidases and nucleic acids encoding same |
EP2415863A1 (en) | 2010-08-03 | 2012-02-08 | B.R.A.I.N. | Mutant glucose oxidase |
WO2012016960A1 (en) | 2010-08-04 | 2012-02-09 | Bayer Pharma Aktiengesellschaft | Genomics of actinoplanes utahensis |
WO2012021883A2 (en) | 2010-08-13 | 2012-02-16 | Dyadic International, Inc. | Novel fungal enzymes |
WO2012021399A1 (en) | 2010-08-12 | 2012-02-16 | Novozymes, Inc. | Compositions comprising a polypeptide having cellulolytic enhancing activity and a nitrogen-containing compound and uses thereof |
WO2012027395A2 (en) | 2010-08-27 | 2012-03-01 | Agrivida, Inc. | Cellulosic processing trait development using a thermoregulated, intein-modified xylanase |
WO2012027282A2 (en) | 2010-08-23 | 2012-03-01 | Codexis, Inc. | Recombinant lignocellulose degradation enzymes for the production of soluble sugars from cellulosic biomass |
WO2012027374A2 (en) | 2010-08-23 | 2012-03-01 | Dyadic International (Usa) Inc. | Novel fungal carbohydrate hydrolases |
WO2012044835A1 (en) | 2010-09-30 | 2012-04-05 | Novozymes, Inc. | Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
WO2012044836A1 (en) | 2010-09-30 | 2012-04-05 | Novozymes, Inc. | Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
WO2012044915A2 (en) | 2010-10-01 | 2012-04-05 | Novozymes, Inc. | Beta-glucosidase variants and polynucleotides encoding same |
WO2012068047A2 (en) | 2010-11-19 | 2012-05-24 | Novozymes North America, Inc. | Processes of producing a fermentation product |
WO2012068509A1 (en) | 2010-11-18 | 2012-05-24 | Novozymes, Inc. | Chimeric polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
WO2012068236A2 (en) | 2010-11-16 | 2012-05-24 | Dyadic International (Usa) Inc. | Novel fungal oxidoreductases |
CN102477438A (en) | 2010-11-30 | 2012-05-30 | 苏州普瑞信生物技术有限公司 | Acid beta-dextranase with recombination genes and application of acid beta- dextranase |
CN102477437A (en) | 2010-11-30 | 2012-05-30 | 苏州普瑞信生物技术有限公司 | Acid alpha-amylase with recombination genes and application thereof |
US20120142534A1 (en) | 2010-12-07 | 2012-06-07 | Mark Linden Dahmer | Granular compositions |
WO2012072777A1 (en) | 2010-12-01 | 2012-06-07 | B.R.A.I.N. Biotechnology Research And Information Network Ag | Novel catalases |
CN102492707A (en) | 2011-12-12 | 2012-06-13 | 江南大学 | Clone and expression of beta-1, 4-inscribe xylanase catalysis domain (Aor Xyn10BC) gene |
WO2012078741A2 (en) | 2010-12-07 | 2012-06-14 | Dyadic International (Usa) Inc. | Novel fungal esterases |
WO2012080202A1 (en) | 2010-12-17 | 2012-06-21 | Henkel Ag & Co. Kgaa | Storage-stable liquid washing or cleaning agent containing protease and amylase |
US20120156734A1 (en) | 2010-10-08 | 2012-06-21 | National Taiwan University | Thermostable paenibacillus xylanases |
EP2468107A1 (en) | 2010-12-21 | 2012-06-27 | Decco Worldwide Post-Harvest Holdings Co. B.V. | Coating for fruit and method for its application |
CN102517304A (en) | 2011-12-16 | 2012-06-27 | 中国农业科学院生物技术研究所 | Optimized gene of recombinant glucose oxidase and expression vector and application of optimized gene |
WO2012088303A2 (en) | 2010-12-22 | 2012-06-28 | Novozymes North America, Inc. | Processes for producing fermentation products |
WO2012088467A2 (en) | 2010-12-22 | 2012-06-28 | Mascoma Corporation | Genetically modified clostridium thermocellum engineered to ferment xylose |
WO2012089024A1 (en) | 2010-12-30 | 2012-07-05 | Novozymes A/S | Method for treating textile with endoglucanase |
WO2012089023A1 (en) | 2010-12-30 | 2012-07-05 | Novozymes A/S | Processes for treating textile with polypeptide having cellulolytic enzyme enhancing activity |
CN102604913A (en) | 2012-04-05 | 2012-07-25 | 湖南尤特尔生化有限公司 | Preparation method and application of thermomyces lanuginosus lipase |
WO2012101206A2 (en) | 2011-01-26 | 2012-08-02 | Novozymes A/S | Novel glycoside hydrolases from thermophilic fungi |
EP2486799A1 (en) | 2011-02-14 | 2012-08-15 | DSM IP Assets B.V. | Method to produce cake with lipolytic enzyme and alpha-amylase |
WO2012106824A1 (en) | 2011-02-09 | 2012-08-16 | Iogen Bio-Products Corporation | Cellulase enzyme mixtures for depilling and uses thereof |
JP2012157315A (en) | 2011-02-02 | 2012-08-23 | Gekkeikan Sake Co Ltd | Method for producing variable domain of heavy chain antibody (vhh) of animal of family camelidae |
US20120227131A1 (en) | 2002-10-02 | 2012-09-06 | Abad Mark S | Transgenic plants with enhanced agronomic traits |
WO2012122308A2 (en) | 2011-03-07 | 2012-09-13 | Agrivida, Inc. | Consolidated pretreatment and hydrolysis of plant biomass expressing cell wall degrading enzymes |
CN102676561A (en) | 2012-05-08 | 2012-09-19 | 陈代文 | Recombinant bacterium for expressing keratinase and fermentation method thereof |
WO2012125865A1 (en) | 2011-03-15 | 2012-09-20 | The Regents Of The University Of California | Mutant cells for protein secretion and lignocellulose degradation |
WO2012125925A2 (en) | 2011-03-17 | 2012-09-20 | Danisco Us Inc. | Method for reducing viscosity in saccharification process |
WO2012129548A2 (en) | 2011-03-23 | 2012-09-27 | Butamax(Tm) Advanced Biofuels Llc | In situ expression of lipase for enzymatic production of alcohol esters during fermentation |
WO2012127001A1 (en) | 2011-03-23 | 2012-09-27 | Novozymes A/S | Methods for producing secreted polypeptides |
WO2012128260A1 (en) | 2011-03-24 | 2012-09-27 | 旭硝子株式会社 | TRANSFORMANT OF YEAST OF GENUS SCHIZOSACCHAROMYCES, METHOD FOR PRODUCING SAME, METHOD FOR PRODUCING β-GLUCOSIDASE, AND METHOD FOR DECOMPOSING CELLULOSE |
CN102703482A (en) | 2011-08-01 | 2012-10-03 | 南京工业大学 | Organic solvent-tolerant alkali protease |
CN102703480A (en) | 2012-05-10 | 2012-10-03 | 宁夏夏盛实业集团有限公司 | Alpha-glucanase, engineering bacteria and applications |
WO2012129699A1 (en) | 2011-04-01 | 2012-10-04 | Adrian Tsang | Cell wall deconstruction enzymes of thermomyces lanuginosus and uses thereof |
WO2012134626A2 (en) | 2011-01-31 | 2012-10-04 | Novozymes North America, Inc. | Processes for enzymatic refining of pretreated cellulosic material for saccharification |
US20120247164A1 (en) | 2011-03-28 | 2012-10-04 | Vitag Corporation | High value organic-enhanced inorganic fertilizers |
WO2012129697A1 (en) | 2011-04-01 | 2012-10-04 | Adrian Tsang | Novel cell wall deconstruction enzymes of talaromyces thermophilus and uses thereof |
WO2012130120A1 (en) | 2011-03-25 | 2012-10-04 | Novozymes A/S | Method for degrading or converting cellulosic material |
US20120258220A1 (en) | 2011-04-05 | 2012-10-11 | Richard Martin Jacobson | Controlled release compositions |
US20120272572A1 (en) | 2009-11-18 | 2012-11-01 | Richard Martin Jacobson | Bonded fiber matrix containing encapsulation complex |
WO2012151480A2 (en) | 2011-05-05 | 2012-11-08 | The Procter & Gamble Company | Compositions and methods comprising serine protease variants |
US20120282380A1 (en) | 2009-12-28 | 2012-11-08 | Nazir Mir | Method of handling bananas |
WO2012151534A1 (en) | 2011-05-05 | 2012-11-08 | Danisco Us Inc. | Compositions and methods comprising serine protease variants |
WO2012159007A1 (en) | 2011-05-19 | 2012-11-22 | Novozymes, Inc. | Methods for enhancing the degradation of cellulosic material with chitin binding proteins |
CN102796751A (en) | 2012-08-21 | 2012-11-28 | 广西科学院 | Mutant Pul 324 of pullulanibacillus naganoensis pullulanase and use thereof |
CN102827821A (en) | 2012-08-31 | 2012-12-19 | 武汉三合益生物科技有限公司 | Mutant enzyme of xylanase 1YNA and application |
WO2012173658A1 (en) | 2011-06-17 | 2012-12-20 | Butamax (Tm) Advanced Biofuels Llc | In situ expression of lipase for enzymatic production of alcohol esters during fermentation |
KR20120140565A (en) | 2011-06-21 | 2012-12-31 | 한국생명공학연구원 | Novel beta-glucosidase and the uses thereof |
EP2540825A2 (en) | 2011-06-30 | 2013-01-02 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants reference to a sequence listing |
CN102851266A (en) | 2012-08-03 | 2013-01-02 | 江南大学 | Heat-resistant alpha-amylase and construction method of gene engineering bacteria thereof |
WO2013001087A2 (en) | 2011-06-30 | 2013-01-03 | Novozymes A/S | Method for screening alpha-amylases |
US20130004634A1 (en) | 2011-06-29 | 2013-01-03 | Rohm And Haas Company | Method of handling mangoes |
WO2013001078A1 (en) | 2011-06-30 | 2013-01-03 | Novozymes A/S | Alpha-amylase variants |
WO2013004636A1 (en) | 2011-07-01 | 2013-01-10 | Novozymes A/S | Stabilized subtilisin composition |
EP2551335A1 (en) | 2011-07-25 | 2013-01-30 | The Procter & Gamble Company | Enzyme stabilized liquid detergent composition |
WO2013023938A1 (en) | 2011-08-12 | 2013-02-21 | Novozymes A/S | Reduction of culture viscosity by manganese addition |
EP2562250A1 (en) | 2011-08-25 | 2013-02-27 | Roche Diagnostics GmbH | Glucose oxidase |
WO2013028915A2 (en) | 2011-08-24 | 2013-02-28 | Novozymes, Inc. | Methods for obtaining positive transformants of a filamentous fungal host cell |
WO2013026575A2 (en) | 2011-08-25 | 2013-02-28 | Roche Diagnostics Gmbh | Glucose oxidase |
WO2013029496A1 (en) | 2011-08-26 | 2013-03-07 | Novozymes A/S | Polypeptides having glucoamylase activity and polynucleotides encoding same |
WO2013034106A1 (en) | 2011-09-09 | 2013-03-14 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
US20130065764A1 (en) | 2010-03-01 | 2013-03-14 | Rohm And Haas Company | Oil formulations comprising cylcopropene compounds |
WO2013036898A2 (en) | 2011-09-09 | 2013-03-14 | Novozymes A/S | Improving properties of paper materials |
FR2979918A1 (en) | 2011-09-08 | 2013-03-15 | Centre Nat Rech Scient | AMAGASAKIENSE PENICILLIUM GLUCOSE OXIDASE MUTANTS |
US20130072383A1 (en) | 2010-02-08 | 2013-03-21 | Alberto Sardo | Method for anti-sprouting and possibly fungicidal treatment of bulbs and/or tubers using clove oil and mint oil |
WO2013039776A1 (en) | 2011-09-13 | 2013-03-21 | Novozymes North America, Inc. | Methods of hydrolyzing and fermenting cellulosic material |
US20130074202A1 (en) | 2001-12-04 | 2013-03-21 | Monsanto Technology Llc | Gene sequences and uses thereof in plants |
CN102994475A (en) | 2012-10-10 | 2013-03-27 | 天津工业生物技术研究所 | Alpha-amylase and recombinant strain for expressing alpha-amylase |
US8409836B2 (en) | 2005-12-22 | 2013-04-02 | Roal Oy | Treatment of cellulosic material and enzymes useful therein |
CN103013960A (en) | 2012-12-21 | 2013-04-03 | 青岛蔚蓝生物集团有限公司 | Alkaline protease and recombinant expression engineering bacterium thereof |
US8420070B2 (en) | 2006-05-22 | 2013-04-16 | Westham Ltd. | Controlling sugar feeding insects |
CN103045559A (en) | 2012-10-23 | 2013-04-17 | 浙江工业大学 | Thermomyces lanuginosus lipase mutant, coding gene and application of mutant |
WO2013055676A1 (en) | 2011-10-11 | 2013-04-18 | Novozymes North America, Inc. | Processes for producing fermentation products |
CN103060290A (en) | 2011-10-18 | 2013-04-24 | 中国科学院微生物研究所 | Alkaline xylanase, its coding gene and application |
WO2013057143A2 (en) | 2011-10-17 | 2013-04-25 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2013057141A2 (en) | 2011-10-17 | 2013-04-25 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2013063460A2 (en) | 2011-10-28 | 2013-05-02 | Danisco Us Inc. | Variant maltohexaose-forming alpha-amylase variants |
US20130123162A1 (en) | 2011-11-10 | 2013-05-16 | The Procter & Gamble Company | Consumer products |
WO2013074956A2 (en) | 2011-11-18 | 2013-05-23 | Novozymes, Inc. | Polypeptides having beta-glucosidase activity, beta-xylosidase activity, or beta-glucosidase and beta-xylosidase activity and polynucleotides encoding same |
WO2013076253A1 (en) | 2011-11-25 | 2013-05-30 | Novozymes A/S | Polypeptides having lysozyme activity and polynucleotides encoding same |
WO2013082486A1 (en) | 2011-12-02 | 2013-06-06 | Novozymes A/S | Processes for producing fermentation products |
WO2013086219A1 (en) | 2011-12-09 | 2013-06-13 | Danisco Us Inc. | Ribosomal promotors from b. subtilis for protein production in microorganisms |
WO2013089889A2 (en) | 2011-09-30 | 2013-06-20 | Novozymes, Inc. | Chimeric polypeptides having beta-glucosidase activity and polynucleotides encoding same |
US20130156835A1 (en) | 2010-04-16 | 2013-06-20 | Alberto Sardo | Novel formulations of active ingredient(s) of plant origin or synthetic analogues thereof or of extract(s) of plant origin containing same, and of lecithin |
EP2607468A1 (en) | 2011-12-20 | 2013-06-26 | Henkel AG & Co. KGaA | Detergent compositions comprising subtilase variants |
WO2013096294A1 (en) | 2011-12-19 | 2013-06-27 | Novozymes A/S | Polypeptides having xylanase activity and polynucleotides encoding same |
WO2013091547A1 (en) | 2011-12-19 | 2013-06-27 | Novozymes, Inc. | Polypeptides having catalase activity and polynucleotides encoding same |
WO2013092635A1 (en) | 2011-12-20 | 2013-06-27 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
CN103184163A (en) | 2011-12-29 | 2013-07-03 | 青岛蔚蓝生物集团有限公司 | Engineered trichoderma strain for heterologous expression of endoglucanase gene and application thereof |
WO2013098205A2 (en) | 2011-12-29 | 2013-07-04 | Novozymes A/S | Detergent compositions |
CN103194419A (en) | 2013-04-03 | 2013-07-10 | 武汉大学 | Microorganism and application thereof |
US20130178489A1 (en) | 2011-10-04 | 2013-07-11 | Xeda International | Method for fungicidal and/or bactericidal treatment of resistant strains using essential oil(s) |
WO2013110242A1 (en) | 2012-01-29 | 2013-08-01 | Novozymes A/S | Methods for degrading or converting cellulosic material |
WO2013110766A1 (en) | 2012-01-26 | 2013-08-01 | Novozymes A/S | Use of polypeptides having protease activity in animal feed and detergents |
CN103232949A (en) | 2012-12-20 | 2013-08-07 | 山东农业大学 | Pichia pastoris engineered strain expressing 61-family glycoside hydrolase gene |
EP2623586A2 (en) | 2012-02-03 | 2013-08-07 | The Procter & Gamble Company | Compositions and methods for surface treatment with lipases |
WO2013113622A1 (en) | 2012-02-03 | 2013-08-08 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
WO2013115305A1 (en) | 2012-01-31 | 2013-08-08 | 国立大学法人長岡技術科学大学 | Method for producing sugar and alcohol from cellulosic biomass, and microorganisms used for same |
CN103243038A (en) | 2013-05-28 | 2013-08-14 | 山东农业大学 | Yeast engineering strain for expressing lipase mutants of thermomyces lanuginosus |
CN103243081A (en) | 2012-02-14 | 2013-08-14 | 兰州小凉河生物技术有限责任公司 | Chymosin gene, amino acid sequence for coding chymosin gene and application of chymosin gene |
WO2013119302A2 (en) | 2011-11-21 | 2013-08-15 | Novozymes, Inc. | Gh61 polypeptide variants and polynucleotides encoding same |
CN103255072A (en) | 2013-05-28 | 2013-08-21 | 山东农业大学 | Pichia pastoris yeast engineering bacterium expressing thermal stability cellulase gene fusant 61F-EG1 |
CN103255156A (en) | 2013-05-30 | 2013-08-21 | 中国农业科学院农产品加工研究所 | Site mutant nattokinase gene high in activity and thermal stability, and application thereof |
CN103275942A (en) | 2013-04-03 | 2013-09-04 | 北京挑战生物技术有限公司 | Glucose oxidase GODJ4A, and gene and application thereof |
US20130236562A1 (en) | 2010-11-24 | 2013-09-12 | Xeda International | Novel method for the pre- or post-harvest treatment of plant products, using phosphonic acid and an essential oil |
WO2013148993A1 (en) | 2012-03-30 | 2013-10-03 | Novozymes North America, Inc. | Processes of producing fermentation products |
CN103343111A (en) | 2013-07-05 | 2013-10-09 | 山东尤特尔生物科技有限公司 | Thermophilic chaetomium cellulase, as well as preparation method and application thereof |
US20130266670A1 (en) | 2010-09-09 | 2013-10-10 | Xeda International | Fungicidal Bactericidal and/or Antioxidant Treatment of Foodstuffs Via Application of Formulations Comprising an Essential Oil and a Dialkylene Glycol |
US20130269061A1 (en) | 2010-06-25 | 2013-10-10 | Agrivida, Inc. | Methods and compositions for processing biomass with elevated levels of starch |
WO2013149858A1 (en) | 2012-04-02 | 2013-10-10 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
WO2013159032A1 (en) | 2012-04-20 | 2013-10-24 | The Sun Products Corporation | Liquid detergent compositions |
WO2013159005A2 (en) | 2012-04-19 | 2013-10-24 | Dyadic International (Usa) Ltd. | A method of improving the activity of cellulase enzyme mixtures in the saccharification of (ligno)cellulosic material |
WO2013160316A1 (en) | 2012-04-23 | 2013-10-31 | Dsm Ip Assets B.V. | Polypeptide expression method |
WO2013164384A1 (en) | 2012-05-04 | 2013-11-07 | Syngenta Participations Ag | New method of use of a pesticide |
WO2013171072A1 (en) | 2012-05-14 | 2013-11-21 | Novozymes A/S | Cutinase variants and polynucleotides encoding same |
US20130306158A1 (en) | 2012-05-21 | 2013-11-21 | Xeda International | Method for producing a gas flow containing an essential oil vapour, method for treating a site with such a gas, and related device |
US20130316458A1 (en) | 2012-05-18 | 2013-11-28 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Photosynthetic microorganisms expressing thermostable lipase |
WO2013182671A1 (en) | 2012-06-08 | 2013-12-12 | Dsm Ip Assets B.V. | Cell wall deconstruction enzymes of aureobasidium pullulans and uses thereof |
WO2013184577A1 (en) | 2012-06-08 | 2013-12-12 | Danisco Us Inc. | Alpha-amylase variants derived from the alpha amylase of cytophaga sp.amylase|(cspamy2). |
WO2013181760A1 (en) | 2012-06-08 | 2013-12-12 | Concordia University | Novel cell wall deconstruction enzymes of scytalidium thermophilum, myriococcum thermophilum, and aureobasidium pullulans, and uses thereof |
WO2013188331A1 (en) | 2012-06-11 | 2013-12-19 | The Procter & Gamble Company | Detergent composition |
US20130341809A1 (en) | 2012-06-25 | 2013-12-26 | Xeda International | Device for evaporating a liquid and related method |
WO2014000746A1 (en) | 2012-06-29 | 2014-01-03 | Carlsberg Breweries A/S | Method for producing beverages by acid removal |
US20140011679A1 (en) | 2013-05-05 | 2014-01-09 | Nazir Mir | Hydrocolloid systems for reducing loss of volatile active compounds from their liquid formulations for pre- and post harvest use on agricultural crops |
CN103525793A (en) | 2013-10-29 | 2014-01-22 | 中国农业科学院饲料研究所 | Alkaline xylanase with improved heat stability, and coding gene and application thereof |
CN103525778A (en) | 2013-10-18 | 2014-01-22 | 江南大学 | Glucose oxidase mutant with high catalytic activity |
WO2014013073A1 (en) | 2012-07-19 | 2014-01-23 | Dsm Ip Assets B.V. | Amylase-deficient strain |
ES2439616A1 (en) | 2012-07-20 | 2014-01-23 | Decco Worldwide Post-Harvest Holding Co. B.V. | Coating formulation comprising cinnamaldehyde and fungistatic food additives (Machine-translation by Google Translate, not legally binding) |
WO2014013074A1 (en) | 2012-07-19 | 2014-01-23 | Dsm Ip Assets B.V. | Agse-deficient strain |
WO2014018368A2 (en) | 2012-07-19 | 2014-01-30 | Novozymes A/S | Methods for increasing enzymatic hydrolysis of cellulosic material |
CN103555751A (en) | 2013-10-24 | 2014-02-05 | 江南大学 | Method for enhancing stability of escherichia coli T7 expression system on basis of double-repression strategy |
CN103555600A (en) | 2013-11-06 | 2014-02-05 | 山东农业大学 | Yeast engineered strain of high-activity-expression thermomyces lanuginosus lipase LN |
WO2014019219A1 (en) | 2012-08-03 | 2014-02-06 | Dupont Nutrition Biosciences Aps | Enzymes |
WO2014027062A1 (en) | 2012-08-17 | 2014-02-20 | Novozymes A/S | Thermostable asparaginase variants and polynucleotides encoding same |
WO2014027063A1 (en) | 2012-08-17 | 2014-02-20 | Novozymes A/S | Method for producing a food product |
CN103602653A (en) | 2013-11-20 | 2014-02-26 | 江南大学 | Keratinase with improved thermal stability and specific activity as well as preparation method and application thereof |
WO2014029808A1 (en) | 2012-08-22 | 2014-02-27 | Dupont Nutrition Biosciences Aps | Variants having glucoamylase activity |
CN103614350A (en) | 2013-12-18 | 2014-03-05 | 江南大学 | Glucose oxidase with improved catalytic efficiency |
WO2014037438A1 (en) | 2012-09-05 | 2014-03-13 | Novozymes A/S | Polypeptides having protease activity |
US20140075603A1 (en) | 2009-09-30 | 2014-03-13 | Novozymes, Inc. | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
US20140080710A1 (en) | 2012-09-17 | 2014-03-20 | Agrofresh Inc. | Compositions with hot melt resin matrix |
WO2014055782A1 (en) | 2012-10-03 | 2014-04-10 | Agrivida, Inc. | Intein-modified proteases, their production and industrial applications |
WO2014059360A1 (en) | 2012-10-12 | 2014-04-17 | Danisco Us Inc. | Compositions and methods comprising a lipolytic enzyme variant |
WO2014060380A1 (en) | 2012-10-16 | 2014-04-24 | Dsm Ip Assets B.V. | Cell wall deconstruction enzymes of thermoascus aurantiacus and uses thereof |
WO2014059541A1 (en) | 2012-10-16 | 2014-04-24 | Concordia University | Novel cell wall deconstruction enzymes of thermoascus aurantiacus, myceliophthora fergusii (corynascus thermophilus), and pseudocercosporella herpotrichoides, and uses thereof |
US20140127309A1 (en) | 2011-06-03 | 2014-05-08 | Rohm And Haas Company | Encapsulated polar materials and methods of preparation |
WO2014070841A1 (en) | 2012-10-31 | 2014-05-08 | Danisco Us Inc. | Compositions and methods of use |
US20140127753A1 (en) | 2004-12-22 | 2014-05-08 | Novozymes A/S | Enzymes for starch processing |
WO2014068109A2 (en) | 2012-11-05 | 2014-05-08 | Novozymes A/S | Enzyme compositions enabling re-use of water in laundry |
CN103789285A (en) | 2014-02-19 | 2014-05-14 | 江南大学 | Amylase mutant having improved heat stability and construction method and application thereof |
CN103805579A (en) | 2014-02-19 | 2014-05-21 | 江南大学 | Thermostable amylase mutant and preparation method and application thereof |
WO2014081700A1 (en) | 2012-11-20 | 2014-05-30 | Codexis, Inc. | Recombinant fungal polypeptides |
WO2014081884A1 (en) | 2012-11-20 | 2014-05-30 | Pronutria, Inc. | Engineered secreted proteins and methods |
CN103834606A (en) | 2014-01-16 | 2014-06-04 | 北京中科星冠生物技术有限责任公司 | Engineering strain expressing acid-resistant high-temperature alpha-amylase gene mutants |
WO2014085251A1 (en) | 2012-11-30 | 2014-06-05 | Novozymes A/S | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
WO2014085439A1 (en) | 2012-11-30 | 2014-06-05 | Novozymes A/S | Processes for producing fermentation products |
CN103865896A (en) | 2014-03-11 | 2014-06-18 | 上海康地恩生物科技有限公司 | Alkaline lipase mutant |
WO2014093123A1 (en) | 2012-12-14 | 2014-06-19 | Danisco Us Inc. | Method of using alpha-amylase from aspergillus fumigatus and pullulanase for saccharification |
WO2014093835A1 (en) | 2012-12-14 | 2014-06-19 | Novozymes A/S | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
WO2014099653A1 (en) | 2012-12-17 | 2014-06-26 | Novozymes A/S | Alpha-amylases and polynucleotides encoding same |
WO2014099416A1 (en) | 2012-12-20 | 2014-06-26 | Danisco Us Inc. | Method of using alpha-amylase from aspergillus terreus and isoamylase for saccharification |
WO2014101753A1 (en) | 2012-12-24 | 2014-07-03 | Novozymes A/S | Polypeptides having endoglucanase activity and polynucleotides encoding same |
US20140187570A1 (en) | 2011-10-04 | 2014-07-03 | Xeda International | Novel formulations of pyrimethanil, and their use in treatment of crops |
WO2014106593A1 (en) | 2013-01-03 | 2014-07-10 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2014114810A1 (en) | 2013-01-28 | 2014-07-31 | Roche Diagnostics Gmbh | Novel glucose oxidases derived from aspergillus niger |
CN103966188A (en) | 2014-02-12 | 2014-08-06 | 华南农业大学 | Recombinant glucanase capable of being expressed and secreted in animal cell as well as recombination method and application of recombinant glucanase |
WO2014120715A2 (en) | 2013-01-30 | 2014-08-07 | Dow Agrosciences Llc | Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts |
CN103981160A (en) | 2014-01-23 | 2014-08-13 | 浙江工业大学 | Thermomyces lanuginosus lipase mutant, coding genes, and applications of thermomyces lanuginosus lipase mutant |
CN103981159A (en) | 2014-06-05 | 2014-08-13 | 青岛蔚蓝生物集团有限公司 | Glucose oxidase mutant and application thereof |
US20140235447A1 (en) | 2013-02-19 | 2014-08-21 | Syngenta Crop Protection Llc | Methods for increasing crop yield |
WO2014124927A2 (en) | 2013-02-14 | 2014-08-21 | Novozymes A/S | Industrial and institutional laundering using multi-enzyme compositions |
US20140242235A1 (en) | 2013-02-28 | 2014-08-28 | Agrofresh Inc. | Methods of handling papaya |
WO2014128321A1 (en) | 2013-02-20 | 2014-08-28 | Decco Worldwide Post-Harvest Holdings B.V. | Method for the treatment and control of post-harvest diseases in fruits and vegetables and compositions comprising natural extracts and plant-strenghtening and/or fungicidal formulations for use in said method |
WO2014131842A1 (en) | 2013-03-01 | 2014-09-04 | Dsm Ip Assets B.V. | Alpha-amylase variants |
WO2014138672A1 (en) | 2013-03-08 | 2014-09-12 | Novozymes A/S | Cellobiohydrolase variants and polynucleotides encoding same |
US20140271758A1 (en) | 2013-03-14 | 2014-09-18 | Syngenta Crop Protection Llc | Overcoated powder particles |
WO2014138983A1 (en) | 2013-03-14 | 2014-09-18 | Concordia University | Novel cell wall deconstruction enzymes of malbranchea cinnamomea, thielavia australiensis, and paecilomyces byssochlamydoides, and uses thereof |
WO2014140165A1 (en) | 2013-03-14 | 2014-09-18 | Dsm Ip Assets B.V. | Cell wall deconstruction enzymes of paecilomyces byssochlamydoides and uses thereof |
WO2014147219A1 (en) | 2013-03-21 | 2014-09-25 | Novozymes A/S | Polypeptides having phospholipase a activity and polynucleotides encoding same |
WO2014147189A1 (en) | 2013-03-21 | 2014-09-25 | Novozymes A/S | Method for producing roasted coffee beans |
WO2014151805A2 (en) | 2013-03-15 | 2014-09-25 | Mascoma Corporation | Expression of beta-glucosidases for hydrolysis of lignocellulose and associated oligomers |
WO2014152878A2 (en) | 2013-03-14 | 2014-09-25 | Agrivida, Inc. | Use of dimerization domains for temperature regulation of enzyme activity |
WO2014164800A1 (en) | 2013-03-11 | 2014-10-09 | Danisco Us Inc. | Alpha-amylase combinatorial variants |
WO2014161987A1 (en) | 2013-04-05 | 2014-10-09 | Novozymes A/S | Polypeptides having dextranase activity and polynucleotides encoding same |
WO2014162001A1 (en) | 2013-04-05 | 2014-10-09 | Novozymes A/S | Enzyme solubility in liquid detergent and use of detergent composition |
WO2014169101A1 (en) | 2013-04-10 | 2014-10-16 | Novozymes A/S | Process for hydrolysis of starch |
WO2014169129A1 (en) | 2013-04-10 | 2014-10-16 | Novozymes A/S | Process for preparation of sugars and syrups |
EP2796547A1 (en) | 2013-04-24 | 2014-10-29 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Novel glucose oxidase variants |
WO2014176311A1 (en) | 2013-04-23 | 2014-10-30 | President And Fellows Of Harvard College | Genetic reprogramming of bacterial biofilms |
CN104130988A (en) | 2014-07-22 | 2014-11-05 | 江南大学 | 1,3-1,4-Beta-glucanase mutant |
WO2014182990A1 (en) | 2013-05-10 | 2014-11-13 | Novozymes A/S | Polypeptides having xylanase activity and polynucleotides encoding same |
WO2014186464A1 (en) | 2013-05-14 | 2014-11-20 | Novozymes A/S | Stabilized humicola lanuginosa lipase varai nts in water-soluble films |
WO2014183921A1 (en) | 2013-05-17 | 2014-11-20 | Novozymes A/S | Polypeptides having alpha amylase activity |
WO2014183920A1 (en) | 2013-05-17 | 2014-11-20 | Novozymes A/S | Polypeptides having alpha amylase activity |
WO2014194034A2 (en) | 2013-05-29 | 2014-12-04 | Danisco Us Inc. | Novel metalloproteases |
WO2014195356A2 (en) | 2013-06-06 | 2014-12-11 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2014197296A1 (en) | 2013-06-05 | 2014-12-11 | Novozymes A/S | Xylanase variants and polynucleotides encoding same |
WO2014202622A2 (en) | 2013-06-19 | 2014-12-24 | Dsm Ip Assets B.V. | Rasamsonia gene and use thereof |
CN104232610A (en) | 2014-09-12 | 2014-12-24 | 江南大学 | Keratinase with improved alpha-keratin substrate specificity as well as construction method and application thereof |
WO2014202616A2 (en) | 2013-06-19 | 2014-12-24 | Dsm Ip Assets B.V. | Rasamsonia gene and use thereof |
WO2014202711A1 (en) | 2013-06-21 | 2014-12-24 | Dupont Nutrition Biosciences Aps | Method of preparing feed additive |
WO2014209800A1 (en) | 2013-06-24 | 2014-12-31 | Novozymes A/S | Processes for recovering oil from fermentation product processes and processes for producing fermentation products |
WO2014207228A1 (en) | 2013-06-27 | 2014-12-31 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
JP2015002686A (en) | 2013-06-19 | 2015-01-08 | 東洋紡株式会社 | Novel glucose oxidase and sequence of polypeptide |
US20150018430A1 (en) | 2013-07-11 | 2015-01-15 | Agrofresh, Inc. | Humidity activated formulation for volatile compounds |
WO2015003908A1 (en) | 2013-07-08 | 2015-01-15 | Basf Se | Compositions comprising a triazole compound and a biopesticide |
CN104293748A (en) | 2014-10-11 | 2015-01-21 | 上海交通大学 | Endo-xylanase with high thermal stability and application thereof |
CN104293744A (en) | 2014-08-19 | 2015-01-21 | 浙江工业大学 | Talaromyces thermophilus derived lipase mutant and application thereof |
WO2015007639A1 (en) | 2013-07-17 | 2015-01-22 | Novozymes A/S | Pullulanase chimeras and polynucleotides encoding same |
WO2015010009A2 (en) | 2013-07-19 | 2015-01-22 | Danisco Us Inc. | Compositions and methods comprising a lipolytic enzyme variant |
CN104313000A (en) | 2014-10-11 | 2015-01-28 | 上海交通大学 | Genetic engineering xylanase and preparation and application of genetic engineering xylanase |
CN104312989A (en) | 2014-10-28 | 2015-01-28 | 江南大学 | Glucose oxidase with improved oxidative resistance |
WO2015017045A1 (en) | 2013-07-03 | 2015-02-05 | Keclon Sa | Modified bacillus cereus phospholipase c protein and method of processing vegetable oil |
US20150045535A1 (en) | 2006-11-29 | 2015-02-12 | Novozymes, Inc. | Bacillus Licheniformis Chromosome |
WO2015038792A1 (en) | 2013-09-12 | 2015-03-19 | Danisco Us Inc. | Compositions and methods comprising lg12-clade protease variants |
WO2015035914A1 (en) | 2013-09-11 | 2015-03-19 | Novozymes A/S | Processes for producing fermentation products |
CN104450650A (en) | 2014-12-01 | 2015-03-25 | 青岛蔚蓝生物集团有限公司 | Alkaline xylanase mutant and application thereof |
CN104450651A (en) | 2014-12-09 | 2015-03-25 | 青岛蔚蓝生物集团有限公司 | Beta-glucosidase mutant and application thereof |
WO2015042064A1 (en) | 2013-09-17 | 2015-03-26 | Edeniq, Inc. | Improved beta-glucosidase enzymes for increased biomass saccharification |
US20150087520A1 (en) | 2013-09-25 | 2015-03-26 | Agrofresh Inc. | Systems and methods for sovlent-free delivery of volatile compounds |
CN104480087A (en) | 2015-01-06 | 2015-04-01 | 天津科技大学 | Novel high-temperature resistant alpha-amylase, preparing method of novel high-temperature resistant alpha-amylase and application of novel high-temperature resistant alpha-amylase |
WO2015048332A2 (en) | 2013-09-25 | 2015-04-02 | Pronutria, Inc. | Secreted nutritive polypeptides and formulations thereof, and methods of production and use thereof |
WO2015044448A1 (en) | 2013-09-30 | 2015-04-02 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2015048339A2 (en) | 2013-09-25 | 2015-04-02 | Pronutria, Inc. | Compositions and formulations for non-human nutrition and methods of production and use thereof |
CN104498456A (en) | 2014-12-01 | 2015-04-08 | 中国农业科学院饲料研究所 | Acidic beta-glucosidase Bgl3B and gene and application thereof |
WO2015050723A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from exiguobacterium, and methods of use, thereof |
CN104561060A (en) | 2014-05-30 | 2015-04-29 | 河北省科学院生物研究所 | Beta-1, 3-1, 4-dextranase gene and application thereof |
WO2015058700A1 (en) | 2013-10-25 | 2015-04-30 | Novozymes A/S | Polypeptides having endoglucanase activity and polynucleotides encoding same |
WO2015066492A1 (en) | 2013-11-01 | 2015-05-07 | Novozymes A/S | Methods of saccharifying and fermenting a cellulosic material |
US20150125925A1 (en) | 2013-11-05 | 2015-05-07 | The Procter & Gamble Company | Compositions and methods comprising serine protease variants |
WO2015065871A1 (en) | 2013-10-28 | 2015-05-07 | Danisco Us Inc. | Large scale genetically engineered active dry yeast |
WO2015067161A1 (en) | 2013-11-07 | 2015-05-14 | 丰益(上海)生物技术研发中心有限公司 | Phospholipase c mutant and use thereof |
WO2015077126A1 (en) | 2013-11-20 | 2015-05-28 | Danisco Us Inc. | Variant alpha-amylases having reduced susceptibility to protease cleavage, and methods of use, thereof |
WO2015079063A1 (en) | 2013-11-29 | 2015-06-04 | Dsm Ip Assets B.V. | Use of bacterial amylases in feed for poultry |
CN104711274A (en) | 2015-03-17 | 2015-06-17 | 中国科学院微生物研究所 | Method for preparing recombinant-penicillium amagasakiense glucose oxidase and application of recombinant-penicillium amagasakiense glucose oxidase |
CN104711273A (en) | 2015-03-17 | 2015-06-17 | 中国科学院微生物研究所 | Method for preparing recombinant-aspergillus niger glucose oxidase and application of recombinant-aspergillus niger glucose oxidase |
WO2015089447A1 (en) | 2013-12-13 | 2015-06-18 | Danisco Us Inc. | Serine proteases of the bacillus gibsonii-clade |
WO2015085920A1 (en) | 2013-12-11 | 2015-06-18 | Novozymes A/S | Cutinase variants and polynucleotides encoding same |
WO2015089441A1 (en) | 2013-12-13 | 2015-06-18 | Danisco Us Inc. | Serine proteases of bacillus species |
WO2015091959A2 (en) | 2013-12-20 | 2015-06-25 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2015091990A1 (en) | 2013-12-20 | 2015-06-25 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
WO2015094809A1 (en) | 2013-12-19 | 2015-06-25 | Danisco Us Inc. | Chimeric fungal alpha-amylases comprising carbohydrate binding module and the use thereof |
WO2015105835A1 (en) | 2014-01-07 | 2015-07-16 | Novozymes A/S | Process for degrading mannan-containing cellulosic materials |
CN104789543A (en) | 2015-04-25 | 2015-07-22 | 上海康地恩生物科技有限公司 | Color protective cellulose and mutant thereof |
US20150208679A1 (en) | 2012-07-25 | 2015-07-30 | Agrofresh, Inc. | Methods of handling avocados and system |
WO2015110058A1 (en) | 2014-01-24 | 2015-07-30 | Novozymes A/S | Swatch for testing lipase activity |
WO2015109405A1 (en) | 2014-01-22 | 2015-07-30 | Concordia University | Novel cell wall deconstruction enzymes of chaetomium thermophilum, thermomyces stellatus, and corynascus sepedonium, and uses thereof |
WO2015110562A1 (en) | 2014-01-26 | 2015-07-30 | Novozymes A/S | A method to produce an antimicrobial polyester textile using cutinase |
WO2015110473A2 (en) | 2014-01-22 | 2015-07-30 | Novozymes A/S | Pullulanase variants and polynucleotides encoding same |
US9102933B1 (en) | 2008-03-11 | 2015-08-11 | Charanjit Sandhu | Targeted pectin hydrolysis by recombinant E. coli expressing chimeric pectinases to facilitate coffee fermentation |
WO2015118123A1 (en) | 2014-02-07 | 2015-08-13 | Novozymes A/S | Compositions for producing glucose syrups |
US20150231588A1 (en) | 2014-02-18 | 2015-08-20 | Rohm And Haas Company | Microcapsules |
CN104862290A (en) | 2015-06-12 | 2015-08-26 | 江南大学 | 1,3-1,4-beta-glucanase mutant |
US20150237877A1 (en) | 2012-09-20 | 2015-08-27 | Agrofresh Inc. | Methods of handling persimmons |
CN104878033A (en) | 2015-04-29 | 2015-09-02 | 江南大学 | Method for promoting extracellular expression of target protein and application of method |
CN104928270A (en) | 2014-03-21 | 2015-09-23 | 中国科学院天津工业生物技术研究所 | Recombinant basic xylanase resistant to chelating agent ethylenediamine tetraacetic acid and construction method thereof |
WO2015143324A1 (en) | 2014-03-21 | 2015-09-24 | Novozymes A/S | Processes for producing ethanol and yeast |
WO2015143360A2 (en) | 2014-03-21 | 2015-09-24 | Danisco Us Inc. | Serine proteases of bacillus species |
WO2015143144A1 (en) | 2014-03-19 | 2015-09-24 | Novozymes A/S | Method for enhancing activity of an x143 polypeptide |
WO2015140275A1 (en) | 2014-03-19 | 2015-09-24 | Novozymes A/S | Polypeptides having phospholipase c activity and polynucleotides encoding same |
US20150272115A1 (en) | 2012-10-11 | 2015-10-01 | Agrofresh Inc. | Yield enhancement for stress-susceptible plants |
WO2015144932A1 (en) | 2014-03-28 | 2015-10-01 | Novozymes A/S | Enzyme variants and polynucleotides encoding same |
WO2015144824A1 (en) | 2014-03-27 | 2015-10-01 | Novozymes A/S | Beta-glucanase variants and polynucleotides encoding same |
WO2015144780A2 (en) | 2014-03-25 | 2015-10-01 | Novozymes A/S | Dishwashing composition |
WO2015144782A1 (en) | 2014-03-25 | 2015-10-01 | Novozymes A/S | Dishwashing composition containing cellulytic enzymes and use thereof |
WO2015144936A1 (en) | 2014-03-28 | 2015-10-01 | Novozymes A/S | Resolubilization of protein crystals at low ph |
WO2015150457A1 (en) | 2014-04-01 | 2015-10-08 | Novozymes A/S | Polypeptides having alpha amylase activity |
WO2015157656A1 (en) | 2014-04-10 | 2015-10-15 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
US20150299720A1 (en) | 2002-02-21 | 2015-10-22 | Monsanto Technology Llc | Expression of microbial proteins in plants for production of plants with improved properties |
CN105002147A (en) | 2015-05-05 | 2015-10-28 | 广东溢多利生物科技股份有限公司 | Mutated glucose oxidase with increased expression quantity and encoding gene and application thereof |
WO2015162038A1 (en) | 2014-04-25 | 2015-10-29 | Basf Se | Amylase variants |
CN105039288A (en) | 2015-09-06 | 2015-11-11 | 青岛蔚蓝生物集团有限公司 | Neutral cellulase mutant and application thereof |
CN105062991A (en) | 2015-07-27 | 2015-11-18 | 中国科学院南海海洋研究所 | Amylase mutants with improved thermal stability as well as coding gene and application of amylase mutants |
WO2015175157A1 (en) | 2014-05-12 | 2015-11-19 | Dow Agrosciences Llc | Volatile applications against pathogens |
WO2015173426A1 (en) | 2014-05-15 | 2015-11-19 | Novozymes A/S | Compositions comprising polypeptides having phospholipase c activity and use thereof |
TR201404579A2 (en) | 2014-04-22 | 2015-11-23 | Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak | The production of xylanase enzyme to be used as a feed additive and the method of obtaining powder preparation and coated product from this enzyme. |
CN105087614A (en) | 2015-09-01 | 2015-11-25 | 浙江大学 | Thermomyces lanuginosus lipase gene, engineering bacteria and application of engineering bacteria |
WO2015182941A1 (en) | 2014-05-27 | 2015-12-03 | 주식회사 제노포커스 | Novel catalase signal sequence and method for catalase expression using same |
CN105132397A (en) | 2015-09-05 | 2015-12-09 | 孙翠言 | Method for improving soybean meal degrading efficiency |
WO2015187697A2 (en) | 2014-06-02 | 2015-12-10 | The Board Of Regents For Oklahoma State University | Systems and methods for production and use of fungal glycosyl hydrolases |
WO2015185689A1 (en) | 2014-06-04 | 2015-12-10 | Novozymes A/S | Detergent composition |
WO2015187935A1 (en) | 2014-06-06 | 2015-12-10 | Novozymes A/S | Enzyme compositions and uses thereof |
CN105155324A (en) | 2015-09-23 | 2015-12-16 | 山东尤特尔生物科技有限公司 | Application of chaetomium thermophilum cellulase in pulping and papermaking process |
WO2015189371A1 (en) | 2014-06-12 | 2015-12-17 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2015189372A1 (en) | 2014-06-12 | 2015-12-17 | Novozymes A/S | Alpha-amylase variants |
WO2015189370A1 (en) | 2014-06-12 | 2015-12-17 | Novozymes A/S | Oxidation stable alpha-amylase variants |
CN105177084A (en) | 2015-10-29 | 2015-12-23 | 福建福大百特生物科技有限公司 | Method for producing fructooligosaccharides by fermenting inulase mutants |
CN105176947A (en) | 2015-10-29 | 2015-12-23 | 福建福大百特生物科技有限公司 | Inulase mutant and application thereof |
CN105176951A (en) | 2015-09-04 | 2015-12-23 | 青岛蔚蓝生物集团有限公司 | Novel alkaline protease mutant |
US20150366230A1 (en) | 2014-06-19 | 2015-12-24 | Agrofresh Inc. | Compositions and methods for packaging produce |
US20150366189A1 (en) | 2013-02-08 | 2015-12-24 | Christian Guy Becker | Dry melt coating process and formulation for volatile compounds |
WO2015200659A1 (en) | 2014-06-25 | 2015-12-30 | Novozymes A/S | Xylanase variants and polynucleotides encoding same |
DE102014212643A1 (en) | 2014-06-30 | 2015-12-31 | Henkel Ag & Co. Kgaa | Liquid detergent containing liquid and solid enzyme formulations |
US20160000072A1 (en) | 2013-01-15 | 2016-01-07 | Agrofresh Inc. | Compositions and methods for stabilizing cyclopropene in solutions |
JP2016015894A (en) | 2014-07-04 | 2016-02-01 | 公立大学法人大阪府立大学 | β-GLUCOSIDASE |
RU2574206C1 (en) | 2014-10-02 | 2016-02-10 | Общество с ограниченной ответственностью Научно-производственная компания "Фермтек" (ООО НПК "Фермтек") | New recombinant strain (versions) of mycelial fungus penicillium verruculosum, and enzymatic agent (versions) intended for hydrolysis of fruit raw material, and method of its production |
WO2016020478A1 (en) | 2014-08-07 | 2016-02-11 | Dsm Ip Assets B.V. | Thermostable alpha amylase |
WO2016029107A1 (en) | 2014-08-21 | 2016-02-25 | Novozymes A/S | Process for saccharifying cellulosic material under oxygen addition |
WO2016026842A1 (en) | 2014-08-21 | 2016-02-25 | Dsm Ip Assets B.V. | Combination of glucose oxidases for improvements in baking |
WO2016030448A1 (en) | 2014-08-28 | 2016-03-03 | Dsm Ip Assets B.V. | Alicyclobacillus pohliae alpha-amylase variants |
WO2016031611A1 (en) | 2014-08-29 | 2016-03-03 | 天野エンザイム株式会社 | Mutant enzyme and application thereof |
EP2993230A1 (en) | 2014-09-02 | 2016-03-09 | Clariant Produkte (Deutschland) GmbH | Polypeptides having xylanase activity with a high conversion rate of xylose-containing polysaccharides |
WO2016036834A1 (en) | 2014-09-02 | 2016-03-10 | Danisco Us Inc. | Dp5-enriched syrups |
US20160066568A1 (en) | 2013-04-26 | 2016-03-10 | Fujun Lu | Methods and compositions for polymer matrix synthesized by polycondensation |
WO2016036648A1 (en) | 2014-09-02 | 2016-03-10 | Novozymes A/S | Processes for producing a fermentation product using a fermenting organism |
WO2016040464A1 (en) | 2014-09-09 | 2016-03-17 | Novozymes A/S | Methods for enhancing the dewaterability of sludge with enzyme treatment |
CN105420252A (en) | 2015-12-07 | 2016-03-23 | 河北省微生物研究所 | Glucose oxidase gene GOD, protein coded by GOD, pichia pastoris transformed by GOD and preparation method of pichia pastoris |
WO2016044542A1 (en) | 2014-09-17 | 2016-03-24 | Bayer Cropscience Lp | Compositions comprising recombinant bacillus cells and an insecticide |
JP2016039821A (en) | 2015-11-20 | 2016-03-24 | Meiji Seikaファルマ株式会社 | Novel cellulase gene |
CN105441415A (en) | 2016-01-22 | 2016-03-30 | 南宁邦尔克生物技术有限责任公司 | Preparation method and application of pullulanase mutant PulB-d99-D436H |
CN105441400A (en) | 2015-06-01 | 2016-03-30 | 南阳师范学院 | Mutation coprinus cinereus peroxidase and preparing method and application thereof |
WO2016046234A2 (en) | 2014-09-22 | 2016-03-31 | Nexttobe Ab | Recombinant phe-free proteins for use in the treatment of phenylketonuria |
WO2016045569A1 (en) | 2014-09-23 | 2016-03-31 | Novozymes A/S | Processes for producing ethanol and fermenting organisms |
US20160095311A1 (en) | 2013-04-26 | 2016-04-07 | Fujun Lu | Gel formulations for extended release of volatile compounds |
WO2016050661A1 (en) | 2014-09-29 | 2016-04-07 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
WO2016050905A1 (en) | 2014-10-02 | 2016-04-07 | Dsm Ip Assets B.V. | Method for preparing a dough comprising addition of penicillium glucose oxidase |
WO2016062875A2 (en) | 2014-10-23 | 2016-04-28 | Novozymes A/S | Glucoamylase variants and polynucleotides encoding same |
WO2016069557A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases of bacillus species |
WO2016069569A2 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
WO2016066896A1 (en) | 2014-10-27 | 2016-05-06 | Ab Enzymes Oy | Fungal endoglucanase variants, their production and use |
WO2016069552A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
WO2016069563A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
WO2016079110A2 (en) | 2014-11-19 | 2016-05-26 | Novozymes A/S | Use of enzyme for cleaning |
WO2016079305A1 (en) | 2014-11-20 | 2016-05-26 | Novozymes A/S | Alicyclobacillus variants and polynucleotides encoding same |
CN105623937A (en) | 2007-12-12 | 2016-06-01 | 诺维信公司 | Saccharifying method |
WO2016087327A1 (en) | 2014-12-01 | 2016-06-09 | Novozymes A/S | Polypeptides having pullulanase activity comprising the x25, x45 and cbm41 domains |
WO2016090059A1 (en) | 2014-12-02 | 2016-06-09 | Novozymes A/S | Laccase variants and polynucleotides encoding same |
WO2016087445A1 (en) | 2014-12-01 | 2016-06-09 | Novozymes A/S | Improved production of glucose syrups |
WO2016087401A1 (en) | 2014-12-05 | 2016-06-09 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
CN105671022A (en) | 2016-03-11 | 2016-06-15 | 江南大学 | 1,3-1,4-beta-glucanase mutant |
CN105671019A (en) | 2014-12-04 | 2016-06-15 | 中国科学院青岛生物能源与过程研究所 | Heat-resistant xylanase and application thereof |
WO2016091870A1 (en) | 2014-12-09 | 2016-06-16 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
DE102014225472A1 (en) | 2014-12-10 | 2016-06-16 | Henkel Ag & Co. Kgaa | Hand dishwashing detergent with improved action against starch |
WO2016090472A1 (en) | 2014-12-09 | 2016-06-16 | Concordia University | Novel cell wall deconstruction enzymes of remersonia thermophila (stilbella thermophila), melanocarpus albomyces, and lentinula edodes, and uses thereof |
WO2016090474A1 (en) | 2014-12-09 | 2016-06-16 | Concordia University | Novel cell wall deconstruction enzymes of chaetomium olivicolor, acremonium thermophilum, and myceliophthora hinnulea, and uses thereof |
WO2016090473A1 (en) | 2014-12-09 | 2016-06-16 | Concordia University | Novel cell wall deconstruction enzymes of rhizomucor miehei, thermoascus thermophilus (dactylomyces thermophilus), and humicola hyalo thermophila, and uses thereof |
DE102014225473A1 (en) | 2014-12-10 | 2016-06-16 | Henkel Ag & Co. Kgaa | Detergents and cleaners with a combination of amylase and protease |
CN105695435A (en) | 2014-11-28 | 2016-06-22 | 华东理工大学 | Thermostable amylase, coding gene thereof and applications of the thermostable amylase |
EP3034592A1 (en) | 2014-12-17 | 2016-06-22 | The Procter and Gamble Company | Method of automatic dishwashing |
WO2016100837A1 (en) | 2014-12-18 | 2016-06-23 | Danisco Us Inc | Engineered multifunctional enzymes and methods of use |
WO2016097405A1 (en) | 2014-12-19 | 2016-06-23 | Novozymes A/S | Stabilized enzyme compositions |
WO2016095856A1 (en) | 2014-12-19 | 2016-06-23 | Novozymes A/S | Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity |
WO2016102356A1 (en) | 2014-12-22 | 2016-06-30 | Novozymes A/S | Detergent compositions, lipase variants and polynucleotides encoding same |
CN105734034A (en) | 2016-04-25 | 2016-07-06 | 江南大学 | Method for improving catalytic performance of pullulanase with truncated flexible residues |
JP2016121081A (en) | 2014-12-24 | 2016-07-07 | 国立大学法人秋田大学 | Antiviral drug and antimicrobial agent |
WO2016107567A1 (en) | 2014-12-31 | 2016-07-07 | Novozymes A/S | Method of treating polyester textile |
WO2016109758A2 (en) | 2014-12-30 | 2016-07-07 | Symbiota, LLC | Seed endophytes across cultivars and species, associated compositions, and methods of use thereof |
CN105746635A (en) | 2016-05-10 | 2016-07-13 | 江南大学 | Application of glucose oxidase in processing of flour products |
CN105802943A (en) | 2016-05-11 | 2016-07-27 | 江南大学 | Performance-improved pullulanase chimera and pichia pastoris mutant strain for highly producing pullulanase chimera |
CN105802940A (en) | 2016-04-18 | 2016-07-27 | 广西大学 | Bacillus licheniformis high-temperature alpha-amylase mutant and application thereof |
WO2016117549A1 (en) | 2015-01-20 | 2016-07-28 | サントリーホールディングス株式会社 | Method for preparing mogroside |
WO2016126294A1 (en) | 2015-02-04 | 2016-08-11 | Nanjing Bestzyme Bio-Engineering Co. Ltd. | Truncated pullulanases, methods of production, and methods of use thereof |
WO2016124651A1 (en) | 2015-02-04 | 2016-08-11 | Novozymes A/S | Detergent composition comprising protease and amylase variants |
US20160235070A1 (en) | 2015-02-12 | 2016-08-18 | Agrofresh Inc. | Fungicidal compounds and compositions |
CN105886520A (en) | 2016-06-29 | 2016-08-24 | 山东大学 | Mutant gene TlXynA_2 of xylanase TlXynA and application thereof |
CN105907775A (en) | 2016-06-29 | 2016-08-31 | 山东大学 | Mutant gene T1XynA-1 of xylanase T1XynA and application thereof |
WO2016145350A1 (en) | 2015-03-12 | 2016-09-15 | Novozymes A/S | Multi-stage enzymatic hydrolysis of lignocellulosic biomass |
WO2016145428A1 (en) | 2015-03-12 | 2016-09-15 | Danisco Us Inc | Compositions and methods comprising lg12-clade protease variants |
WO2016145358A1 (en) | 2015-03-12 | 2016-09-15 | Novozymes A/S | Enzymatic hydrolysis with hemicellulolytic enzymes |
CN105950577A (en) | 2016-07-06 | 2016-09-21 | 青岛红樱桃生物技术有限公司 | Glucose oxidase mutant with improved thermal stability as well as encoding genes and application thereof |
CN105950578A (en) | 2016-07-06 | 2016-09-21 | 青岛红樱桃生物技术有限公司 | Heat-resisting glucose oxidase mutant as well as encoding gene and application thereof |
CN105969783A (en) | 2016-06-29 | 2016-09-28 | 山东大学 | Mutant gene TlXynA_3 of xylanase TlXynA and application thereof |
WO2016153924A1 (en) | 2015-03-20 | 2016-09-29 | Novozymes A/S | Processes for producing ethanol and ethanol producing yeast |
WO2016164596A2 (en) | 2015-04-07 | 2016-10-13 | Novozymes A/S | Methods for selecting enzymes having lipase activity |
WO2016164096A1 (en) | 2015-04-06 | 2016-10-13 | Dupont Nutrition Biosciences Aps | Proteases for high protein fermented milk products |
WO2016167235A1 (en) | 2015-04-14 | 2016-10-20 | 国立研究開発法人産業技術総合研究所 | Modified xylanase |
WO2016174234A2 (en) | 2015-04-29 | 2016-11-03 | Novozymes A/S | Polypeptides suitable for detergent |
CN106084016A (en) | 2016-03-07 | 2016-11-09 | 南宁邦尔克生物技术有限责任公司 | A kind of mutant of signal peptide that can improve restructuring pullulanase expression and application thereof |
EP3091080A1 (en) | 2015-05-05 | 2016-11-09 | Evonik Degussa GmbH | Process for producing acyl amino acids employing lipases |
AU2016101771A4 (en) | 2015-10-06 | 2016-11-10 | Novozymes A/S | Extraction of crude palm oil using enzymes |
US20160324147A1 (en) | 2015-05-06 | 2016-11-10 | Agrofresh Inc. | Stable emulsion formulations of encapsulated volatile compounds |
CN106119219A (en) | 2016-07-06 | 2016-11-16 | 青岛红樱桃生物技术有限公司 | Glucoseoxidase mutant that enzymatic activity improves and expression vector and application |
WO2016183509A1 (en) | 2015-05-13 | 2016-11-17 | Danisco Us Inc. | AprL-CLADE PROTEASE VARIANTS AND USES THEREOF |
WO2016180928A1 (en) | 2015-05-12 | 2016-11-17 | Novozymes A/S | Bacillus licheniformis host cell with deleted lantibiotic gene(s) |
US20160330987A1 (en) | 2014-01-20 | 2016-11-17 | Xeda International S.A. | Anti-sprouting compositions for coating bulbs and tubers and the use thereof for anti-sprouting treatment |
WO2016180792A1 (en) | 2015-05-08 | 2016-11-17 | Novozymes A/S | Alpha-amylase variants having improved performance and stability |
WO2016180749A1 (en) | 2015-05-08 | 2016-11-17 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2016180748A1 (en) | 2015-05-08 | 2016-11-17 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
CN106148235A (en) | 2016-04-28 | 2016-11-23 | 中国水产科学研究院黄海水产研究所 | A kind of bacillus marinus N6 2 and the anti-tumor active protein produced thereof |
US20160345588A1 (en) | 2001-02-02 | 2016-12-01 | Novozymes Bioag A/S | Increasing Plant Yield with Bacterial/Fungal Combinations |
EP3101108A1 (en) | 2015-06-04 | 2016-12-07 | The Procter and Gamble Company | Hand dishwashing liquid detergent composition |
CN106190934A (en) | 2016-07-05 | 2016-12-07 | 江南大学 | A kind of recombined bacillus subtilis producing pullulanase and structure thereof |
EP3101109A1 (en) | 2015-06-04 | 2016-12-07 | The Procter and Gamble Company | Hand dishwashing liquid detergent composition |
US20160355443A1 (en) | 2015-06-05 | 2016-12-08 | Anuvia Plant Nutrients Corporation | High Value Organic Containing Fertilizers and Methods of Manufacture |
WO2016196202A1 (en) | 2015-05-29 | 2016-12-08 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
WO2016201284A2 (en) | 2015-06-10 | 2016-12-15 | Newleaf Symbiotics, Inc. | Antifungal methylobacterium compositions and methods of use |
EP3106508A1 (en) | 2015-06-18 | 2016-12-21 | Henkel AG & Co. KGaA | Detergent composition comprising subtilase variants |
WO2016203064A2 (en) | 2015-10-28 | 2016-12-22 | Novozymes A/S | Detergent composition comprising protease and amylase variants |
WO2016205755A1 (en) | 2015-06-17 | 2016-12-22 | Danisco Us Inc. | Bacillus gibsonii-clade serine proteases |
WO2016205710A1 (en) | 2015-06-17 | 2016-12-22 | Danisco Us Inc. | Proteases with modified propeptide regions |
WO2016206621A1 (en) | 2015-06-26 | 2016-12-29 | Novozymes A/S | Biofinishing system |
WO2016208492A1 (en) | 2015-06-26 | 2016-12-29 | 花王株式会社 | Novel xylanase |
WO2016210238A1 (en) | 2015-06-26 | 2016-12-29 | Indigo Agriculture, Inc | Penicillium endophyte compositions and methods for improved agronomic traits in plants |
WO2017001502A1 (en) | 2015-06-29 | 2017-01-05 | Xeda International S.A. | Coating compositions made of shellac and emulsifier, and methods for coating food products |
WO2017001673A1 (en) | 2015-07-01 | 2017-01-05 | Novozymes A/S | Methods of reducing odor |
WO2017005640A1 (en) | 2015-07-03 | 2017-01-12 | Novozymes A/S | Detergent compositions with improved stability in the presence of sulfites |
WO2017006266A1 (en) | 2015-07-06 | 2017-01-12 | Denovo Genomics, Inc. | Variants of the subtilisin carlsberg polypeptide with decreased thermostability |
FR3038495A1 (en) | 2015-07-06 | 2017-01-13 | Xeda International | COATING DEVICE FOR FOOD PRODUCTS, IN PARTICULAR FRUIT AND VEGETABLES, AND METHOD THEREOF |
WO2017010833A1 (en) | 2015-07-15 | 2017-01-19 | 주식회사 제노포커스 | Novel alpha-1,3-glucanase |
CN106350530A (en) | 2016-11-04 | 2017-01-25 | 江南大学 | Keratinase and gene sequence and application method thereof |
WO2017015233A1 (en) | 2015-07-17 | 2017-01-26 | Keclon Sa | Compositions and methods for oil degumming |
WO2017014974A1 (en) | 2015-07-21 | 2017-01-26 | Novozymes A/S | Polypeptides having pullulanase activity suitable for use in liquefaction |
WO2017019490A1 (en) | 2015-07-24 | 2017-02-02 | Novozymes Inc. | Polypeptides having arabinofuranosidase activity and polynucleotides encoding same |
WO2017029238A2 (en) | 2015-08-14 | 2017-02-23 | Basf Se | Aqueous surface treatment composition for paper and board |
WO2017040907A1 (en) | 2015-09-04 | 2017-03-09 | Novozymes A/S | Methods of inhibiting aa9 lytic polysaccharide monooxygenase catalyzed inactivation of enzyme compositions |
WO2017044545A1 (en) | 2015-09-11 | 2017-03-16 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
CN106544329A (en) | 2016-11-25 | 2017-03-29 | 山东大学 | A kind of extracellular polysaccharide monooxygenase PoLPMO1 and its application |
WO2017050291A1 (en) | 2015-09-25 | 2017-03-30 | Novozymes A/S | Use of serine proteases for improving ethanol yield |
CN106591258A (en) | 2016-09-14 | 2017-04-26 | 新余学院 | Lipase gene, vector, engineering bacterium and application thereof |
WO2017070219A1 (en) | 2015-10-20 | 2017-04-27 | Novozymes A/S | Lytic polysaccharide monooxygenase (lpmo) variants and polynucleotides encoding same |
CN106632683A (en) | 2015-11-03 | 2017-05-10 | 丰益(上海)生物技术研发中心有限公司 | Polypeptide having pNPPC hydrolase activity and coding gene, preparation method and application thereof |
CN106635846A (en) | 2016-12-28 | 2017-05-10 | 青岛蔚蓝生物集团有限公司 | Aspergillus niger strain for production of high-yield pectin methylesterase |
CN106676084A (en) | 2017-02-09 | 2017-05-17 | 浙江工业大学 | Lipase mutant deriving from talaromyces thermophilus, coding gene and application thereof |
WO2017081274A1 (en) | 2015-11-12 | 2017-05-18 | Novozymes A/S | Fermentation processes with reduced foaming |
WO2017083049A1 (en) | 2015-11-09 | 2017-05-18 | Oro Agri, Inc. | An adjuvant |
WO2017083226A1 (en) | 2015-11-13 | 2017-05-18 | E. I. Du Pont De Nemours And Company | Glucan fiber compositions for use in laundry care and fabric care |
JP2017079639A (en) | 2015-10-28 | 2017-05-18 | 花王株式会社 | Bacillus-subtilis mutant and application thereof |
WO2017084560A1 (en) | 2015-11-16 | 2017-05-26 | Novozymes A/S | Cellulase variants and polynucleotides encoding same |
CN106754825A (en) | 2017-01-16 | 2017-05-31 | 广东溢多利生物科技股份有限公司 | Improve than alpha amylase BaAmy mutant living and its encoding gene and application |
CN106754826A (en) | 2017-01-16 | 2017-05-31 | 广东溢多利生物科技股份有限公司 | Alpha amylase AmyL mutant and its encoding gene and application that activity is improved |
WO2017089456A1 (en) | 2015-11-24 | 2017-06-01 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
WO2017088820A1 (en) | 2015-11-26 | 2017-06-01 | Novozymes A/S | Milling process |
WO2017089093A1 (en) | 2015-11-25 | 2017-06-01 | Unilever N.V. | A liquid detergent composition |
WO2017089304A1 (en) | 2015-11-23 | 2017-06-01 | Novozymes A/S | Enzymatic epoxydation of natural rubber |
WO2017089366A1 (en) | 2015-11-24 | 2017-06-01 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
CN106801046A (en) | 2016-09-13 | 2017-06-06 | 中国农业科学院生物技术研究所 | Acidic pullulanase mutant and its encoding gene and application that heat endurance is improved |
CN106801048A (en) | 2017-03-01 | 2017-06-06 | 中国科学院天津工业生物技术研究所 | A kind of low-temperature alkaline protease and preparation method thereof |
WO2017093318A1 (en) | 2015-12-01 | 2017-06-08 | Novozymes A/S | Methods for producing lipases |
AU2017203481A1 (en) | 2003-03-06 | 2017-06-15 | Basf Enzymes Llc | Amylases, nucleic acids encoding them and methods for making and using them |
WO2017097861A1 (en) | 2015-12-07 | 2017-06-15 | Henkel Ag & Co. Kgaa | Dishwashing compositions comprising polypeptides having beta-glucanase activity and uses thereof |
WO2017097896A1 (en) | 2015-12-10 | 2017-06-15 | Dsm Ip Assets B.V. | Beta-glucosidase and uses thereof |
WO2017097897A1 (en) | 2015-12-10 | 2017-06-15 | Dsm Ip Assets B.V. | Beta-glucosidase and uses thereof |
WO2017106676A1 (en) | 2015-12-18 | 2017-06-22 | Danisco Us Inc | Polypeptides with endoglucanase activity and uses thereof |
WO2017101801A1 (en) | 2015-12-16 | 2017-06-22 | 丰益(上海)生物技术研发中心有限公司 | Efficient phospholipase c mutant that does not rely on zinc ions |
CN106884030A (en) | 2015-12-16 | 2017-06-23 | 丰益(上海)生物技术研发中心有限公司 | The method for improving the fermentation yield of the fusion protein of containing cellulose binding domain |
WO2017112643A1 (en) | 2015-12-21 | 2017-06-29 | Danisco Us Inc. | Improved granular starch conversion enzymes and methods |
WO2017112631A1 (en) | 2015-12-21 | 2017-06-29 | Danisco Us Inc. | Improved granular starch conversion enzymes and methods |
WO2017112540A1 (en) | 2015-12-22 | 2017-06-29 | Novozymes A/S | Processes for producing fermentation products |
WO2017114891A1 (en) | 2015-12-30 | 2017-07-06 | Novozymes A/S | Enzyme variants and polynucleotides encoding the same |
WO2017116846A1 (en) | 2015-12-28 | 2017-07-06 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
WO2017116837A1 (en) | 2015-12-28 | 2017-07-06 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
CN106929495A (en) | 2017-01-16 | 2017-07-07 | 广东溢多利生物科技股份有限公司 | Improve than alpha amylase BasAmy mutant living and its encoding gene and application |
WO2017129754A1 (en) | 2016-01-29 | 2017-08-03 | Novozymes A/S | Beta-glucanase variants and polynucleotides encoding same |
CN107012130A (en) | 2017-06-02 | 2017-08-04 | 中国农业科学院饲料研究所 | A kind of glucose oxidase mutant and its encoding gene and application |
CN107022588A (en) | 2017-03-10 | 2017-08-08 | 丰宁平安高科实业有限公司 | Using endoinulase FOS is produced using witloof or jerusalem artichoke as raw material |
CN107058264A (en) | 2017-01-16 | 2017-08-18 | 广东溢多利生物科技股份有限公司 | Than the alpha amylase JcAmy mutant living improved and its encoding gene and application |
WO2017144177A1 (en) | 2016-02-26 | 2017-08-31 | Keskin Hüseyin | Driving and/or flight simulator |
WO2017144008A1 (en) | 2016-02-26 | 2017-08-31 | 南京百斯杰生物工程有限公司 | Αlpha amylase variant and use thereof |
US20170251673A1 (en) | 2016-03-07 | 2017-09-07 | Agrofresh Inc. | Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops |
US20170251669A1 (en) | 2016-03-07 | 2017-09-07 | Agrofresh Inc. | Vaporized administration of pesticides |
US20170251662A1 (en) | 2016-03-07 | 2017-09-07 | Agrofresh Inc. | Alternative device and methods for application of 1-methylcyclopropene to fruit |
WO2017147690A1 (en) | 2016-03-02 | 2017-09-08 | Valorbec Société en Commandite | Engineered beta-glucosidases and methods of use thereof |
WO2017152169A1 (en) | 2016-03-04 | 2017-09-08 | Danisco Us Inc. | Engineered ribosomal promoters for protein production in microorganisms |
CN107151660A (en) | 2017-01-11 | 2017-09-12 | 广东溢多利生物科技股份有限公司 | lipase variant Ala36Ser/Asp49His/Ala52Val/Asn55Asp |
US20170265462A1 (en) | 2016-03-18 | 2017-09-21 | Agrofresh Inc. | Long term methods of improving disease tolerance in plants |
WO2017161091A1 (en) | 2016-03-16 | 2017-09-21 | Spogen Biotech Inc. | Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes |
DE102016204813A1 (en) | 2016-03-23 | 2017-09-28 | Henkel Ag & Co. Kgaa | Lipases for use in detergents and cleaners |
CN107236692A (en) | 2017-07-03 | 2017-10-10 | 华中师范大学 | The molten fiber series bacillus NP1 of termite, zytase PtXyn1 and its encoding gene and application |
EP3228703A1 (en) | 2016-04-08 | 2017-10-11 | Novozymes A/S | Stabilized alpha-amylase variants and use of the same |
WO2017177153A1 (en) | 2016-04-07 | 2017-10-12 | Novozymes A/S | Methods for selecting enzymes having protease activity |
WO2017180695A1 (en) | 2016-04-15 | 2017-10-19 | Agrofresh Inc. | Large-scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
WO2017182666A1 (en) | 2016-04-22 | 2017-10-26 | Novozymes A/S | Use of phospholipase c in palm oil milling |
WO2017186928A1 (en) | 2016-04-29 | 2017-11-02 | Curevac Ag | Rna encoding an antibody |
WO2017189720A1 (en) | 2016-04-27 | 2017-11-02 | Bioresource International | Thermostable protease and methods of making and using the same |
CN107312763A (en) | 2016-09-12 | 2017-11-03 | 南京百斯杰生物工程有限公司 | L-type alpha-amylase variants and its production method |
CN107326020A (en) | 2017-05-25 | 2017-11-07 | 南京百斯杰生物工程有限公司 | A kind of L-type amylase variant and application |
EP3241890A1 (en) | 2016-05-03 | 2017-11-08 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3241891A1 (en) | 2016-05-03 | 2017-11-08 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
WO2017192692A1 (en) | 2016-05-03 | 2017-11-09 | Danisco Us Inc | Protease variants and uses thereof |
WO2017191109A1 (en) | 2016-05-02 | 2017-11-09 | Carlsberg Breweries A/S | Beverages containing barley beta-glucan |
US20170318804A1 (en) | 2016-05-04 | 2017-11-09 | Agrofresh Inc. | Preparation and dispersion of stable emulsion formulations |
WO2017191160A1 (en) | 2016-05-03 | 2017-11-09 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding the same |
WO2017194487A1 (en) | 2016-05-09 | 2017-11-16 | Novozymes A/S | Variant polypeptides with improved performance and use of the same |
CN107384897A (en) | 2017-08-02 | 2017-11-24 | 北京科为博生物科技有限公司 | A kind of alkali protease and its gene and application |
WO2017205800A1 (en) | 2016-05-27 | 2017-11-30 | Agro Research International, LLC | Biopesticide composition for use preventing or minimizing plant disease |
WO2017205337A1 (en) | 2016-05-23 | 2017-11-30 | Dupont Nutrition Biosciences Aps | Baking process and a method thereof |
WO2017210295A1 (en) | 2016-05-31 | 2017-12-07 | Danisco Us Inc. | Protease variants and uses thereof |
WO2017210163A1 (en) | 2016-05-31 | 2017-12-07 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
WO2017210166A1 (en) | 2016-05-31 | 2017-12-07 | Novozymes Bioag A/S | Stable liquid inoculant compositions and coated plant propagation materials comprising same |
CN107475219A (en) | 2017-09-29 | 2017-12-15 | 天津科技大学 | Three kinds recombinate carbohydrase and preparation method and application |
CN107488647A (en) | 2016-06-10 | 2017-12-19 | 广东溢多利生物科技股份有限公司 | The lipase TTL mutant TTL-Gly60Glu and its gene and application that a kind of heat endurance improves |
CN107488648A (en) | 2016-06-10 | 2017-12-19 | 广东溢多利生物科技股份有限公司 | The lipase TTL mutant TTL-Arg59Ser/Gly60Glu/Ser61Asn and gene and application that heat endurance improves |
CN107488645A (en) | 2016-06-10 | 2017-12-19 | 广东溢多利生物科技股份有限公司 | The lipase TTL mutant TTL-Ser61Asn and its gene and application that a kind of heat endurance improves |
CN107488646A (en) | 2016-06-10 | 2017-12-19 | 广东溢多利生物科技股份有限公司 | Lipase mutant TTL Arg59Ser/Gly60Glu/Ser61Asn/Ile62Val and its gene and application |
CN107488644A (en) | 2016-06-10 | 2017-12-19 | 广东溢多利生物科技股份有限公司 | The lipase TTL mutant TTL-Gly60Glu/Ser61Asn and its gene and application that a kind of heat endurance improves |
WO2017217453A1 (en) | 2016-06-14 | 2017-12-21 | 味の素株式会社 | Cellulase |
WO2017219011A1 (en) | 2016-06-17 | 2017-12-21 | Danisco Us Inc | Protease variants and uses thereof |
CN107513527A (en) | 2016-06-16 | 2017-12-26 | 青岛蔚蓝生物集团有限公司 | A kind of cellulase variants and its application |
WO2017220581A1 (en) | 2016-06-20 | 2017-12-28 | Xeda International S.A. | Method for treating plant products using alcohol vapours |
WO2017220422A1 (en) | 2016-06-23 | 2017-12-28 | Novozymes A/S | Use of enzymes, composition and method for removing soil |
KR101814024B1 (en) | 2016-08-23 | 2018-01-02 | 주식회사농심 | Bacillus Strain, Enzyme Produced by the Strain and Application Thereof |
WO2018001959A1 (en) | 2016-06-30 | 2018-01-04 | Novozymes A/S | Lipase variants and compositions comprising surfactant and lipase variant |
WO2018002261A1 (en) | 2016-07-01 | 2018-01-04 | Novozymes A/S | Detergent compositions |
CN107586767A (en) | 2017-11-08 | 2018-01-16 | 南京林业大学 | A kind of heat-resisting internal cutting type xylanase EpXYN1 and its encoding gene and application |
US20180019412A1 (en) | 2010-08-12 | 2018-01-18 | Novozymes, Inc. | Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Quinone Compound And Uses Thereof |
CN107603965A (en) | 2016-07-11 | 2018-01-19 | 华东理工大学 | Acid starch enzyme mutant that heat endurance improves and its preparation method and application |
WO2018015303A1 (en) | 2016-07-21 | 2018-01-25 | Novozymes A/S | Serine protease variants and polynucleotides encoding same |
WO2018015304A1 (en) | 2016-07-21 | 2018-01-25 | Novozymes A/S | Serine protease variants and polynucleotides encoding same |
WO2018015295A1 (en) | 2016-07-18 | 2018-01-25 | Novozymes A/S | Lipase variants, polynucleotides encoding same and the use thereof |
EP3275988A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
WO2018019948A1 (en) | 2016-07-29 | 2018-02-01 | Dsm Ip Assets B.V. | Polypeptides having cellulolytic enhancing activity and uses thereof |
WO2018027131A1 (en) | 2016-08-05 | 2018-02-08 | Cargill, Incorporated | Leader-modified glucoamylase polypeptides and engineered yeast strains having enhanced bioproduct production |
WO2018039802A1 (en) | 2016-09-02 | 2018-03-08 | Creative Protein Solutions Inc | Allosteric split trehalase biosensor |
CN107815460A (en) | 2017-09-30 | 2018-03-20 | 武汉轻工大学 | The preparation method of lipase gene, recombinant expression carrier, recombinant strains, lipase and preparation method thereof and biodiesel |
WO2018053220A1 (en) | 2016-09-16 | 2018-03-22 | Novozymes A/S | Fiber washing method and system |
CN107828765A (en) | 2017-11-01 | 2018-03-23 | 江南大学 | The keratinase mutant of improved thermo stability and its application |
CN107828754A (en) | 2017-12-13 | 2018-03-23 | 江南大学 | The γ glutamyl transpeptidases mutant and its construction method that a kind of enzyme activity improves |
EP3301147A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Low ph laundry detergent composition |
EP3301166A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Method for laundering fabric |
EP3301156A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Laundry detergent composition |
EP3301145A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Low ph laundry detergent composition |
EP3301169A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Laundry detergent composition |
EP3301163A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Low ph laundry detergent composition |
EP3301165A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Low ph laundry detergent composition |
EP3301161A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Laundry detergent composition |
EP3301162A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Low ph laundry detergent composition |
EP3301154A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Laundry detergent composition |
EP3301155A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Laundry detergent composition |
US20180094228A1 (en) | 2016-10-03 | 2018-04-05 | The Procter & Gamble Company | Laundry detergent composition |
EP3309244A1 (en) | 2016-10-11 | 2018-04-18 | Basf Se | Low temperature protease |
CN107937374A (en) | 2017-12-19 | 2018-04-20 | 江南大学 | The Nattokinase that a kind of heat endurance improves |
CN107937372A (en) | 2017-12-19 | 2018-04-20 | 江南大学 | The Nattokinase that a kind of acid resistance improves |
WO2018075430A1 (en) | 2016-10-17 | 2018-04-26 | Novozymes A/S | Methods of reducing foam during ethanol fermentation |
CN107988177A (en) | 2016-10-26 | 2018-05-04 | 青岛蔚蓝生物集团有限公司 | Glucose oxidase mutant |
CN108004220A (en) | 2017-12-25 | 2018-05-08 | 刘丹妮 | Improve alkali protease BmP mutant and its gene and the application of heat endurance |
CN108003244A (en) | 2018-01-24 | 2018-05-08 | 江南大学 | A kind of method for improving glucose oxidase heat endurance |
CN108004256A (en) | 2017-12-14 | 2018-05-08 | 河北省微生物研究所 | Glucose oxidase gene Glox, albumen, pichia pastoris yeast and its preparation and application |
WO2018085524A2 (en) | 2016-11-07 | 2018-05-11 | Danisco Us Inc | Laundry detergent composition |
WO2018089391A1 (en) | 2016-11-08 | 2018-05-17 | Dots Technology Corp. | Allergen detection agents and assays |
US20180139975A1 (en) | 2016-11-23 | 2018-05-24 | Agrofresh Inc. | Methods and device for co-treatment of crop protection chemicals with plant growth regulators |
WO2018094181A1 (en) | 2016-11-21 | 2018-05-24 | Novozymes A/S | Yeast cell extract assisted construction of dna molecules |
CN108070574A (en) | 2016-11-14 | 2018-05-25 | 福建力多利生物科技有限公司 | The mutant and its encoding gene of the peroxidase in Coprinus cinereus source and application |
WO2018098381A1 (en) | 2016-11-23 | 2018-05-31 | Novozymes A/S | Improved yeast for ethanol production |
WO2018098124A1 (en) | 2016-11-23 | 2018-05-31 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
CN108102934A (en) | 2017-12-07 | 2018-06-01 | 青岛蔚蓝生物集团有限公司 | A kind of Aspergillus niger strain of high yield pectin lyase |
CN108118037A (en) | 2016-11-28 | 2018-06-05 | 青岛蔚蓝生物集团有限公司 | The glucose oxidase mutant that a kind of heat resistance improves |
CN108118039A (en) | 2016-11-28 | 2018-06-05 | 丰益(上海)生物技术研发中心有限公司 | A kind of phospholipase C mutant |
CN108118036A (en) | 2016-11-28 | 2018-06-05 | 青岛蔚蓝生物集团有限公司 | Novel grape carbohydrate oxidase mutant |
CN108118038A (en) | 2016-11-28 | 2018-06-05 | 青岛蔚蓝生物集团有限公司 | A kind of glucose oxidase mutant |
EP3330349A1 (en) | 2016-12-02 | 2018-06-06 | The Procter & Gamble Company | Cleaning compositions including enzymes |
WO2018102348A1 (en) | 2016-11-29 | 2018-06-07 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
US20180155744A1 (en) | 2016-12-05 | 2018-06-07 | Stellenbosch University | Recombinant yeast and use thereof |
US20180163191A1 (en) | 2015-12-09 | 2018-06-14 | Danisco Us Inc. | Alpha-Amylase Combinatorial Variants |
WO2018106656A1 (en) | 2016-12-06 | 2018-06-14 | Danisco Us Inc | Truncated lpmo enzymes and use thereof |
EP3339423A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3339422A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
WO2018118740A1 (en) | 2016-12-20 | 2018-06-28 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
WO2018116027A1 (en) | 2016-11-21 | 2018-06-28 | Decco Worldwide Post-Harvest Holdings B.V. | Composition for the treatment and/or prevention of the black sigatoka fungal disease in banana crops |
WO2018118950A1 (en) | 2016-12-21 | 2018-06-28 | Danisco Us Inc. | Bacillus gibsonii-clade serine proteases |
WO2018118917A1 (en) | 2016-12-21 | 2018-06-28 | Danisco Us Inc. | Protease variants and uses thereof |
CN108239626A (en) | 2016-12-27 | 2018-07-03 | 丰益(上海)生物技术研发中心有限公司 | A kind of lipase mutant of high esterification activity |
CN108239627A (en) | 2016-12-27 | 2018-07-03 | 丰益(上海)生物技术研发中心有限公司 | The lipase and its application that activity improves |
CN108251389A (en) | 2017-08-18 | 2018-07-06 | 青岛蔚蓝生物集团有限公司 | The glucose oxidase mutant that a kind of heat resistance improves |
CN108251391A (en) | 2017-08-18 | 2018-07-06 | 青岛蔚蓝生物集团有限公司 | Novel grape carbohydrate oxidase mutant |
CN108251390A (en) | 2017-08-18 | 2018-07-06 | 青岛蔚蓝生物集团有限公司 | A kind of glucose oxidase mutant |
CN108251392A (en) | 2018-03-30 | 2018-07-06 | 广东溢多利生物科技股份有限公司 | It improves than living and the glucose oxidase mutant of thermal stability and its encoding gene and application |
WO2018127486A1 (en) | 2017-01-03 | 2018-07-12 | Novozymes A/S | Enzymatic dehusking of pulses |
WO2018128807A1 (en) | 2017-01-03 | 2018-07-12 | DePuy Synthes Products, Inc. | Mini cable tensioner for orthopedic cable tensioning |
CN108277212A (en) | 2017-12-29 | 2018-07-13 | 广东溢多利生物科技股份有限公司 | Lipase mutant Gly183Cys/Gly212Cys and its gene and application |
WO2018130654A1 (en) | 2017-01-13 | 2018-07-19 | Novozymes A/S | Sterile filtered lactase preparation comprising salt with monovalent cation |
CN108315312A (en) | 2018-04-11 | 2018-07-24 | 广东溢多利生物科技股份有限公司 | The lipase TTL mutant and its encoding gene and application that a kind of thermal stability improves |
US20180216039A1 (en) | 2017-02-01 | 2018-08-02 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants |
CN108359655A (en) | 2018-02-08 | 2018-08-03 | 刘丹妮 | A kind of lipase mutant TDL-mut and its encoding gene that thermal stability is high |
CN108359659A (en) | 2018-02-06 | 2018-08-03 | 横琴仲泰生物医药有限公司 | A kind of alkali protease BmP mutant and its encoding gene that thermal stability is high |
CN108374001A (en) | 2018-03-30 | 2018-08-07 | 广东溢多利生物科技股份有限公司 | It improves than glucose oxidase mutant living and its encoding gene and application |
WO2018142002A1 (en) | 2017-02-01 | 2018-08-09 | Abengoa Bioenergía Nuevas Tecnologías, S.A. | Polypeptides with polysaccharide monooxygenase activity and use thereof for the production of fermentable sugars |
CN108384771A (en) | 2018-02-06 | 2018-08-10 | 珠海市双指环投资有限公司 | A kind of alkali protease mutation body and its encoding gene improving Rate activity |
WO2018161899A1 (en) | 2017-03-06 | 2018-09-13 | Novozymes A/S | Use of one or more enzymes in preventing, inhibiting or reducing microbe growth on a surface |
WO2018165594A1 (en) | 2017-03-10 | 2018-09-13 | Bolt Threads, Inc. | Compositions and methods for producing high secreted yields of recombinant proteins |
WO2018167670A1 (en) | 2017-03-13 | 2018-09-20 | Lallemand Hungary Liquidity Management Llc | Recombinant yeast host cells expressing cell-associated heterologous proteins |
WO2018167669A1 (en) | 2017-03-13 | 2018-09-20 | Lallemand Hungary Liquidity Management Llc | Cell-associated heterologous food and/or feed enzymes |
CN108570461A (en) | 2018-04-17 | 2018-09-25 | 横琴仲泰生物医药有限公司 | A kind of alkali protease BmP mutant and its encoding gene improving Rate activity |
WO2018171552A1 (en) | 2017-03-20 | 2018-09-27 | Novozymes A/S | Method for degumming and refining of vegetable oil |
WO2018175681A1 (en) | 2017-03-22 | 2018-09-27 | Novozymes Bioag A/S | Recovery of stressed bacteria |
CN108588056A (en) | 2018-03-12 | 2018-09-28 | 中国农业科学院饲料研究所 | A kind of low temperature alpha-amylase Tcamy and its gene and application |
CN108611333A (en) | 2018-05-10 | 2018-10-02 | 江南大学 | A kind of gamma glutamyl transpeptidase mutant and its construction method turning the raising of peptide vigor |
CN108611339A (en) | 2018-05-11 | 2018-10-02 | 中国农业科学院饲料研究所 | Glucoamylase TlGa15 and its gene and application |
WO2018183491A1 (en) | 2017-03-30 | 2018-10-04 | Novozymes Bioag A/S | Recovery of dried bacteria |
WO2018184004A1 (en) | 2017-03-31 | 2018-10-04 | Danisco Us Inc | Alpha-amylase combinatorial variants |
CN108623652A (en) | 2018-03-13 | 2018-10-09 | 广西科学院 | A kind of method that heat stability of protein is transformed and its application in Pullulanase |
WO2018186307A1 (en) | 2017-04-04 | 2018-10-11 | 国立大学法人岐阜大学 | Strain belonging to genus mitsuaria and microbial pesticide using said strain |
WO2018185048A1 (en) | 2017-04-03 | 2018-10-11 | Novozymes A/S | Recovery process |
WO2018188667A1 (en) | 2017-04-14 | 2018-10-18 | Novozymes A/S | Processes for solubilizing municipal solid waste with enzyme compositions comprising protease and enzyme compositions thereof |
WO2018204483A2 (en) | 2017-05-03 | 2018-11-08 | Senomyx, Inc. | Methods for making high intensity sweeteners |
CN108795781A (en) | 2017-05-03 | 2018-11-13 | 中国科学院微生物研究所 | A kind of recombinant bacterium of high yield Trichoderma harzianum α -1,3- dextranases and its application |
WO2018209345A1 (en) | 2017-05-12 | 2018-11-15 | The Trustees Of The University Of Pennsylvania | Compositions and methods for inhibiting biofilm deposition and production |
CN108823186A (en) | 2018-07-03 | 2018-11-16 | 江西省科学院微生物研究所 | A kind of thermophilic acidic uncooked amylum alpha-amylase mutant and its preparation method and application that cornstarch degradation capability improves |
CN108841809A (en) | 2018-03-21 | 2018-11-20 | 中国农业科学院饲料研究所 | With height than amylase mutant and its gene and application living and thermal stability |
CN108893453A (en) | 2018-06-04 | 2018-11-27 | 中国农业科学院饲料研究所 | Glucose oxidase GOD mutant and its gene and application |
WO2018218016A1 (en) | 2017-05-26 | 2018-11-29 | Novozymes Bioag A/S | Stable inoculant compositions comprising paraffin oils/waxes |
WO2018218035A1 (en) | 2017-05-26 | 2018-11-29 | Novozymes Bioag A/S | Stable inoculant compositions comprising methylated plant oils |
WO2018218008A1 (en) | 2017-05-26 | 2018-11-29 | Novozymes Bioag A/S | Stable liquid inoculant compositions comprising dodecane |
CN108913675A (en) | 2018-07-09 | 2018-11-30 | 华南理工大学 | The lipase mutant and its application that a kind of thermal stability improves |
CN108929866A (en) | 2018-06-11 | 2018-12-04 | 黑龙江八农垦大学 | The new function and its antibacterial peptide of bacillus subtilis GGT protein degradation product are identified |
WO2018219854A1 (en) | 2017-05-30 | 2018-12-06 | Novozymes A/S | Starch extraction method |
WO2018222990A1 (en) | 2017-06-02 | 2018-12-06 | Novozymes A/S | Improved yeast for ethanol production |
US20180356384A1 (en) | 2017-06-08 | 2018-12-13 | Agrofresh Inc. | Method and system for centralized management, monitoring, and controlled delivery of biological compounds to fruit storage rooms |
WO2018224544A1 (en) | 2017-06-08 | 2018-12-13 | Novozymes A/S | Compositions comprising polypeptides having cellulase activity and amylase activity, and uses thereof in cleaning and detergent compositions |
CN109022396A (en) | 2018-08-30 | 2018-12-18 | 江南大学 | The alpha-amylase mutant and its application that a kind of enzyme activity improves |
JP2018198581A (en) | 2017-05-29 | 2018-12-20 | アイシン精機株式会社 | Flavin adenine dinucleotide dependent formic acid oxidase variant, nucleic acid molecule, enzyme electrode, bio battery, and biosensor |
CN109055439A (en) | 2018-08-17 | 2018-12-21 | 中国科学院青岛生物能源与过程研究所 | The method that ethyl alcohol is prepared using lignocellulosic |
WO2018234382A1 (en) | 2017-06-22 | 2018-12-27 | Novozymes A/S | Dough relaxation using gamma glutamyl transpeptidase |
WO2019005755A1 (en) | 2017-06-28 | 2019-01-03 | Novozymes A/S | Polypeptides having trehalase activity and polynucleotides encoding same |
CN109207446A (en) | 2017-06-30 | 2019-01-15 | 青岛蔚蓝生物集团有限公司 | glucose oxidase mutant |
CN109207458A (en) | 2018-10-31 | 2019-01-15 | 福州大学 | Heat resistant type mesophilicα-diastase and its application |
WO2019014118A1 (en) | 2017-07-09 | 2019-01-17 | Igc Bio, Inc. | Pross optimized enzymes |
CN109234339A (en) | 2018-11-22 | 2019-01-18 | 湖南汇升生物科技有限公司 | A kind of production method of high-purity crystallized maltose |
CN109321552A (en) | 2018-10-11 | 2019-02-12 | 山东隆科特酶制剂有限公司 | A kind of novel Pullulanase and its gene, engineering bacteria and preparation method |
CN109321546A (en) | 2017-12-12 | 2019-02-12 | 丰益(上海)生物技术研发中心有限公司 | Phospholipase C and its encoding gene |
CN109321586A (en) | 2018-11-03 | 2019-02-12 | 中国农业科学院生物技术研究所 | Recombinant Aspergillus niger Glucose Oxidase optimization gene and its expression vector and application |
EP3444323A1 (en) | 2017-08-18 | 2019-02-20 | The Procter & Gamble Company | Cleaning kit |
WO2019036721A2 (en) | 2017-08-18 | 2019-02-21 | Danisco Us Inc | Alpha-amylase variants |
CN109370973A (en) | 2018-11-22 | 2019-02-22 | 湖南汇升生物科技有限公司 | A kind of maltogenic amylase production bacterial strain |
CN109423483A (en) | 2017-08-30 | 2019-03-05 | 青岛蔚蓝生物集团有限公司 | Glucose oxidase mutant |
WO2019042971A1 (en) | 2017-08-29 | 2019-03-07 | Novozymes A/S | Baker's yeast expressing anti-staling/freshness amylases |
CN109439607A (en) | 2018-11-22 | 2019-03-08 | 湖南汇升生物科技有限公司 | A kind of application of maltogenic amylase production bacterial strain |
CN109439641A (en) | 2018-11-22 | 2019-03-08 | 湖南汇升生物科技有限公司 | A kind of application of maltogenic amylase production bacterial strain |
CN109456957A (en) | 2018-12-19 | 2019-03-12 | 广州立白企业集团有限公司 | Ease variants, liquid detergent composition and its application |
WO2019048486A1 (en) | 2017-09-05 | 2019-03-14 | Henkel Ag & Co. Kgaa | Performance-enhanced protease variants ii |
WO2019048495A1 (en) | 2017-09-05 | 2019-03-14 | Henkel Ag & Co. Kgaa | Performance-enhanced protease variants i |
CN109468301A (en) | 2018-12-13 | 2019-03-15 | 浙江大学 | A kind of lipase mutant and its preparation method and application that thermal stability improves |
CN109486689A (en) | 2018-12-27 | 2019-03-19 | 江南大学 | A kind of acid proof method of enhancing L-ASP |
US10233430B1 (en) | 2017-10-13 | 2019-03-19 | Dongguan Apac Biotechnology Co.,Ltd. | Glucose oxidase having improved thermostability |
CN109486791A (en) | 2018-11-22 | 2019-03-19 | 湖南汇升生物科技有限公司 | A kind of preparation and its application of maltogenic amylase enzyme mutant |
WO2019058211A1 (en) | 2017-09-22 | 2019-03-28 | Decco Worldwide Post-Harvest Holdings B.V. | A method for treating and controlling post-harvest physiological disorders in fruit via edible coatings |
WO2019060574A1 (en) | 2017-09-20 | 2019-03-28 | Spogen Biotech Inc. | Fusion proteins, recombinant bacteria, and exosporium fragments for plant health |
CN109554355A (en) | 2018-12-20 | 2019-04-02 | 山东恒鲁生物科技有限公司 | Enhance active polypeptide and its application with cellulose degradation |
WO2019063543A1 (en) | 2017-09-29 | 2019-04-04 | Dsm Ip Assets B.V. | Improved glycerol free ethanol production |
WO2019063499A1 (en) | 2017-09-27 | 2019-04-04 | Novozymes A/S | Lipase variants and microcapsule compositions comprising such lipase variants |
CN109593746A (en) | 2019-01-24 | 2019-04-09 | 江南大学 | The keratinase mutant and application that a kind of catalytic performance improves |
WO2019068850A1 (en) | 2017-10-06 | 2019-04-11 | Novozymes A/S | Enzyme assisted crude palm oil extraction |
CN109666657A (en) | 2017-10-13 | 2019-04-23 | 东莞泛亚太生物科技有限公司 | Promote the glucose oxidase of heat resistance |
WO2019083831A1 (en) | 2017-10-23 | 2019-05-02 | Novozymes A/S | Processes for reducing lactic acid in a biofuel fermentation system |
CN109776686A (en) | 2019-03-27 | 2019-05-21 | 云南师范大学 | A kind of pattern of fusion lipase and its preparation method and application that thermostability improves |
CN109777795A (en) | 2019-03-12 | 2019-05-21 | 中粮集团有限公司 | Built-up starch enzyme preparation and its method of application and starch liquefacation in starch liquefacation |
EP3485734A1 (en) | 2017-11-21 | 2019-05-22 | Technische Universität München | Method for preparing food products comprising rye |
US20190153414A1 (en) | 2012-04-27 | 2019-05-23 | Novoyzmes A/S | GH61 Polypeptide Variants and Polynucleotides Encoding Same |
WO2019099235A1 (en) | 2017-11-14 | 2019-05-23 | Danisco Us Inc | Alpha-amylase, composition and method |
CN109810961A (en) | 2019-03-20 | 2019-05-28 | 中粮集团有限公司 | A- amylase mutant and its encoding gene and their application for high concentration starch liquefacation |
US20190159470A1 (en) | 2016-06-20 | 2019-05-30 | Xeda International S.A. | Method and assembly for the treatment of the atmosphere in a storage space for vegetable products |
US20190159469A1 (en) | 2016-06-20 | 2019-05-30 | Xeda International S.A. | Method of treatment using a biocidal or phytoprotective product, device and corresponding treatment assembly |
CN109825466A (en) | 2019-04-10 | 2019-05-31 | 江南大学 | A kind of method that straight chain maltopentaose generates enzyme secreting, expressing in bacillus subtilis |
WO2019108599A1 (en) | 2017-11-29 | 2019-06-06 | Danisco Us Inc | Subtilisin variants having improved stability |
WO2019110462A1 (en) | 2017-12-04 | 2019-06-13 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
WO2019113413A1 (en) | 2017-12-08 | 2019-06-13 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2019110538A1 (en) | 2017-12-04 | 2019-06-13 | Institut National De La Recherche Agronomique | Novel phytopharmaceutical compounds and compositions, preparation and uses thereof |
WO2019110497A1 (en) | 2017-12-05 | 2019-06-13 | Chr. Hansen A/S | Use of cellobiose oxidase for reduction of reduction of maillard reaction |
WO2019113415A1 (en) | 2017-12-08 | 2019-06-13 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
CN109897842A (en) | 2019-03-25 | 2019-06-18 | 中国农业科学院饲料研究所 | Amylase mutant ZDAMYA and its encoding gene and application |
US20190185789A1 (en) | 2017-12-19 | 2019-06-20 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
US20190185788A1 (en) | 2017-12-19 | 2019-06-20 | The Procter & Gamble Company | Automatic dishwashing detergent compositions |
CN109929821A (en) | 2018-12-27 | 2019-06-25 | 江南大学 | A kind of cutin enzyme mutant and its application in plain boiled water processing |
EP3502243A1 (en) | 2017-12-21 | 2019-06-26 | AB Enzymes Oy | Variants of fungal cellulase |
EP3502242A1 (en) | 2017-12-20 | 2019-06-26 | Technische Universität München | New xylanase with improved thermostability and increased enzyme activity on arabinoxylan |
WO2019121937A1 (en) | 2017-12-20 | 2019-06-27 | Dsm Ip Assets B.V. | Animal feed compositions comprising muramidase and uses thereof |
US20190194634A1 (en) | 2017-12-21 | 2019-06-27 | Ab Enzymes Oy | Variants of Fungal Cellulase |
WO2019121930A1 (en) | 2017-12-20 | 2019-06-27 | Dsm Ip Assets B.V. | Animal feed compositions and uses thereof |
WO2019137289A1 (en) | 2018-01-09 | 2019-07-18 | Novozymes A/S | Use of enzyme in removing airborne particulate matter from textile |
CN110066777A (en) | 2019-04-30 | 2019-07-30 | 江南大学 | A kind of endoinulase and its application in production oligofructose |
CN110093326A (en) | 2019-05-06 | 2019-08-06 | 南京林业大学 | A kind of extracellular AA9 family polysaccharide monooxygenase EpLPMOa and its application |
WO2019154955A1 (en) | 2018-02-08 | 2019-08-15 | Novozymes A/S | Lipase variants and compositions thereof |
WO2019154951A1 (en) | 2018-02-08 | 2019-08-15 | Novozymes A/S | Lipases, lipase variants and compositions thereof |
CN110129301A (en) | 2019-06-17 | 2019-08-16 | 云南师范大学 | The lipase mutant and its application that a kind of catalytic activity improves |
WO2019161227A1 (en) | 2018-02-15 | 2019-08-22 | Novozymes A/S | Improved yeast for ethanol production |
CN110157688A (en) | 2019-05-31 | 2019-08-23 | 江南大学 | A kind of linear maltooligosacchaeides generation enzyme mutant for producing maltopentaose ability and improving |
WO2019163886A1 (en) | 2018-02-26 | 2019-08-29 | 花王株式会社 | MUTANT β-GLUCOSIDASE |
JP2019146520A (en) | 2018-02-27 | 2019-09-05 | 花王株式会社 | Mutant β-glucosidase |
CN110229800A (en) | 2019-06-11 | 2019-09-13 | 江南大学 | A kind of linear maltooligosacchaeides generation enzyme mutant for producing maltose ability and improving |
WO2019180111A1 (en) | 2018-03-23 | 2019-09-26 | Novozymes A/S | Subtilase variants and compositions comprising same |
JP2019165727A (en) | 2018-03-22 | 2019-10-03 | 物産フードサイエンス株式会社 | New application of lipase in dough |
WO2019193102A1 (en) | 2018-04-05 | 2019-10-10 | Dsm Ip Assets B.V. | Variant maltogenic alpha-amylase |
CN110343687A (en) | 2019-07-18 | 2019-10-18 | 南京林业大学 | A kind of Pullulan enzymatic mutant and its application with hypersecretion ability |
WO2019201725A1 (en) | 2018-04-19 | 2019-10-24 | Novozymes A/S | Process for improving freshness of flat breads involving combination of maltogenic alpha amylase variants |
WO2019201785A1 (en) | 2018-04-19 | 2019-10-24 | Novozymes A/S | Stabilized cellulase variants |
WO2019201783A1 (en) | 2018-04-19 | 2019-10-24 | Novozymes A/S | Stabilized cellulase variants |
CN110423737A (en) | 2019-09-10 | 2019-11-08 | 白银赛诺生物科技有限公司 | From the heat resistant type alpha-amylase of Geobacillus stearothermophilus and its application |
WO2019215078A1 (en) | 2018-05-07 | 2019-11-14 | Dsm Ip Assets B.V. | Process for enzymatic oil degumming |
US20190345572A1 (en) | 2017-01-05 | 2019-11-14 | Novozymes Bioag A/S | Lysinibacillus isolates and uses thereof |
DE102018004207A1 (en) | 2018-05-18 | 2019-11-21 | Henkel Ag & Co. Kgaa | Performance-enhanced variants of the alkaline protease from B. lentus |
CN110495549A (en) | 2019-07-05 | 2019-11-26 | 中国农业大学 | A kind of 1,4 beta-glucanase and its application in inhibition Aspergillus ochraceus |
EP3572503A1 (en) | 2018-05-22 | 2019-11-27 | ARKRAY, Inc. | Mutant glucose oxidase and use thereof |
WO2019229228A1 (en) | 2018-05-31 | 2019-12-05 | Novozymes A/S | Method for treating dissolving pulp using lytic polysaccharide monooxygenase |
WO2019228448A1 (en) | 2018-06-01 | 2019-12-05 | Novozymes A/S | Polypeptides |
WO2019236717A1 (en) | 2018-06-05 | 2019-12-12 | Novozymes Bioag A/S | Methods of protecting a plant from insect pests |
CN110577939A (en) | 2018-06-07 | 2019-12-17 | 青岛红樱桃生物技术有限公司 | glucose oxidase mutant with improved heat resistance as well as coding gene and application thereof |
WO2019238761A1 (en) | 2018-06-15 | 2019-12-19 | Basf Se | Water soluble multilayer films containing wash active chemicals and enzymes |
CN110592034A (en) | 2019-08-06 | 2019-12-20 | 广东溢多利生物科技股份有限公司 | Glucose oxidase mutant and carrier and application thereof |
CN110592051A (en) | 2019-10-14 | 2019-12-20 | 北京工商大学 | Mutant of xylanase T-Xyn and application thereof |
WO2019245838A1 (en) | 2018-06-19 | 2019-12-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2019245839A1 (en) | 2018-06-19 | 2019-12-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2019245704A1 (en) | 2018-06-19 | 2019-12-26 | Danisco Us Inc | Subtilisin variants |
WO2019245705A1 (en) | 2018-06-19 | 2019-12-26 | Danisco Us Inc | Subtilisin variants |
CN110628738A (en) | 2019-09-27 | 2019-12-31 | 华东理工大学 | Method for improving activity of glucose oxidase, mutant and application thereof |
US20200000098A1 (en) | 2017-01-04 | 2020-01-02 | Novozymes Bioag A/S | Bacillus isolates and uses thereof |
WO2020002255A1 (en) | 2018-06-29 | 2020-01-02 | Novozymes A/S | Subtilase variants and compositions comprising same |
WO2020002574A1 (en) | 2018-06-28 | 2020-01-02 | Novozymes A/S | Enzymatic processing of sugar beets |
WO2020007875A1 (en) | 2018-07-03 | 2020-01-09 | Novozymes A/S | Cleaning compositions and uses thereof |
WO2020007863A1 (en) | 2018-07-02 | 2020-01-09 | Novozymes A/S | Cleaning compositions and uses thereof |
WO2020014407A1 (en) | 2018-07-11 | 2020-01-16 | Novozymes A/S | Processes for producing fermentation products |
WO2020016728A1 (en) | 2018-07-16 | 2020-01-23 | Upl Ltd | Gas releasing composition and process of preparation thereof |
WO2020016154A1 (en) | 2018-07-16 | 2020-01-23 | Xeda International S.A. | Extended-release essential oil formulation, and method for treating plant products using said formulation |
US20200022719A1 (en) | 2017-08-17 | 2020-01-23 | GYRUS ACMI, INC., d/b/a Olympus Surgical Technologies America | Forceps with tissue stops |
CN110724646A (en) | 2018-07-16 | 2020-01-24 | 青岛蔚蓝生物集团有限公司 | Pichia pastoris strain and application thereof in xylanase production |
CN110724645A (en) | 2018-07-16 | 2020-01-24 | 青岛蔚蓝生物集团有限公司 | Pichia pastoris mutant strain and application thereof |
WO2020023411A1 (en) | 2018-07-25 | 2020-01-30 | Novozymes A/S | Enzyme-expressing yeast for ethanol production |
CN110746494A (en) | 2019-09-27 | 2020-02-04 | 深圳市诺维健生物技术有限责任公司 | A group of special dietary proteins |
WO2020028443A1 (en) | 2018-07-31 | 2020-02-06 | Danisco Us Inc | Variant alpha-amylases having amino acid substitutions that lower the pka of the general acid |
CN110760531A (en) | 2019-11-08 | 2020-02-07 | 广西中烟工业有限责任公司 | Method for splicing intron in pectinase gene |
CN110777136A (en) | 2019-11-26 | 2020-02-11 | 山西大学 | Alkaline protease mutant for washing and application thereof in liquid detergent |
US10563185B1 (en) | 2019-03-25 | 2020-02-18 | Dongguan APAC Biotechnology Co., Ltd. | Beta-glucosidase having improved enzymatic activity |
US20200055794A1 (en) | 2018-08-16 | 2020-02-20 | Anuvia Plant Nutrients Corporation | Reactive Inorganic Coatings for Agricultural Fertilizers |
CN110819612A (en) | 2019-11-29 | 2020-02-21 | 天津科技大学 | Screening of novel autocleavage-resistant alkaline protease |
US20200060300A1 (en) | 2017-03-22 | 2020-02-27 | Xeda International S.A. | Process for treatment by at least one moderately volatile biocidal and/or plant-protection product, corresponding treatment assembly and storage assembly |
WO2020046613A1 (en) | 2018-08-30 | 2020-03-05 | Danisco Us Inc | Compositions comprising a lipolytic enzyme variant and methods of use thereof |
CN110862979A (en) | 2020-01-20 | 2020-03-06 | 中国科学院天津工业生物技术研究所 | Mutant of alkaline protease and application thereof |
CN110885801A (en) | 2019-11-25 | 2020-03-17 | 中国海洋大学 | Glucose oxidase M5GOD and coding gene and application thereof |
WO2020053276A1 (en) | 2018-09-11 | 2020-03-19 | Dsm Ip Assets B.V. | Animal feed composition and use thereof |
WO2020058228A1 (en) | 2018-09-17 | 2020-03-26 | Dsm Ip Assets B.V. | Animal feed compositions and uses thereof |
CN110923221A (en) | 2019-12-13 | 2020-03-27 | 中国科学院天津工业生物技术研究所 | Novel alkaline protease high-temperature mutant from bacillus licheniformis |
CN110923222A (en) | 2019-12-13 | 2020-03-27 | 中国科学院天津工业生物技术研究所 | Novel alkaline protease acid mutant from bacillus licheniformis |
CN110951628A (en) | 2019-12-30 | 2020-04-03 | 乐陵胜利新能源有限责任公司 | Construction method and application of trichoderma reesei engineering strain with high β -glucosidase activity for straw degradation |
WO2020070199A1 (en) | 2018-10-03 | 2020-04-09 | Novozymes A/S | Polypeptides having alpha-mannan degrading activity and polynucleotides encoding same |
CN111004786A (en) | 2019-12-25 | 2020-04-14 | 广东溢多利生物科技股份有限公司 | Glucose oxidase and carrier and application thereof |
CN111004794A (en) | 2019-12-30 | 2020-04-14 | 江南大学 | Subtilisin E mutant with improved thermal stability and application thereof |
WO2020076697A1 (en) | 2018-10-08 | 2020-04-16 | Novozymes A/S | Enzyme-expressing yeast for ethanol production |
WO2020077331A2 (en) | 2018-10-12 | 2020-04-16 | Danisco Us Inc | Alpha-amylases with mutations that improve stability in the presence of chelants |
WO2020086430A2 (en) | 2018-10-22 | 2020-04-30 | Dupont Nutrition Biosciences Aps | Enzymes for infusion mashing in adjunct brewing technical field |
JP2020065514A (en) | 2018-10-26 | 2020-04-30 | 花王株式会社 | Novel arabinofuranosidase |
WO2020088393A1 (en) | 2018-10-31 | 2020-05-07 | 青岛蔚蓝生物集团有限公司 | Method for producing washing enzyme having protease resistance |
WO2020096905A1 (en) | 2018-11-07 | 2020-05-14 | Firmenich Incorporated | Methods for making high intensity sweeteners |
US20200148605A1 (en) | 2018-11-14 | 2020-05-14 | Anuvia Plant Nutrients Corporation | Delivery of Bioactive Molecules in Coatings or Surface Layers of Organically Enhanced Inorganic Fertilizers |
WO2020096907A1 (en) | 2018-11-07 | 2020-05-14 | Firmenich Incorporated | Methods for making high intensity sweeteners |
EP3653705A1 (en) | 2018-11-13 | 2020-05-20 | AB Enzymes Oy | Fungal cellulase variants with improved stability |
EP3653706A1 (en) | 2018-11-13 | 2020-05-20 | AB Enzymes Oy | Fusion protein |
WO2020106600A1 (en) | 2018-11-19 | 2020-05-28 | Basf Se | Leader sequence for yeast |
WO2020103861A1 (en) | 2018-11-21 | 2020-05-28 | Novozymes A/S | Polypeptides having lipase activity and use thereof for wheat separation |
EP3660146A1 (en) | 2018-11-29 | 2020-06-03 | Henkel AG & Co. KGaA | Storage stable protease variants with improved performance |
EP3660151A1 (en) | 2018-11-29 | 2020-06-03 | Henkel AG & Co. KGaA | Storage stable protease variants with improved performance |
WO2020112599A1 (en) | 2018-11-28 | 2020-06-04 | Danisco Us Inc | Subtilisin variants having improved stability |
WO2020114965A1 (en) | 2018-12-03 | 2020-06-11 | Novozymes A/S | LOW pH POWDER DETERGENT COMPOSITION |
WO2020114968A1 (en) | 2018-12-03 | 2020-06-11 | Novozymes A/S | Powder detergent compositions |
US20200181593A1 (en) | 2001-05-15 | 2020-06-11 | Novozymes A/S | Alpha-amylase variant with altered properties |
WO2020115179A1 (en) | 2018-12-05 | 2020-06-11 | Novozymes A/S | Use of an enzyme granule |
WO2020123463A1 (en) | 2018-12-12 | 2020-06-18 | Novozymes A/S | Polypeptides having xylanase activity and polynucleotides encoding same |
WO2020131691A2 (en) | 2018-12-17 | 2020-06-25 | Gro Biosciences Inc. | Diselenide-stabilized feed enzymes |
WO2020125700A1 (en) | 2018-12-20 | 2020-06-25 | 南京百斯杰生物工程有限公司 | Glucose oxidase mutant and use thereof in industrial production |
WO2020127775A1 (en) | 2018-12-21 | 2020-06-25 | Novozymes A/S | Detergent pouch comprising metalloproteases |
CN111334494A (en) | 2019-10-09 | 2020-06-26 | 天津科技大学 | Screening of novel high-stability alkaline protease mutants |
WO2020135657A1 (en) | 2018-12-28 | 2020-07-02 | 丰益(上海)生物技术研发中心有限公司 | Phospholipase c mutant with high enzyme activity |
WO2020135658A1 (en) | 2018-12-28 | 2020-07-02 | 丰益(上海)生物技术研发中心有限公司 | Polypeptide having phospholipase c activity and use thereof |
CN111369138A (en) | 2020-03-03 | 2020-07-03 | 浙江中控技术股份有限公司 | Method and device for generating job form |
CN111378583A (en) | 2018-12-27 | 2020-07-07 | 青岛蔚蓝生物集团有限公司 | Trichoderma reesei and application thereof |
US20200221719A1 (en) | 2017-06-28 | 2020-07-16 | Xeda International S.A. | Treatment unit and method, unit for storing and culturing plant products comprising the treatment unit |
CN111454929A (en) | 2019-01-22 | 2020-07-28 | 中国农业大学 | High-temperature-resistant xylanase gene and application thereof |
WO2020154387A1 (en) | 2019-01-23 | 2020-07-30 | Spogen Biotech Inc. | Compositions for treating citrus disease and promoting yield increase in row crops |
WO2020156903A1 (en) | 2019-01-30 | 2020-08-06 | Novozymes A/S | Cognate foldase co-expression |
WO2020157714A1 (en) | 2019-02-01 | 2020-08-06 | Decco Worldwide Post-Harvest Holdings B.V. | Multilayer structure for active packaging, process and method of using the same |
WO2020156419A1 (en) | 2019-01-28 | 2020-08-06 | Novozymes A/S | Subtilase variants and compositions comprising same |
CN111500558A (en) | 2019-01-31 | 2020-08-07 | 东莞泛亚太生物科技有限公司 | Glucosidase with enhanced activity |
CN111518792A (en) | 2020-05-26 | 2020-08-11 | 江西师范大学 | Beta-glucosidase mutant TLE of penicillium oxalicum 16 and application thereof |
US20200263734A1 (en) | 2019-02-19 | 2020-08-20 | Schaeffler Technologies AG & Co. KG | Electrically isolated non-sealed bearing |
CN111575265A (en) | 2020-05-22 | 2020-08-25 | 江南大学 | Keratinase mutant with improved thermal stability |
WO2020169564A1 (en) | 2019-02-20 | 2020-08-27 | Basf Se | Industrial fermentation process for bacillus using defined medium and trace element feed |
WO2020169840A1 (en) | 2019-02-21 | 2020-08-27 | Cambridge Enterprise Limited | Bispecific proteins with a chimeric scaffold |
WO2020176443A1 (en) | 2019-02-25 | 2020-09-03 | Dupont Nutrition Biosciences Aps | Protein hydrolysates with increased yield of n-terminal amino acid |
WO2020173817A1 (en) | 2019-02-28 | 2020-09-03 | Novozymes A/S | Calcite binding proteins |
WO2020174070A1 (en) | 2019-02-27 | 2020-09-03 | Cyca Oncosolutions Limited | Cell membrane penetrating conjugates for gene editing |
CN111621490A (en) | 2020-05-26 | 2020-09-04 | 江西师范大学 | Beta-glucosidase mutant SVS of penicillium oxalicum 16 and application thereof |
WO2020188095A1 (en) | 2019-03-21 | 2020-09-24 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2020187883A1 (en) | 2019-03-18 | 2020-09-24 | Novozymes A/S | Polypeptides having pullulanase activity suitable for use in liquefaction |
WO2020190782A1 (en) | 2019-03-15 | 2020-09-24 | Danisco Us Inc | Improved lipase for defoaming |
WO2020193532A1 (en) | 2019-03-25 | 2020-10-01 | Basf Se | Cleaning composition having amylase enzymes |
WO2020193534A2 (en) | 2019-03-25 | 2020-10-01 | Basf Se | Amylase enzymes |
WO2020193535A2 (en) | 2019-03-25 | 2020-10-01 | Basf Se | Amylase enzymes |
WO2020200322A1 (en) | 2019-04-05 | 2020-10-08 | Novozymes A/S | Redox enzymes in animal feed compositions |
WO2020200234A1 (en) | 2019-04-01 | 2020-10-08 | Beijing Bytedance Network Technology Co., Ltd. | Alternative interpolation filters in video coding |
WO2020200321A1 (en) | 2019-04-05 | 2020-10-08 | Novozymes A/S | Redox enzymes in animal feed compositions |
WO2020200198A1 (en) | 2019-04-02 | 2020-10-08 | Novozymes A/S | Liquid dishwashing detergent compositions |
WO2020201403A1 (en) | 2019-04-03 | 2020-10-08 | Novozymes A/S | Polypeptides having beta-glucanase activity, polynucleotides encoding same and uses thereof in cleaning and detergent compositions |
WO2020207944A1 (en) | 2019-04-10 | 2020-10-15 | Novozymes A/S | Polypeptide variants |
WO2020208056A1 (en) | 2019-04-12 | 2020-10-15 | Novozymes A/S | Stabilized glycoside hydrolase variants |
CN111793613A (en) | 2019-04-09 | 2020-10-20 | 青岛蔚蓝生物集团有限公司 | Low-temperature cellulase mutant and application thereof |
CN111826377A (en) | 2020-07-30 | 2020-10-27 | 吉林中粮生化有限公司 | Signal peptide for promoting pullulanase extracellular expression |
DE102019111057A1 (en) | 2019-04-29 | 2020-10-29 | Henkel Ag & Co. Kgaa | Proteases with improved enzyme stability in detergents and cleaning agents III |
DE102019111075A1 (en) | 2019-04-29 | 2020-10-29 | Henkel Ag & Co. Kgaa | Improved cleaning performance against protein-sensitive soiling VI |
DE102019111047A1 (en) | 2019-04-29 | 2020-10-29 | Henkel Ag & Co. Kgaa | Improved cleaning performance against protein-sensitive soiling V |
CN111893126A (en) | 2020-07-01 | 2020-11-06 | 深圳润康生态环境股份有限公司 | Alkaline protease gene, alkaline protease, preparation method and application thereof |
CN111909979A (en) | 2019-05-09 | 2020-11-10 | 武汉英凯生物技术研究院有限公司 | Preparation method of L-glufosinate-ammonium |
WO2020225276A1 (en) | 2019-05-08 | 2020-11-12 | Bayer Aktiengesellschaft | Agrochemical formulation with enhanced performance and enhanced performance at low spray volumes and by uav application |
US20200352183A1 (en) | 2017-11-15 | 2020-11-12 | Xeda International S.A. | Process and assembly for the treatment of the atmosphere of a storage of plant products with high relative humidity |
WO2020225066A1 (en) | 2019-05-03 | 2020-11-12 | Xeda International S.A. | Method and assembly for treating a store of plant products at low temperature and high relative humidity |
JP2020184937A (en) | 2019-05-15 | 2020-11-19 | 雪印種苗株式会社 | Compositions and mutant strains with enhanced cellulose degrading ability |
WO2020243738A1 (en) | 2019-05-24 | 2020-12-03 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2020239064A1 (en) | 2019-05-31 | 2020-12-03 | 南京百斯杰生物工程有限公司 | Thermostable glucose oxidase |
CN112063678A (en) | 2020-09-21 | 2020-12-11 | 中国药科大学 | Biosynthesis method of Siamenoside I |
CN112111468A (en) | 2020-09-23 | 2020-12-22 | 江南大学 | Gamma-glutamine transpeptidase mutant and application thereof |
WO2020254336A1 (en) | 2019-06-21 | 2020-12-24 | Ecole Polytechnique Federale De Lausanne (Epfl) | Sensing platform |
CN112143717A (en) | 2019-06-26 | 2020-12-29 | 青岛蔚蓝生物集团有限公司 | Glucose oxidase mutant with improved specific activity |
WO2020264552A1 (en) | 2019-06-24 | 2020-12-30 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants |
WO2020260223A1 (en) | 2019-06-24 | 2020-12-30 | Novozymes A/S | Alpha-amylase variants |
CN112175976A (en) | 2020-11-12 | 2021-01-05 | 武汉轻工大学 | High-temperature-resistant lipase gene tllgold and application thereof |
US20210015105A1 (en) | 2014-09-17 | 2021-01-21 | Basf Corporation | Compositions comprising recombinant bacillus cells and another biological control agent |
WO2021013685A1 (en) | 2019-07-22 | 2021-01-28 | Henkel Ag & Co. Kgaa | Dishwashing agent with bleaching catalyst and bacillus gibsonii protease |
DE102019210806A1 (en) | 2019-07-22 | 2021-01-28 | Henkel Ag & Co. Kgaa | Laundry detergent with a Bacillus gibsonii protease |
WO2021013686A1 (en) | 2019-07-22 | 2021-01-28 | Henkel Ag & Co. Kgaa | Protease-containing cleaning agent for automatic metering |
CN112301023A (en) | 2020-11-14 | 2021-02-02 | 山西大学 | 2709 alkaline protease mutant modified based on molecular dynamics calculation and application thereof |
WO2021018321A2 (en) | 2019-07-31 | 2021-02-04 | Centro De Ingenieria Genetica Y Biotecnologia | Biopesticide and biofertiliser composition |
CN112342208A (en) | 2020-12-01 | 2021-02-09 | 天津科技大学 | Pullulanase mutant |
WO2021025872A1 (en) | 2019-08-06 | 2021-02-11 | Novozymes A/S | Fusion proteins for improved enzyme expression |
WO2021026201A1 (en) | 2019-08-05 | 2021-02-11 | Novozymes A/S | Enzyme blends and processes for producing a high protein feed ingredient from a whole stillage byproduct |
WO2021030400A1 (en) | 2019-08-13 | 2021-02-18 | Novozymes Bioag A/S | Pesticidal combinations of yersinia and proteases |
WO2021032881A1 (en) | 2019-08-22 | 2021-02-25 | Basf Se | Amylase variants |
WO2021037878A1 (en) | 2019-08-27 | 2021-03-04 | Novozymes A/S | Composition comprising a lipase |
CN112458072A (en) | 2020-12-21 | 2021-03-09 | 山东隆科特酶制剂有限公司 | Alkaline protease mutant and preparation thereof |
CN112501149A (en) | 2020-12-21 | 2021-03-16 | 天津科技大学 | Alkaline protease mutant and gene, engineering bacterium, preparation method and application thereof |
CN112522227A (en) | 2020-12-21 | 2021-03-19 | 广东溢多利生物科技股份有限公司 | Catalase with high enzyme activity, gene, recombinant strain with high catalase yield and application |
CN112522238A (en) | 2020-12-30 | 2021-03-19 | 浙江大学 | Method for producing amylase by using transgenic corn |
WO2021055316A1 (en) | 2019-09-16 | 2021-03-25 | Eastman Chemical Company | Agricultural inert package formulation containing a sulfopolymer |
WO2021055395A1 (en) | 2019-09-16 | 2021-03-25 | Novozymes A/S | Polypeptides having beta-glucanase activity and polynucleotides encoding same |
CN112552382A (en) | 2020-01-22 | 2021-03-26 | 天津科技大学 | Signal peptide mutant and application thereof |
CN112574978A (en) | 2021-01-19 | 2021-03-30 | 青岛尚德生物技术有限公司 | Protease mutant capable of improving alcohol-soluble protein degradation capacity and coding gene and application thereof |
WO2021058022A1 (en) | 2019-09-29 | 2021-04-01 | Novozymes A/S | Use of cellulase for improvement of sustainability of detergents |
US20210102245A1 (en) | 2017-04-28 | 2021-04-08 | Spartan Bioscience Inc. | Direct nucleic acid analysis of environmental and biological samples |
CN112662653A (en) | 2021-01-26 | 2021-04-16 | 江南大学 | Keratinase mutant with improved low-temperature enzymolysis performance and application thereof |
CN112662652A (en) | 2021-01-20 | 2021-04-16 | 天津科技大学 | Alkaline protease mutant with reduced collagen degradation activity |
CN112680433A (en) | 2019-10-18 | 2021-04-20 | 清华大学 | Method for producing and secreting protein by using halophilic bacteria |
US20210122998A1 (en) | 2019-10-24 | 2021-04-29 | The Procter & Gamble Company | Automatic dishwashing detergent composition comprising an amylase |
WO2021080948A2 (en) | 2019-10-24 | 2021-04-29 | Danisco Us Inc | Variant maltopentaose/maltohexaose-forming alpha-amylases |
US20210122997A1 (en) | 2019-10-24 | 2021-04-29 | The Procter & Gamble Company | Automatic dishwashing detergent composition comprising a protease |
CN112760299A (en) | 2021-02-06 | 2021-05-07 | 江南大学 | Glucose oxidase mutant with improved thermal stability as well as coding gene and application thereof |
CN112795555A (en) | 2019-11-13 | 2021-05-14 | 青岛蔚蓝生物集团有限公司 | High-specific-activity cellulase mutant and application thereof |
CN112795554A (en) | 2019-11-13 | 2021-05-14 | 青岛蔚蓝生物集团有限公司 | Low temperature resistant cellulase mutant |
WO2021101937A1 (en) | 2019-11-20 | 2021-05-27 | Novozymes Bioag A/S | Pseudomonas isolates and uses thereof |
WO2021101949A1 (en) | 2019-11-22 | 2021-05-27 | Novozymes Bioag A/S | Paenibacillus isolates and uses thereof |
WO2021099457A1 (en) | 2019-11-22 | 2021-05-27 | Novozymes A/S | Method for obtaining an oat-based product |
CN112877306A (en) | 2021-04-28 | 2021-06-01 | 中国农业科学院北京畜牧兽医研究所 | Super heat-resistant glucose oxidase AtGOD, gene and application thereof |
US20210163995A1 (en) | 2019-11-29 | 2021-06-03 | Lallemand Hungary Liquidity Management Llc | Process for displacing an exogenous enzyme |
WO2021119304A1 (en) | 2019-12-10 | 2021-06-17 | Novozymes A/S | Microorganism for improved pentose fermentation |
WO2021123184A2 (en) | 2019-12-19 | 2021-06-24 | Novozymes A/S | Alpha-amylase variants |
WO2021122120A2 (en) | 2019-12-20 | 2021-06-24 | Henkel Ag & Co. Kgaa | Cleaning compositions comprising dispersins viii |
WO2021127319A1 (en) | 2019-12-19 | 2021-06-24 | The Procter & Gamble Company | Cleaning compositions comprising polypeptides having alpha amylase activity |
CN113025595A (en) | 2019-12-25 | 2021-06-25 | 丰益(上海)生物技术研发中心有限公司 | Acid-tolerant lipases |
CN113025596A (en) | 2019-12-25 | 2021-06-25 | 丰益(上海)生物技术研发中心有限公司 | Methanol-tolerant lipase |
WO2021133701A1 (en) | 2019-12-23 | 2021-07-01 | The Procter & Gamble Company | Compositions comprising enzymes |
WO2021133658A1 (en) | 2019-12-23 | 2021-07-01 | Cargill, Incorporated | Fermentation method and uses thereof |
WO2021130167A1 (en) | 2019-12-23 | 2021-07-01 | Novozymes A/S | Enzyme compositions and uses thereof |
CN113061189A (en) | 2020-10-09 | 2021-07-02 | 山东省科学院生物研究所 | Biosensor based on specific binding of CBM and cellulose |
CN113122520A (en) | 2019-12-30 | 2021-07-16 | 丰益(上海)生物技术研发中心有限公司 | Novel glycerol mono-diacyl ester lipase |
WO2021144342A1 (en) | 2020-01-14 | 2021-07-22 | The Protein Brewery B.V. | Expression of ovalbumin and its natural variants |
CN113151327A (en) | 2021-04-23 | 2021-07-23 | 广西大学 | Mutant of bacillus cereus high-yield maltopentaose alpha-amylase and application thereof |
WO2021148364A1 (en) | 2020-01-23 | 2021-07-29 | Novozymes A/S | Enzyme compositions and uses thereof |
WO2021152123A1 (en) | 2020-01-31 | 2021-08-05 | Novozymes A/S | Mannanase variants and polynucleotides encoding same |
WO2021152120A1 (en) | 2020-01-31 | 2021-08-05 | Novozymes A/S | Mannanase variants and polynucleotides encoding same |
US20210238201A1 (en) | 2020-02-05 | 2021-08-05 | Agrofresh Inc. | Antimicrobial compounds and compositions |
CN113215130A (en) | 2021-05-11 | 2021-08-06 | 集美大学 | Phospholipase C mutant, preparation method and application thereof |
CN113234705A (en) | 2021-04-21 | 2021-08-10 | 江南大学 | Acid-tolerant 1,3-1, 4-beta-glucanase mutants |
WO2021163030A2 (en) | 2020-02-10 | 2021-08-19 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
WO2021163036A1 (en) | 2020-02-10 | 2021-08-19 | Novozymes A/S | Raw starch hydrolysis process for producing a fermentation product |
WO2021170799A1 (en) | 2020-02-28 | 2021-09-02 | Chr. Hansen A/S | Lipases, compositions, methods and uses thereof |
CN113338044A (en) | 2021-05-31 | 2021-09-03 | 江南大学 | Method for modifying terylene based on Humicola insolens cutinase |
DE102020105721A1 (en) | 2020-03-03 | 2021-09-09 | Henkel Ag & Co. Kgaa | Performance-Enhanced Protease Variants VII |
DE102020105720A1 (en) | 2020-03-03 | 2021-09-09 | Henkel Ag & Co. Kgaa | Stability-improved protease variants VI |
CN113403290A (en) | 2021-05-26 | 2021-09-17 | 广东溢多利生物科技股份有限公司 | Glucose oxidase mutant with improved thermal stability as well as coding gene and application thereof |
US20210292688A1 (en) | 2020-03-20 | 2021-09-23 | Danstar Ferment Ag | Beta-glucosidase expressing yeast for enhanced flavor and aroma in beverage production |
US20210300837A1 (en) | 2018-08-27 | 2021-09-30 | Syngenta Crop Protection Ag | Fertilizer pouch |
WO2021202479A1 (en) | 2020-04-03 | 2021-10-07 | Novozymes A/S | Submerged fermentation process |
WO2021204838A1 (en) | 2020-04-08 | 2021-10-14 | Novozymes A/S | Carbohydrate binding module variants |
WO2021212095A1 (en) | 2020-04-17 | 2021-10-21 | Danisco Us Inc. | Glucoamylase and methods of use thereof |
WO2021209548A1 (en) | 2020-04-15 | 2021-10-21 | Henlez Aps | Compositions and methods for treating hair follicle-linked conditions |
CN113528476A (en) | 2021-08-20 | 2021-10-22 | 福建福大百特生物科技有限公司 | Glucose oxidase mutant and coding gene and efficient recombinant expression thereof |
CN113528493A (en) | 2021-05-28 | 2021-10-22 | 江南大学 | Keratinase mutant with improved thermal stability and application thereof |
WO2021214059A1 (en) | 2020-04-21 | 2021-10-28 | Novozymes A/S | Cleaning compositions comprising polypeptides having fructan degrading activity |
CN113584075A (en) | 2021-08-31 | 2021-11-02 | 浙江大学 | Method for producing alpha-amylase by using transgenic soybean and expression vector |
DE102020205381A1 (en) | 2020-04-29 | 2021-11-04 | Henkel Ag & Co. Kgaa | Highly alkaline laundry detergent with protease |
DE102020205400A1 (en) | 2020-04-29 | 2021-11-04 | Henkel Ag & Co. Kgaa | Highly alkaline laundry detergent with protease |
WO2021231623A1 (en) | 2020-05-13 | 2021-11-18 | Novozymes A/S | Engineered microorganism for improved pentose fermentation |
WO2021230359A1 (en) | 2020-05-15 | 2021-11-18 | Jnc株式会社 | Antiviral agent |
WO2021231621A1 (en) | 2020-05-13 | 2021-11-18 | Novozymes A/S | Improved microorganisms for arabinose fermentation |
CN113667662A (en) | 2021-07-05 | 2021-11-19 | 南京纽田科技有限公司 | Construction of high-performance starch debranching enzyme chimera strain, production method and application thereof |
WO2021233900A1 (en) | 2020-05-19 | 2021-11-25 | Xeda International S.A. | Novel method for treating fruits and vegetables |
WO2021236715A1 (en) | 2020-05-21 | 2021-11-25 | Dupont Nutrition Biosciences Aps | Unihibited amylases for brewing with high tannin materials |
CN113717864A (en) | 2018-01-30 | 2021-11-30 | 青岛蔚蓝生物集团有限公司 | Cellulase high-yield strain and application thereof |
WO2021239267A1 (en) | 2020-05-29 | 2021-12-02 | Novozymes A/S | Pulse and/or legume protein-fortified doughs and baked goods comprising lipase |
CN113736817A (en) | 2021-10-08 | 2021-12-03 | 枣庄市杰诺生物酶有限公司 | Method for improving secretion efficiency and enzyme activity of alkaline lipase in pichia pastoris |
CN113755509A (en) | 2021-10-11 | 2021-12-07 | 南京正扬生物科技有限公司 | Lysophospholipase variant, construction method thereof and expression in aspergillus niger strain |
WO2021247915A1 (en) | 2020-06-03 | 2021-12-09 | Sound Agriculture Company | Compounds and methods for stimulating plants |
WO2021248045A2 (en) | 2020-06-04 | 2021-12-09 | California Institute Of Technology | Novel signal peptides generated by attention-based neural networks |
CN113817709A (en) | 2021-08-12 | 2021-12-21 | 中国科学院天津工业生物技术研究所 | Carbohydrate-binding domain CBM68 and uses thereof |
WO2021255118A1 (en) | 2020-06-18 | 2021-12-23 | Bayer Aktiengesellschaft | Composition for use in agriculture |
CN113832131A (en) | 2021-10-05 | 2021-12-24 | 上海佶凯星生物科技有限公司 | High-stability alkaline protease mutant and application thereof in liquid detergent |
CN113832130A (en) | 2021-10-05 | 2021-12-24 | 上海佶凯星生物科技有限公司 | Alkaline protease mutant for washing and application thereof in liquid detergent |
CN113846074A (en) | 2021-10-20 | 2021-12-28 | 南京林业大学 | Thermomyces lanuginosus lipase mutant G91C and application thereof |
CN113862233A (en) | 2021-12-03 | 2021-12-31 | 中国农业科学院北京畜牧兽医研究所 | Method for improving acid stability of glucose oxidase, mutant Q241E/R499E, gene and application |
CN113862244A (en) | 2021-10-05 | 2021-12-31 | 上海佶凯星生物科技有限公司 | High-specific-activity alkaline protease mutant and application thereof in liquid detergent |
CN113881654A (en) | 2021-09-08 | 2022-01-04 | 暨南大学 | Alpha-amylase with improved resistance to pepsin |
WO2022014428A1 (en) | 2020-07-15 | 2022-01-20 | 花王株式会社 | Amylase-incorporated cleaning agent composition |
WO2022020665A2 (en) | 2020-07-23 | 2022-01-27 | Kiwi Health, Inc | Food supplement composition to aid in digestion of fructan, mannitol, and sorbitol |
WO2022029221A1 (en) | 2020-08-05 | 2022-02-10 | Syngenta Crop Protection Ag | Agricultural formulations having improved compatibility with liquid fertilizers |
WO2022029293A1 (en) | 2020-08-07 | 2022-02-10 | Novozymes A/S | Controlled enzymatic browning of a non-meat protein containing material comprising pigment and laccase |
WO2022029224A1 (en) | 2020-08-05 | 2022-02-10 | Syngenta Crop Protection Ag | Methods for improving the compatibility of crop protection formulations and tank mix applications with liquid fertilizers |
CN114058637A (en) | 2021-03-31 | 2022-02-18 | 山西大禹生物工程股份有限公司 | Efficient expression method of aspergillus niger glucose oxidase gene |
CN114107266A (en) | 2021-11-29 | 2022-03-01 | 青岛尚德生物技术有限公司 | Protease mutant with improved heat resistance, and coding gene and application thereof |
WO2022047264A1 (en) | 2020-08-28 | 2022-03-03 | Codexis, Inc. | Engineered amylase variants |
WO2022043273A2 (en) | 2020-08-24 | 2022-03-03 | Novozymes A/S | Oral care composition comprising a fructanase |
WO2022043563A1 (en) | 2020-08-28 | 2022-03-03 | Novozymes A/S | Polyester degrading protease variants |
WO2022043745A1 (en) | 2020-08-28 | 2022-03-03 | Kerry Luxembourg S.a.r.l. | Feed composition supplemented with a protease combination comprising neutral metalloprotease and serine alkaline protease at a given ratio |
WO2022044629A1 (en) | 2020-08-31 | 2022-03-03 | 花王株式会社 | α-AMYLASE VARIANT |
WO2022051661A1 (en) | 2020-09-03 | 2022-03-10 | Drexel University | Use of erythritol compositions as mammal-safe insecticides |
WO2022049139A1 (en) | 2020-09-02 | 2022-03-10 | Xeda International S.A. | Method for protecting plant products during transport, and corresponding treatment device |
CN114181916A (en) | 2021-11-16 | 2022-03-15 | 华东师范大学 | Artificially modified enzyme based on glucose oxidase and expression application thereof |
JP2022045888A (en) | 2020-09-09 | 2022-03-22 | 株式会社バイオインテグレンス | Method for preventing infection of coronavirus |
US20220087261A1 (en) | 2021-12-01 | 2022-03-24 | Syngenta Crop Protection Ag | Post-Harvest Fungicidal Uses |
WO2022063699A1 (en) | 2020-09-22 | 2022-03-31 | Basf Se | Improved combination of protease and protease inhibitor with secondary enzyme |
WO2022071451A1 (en) | 2020-10-02 | 2022-04-07 | 花王株式会社 | α-AMYLASE VARIANT |
CN114317490A (en) | 2021-12-03 | 2022-04-12 | 南通常佑药业科技有限公司 | Thermomyces lanuginosus lipase mutant and encoding gene thereof |
CN114317502A (en) | 2021-12-06 | 2022-04-12 | 江南大学 | Nattokinase mutant with high activity and high thermal stability |
WO2022074170A1 (en) | 2020-10-07 | 2022-04-14 | Novozymes A/S | Enzymatic preservation of probiotics in animal feed |
WO2022074037A2 (en) | 2020-10-07 | 2022-04-14 | Novozymes A/S | Alpha-amylase variants |
CN114350637A (en) | 2021-12-01 | 2022-04-15 | 武汉金科天成科技有限公司 | Endo-type inuunit of inulinase, preparation method and application thereof |
CN114369588A (en) | 2020-10-14 | 2022-04-19 | 潍坊康地恩生物科技有限公司 | Neutral cellulase mutant and application thereof |
EP3984368A1 (en) | 2020-10-13 | 2022-04-20 | Mühlenchemie GmbH & Co. KG | Enzymatically stabilized pasta structure and method of preparing the same |
CN114395540A (en) | 2022-01-25 | 2022-04-26 | 华南理工大学 | Application of aspergillus guani glucose oxidase in improving flour processing quality |
CN114395541A (en) | 2022-02-22 | 2022-04-26 | 广东溢多利生物科技股份有限公司 | Glucose oxidase mutant GOx1-MUT with improved thermal stability and specific activity, and coding gene and application thereof |
WO2022090361A2 (en) | 2020-10-29 | 2022-05-05 | Novozymes A/S | Lipase variants and compositions comprising such lipase variants |
WO2022094214A1 (en) | 2020-10-30 | 2022-05-05 | Agrofresh Inc. | Treatment and system for cannabis plant species applications with ethylene inhibitors |
WO2022089571A1 (en) | 2020-10-30 | 2022-05-05 | Novozymes A/S | Detergent composition and cleaning method |
CN114457056A (en) | 2022-01-25 | 2022-05-10 | 华南理工大学 | Application of lactobacillus salinus xylanase in improvement of flour processing quality |
WO2022096691A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift, uptake and rainfastness properties |
WO2022096694A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading and ulv tank mix adjuvant formulation |
WO2022096693A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Low drift, rainfastness, high uptake and ulv tank mix adjuvant formulation |
WO2022096688A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift, spreading and rainfastness properties |
WO2022096695A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading, high uptake and ulv tank mix adjuvant formulation |
WO2022096692A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift, spreading, uptake and rainfastness properties |
WO2022096696A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading, high uptake and ulv tank mix adjuvant formulation |
US20220154236A1 (en) | 2020-11-18 | 2022-05-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Recombinant endoxylanases and related compositions and methods of use |
WO2022103725A1 (en) | 2020-11-13 | 2022-05-19 | Novozymes A/S | Detergent composition comprising a lipase |
EP4001389A1 (en) | 2016-12-02 | 2022-05-25 | The Procter & Gamble Company | Cleaning compositions including enzymes |
WO2022106400A1 (en) | 2020-11-18 | 2022-05-27 | Novozymes A/S | Combination of immunochemically different proteases |
CN114540330A (en) | 2022-04-21 | 2022-05-27 | 深圳润康生态环境股份有限公司 | Alkaline protease mutant AprBpM and application thereof |
CN114561375A (en) | 2020-04-27 | 2022-05-31 | 青岛尚德生物技术有限公司 | Protease mutant BLAPR2 with improved heat stability and coding gene and application thereof |
CN114574469A (en) | 2022-03-21 | 2022-06-03 | 江南大学 | Keratinase mutant based on directed evolution transformation and application thereof |
US20220177812A1 (en) | 2017-09-27 | 2022-06-09 | The Procter & Gamble Company | Detergent composition |
CN114606216A (en) | 2022-03-31 | 2022-06-10 | 山东隆科特酶制剂有限公司 | Alpha-amylase mutant Q441N/N442H with improved expression level as well as coding gene and application thereof |
CN114621941A (en) | 2020-12-10 | 2022-06-14 | 丰益(上海)生物技术研发中心有限公司 | Protein with lysophospholipase and phospholipase activity |
WO2022129166A1 (en) | 2020-12-15 | 2022-06-23 | Novozymes A/S | Mutated host cells with reduced cell motility |
WO2022138668A1 (en) | 2020-12-21 | 2022-06-30 | 天野エンザイム株式会社 | Modified glucose dehydrogenase |
US20220204956A1 (en) | 2020-12-22 | 2022-06-30 | Fornia Biosolutions, Inc. | Additional Endoglucanase Variants and Methods |
CN114686386A (en) | 2022-06-01 | 2022-07-01 | 中国科学院天津工业生物技术研究所 | Pichia pastoris for producing methanol mycoprotein and co-producing cellulase and application thereof |
CN114736880A (en) | 2022-06-09 | 2022-07-12 | 中国农业科学院北京畜牧兽医研究所 | Mutant D497N of glucose oxidase GoxM10 with improved acid stability as well as derivative mutant and application thereof |
CN114736879A (en) | 2022-06-09 | 2022-07-12 | 中国农业科学院北京畜牧兽医研究所 | Glucose oxidase GoxM10 mutant E361P with improved heat stability and derivative mutant and application thereof |
CN114736881A (en) | 2022-06-09 | 2022-07-12 | 中国农业科学院北京畜牧兽医研究所 | Glucose oxidase GoxM10 mutant A4D with improved acid stability and derivative mutant and application thereof |
CN114752583A (en) | 2022-03-30 | 2022-07-15 | 齐鲁工业大学 | Heat-resistant beta-1, 3-1, 4-glucanase mutant and preparation method and application thereof |
CN114774396A (en) | 2022-06-20 | 2022-07-22 | 山东龙昌动物保健品有限公司 | Keratinase mutant, compound preparation of keratinase mutant and bile acid and application of compound preparation in additive |
CN114806988A (en) | 2022-04-28 | 2022-07-29 | 青岛蔚蓝生物集团有限公司 | Bacillus subtilis and application thereof in production of glutaminase |
CN114806990A (en) | 2022-05-11 | 2022-07-29 | 辽宁大学 | Heat-resistant nattokinase recombinant gene engineering bacterium and construction method and application thereof |
CN114836408A (en) | 2022-05-28 | 2022-08-02 | 湖北大学 | Alkaline protease containing propeptide mutant and application |
CN114908074A (en) | 2022-06-21 | 2022-08-16 | 山西大学 | Aqueous solution stable alkaline protease 2709 mutant and preparation method and application thereof |
WO2022173694A1 (en) | 2021-02-10 | 2022-08-18 | Novozymes A/S | Polypeptides having pectinase activity, polynucleotides encoding same, and uses thereof |
WO2022171780A2 (en) | 2021-02-12 | 2022-08-18 | Novozymes A/S | Alpha-amylase variants |
WO2022171120A1 (en) | 2021-02-10 | 2022-08-18 | Novozymes A/S | Enhanced enzymatic cleaner for membranes and method of cleaning thereof |
WO2022171667A1 (en) | 2021-02-12 | 2022-08-18 | Fresenius Kabi Ipsum S.R.L. | Subtilisin variants and their use |
EP4047088A1 (en) | 2021-02-22 | 2022-08-24 | Basf Se | Amylase variants |
WO2022175263A2 (en) | 2021-02-16 | 2022-08-25 | Dsm Ip Assets B.V. | Methods of selectively promoting animal welfare through modulation of microbiome |
WO2022175435A1 (en) | 2021-02-22 | 2022-08-25 | Basf Se | Amylase variants |
CN114958897A (en) | 2022-06-14 | 2022-08-30 | 中农华威生物制药(湖北)有限公司 | Bacillus subtilis construction method capable of efficiently expressing low-temperature keratinase for feed |
US20220283151A1 (en) | 2021-03-05 | 2022-09-08 | Brigham Young University | Method for controlling protein dimerization using an intramolecular to intermolecular conformational switch |
CN115029337A (en) | 2022-06-28 | 2022-09-09 | 山东龙昌动物保健品有限公司 | Additive compounded by keratinase mutant and eucommia ulmoides leaf extract and application thereof |
CN115029334A (en) | 2022-07-12 | 2022-09-09 | 青岛蔚蓝生物集团有限公司 | High-specific-activity alkaline xylanase mutant |
CN115029327A (en) | 2022-04-24 | 2022-09-09 | 广东溢多利生物科技股份有限公司 | Glucose oxidase mutant GOx-MUT 7-11 and coding gene and application thereof |
CN115029328A (en) | 2022-04-24 | 2022-09-09 | 广东溢多利生物科技股份有限公司 | Glucose oxidase mutant GOx-MUT 1-6 and coding gene and application thereof |
CN115074345A (en) | 2021-03-10 | 2022-09-20 | 中国农业科学院农业资源与农业区划研究所 | Heat-resistant beta-1, 4-endo-xylanase, coding gene and application thereof |
CN115074347A (en) | 2022-06-29 | 2022-09-20 | 山东龙昌动物保健品有限公司 | Feed additive containing keratinase mutant and bile acid and application thereof |
US20220298533A1 (en) | 2021-03-22 | 2022-09-22 | Cb Therapeutics, Inc. | Biosynthetic methods for the modification of cannabinoids |
CN115125226A (en) | 2022-07-26 | 2022-09-30 | 青岛蔚蓝生物集团有限公司 | High specific activity amylase mutant |
WO2022214457A1 (en) | 2021-04-06 | 2022-10-13 | Dsm Ip Assets B.V. | Enzyme composition |
WO2022214459A1 (en) | 2021-04-06 | 2022-10-13 | Dsm Ip Assets B.V. | Enzyme composition |
WO2022226158A2 (en) | 2021-04-23 | 2022-10-27 | Danisco Us Inc. | Trypsin-like serine proteases and uses thereof |
WO2022225696A2 (en) | 2021-04-19 | 2022-10-27 | Basf Se | Systems and methods for generating divergent protein sequences |
WO2022226376A2 (en) | 2021-04-22 | 2022-10-27 | Indigo Ag, Inc. | Endophyte compositions and methods for improved plant health |
CN115247165A (en) | 2021-04-26 | 2022-10-28 | 宜昌东阳光生化制药有限公司 | Cellulase mutant with improved specific activity and thermal stability |
CN115247166A (en) | 2021-04-27 | 2022-10-28 | 南京百斯杰生物工程有限公司 | Protease mutant |
US20220347262A1 (en) | 2013-09-25 | 2022-11-03 | Axcella Health Inc. | Compositions and Formulations and Methods of Production and Use Thereof |
WO2022251056A1 (en) | 2021-05-27 | 2022-12-01 | Novozymes A/S | Transcriptional regulators and polynucleotides encoding the same |
WO2022256274A1 (en) | 2021-05-30 | 2022-12-08 | Bee-Io-Honey Technologies Ltd. | Methods and systems for producing emulated honey |
WO2022261003A1 (en) | 2021-06-07 | 2022-12-15 | Novozymes A/S | Engineered microorganism for improved ethanol fermentation |
CN115478061A (en) | 2021-05-31 | 2022-12-16 | 宜昌东阳光药业股份有限公司 | Cellulase mutants and compositions thereof |
CN115521925A (en) | 2021-06-24 | 2022-12-27 | 丰益(上海)生物技术研发中心有限公司 | Protein having lysophospholipase and/or phospholipase activity |
WO2022268885A1 (en) | 2021-06-23 | 2022-12-29 | Novozymes A/S | Alpha-amylase polypeptides |
WO2022270590A1 (en) | 2021-06-23 | 2022-12-29 | 天野エンザイム株式会社 | Laccase |
WO2023274282A1 (en) | 2021-06-29 | 2023-01-05 | Novozymes A/S | Processes for producing fermentation products using fiber-degrading enzymes in fermentation |
CN115612628A (en) | 2022-01-12 | 2023-01-17 | 上海国龙生物科技有限公司 | Pichia pastoris, preparation method thereof and application of pichia pastoris in catalyzing sucrose to produce fructo-oligosaccharide |
WO2023288294A1 (en) | 2021-07-16 | 2023-01-19 | Novozymes A/S | Compositions and methods for improving the rainfastness of proteins on plant surfaces |
WO2023004432A2 (en) | 2021-07-22 | 2023-01-26 | Solugen, Inc. | Compositions and methods for production of value-added chemicals |
WO2023002065A2 (en) | 2021-07-23 | 2023-01-26 | Università Degli Studi Dell'aquila | Fungus strain and uses thereof |
WO2023019266A2 (en) | 2021-08-13 | 2023-02-16 | Anagram Therapeutics, Inc. | Methods and compositions for treating fructose intolerance and fructose malabsorption |
CN115703996A (en) | 2021-08-16 | 2023-02-17 | 潍坊康地恩生物科技有限公司 | Trichoderma reesei strain for high xylanase yield and application thereof |
CN115704017A (en) | 2021-08-06 | 2023-02-17 | 青岛蔚蓝生物集团有限公司 | Alkaline xylanase mutant |
CN115704019A (en) | 2021-08-06 | 2023-02-17 | 青岛蔚蓝生物集团有限公司 | High specific activity alkaline xylanase mutant |
CN115704018A (en) | 2021-08-06 | 2023-02-17 | 青岛蔚蓝生物集团有限公司 | Alkaline xylanase mutant and application thereof |
WO2023023642A2 (en) | 2021-08-20 | 2023-02-23 | Danisco Us Inc. | Methods and compositions for enhanced protein production in bacillus cells |
CN115717134A (en) | 2022-12-19 | 2023-02-28 | 无锡蔚蓝生物科技有限公司 | Lipase mutant and application thereof in natural vitamin E purification |
WO2023032952A1 (en) | 2021-08-30 | 2023-03-09 | 天野エンザイム株式会社 | Enzymatic agent for transesterification containing lipase as active ingredient |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL178652B1 (en) * | 1993-11-24 | 2000-05-31 | Monsanto Co | Method of fighting against plant pathogens |
EP1802740A4 (en) * | 2004-09-22 | 2008-02-27 | Bioworks Inc | Transgenic strains of trichoderma and their use in biocontrol |
-
2023
- 2023-05-12 WO PCT/US2023/066918 patent/WO2023225459A2/en unknown
Patent Citations (1700)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4016040A (en) | 1969-12-10 | 1977-04-05 | Colgate-Palmolive Company | Preparation of enzyme-containing beads |
GB1483591A (en) | 1973-07-23 | 1977-08-24 | Novo Industri As | Process for coating water soluble or water dispersible particles by means of the fluid bed technique |
US4106991A (en) | 1976-07-07 | 1978-08-15 | Novo Industri A/S | Enzyme granulate composition and process for forming enzyme granulates |
EP0000027A1 (en) | 1977-06-14 | 1978-12-20 | BASF Aktiengesellschaft | Process for the manufacture, according to the Levitherm process, of hard polyvinyl chloride films |
US4510133A (en) | 1982-04-22 | 1985-04-09 | Imperial Chemical Industries Plc | Method for combating pests |
WO1984002921A2 (en) | 1983-01-28 | 1984-08-02 | Cetus Corp | Glucoamylase cdna |
EP0133756A2 (en) | 1983-07-06 | 1985-03-06 | Genex Corporation | Vector for expression of polypeptides |
US5652136A (en) | 1984-05-29 | 1997-07-29 | Genencor International, Inc. | Substrate assisted catalysis |
EP0170360A1 (en) | 1984-05-29 | 1986-02-05 | Novo Nordisk A/S | Enzyme containing granulates suitable for use as detergent additives |
US5371008A (en) | 1984-05-29 | 1994-12-06 | Genencor International, Inc. | Substrate assisted catalysis |
US4661452A (en) | 1984-05-29 | 1987-04-28 | Novo Industri A/S | Enzyme containing granulates useful as detergent additives |
US5472855A (en) | 1984-05-29 | 1995-12-05 | Genentech, Inc. | Substrate assisted catalysis |
US4713245A (en) | 1984-06-04 | 1987-12-15 | Mitsui Toatsu Chemicals, Incorporated | Granule containing physiologically-active substance, method for preparing same and use thereof |
EP0208491A2 (en) | 1985-07-03 | 1987-01-14 | Genencor International, Inc. | Hybrid polypeptides and process for their preparation |
JPS62104580A (en) | 1985-10-30 | 1987-05-15 | Kunio Yamane | Dna-expressing heat-resistant enzyme |
US4980288A (en) | 1986-02-12 | 1990-12-25 | Genex Corporation | Subtilisin with increased thermal stability |
EP0238216A1 (en) | 1986-02-20 | 1987-09-23 | Albright & Wilson Limited | Protected enzyme systems |
EP0238023A2 (en) | 1986-03-17 | 1987-09-23 | Novo Nordisk A/S | Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus |
EP0245970A1 (en) | 1986-04-25 | 1987-11-19 | Rohm And Haas Company | Dithiocarbamate compostions having increased rain fastness |
EP0260160A1 (en) | 1986-06-10 | 1988-03-16 | Transgene S.A. | Block for the expression of amyloglucosidase in yeast, as well as yeasts containing it |
EP0683228A2 (en) | 1987-02-04 | 1995-11-22 | Ciba-Geigy Ag | Novel expression system |
EP0285123A2 (en) | 1987-04-03 | 1988-10-05 | Stabra AG | A method for complete mutagenesis of nucleic acids |
WO1988007581A1 (en) | 1987-04-03 | 1988-10-06 | Amgen Inc. | Novel proteolytic enzymes |
US5260207A (en) | 1987-04-06 | 1993-11-09 | Enzon Labs Inc. | Engineering of electrostatic interactions at metal ion binding sites for the stabilization of proteins |
JPH01137972A (en) | 1987-08-03 | 1989-05-30 | Ajinomoto Co Inc | Novel subtilisin |
EP0304332A2 (en) | 1987-08-21 | 1989-02-22 | Novo Nordisk A/S | Enzyme containing granulate and method for production thereof |
EP0304331A2 (en) | 1987-08-21 | 1989-02-22 | Novo Nordisk A/S | Method for production of an enzyme granulate |
EP0305216A1 (en) | 1987-08-28 | 1989-03-01 | Novo Nordisk A/S | Recombinant Humicola lipase and process for the production of recombinant humicola lipases |
EP0571049A1 (en) | 1988-02-11 | 1993-11-24 | Genencor International, Inc. | Novel proteolytic enzymes and their use in detergents |
DD272102A1 (en) | 1988-05-12 | 1989-09-27 | Akad Wissenschaften Ddr | PROCESS FOR PREPARING THERMOSTATIC BACILLUS BETA-1,3-1,4-GLUCANASE |
WO1989012675A1 (en) | 1988-06-21 | 1989-12-28 | Chiron Corporation | Production of glucose oxidase in recombinant systems |
DE3821491A1 (en) | 1988-06-25 | 1989-12-28 | Henkel Kgaa | HYBRID PLASMIDE FOR THE PRODUCTION OF SUBTILISIN CARLSBERG IN BACILLUS |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
JPH0276586A (en) | 1988-09-12 | 1990-03-15 | Nippon Petrochem Co Ltd | Gene to code elastase |
US5316941A (en) | 1989-01-06 | 1994-05-31 | Genencor, Inc. | Non-human carbonyl hydrolase mutants, DNA sequences and vectors encoding same and hosts transformed with said vectors |
WO1990009436A1 (en) | 1989-02-16 | 1990-08-23 | Carlsberg A/S | A THERMOSTABLE (1,3-1,4)-β-GLUCANASE |
WO1990009428A1 (en) | 1989-02-20 | 1990-08-23 | Novo Nordisk A/S | Detergent additive granulate and method for production thereof |
WO1990009440A1 (en) | 1989-02-20 | 1990-08-23 | Novo Nordisk A/S | Enzyme containing granulate and method for production thereof |
US5719021A (en) | 1989-05-02 | 1998-02-17 | University Of Medicine And Dentistry Of New Jersey | Protein activation |
EP0398539A1 (en) | 1989-05-17 | 1990-11-22 | Amgen Inc. | Multiply mutated subtilisins |
EP0405902A1 (en) | 1989-06-26 | 1991-01-02 | Unilever Plc | Enymatic detergent compositions |
EP0405901A1 (en) | 1989-06-26 | 1991-01-02 | Unilever Plc | Enzymatic detergent compositions |
EP0409299A2 (en) | 1989-06-29 | 1991-01-23 | Gist-Brocades N.V. | Mutant enzyme having reduced stability under industrial application conditions |
WO1991000353A2 (en) | 1989-06-29 | 1991-01-10 | Gist-Brocades N.V. | MUTANT MICROBIAL α-AMYLASES WITH INCREASED THERMAL, ACID AND/OR ALKALINE STABILITY |
EP0416967A1 (en) | 1989-08-11 | 1991-03-13 | Mitsubishi Gas Chemical Company, Inc. | Novel alkaline protease |
WO1991002792A1 (en) | 1989-08-25 | 1991-03-07 | Henkel Research Corporation | Alkaline proteolytic enzyme and method of production |
EP0415296A2 (en) | 1989-08-31 | 1991-03-06 | Solvay Enzymes GmbH & Co. KG | High alkaline proteases |
US6271012B1 (en) | 1989-10-11 | 2001-08-07 | Genencor International, Inc. | Protease muteins and their use in detergents |
WO1991006637A1 (en) | 1989-10-31 | 1991-05-16 | Genencor International, Inc. | Subtilisin mutants |
EP0430637A1 (en) | 1989-11-27 | 1991-06-05 | NIHON CHEMICAL RESEARCH KABUSHIKI KAISHA also known as JAPAN CHEMICAL RESEARCH CO., LTD | Fibrinolytic protein and production method thereof |
US5290556A (en) | 1990-02-02 | 1994-03-01 | The United States Of America As Represented By The Secretary Of Agriculture | Plastic bait composition for attracting and killing crop pests |
EP0441353A2 (en) | 1990-02-07 | 1991-08-14 | Kyowa Hakko Kogyo Co., Ltd. | Process for the production of gamma-glutamyl transpeptidase |
EP0443476A2 (en) | 1990-02-23 | 1991-08-28 | ENIRICERCHE S.p.A. | Thermostable mutants of neutral protease and means for their preparation |
WO1991014772A1 (en) | 1990-03-23 | 1991-10-03 | Gist-Brocades N.V. | Production of enzymes in seeds and their use |
JPH0476A (en) | 1990-04-17 | 1992-01-06 | Smc Corp | Valve |
WO1991017244A1 (en) | 1990-05-09 | 1991-11-14 | Novo Nordisk A/S | An enzyme capable of degrading cellulose or hemicellulose |
JPH0458889A (en) | 1990-06-25 | 1992-02-25 | Aizo Matsushiro | Alpha-1,3-glucanase gene |
FR2665178A1 (en) | 1990-07-30 | 1992-01-31 | Agronomique Inst Nat Rech | Heat-stable variants of the alpha-amylase of Bacillus licheniformis, process for their preparation and their use |
US6395966B1 (en) | 1990-08-09 | 2002-05-28 | Dekalb Genetics Corp. | Fertile transgenic maize plants containing a gene encoding the pat protein |
WO1992003540A1 (en) | 1990-08-24 | 1992-03-05 | Novo Nordisk A/S | Enzymes with xylanolytic activity |
WO1992005249A1 (en) | 1990-09-13 | 1992-04-02 | Novo Nordisk A/S | Lipase variants |
WO1992006204A1 (en) | 1990-09-28 | 1992-04-16 | Ixsys, Inc. | Surface expression libraries of heteromeric receptors |
EP0482879A2 (en) | 1990-10-24 | 1992-04-29 | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. | Protease from Bacillus licheniformis |
WO1992008355A1 (en) | 1990-11-13 | 1992-05-29 | Liphatech, Inc. | Process for preparation of bacterial agricultural products |
EP0486067A2 (en) | 1990-11-16 | 1992-05-20 | Suntory Limited | Peroxidase gene of microbial origin |
US5401506A (en) | 1990-12-07 | 1995-03-28 | Temple University | Stabilized insect nematode compositions |
WO1992011348A1 (en) | 1990-12-21 | 1992-07-09 | Unilever N.V. | Enzymes and enzymatic detergent compositions |
WO1992011357A1 (en) | 1990-12-21 | 1992-07-09 | Novo Nordisk A/S | ENZYME MUTANTS HAVING A LOW DEGREE OF VARIATION OF THE MOLECULAR CHARGE OVER A pH RANGE |
WO1992011856A1 (en) | 1991-01-09 | 1992-07-23 | Wright James E | Biopesticide composition and process for insect pest control |
EP0495257A1 (en) | 1991-01-16 | 1992-07-22 | The Procter & Gamble Company | Compact detergent compositions with high activity cellulase |
WO1992017571A1 (en) | 1991-03-27 | 1992-10-15 | Novo Nordisk A/S | Catalase, its production and use |
WO1992018688A1 (en) | 1991-04-22 | 1992-10-29 | Novo Nordisk A/S | Use of cellulase for pulp treatment |
EP0516200A1 (en) | 1991-05-01 | 1992-12-02 | Unilever N.V. | Detergent compositions containing stabilized enzymes |
WO1992019726A1 (en) | 1991-05-01 | 1992-11-12 | Novo Nordisk A/S | Stabilized enzymes |
FR2676456A1 (en) | 1991-05-13 | 1992-11-20 | Agronomique Inst Nat Rech | Thermostable variants of Bacillus licheniformis alpha -amylase, process for preparing them and their use |
WO1992021760A1 (en) | 1991-05-29 | 1992-12-10 | Cognis, Inc. | Mutant proteolytic enzymes from bacillus |
DE4224125A1 (en) | 1991-07-27 | 1993-01-28 | Solvay Enzymes Gmbh & Co Kg | METHOD FOR IMPROVING THE STABILITY OF ENZYMS AND STABILIZED ENZYMES |
WO1993007263A2 (en) | 1991-10-07 | 1993-04-15 | Genencor International, Inc. | Coated enzyme containing granule |
WO1993007276A1 (en) | 1991-10-08 | 1993-04-15 | Chemgen Corporation | A novel alkaline protease produced by a bacillus |
US5607684A (en) | 1991-10-31 | 1997-03-04 | Micro Flo Company | Manufacture of bait with hot melt binder |
EP0540784A1 (en) | 1991-11-06 | 1993-05-12 | The Procter & Gamble Company | Dye transfer inhibiting compositions |
EP0563963A1 (en) | 1992-04-02 | 1993-10-06 | AgriSense | Delivery system for insecticides |
US5316935A (en) | 1992-04-06 | 1994-05-31 | California Institute Of Technology | Subtilisin variants suitable for hydrolysis and synthesis in organic media |
WO1994002618A1 (en) | 1992-07-17 | 1994-02-03 | Gist-Brocades N.V. | High alkaline serine proteases |
WO1994002597A1 (en) | 1992-07-23 | 1994-02-03 | Novo Nordisk A/S | MUTANT α-AMYLASE, DETERGENT, DISH WASHING AGENT, AND LIQUEFACTION AGENT |
WO1994007998A1 (en) | 1992-10-06 | 1994-04-14 | Novo Nordisk A/S | Cellulase variants |
EP0605040A1 (en) | 1992-12-28 | 1994-07-06 | SOLVAY (Société Anonyme) | Pullulanase, micro-organisms producing the same, method for preparation thereof as well as its use |
WO1994018329A2 (en) | 1993-02-04 | 1994-08-18 | Genentech, Inc. | Serine protease variants having peptide ligase activity |
US5824532A (en) | 1993-02-11 | 1998-10-20 | Genencor International, Inc. | Oxidativley stable alpha-amylase |
WO1994018314A1 (en) | 1993-02-11 | 1994-08-18 | Genencor International, Inc. | Oxidatively stable alpha-amylase |
US5849549A (en) | 1993-02-11 | 1998-12-15 | Genencor International | Oxidatively stable alpha-amylase |
WO1994023053A1 (en) | 1993-04-01 | 1994-10-13 | Novo Nordisk A/S | Protease variants |
WO1994025577A1 (en) | 1993-04-23 | 1994-11-10 | Novo Nordisk A/S | Lipase variants |
WO1994025575A1 (en) | 1993-04-30 | 1994-11-10 | Novo Nordisk A/S | An enzyme exhibiting pectin methylesterase activity |
WO1994025612A2 (en) | 1993-05-05 | 1994-11-10 | Institut Pasteur | Nucleotide sequences for the control of the expression of dna sequences in a cellular host |
EP0633311A1 (en) | 1993-06-28 | 1995-01-11 | The Procter & Gamble Company | Hydrophobic amines for cellulase stabilization in liquid detergent compositions containing anionic surfactant and cellulase |
WO1995002046A1 (en) | 1993-07-09 | 1995-01-19 | Novo Nordisk A/S | Boronic acid or borinic acid derivatives as enzyme stabilizers |
WO1995002675A1 (en) | 1993-07-12 | 1995-01-26 | Novo Nordisk A/S | A detergent composition comprising two cellulase components |
JPH0759574A (en) | 1993-08-23 | 1995-03-07 | Mitsui Toatsu Chem Inc | Novel dna |
WO1995007991A2 (en) | 1993-09-15 | 1995-03-23 | The Procter & Gamble Company | Subtilisin bpn' variants with decreased adsorption and increased hydrolysis |
US6440717B1 (en) | 1993-09-15 | 2002-08-27 | The Procter & Gamble Company | BPN′ variants having decreased adsorption and increased hydrolysis |
WO1995010591A1 (en) | 1993-10-14 | 1995-04-20 | The Procter & Gamble Company | Protease-containing cleaning compositions |
WO1995010615A1 (en) | 1993-10-14 | 1995-04-20 | Genencor International, Inc. | Subtilisin variants |
US6017871A (en) | 1993-10-14 | 2000-01-25 | The Procter & Gamble Company | Protease-containing cleaning compositions |
US5677272A (en) | 1993-10-14 | 1997-10-14 | The Procter & Gamble Company | Bleaching compositions comprising protease enzymes |
US5679630A (en) | 1993-10-14 | 1997-10-21 | The Procter & Gamble Company | Protease-containing cleaning compositions |
WO1995017413A1 (en) | 1993-12-21 | 1995-06-29 | Evotec Biosystems Gmbh | Process for the evolutive design and synthesis of functional polymers based on designer elements and codes |
WO1995018219A1 (en) | 1993-12-24 | 1995-07-06 | Gist-Brocades N.V. | Alkali-tolerant xylanases |
WO1995021924A1 (en) | 1994-02-10 | 1995-08-17 | Commonwealth Scientific And Industrial Research Organisation | Expression of the glucose oxidase gene in transgenic organisms |
WO1995022625A1 (en) | 1994-02-17 | 1995-08-24 | Affymax Technologies N.V. | Dna mutagenesis by random fragmentation and reassembly |
WO1995022615A1 (en) | 1994-02-22 | 1995-08-24 | Novo Nordisk A/S | A method of preparing a variant of a lipolytic enzyme |
WO1995023221A1 (en) | 1994-02-24 | 1995-08-31 | Cognis, Inc. | Improved enzymes and detergents containing them |
WO1995023614A1 (en) | 1994-03-01 | 1995-09-08 | E.R. Squibb & Sons, Inc. | Enzymatic debridement compositions and methods |
WO1995024471A1 (en) | 1994-03-08 | 1995-09-14 | Novo Nordisk A/S | Novel alkaline cellulases |
WO1995026397A1 (en) | 1994-03-29 | 1995-10-05 | Novo Nordisk A/S | Alkaline bacillus amylase |
DE4411223A1 (en) | 1994-03-31 | 1995-10-05 | Solvay Enzymes Gmbh & Co Kg | Use of alkaline proteases in commercial textile washing processes |
WO1995030011A2 (en) | 1994-05-02 | 1995-11-09 | The Procter & Gamble Company | Subtilisin 309 variants having decreased adsorption and increased hydrolysis |
WO1995033836A1 (en) | 1994-06-03 | 1995-12-14 | Novo Nordisk Biotech, Inc. | Phosphonyldipeptides useful in the treatment of cardiovascular diseases |
WO1995034662A1 (en) | 1994-06-14 | 1995-12-21 | Gist-Brocades B.V. | Thermostable xylanases |
EP0687733A1 (en) | 1994-06-16 | 1995-12-20 | The Procter & Gamble Company | Detergent composition containing wool compatible high alkaline proteases |
WO1995035382A2 (en) | 1994-06-17 | 1995-12-28 | Genecor International Inc. | NOVEL AMYLOLYTIC ENZYMES DERIVED FROM THE B. LICHENIFORMIS α-AMYLASE, HAVING IMPROVED CHARACTERISTICS |
WO1996005295A2 (en) | 1994-08-11 | 1996-02-22 | Genencor International, Inc. | An improved cleaning composition |
WO1996013580A1 (en) | 1994-10-26 | 1996-05-09 | Novo Nordisk A/S | An enzyme with lipolytic activity |
WO1996017994A1 (en) | 1994-12-05 | 1996-06-13 | Novo Nordisk A/S | A method of obtaining a cellulosic textile fabric with reduced tendency to pilling formation |
WO1996022366A1 (en) | 1995-01-19 | 1996-07-25 | Novo Nordisk A/S | Transglutaminases from oomycetes |
WO1996023062A1 (en) | 1995-01-26 | 1996-08-01 | Novo Nordisk A/S | Animal feed additives comprising xylanase |
WO1996023873A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | Amylase variants |
WO1996023874A1 (en) | 1995-02-03 | 1996-08-08 | Novo Nordisk A/S | A method of designing alpha-amylase mutants with predetermined properties |
WO1996028566A2 (en) | 1995-03-08 | 1996-09-19 | The Procter & Gamble Company | Subtilisin carlsberg variants having decreased adsorption and increased hydrolysis |
WO1996028557A2 (en) | 1995-03-09 | 1996-09-19 | The Procter & Gamble Company | Subtilisin dy variants having decreased adsorption and increased hydrolysis |
WO1996029397A1 (en) | 1995-03-17 | 1996-09-26 | Novo Nordisk A/S | Novel endoglucanases |
WO1996030481A1 (en) | 1995-03-24 | 1996-10-03 | Genencor International, Inc. | An improved laundry detergent composition comprising amylase |
WO1996034935A2 (en) | 1995-05-05 | 1996-11-07 | Unilever N.V. | Subtilisin variants |
WO1996034946A1 (en) | 1995-05-05 | 1996-11-07 | Novo Nordisk A/S | Protease variants and compositions |
WO1996039528A2 (en) | 1995-06-06 | 1996-12-12 | Genencor International, Inc. | MUTANT α-AMYLASE |
US20050287250A1 (en) | 1995-06-07 | 2005-12-29 | Danisco A/S | Method |
WO1996041859A1 (en) | 1995-06-13 | 1996-12-27 | Novo Nordisk A/S | 4-substituted-phenyl-boronic acids as enzyme stabilizers |
US5496568A (en) | 1995-06-26 | 1996-03-05 | Church & Dwight Co., Inc. | Fungal disease control in cultivated plants |
WO1997004079A1 (en) | 1995-07-14 | 1997-02-06 | Novo Nordisk A/S | A modified enzyme with lipolytic activity |
WO1997007206A1 (en) | 1995-08-11 | 1997-02-27 | Okkels, Jens, Sigurd | Method for preparing polypeptide variants |
WO1997007202A1 (en) | 1995-08-11 | 1997-02-27 | Novo Nordisk A/S | Novel lipolytic enzymes |
WO1997007205A1 (en) | 1995-08-11 | 1997-02-27 | Novo Nordisk A/S | Method for preparing polypeptide variants |
DE19530816A1 (en) | 1995-08-23 | 1997-02-27 | Cognis Bio Umwelt | Use of mutant subtilisin protease in cosmetic products |
WO1997014804A1 (en) | 1995-10-17 | 1997-04-24 | Röhn Enzyme Finland OY | Cellulases, the genes encoding them and uses thereof |
WO1997023606A1 (en) | 1995-12-22 | 1997-07-03 | Genencor International, Inc. | Enzyme containing coated granules |
WO1997028256A1 (en) | 1996-01-29 | 1997-08-07 | Novo Nordisk A/S | Process for desizing cellulosic fabric |
US5858436A (en) | 1996-03-12 | 1999-01-12 | Xeda International | Process for the treatment of fruits and vegetables |
JPH09249893A (en) | 1996-03-15 | 1997-09-22 | Lion Corp | Detergent composition |
JPH09249891A (en) | 1996-03-15 | 1997-09-22 | Lion Corp | Detergent composition |
WO1997039116A1 (en) | 1996-04-12 | 1997-10-23 | Novo Nordisk A/S | Enzyme-containing granules and process for the production thereof |
WO1997043409A2 (en) | 1996-05-10 | 1997-11-20 | Novo Nordisk A/S | Method of providing novel dna sequences |
WO1997043424A1 (en) | 1996-05-14 | 1997-11-20 | Genencor International, Inc. | MODIFIED α-AMYLASES HAVING ALTERED CALCIUM BINDING PROPERTIES |
WO1998003639A1 (en) | 1996-07-24 | 1998-01-29 | Iowa State University Research Foundation, Inc. | PROTEIN ENGINEERING OF GLUCOAMYLASE TO INCREASE pH OPTIMUM, SUBSTRATE SPECIFICITY AND THERMOSTABILITY |
WO1998004663A1 (en) | 1996-07-30 | 1998-02-05 | The Procter & Gamble Company | Detergent composition comprising two cellulase components, with and without a cellulose-binding domain |
EP0828002A2 (en) | 1996-09-09 | 1998-03-11 | National Research Council Of Canada | Modification of xylanase to improve thermophilicity, alkophilicity and thermostability |
WO1998011239A1 (en) | 1996-09-13 | 1998-03-19 | Meiji Seika Kaisha, Ltd. | REGULATORY SEQUENCE OF CELLULASE cbh1 GENES ORIGINATING IN TRICHODERMA VIRIDE AND SYSTEM FOR MASS-PRODUCING PROTEINS OR PEPTIDES THEREWITH |
WO1998012307A1 (en) | 1996-09-17 | 1998-03-26 | Novo Nordisk A/S | Cellulase variants |
WO1998016633A1 (en) | 1996-10-11 | 1998-04-23 | Novo Nordisk A/S | Alpha-amylase fused to cellulose binding domain, for starch degradation |
WO1998018437A1 (en) | 1996-10-25 | 1998-05-07 | Novo Nordisk A/S | An oral care product comprising a mutan binding domain |
WO1998020115A1 (en) | 1996-11-04 | 1998-05-14 | Novo Nordisk A/S | Subtilase variants and compositions |
WO1998026078A1 (en) | 1996-12-09 | 1998-06-18 | Genencor International, Inc. | H mutant alpha-amylase enzymes |
NZ524303A (en) | 1996-12-09 | 2004-06-25 | Genencor Int | Alpha amylase enzymes with increased stability |
WO1998030682A1 (en) | 1997-01-10 | 1998-07-16 | Novo Nordisk A/S | Enzyme coupled with polymeric molecules for skin care |
WO1998038286A1 (en) | 1997-02-28 | 1998-09-03 | Novo Nordisk A/S | Laccase mutants |
WO1998044126A1 (en) | 1997-03-31 | 1998-10-08 | Kao Corporation | MUTATED α-AMYLASES |
WO1998055634A1 (en) | 1997-06-04 | 1998-12-10 | The Procter & Gamble Company | Protease enzymes for tough cleaning and/or spot and film reduction and compositions incorporating same |
WO1999009183A1 (en) | 1997-08-19 | 1999-02-25 | Genencor International, Inc. | MUTANT α-AMYLASE COMPRISING MODIFICATION AT RESIDUES CORRESPONDING TO A210, H405 AND/OR T412 IN $i(BACILLUS LICHENIFORMIS) |
JPH11137282A (en) | 1997-09-04 | 1999-05-25 | Natl Sci Council | Variant subtilisin yab and its application |
WO1999019467A1 (en) | 1997-10-13 | 1999-04-22 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
US6312936B1 (en) | 1997-10-23 | 2001-11-06 | Genencor International, Inc. | Multiply-substituted protease variants |
WO1999020770A2 (en) | 1997-10-23 | 1999-04-29 | Genencor International, Inc. | Multiply-substituted protease variants |
WO1999023211A1 (en) | 1997-10-30 | 1999-05-14 | Novo Nordisk A/S | α-AMYLASE MUTANTS |
WO1999027082A1 (en) | 1997-11-21 | 1999-06-03 | Novo Nordisk A/S | Protease variants and compositions |
WO1999027083A1 (en) | 1997-11-24 | 1999-06-03 | Novo Nordisk A/S | PECTIN DEGRADING ENZYMES FROM $i(BACILLUS LICHENIFORMIS) |
WO1999029876A2 (en) | 1997-12-09 | 1999-06-17 | Genencor International, Inc. | Mutant bacillus licheniformis alpha-amylase |
WO1999032595A1 (en) | 1997-12-20 | 1999-07-01 | Genencor International, Inc. | Granule with hydrated barrier material |
US6060442A (en) | 1998-02-24 | 2000-05-09 | Novo Nordisk A/S | Laccase mutants |
WO1999045124A2 (en) | 1998-03-04 | 1999-09-10 | Genencor International, Inc. | Modified forms of pullulanase |
WO1999046399A1 (en) | 1998-03-09 | 1999-09-16 | Novo Nordisk A/S | Enzymatic preparation of glucose syrup from starch |
WO1999057256A1 (en) | 1998-05-01 | 1999-11-11 | The Procter & Gamble Company | Laundry detergent and/or fabric care compositions comprising a modified cellulase |
WO1999057260A1 (en) | 1998-05-01 | 1999-11-11 | The Procter & Gamble Company | Laundry detergent and/or fabric care compositions comprising a modified cellulase |
WO1999067370A1 (en) | 1998-06-23 | 1999-12-29 | Novozymes A/S | A polypeptide-polymer conjugate |
WO2000001793A1 (en) | 1998-06-30 | 2000-01-13 | Novozymes A/S | A new improved enzyme containing granule |
WO2000001796A2 (en) | 1998-07-02 | 2000-01-13 | Novozymes A/S | Starch debranching enzymes |
EP0972450A1 (en) | 1998-07-13 | 2000-01-19 | Xeda International | Fruit and vegetable treatment process |
WO2000011211A1 (en) | 1998-08-19 | 2000-03-02 | Novozymes A/S | Enzyme activity screen with substrate replacement |
WO2000010386A1 (en) | 1998-08-20 | 2000-03-02 | Biotechnologies For Horticulture, Inc. | Plant ethylene response inhibition compounds and complexes |
JP2000135093A (en) | 1998-08-24 | 2000-05-16 | Daiwa Kasei Kk | New amylase for baking and its gene |
US6221414B1 (en) | 1998-09-02 | 2001-04-24 | Xeda International | Process for treating fruits and vegetables after harvesting, with purification of plant-protection products contaminated with aromatic primary amines |
WO2000022103A1 (en) | 1998-10-13 | 2000-04-20 | Novozymes A/S | A modified polypeptide with reduced immune response |
US7504490B1 (en) | 1998-10-16 | 2009-03-17 | Oscient Pharmaceuticals Corporation | Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics |
WO2000024924A2 (en) | 1998-10-23 | 2000-05-04 | The Procter & Gamble Company | Methods for screening protease variants for use in detergent compositions |
US20040146617A1 (en) | 1998-10-27 | 2004-07-29 | Schrader Lawrence E | Compositions and methods for suppressing cracking and water loss from cherries |
US6887986B1 (en) | 1998-11-16 | 2005-05-03 | Novozymes A/S | α-amylase variants |
US20050196853A1 (en) | 1998-11-16 | 2005-09-08 | Novozymes A/S | Alpha-amylase variants |
US20130252850A1 (en) | 1998-11-16 | 2013-09-26 | Novozymes A/S | Alpha-Amylase Variants |
US20120252095A1 (en) | 1998-11-16 | 2012-10-04 | Novozymes A/S | Alpha-Amylase Variants |
US20090203109A1 (en) | 1998-11-16 | 2009-08-13 | Novozymes A/S | Alpha-Amylase Variants |
US20110287516A1 (en) | 1998-11-16 | 2011-11-24 | Novozymes A/S | Alpha-Amylase Variants |
WO2000029560A1 (en) | 1998-11-16 | 2000-05-25 | Novozymes A/S | α-AMYLASE VARIANTS |
WO2000028824A1 (en) | 1998-11-16 | 2000-05-25 | Aventis Cropscience S.A. | Compositions and methods for controlling insects |
CA2715086A1 (en) | 1998-11-27 | 2000-06-08 | Novozymes A/S | Lipolytic enzyme variants |
US6723364B1 (en) | 1998-12-03 | 2004-04-20 | Xeda International | Fog treatment method using a liquid composition for treating fruits and vegetables and implementing device |
WO2000034450A1 (en) | 1998-12-04 | 2000-06-15 | Novozymes A/S | Cutinase variants |
WO2000034452A1 (en) | 1998-12-07 | 2000-06-15 | Novozymes A/S | Glucoamylases with n-terminal extensions |
WO2000037621A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
WO2000037627A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
WO2000037623A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
WO2000037624A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
WO2000037626A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
WO2000037599A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in the active site loop region |
WO2000037625A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
WO2000037622A1 (en) | 1998-12-18 | 2000-06-29 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region |
WO2000043504A1 (en) | 1999-01-22 | 2000-07-27 | Iowa State University Research Foundation, Inc. | PROTEIN ENGINEERING OF GLUCOAMYLASE TO INCREASE pH OPTIMUM, SUBSTRATE SPECIFICITY AND THERMOSTABILITY |
CN1229139A (en) | 1999-01-28 | 1999-09-22 | 中国农业科学院生物技术研究中心 | Application of glucose oxidase gen to breeding disease-resistant transfer-gen |
JP2000245466A (en) | 1999-02-25 | 2000-09-12 | Kao Corp | Mutant alpha-amylase |
WO2000049880A1 (en) | 1999-02-26 | 2000-08-31 | Xeda International | Treatment method for fruits and vegetables |
US6403139B1 (en) | 1999-03-03 | 2002-06-11 | Xeda International | Process for treating fruit and vegetables using tocopherols as antioxidants |
WO2000060059A2 (en) | 1999-03-30 | 2000-10-12 | NovozymesA/S | Alpha-amylase variants |
WO2000060058A2 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
WO2000060063A1 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Lipase variant |
US6682923B1 (en) | 1999-05-12 | 2004-01-27 | Xencor | Thermostable alkaliphilic xylanase |
WO2000071683A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 130 and 131 |
WO2000071689A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 127 and 128 |
WO2000071684A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 131 and 132 |
WO2000071685A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 132 and 133 |
WO2000071686A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 97 and 98 |
WO2000071687A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 129 and 130 |
WO2000071690A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 128 and 129 |
WO2000071691A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 125 and 126 |
WO2000071688A1 (en) | 1999-05-20 | 2000-11-30 | Novozymes A/S | Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 126 and 127 |
WO2001004279A1 (en) | 1999-07-09 | 2001-01-18 | Novozymes A/S | A process for preparing an enzyme containing granule |
WO2001009294A1 (en) | 1999-07-31 | 2001-02-08 | Newbiotechnic, S.A. | Antifungic compositions and method for controlling fungi |
WO2001016285A2 (en) | 1999-08-31 | 2001-03-08 | Novozymes A/S | Novel proteases and variants thereof |
WO2001016349A1 (en) | 1999-09-01 | 2001-03-08 | Novozymes A/S | Method for production of maltose and/or enzymatically modified starch |
KR20010027418A (en) | 1999-09-09 | 2001-04-06 | 박종헌 | Crystals of maltogenic amylase comprising and structure thereof |
WO2001027251A1 (en) | 1999-10-14 | 2001-04-19 | Novozymes A/S | Lysophospholipase from aspergillus |
WO2001036586A2 (en) | 1999-11-19 | 2001-05-25 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Aspegillus niger beta-glucosidase gene, protein and uses thereof |
WO2001042433A2 (en) | 1999-12-07 | 2001-06-14 | Danisco A/S | Talaromyces emersonii xylanase |
WO2001043548A1 (en) | 1999-12-17 | 2001-06-21 | Agrofresh Inc. | Synthesis methods, complexes and delivery methods for the safe and convenient storage, transport and application of compounds for inhibiting the ethylene response in plants |
WO2001047956A2 (en) | 1999-12-23 | 2001-07-05 | Genencor International, Inc. | Method for obtaining proteins having improved functional characteristics |
WO2001051620A2 (en) | 2000-01-12 | 2001-07-19 | Novozymes A/S | Pullulanase variants and methods for preparing such variants with predetermined properties |
WO2001059141A2 (en) | 2000-02-10 | 2001-08-16 | Washington State University Research Foundation | Methods and compositions that utilize barley as a foodstuff for animals |
WO2001064852A1 (en) | 2000-03-03 | 2001-09-07 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
WO2001068821A2 (en) | 2000-03-14 | 2001-09-20 | Novozymes A/S | Novel subtilase enzymes having an improved wash performance on egg stains |
WO2001075087A2 (en) | 2000-04-03 | 2001-10-11 | Maxygen, Inc. | Subtilisin variants |
WO2001083559A2 (en) | 2000-04-28 | 2001-11-08 | Novozymes A/S | Production and use of protein variants having modified immunogenecity |
WO2001088107A2 (en) | 2000-05-12 | 2001-11-22 | Novozymes A/S | Alpha-amylase variants with altered 1,6-activity |
WO2001092502A1 (en) | 2000-06-02 | 2001-12-06 | Novozymes A/S | Cutinase variants |
WO2002012511A1 (en) | 2000-07-28 | 2002-02-14 | Consejo Superior De Investigaciones Científicas | Novel method for overproduction of lichenase in bacteria by isolating the genes directly from natural samples (lichenaturase) |
WO2002010183A1 (en) | 2000-07-31 | 2002-02-07 | Menzel, Rolf | Compositions and methods for directed gene assembly |
WO2002010355A2 (en) | 2000-08-01 | 2002-02-07 | Novozymes A/S | Alpha-amylase mutants with altered stability |
WO2002016547A2 (en) | 2000-08-21 | 2002-02-28 | Novozymes A/S | Subtilase enzymes |
WO2002018588A1 (en) | 2000-08-29 | 2002-03-07 | Novozymes A/S | Method for screening highly active proteases and inhibitors |
WO2002022796A1 (en) | 2000-09-11 | 2002-03-21 | University Of Maryland Biotechnology Institute | Calcium free subtilisin mutants |
US20020058592A1 (en) | 2000-09-28 | 2002-05-16 | Kostansek Edward Charles | Delivery system for cyclopropenes |
US20020043730A1 (en) | 2000-09-29 | 2002-04-18 | Chong Joshua Anthony | Continuous process for the preparation of encapsulated cyclopropenes |
US20020061822A1 (en) | 2000-09-29 | 2002-05-23 | Kostansek Edward Charles | Delivery systems for cyclopropenes requiring less water |
WO2002040997A2 (en) | 2000-10-02 | 2002-05-23 | Genencor International, Inc. | Production and use of proteins producing an altered immunogenic response |
WO2002031133A1 (en) | 2000-10-13 | 2002-04-18 | Novozymes A/S | Subtilase variants |
US20070044171A1 (en) | 2000-12-14 | 2007-02-22 | Kovalic David K | Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
CN1361279A (en) | 2000-12-28 | 2002-07-31 | 福建福大百特科技发展有限公司 | Lichenized bacillus L-25 keratinase and its encoding DNA |
US20040091474A1 (en) | 2001-01-08 | 2004-05-13 | Health Protection Agency | Degradation and detection of TSE infectivity |
US7151204B2 (en) | 2001-01-09 | 2006-12-19 | Monsanto Technology Llc | Maize chloroplast aldolase promoter compositions and methods for use thereof |
WO2002055679A2 (en) | 2001-01-10 | 2002-07-18 | Novozymes A/S | Thermostable lipolytic enzyme variant |
US20180168168A1 (en) | 2001-02-02 | 2018-06-21 | Novozymes Bioag A/S | Increasing plant yield with bacterial/fungal combinations |
US20080320615A1 (en) | 2001-02-02 | 2008-12-25 | Johnson Thomas D | Plant seed assemblies comprising bacterial/fungal antagonists |
US20160345588A1 (en) | 2001-02-02 | 2016-12-01 | Novozymes Bioag A/S | Increasing Plant Yield with Bacterial/Fungal Combinations |
WO2002062973A2 (en) | 2001-02-07 | 2002-08-15 | Novozymes A/S | Lipase variants |
WO2002068597A2 (en) | 2001-02-21 | 2002-09-06 | Diversa Corporation | Enzymes having alpha amylase activity and methods of use thereof |
WO2002068589A2 (en) | 2001-02-21 | 2002-09-06 | Diversa Corporation | Enzymes having alpha amylase activity and methods of use thereof |
WO2002066622A2 (en) | 2001-02-23 | 2002-08-29 | Novozymes A/S | Method of generating diversity into lipolytic enzymes and lipolytic enzyme genes |
US20020198107A1 (en) | 2001-02-26 | 2002-12-26 | Kostansek Edward Charles | Delivery systems for cyclopropenes |
WO2002077289A1 (en) | 2001-03-21 | 2002-10-03 | Hercules Incorporated | Methods for the synthesis of polynucleotides and combinatorial libraries of polynucleotides |
WO2002088340A2 (en) | 2001-05-02 | 2002-11-07 | Henkel Kommanditgesellschaft Auf Aktien | Alkaline protease variants and detergents and cleaning agents containing said alkaline protease variants |
US20200181593A1 (en) | 2001-05-15 | 2020-06-11 | Novozymes A/S | Alpha-amylase variant with altered properties |
WO2002095127A2 (en) | 2001-05-21 | 2002-11-28 | Novozymes A/S | Use of lipolytic enzymes for stickies control |
US20030082164A1 (en) | 2001-06-22 | 2003-05-01 | Drahos David Joseph | Novel biofungicide |
US20040197894A1 (en) | 2001-07-12 | 2004-10-07 | Fano Tina Sejersgard | Subtilase variants |
WO2003012071A2 (en) | 2001-08-03 | 2003-02-13 | Elitra Pharmaceuticals, Inc. | Nucleic acids of aspergillus fumigatus encoding industrial enzymes and methods of use |
WO2003014358A2 (en) | 2001-08-07 | 2003-02-20 | Henkel Kommanditgesellschaft Auf Aktien | Detergent and cleaning agent with hybrid alpha amylases |
US6773727B1 (en) | 2001-08-13 | 2004-08-10 | The United States Of America As Represented By The Secretary Of Agriculture | Use of gossypol and related terpenes for control of urban and agricultural pests |
WO2003016510A1 (en) | 2001-08-14 | 2003-02-27 | Pioneer Co., Ltd. | New biopesticide using gene from erwinia pyrifoliaewt#3, novel pathogen that affects asian pear trees |
WO2003016535A2 (en) | 2001-08-16 | 2003-02-27 | Dsm Ip Assets B.V. | Novel amylases and uses thereof |
WO2003018766A2 (en) | 2001-08-27 | 2003-03-06 | Syngenta Participations Ag | Self-processing plants and plant parts |
WO2003020030A1 (en) | 2001-09-03 | 2003-03-13 | The State Of Queensland Through Its Department Of Primary Industries | Synthetic fruitpiercing moth attractant |
US20030100450A1 (en) | 2001-10-18 | 2003-05-29 | Kostansek Edward Charles | Delivery system for cyclopropenes |
WO2003038082A2 (en) | 2001-10-31 | 2003-05-08 | Henkel Kommanditgesellschaft Auf Aktien | Novel alkaline protease variants and detergents and cleansers containing these novel alkaline protease variants |
US20130074202A1 (en) | 2001-12-04 | 2013-03-21 | Monsanto Technology Llc | Gene sequences and uses thereof in plants |
US20090158452A1 (en) | 2001-12-04 | 2009-06-18 | Johnson Richard G | Transgenic plants with enhanced agronomic traits |
US20050108791A1 (en) | 2001-12-04 | 2005-05-19 | Edgerton Michael D. | Transgenic plants with improved phenotypes |
US20150337329A1 (en) | 2001-12-04 | 2015-11-26 | Monsanto Technology Llc | Gene sequences and uses thereof in plants |
WO2003054184A1 (en) | 2001-12-20 | 2003-07-03 | Henkel Kommanditgesellschaft Auf Aktien | Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
WO2003054185A1 (en) | 2001-12-20 | 2003-07-03 | Henkel Kommanditgesellschaft Auf Aktien | Novel alkaline protease from bacillus gibsonii (dsm 14391) and washing and cleaning agents containing said novel alkaline protease |
WO2003055974A2 (en) | 2001-12-22 | 2003-07-10 | Henkel Kommanditgesellschaft Auf Aktien | Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
WO2003057713A2 (en) | 2001-12-31 | 2003-07-17 | Genencor International, Inc. | Proteases producing an altered immunogenic response and methods of making and using the same |
WO2003060112A1 (en) | 2002-01-16 | 2003-07-24 | Novozymes A/S | Lipolytic enzyme variants and method for their production |
WO2003062381A2 (en) | 2002-01-16 | 2003-07-31 | Genencor International, Inc. | Multiply-substituted protease variants |
CA2829859A1 (en) | 2002-01-16 | 2003-07-31 | Genencor International, Inc. | Multiply-substituted protease variants |
US20170342433A1 (en) | 2002-02-21 | 2017-11-30 | Monsanto Technology Llc | Expression of Microbial Proteins in Plants for Production of Plants with Improved Properties |
US20150299720A1 (en) | 2002-02-21 | 2015-10-22 | Monsanto Technology Llc | Expression of microbial proteins in plants for production of plants with improved properties |
US20040072694A1 (en) | 2002-02-25 | 2004-04-15 | Jacobson Richard Martin | Method to inhibit ethylene responses in plants |
WO2003087149A2 (en) | 2002-04-10 | 2003-10-23 | Novozymes A/S | Bacillus licheniformis mutant host cell |
WO2003093453A2 (en) | 2002-04-10 | 2003-11-13 | Novozymes A/S | Bacillus licheniformis mutant host cell |
US20050129662A1 (en) | 2002-04-17 | 2005-06-16 | Paolo Lameri | Use of vegetable oil as an adjuvant for substances having a fungicide, bactericide, insecticide and herbicide activity |
WO2003089614A2 (en) | 2002-04-18 | 2003-10-30 | Genencor International, Inc. | Production of functional antibodies in filamentous fungi |
US20040053425A1 (en) | 2002-04-19 | 2004-03-18 | Baylor College Of Medicine | Quantitative measurement of proteins using genetically-engineeredglucose oxidase fusion molecules |
WO2003089620A2 (en) | 2002-04-19 | 2003-10-30 | Diversa Corporation | Phospholipases, nucleic acids encoding them and methods for making and using them |
CN1465699A (en) | 2002-06-12 | 2004-01-07 | 大连轻工业学院 | Gene engineering of producing fructose by inulase hydrolyzing helianthus tuberosus |
EP2314698A1 (en) | 2002-06-14 | 2011-04-27 | Verenium Corporation | Xylanases, nucleic acids encoding them and methods for making and using them |
EP2298904A1 (en) | 2002-06-14 | 2011-03-23 | Verenium Corporation | Xylanases, nucleic acids encoding them and methods for making and using them |
WO2004003186A2 (en) | 2002-06-26 | 2004-01-08 | Novozymes A/S | Subtilases and subtilase variants having altered immunogenicity |
JP2004043660A (en) | 2002-07-12 | 2004-02-12 | Toto Ltd | Enzymic depilatory and enzymic depilation method |
KR20040006812A (en) | 2002-07-15 | 2004-01-24 | 주식회사 제노포커스 | Maltopentaose-producing amylase and process for producing maltopentaose |
US20040077502A1 (en) | 2002-08-06 | 2004-04-22 | Jacobson Richard Martin | Stable ethylene inhibiting compounds and methods for their preparation |
WO2004016752A2 (en) | 2002-08-14 | 2004-02-26 | The Regents Of The University Of California | Proteome-wide mapping of post-translational modifications using endonucleases |
US20120227131A1 (en) | 2002-10-02 | 2012-09-06 | Abad Mark S | Transgenic plants with enhanced agronomic traits |
WO2004032648A1 (en) | 2002-10-11 | 2004-04-22 | Novozymes A/S | Method of preparing a heat-treated product |
WO2004042049A1 (en) | 2002-10-24 | 2004-05-21 | Meiji Seika Kaisha, Ltd. | Method of degrading hardly degradable protein |
DE10260903A1 (en) | 2002-12-20 | 2004-07-08 | Henkel Kgaa | New perhydrolases |
WO2004064744A2 (en) | 2003-01-16 | 2004-08-05 | Genencor International Inc. | Methods for site-directed mutagenesis and targeted randomization |
DE10309803A1 (en) | 2003-03-05 | 2004-09-23 | Henkel Kgaa | New alpha-amylase variants, useful in cleaning and washing compositions and for desizing cotton, have improved activity in alkaline media, also nucleic acid that encodes them |
AU2017203481A1 (en) | 2003-03-06 | 2017-06-15 | Basf Enzymes Llc | Amylases, nucleic acids encoding them and methods for making and using them |
WO2004091544A2 (en) | 2003-03-06 | 2004-10-28 | Diversa Corporation | Amylases, nucleic acids encoding them and methods for making and using them |
WO2005032496A2 (en) | 2003-03-07 | 2005-04-14 | Diversa Corporation | Hydrolases, nucleic acids encoding them and mehods for making and using them |
WO2004080923A2 (en) | 2003-03-10 | 2004-09-23 | Novozymes A/S | Alcohol product processes |
WO2004081171A2 (en) | 2003-03-12 | 2004-09-23 | Danisco A/S | Variants of enzymes of the alpha-amylase family |
US20080044858A1 (en) | 2003-03-31 | 2008-02-21 | Novozymes, Inc. | Methods for producing biological substances in enzyme-deficient mutants of aspergillus niger |
US20100323448A1 (en) | 2003-03-31 | 2010-12-23 | Novozymes, Inc. | Methods For Producing Biological Substances In Enzyme-Deficient Mutants Of Aspergillus niger |
US20040191864A1 (en) | 2003-03-31 | 2004-09-30 | Novozymes Biotech, Inc. | Methods for producing biological substances in enzyme-deficient mutants of Aspergillus |
US20060228458A1 (en) | 2003-04-08 | 2006-10-12 | Alberto Sardo | Method for processing fruits and vegetables on the base of lecithin |
JP2004313022A (en) | 2003-04-11 | 2004-11-11 | Meiji Seika Kaisha Ltd | Endoglucanase mte1 and cellulase preparation containing the same |
JP2004313043A (en) | 2003-04-14 | 2004-11-11 | Kao Corp | Alkali protease |
WO2004099401A1 (en) | 2003-05-07 | 2004-11-18 | Novozymes A/S | Variant subtilisin enzymes (subtilases) |
US20040223962A1 (en) | 2003-05-07 | 2004-11-11 | Riordan Neil H. | Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism |
WO2004099400A2 (en) | 2003-05-09 | 2004-11-18 | Novozymes A/S | Variant lipolytic ensymes |
WO2005001036A2 (en) | 2003-05-29 | 2005-01-06 | Genencor International, Inc. | Novel trichoderma genes |
WO2004108765A2 (en) | 2003-06-10 | 2004-12-16 | Ace Biosciences A/S | Extracellular aspergillus polypeptides |
WO2004111219A1 (en) | 2003-06-19 | 2004-12-23 | Novozymes A/S | Improved proteases and methods for producing them |
WO2004111216A2 (en) | 2003-06-19 | 2004-12-23 | Novozymes A/S | Phospholipase variants |
WO2005003311A2 (en) | 2003-06-25 | 2005-01-13 | Novozymes A/S | Enzymes for starch processing |
WO2004113551A1 (en) | 2003-06-25 | 2004-12-29 | Novozymes A/S | Process for the hydrolysis of starch |
WO2005001064A2 (en) | 2003-06-25 | 2005-01-06 | Novozymes A/S | Polypeptides having alpha-amylase activity and polypeptides encoding same |
EP2404930A1 (en) | 2003-07-02 | 2012-01-11 | Verenium Corporation | Glucanases, nucleic acids encoding them and methods for making and using them |
EP2404928A1 (en) | 2003-07-02 | 2012-01-11 | Verenium Corporation | Glucanases, nucleic acids encoding them and methods for making and using them |
CN1594542A (en) | 2003-08-19 | 2005-03-16 | 中国农业科学院饲料研究所 | Aspergillus niger inulin endopeptidase gene and recombinant Pichia strain for expressing same |
US20050043179A1 (en) | 2003-08-21 | 2005-02-24 | Jacobson Richard Martin | Method to inhibit ethylene responses in plants |
WO2005019443A2 (en) | 2003-08-22 | 2005-03-03 | Novozymes A/S | Fungal alpha-amylase variants |
WO2005024002A1 (en) | 2003-09-11 | 2005-03-17 | Novozymes A/S | Recombinant production of antimicrobial agents |
WO2005035747A1 (en) | 2003-10-10 | 2005-04-21 | Novozymes A/S | Protease variants |
WO2005045018A1 (en) | 2003-10-28 | 2005-05-19 | Novozymes North America, Inc. | Hybrid enzymes |
WO2005052148A2 (en) | 2003-11-21 | 2005-06-09 | Genencor International, Inc. | Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates |
WO2005054475A1 (en) | 2003-12-03 | 2005-06-16 | Meiji Seika Kaisha, Ltd. | Endoglucanase stce and cellulase preparation containing the same |
WO2005056787A1 (en) | 2003-12-08 | 2005-06-23 | Meiji Seika Kaisha, Ltd. | Surfactant-tolerant cellulase and method of converting the same |
JP2005171409A (en) | 2003-12-10 | 2005-06-30 | Oji Paper Co Ltd | Method for improving pulp-bleaching ability of xylanase |
WO2005058014A1 (en) | 2003-12-16 | 2005-06-30 | Ultimate Nominees Pty Ltd | Fruit ripening method and liquid coating composition |
US20050137090A1 (en) | 2003-12-18 | 2005-06-23 | Alberto Sardo | Solutions of CIPC and of a terpene or of a terpene oil and their uses for the antigerminative treatment of bulbs or tubers |
US20050187107A1 (en) | 2003-12-23 | 2005-08-25 | Nitragin, Inc. | Methods and compositions providing agronomically beneficial effects in legumes and non-legumes |
WO2005073368A1 (en) | 2004-01-30 | 2005-08-11 | Lifenza Co., Ltd. | Protein with activity of hydrolyzing dextran, starch, mutan, inulin and levan, gene encoding the same, cell expressing the same, and production method thereof |
WO2005075652A1 (en) | 2004-02-03 | 2005-08-18 | Kyoto University | Process for producing modified ϝ-glutamyltranspeptidase (modified ggt) having enhanced glutaryl-7-aminosephalosporanic acid (gl-7-aca) acylase activity |
WO2005078074A2 (en) | 2004-02-13 | 2005-08-25 | Novozymes A/S | Protease variants |
WO2005079826A1 (en) | 2004-02-24 | 2005-09-01 | Ajinomoto Co., Inc. | Soothing agent and food for treating fatigue |
WO2005096804A2 (en) | 2004-03-08 | 2005-10-20 | Syngenta Participations Ag | Self-processing plants and plant parts |
WO2005086900A2 (en) | 2004-03-08 | 2005-09-22 | Diversa Corporation | Phospholipases, nucleic acids encoding them and methods for making and using them |
US20050214410A1 (en) | 2004-03-25 | 2005-09-29 | Iogen Bio-Products Corporation | Modified xylanases exhibiting improved expression |
EP2292773A1 (en) | 2004-03-25 | 2011-03-09 | Monsanto Technology LLC | Genes and uses for plant improvement |
US20090111155A1 (en) | 2004-03-25 | 2009-04-30 | Iogen Bio-Products Corporation | Modified xylanase exhibiting improved expression |
WO2005095592A2 (en) | 2004-04-02 | 2005-10-13 | Novozymes A/S | Subtilase variants having altered immunogenicity |
WO2005111203A2 (en) | 2004-04-08 | 2005-11-24 | Genencor International, Inc. | MUTANT α ΑMYLASES |
WO2005108537A1 (en) | 2004-04-27 | 2005-11-17 | Henkel Kommanditgesellschaft Auf Aktien | DETERGENTS COMPRISING A RINSING SURFACTANT AND A SPECIAL α-AMYLASE |
US20050250649A1 (en) | 2004-05-05 | 2005-11-10 | Jacobson Richard M | Humidity activated delivery systems for cyclopropenes |
WO2005113785A2 (en) | 2004-05-13 | 2005-12-01 | Novozymes North America, Inc. | A process of producing a fermentation product |
US20050261131A1 (en) | 2004-05-19 | 2005-11-24 | Basel Richard M | Compositions with cyclopropenes and adjuvants |
US20050261132A1 (en) | 2004-05-19 | 2005-11-24 | Kostansek Edward C | Compositions with cyclopropenes and metal-complexing agents |
WO2005115445A1 (en) | 2004-05-24 | 2005-12-08 | Novozymes A/S | Enzymes for pharmaceutical use |
WO2005117756A2 (en) | 2004-05-27 | 2005-12-15 | Genencor International, Inc. | Acid-stable alpha amylases having granular starch hydrolyzing activity and enzyme compositions |
WO2005118793A2 (en) | 2004-06-02 | 2005-12-15 | Henkel Kommanditgesellschaft Auf Aktien | Alkaline protease variants having improved performance and washing and cleaning agents containing said alkaline protease variants having improved performance |
WO2005124012A1 (en) | 2004-06-18 | 2005-12-29 | Henkel Kommanditgesellschaft Auf Aktien | New enzymatic bleaching system |
WO2005123911A2 (en) | 2004-06-21 | 2005-12-29 | Novozymes A/S | Proteases |
WO2005123914A1 (en) | 2004-06-21 | 2005-12-29 | Novozymes A/S | Improved methods of producing heterologous proteases |
US20050288189A1 (en) | 2004-06-24 | 2005-12-29 | Jacobson Richard M | Method for treating plants or plant parts |
WO2006002643A2 (en) | 2004-07-05 | 2006-01-12 | Novozymes A/S | Alpha-amylase variants with altered properties |
EP2295582A2 (en) | 2004-07-31 | 2011-03-16 | Monsanto Technology LLC | Genes and uses for plant improvement |
WO2006012902A2 (en) | 2004-08-02 | 2006-02-09 | Novozymes A/S | Creation of diversity in polypeptides |
WO2006012899A1 (en) | 2004-08-02 | 2006-02-09 | Novozymes A/S | Maltogenic alpha-amylase variants |
WO2006031554A2 (en) | 2004-09-10 | 2006-03-23 | Novozymes North America, Inc. | Methods for preventing, removing, reducing, or disrupting biofilm |
WO2006034710A1 (en) | 2004-09-27 | 2006-04-06 | Novozymes A/S | Enzyme granules |
WO2006037483A2 (en) | 2004-10-01 | 2006-04-13 | Henkel Kommanditgesellschaft Auf Aktien | Alpha-amylase variants stabilized against dimerization and/or multimerization, method for the production thereof, and detergents and cleansers containing these alpha-amylase variants |
WO2007044043A2 (en) | 2004-12-21 | 2007-04-19 | Monsanto Technology, Llc | Transgenic plants with enhanced agronomic traits |
WO2006066596A2 (en) | 2004-12-22 | 2006-06-29 | Novozymes A/S | Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate -binding module as second amino acid sequence |
US20140127753A1 (en) | 2004-12-22 | 2014-05-08 | Novozymes A/S | Enzymes for starch processing |
WO2006069290A2 (en) | 2004-12-22 | 2006-06-29 | Novozymes A/S | Enzymes for starch processing |
WO2006066594A2 (en) | 2004-12-23 | 2006-06-29 | Novozymes A/S | Alpha-amylase variants |
CN1814746A (en) | 2005-01-31 | 2006-08-09 | 中国科学院微生物研究所 | Nattokinase and its coding gene and clone and expressing method |
WO2006084470A2 (en) | 2005-02-10 | 2006-08-17 | Novozymes A/S | Enzymatic enantioselective ester or amide hydrolysis or synthesis |
WO2006088325A1 (en) | 2005-02-18 | 2006-08-24 | Inha-Industry Partnership Institute | Bacillus sp. i-52, a detergent- and oxidant-stable haloalkalophilic protease therefrom, a gene encoding the same and a use thereof |
US20170088474A1 (en) | 2005-02-23 | 2017-03-30 | Vitag Corporation | Manufacturing of Bioorganic-Augmented High Nitrogen Containing Inorganic Fertilizer |
US20060243009A1 (en) | 2005-02-23 | 2006-11-02 | Burnham Jeffrey C | Manufacturing of bioorganic-augmented high nitrogen-containing inorganic fertilizer |
WO2006114616A1 (en) | 2005-04-26 | 2006-11-02 | University Of Sussex | Engineered peroxidases with veratryl alcohol oxidase activity |
US20100204080A1 (en) | 2005-04-29 | 2010-08-12 | Ab Enzymes Oy | Novel Cellulases and Their Uses |
WO2006117432A1 (en) | 2005-04-29 | 2006-11-09 | Ab Enzymes Oy | Improved cellulases |
US20060246566A1 (en) | 2005-04-29 | 2006-11-02 | Ab Enzymes Gmbh | Novel cellulases and their uses |
US20060258534A1 (en) | 2005-05-16 | 2006-11-16 | Hill James D | Rhizobium leguminosarum strain and use thereof as plant inoculant |
US20060276336A1 (en) | 2005-06-02 | 2006-12-07 | Alberto Sardo | Process for the anti-germination and/or biocide treatment of bulbs or tubers by means of CIPC and a terpene or terpene oil |
WO2006136160A2 (en) | 2005-06-24 | 2006-12-28 | Novozymes A/S | Proteases for pharmaceutical use |
WO2006136159A2 (en) | 2005-06-24 | 2006-12-28 | Novozymes A/S | Lipases for pharmaceutical use |
US20100173773A1 (en) | 2005-06-30 | 2010-07-08 | Syngenta Crop Protection, Inc. | Method of reducing mycotoxin contamination of the harvest |
WO2007006305A1 (en) | 2005-07-08 | 2007-01-18 | Novozymes A/S | Subtilase variants |
CA2512256A1 (en) | 2005-07-15 | 2007-01-15 | Rohm And Haas Company | Compositions with cyclopropenes and adjuvants |
CA2512254A1 (en) | 2005-07-15 | 2007-01-15 | Rohm And Haas Company | Compositions with cyclopropenes and metal-complexing agents |
EP1764411A1 (en) | 2005-07-26 | 2007-03-21 | Kao Corporation | Alkaline xylanase |
WO2007020428A1 (en) | 2005-08-15 | 2007-02-22 | University Of Sussex | Novel peroxidases and uses |
WO2007019858A2 (en) | 2005-08-16 | 2007-02-22 | Novozymes A/S | Subtilases |
WO2007028088A2 (en) | 2005-09-02 | 2007-03-08 | Novozymes North America, Inc. | Methods for enhancing the dewaterability of sludge with alpha-amylase treatment |
WO2007025549A1 (en) | 2005-09-02 | 2007-03-08 | Novozymes A/S | Stabilization of concentrated liquid enzyme additives |
WO2007044993A2 (en) | 2005-10-12 | 2007-04-19 | Genencor International, Inc. | Use and production of storage-stable neutral metalloprotease |
US20070118916A1 (en) | 2005-10-14 | 2007-05-24 | Metanomics Gmbh | Process for the production of fine chemicals |
US20070117720A1 (en) | 2005-11-18 | 2007-05-24 | Jacobson Richard M | Compositions with cyclopropenes |
JP2007143405A (en) | 2005-11-24 | 2007-06-14 | Mitsubishi Gas Chem Co Inc | Catalase b gene and catalase b protein |
US20080148432A1 (en) | 2005-12-21 | 2008-06-19 | Mark Scott Abad | Transgenic plants with enhanced agronomic traits |
US8409836B2 (en) | 2005-12-22 | 2013-04-02 | Roal Oy | Treatment of cellulosic material and enzymes useful therein |
WO2007071820A1 (en) | 2005-12-22 | 2007-06-28 | Ab Enzymes Oy | Novel enzymes |
WO2007080197A2 (en) | 2006-01-16 | 2007-07-19 | Novozymes A/S | Immobilised enzymes |
WO2007087319A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Detergent compositions |
WO2007087243A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Detergent compositions |
WO2007087508A2 (en) | 2006-01-23 | 2007-08-02 | Novozymes A/S | Lipase variants |
US20070173430A1 (en) | 2006-01-23 | 2007-07-26 | The Procter & Gamble Company | Composition comprising a lipase and a bleach catalyst |
WO2007087318A2 (en) | 2006-01-23 | 2007-08-02 | The Procter & Gamble Company | Detergent compositions |
CN1834249A (en) | 2006-03-29 | 2006-09-20 | 浙江大学 | Fusion gene of beta-glucanase and xylanase, constitution method and application |
WO2007113241A1 (en) | 2006-03-31 | 2007-10-11 | Novozymes A/S | A stabilized liquid enzyme composition |
WO2007113292A2 (en) | 2006-04-04 | 2007-10-11 | Novozymes A/S | Mashing process |
US20070244020A1 (en) | 2006-04-13 | 2007-10-18 | Ab Enzymes Oy | Enzyme fusion proteins and their use |
WO2007122175A1 (en) | 2006-04-20 | 2007-11-01 | Novozymes A/S | Savinase variants having an improved wash performance on egg stains |
US20080175926A1 (en) | 2006-04-27 | 2008-07-24 | Gilbert Bompeix | Process for treating storage reservoirs contaminated with mycotoxins |
US20070265166A1 (en) | 2006-05-15 | 2007-11-15 | Eduardo Jose Bardella | Contacting crop plants with compositions |
US8420070B2 (en) | 2006-05-22 | 2013-04-16 | Westham Ltd. | Controlling sugar feeding insects |
WO2007142543A2 (en) | 2006-06-08 | 2007-12-13 | Encoate Holdings Limited | Novel bacteria and uses thereof |
WO2007146944A2 (en) | 2006-06-16 | 2007-12-21 | Syngenta Participations Ag | Catalytically inactive proteins and method for recovery of enzymes from plant-derived materials |
US20120006737A1 (en) | 2006-06-20 | 2012-01-12 | Cummins Filtration Ip, Inc. | Replaceable filter elements including plural filter media and related filtration systems, techniques and methods |
WO2007149699A2 (en) | 2006-06-21 | 2007-12-27 | Novozymes North America, Inc. | Desizing and scouring process |
WO2008000632A1 (en) | 2006-06-29 | 2008-01-03 | Dsm Ip Assets B.V. | A method for achieving improved polypeptide expression |
WO2008006881A1 (en) | 2006-07-13 | 2008-01-17 | Dsm Ip Assets B.V. | Use of bacterial amylases in feed for bovine animals |
WO2008010925A2 (en) | 2006-07-18 | 2008-01-24 | Danisco Us, Inc., Genencor Division | Protease variants active over a broad temperature range |
WO2008057637A2 (en) | 2006-07-21 | 2008-05-15 | Novozymes, Inc. | Methods of increasing secretion of polypeptides having biological activity |
US20080016766A1 (en) | 2006-07-24 | 2008-01-24 | Alberto Sardo | Device for thermal nebulisation of a liquid composition for treating fruits or vegetables and corresponding use |
JP2008022828A (en) | 2006-07-25 | 2008-02-07 | Kao Corp | Control of protease activation with surfactant |
WO2008015861A1 (en) | 2006-08-04 | 2008-02-07 | Amano Enzyme Inc. | Method for designing mutated enzyme, method for preparing the same and mutated enzyme |
US20180258442A1 (en) | 2006-08-17 | 2018-09-13 | Monsanto Technology Llc | Transgenic plants with enhanced agronomic traits |
US20110252501A1 (en) | 2006-08-17 | 2011-10-13 | Monsanto Technology Llc | Transgenic plants with enhanced agronomic traits |
EP1892529A1 (en) | 2006-08-23 | 2008-02-27 | Canon Kabushiki Kaisha | Enzyme electrode, enzyme electrode producing method, sensor and fuel cell each using enzyme electrode |
WO2008024372A2 (en) | 2006-08-23 | 2008-02-28 | Danisco Us, Inc., Genencor Division | Pullulanase variants with increased productivity |
TW200811294A (en) | 2006-08-25 | 2008-03-01 | Da Guang Biotechnology Co Ltd | A method of producing protein rich in functional peptide that may reduce triglycerides |
CN101134949A (en) | 2006-08-30 | 2008-03-05 | 中国农业科学院饲料研究所 | Beta-glucanase, encoding gene thereof, recombinant plasmid and bacterial strain and uses thereof |
WO2008073169A2 (en) | 2006-08-31 | 2008-06-19 | The Trustees Of The University Of Pennsylvania | Methods, compositions and kits comprising attenuated anthrax vaccines and methods of delivery |
US20080113867A1 (en) | 2006-11-09 | 2008-05-15 | Edward Charles Kostansek | Cyclopropene compositions |
US20150045535A1 (en) | 2006-11-29 | 2015-02-12 | Novozymes, Inc. | Bacillus Licheniformis Chromosome |
US20080145499A1 (en) | 2006-12-07 | 2008-06-19 | Alberto Sardo | Method for treating fruit or vegetables with phosphorous ions and corresponding compositions |
WO2008080093A2 (en) | 2006-12-21 | 2008-07-03 | Verenium Corporation | Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
WO2008079685A2 (en) | 2006-12-21 | 2008-07-03 | Novozymes A/S | Lipase variants for pharmaceutical use |
US20100144533A1 (en) | 2007-01-17 | 2010-06-10 | Gretchen Baier | Delivery of ethylene blocking and/or promoting agents |
KR100834708B1 (en) | 2007-02-01 | 2008-06-02 | 경북대학교 산학협력단 | Amylase gene isolated from Tricholoma matsutake and protein encoded thereby |
US20100092631A1 (en) | 2007-02-16 | 2010-04-15 | Alberto Sardo | Combinations of abietic acid esters with one or mote terpenes and use thereof for coating fruit or vegetables |
US20080206823A1 (en) | 2007-02-22 | 2008-08-28 | Richard Martin Jacobson | Method of making a complex |
WO2008112459A2 (en) | 2007-03-09 | 2008-09-18 | Danisco Us Inc., Genencor Division | Alkaliphilic bacillus species a-amylase variants, compositions comprising a-amylase variants, and methods of use |
WO2008110513A1 (en) | 2007-03-09 | 2008-09-18 | Novozymes A/S | Thermostable asparaginases |
WO2008112258A2 (en) | 2007-03-12 | 2008-09-18 | Danisco Us Inc. | Modified proteases |
US20100081636A1 (en) | 2007-03-30 | 2010-04-01 | Alberto Sardo | Method for the nematocidal treatment of plants using eugenol and/or lecithin(s) and/or derivatives thereof |
WO2008122640A2 (en) | 2007-04-09 | 2008-10-16 | Novozymes A/S | An enzymatic treatment of skin and hide degreasing |
US7989393B2 (en) | 2007-04-09 | 2011-08-02 | Novosymes Biologicals, Inc. | Methods of controlling algae with thaxtomin and thaxtomin compositions |
WO2008128974A1 (en) | 2007-04-20 | 2008-10-30 | Dsm Ip Assets B.V. | Asparaginase enzyme variants and uses thereof |
WO2008128975A1 (en) | 2007-04-20 | 2008-10-30 | Dsm Ip Assets B.V. | Novel asparaginases and uses thereof |
WO2008141281A1 (en) | 2007-05-10 | 2008-11-20 | Danisco Us Inc., Genencor Division | A modified secretion system to increase expression of polypeptides in bacteria |
WO2008144024A2 (en) | 2007-05-18 | 2008-11-27 | Agion Technologies, Inc. | Disinfecting methods and compositions |
WO2008153805A2 (en) | 2007-05-30 | 2008-12-18 | Danisco Us, Inc., Genencor Division | Improved variants of the bacillus licheniformis alpha-amylase |
US20080299613A1 (en) | 2007-05-31 | 2008-12-04 | Novozymes, Inc. | Compositions for degrading cellulosic material |
US20160032267A1 (en) | 2007-06-06 | 2016-02-04 | Danisco Us Inc. | Methods for improving multiple protein properties |
WO2008153934A2 (en) | 2007-06-06 | 2008-12-18 | Danisco Us, Inc., Genencor Division | Methods for improving protein performance |
WO2008153935A2 (en) | 2007-06-06 | 2008-12-18 | Danisco Us, Inc., Genencor Division | Methods for improving protein properties |
WO2008148845A2 (en) | 2007-06-07 | 2008-12-11 | Novozymes A/S | Method of preparing a dough-based product |
WO2009005647A2 (en) | 2007-06-27 | 2009-01-08 | Bioverdant, Inc. | Compounds and process to prepare chiral intermediates for synthesis of paroxetine |
CN101348795A (en) | 2007-07-19 | 2009-01-21 | 中国科学院武汉病毒研究所 | Encoding gene of glucose oxidase, preparation and use thereof |
CN101348794A (en) | 2007-07-19 | 2009-01-21 | 中国科学院武汉病毒研究所 | Encoding gene of high activity glucose oxidase, preparation and use thereof |
US20090035380A1 (en) | 2007-08-03 | 2009-02-05 | Edward Charles Kostansek | Oil formulations |
WO2009021867A2 (en) | 2007-08-10 | 2009-02-19 | Henkel Ag & Co. Kgaa | Agents containing proteases |
WO2009026397A2 (en) | 2007-08-20 | 2009-02-26 | Fraunhofer Usa, Inc. | Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods |
CN101139556A (en) | 2007-08-21 | 2008-03-12 | 华东理工大学 | Highly effective production method for recombinant alpha-glucanase fusion protein and related expression carrier and bacterial strain |
US20090077684A1 (en) | 2007-09-17 | 2009-03-19 | Rohm And Haas Company | Compositions and methods for the modification of physiological responses in plants |
WO2009037279A1 (en) | 2007-09-18 | 2009-03-26 | Basf Plant Science Gmbh | Plants with increased yield |
US20090087888A1 (en) | 2007-10-01 | 2009-04-02 | Subash Buddoo | Production of monatin stereoisomers |
CN101173226A (en) | 2007-10-22 | 2008-05-07 | 中国农业大学 | Pichia pastoris phaff recombined bacterium and uses thereof |
WO2009058518A1 (en) | 2007-10-31 | 2009-05-07 | Danisco Us Inc., Genencor Division | Use and production of neutral metallproteases in a serine protease-free background |
US20100021587A1 (en) | 2007-11-05 | 2010-01-28 | Danisco Us Inc., Genencor Division | VARIANTS OF BACILLUS sp. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES |
US20110269210A1 (en) | 2007-11-05 | 2011-11-03 | Danisco Us Inc. | Alpha-amylase variants with altered properties |
US20090252828A1 (en) | 2007-11-05 | 2009-10-08 | Danisco Us Inc., Genencor Division | Alpha-amylase variants with altered properties |
US20090209026A1 (en) | 2007-11-05 | 2009-08-20 | Danisco Us Inc., Genencor Division | Alpha-amylase variants with altered properties |
US20090117642A1 (en) | 2007-11-05 | 2009-05-07 | Power Scott D | Alpha-amylase variants with altered properties |
US20090238923A1 (en) | 2007-11-05 | 2009-09-24 | Danisco Us Inc., Genencor Division | Variants of bacillus licheniformis alpha-amylase with increased thermostability and/or decreased calcium dependence |
US20130011882A1 (en) | 2007-11-05 | 2013-01-10 | Danisco Us Inc. | Alpha-amylase variants with altered properties |
WO2009061379A2 (en) | 2007-11-05 | 2009-05-14 | Danisco Us Inc., Genencor Division | Alpha-amylase variants with altered properties |
US20090118492A1 (en) | 2007-11-06 | 2009-05-07 | Richard Martin Jacobson | Method for making inclusion complex |
US20110003694A1 (en) | 2007-11-09 | 2011-01-06 | Zone Artisanale La Crau Route Nationale 7 | Use of solutions of mint oil or of l-carvone for the fungicidal and/or anti-germinating treatment of bulbs and/or tubers |
US20110008475A1 (en) | 2007-11-09 | 2011-01-13 | Alberto Sardo | Use of an emulsion of mint oil or of l-carvone for the fungicidal treatment of fruit, vegetables or plants |
WO2009062942A2 (en) | 2007-11-12 | 2009-05-22 | Novozymes A/S | Dual affinity polypeptides for purification |
WO2009071550A1 (en) | 2007-12-04 | 2009-06-11 | Novozymes A/S | Protease variants for pharmaceutical use |
WO2009075682A1 (en) | 2007-12-12 | 2009-06-18 | Novozymes A/S | Mashing process |
WO2009074650A2 (en) | 2007-12-12 | 2009-06-18 | Novozymes A/S | Brewing process |
WO2009075860A2 (en) | 2007-12-12 | 2009-06-18 | Monsanto Technology, Llc | Transgenic plants with enhanced agronomic traits |
CN105623937A (en) | 2007-12-12 | 2016-06-01 | 诺维信公司 | Saccharifying method |
WO2009076655A2 (en) | 2007-12-13 | 2009-06-18 | University Of Washington | Synthetic enzymes derived from computational design |
US20090155415A1 (en) | 2007-12-14 | 2009-06-18 | Novozymes A/S | Laccase for detoxification of feed products |
US20090162480A1 (en) | 2007-12-20 | 2009-06-25 | Novozymes A/S | Cutinase for detoxification of feed products |
WO2009083607A1 (en) | 2008-01-03 | 2009-07-09 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disorders |
US20090181874A1 (en) | 2008-01-11 | 2009-07-16 | Philip Frank Souter | Cleaning And/Or Treatment Compositions |
US20110039751A1 (en) | 2008-01-11 | 2011-02-17 | Philip Frank Souter | Cleaning and/or treatment compositions |
WO2009098229A2 (en) | 2008-02-04 | 2009-08-13 | Danisco Us Inc., Genencor Division | A method of preparing food products using ts23 alpha-amylase |
WO2009100138A2 (en) | 2008-02-04 | 2009-08-13 | Danisco Us Inc., Genencor Division | Variants of bacillus stearothermophilus alpha-amylase and uses thereof |
WO2009100102A2 (en) | 2008-02-04 | 2009-08-13 | Danisco Us Inc., Genencor Division | Ts23 alpha-amylase variants with altered properties |
WO2009100990A1 (en) | 2008-02-13 | 2009-08-20 | Dsm Ip Assets B.V. | Process for the production of a peptide |
WO2009104622A1 (en) | 2008-02-18 | 2009-08-27 | 明治製菓株式会社 | Thermotolerant catalase |
US20090217463A1 (en) | 2008-02-29 | 2009-09-03 | Philip Frank Souter | Detergent composition comprising lipase |
US20090217464A1 (en) | 2008-02-29 | 2009-09-03 | Philip Frank Souter | Detergent composition comprising lipase |
US20090221033A1 (en) | 2008-02-29 | 2009-09-03 | Novozymes A/S | Polypeptides Having Lipase Activity And Polynucleotides Encoding Same |
US20090221034A1 (en) | 2008-02-29 | 2009-09-03 | Novozymes A/S | Lipolytic Enzyme Variant With Improved Stability And Polynucleotides Encoding Same |
WO2009108941A2 (en) | 2008-02-29 | 2009-09-03 | University Of Central Florida Research Foundation, Inc. | Production and use of plant degrading materials |
US9102933B1 (en) | 2008-03-11 | 2015-08-11 | Charanjit Sandhu | Targeted pectin hydrolysis by recombinant E. coli expressing chimeric pectinases to facilitate coffee fermentation |
US20090230350A1 (en) | 2008-03-13 | 2009-09-17 | Richard Martin Jacobson | Cyclopropene complex compositions |
EP2100948A1 (en) | 2008-03-14 | 2009-09-16 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP2100950A1 (en) | 2008-03-14 | 2009-09-16 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
WO2009112992A1 (en) | 2008-03-14 | 2009-09-17 | The Procter & Gamble Company | Automatic detergent dishwashing composition |
WO2009118375A2 (en) | 2008-03-26 | 2009-10-01 | Novozymes A/S | Stabilized liquid enzyme compositions |
US20090253579A1 (en) | 2008-04-03 | 2009-10-08 | Heiman Daniel F | Methods of Applying Ethylene Biosynthesis Inhibitor Compositions by Thermal Fogging |
US20090253578A1 (en) | 2008-04-03 | 2009-10-08 | Heiman Daniel F | Ethylene Biosynthesis Inhibitor Compositions Suitable for Thermal Fogging Applications |
WO2009126773A1 (en) | 2008-04-11 | 2009-10-15 | Danisco Us Inc., Genencor Division | Alpha-glucanase and oral care composition containing the same |
WO2009133096A2 (en) | 2008-04-29 | 2009-11-05 | Dsm Ip Assets B.V. | β-LACTAM PRODUCING STRAINS |
WO2009135049A1 (en) | 2008-04-30 | 2009-11-05 | Novus International Inc. | Methods and compositions of plant micronutrients |
WO2009134670A2 (en) | 2008-04-30 | 2009-11-05 | Danisco Us Inc., Genencor Division | New chimeric alpha-amylase variants |
WO2009133177A1 (en) | 2008-04-30 | 2009-11-05 | Novozymes A/S | Isolated peptides having phospholipase inhibitory activity |
EP2116136A1 (en) | 2008-05-08 | 2009-11-11 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | Novel phytases |
WO2009149200A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc. | Compositions and methods comprising variant microbial proteases |
WO2009149145A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc., Genencor Division | Compositions and methods comprising variant microbial proteases |
WO2009149395A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc., Genencor Division | Variant alpha-amylases from bacillus subtilis and methods of use, thereof |
WO2009149144A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc. | Compositions and methods comprising variant microbial proteases |
WO2009149271A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc. | Production of glucose from starch using alpha-amylases from bacillus subtilis |
WO2009149130A2 (en) | 2008-06-06 | 2009-12-10 | Danisco Us Inc. | Geobacillus stearothermophilus alpha-amylase (amys) variants with improved properties |
CN101298604A (en) | 2008-06-25 | 2008-11-05 | 天津科技大学 | High-temperature acid-resistant alpha-amylase mutant strain and construction method thereof |
WO2009158716A1 (en) | 2008-06-28 | 2009-12-30 | The Donald Danforth Plant Science Center | Improved protein production and storage in plants |
WO2009158694A1 (en) | 2008-06-28 | 2009-12-30 | The Donald Danforth Plant Science Center | Improved protein production and storage in plants |
JP2010044058A (en) | 2008-07-15 | 2010-02-25 | Kikkoman Corp | Enzyme immunoassay using enzyme labeled antibody |
EP2145904A1 (en) | 2008-07-18 | 2010-01-20 | Basf Se | Method for enzyme-catalysed hydrolysis of polyacrylic acid esters and esterases to be used |
US20100047408A1 (en) | 2008-08-25 | 2010-02-25 | Todd Bryan Edgington | Banana Treatments |
WO2010027857A2 (en) | 2008-08-26 | 2010-03-11 | University Of Georgia Research Foundation, Inc. | Methods, microorganisms, and compositions for plant biomass processing |
WO2010027755A1 (en) | 2008-08-27 | 2010-03-11 | The Procter & Gamble Company | Cleaning and/or treatment compositions |
WO2010022518A1 (en) | 2008-08-29 | 2010-03-04 | Iogen Energy Corporation | Modified beta-glucosidases with improved stability |
EP2166092A1 (en) | 2008-09-18 | 2010-03-24 | The Procter and Gamble Company | Detergent composition |
US20110244095A1 (en) | 2008-09-22 | 2011-10-06 | Xeda International | Method for Coating Food Products |
WO2010036515A1 (en) | 2008-09-25 | 2010-04-01 | Danisco Us Inc. | Alpha-amylase blends and methods for using said blends |
WO2010036970A2 (en) | 2008-09-25 | 2010-04-01 | Fraunhofer Usa, Inc. | Influenza vaccines, antigens, compositions, and methods |
WO2010039840A1 (en) | 2008-09-30 | 2010-04-08 | Novozymes, Inc. | Methods for producing polypeptides in enzyme-deficient mutants of fusarium venenatum |
WO2010053161A1 (en) | 2008-11-06 | 2010-05-14 | ユニチカ株式会社 | Modified flavin-adenine-dinucleotide-dependent glucose dehydrogenase |
CN101659948A (en) | 2008-11-10 | 2010-03-03 | 中国农业大学 | Heat resistant xylanase as well as coding gene and application thereof |
WO2010056640A2 (en) | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Compositions and methods comprising serine protease variants |
WO2010056653A2 (en) | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Proteases comprising one or more combinable mutations |
WO2010056671A1 (en) | 2008-11-11 | 2010-05-20 | Danisco Us Inc. | Compositions and methods comprising a subtilisin variant |
US20190360012A1 (en) | 2008-11-18 | 2019-11-28 | Novozymes, Inc. | Methods and compositions for degrading cellulosic material |
US20100124769A1 (en) | 2008-11-18 | 2010-05-20 | Novozymes, Inc. | Methods and compositions for degrading cellulosic material |
US20170247730A1 (en) | 2008-11-18 | 2017-08-31 | Novozymes, Inc. | Methods and compositions for degrading cellulosic material |
CN101457230A (en) | 2008-12-08 | 2009-06-17 | 江南大学 | High efficiency preparation method of high temperature alpha-amylase and mutant thereof |
WO2010074999A1 (en) | 2008-12-15 | 2010-07-01 | Danisco Us Inc. | Hybrid alpha-amylases |
WO2010072225A1 (en) | 2008-12-23 | 2010-07-01 | Danisco A/S | Polypeptides with xylanase activity |
WO2010072224A1 (en) | 2008-12-23 | 2010-07-01 | Danisco A/S | Polypeptides with xylanase activity |
WO2010078462A1 (en) | 2008-12-31 | 2010-07-08 | Solae, Llc | Protein hydrolysate compositions |
CN101870956A (en) | 2009-01-12 | 2010-10-27 | 北京挑战生物技术有限公司 | Cellulase-producing fungus agent and application thereof |
CN101492661A (en) | 2009-01-16 | 2009-07-29 | 江南大学 | Clone, expression of beta-glucosidase gene, and preparation for gentian oligose |
US20100292080A1 (en) | 2009-02-13 | 2010-11-18 | Bayer Cropscience Ag | Use of succinate dehydrogenase inhibitors for extending shelf life of fruits and vegetables |
CN101824401A (en) | 2009-03-03 | 2010-09-08 | 福建福大百特科技发展有限公司 | Glucanase and coding nucleic acid and expression thereof |
US20110321191A1 (en) | 2009-03-05 | 2011-12-29 | Rosichan Jeffrey L | Control of targeted turnover of key ethylene hormone signaling pathway proteins to modulate ethylene sensitivity in plants |
WO2010104675A1 (en) | 2009-03-10 | 2010-09-16 | Danisco Us Inc. | Bacillus megaterium strain dsm90-related alpha-amylases, and methods of use, thereof |
WO2010102982A1 (en) | 2009-03-10 | 2010-09-16 | Dsm Ip Assets B.V. | Method for improving the yield of a polypeptide |
WO2010115021A2 (en) | 2009-04-01 | 2010-10-07 | Danisco Us Inc. | Compositions and methods comprising alpha-amylase variants with altered properties |
WO2010115156A2 (en) | 2009-04-03 | 2010-10-07 | Synthetic Genomics, Inc. | Endophytic fungus and uses therefor |
WO2010121933A1 (en) | 2009-04-22 | 2010-10-28 | Dsm Ip Assets B.V. | Process for the production of a recombinant polypeptide of interest |
WO2010123754A1 (en) | 2009-04-24 | 2010-10-28 | Danisco Us Inc. | Proteases with modified pro regions |
WO2010132157A2 (en) | 2009-05-11 | 2010-11-18 | Danisco Us Inc. | Improved production of maltotetraose syrup using a pseudomonas saccharophila maltotetraohydrolase variant and a debranching enzyme |
US20100298147A1 (en) | 2009-05-19 | 2010-11-25 | Alberto Sardo | Concentrated formulations of cipc in a dialkylene glycol and uses thereof for the anti-germinating treatment of bulbs or tubers |
WO2010135499A1 (en) | 2009-05-21 | 2010-11-25 | Danisco Us Inc. | Dish detergent comprising bleaching enzymes |
WO2010138754A1 (en) | 2009-05-29 | 2010-12-02 | Novozymes, Inc. | Methods for enhancing the degradation or conversion of cellulosic material |
WO2010135836A1 (en) | 2009-05-29 | 2010-12-02 | Iogen Energy Corporation | Novel beta-glucosidase enzymes |
WO2010148148A2 (en) | 2009-06-16 | 2010-12-23 | Codexis, Inc. | β-GLUCOSIDASE VARIANTS |
US20140256018A1 (en) | 2009-06-16 | 2014-09-11 | Codexis, Inc. | Beta-glucosidase variants |
US20150064766A1 (en) | 2009-06-16 | 2015-03-05 | Codexis, Inc. | Beta-glucosidase variants |
US20110014334A1 (en) | 2009-07-14 | 2011-01-20 | Giovanni Regiroli | Treatment of Produce |
CN101962633A (en) | 2009-07-23 | 2011-02-02 | 福建福大百特科技发展有限公司 | Alpha-amylase, encoding gene and expression thereof |
WO2011014278A1 (en) | 2009-07-31 | 2011-02-03 | Danisco Us Inc. | Proteases with modified pre-pro regions |
KR20110013726A (en) | 2009-08-03 | 2011-02-10 | 한국화학연구원 | Thermostable coprinus cinereus peroxidase mutant protein |
US20110034335A1 (en) | 2009-08-06 | 2011-02-10 | James Daly | Treatment of Ornamental Plants |
KR20110017208A (en) | 2009-08-13 | 2011-02-21 | 한국생명공학연구원 | Novel bacillus sp. hy-20 strain isolated from apis melifera and xylanase produced from it |
WO2011020852A1 (en) | 2009-08-19 | 2011-02-24 | Danisco A/S | Variants of glucoamylase |
WO2011036263A1 (en) | 2009-09-25 | 2011-03-31 | Novozymes A/S | Subtilase variants |
WO2011041391A1 (en) | 2009-09-29 | 2011-04-07 | Fraunhofer Usa, Inc. | Influenza hemagglutinin antibodies, compositions, and related methods |
US20140075603A1 (en) | 2009-09-30 | 2014-03-13 | Novozymes, Inc. | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
WO2011046815A1 (en) | 2009-10-16 | 2011-04-21 | Bunge Oils, Inc. | Oil degumming methods |
WO2011046812A1 (en) | 2009-10-16 | 2011-04-21 | Verenium Corporation | Phospholipases, nucleic acids encoding them and methods for making and using them |
WO2011048852A1 (en) | 2009-10-19 | 2011-04-28 | バイオアイ株式会社 | Pectin lyase, pectin lyase gene, enzyme preparation, and method for production of single cells of plant tissue |
US20110099671A1 (en) | 2009-10-23 | 2011-04-28 | Novozymes, Inc. | Cellobiohydrolase variants and polynucleotides encoding same |
US20140017737A1 (en) | 2009-10-23 | 2014-01-16 | Novozymes, Inc. | Cellobiohydrolase variants and polynucleotides encoding same |
WO2011057140A1 (en) | 2009-11-06 | 2011-05-12 | Novozymes, Inc. | Compositions for saccharification of cellulosic material |
US20210254115A1 (en) | 2009-11-06 | 2021-08-19 | Agrivida, Inc. | Plants expressing cell wall degrading enzymes and expression vectors |
WO2011057163A2 (en) | 2009-11-06 | 2011-05-12 | Agrivida, Inc. | Intein-modified enzymes, their production and industrial applications |
WO2011057101A1 (en) | 2009-11-06 | 2011-05-12 | Agrivida, Inc. | Intein-modified enzymes, their production and industrial applications |
WO2011057159A1 (en) | 2009-11-06 | 2011-05-12 | Agrivida, Inc. | Plants expressing cell wall degrading enzymes and expression vectors |
US20120272572A1 (en) | 2009-11-18 | 2012-11-01 | Richard Martin Jacobson | Bonded fiber matrix containing encapsulation complex |
WO2011066187A1 (en) | 2009-11-25 | 2011-06-03 | Codexis, Inc. | Recombinant thermoascus aurantiacus beta-glucosidase variants for production of fermentable sugars from cellulosic biomass |
WO2011068297A1 (en) | 2009-12-01 | 2011-06-09 | Korea Research Institute Of Chemical Technology | Peroxidase variant having improved radical stability |
WO2011068050A1 (en) | 2009-12-05 | 2011-06-09 | 天野エンザイム株式会社 | Mutant enzyme and application thereof |
WO2011072099A2 (en) | 2009-12-09 | 2011-06-16 | Danisco Us Inc. | Compositions and methods comprising protease variants |
WO2011072117A1 (en) | 2009-12-09 | 2011-06-16 | The Procter & Gamble Company | Fabric and home care products |
WO2011076897A1 (en) | 2009-12-22 | 2011-06-30 | Novozymes A/S | Use of amylase variants at low temperature |
WO2011076123A1 (en) | 2009-12-22 | 2011-06-30 | Novozymes A/S | Compositions comprising boosting polypeptide and starch degrading enzyme and uses thereof |
CN102021191A (en) | 2009-12-24 | 2011-04-20 | 江南大学 | Method for evolving beta-glucanase in vitro |
CN101899458A (en) | 2009-12-24 | 2010-12-01 | 江南大学 | High-yield and temperature-resistant beta-dextranase pichia pastoris and construction thereof |
US20120282380A1 (en) | 2009-12-28 | 2012-11-08 | Nazir Mir | Method of handling bananas |
WO2011080267A2 (en) | 2009-12-29 | 2011-07-07 | Novozymes A/S | Polypetides having detergency enhancing effect |
US20110154873A1 (en) | 2009-12-30 | 2011-06-30 | Vitag Corporation | Bioorganically-augmented high value fertilizer |
WO2011080354A1 (en) | 2010-01-04 | 2011-07-07 | Novozymes A/S | Alpha-amylases |
WO2011080353A1 (en) | 2010-01-04 | 2011-07-07 | Novozymes A/S | Stabilization of alpha-amylases towards calcium depletion and acidic ph |
WO2011080352A1 (en) | 2010-01-04 | 2011-07-07 | Novozymes A/S | Alpha-amylases |
WO2011082425A2 (en) | 2010-01-04 | 2011-07-07 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2011082429A1 (en) | 2010-01-04 | 2011-07-07 | Novozymes A/S | Alpha-amylases |
JP2011139677A (en) | 2010-01-08 | 2011-07-21 | Unitika Ltd | Modified flavine-adenine-dinucleotide-dependent glucose dehydrogenase |
WO2011091370A1 (en) | 2010-01-25 | 2011-07-28 | Allergan, Inc. | Methods of intracellular conversion of single-chain proteins into their di-chain form |
US20130072383A1 (en) | 2010-02-08 | 2013-03-21 | Alberto Sardo | Method for anti-sprouting and possibly fungicidal treatment of bulbs and/or tubers using clove oil and mint oil |
EP3428260A2 (en) | 2010-02-10 | 2019-01-16 | The Procter & Gamble Company | Cleaning composition comprising amylase variants with high stability in the presence of a chelating agent |
US20110195481A1 (en) | 2010-02-10 | 2011-08-11 | Novozymes A/S | Variants And Compositions Comprising Variants With High Stability In Presence Of A Chelating Agent |
EP2357220A1 (en) | 2010-02-10 | 2011-08-17 | The Procter & Gamble Company | Cleaning composition comprising amylase variants with high stability in the presence of a chelating agent |
US20180010111A1 (en) | 2010-02-10 | 2018-01-11 | Novozymes A/S | Variants and compositions comprising variants with high stability in presence of a chelating agent |
US20190359961A1 (en) | 2010-02-10 | 2019-11-28 | Novozymes A/S | Variants and compositions comprising variants with high stability in presence of a chelating agent |
US20230002748A1 (en) | 2010-02-10 | 2023-01-05 | Novozymes A/S | Variants and compositions comprising variants with high stability in presence of a chelating agent |
US20210317431A1 (en) | 2010-02-10 | 2021-10-14 | Novozymes A/S | Variants and compositions comprising variants with high stability in presence of a chelating agent |
EP3730595A2 (en) | 2010-02-10 | 2020-10-28 | The Procter & Gamble Company | Cleaning composition comprising amylase variants with high stability in the presence of a chelating agent |
US20200270593A1 (en) | 2010-02-10 | 2020-08-27 | Novozymes A/S | Variants and compositions comprising variants with high stability in presence of a chelating agent |
US20130065764A1 (en) | 2010-03-01 | 2013-03-14 | Rohm And Haas Company | Oil formulations comprising cylcopropene compounds |
WO2011110625A1 (en) | 2010-03-11 | 2011-09-15 | Henkel Ag & Co. Kgaa | Performance-enhanced protease variant |
KR20110106174A (en) | 2010-03-22 | 2011-09-28 | 한국해양연구원 | Cold-active and thermostable cellulase gene |
WO2011126832A2 (en) | 2010-03-30 | 2011-10-13 | University Of Central Florida Research Foundation, Inc. | Multifunctional silica-based compositions and gels, methods of making them, and methods of using them |
WO2011121768A1 (en) | 2010-03-31 | 2011-10-06 | 明治製菓株式会社 | Novel cellulase gene |
GB2479462A (en) | 2010-04-09 | 2011-10-12 | Univ Exeter | Polysaccharide degrading enzymes from Coleoptera insects |
WO2011128712A1 (en) | 2010-04-12 | 2011-10-20 | Stellenbosch University | Biofuel production |
WO2011127820A1 (en) | 2010-04-14 | 2011-10-20 | Novozymes A/S | Processes for producing fermentation products |
WO2011130076A1 (en) | 2010-04-15 | 2011-10-20 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2011130222A2 (en) | 2010-04-15 | 2011-10-20 | Danisco Us Inc. | Compositions and methods comprising variant proteases |
US20130156835A1 (en) | 2010-04-16 | 2013-06-20 | Alberto Sardo | Novel formulations of active ingredient(s) of plant origin or synthetic analogues thereof or of extract(s) of plant origin containing same, and of lecithin |
JP2011223962A (en) | 2010-04-22 | 2011-11-10 | Osaka Prefecture Univ | New cellulase |
WO2011134916A1 (en) | 2010-04-27 | 2011-11-03 | Dsm Ip Assets B.V. | Novel asparaginase enzyme |
WO2011140364A1 (en) | 2010-05-06 | 2011-11-10 | Danisco Us Inc. | Compositions and methods comprising subtilisin variants |
WO2011140316A1 (en) | 2010-05-06 | 2011-11-10 | The Procter & Gamble Company | Consumer products with protease variants |
JP2011234685A (en) | 2010-05-12 | 2011-11-24 | Kao Corp | Recombinant microorganism |
US20110293801A1 (en) | 2010-05-25 | 2011-12-01 | Deirdre Margaret Holcroft | Waxy Coatings on Plant Parts |
WO2011153516A2 (en) | 2010-06-03 | 2011-12-08 | Mascoma Corporation | Yeast expressing saccharolytic enzymes for consolidated bioprocessing using starch and cellulose |
US20110312057A1 (en) | 2010-06-21 | 2011-12-22 | Toyota Motor Engineering & Manufacturing North America, Inc. | Lipase-containing polymeric coatings for the facilitated removal of fingerprints |
US20130269061A1 (en) | 2010-06-25 | 2013-10-10 | Agrivida, Inc. | Methods and compositions for processing biomass with elevated levels of starch |
WO2012000892A1 (en) | 2010-06-29 | 2012-01-05 | Dsm Ip Assets B.V. | Polypeptide having or assisting in carbohydrate material degrading activity and uses thereof |
US20120004108A1 (en) | 2010-07-02 | 2012-01-05 | Yueqian Zhen | Coated powder particles |
WO2012013197A2 (en) | 2010-07-30 | 2012-02-02 | Aalborg Universitet | Aspergillus encoding beta-glucosidases and nucleic acids encoding same |
EP2415863A1 (en) | 2010-08-03 | 2012-02-08 | B.R.A.I.N. | Mutant glucose oxidase |
WO2012016960A1 (en) | 2010-08-04 | 2012-02-09 | Bayer Pharma Aktiengesellschaft | Genomics of actinoplanes utahensis |
WO2012021395A1 (en) | 2010-08-12 | 2012-02-16 | Novozymes, Inc. | Compositions comprising a polypeptide having cellulolytic enhancing activity and a sulfur-containing compound and uses thereof |
WO2012021400A1 (en) | 2010-08-12 | 2012-02-16 | Novozymes, Inc. | Compositions comprising a polypeptide having cellulolytic enhancing activity and a heterocyclic compound and uses thereof |
WO2012021394A1 (en) | 2010-08-12 | 2012-02-16 | Novozymes, Inc. | Compositions comprising a polypeptide having cellulolytic enhancing activity and a quinone compound and uses thereof |
US20180019412A1 (en) | 2010-08-12 | 2018-01-18 | Novozymes, Inc. | Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Quinone Compound And Uses Thereof |
WO2012021399A1 (en) | 2010-08-12 | 2012-02-16 | Novozymes, Inc. | Compositions comprising a polypeptide having cellulolytic enhancing activity and a nitrogen-containing compound and uses thereof |
WO2012021883A2 (en) | 2010-08-13 | 2012-02-16 | Dyadic International, Inc. | Novel fungal enzymes |
WO2012027374A2 (en) | 2010-08-23 | 2012-03-01 | Dyadic International (Usa) Inc. | Novel fungal carbohydrate hydrolases |
WO2012027282A2 (en) | 2010-08-23 | 2012-03-01 | Codexis, Inc. | Recombinant lignocellulose degradation enzymes for the production of soluble sugars from cellulosic biomass |
WO2012027395A2 (en) | 2010-08-27 | 2012-03-01 | Agrivida, Inc. | Cellulosic processing trait development using a thermoregulated, intein-modified xylanase |
US20130266670A1 (en) | 2010-09-09 | 2013-10-10 | Xeda International | Fungicidal Bactericidal and/or Antioxidant Treatment of Foodstuffs Via Application of Formulations Comprising an Essential Oil and a Dialkylene Glycol |
WO2012044835A1 (en) | 2010-09-30 | 2012-04-05 | Novozymes, Inc. | Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
WO2012044836A1 (en) | 2010-09-30 | 2012-04-05 | Novozymes, Inc. | Variants of polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
WO2012044915A2 (en) | 2010-10-01 | 2012-04-05 | Novozymes, Inc. | Beta-glucosidase variants and polynucleotides encoding same |
US20120156734A1 (en) | 2010-10-08 | 2012-06-21 | National Taiwan University | Thermostable paenibacillus xylanases |
WO2012068236A2 (en) | 2010-11-16 | 2012-05-24 | Dyadic International (Usa) Inc. | Novel fungal oxidoreductases |
WO2012068509A1 (en) | 2010-11-18 | 2012-05-24 | Novozymes, Inc. | Chimeric polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
WO2012068047A2 (en) | 2010-11-19 | 2012-05-24 | Novozymes North America, Inc. | Processes of producing a fermentation product |
US20130236562A1 (en) | 2010-11-24 | 2013-09-12 | Xeda International | Novel method for the pre- or post-harvest treatment of plant products, using phosphonic acid and an essential oil |
CN102477438A (en) | 2010-11-30 | 2012-05-30 | 苏州普瑞信生物技术有限公司 | Acid beta-dextranase with recombination genes and application of acid beta- dextranase |
CN102477437A (en) | 2010-11-30 | 2012-05-30 | 苏州普瑞信生物技术有限公司 | Acid alpha-amylase with recombination genes and application thereof |
WO2012072777A1 (en) | 2010-12-01 | 2012-06-07 | B.R.A.I.N. Biotechnology Research And Information Network Ag | Novel catalases |
US20120142534A1 (en) | 2010-12-07 | 2012-06-07 | Mark Linden Dahmer | Granular compositions |
WO2012078741A2 (en) | 2010-12-07 | 2012-06-14 | Dyadic International (Usa) Inc. | Novel fungal esterases |
WO2012080202A1 (en) | 2010-12-17 | 2012-06-21 | Henkel Ag & Co. Kgaa | Storage-stable liquid washing or cleaning agent containing protease and amylase |
EP2468107A1 (en) | 2010-12-21 | 2012-06-27 | Decco Worldwide Post-Harvest Holdings Co. B.V. | Coating for fruit and method for its application |
WO2012088303A2 (en) | 2010-12-22 | 2012-06-28 | Novozymes North America, Inc. | Processes for producing fermentation products |
WO2012088467A2 (en) | 2010-12-22 | 2012-06-28 | Mascoma Corporation | Genetically modified clostridium thermocellum engineered to ferment xylose |
WO2012089023A1 (en) | 2010-12-30 | 2012-07-05 | Novozymes A/S | Processes for treating textile with polypeptide having cellulolytic enzyme enhancing activity |
WO2012089024A1 (en) | 2010-12-30 | 2012-07-05 | Novozymes A/S | Method for treating textile with endoglucanase |
WO2012101206A2 (en) | 2011-01-26 | 2012-08-02 | Novozymes A/S | Novel glycoside hydrolases from thermophilic fungi |
WO2012134626A2 (en) | 2011-01-31 | 2012-10-04 | Novozymes North America, Inc. | Processes for enzymatic refining of pretreated cellulosic material for saccharification |
JP2012157315A (en) | 2011-02-02 | 2012-08-23 | Gekkeikan Sake Co Ltd | Method for producing variable domain of heavy chain antibody (vhh) of animal of family camelidae |
WO2012106824A1 (en) | 2011-02-09 | 2012-08-16 | Iogen Bio-Products Corporation | Cellulase enzyme mixtures for depilling and uses thereof |
EP2486799A1 (en) | 2011-02-14 | 2012-08-15 | DSM IP Assets B.V. | Method to produce cake with lipolytic enzyme and alpha-amylase |
WO2012122308A2 (en) | 2011-03-07 | 2012-09-13 | Agrivida, Inc. | Consolidated pretreatment and hydrolysis of plant biomass expressing cell wall degrading enzymes |
WO2012125865A1 (en) | 2011-03-15 | 2012-09-20 | The Regents Of The University Of California | Mutant cells for protein secretion and lignocellulose degradation |
WO2012125925A2 (en) | 2011-03-17 | 2012-09-20 | Danisco Us Inc. | Method for reducing viscosity in saccharification process |
WO2012127001A1 (en) | 2011-03-23 | 2012-09-27 | Novozymes A/S | Methods for producing secreted polypeptides |
WO2012129548A2 (en) | 2011-03-23 | 2012-09-27 | Butamax(Tm) Advanced Biofuels Llc | In situ expression of lipase for enzymatic production of alcohol esters during fermentation |
WO2012128260A1 (en) | 2011-03-24 | 2012-09-27 | 旭硝子株式会社 | TRANSFORMANT OF YEAST OF GENUS SCHIZOSACCHAROMYCES, METHOD FOR PRODUCING SAME, METHOD FOR PRODUCING β-GLUCOSIDASE, AND METHOD FOR DECOMPOSING CELLULOSE |
WO2012130120A1 (en) | 2011-03-25 | 2012-10-04 | Novozymes A/S | Method for degrading or converting cellulosic material |
US20120247164A1 (en) | 2011-03-28 | 2012-10-04 | Vitag Corporation | High value organic-enhanced inorganic fertilizers |
WO2012129699A1 (en) | 2011-04-01 | 2012-10-04 | Adrian Tsang | Cell wall deconstruction enzymes of thermomyces lanuginosus and uses thereof |
WO2012129697A1 (en) | 2011-04-01 | 2012-10-04 | Adrian Tsang | Novel cell wall deconstruction enzymes of talaromyces thermophilus and uses thereof |
US20120258220A1 (en) | 2011-04-05 | 2012-10-11 | Richard Martin Jacobson | Controlled release compositions |
WO2012151534A1 (en) | 2011-05-05 | 2012-11-08 | Danisco Us Inc. | Compositions and methods comprising serine protease variants |
WO2012151480A2 (en) | 2011-05-05 | 2012-11-08 | The Procter & Gamble Company | Compositions and methods comprising serine protease variants |
WO2012159007A1 (en) | 2011-05-19 | 2012-11-22 | Novozymes, Inc. | Methods for enhancing the degradation of cellulosic material with chitin binding proteins |
US20140127309A1 (en) | 2011-06-03 | 2014-05-08 | Rohm And Haas Company | Encapsulated polar materials and methods of preparation |
WO2012173658A1 (en) | 2011-06-17 | 2012-12-20 | Butamax (Tm) Advanced Biofuels Llc | In situ expression of lipase for enzymatic production of alcohol esters during fermentation |
KR20120140565A (en) | 2011-06-21 | 2012-12-31 | 한국생명공학연구원 | Novel beta-glucosidase and the uses thereof |
US20130004634A1 (en) | 2011-06-29 | 2013-01-03 | Rohm And Haas Company | Method of handling mangoes |
EP3121270A2 (en) | 2011-06-30 | 2017-01-25 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants reference to a sequence listing |
WO2013001078A1 (en) | 2011-06-30 | 2013-01-03 | Novozymes A/S | Alpha-amylase variants |
WO2013001087A2 (en) | 2011-06-30 | 2013-01-03 | Novozymes A/S | Method for screening alpha-amylases |
EP2540825A2 (en) | 2011-06-30 | 2013-01-02 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants reference to a sequence listing |
WO2013004636A1 (en) | 2011-07-01 | 2013-01-10 | Novozymes A/S | Stabilized subtilisin composition |
EP2551335A1 (en) | 2011-07-25 | 2013-01-30 | The Procter & Gamble Company | Enzyme stabilized liquid detergent composition |
CN102703482A (en) | 2011-08-01 | 2012-10-03 | 南京工业大学 | Organic solvent-tolerant alkali protease |
WO2013023938A1 (en) | 2011-08-12 | 2013-02-21 | Novozymes A/S | Reduction of culture viscosity by manganese addition |
WO2013028915A2 (en) | 2011-08-24 | 2013-02-28 | Novozymes, Inc. | Methods for obtaining positive transformants of a filamentous fungal host cell |
EP2562250A1 (en) | 2011-08-25 | 2013-02-27 | Roche Diagnostics GmbH | Glucose oxidase |
WO2013026575A2 (en) | 2011-08-25 | 2013-02-28 | Roche Diagnostics Gmbh | Glucose oxidase |
WO2013029496A1 (en) | 2011-08-26 | 2013-03-07 | Novozymes A/S | Polypeptides having glucoamylase activity and polynucleotides encoding same |
FR2979918A1 (en) | 2011-09-08 | 2013-03-15 | Centre Nat Rech Scient | AMAGASAKIENSE PENICILLIUM GLUCOSE OXIDASE MUTANTS |
WO2013034106A1 (en) | 2011-09-09 | 2013-03-14 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
WO2013036898A2 (en) | 2011-09-09 | 2013-03-14 | Novozymes A/S | Improving properties of paper materials |
WO2013039776A1 (en) | 2011-09-13 | 2013-03-21 | Novozymes North America, Inc. | Methods of hydrolyzing and fermenting cellulosic material |
WO2013089889A2 (en) | 2011-09-30 | 2013-06-20 | Novozymes, Inc. | Chimeric polypeptides having beta-glucosidase activity and polynucleotides encoding same |
US20130178489A1 (en) | 2011-10-04 | 2013-07-11 | Xeda International | Method for fungicidal and/or bactericidal treatment of resistant strains using essential oil(s) |
US20140187570A1 (en) | 2011-10-04 | 2014-07-03 | Xeda International | Novel formulations of pyrimethanil, and their use in treatment of crops |
WO2013055676A1 (en) | 2011-10-11 | 2013-04-18 | Novozymes North America, Inc. | Processes for producing fermentation products |
WO2013057141A2 (en) | 2011-10-17 | 2013-04-25 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2013057143A2 (en) | 2011-10-17 | 2013-04-25 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
CN103060290A (en) | 2011-10-18 | 2013-04-24 | 中国科学院微生物研究所 | Alkaline xylanase, its coding gene and application |
WO2013063460A2 (en) | 2011-10-28 | 2013-05-02 | Danisco Us Inc. | Variant maltohexaose-forming alpha-amylase variants |
US20130123162A1 (en) | 2011-11-10 | 2013-05-16 | The Procter & Gamble Company | Consumer products |
WO2013074956A2 (en) | 2011-11-18 | 2013-05-23 | Novozymes, Inc. | Polypeptides having beta-glucosidase activity, beta-xylosidase activity, or beta-glucosidase and beta-xylosidase activity and polynucleotides encoding same |
WO2013119302A2 (en) | 2011-11-21 | 2013-08-15 | Novozymes, Inc. | Gh61 polypeptide variants and polynucleotides encoding same |
WO2013076253A1 (en) | 2011-11-25 | 2013-05-30 | Novozymes A/S | Polypeptides having lysozyme activity and polynucleotides encoding same |
WO2013082486A1 (en) | 2011-12-02 | 2013-06-06 | Novozymes A/S | Processes for producing fermentation products |
WO2013086219A1 (en) | 2011-12-09 | 2013-06-13 | Danisco Us Inc. | Ribosomal promotors from b. subtilis for protein production in microorganisms |
CN102492707A (en) | 2011-12-12 | 2012-06-13 | 江南大学 | Clone and expression of beta-1, 4-inscribe xylanase catalysis domain (Aor Xyn10BC) gene |
CN102517304A (en) | 2011-12-16 | 2012-06-27 | 中国农业科学院生物技术研究所 | Optimized gene of recombinant glucose oxidase and expression vector and application of optimized gene |
WO2013091547A1 (en) | 2011-12-19 | 2013-06-27 | Novozymes, Inc. | Polypeptides having catalase activity and polynucleotides encoding same |
WO2013096294A1 (en) | 2011-12-19 | 2013-06-27 | Novozymes A/S | Polypeptides having xylanase activity and polynucleotides encoding same |
EP3323875A1 (en) | 2011-12-20 | 2018-05-23 | Henkel AG & Co. KGaA | Detergent compositions comprising subtilase variants |
WO2013092635A1 (en) | 2011-12-20 | 2013-06-27 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
EP2607468A1 (en) | 2011-12-20 | 2013-06-26 | Henkel AG & Co. KGaA | Detergent compositions comprising subtilase variants |
WO2013098205A2 (en) | 2011-12-29 | 2013-07-04 | Novozymes A/S | Detergent compositions |
CN103184163A (en) | 2011-12-29 | 2013-07-03 | 青岛蔚蓝生物集团有限公司 | Engineered trichoderma strain for heterologous expression of endoglucanase gene and application thereof |
WO2013110766A1 (en) | 2012-01-26 | 2013-08-01 | Novozymes A/S | Use of polypeptides having protease activity in animal feed and detergents |
WO2013110242A1 (en) | 2012-01-29 | 2013-08-01 | Novozymes A/S | Methods for degrading or converting cellulosic material |
WO2013115305A1 (en) | 2012-01-31 | 2013-08-08 | 国立大学法人長岡技術科学大学 | Method for producing sugar and alcohol from cellulosic biomass, and microorganisms used for same |
EP2623586A2 (en) | 2012-02-03 | 2013-08-07 | The Procter & Gamble Company | Compositions and methods for surface treatment with lipases |
WO2013113622A1 (en) | 2012-02-03 | 2013-08-08 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
CN103243081A (en) | 2012-02-14 | 2013-08-14 | 兰州小凉河生物技术有限责任公司 | Chymosin gene, amino acid sequence for coding chymosin gene and application of chymosin gene |
WO2013148993A1 (en) | 2012-03-30 | 2013-10-03 | Novozymes North America, Inc. | Processes of producing fermentation products |
US20210230644A1 (en) | 2012-03-30 | 2021-07-29 | Novozymes A/S | Processes for producing a fermentation product |
WO2013149858A1 (en) | 2012-04-02 | 2013-10-10 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
CN102604913A (en) | 2012-04-05 | 2012-07-25 | 湖南尤特尔生化有限公司 | Preparation method and application of thermomyces lanuginosus lipase |
WO2013159005A2 (en) | 2012-04-19 | 2013-10-24 | Dyadic International (Usa) Ltd. | A method of improving the activity of cellulase enzyme mixtures in the saccharification of (ligno)cellulosic material |
WO2013159032A1 (en) | 2012-04-20 | 2013-10-24 | The Sun Products Corporation | Liquid detergent compositions |
WO2013160316A1 (en) | 2012-04-23 | 2013-10-31 | Dsm Ip Assets B.V. | Polypeptide expression method |
US20190153414A1 (en) | 2012-04-27 | 2019-05-23 | Novoyzmes A/S | GH61 Polypeptide Variants and Polynucleotides Encoding Same |
WO2013164384A1 (en) | 2012-05-04 | 2013-11-07 | Syngenta Participations Ag | New method of use of a pesticide |
CN102676561A (en) | 2012-05-08 | 2012-09-19 | 陈代文 | Recombinant bacterium for expressing keratinase and fermentation method thereof |
CN102703480A (en) | 2012-05-10 | 2012-10-03 | 宁夏夏盛实业集团有限公司 | Alpha-glucanase, engineering bacteria and applications |
WO2013171072A1 (en) | 2012-05-14 | 2013-11-21 | Novozymes A/S | Cutinase variants and polynucleotides encoding same |
US20130316458A1 (en) | 2012-05-18 | 2013-11-28 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Photosynthetic microorganisms expressing thermostable lipase |
US20130306158A1 (en) | 2012-05-21 | 2013-11-21 | Xeda International | Method for producing a gas flow containing an essential oil vapour, method for treating a site with such a gas, and related device |
WO2013184577A1 (en) | 2012-06-08 | 2013-12-12 | Danisco Us Inc. | Alpha-amylase variants derived from the alpha amylase of cytophaga sp.amylase|(cspamy2). |
WO2014007921A1 (en) | 2012-06-08 | 2014-01-09 | Danisco Us Inc. | Variant alpha amylases with enhanced activity on starch polymers |
WO2013182671A1 (en) | 2012-06-08 | 2013-12-12 | Dsm Ip Assets B.V. | Cell wall deconstruction enzymes of aureobasidium pullulans and uses thereof |
WO2013181760A1 (en) | 2012-06-08 | 2013-12-12 | Concordia University | Novel cell wall deconstruction enzymes of scytalidium thermophilum, myriococcum thermophilum, and aureobasidium pullulans, and uses thereof |
WO2013188331A1 (en) | 2012-06-11 | 2013-12-19 | The Procter & Gamble Company | Detergent composition |
US20130341809A1 (en) | 2012-06-25 | 2013-12-26 | Xeda International | Device for evaporating a liquid and related method |
WO2014000746A1 (en) | 2012-06-29 | 2014-01-03 | Carlsberg Breweries A/S | Method for producing beverages by acid removal |
WO2014013073A1 (en) | 2012-07-19 | 2014-01-23 | Dsm Ip Assets B.V. | Amylase-deficient strain |
WO2014018368A2 (en) | 2012-07-19 | 2014-01-30 | Novozymes A/S | Methods for increasing enzymatic hydrolysis of cellulosic material |
WO2014013074A1 (en) | 2012-07-19 | 2014-01-23 | Dsm Ip Assets B.V. | Agse-deficient strain |
ES2439616A1 (en) | 2012-07-20 | 2014-01-23 | Decco Worldwide Post-Harvest Holding Co. B.V. | Coating formulation comprising cinnamaldehyde and fungistatic food additives (Machine-translation by Google Translate, not legally binding) |
US20150208679A1 (en) | 2012-07-25 | 2015-07-30 | Agrofresh, Inc. | Methods of handling avocados and system |
CN102851266A (en) | 2012-08-03 | 2013-01-02 | 江南大学 | Heat-resistant alpha-amylase and construction method of gene engineering bacteria thereof |
WO2014019219A1 (en) | 2012-08-03 | 2014-02-06 | Dupont Nutrition Biosciences Aps | Enzymes |
WO2014027062A1 (en) | 2012-08-17 | 2014-02-20 | Novozymes A/S | Thermostable asparaginase variants and polynucleotides encoding same |
WO2014027063A1 (en) | 2012-08-17 | 2014-02-20 | Novozymes A/S | Method for producing a food product |
CN102796751A (en) | 2012-08-21 | 2012-11-28 | 广西科学院 | Mutant Pul 324 of pullulanibacillus naganoensis pullulanase and use thereof |
WO2014029808A1 (en) | 2012-08-22 | 2014-02-27 | Dupont Nutrition Biosciences Aps | Variants having glucoamylase activity |
CN102827821A (en) | 2012-08-31 | 2012-12-19 | 武汉三合益生物科技有限公司 | Mutant enzyme of xylanase 1YNA and application |
WO2014037438A1 (en) | 2012-09-05 | 2014-03-13 | Novozymes A/S | Polypeptides having protease activity |
US20140080710A1 (en) | 2012-09-17 | 2014-03-20 | Agrofresh Inc. | Compositions with hot melt resin matrix |
US20150237877A1 (en) | 2012-09-20 | 2015-08-27 | Agrofresh Inc. | Methods of handling persimmons |
WO2014055778A2 (en) | 2012-10-03 | 2014-04-10 | Agrivida, Inc. | Multiprotein expression cassettes |
WO2014055782A1 (en) | 2012-10-03 | 2014-04-10 | Agrivida, Inc. | Intein-modified proteases, their production and industrial applications |
CN102994475A (en) | 2012-10-10 | 2013-03-27 | 天津工业生物技术研究所 | Alpha-amylase and recombinant strain for expressing alpha-amylase |
US20150272115A1 (en) | 2012-10-11 | 2015-10-01 | Agrofresh Inc. | Yield enhancement for stress-susceptible plants |
WO2014059360A1 (en) | 2012-10-12 | 2014-04-17 | Danisco Us Inc. | Compositions and methods comprising a lipolytic enzyme variant |
WO2014059541A1 (en) | 2012-10-16 | 2014-04-24 | Concordia University | Novel cell wall deconstruction enzymes of thermoascus aurantiacus, myceliophthora fergusii (corynascus thermophilus), and pseudocercosporella herpotrichoides, and uses thereof |
WO2014060380A1 (en) | 2012-10-16 | 2014-04-24 | Dsm Ip Assets B.V. | Cell wall deconstruction enzymes of thermoascus aurantiacus and uses thereof |
CN103045559A (en) | 2012-10-23 | 2013-04-17 | 浙江工业大学 | Thermomyces lanuginosus lipase mutant, coding gene and application of mutant |
WO2014070841A1 (en) | 2012-10-31 | 2014-05-08 | Danisco Us Inc. | Compositions and methods of use |
WO2014068109A2 (en) | 2012-11-05 | 2014-05-08 | Novozymes A/S | Enzyme compositions enabling re-use of water in laundry |
WO2014081884A1 (en) | 2012-11-20 | 2014-05-30 | Pronutria, Inc. | Engineered secreted proteins and methods |
WO2014081700A1 (en) | 2012-11-20 | 2014-05-30 | Codexis, Inc. | Recombinant fungal polypeptides |
WO2014085439A1 (en) | 2012-11-30 | 2014-06-05 | Novozymes A/S | Processes for producing fermentation products |
WO2014085251A1 (en) | 2012-11-30 | 2014-06-05 | Novozymes A/S | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
WO2014093123A1 (en) | 2012-12-14 | 2014-06-19 | Danisco Us Inc. | Method of using alpha-amylase from aspergillus fumigatus and pullulanase for saccharification |
WO2014093835A1 (en) | 2012-12-14 | 2014-06-19 | Novozymes A/S | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
WO2014099653A1 (en) | 2012-12-17 | 2014-06-26 | Novozymes A/S | Alpha-amylases and polynucleotides encoding same |
WO2014099416A1 (en) | 2012-12-20 | 2014-06-26 | Danisco Us Inc. | Method of using alpha-amylase from aspergillus terreus and isoamylase for saccharification |
CN103232949A (en) | 2012-12-20 | 2013-08-07 | 山东农业大学 | Pichia pastoris engineered strain expressing 61-family glycoside hydrolase gene |
CN103013960A (en) | 2012-12-21 | 2013-04-03 | 青岛蔚蓝生物集团有限公司 | Alkaline protease and recombinant expression engineering bacterium thereof |
WO2014101753A1 (en) | 2012-12-24 | 2014-07-03 | Novozymes A/S | Polypeptides having endoglucanase activity and polynucleotides encoding same |
WO2014106593A1 (en) | 2013-01-03 | 2014-07-10 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
US20160000072A1 (en) | 2013-01-15 | 2016-01-07 | Agrofresh Inc. | Compositions and methods for stabilizing cyclopropene in solutions |
WO2014114810A1 (en) | 2013-01-28 | 2014-07-31 | Roche Diagnostics Gmbh | Novel glucose oxidases derived from aspergillus niger |
WO2014120715A2 (en) | 2013-01-30 | 2014-08-07 | Dow Agrosciences Llc | Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts |
US20150366189A1 (en) | 2013-02-08 | 2015-12-24 | Christian Guy Becker | Dry melt coating process and formulation for volatile compounds |
WO2014124927A2 (en) | 2013-02-14 | 2014-08-21 | Novozymes A/S | Industrial and institutional laundering using multi-enzyme compositions |
US20140235447A1 (en) | 2013-02-19 | 2014-08-21 | Syngenta Crop Protection Llc | Methods for increasing crop yield |
WO2014128321A1 (en) | 2013-02-20 | 2014-08-28 | Decco Worldwide Post-Harvest Holdings B.V. | Method for the treatment and control of post-harvest diseases in fruits and vegetables and compositions comprising natural extracts and plant-strenghtening and/or fungicidal formulations for use in said method |
US20140242235A1 (en) | 2013-02-28 | 2014-08-28 | Agrofresh Inc. | Methods of handling papaya |
WO2014131842A1 (en) | 2013-03-01 | 2014-09-04 | Dsm Ip Assets B.V. | Alpha-amylase variants |
WO2014138672A1 (en) | 2013-03-08 | 2014-09-12 | Novozymes A/S | Cellobiohydrolase variants and polynucleotides encoding same |
WO2014164834A1 (en) | 2013-03-11 | 2014-10-09 | Danisco Us Inc. | Alpha-amylase combinatorial variants |
WO2014164800A1 (en) | 2013-03-11 | 2014-10-09 | Danisco Us Inc. | Alpha-amylase combinatorial variants |
WO2014164777A1 (en) | 2013-03-11 | 2014-10-09 | Danisco Us Inc. | Alpha-amylase combinatorial variants |
WO2014152878A2 (en) | 2013-03-14 | 2014-09-25 | Agrivida, Inc. | Use of dimerization domains for temperature regulation of enzyme activity |
US20140271758A1 (en) | 2013-03-14 | 2014-09-18 | Syngenta Crop Protection Llc | Overcoated powder particles |
WO2014138983A1 (en) | 2013-03-14 | 2014-09-18 | Concordia University | Novel cell wall deconstruction enzymes of malbranchea cinnamomea, thielavia australiensis, and paecilomyces byssochlamydoides, and uses thereof |
WO2014140165A1 (en) | 2013-03-14 | 2014-09-18 | Dsm Ip Assets B.V. | Cell wall deconstruction enzymes of paecilomyces byssochlamydoides and uses thereof |
WO2014151805A2 (en) | 2013-03-15 | 2014-09-25 | Mascoma Corporation | Expression of beta-glucosidases for hydrolysis of lignocellulose and associated oligomers |
WO2014147219A1 (en) | 2013-03-21 | 2014-09-25 | Novozymes A/S | Polypeptides having phospholipase a activity and polynucleotides encoding same |
WO2014147189A1 (en) | 2013-03-21 | 2014-09-25 | Novozymes A/S | Method for producing roasted coffee beans |
CN103275942A (en) | 2013-04-03 | 2013-09-04 | 北京挑战生物技术有限公司 | Glucose oxidase GODJ4A, and gene and application thereof |
CN103194419A (en) | 2013-04-03 | 2013-07-10 | 武汉大学 | Microorganism and application thereof |
WO2014161987A1 (en) | 2013-04-05 | 2014-10-09 | Novozymes A/S | Polypeptides having dextranase activity and polynucleotides encoding same |
WO2014162001A1 (en) | 2013-04-05 | 2014-10-09 | Novozymes A/S | Enzyme solubility in liquid detergent and use of detergent composition |
WO2014169101A1 (en) | 2013-04-10 | 2014-10-16 | Novozymes A/S | Process for hydrolysis of starch |
WO2014169129A1 (en) | 2013-04-10 | 2014-10-16 | Novozymes A/S | Process for preparation of sugars and syrups |
WO2014176311A1 (en) | 2013-04-23 | 2014-10-30 | President And Fellows Of Harvard College | Genetic reprogramming of bacterial biofilms |
EP2796547A1 (en) | 2013-04-24 | 2014-10-29 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Novel glucose oxidase variants |
WO2014173822A2 (en) | 2013-04-24 | 2014-10-30 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Novel glucose oxidase variants |
US20160066568A1 (en) | 2013-04-26 | 2016-03-10 | Fujun Lu | Methods and compositions for polymer matrix synthesized by polycondensation |
US20160095311A1 (en) | 2013-04-26 | 2016-04-07 | Fujun Lu | Gel formulations for extended release of volatile compounds |
US20140011679A1 (en) | 2013-05-05 | 2014-01-09 | Nazir Mir | Hydrocolloid systems for reducing loss of volatile active compounds from their liquid formulations for pre- and post harvest use on agricultural crops |
WO2014182990A1 (en) | 2013-05-10 | 2014-11-13 | Novozymes A/S | Polypeptides having xylanase activity and polynucleotides encoding same |
WO2014186464A1 (en) | 2013-05-14 | 2014-11-20 | Novozymes A/S | Stabilized humicola lanuginosa lipase varai nts in water-soluble films |
WO2014184164A1 (en) | 2013-05-14 | 2014-11-20 | Novozymes A/S | Detergent compositions |
WO2014183920A1 (en) | 2013-05-17 | 2014-11-20 | Novozymes A/S | Polypeptides having alpha amylase activity |
WO2014183921A1 (en) | 2013-05-17 | 2014-11-20 | Novozymes A/S | Polypeptides having alpha amylase activity |
CN103255072A (en) | 2013-05-28 | 2013-08-21 | 山东农业大学 | Pichia pastoris yeast engineering bacterium expressing thermal stability cellulase gene fusant 61F-EG1 |
CN103243038A (en) | 2013-05-28 | 2013-08-14 | 山东农业大学 | Yeast engineering strain for expressing lipase mutants of thermomyces lanuginosus |
WO2014194034A2 (en) | 2013-05-29 | 2014-12-04 | Danisco Us Inc. | Novel metalloproteases |
CN103255156A (en) | 2013-05-30 | 2013-08-21 | 中国农业科学院农产品加工研究所 | Site mutant nattokinase gene high in activity and thermal stability, and application thereof |
WO2014197296A1 (en) | 2013-06-05 | 2014-12-11 | Novozymes A/S | Xylanase variants and polynucleotides encoding same |
WO2014195356A2 (en) | 2013-06-06 | 2014-12-11 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
JP2015002686A (en) | 2013-06-19 | 2015-01-08 | 東洋紡株式会社 | Novel glucose oxidase and sequence of polypeptide |
WO2014202622A2 (en) | 2013-06-19 | 2014-12-24 | Dsm Ip Assets B.V. | Rasamsonia gene and use thereof |
WO2014202616A2 (en) | 2013-06-19 | 2014-12-24 | Dsm Ip Assets B.V. | Rasamsonia gene and use thereof |
WO2014202711A1 (en) | 2013-06-21 | 2014-12-24 | Dupont Nutrition Biosciences Aps | Method of preparing feed additive |
WO2014209800A1 (en) | 2013-06-24 | 2014-12-31 | Novozymes A/S | Processes for recovering oil from fermentation product processes and processes for producing fermentation products |
WO2014207228A1 (en) | 2013-06-27 | 2014-12-31 | Novozymes A/S | Subtilase variants and polynucleotides encoding same |
WO2015017045A1 (en) | 2013-07-03 | 2015-02-05 | Keclon Sa | Modified bacillus cereus phospholipase c protein and method of processing vegetable oil |
CN103343111A (en) | 2013-07-05 | 2013-10-09 | 山东尤特尔生物科技有限公司 | Thermophilic chaetomium cellulase, as well as preparation method and application thereof |
WO2015003908A1 (en) | 2013-07-08 | 2015-01-15 | Basf Se | Compositions comprising a triazole compound and a biopesticide |
US20150018430A1 (en) | 2013-07-11 | 2015-01-15 | Agrofresh, Inc. | Humidity activated formulation for volatile compounds |
WO2015007639A1 (en) | 2013-07-17 | 2015-01-22 | Novozymes A/S | Pullulanase chimeras and polynucleotides encoding same |
WO2015010009A2 (en) | 2013-07-19 | 2015-01-22 | Danisco Us Inc. | Compositions and methods comprising a lipolytic enzyme variant |
WO2015035914A1 (en) | 2013-09-11 | 2015-03-19 | Novozymes A/S | Processes for producing fermentation products |
WO2015038792A1 (en) | 2013-09-12 | 2015-03-19 | Danisco Us Inc. | Compositions and methods comprising lg12-clade protease variants |
WO2015042064A1 (en) | 2013-09-17 | 2015-03-26 | Edeniq, Inc. | Improved beta-glucosidase enzymes for increased biomass saccharification |
WO2015048332A2 (en) | 2013-09-25 | 2015-04-02 | Pronutria, Inc. | Secreted nutritive polypeptides and formulations thereof, and methods of production and use thereof |
WO2015048342A2 (en) | 2013-09-25 | 2015-04-02 | Pronutria, Inc. | Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof |
US20150087520A1 (en) | 2013-09-25 | 2015-03-26 | Agrofresh Inc. | Systems and methods for sovlent-free delivery of volatile compounds |
WO2015048340A2 (en) | 2013-09-25 | 2015-04-02 | Pronutria, Inc. | Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof |
WO2015048339A2 (en) | 2013-09-25 | 2015-04-02 | Pronutria, Inc. | Compositions and formulations for non-human nutrition and methods of production and use thereof |
US20200306342A1 (en) | 2013-09-25 | 2020-10-01 | Axcella Health Inc. | Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof |
US20220347262A1 (en) | 2013-09-25 | 2022-11-03 | Axcella Health Inc. | Compositions and Formulations and Methods of Production and Use Thereof |
WO2015044448A1 (en) | 2013-09-30 | 2015-04-02 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2015050723A1 (en) | 2013-10-03 | 2015-04-09 | Danisco Us Inc. | Alpha-amylases from exiguobacterium, and methods of use, thereof |
CN103525778A (en) | 2013-10-18 | 2014-01-22 | 江南大学 | Glucose oxidase mutant with high catalytic activity |
CN103555751A (en) | 2013-10-24 | 2014-02-05 | 江南大学 | Method for enhancing stability of escherichia coli T7 expression system on basis of double-repression strategy |
WO2015058700A1 (en) | 2013-10-25 | 2015-04-30 | Novozymes A/S | Polypeptides having endoglucanase activity and polynucleotides encoding same |
WO2015065871A1 (en) | 2013-10-28 | 2015-05-07 | Danisco Us Inc. | Large scale genetically engineered active dry yeast |
CN103525793A (en) | 2013-10-29 | 2014-01-22 | 中国农业科学院饲料研究所 | Alkaline xylanase with improved heat stability, and coding gene and application thereof |
WO2015066492A1 (en) | 2013-11-01 | 2015-05-07 | Novozymes A/S | Methods of saccharifying and fermenting a cellulosic material |
US20150125925A1 (en) | 2013-11-05 | 2015-05-07 | The Procter & Gamble Company | Compositions and methods comprising serine protease variants |
CN103555600A (en) | 2013-11-06 | 2014-02-05 | 山东农业大学 | Yeast engineered strain of high-activity-expression thermomyces lanuginosus lipase LN |
WO2015067161A1 (en) | 2013-11-07 | 2015-05-14 | 丰益(上海)生物技术研发中心有限公司 | Phospholipase c mutant and use thereof |
CN103602653A (en) | 2013-11-20 | 2014-02-26 | 江南大学 | Keratinase with improved thermal stability and specific activity as well as preparation method and application thereof |
WO2015077126A1 (en) | 2013-11-20 | 2015-05-28 | Danisco Us Inc. | Variant alpha-amylases having reduced susceptibility to protease cleavage, and methods of use, thereof |
WO2015079063A1 (en) | 2013-11-29 | 2015-06-04 | Dsm Ip Assets B.V. | Use of bacterial amylases in feed for poultry |
WO2015085920A1 (en) | 2013-12-11 | 2015-06-18 | Novozymes A/S | Cutinase variants and polynucleotides encoding same |
WO2015089447A1 (en) | 2013-12-13 | 2015-06-18 | Danisco Us Inc. | Serine proteases of the bacillus gibsonii-clade |
WO2015089441A1 (en) | 2013-12-13 | 2015-06-18 | Danisco Us Inc. | Serine proteases of bacillus species |
CN103614350A (en) | 2013-12-18 | 2014-03-05 | 江南大学 | Glucose oxidase with improved catalytic efficiency |
WO2015094809A1 (en) | 2013-12-19 | 2015-06-25 | Danisco Us Inc. | Chimeric fungal alpha-amylases comprising carbohydrate binding module and the use thereof |
WO2015091959A2 (en) | 2013-12-20 | 2015-06-25 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2015091990A1 (en) | 2013-12-20 | 2015-06-25 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
WO2015105835A1 (en) | 2014-01-07 | 2015-07-16 | Novozymes A/S | Process for degrading mannan-containing cellulosic materials |
CN103834606A (en) | 2014-01-16 | 2014-06-04 | 北京中科星冠生物技术有限责任公司 | Engineering strain expressing acid-resistant high-temperature alpha-amylase gene mutants |
US20160330987A1 (en) | 2014-01-20 | 2016-11-17 | Xeda International S.A. | Anti-sprouting compositions for coating bulbs and tubers and the use thereof for anti-sprouting treatment |
WO2015109405A1 (en) | 2014-01-22 | 2015-07-30 | Concordia University | Novel cell wall deconstruction enzymes of chaetomium thermophilum, thermomyces stellatus, and corynascus sepedonium, and uses thereof |
WO2015110473A2 (en) | 2014-01-22 | 2015-07-30 | Novozymes A/S | Pullulanase variants and polynucleotides encoding same |
CN103981160A (en) | 2014-01-23 | 2014-08-13 | 浙江工业大学 | Thermomyces lanuginosus lipase mutant, coding genes, and applications of thermomyces lanuginosus lipase mutant |
WO2015110058A1 (en) | 2014-01-24 | 2015-07-30 | Novozymes A/S | Swatch for testing lipase activity |
WO2015110562A1 (en) | 2014-01-26 | 2015-07-30 | Novozymes A/S | A method to produce an antimicrobial polyester textile using cutinase |
WO2015118123A1 (en) | 2014-02-07 | 2015-08-13 | Novozymes A/S | Compositions for producing glucose syrups |
CN103966188A (en) | 2014-02-12 | 2014-08-06 | 华南农业大学 | Recombinant glucanase capable of being expressed and secreted in animal cell as well as recombination method and application of recombinant glucanase |
US20150231588A1 (en) | 2014-02-18 | 2015-08-20 | Rohm And Haas Company | Microcapsules |
CN103789285A (en) | 2014-02-19 | 2014-05-14 | 江南大学 | Amylase mutant having improved heat stability and construction method and application thereof |
CN103805579A (en) | 2014-02-19 | 2014-05-21 | 江南大学 | Thermostable amylase mutant and preparation method and application thereof |
CN103865896A (en) | 2014-03-11 | 2014-06-18 | 上海康地恩生物科技有限公司 | Alkaline lipase mutant |
WO2015140275A1 (en) | 2014-03-19 | 2015-09-24 | Novozymes A/S | Polypeptides having phospholipase c activity and polynucleotides encoding same |
WO2015143144A1 (en) | 2014-03-19 | 2015-09-24 | Novozymes A/S | Method for enhancing activity of an x143 polypeptide |
WO2015143360A2 (en) | 2014-03-21 | 2015-09-24 | Danisco Us Inc. | Serine proteases of bacillus species |
CN104928270A (en) | 2014-03-21 | 2015-09-23 | 中国科学院天津工业生物技术研究所 | Recombinant basic xylanase resistant to chelating agent ethylenediamine tetraacetic acid and construction method thereof |
WO2015143324A1 (en) | 2014-03-21 | 2015-09-24 | Novozymes A/S | Processes for producing ethanol and yeast |
WO2015144780A2 (en) | 2014-03-25 | 2015-10-01 | Novozymes A/S | Dishwashing composition |
WO2015144782A1 (en) | 2014-03-25 | 2015-10-01 | Novozymes A/S | Dishwashing composition containing cellulytic enzymes and use thereof |
WO2015144824A1 (en) | 2014-03-27 | 2015-10-01 | Novozymes A/S | Beta-glucanase variants and polynucleotides encoding same |
WO2015144932A1 (en) | 2014-03-28 | 2015-10-01 | Novozymes A/S | Enzyme variants and polynucleotides encoding same |
WO2015144936A1 (en) | 2014-03-28 | 2015-10-01 | Novozymes A/S | Resolubilization of protein crystals at low ph |
WO2015150457A1 (en) | 2014-04-01 | 2015-10-08 | Novozymes A/S | Polypeptides having alpha amylase activity |
WO2015157656A1 (en) | 2014-04-10 | 2015-10-15 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
TR201404579A2 (en) | 2014-04-22 | 2015-11-23 | Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak | The production of xylanase enzyme to be used as a feed additive and the method of obtaining powder preparation and coated product from this enzyme. |
WO2015162038A1 (en) | 2014-04-25 | 2015-10-29 | Basf Se | Amylase variants |
WO2015175157A1 (en) | 2014-05-12 | 2015-11-19 | Dow Agrosciences Llc | Volatile applications against pathogens |
WO2015173426A1 (en) | 2014-05-15 | 2015-11-19 | Novozymes A/S | Compositions comprising polypeptides having phospholipase c activity and use thereof |
WO2015182941A1 (en) | 2014-05-27 | 2015-12-03 | 주식회사 제노포커스 | Novel catalase signal sequence and method for catalase expression using same |
CN104561060A (en) | 2014-05-30 | 2015-04-29 | 河北省科学院生物研究所 | Beta-1, 3-1, 4-dextranase gene and application thereof |
WO2015187697A2 (en) | 2014-06-02 | 2015-12-10 | The Board Of Regents For Oklahoma State University | Systems and methods for production and use of fungal glycosyl hydrolases |
WO2015185689A1 (en) | 2014-06-04 | 2015-12-10 | Novozymes A/S | Detergent composition |
CN103981159A (en) | 2014-06-05 | 2014-08-13 | 青岛蔚蓝生物集团有限公司 | Glucose oxidase mutant and application thereof |
WO2015187935A1 (en) | 2014-06-06 | 2015-12-10 | Novozymes A/S | Enzyme compositions and uses thereof |
WO2015189372A1 (en) | 2014-06-12 | 2015-12-17 | Novozymes A/S | Alpha-amylase variants |
WO2015189370A1 (en) | 2014-06-12 | 2015-12-17 | Novozymes A/S | Oxidation stable alpha-amylase variants |
WO2015189371A1 (en) | 2014-06-12 | 2015-12-17 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
US20150366230A1 (en) | 2014-06-19 | 2015-12-24 | Agrofresh Inc. | Compositions and methods for packaging produce |
WO2015200659A1 (en) | 2014-06-25 | 2015-12-30 | Novozymes A/S | Xylanase variants and polynucleotides encoding same |
DE102014212643A1 (en) | 2014-06-30 | 2015-12-31 | Henkel Ag & Co. Kgaa | Liquid detergent containing liquid and solid enzyme formulations |
JP2016015894A (en) | 2014-07-04 | 2016-02-01 | 公立大学法人大阪府立大学 | β-GLUCOSIDASE |
CN104130988A (en) | 2014-07-22 | 2014-11-05 | 江南大学 | 1,3-1,4-Beta-glucanase mutant |
WO2016020478A1 (en) | 2014-08-07 | 2016-02-11 | Dsm Ip Assets B.V. | Thermostable alpha amylase |
CN104293744A (en) | 2014-08-19 | 2015-01-21 | 浙江工业大学 | Talaromyces thermophilus derived lipase mutant and application thereof |
WO2016026842A1 (en) | 2014-08-21 | 2016-02-25 | Dsm Ip Assets B.V. | Combination of glucose oxidases for improvements in baking |
WO2016029107A1 (en) | 2014-08-21 | 2016-02-25 | Novozymes A/S | Process for saccharifying cellulosic material under oxygen addition |
WO2016030448A1 (en) | 2014-08-28 | 2016-03-03 | Dsm Ip Assets B.V. | Alicyclobacillus pohliae alpha-amylase variants |
WO2016031611A1 (en) | 2014-08-29 | 2016-03-03 | 天野エンザイム株式会社 | Mutant enzyme and application thereof |
EP2993230A1 (en) | 2014-09-02 | 2016-03-09 | Clariant Produkte (Deutschland) GmbH | Polypeptides having xylanase activity with a high conversion rate of xylose-containing polysaccharides |
WO2016036648A1 (en) | 2014-09-02 | 2016-03-10 | Novozymes A/S | Processes for producing a fermentation product using a fermenting organism |
WO2016036834A1 (en) | 2014-09-02 | 2016-03-10 | Danisco Us Inc. | Dp5-enriched syrups |
WO2016040464A1 (en) | 2014-09-09 | 2016-03-17 | Novozymes A/S | Methods for enhancing the dewaterability of sludge with enzyme treatment |
CN104232610A (en) | 2014-09-12 | 2014-12-24 | 江南大学 | Keratinase with improved alpha-keratin substrate specificity as well as construction method and application thereof |
WO2016044542A1 (en) | 2014-09-17 | 2016-03-24 | Bayer Cropscience Lp | Compositions comprising recombinant bacillus cells and an insecticide |
US20210015105A1 (en) | 2014-09-17 | 2021-01-21 | Basf Corporation | Compositions comprising recombinant bacillus cells and another biological control agent |
WO2016046234A2 (en) | 2014-09-22 | 2016-03-31 | Nexttobe Ab | Recombinant phe-free proteins for use in the treatment of phenylketonuria |
WO2016045569A1 (en) | 2014-09-23 | 2016-03-31 | Novozymes A/S | Processes for producing ethanol and fermenting organisms |
WO2016050661A1 (en) | 2014-09-29 | 2016-04-07 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
WO2016050905A1 (en) | 2014-10-02 | 2016-04-07 | Dsm Ip Assets B.V. | Method for preparing a dough comprising addition of penicillium glucose oxidase |
RU2574206C1 (en) | 2014-10-02 | 2016-02-10 | Общество с ограниченной ответственностью Научно-производственная компания "Фермтек" (ООО НПК "Фермтек") | New recombinant strain (versions) of mycelial fungus penicillium verruculosum, and enzymatic agent (versions) intended for hydrolysis of fruit raw material, and method of its production |
CN104293748A (en) | 2014-10-11 | 2015-01-21 | 上海交通大学 | Endo-xylanase with high thermal stability and application thereof |
CN104313000A (en) | 2014-10-11 | 2015-01-28 | 上海交通大学 | Genetic engineering xylanase and preparation and application of genetic engineering xylanase |
WO2016062875A2 (en) | 2014-10-23 | 2016-04-28 | Novozymes A/S | Glucoamylase variants and polynucleotides encoding same |
WO2016069557A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases of bacillus species |
WO2016069563A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
WO2016066896A1 (en) | 2014-10-27 | 2016-05-06 | Ab Enzymes Oy | Fungal endoglucanase variants, their production and use |
WO2016069569A2 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
WO2016069552A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
CN104312989A (en) | 2014-10-28 | 2015-01-28 | 江南大学 | Glucose oxidase with improved oxidative resistance |
WO2016079110A2 (en) | 2014-11-19 | 2016-05-26 | Novozymes A/S | Use of enzyme for cleaning |
WO2016079305A1 (en) | 2014-11-20 | 2016-05-26 | Novozymes A/S | Alicyclobacillus variants and polynucleotides encoding same |
CN105695435A (en) | 2014-11-28 | 2016-06-22 | 华东理工大学 | Thermostable amylase, coding gene thereof and applications of the thermostable amylase |
WO2016087327A1 (en) | 2014-12-01 | 2016-06-09 | Novozymes A/S | Polypeptides having pullulanase activity comprising the x25, x45 and cbm41 domains |
CN104450650A (en) | 2014-12-01 | 2015-03-25 | 青岛蔚蓝生物集团有限公司 | Alkaline xylanase mutant and application thereof |
CN104498456A (en) | 2014-12-01 | 2015-04-08 | 中国农业科学院饲料研究所 | Acidic beta-glucosidase Bgl3B and gene and application thereof |
WO2016087445A1 (en) | 2014-12-01 | 2016-06-09 | Novozymes A/S | Improved production of glucose syrups |
WO2016090059A1 (en) | 2014-12-02 | 2016-06-09 | Novozymes A/S | Laccase variants and polynucleotides encoding same |
CN105671019A (en) | 2014-12-04 | 2016-06-15 | 中国科学院青岛生物能源与过程研究所 | Heat-resistant xylanase and application thereof |
WO2016087401A1 (en) | 2014-12-05 | 2016-06-09 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
WO2016090474A1 (en) | 2014-12-09 | 2016-06-16 | Concordia University | Novel cell wall deconstruction enzymes of chaetomium olivicolor, acremonium thermophilum, and myceliophthora hinnulea, and uses thereof |
WO2016090473A1 (en) | 2014-12-09 | 2016-06-16 | Concordia University | Novel cell wall deconstruction enzymes of rhizomucor miehei, thermoascus thermophilus (dactylomyces thermophilus), and humicola hyalo thermophila, and uses thereof |
CN104450651A (en) | 2014-12-09 | 2015-03-25 | 青岛蔚蓝生物集团有限公司 | Beta-glucosidase mutant and application thereof |
WO2016090472A1 (en) | 2014-12-09 | 2016-06-16 | Concordia University | Novel cell wall deconstruction enzymes of remersonia thermophila (stilbella thermophila), melanocarpus albomyces, and lentinula edodes, and uses thereof |
WO2016091870A1 (en) | 2014-12-09 | 2016-06-16 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
DE102014225473A1 (en) | 2014-12-10 | 2016-06-16 | Henkel Ag & Co. Kgaa | Detergents and cleaners with a combination of amylase and protease |
DE102014225472A1 (en) | 2014-12-10 | 2016-06-16 | Henkel Ag & Co. Kgaa | Hand dishwashing detergent with improved action against starch |
EP3034592A1 (en) | 2014-12-17 | 2016-06-22 | The Procter and Gamble Company | Method of automatic dishwashing |
WO2016100837A1 (en) | 2014-12-18 | 2016-06-23 | Danisco Us Inc | Engineered multifunctional enzymes and methods of use |
WO2016097405A1 (en) | 2014-12-19 | 2016-06-23 | Novozymes A/S | Stabilized enzyme compositions |
WO2016095856A1 (en) | 2014-12-19 | 2016-06-23 | Novozymes A/S | Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity |
WO2016102356A1 (en) | 2014-12-22 | 2016-06-30 | Novozymes A/S | Detergent compositions, lipase variants and polynucleotides encoding same |
JP2016121081A (en) | 2014-12-24 | 2016-07-07 | 国立大学法人秋田大学 | Antiviral drug and antimicrobial agent |
WO2016109758A2 (en) | 2014-12-30 | 2016-07-07 | Symbiota, LLC | Seed endophytes across cultivars and species, associated compositions, and methods of use thereof |
WO2016107567A1 (en) | 2014-12-31 | 2016-07-07 | Novozymes A/S | Method of treating polyester textile |
CN104480087A (en) | 2015-01-06 | 2015-04-01 | 天津科技大学 | Novel high-temperature resistant alpha-amylase, preparing method of novel high-temperature resistant alpha-amylase and application of novel high-temperature resistant alpha-amylase |
WO2016117549A1 (en) | 2015-01-20 | 2016-07-28 | サントリーホールディングス株式会社 | Method for preparing mogroside |
WO2016124651A1 (en) | 2015-02-04 | 2016-08-11 | Novozymes A/S | Detergent composition comprising protease and amylase variants |
WO2016126294A1 (en) | 2015-02-04 | 2016-08-11 | Nanjing Bestzyme Bio-Engineering Co. Ltd. | Truncated pullulanases, methods of production, and methods of use thereof |
US20160235070A1 (en) | 2015-02-12 | 2016-08-18 | Agrofresh Inc. | Fungicidal compounds and compositions |
WO2016145350A1 (en) | 2015-03-12 | 2016-09-15 | Novozymes A/S | Multi-stage enzymatic hydrolysis of lignocellulosic biomass |
WO2016145428A1 (en) | 2015-03-12 | 2016-09-15 | Danisco Us Inc | Compositions and methods comprising lg12-clade protease variants |
WO2016145358A1 (en) | 2015-03-12 | 2016-09-15 | Novozymes A/S | Enzymatic hydrolysis with hemicellulolytic enzymes |
CN104711273A (en) | 2015-03-17 | 2015-06-17 | 中国科学院微生物研究所 | Method for preparing recombinant-aspergillus niger glucose oxidase and application of recombinant-aspergillus niger glucose oxidase |
CN104711274A (en) | 2015-03-17 | 2015-06-17 | 中国科学院微生物研究所 | Method for preparing recombinant-penicillium amagasakiense glucose oxidase and application of recombinant-penicillium amagasakiense glucose oxidase |
WO2016153924A1 (en) | 2015-03-20 | 2016-09-29 | Novozymes A/S | Processes for producing ethanol and ethanol producing yeast |
WO2016164096A1 (en) | 2015-04-06 | 2016-10-13 | Dupont Nutrition Biosciences Aps | Proteases for high protein fermented milk products |
WO2016164596A2 (en) | 2015-04-07 | 2016-10-13 | Novozymes A/S | Methods for selecting enzymes having lipase activity |
WO2016167235A1 (en) | 2015-04-14 | 2016-10-20 | 国立研究開発法人産業技術総合研究所 | Modified xylanase |
CN104789543A (en) | 2015-04-25 | 2015-07-22 | 上海康地恩生物科技有限公司 | Color protective cellulose and mutant thereof |
CN104878033A (en) | 2015-04-29 | 2015-09-02 | 江南大学 | Method for promoting extracellular expression of target protein and application of method |
WO2016174234A2 (en) | 2015-04-29 | 2016-11-03 | Novozymes A/S | Polypeptides suitable for detergent |
EP3091080A1 (en) | 2015-05-05 | 2016-11-09 | Evonik Degussa GmbH | Process for producing acyl amino acids employing lipases |
CN105002147A (en) | 2015-05-05 | 2015-10-28 | 广东溢多利生物科技股份有限公司 | Mutated glucose oxidase with increased expression quantity and encoding gene and application thereof |
US20160324147A1 (en) | 2015-05-06 | 2016-11-10 | Agrofresh Inc. | Stable emulsion formulations of encapsulated volatile compounds |
WO2016180749A1 (en) | 2015-05-08 | 2016-11-17 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2016180792A1 (en) | 2015-05-08 | 2016-11-17 | Novozymes A/S | Alpha-amylase variants having improved performance and stability |
WO2016180748A1 (en) | 2015-05-08 | 2016-11-17 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2016180928A1 (en) | 2015-05-12 | 2016-11-17 | Novozymes A/S | Bacillus licheniformis host cell with deleted lantibiotic gene(s) |
WO2016183509A1 (en) | 2015-05-13 | 2016-11-17 | Danisco Us Inc. | AprL-CLADE PROTEASE VARIANTS AND USES THEREOF |
WO2016196202A1 (en) | 2015-05-29 | 2016-12-08 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
CN105441400A (en) | 2015-06-01 | 2016-03-30 | 南阳师范学院 | Mutation coprinus cinereus peroxidase and preparing method and application thereof |
EP3287513A1 (en) | 2015-06-04 | 2018-02-28 | The Procter & Gamble Company | Hand dishwashing liquid detergent composition |
EP3284811A1 (en) | 2015-06-04 | 2018-02-21 | The Procter & Gamble Company | Hand dishwashing liquid detergent composition |
EP3101108A1 (en) | 2015-06-04 | 2016-12-07 | The Procter and Gamble Company | Hand dishwashing liquid detergent composition |
EP3101109A1 (en) | 2015-06-04 | 2016-12-07 | The Procter and Gamble Company | Hand dishwashing liquid detergent composition |
US20160355443A1 (en) | 2015-06-05 | 2016-12-08 | Anuvia Plant Nutrients Corporation | High Value Organic Containing Fertilizers and Methods of Manufacture |
WO2016201284A2 (en) | 2015-06-10 | 2016-12-15 | Newleaf Symbiotics, Inc. | Antifungal methylobacterium compositions and methods of use |
CN104862290A (en) | 2015-06-12 | 2015-08-26 | 江南大学 | 1,3-1,4-beta-glucanase mutant |
WO2016205755A1 (en) | 2015-06-17 | 2016-12-22 | Danisco Us Inc. | Bacillus gibsonii-clade serine proteases |
WO2016205710A1 (en) | 2015-06-17 | 2016-12-22 | Danisco Us Inc. | Proteases with modified propeptide regions |
EP3106508A1 (en) | 2015-06-18 | 2016-12-21 | Henkel AG & Co. KGaA | Detergent composition comprising subtilase variants |
WO2016206621A1 (en) | 2015-06-26 | 2016-12-29 | Novozymes A/S | Biofinishing system |
WO2016208492A1 (en) | 2015-06-26 | 2016-12-29 | 花王株式会社 | Novel xylanase |
WO2016210238A1 (en) | 2015-06-26 | 2016-12-29 | Indigo Agriculture, Inc | Penicillium endophyte compositions and methods for improved agronomic traits in plants |
WO2017001502A1 (en) | 2015-06-29 | 2017-01-05 | Xeda International S.A. | Coating compositions made of shellac and emulsifier, and methods for coating food products |
WO2017001673A1 (en) | 2015-07-01 | 2017-01-05 | Novozymes A/S | Methods of reducing odor |
WO2017005640A1 (en) | 2015-07-03 | 2017-01-12 | Novozymes A/S | Detergent compositions with improved stability in the presence of sulfites |
FR3038495A1 (en) | 2015-07-06 | 2017-01-13 | Xeda International | COATING DEVICE FOR FOOD PRODUCTS, IN PARTICULAR FRUIT AND VEGETABLES, AND METHOD THEREOF |
WO2017006266A1 (en) | 2015-07-06 | 2017-01-12 | Denovo Genomics, Inc. | Variants of the subtilisin carlsberg polypeptide with decreased thermostability |
WO2017010833A1 (en) | 2015-07-15 | 2017-01-19 | 주식회사 제노포커스 | Novel alpha-1,3-glucanase |
WO2017015233A1 (en) | 2015-07-17 | 2017-01-26 | Keclon Sa | Compositions and methods for oil degumming |
WO2017014974A1 (en) | 2015-07-21 | 2017-01-26 | Novozymes A/S | Polypeptides having pullulanase activity suitable for use in liquefaction |
WO2017019490A1 (en) | 2015-07-24 | 2017-02-02 | Novozymes Inc. | Polypeptides having arabinofuranosidase activity and polynucleotides encoding same |
CN105062991A (en) | 2015-07-27 | 2015-11-18 | 中国科学院南海海洋研究所 | Amylase mutants with improved thermal stability as well as coding gene and application of amylase mutants |
WO2017029238A2 (en) | 2015-08-14 | 2017-02-23 | Basf Se | Aqueous surface treatment composition for paper and board |
CN105087614A (en) | 2015-09-01 | 2015-11-25 | 浙江大学 | Thermomyces lanuginosus lipase gene, engineering bacteria and application of engineering bacteria |
WO2017040907A1 (en) | 2015-09-04 | 2017-03-09 | Novozymes A/S | Methods of inhibiting aa9 lytic polysaccharide monooxygenase catalyzed inactivation of enzyme compositions |
CN105176951A (en) | 2015-09-04 | 2015-12-23 | 青岛蔚蓝生物集团有限公司 | Novel alkaline protease mutant |
CN108570462A (en) | 2015-09-05 | 2018-09-25 | 陈玉玲 | A method of improving beans Hectometer degradation efficiencies |
CN105132397A (en) | 2015-09-05 | 2015-12-09 | 孙翠言 | Method for improving soybean meal degrading efficiency |
CN105039288A (en) | 2015-09-06 | 2015-11-11 | 青岛蔚蓝生物集团有限公司 | Neutral cellulase mutant and application thereof |
WO2017044473A1 (en) | 2015-09-11 | 2017-03-16 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
US20180279624A1 (en) | 2015-09-11 | 2018-10-04 | Novozymes Bioag A/S | Stable Inoculant Compositions and Methods for Producing Same |
US11472981B2 (en) | 2015-09-11 | 2022-10-18 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
WO2017044545A1 (en) | 2015-09-11 | 2017-03-16 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
US10820594B2 (en) | 2015-09-11 | 2020-11-03 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
CN105155324A (en) | 2015-09-23 | 2015-12-16 | 山东尤特尔生物科技有限公司 | Application of chaetomium thermophilum cellulase in pulping and papermaking process |
WO2017050291A1 (en) | 2015-09-25 | 2017-03-30 | Novozymes A/S | Use of serine proteases for improving ethanol yield |
AU2016101771A4 (en) | 2015-10-06 | 2016-11-10 | Novozymes A/S | Extraction of crude palm oil using enzymes |
WO2017070219A1 (en) | 2015-10-20 | 2017-04-27 | Novozymes A/S | Lytic polysaccharide monooxygenase (lpmo) variants and polynucleotides encoding same |
JP2017079639A (en) | 2015-10-28 | 2017-05-18 | 花王株式会社 | Bacillus-subtilis mutant and application thereof |
WO2016203064A2 (en) | 2015-10-28 | 2016-12-22 | Novozymes A/S | Detergent composition comprising protease and amylase variants |
CN105177084A (en) | 2015-10-29 | 2015-12-23 | 福建福大百特生物科技有限公司 | Method for producing fructooligosaccharides by fermenting inulase mutants |
CN105176947A (en) | 2015-10-29 | 2015-12-23 | 福建福大百特生物科技有限公司 | Inulase mutant and application thereof |
CN106632683A (en) | 2015-11-03 | 2017-05-10 | 丰益(上海)生物技术研发中心有限公司 | Polypeptide having pNPPC hydrolase activity and coding gene, preparation method and application thereof |
WO2017083049A1 (en) | 2015-11-09 | 2017-05-18 | Oro Agri, Inc. | An adjuvant |
WO2017081274A1 (en) | 2015-11-12 | 2017-05-18 | Novozymes A/S | Fermentation processes with reduced foaming |
WO2017083226A1 (en) | 2015-11-13 | 2017-05-18 | E. I. Du Pont De Nemours And Company | Glucan fiber compositions for use in laundry care and fabric care |
WO2017084560A1 (en) | 2015-11-16 | 2017-05-26 | Novozymes A/S | Cellulase variants and polynucleotides encoding same |
JP2016039821A (en) | 2015-11-20 | 2016-03-24 | Meiji Seikaファルマ株式会社 | Novel cellulase gene |
WO2017089304A1 (en) | 2015-11-23 | 2017-06-01 | Novozymes A/S | Enzymatic epoxydation of natural rubber |
WO2017089366A1 (en) | 2015-11-24 | 2017-06-01 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
WO2017089456A1 (en) | 2015-11-24 | 2017-06-01 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
WO2017089093A1 (en) | 2015-11-25 | 2017-06-01 | Unilever N.V. | A liquid detergent composition |
WO2017088820A1 (en) | 2015-11-26 | 2017-06-01 | Novozymes A/S | Milling process |
WO2017093318A1 (en) | 2015-12-01 | 2017-06-08 | Novozymes A/S | Methods for producing lipases |
WO2017097861A1 (en) | 2015-12-07 | 2017-06-15 | Henkel Ag & Co. Kgaa | Dishwashing compositions comprising polypeptides having beta-glucanase activity and uses thereof |
WO2017097866A1 (en) | 2015-12-07 | 2017-06-15 | Novozymes A/S | Polypeptides having beta-glucanase activity, polynucleotides encoding same and uses thereof in cleaning and detergent compositions |
CN105420252A (en) | 2015-12-07 | 2016-03-23 | 河北省微生物研究所 | Glucose oxidase gene GOD, protein coded by GOD, pichia pastoris transformed by GOD and preparation method of pichia pastoris |
US20180163191A1 (en) | 2015-12-09 | 2018-06-14 | Danisco Us Inc. | Alpha-Amylase Combinatorial Variants |
WO2017097897A1 (en) | 2015-12-10 | 2017-06-15 | Dsm Ip Assets B.V. | Beta-glucosidase and uses thereof |
WO2017097896A1 (en) | 2015-12-10 | 2017-06-15 | Dsm Ip Assets B.V. | Beta-glucosidase and uses thereof |
WO2017101801A1 (en) | 2015-12-16 | 2017-06-22 | 丰益(上海)生物技术研发中心有限公司 | Efficient phospholipase c mutant that does not rely on zinc ions |
CN106884030A (en) | 2015-12-16 | 2017-06-23 | 丰益(上海)生物技术研发中心有限公司 | The method for improving the fermentation yield of the fusion protein of containing cellulose binding domain |
WO2017106676A1 (en) | 2015-12-18 | 2017-06-22 | Danisco Us Inc | Polypeptides with endoglucanase activity and uses thereof |
WO2017112643A1 (en) | 2015-12-21 | 2017-06-29 | Danisco Us Inc. | Improved granular starch conversion enzymes and methods |
WO2017112631A1 (en) | 2015-12-21 | 2017-06-29 | Danisco Us Inc. | Improved granular starch conversion enzymes and methods |
WO2017112540A1 (en) | 2015-12-22 | 2017-06-29 | Novozymes A/S | Processes for producing fermentation products |
US20190014787A1 (en) | 2015-12-28 | 2019-01-17 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
WO2017116837A1 (en) | 2015-12-28 | 2017-07-06 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
US11076603B2 (en) | 2015-12-28 | 2021-08-03 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
US20190014786A1 (en) | 2015-12-28 | 2019-01-17 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
WO2017116846A1 (en) | 2015-12-28 | 2017-07-06 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
US10856552B2 (en) | 2015-12-28 | 2020-12-08 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
US10874109B2 (en) | 2015-12-28 | 2020-12-29 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
WO2017114891A1 (en) | 2015-12-30 | 2017-07-06 | Novozymes A/S | Enzyme variants and polynucleotides encoding the same |
CN105441415A (en) | 2016-01-22 | 2016-03-30 | 南宁邦尔克生物技术有限责任公司 | Preparation method and application of pullulanase mutant PulB-d99-D436H |
WO2017129754A1 (en) | 2016-01-29 | 2017-08-03 | Novozymes A/S | Beta-glucanase variants and polynucleotides encoding same |
WO2017144008A1 (en) | 2016-02-26 | 2017-08-31 | 南京百斯杰生物工程有限公司 | Αlpha amylase variant and use thereof |
WO2017144177A1 (en) | 2016-02-26 | 2017-08-31 | Keskin Hüseyin | Driving and/or flight simulator |
WO2017147690A1 (en) | 2016-03-02 | 2017-09-08 | Valorbec Société en Commandite | Engineered beta-glucosidases and methods of use thereof |
WO2017152169A1 (en) | 2016-03-04 | 2017-09-08 | Danisco Us Inc. | Engineered ribosomal promoters for protein production in microorganisms |
CN106084016A (en) | 2016-03-07 | 2016-11-09 | 南宁邦尔克生物技术有限责任公司 | A kind of mutant of signal peptide that can improve restructuring pullulanase expression and application thereof |
US20170251662A1 (en) | 2016-03-07 | 2017-09-07 | Agrofresh Inc. | Alternative device and methods for application of 1-methylcyclopropene to fruit |
US20170251669A1 (en) | 2016-03-07 | 2017-09-07 | Agrofresh Inc. | Vaporized administration of pesticides |
US20170251673A1 (en) | 2016-03-07 | 2017-09-07 | Agrofresh Inc. | Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops |
CN105671022A (en) | 2016-03-11 | 2016-06-15 | 江南大学 | 1,3-1,4-beta-glucanase mutant |
WO2017161091A1 (en) | 2016-03-16 | 2017-09-21 | Spogen Biotech Inc. | Methods for promoting plant health using free enzymes and microorganisms that overexpress enzymes |
US20170265462A1 (en) | 2016-03-18 | 2017-09-21 | Agrofresh Inc. | Long term methods of improving disease tolerance in plants |
DE102016204813A1 (en) | 2016-03-23 | 2017-09-28 | Henkel Ag & Co. Kgaa | Lipases for use in detergents and cleaners |
WO2017177153A1 (en) | 2016-04-07 | 2017-10-12 | Novozymes A/S | Methods for selecting enzymes having protease activity |
EP3228703A1 (en) | 2016-04-08 | 2017-10-11 | Novozymes A/S | Stabilized alpha-amylase variants and use of the same |
WO2017180695A1 (en) | 2016-04-15 | 2017-10-19 | Agrofresh Inc. | Large-scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
CN105802940A (en) | 2016-04-18 | 2016-07-27 | 广西大学 | Bacillus licheniformis high-temperature alpha-amylase mutant and application thereof |
WO2017182666A1 (en) | 2016-04-22 | 2017-10-26 | Novozymes A/S | Use of phospholipase c in palm oil milling |
CN105734034A (en) | 2016-04-25 | 2016-07-06 | 江南大学 | Method for improving catalytic performance of pullulanase with truncated flexible residues |
WO2017189720A1 (en) | 2016-04-27 | 2017-11-02 | Bioresource International | Thermostable protease and methods of making and using the same |
CN106148235A (en) | 2016-04-28 | 2016-11-23 | 中国水产科学研究院黄海水产研究所 | A kind of bacillus marinus N6 2 and the anti-tumor active protein produced thereof |
WO2017186928A1 (en) | 2016-04-29 | 2017-11-02 | Curevac Ag | Rna encoding an antibody |
WO2017191109A1 (en) | 2016-05-02 | 2017-11-09 | Carlsberg Breweries A/S | Beverages containing barley beta-glucan |
WO2017192692A1 (en) | 2016-05-03 | 2017-11-09 | Danisco Us Inc | Protease variants and uses thereof |
WO2017191160A1 (en) | 2016-05-03 | 2017-11-09 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding the same |
EP3241891A1 (en) | 2016-05-03 | 2017-11-08 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3241890A1 (en) | 2016-05-03 | 2017-11-08 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
US20170318804A1 (en) | 2016-05-04 | 2017-11-09 | Agrofresh Inc. | Preparation and dispersion of stable emulsion formulations |
WO2017194487A1 (en) | 2016-05-09 | 2017-11-16 | Novozymes A/S | Variant polypeptides with improved performance and use of the same |
CN105746635A (en) | 2016-05-10 | 2016-07-13 | 江南大学 | Application of glucose oxidase in processing of flour products |
CN105802943A (en) | 2016-05-11 | 2016-07-27 | 江南大学 | Performance-improved pullulanase chimera and pichia pastoris mutant strain for highly producing pullulanase chimera |
WO2017205337A1 (en) | 2016-05-23 | 2017-11-30 | Dupont Nutrition Biosciences Aps | Baking process and a method thereof |
WO2017205800A1 (en) | 2016-05-27 | 2017-11-30 | Agro Research International, LLC | Biopesticide composition for use preventing or minimizing plant disease |
WO2017210295A1 (en) | 2016-05-31 | 2017-12-07 | Danisco Us Inc. | Protease variants and uses thereof |
WO2017210163A1 (en) | 2016-05-31 | 2017-12-07 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
WO2017210166A1 (en) | 2016-05-31 | 2017-12-07 | Novozymes Bioag A/S | Stable liquid inoculant compositions and coated plant propagation materials comprising same |
CN107488647A (en) | 2016-06-10 | 2017-12-19 | 广东溢多利生物科技股份有限公司 | The lipase TTL mutant TTL-Gly60Glu and its gene and application that a kind of heat endurance improves |
CN107488644A (en) | 2016-06-10 | 2017-12-19 | 广东溢多利生物科技股份有限公司 | The lipase TTL mutant TTL-Gly60Glu/Ser61Asn and its gene and application that a kind of heat endurance improves |
CN107488645A (en) | 2016-06-10 | 2017-12-19 | 广东溢多利生物科技股份有限公司 | The lipase TTL mutant TTL-Ser61Asn and its gene and application that a kind of heat endurance improves |
CN107488648A (en) | 2016-06-10 | 2017-12-19 | 广东溢多利生物科技股份有限公司 | The lipase TTL mutant TTL-Arg59Ser/Gly60Glu/Ser61Asn and gene and application that heat endurance improves |
CN107488646A (en) | 2016-06-10 | 2017-12-19 | 广东溢多利生物科技股份有限公司 | Lipase mutant TTL Arg59Ser/Gly60Glu/Ser61Asn/Ile62Val and its gene and application |
WO2017217453A1 (en) | 2016-06-14 | 2017-12-21 | 味の素株式会社 | Cellulase |
CN107513527A (en) | 2016-06-16 | 2017-12-26 | 青岛蔚蓝生物集团有限公司 | A kind of cellulase variants and its application |
WO2017219011A1 (en) | 2016-06-17 | 2017-12-21 | Danisco Us Inc | Protease variants and uses thereof |
US20190159469A1 (en) | 2016-06-20 | 2019-05-30 | Xeda International S.A. | Method of treatment using a biocidal or phytoprotective product, device and corresponding treatment assembly |
WO2017220581A1 (en) | 2016-06-20 | 2017-12-28 | Xeda International S.A. | Method for treating plant products using alcohol vapours |
US20190159470A1 (en) | 2016-06-20 | 2019-05-30 | Xeda International S.A. | Method and assembly for the treatment of the atmosphere in a storage space for vegetable products |
WO2017220422A1 (en) | 2016-06-23 | 2017-12-28 | Novozymes A/S | Use of enzymes, composition and method for removing soil |
CN105886520A (en) | 2016-06-29 | 2016-08-24 | 山东大学 | Mutant gene TlXynA_2 of xylanase TlXynA and application thereof |
CN105969783A (en) | 2016-06-29 | 2016-09-28 | 山东大学 | Mutant gene TlXynA_3 of xylanase TlXynA and application thereof |
CN105907775A (en) | 2016-06-29 | 2016-08-31 | 山东大学 | Mutant gene T1XynA-1 of xylanase T1XynA and application thereof |
WO2018001959A1 (en) | 2016-06-30 | 2018-01-04 | Novozymes A/S | Lipase variants and compositions comprising surfactant and lipase variant |
WO2018002261A1 (en) | 2016-07-01 | 2018-01-04 | Novozymes A/S | Detergent compositions |
CN106190934A (en) | 2016-07-05 | 2016-12-07 | 江南大学 | A kind of recombined bacillus subtilis producing pullulanase and structure thereof |
CN105950578A (en) | 2016-07-06 | 2016-09-21 | 青岛红樱桃生物技术有限公司 | Heat-resisting glucose oxidase mutant as well as encoding gene and application thereof |
CN105950577A (en) | 2016-07-06 | 2016-09-21 | 青岛红樱桃生物技术有限公司 | Glucose oxidase mutant with improved thermal stability as well as encoding genes and application thereof |
CN106119219A (en) | 2016-07-06 | 2016-11-16 | 青岛红樱桃生物技术有限公司 | Glucoseoxidase mutant that enzymatic activity improves and expression vector and application |
CN107603965A (en) | 2016-07-11 | 2018-01-19 | 华东理工大学 | Acid starch enzyme mutant that heat endurance improves and its preparation method and application |
WO2018015295A1 (en) | 2016-07-18 | 2018-01-25 | Novozymes A/S | Lipase variants, polynucleotides encoding same and the use thereof |
WO2018015303A1 (en) | 2016-07-21 | 2018-01-25 | Novozymes A/S | Serine protease variants and polynucleotides encoding same |
WO2018015304A1 (en) | 2016-07-21 | 2018-01-25 | Novozymes A/S | Serine protease variants and polynucleotides encoding same |
EP3275988A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
WO2018019948A1 (en) | 2016-07-29 | 2018-02-01 | Dsm Ip Assets B.V. | Polypeptides having cellulolytic enhancing activity and uses thereof |
WO2018027131A1 (en) | 2016-08-05 | 2018-02-08 | Cargill, Incorporated | Leader-modified glucoamylase polypeptides and engineered yeast strains having enhanced bioproduct production |
KR101814024B1 (en) | 2016-08-23 | 2018-01-02 | 주식회사농심 | Bacillus Strain, Enzyme Produced by the Strain and Application Thereof |
WO2018039802A1 (en) | 2016-09-02 | 2018-03-08 | Creative Protein Solutions Inc | Allosteric split trehalase biosensor |
CN107312763A (en) | 2016-09-12 | 2017-11-03 | 南京百斯杰生物工程有限公司 | L-type alpha-amylase variants and its production method |
CN106801046A (en) | 2016-09-13 | 2017-06-06 | 中国农业科学院生物技术研究所 | Acidic pullulanase mutant and its encoding gene and application that heat endurance is improved |
CN106591258A (en) | 2016-09-14 | 2017-04-26 | 新余学院 | Lipase gene, vector, engineering bacterium and application thereof |
WO2018053220A1 (en) | 2016-09-16 | 2018-03-22 | Novozymes A/S | Fiber washing method and system |
US20180094228A1 (en) | 2016-10-03 | 2018-04-05 | The Procter & Gamble Company | Laundry detergent composition |
EP3301165A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Low ph laundry detergent composition |
EP3301156A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Laundry detergent composition |
EP3301166A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Method for laundering fabric |
EP3301154A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Laundry detergent composition |
EP3301162A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Low ph laundry detergent composition |
EP3301155A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Laundry detergent composition |
EP3301147A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Low ph laundry detergent composition |
EP3301161A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Laundry detergent composition |
EP3301145A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Low ph laundry detergent composition |
EP3301163A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Low ph laundry detergent composition |
EP3301169A1 (en) | 2016-10-03 | 2018-04-04 | The Procter & Gamble Company | Laundry detergent composition |
EP3309244A1 (en) | 2016-10-11 | 2018-04-18 | Basf Se | Low temperature protease |
WO2018075430A1 (en) | 2016-10-17 | 2018-04-26 | Novozymes A/S | Methods of reducing foam during ethanol fermentation |
CN107988177A (en) | 2016-10-26 | 2018-05-04 | 青岛蔚蓝生物集团有限公司 | Glucose oxidase mutant |
CN106350530A (en) | 2016-11-04 | 2017-01-25 | 江南大学 | Keratinase and gene sequence and application method thereof |
WO2018085524A2 (en) | 2016-11-07 | 2018-05-11 | Danisco Us Inc | Laundry detergent composition |
WO2018089391A1 (en) | 2016-11-08 | 2018-05-17 | Dots Technology Corp. | Allergen detection agents and assays |
CN108070574A (en) | 2016-11-14 | 2018-05-25 | 福建力多利生物科技有限公司 | The mutant and its encoding gene of the peroxidase in Coprinus cinereus source and application |
WO2018094181A1 (en) | 2016-11-21 | 2018-05-24 | Novozymes A/S | Yeast cell extract assisted construction of dna molecules |
WO2018116027A1 (en) | 2016-11-21 | 2018-06-28 | Decco Worldwide Post-Harvest Holdings B.V. | Composition for the treatment and/or prevention of the black sigatoka fungal disease in banana crops |
WO2018098124A1 (en) | 2016-11-23 | 2018-05-31 | Novozymes A/S | Polypeptides having protease activity and polynucleotides encoding same |
WO2018098381A1 (en) | 2016-11-23 | 2018-05-31 | Novozymes A/S | Improved yeast for ethanol production |
US20180139975A1 (en) | 2016-11-23 | 2018-05-24 | Agrofresh Inc. | Methods and device for co-treatment of crop protection chemicals with plant growth regulators |
CN106544329A (en) | 2016-11-25 | 2017-03-29 | 山东大学 | A kind of extracellular polysaccharide monooxygenase PoLPMO1 and its application |
CN108118037A (en) | 2016-11-28 | 2018-06-05 | 青岛蔚蓝生物集团有限公司 | The glucose oxidase mutant that a kind of heat resistance improves |
CN108118039A (en) | 2016-11-28 | 2018-06-05 | 丰益(上海)生物技术研发中心有限公司 | A kind of phospholipase C mutant |
CN108118036A (en) | 2016-11-28 | 2018-06-05 | 青岛蔚蓝生物集团有限公司 | Novel grape carbohydrate oxidase mutant |
CN108118038A (en) | 2016-11-28 | 2018-06-05 | 青岛蔚蓝生物集团有限公司 | A kind of glucose oxidase mutant |
WO2018102348A1 (en) | 2016-11-29 | 2018-06-07 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
EP3330349A1 (en) | 2016-12-02 | 2018-06-06 | The Procter & Gamble Company | Cleaning compositions including enzymes |
EP4001389A1 (en) | 2016-12-02 | 2022-05-25 | The Procter & Gamble Company | Cleaning compositions including enzymes |
US20180155744A1 (en) | 2016-12-05 | 2018-06-07 | Stellenbosch University | Recombinant yeast and use thereof |
WO2018106656A1 (en) | 2016-12-06 | 2018-06-14 | Danisco Us Inc | Truncated lpmo enzymes and use thereof |
WO2018112123A1 (en) | 2016-12-15 | 2018-06-21 | Danisco Us Inc. | Polypeptides with endoglucanase activity and uses thereof |
US20200085065A1 (en) | 2016-12-20 | 2020-03-19 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
WO2018118740A1 (en) | 2016-12-20 | 2018-06-28 | Novozymes Bioag A/S | Stable inoculant compositions and methods for producing same |
WO2018118917A1 (en) | 2016-12-21 | 2018-06-28 | Danisco Us Inc. | Protease variants and uses thereof |
WO2018118950A1 (en) | 2016-12-21 | 2018-06-28 | Danisco Us Inc. | Bacillus gibsonii-clade serine proteases |
EP3339423A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3339422A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Laundry detergent composition |
CN108239627A (en) | 2016-12-27 | 2018-07-03 | 丰益(上海)生物技术研发中心有限公司 | The lipase and its application that activity improves |
CN108239626A (en) | 2016-12-27 | 2018-07-03 | 丰益(上海)生物技术研发中心有限公司 | A kind of lipase mutant of high esterification activity |
CN106635846A (en) | 2016-12-28 | 2017-05-10 | 青岛蔚蓝生物集团有限公司 | Aspergillus niger strain for production of high-yield pectin methylesterase |
WO2018127486A1 (en) | 2017-01-03 | 2018-07-12 | Novozymes A/S | Enzymatic dehusking of pulses |
WO2018128807A1 (en) | 2017-01-03 | 2018-07-12 | DePuy Synthes Products, Inc. | Mini cable tensioner for orthopedic cable tensioning |
US20200000098A1 (en) | 2017-01-04 | 2020-01-02 | Novozymes Bioag A/S | Bacillus isolates and uses thereof |
US20190345572A1 (en) | 2017-01-05 | 2019-11-14 | Novozymes Bioag A/S | Lysinibacillus isolates and uses thereof |
CN107151660A (en) | 2017-01-11 | 2017-09-12 | 广东溢多利生物科技股份有限公司 | lipase variant Ala36Ser/Asp49His/Ala52Val/Asn55Asp |
WO2018130654A1 (en) | 2017-01-13 | 2018-07-19 | Novozymes A/S | Sterile filtered lactase preparation comprising salt with monovalent cation |
CN110713999A (en) | 2017-01-16 | 2020-01-21 | 广东溢多利生物科技股份有限公司 | Alpha-amylase mutant BasAmy-3 capable of improving specific activity and coding gene and application thereof |
CN107058264A (en) | 2017-01-16 | 2017-08-18 | 广东溢多利生物科技股份有限公司 | Than the alpha amylase JcAmy mutant living improved and its encoding gene and application |
CN106754825A (en) | 2017-01-16 | 2017-05-31 | 广东溢多利生物科技股份有限公司 | Improve than alpha amylase BaAmy mutant living and its encoding gene and application |
CN106929495A (en) | 2017-01-16 | 2017-07-07 | 广东溢多利生物科技股份有限公司 | Improve than alpha amylase BasAmy mutant living and its encoding gene and application |
CN106754826A (en) | 2017-01-16 | 2017-05-31 | 广东溢多利生物科技股份有限公司 | Alpha amylase AmyL mutant and its encoding gene and application that activity is improved |
CN110699337A (en) | 2017-01-16 | 2020-01-17 | 广东溢多利生物科技股份有限公司 | Alpha-amylase mutant BasAmy-4 capable of improving specific activity and coding gene and application thereof |
CN110628748A (en) | 2017-01-16 | 2019-12-31 | 广东溢多利生物科技股份有限公司 | Alpha-amylase mutant BasAmy-2 capable of improving specific activity and coding gene and application thereof |
US20200339917A1 (en) | 2017-02-01 | 2020-10-29 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants |
WO2018142002A1 (en) | 2017-02-01 | 2018-08-09 | Abengoa Bioenergía Nuevas Tecnologías, S.A. | Polypeptides with polysaccharide monooxygenase activity and use thereof for the production of fermentable sugars |
US20180216039A1 (en) | 2017-02-01 | 2018-08-02 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants |
CN106676084A (en) | 2017-02-09 | 2017-05-17 | 浙江工业大学 | Lipase mutant deriving from talaromyces thermophilus, coding gene and application thereof |
CN106801048A (en) | 2017-03-01 | 2017-06-06 | 中国科学院天津工业生物技术研究所 | A kind of low-temperature alkaline protease and preparation method thereof |
WO2018161899A1 (en) | 2017-03-06 | 2018-09-13 | Novozymes A/S | Use of one or more enzymes in preventing, inhibiting or reducing microbe growth on a surface |
CN107022588A (en) | 2017-03-10 | 2017-08-08 | 丰宁平安高科实业有限公司 | Using endoinulase FOS is produced using witloof or jerusalem artichoke as raw material |
WO2018165594A1 (en) | 2017-03-10 | 2018-09-13 | Bolt Threads, Inc. | Compositions and methods for producing high secreted yields of recombinant proteins |
WO2018167669A1 (en) | 2017-03-13 | 2018-09-20 | Lallemand Hungary Liquidity Management Llc | Cell-associated heterologous food and/or feed enzymes |
WO2018167670A1 (en) | 2017-03-13 | 2018-09-20 | Lallemand Hungary Liquidity Management Llc | Recombinant yeast host cells expressing cell-associated heterologous proteins |
WO2018171552A1 (en) | 2017-03-20 | 2018-09-27 | Novozymes A/S | Method for degumming and refining of vegetable oil |
WO2018175681A1 (en) | 2017-03-22 | 2018-09-27 | Novozymes Bioag A/S | Recovery of stressed bacteria |
US20200060300A1 (en) | 2017-03-22 | 2020-02-27 | Xeda International S.A. | Process for treatment by at least one moderately volatile biocidal and/or plant-protection product, corresponding treatment assembly and storage assembly |
WO2018183491A1 (en) | 2017-03-30 | 2018-10-04 | Novozymes Bioag A/S | Recovery of dried bacteria |
WO2018184004A1 (en) | 2017-03-31 | 2018-10-04 | Danisco Us Inc | Alpha-amylase combinatorial variants |
WO2018185048A1 (en) | 2017-04-03 | 2018-10-11 | Novozymes A/S | Recovery process |
WO2018186307A1 (en) | 2017-04-04 | 2018-10-11 | 国立大学法人岐阜大学 | Strain belonging to genus mitsuaria and microbial pesticide using said strain |
WO2018188667A1 (en) | 2017-04-14 | 2018-10-18 | Novozymes A/S | Processes for solubilizing municipal solid waste with enzyme compositions comprising protease and enzyme compositions thereof |
US20210102245A1 (en) | 2017-04-28 | 2021-04-08 | Spartan Bioscience Inc. | Direct nucleic acid analysis of environmental and biological samples |
WO2018204483A2 (en) | 2017-05-03 | 2018-11-08 | Senomyx, Inc. | Methods for making high intensity sweeteners |
CN108795781A (en) | 2017-05-03 | 2018-11-13 | 中国科学院微生物研究所 | A kind of recombinant bacterium of high yield Trichoderma harzianum α -1,3- dextranases and its application |
WO2018209345A1 (en) | 2017-05-12 | 2018-11-15 | The Trustees Of The University Of Pennsylvania | Compositions and methods for inhibiting biofilm deposition and production |
CN107326020A (en) | 2017-05-25 | 2017-11-07 | 南京百斯杰生物工程有限公司 | A kind of L-type amylase variant and application |
WO2018218035A1 (en) | 2017-05-26 | 2018-11-29 | Novozymes Bioag A/S | Stable inoculant compositions comprising methylated plant oils |
WO2018218008A1 (en) | 2017-05-26 | 2018-11-29 | Novozymes Bioag A/S | Stable liquid inoculant compositions comprising dodecane |
US20200093125A1 (en) | 2017-05-26 | 2020-03-26 | Novozymes Bioag A/S | Stable inoculant compositions comprising paraffin oils/waxes |
WO2018218016A1 (en) | 2017-05-26 | 2018-11-29 | Novozymes Bioag A/S | Stable inoculant compositions comprising paraffin oils/waxes |
JP2018198581A (en) | 2017-05-29 | 2018-12-20 | アイシン精機株式会社 | Flavin adenine dinucleotide dependent formic acid oxidase variant, nucleic acid molecule, enzyme electrode, bio battery, and biosensor |
WO2018219854A1 (en) | 2017-05-30 | 2018-12-06 | Novozymes A/S | Starch extraction method |
WO2018222990A1 (en) | 2017-06-02 | 2018-12-06 | Novozymes A/S | Improved yeast for ethanol production |
CN107012130A (en) | 2017-06-02 | 2017-08-04 | 中国农业科学院饲料研究所 | A kind of glucose oxidase mutant and its encoding gene and application |
US20180356384A1 (en) | 2017-06-08 | 2018-12-13 | Agrofresh Inc. | Method and system for centralized management, monitoring, and controlled delivery of biological compounds to fruit storage rooms |
WO2018224544A1 (en) | 2017-06-08 | 2018-12-13 | Novozymes A/S | Compositions comprising polypeptides having cellulase activity and amylase activity, and uses thereof in cleaning and detergent compositions |
WO2018234382A1 (en) | 2017-06-22 | 2018-12-27 | Novozymes A/S | Dough relaxation using gamma glutamyl transpeptidase |
WO2019005755A1 (en) | 2017-06-28 | 2019-01-03 | Novozymes A/S | Polypeptides having trehalase activity and polynucleotides encoding same |
US20200221719A1 (en) | 2017-06-28 | 2020-07-16 | Xeda International S.A. | Treatment unit and method, unit for storing and culturing plant products comprising the treatment unit |
CN109207446A (en) | 2017-06-30 | 2019-01-15 | 青岛蔚蓝生物集团有限公司 | glucose oxidase mutant |
CN107236692A (en) | 2017-07-03 | 2017-10-10 | 华中师范大学 | The molten fiber series bacillus NP1 of termite, zytase PtXyn1 and its encoding gene and application |
WO2019014118A1 (en) | 2017-07-09 | 2019-01-17 | Igc Bio, Inc. | Pross optimized enzymes |
CN107384897A (en) | 2017-08-02 | 2017-11-24 | 北京科为博生物科技有限公司 | A kind of alkali protease and its gene and application |
US20200022719A1 (en) | 2017-08-17 | 2020-01-23 | GYRUS ACMI, INC., d/b/a Olympus Surgical Technologies America | Forceps with tissue stops |
CN108251389A (en) | 2017-08-18 | 2018-07-06 | 青岛蔚蓝生物集团有限公司 | The glucose oxidase mutant that a kind of heat resistance improves |
CN108251391A (en) | 2017-08-18 | 2018-07-06 | 青岛蔚蓝生物集团有限公司 | Novel grape carbohydrate oxidase mutant |
EP3444323A1 (en) | 2017-08-18 | 2019-02-20 | The Procter & Gamble Company | Cleaning kit |
WO2019036721A2 (en) | 2017-08-18 | 2019-02-21 | Danisco Us Inc | Alpha-amylase variants |
CN108251390A (en) | 2017-08-18 | 2018-07-06 | 青岛蔚蓝生物集团有限公司 | A kind of glucose oxidase mutant |
WO2019042971A1 (en) | 2017-08-29 | 2019-03-07 | Novozymes A/S | Baker's yeast expressing anti-staling/freshness amylases |
CN109423483A (en) | 2017-08-30 | 2019-03-05 | 青岛蔚蓝生物集团有限公司 | Glucose oxidase mutant |
WO2019048495A1 (en) | 2017-09-05 | 2019-03-14 | Henkel Ag & Co. Kgaa | Performance-enhanced protease variants i |
WO2019048486A1 (en) | 2017-09-05 | 2019-03-14 | Henkel Ag & Co. Kgaa | Performance-enhanced protease variants ii |
WO2019060574A1 (en) | 2017-09-20 | 2019-03-28 | Spogen Biotech Inc. | Fusion proteins, recombinant bacteria, and exosporium fragments for plant health |
WO2019058211A1 (en) | 2017-09-22 | 2019-03-28 | Decco Worldwide Post-Harvest Holdings B.V. | A method for treating and controlling post-harvest physiological disorders in fruit via edible coatings |
US20220177812A1 (en) | 2017-09-27 | 2022-06-09 | The Procter & Gamble Company | Detergent composition |
WO2019063499A1 (en) | 2017-09-27 | 2019-04-04 | Novozymes A/S | Lipase variants and microcapsule compositions comprising such lipase variants |
CN107475219A (en) | 2017-09-29 | 2017-12-15 | 天津科技大学 | Three kinds recombinate carbohydrase and preparation method and application |
WO2019063543A1 (en) | 2017-09-29 | 2019-04-04 | Dsm Ip Assets B.V. | Improved glycerol free ethanol production |
CN107815460A (en) | 2017-09-30 | 2018-03-20 | 武汉轻工大学 | The preparation method of lipase gene, recombinant expression carrier, recombinant strains, lipase and preparation method thereof and biodiesel |
WO2019068850A1 (en) | 2017-10-06 | 2019-04-11 | Novozymes A/S | Enzyme assisted crude palm oil extraction |
US10233430B1 (en) | 2017-10-13 | 2019-03-19 | Dongguan Apac Biotechnology Co.,Ltd. | Glucose oxidase having improved thermostability |
CN109666657A (en) | 2017-10-13 | 2019-04-23 | 东莞泛亚太生物科技有限公司 | Promote the glucose oxidase of heat resistance |
WO2019083831A1 (en) | 2017-10-23 | 2019-05-02 | Novozymes A/S | Processes for reducing lactic acid in a biofuel fermentation system |
CN107828765A (en) | 2017-11-01 | 2018-03-23 | 江南大学 | The keratinase mutant of improved thermo stability and its application |
CN107586767A (en) | 2017-11-08 | 2018-01-16 | 南京林业大学 | A kind of heat-resisting internal cutting type xylanase EpXYN1 and its encoding gene and application |
WO2019099235A1 (en) | 2017-11-14 | 2019-05-23 | Danisco Us Inc | Alpha-amylase, composition and method |
US20200352183A1 (en) | 2017-11-15 | 2020-11-12 | Xeda International S.A. | Process and assembly for the treatment of the atmosphere of a storage of plant products with high relative humidity |
EP3485734A1 (en) | 2017-11-21 | 2019-05-22 | Technische Universität München | Method for preparing food products comprising rye |
WO2019108599A1 (en) | 2017-11-29 | 2019-06-06 | Danisco Us Inc | Subtilisin variants having improved stability |
WO2019110462A1 (en) | 2017-12-04 | 2019-06-13 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
WO2019110538A1 (en) | 2017-12-04 | 2019-06-13 | Institut National De La Recherche Agronomique | Novel phytopharmaceutical compounds and compositions, preparation and uses thereof |
WO2019110497A1 (en) | 2017-12-05 | 2019-06-13 | Chr. Hansen A/S | Use of cellobiose oxidase for reduction of reduction of maillard reaction |
CN108102934A (en) | 2017-12-07 | 2018-06-01 | 青岛蔚蓝生物集团有限公司 | A kind of Aspergillus niger strain of high yield pectin lyase |
WO2019113415A1 (en) | 2017-12-08 | 2019-06-13 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2019113413A1 (en) | 2017-12-08 | 2019-06-13 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
CN109321546A (en) | 2017-12-12 | 2019-02-12 | 丰益(上海)生物技术研发中心有限公司 | Phospholipase C and its encoding gene |
CN107828754A (en) | 2017-12-13 | 2018-03-23 | 江南大学 | The γ glutamyl transpeptidases mutant and its construction method that a kind of enzyme activity improves |
CN108004256A (en) | 2017-12-14 | 2018-05-08 | 河北省微生物研究所 | Glucose oxidase gene Glox, albumen, pichia pastoris yeast and its preparation and application |
CN107937374A (en) | 2017-12-19 | 2018-04-20 | 江南大学 | The Nattokinase that a kind of heat endurance improves |
US20190185788A1 (en) | 2017-12-19 | 2019-06-20 | The Procter & Gamble Company | Automatic dishwashing detergent compositions |
US20220098524A1 (en) | 2017-12-19 | 2022-03-31 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
US20190185789A1 (en) | 2017-12-19 | 2019-06-20 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
CN107937372A (en) | 2017-12-19 | 2018-04-20 | 江南大学 | The Nattokinase that a kind of acid resistance improves |
WO2019121930A1 (en) | 2017-12-20 | 2019-06-27 | Dsm Ip Assets B.V. | Animal feed compositions and uses thereof |
EP3502242A1 (en) | 2017-12-20 | 2019-06-26 | Technische Universität München | New xylanase with improved thermostability and increased enzyme activity on arabinoxylan |
WO2019121937A1 (en) | 2017-12-20 | 2019-06-27 | Dsm Ip Assets B.V. | Animal feed compositions comprising muramidase and uses thereof |
US20190194634A1 (en) | 2017-12-21 | 2019-06-27 | Ab Enzymes Oy | Variants of Fungal Cellulase |
EP3502243A1 (en) | 2017-12-21 | 2019-06-26 | AB Enzymes Oy | Variants of fungal cellulase |
CN108004220A (en) | 2017-12-25 | 2018-05-08 | 刘丹妮 | Improve alkali protease BmP mutant and its gene and the application of heat endurance |
CN108277212A (en) | 2017-12-29 | 2018-07-13 | 广东溢多利生物科技股份有限公司 | Lipase mutant Gly183Cys/Gly212Cys and its gene and application |
WO2019137289A1 (en) | 2018-01-09 | 2019-07-18 | Novozymes A/S | Use of enzyme in removing airborne particulate matter from textile |
CN108003244A (en) | 2018-01-24 | 2018-05-08 | 江南大学 | A kind of method for improving glucose oxidase heat endurance |
CN113717864A (en) | 2018-01-30 | 2021-11-30 | 青岛蔚蓝生物集团有限公司 | Cellulase high-yield strain and application thereof |
CN108359659A (en) | 2018-02-06 | 2018-08-03 | 横琴仲泰生物医药有限公司 | A kind of alkali protease BmP mutant and its encoding gene that thermal stability is high |
CN108384771A (en) | 2018-02-06 | 2018-08-10 | 珠海市双指环投资有限公司 | A kind of alkali protease mutation body and its encoding gene improving Rate activity |
WO2019154951A1 (en) | 2018-02-08 | 2019-08-15 | Novozymes A/S | Lipases, lipase variants and compositions thereof |
WO2019154954A1 (en) | 2018-02-08 | 2019-08-15 | Novozymes A/S | Lipase variants and compositions thereof |
CN108359655A (en) | 2018-02-08 | 2018-08-03 | 刘丹妮 | A kind of lipase mutant TDL-mut and its encoding gene that thermal stability is high |
WO2019154955A1 (en) | 2018-02-08 | 2019-08-15 | Novozymes A/S | Lipase variants and compositions thereof |
WO2019154952A1 (en) | 2018-02-08 | 2019-08-15 | Novozymes A/S | Lipase variants and compositions thereof |
WO2019161227A1 (en) | 2018-02-15 | 2019-08-22 | Novozymes A/S | Improved yeast for ethanol production |
WO2019163886A1 (en) | 2018-02-26 | 2019-08-29 | 花王株式会社 | MUTANT β-GLUCOSIDASE |
JP2019146520A (en) | 2018-02-27 | 2019-09-05 | 花王株式会社 | Mutant β-glucosidase |
CN108588056A (en) | 2018-03-12 | 2018-09-28 | 中国农业科学院饲料研究所 | A kind of low temperature alpha-amylase Tcamy and its gene and application |
CN108623652A (en) | 2018-03-13 | 2018-10-09 | 广西科学院 | A kind of method that heat stability of protein is transformed and its application in Pullulanase |
CN108841809A (en) | 2018-03-21 | 2018-11-20 | 中国农业科学院饲料研究所 | With height than amylase mutant and its gene and application living and thermal stability |
JP2019165727A (en) | 2018-03-22 | 2019-10-03 | 物産フードサイエンス株式会社 | New application of lipase in dough |
WO2019180111A1 (en) | 2018-03-23 | 2019-09-26 | Novozymes A/S | Subtilase variants and compositions comprising same |
CN108251392A (en) | 2018-03-30 | 2018-07-06 | 广东溢多利生物科技股份有限公司 | It improves than living and the glucose oxidase mutant of thermal stability and its encoding gene and application |
CN108374001A (en) | 2018-03-30 | 2018-08-07 | 广东溢多利生物科技股份有限公司 | It improves than glucose oxidase mutant living and its encoding gene and application |
WO2019193102A1 (en) | 2018-04-05 | 2019-10-10 | Dsm Ip Assets B.V. | Variant maltogenic alpha-amylase |
CN108315312A (en) | 2018-04-11 | 2018-07-24 | 广东溢多利生物科技股份有限公司 | The lipase TTL mutant and its encoding gene and application that a kind of thermal stability improves |
CN108570461A (en) | 2018-04-17 | 2018-09-25 | 横琴仲泰生物医药有限公司 | A kind of alkali protease BmP mutant and its encoding gene improving Rate activity |
WO2019201785A1 (en) | 2018-04-19 | 2019-10-24 | Novozymes A/S | Stabilized cellulase variants |
WO2019201783A1 (en) | 2018-04-19 | 2019-10-24 | Novozymes A/S | Stabilized cellulase variants |
WO2019201725A1 (en) | 2018-04-19 | 2019-10-24 | Novozymes A/S | Process for improving freshness of flat breads involving combination of maltogenic alpha amylase variants |
WO2019215078A1 (en) | 2018-05-07 | 2019-11-14 | Dsm Ip Assets B.V. | Process for enzymatic oil degumming |
CN108611333A (en) | 2018-05-10 | 2018-10-02 | 江南大学 | A kind of gamma glutamyl transpeptidase mutant and its construction method turning the raising of peptide vigor |
CN108611339A (en) | 2018-05-11 | 2018-10-02 | 中国农业科学院饲料研究所 | Glucoamylase TlGa15 and its gene and application |
DE102018004207A1 (en) | 2018-05-18 | 2019-11-21 | Henkel Ag & Co. Kgaa | Performance-enhanced variants of the alkaline protease from B. lentus |
EP3572503A1 (en) | 2018-05-22 | 2019-11-27 | ARKRAY, Inc. | Mutant glucose oxidase and use thereof |
WO2019229228A1 (en) | 2018-05-31 | 2019-12-05 | Novozymes A/S | Method for treating dissolving pulp using lytic polysaccharide monooxygenase |
WO2019228448A1 (en) | 2018-06-01 | 2019-12-05 | Novozymes A/S | Polypeptides |
CN108893453A (en) | 2018-06-04 | 2018-11-27 | 中国农业科学院饲料研究所 | Glucose oxidase GOD mutant and its gene and application |
WO2019236717A1 (en) | 2018-06-05 | 2019-12-12 | Novozymes Bioag A/S | Methods of protecting a plant from insect pests |
CN110577939A (en) | 2018-06-07 | 2019-12-17 | 青岛红樱桃生物技术有限公司 | glucose oxidase mutant with improved heat resistance as well as coding gene and application thereof |
CN108929866A (en) | 2018-06-11 | 2018-12-04 | 黑龙江八农垦大学 | The new function and its antibacterial peptide of bacillus subtilis GGT protein degradation product are identified |
WO2019238761A1 (en) | 2018-06-15 | 2019-12-19 | Basf Se | Water soluble multilayer films containing wash active chemicals and enzymes |
WO2019245705A1 (en) | 2018-06-19 | 2019-12-26 | Danisco Us Inc | Subtilisin variants |
WO2019245838A1 (en) | 2018-06-19 | 2019-12-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2019245839A1 (en) | 2018-06-19 | 2019-12-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
WO2019245704A1 (en) | 2018-06-19 | 2019-12-26 | Danisco Us Inc | Subtilisin variants |
WO2020002574A1 (en) | 2018-06-28 | 2020-01-02 | Novozymes A/S | Enzymatic processing of sugar beets |
WO2020002255A1 (en) | 2018-06-29 | 2020-01-02 | Novozymes A/S | Subtilase variants and compositions comprising same |
WO2020007863A1 (en) | 2018-07-02 | 2020-01-09 | Novozymes A/S | Cleaning compositions and uses thereof |
CN108823186A (en) | 2018-07-03 | 2018-11-16 | 江西省科学院微生物研究所 | A kind of thermophilic acidic uncooked amylum alpha-amylase mutant and its preparation method and application that cornstarch degradation capability improves |
WO2020007875A1 (en) | 2018-07-03 | 2020-01-09 | Novozymes A/S | Cleaning compositions and uses thereof |
CN108913675A (en) | 2018-07-09 | 2018-11-30 | 华南理工大学 | The lipase mutant and its application that a kind of thermal stability improves |
WO2020014407A1 (en) | 2018-07-11 | 2020-01-16 | Novozymes A/S | Processes for producing fermentation products |
CN110724645A (en) | 2018-07-16 | 2020-01-24 | 青岛蔚蓝生物集团有限公司 | Pichia pastoris mutant strain and application thereof |
WO2020016728A1 (en) | 2018-07-16 | 2020-01-23 | Upl Ltd | Gas releasing composition and process of preparation thereof |
WO2020016154A1 (en) | 2018-07-16 | 2020-01-23 | Xeda International S.A. | Extended-release essential oil formulation, and method for treating plant products using said formulation |
CN110724646A (en) | 2018-07-16 | 2020-01-24 | 青岛蔚蓝生物集团有限公司 | Pichia pastoris strain and application thereof in xylanase production |
WO2020023411A1 (en) | 2018-07-25 | 2020-01-30 | Novozymes A/S | Enzyme-expressing yeast for ethanol production |
WO2020028443A1 (en) | 2018-07-31 | 2020-02-06 | Danisco Us Inc | Variant alpha-amylases having amino acid substitutions that lower the pka of the general acid |
US20200055794A1 (en) | 2018-08-16 | 2020-02-20 | Anuvia Plant Nutrients Corporation | Reactive Inorganic Coatings for Agricultural Fertilizers |
CN109055439A (en) | 2018-08-17 | 2018-12-21 | 中国科学院青岛生物能源与过程研究所 | The method that ethyl alcohol is prepared using lignocellulosic |
US20210300837A1 (en) | 2018-08-27 | 2021-09-30 | Syngenta Crop Protection Ag | Fertilizer pouch |
CN109022396A (en) | 2018-08-30 | 2018-12-18 | 江南大学 | The alpha-amylase mutant and its application that a kind of enzyme activity improves |
WO2020046613A1 (en) | 2018-08-30 | 2020-03-05 | Danisco Us Inc | Compositions comprising a lipolytic enzyme variant and methods of use thereof |
WO2020053276A1 (en) | 2018-09-11 | 2020-03-19 | Dsm Ip Assets B.V. | Animal feed composition and use thereof |
WO2020058228A1 (en) | 2018-09-17 | 2020-03-26 | Dsm Ip Assets B.V. | Animal feed compositions and uses thereof |
WO2020070199A1 (en) | 2018-10-03 | 2020-04-09 | Novozymes A/S | Polypeptides having alpha-mannan degrading activity and polynucleotides encoding same |
WO2020076697A1 (en) | 2018-10-08 | 2020-04-16 | Novozymes A/S | Enzyme-expressing yeast for ethanol production |
CN109321552A (en) | 2018-10-11 | 2019-02-12 | 山东隆科特酶制剂有限公司 | A kind of novel Pullulanase and its gene, engineering bacteria and preparation method |
WO2020077331A2 (en) | 2018-10-12 | 2020-04-16 | Danisco Us Inc | Alpha-amylases with mutations that improve stability in the presence of chelants |
WO2020086430A2 (en) | 2018-10-22 | 2020-04-30 | Dupont Nutrition Biosciences Aps | Enzymes for infusion mashing in adjunct brewing technical field |
JP2020065514A (en) | 2018-10-26 | 2020-04-30 | 花王株式会社 | Novel arabinofuranosidase |
CN109207458A (en) | 2018-10-31 | 2019-01-15 | 福州大学 | Heat resistant type mesophilicα-diastase and its application |
WO2020088393A1 (en) | 2018-10-31 | 2020-05-07 | 青岛蔚蓝生物集团有限公司 | Method for producing washing enzyme having protease resistance |
CN109321586A (en) | 2018-11-03 | 2019-02-12 | 中国农业科学院生物技术研究所 | Recombinant Aspergillus niger Glucose Oxidase optimization gene and its expression vector and application |
WO2020096905A1 (en) | 2018-11-07 | 2020-05-14 | Firmenich Incorporated | Methods for making high intensity sweeteners |
WO2020096907A1 (en) | 2018-11-07 | 2020-05-14 | Firmenich Incorporated | Methods for making high intensity sweeteners |
EP3653705A1 (en) | 2018-11-13 | 2020-05-20 | AB Enzymes Oy | Fungal cellulase variants with improved stability |
EP3653706A1 (en) | 2018-11-13 | 2020-05-20 | AB Enzymes Oy | Fusion protein |
US20200148605A1 (en) | 2018-11-14 | 2020-05-14 | Anuvia Plant Nutrients Corporation | Delivery of Bioactive Molecules in Coatings or Surface Layers of Organically Enhanced Inorganic Fertilizers |
WO2020106600A1 (en) | 2018-11-19 | 2020-05-28 | Basf Se | Leader sequence for yeast |
WO2020103861A1 (en) | 2018-11-21 | 2020-05-28 | Novozymes A/S | Polypeptides having lipase activity and use thereof for wheat separation |
CN109439641A (en) | 2018-11-22 | 2019-03-08 | 湖南汇升生物科技有限公司 | A kind of application of maltogenic amylase production bacterial strain |
CN109486791A (en) | 2018-11-22 | 2019-03-19 | 湖南汇升生物科技有限公司 | A kind of preparation and its application of maltogenic amylase enzyme mutant |
CN109234339A (en) | 2018-11-22 | 2019-01-18 | 湖南汇升生物科技有限公司 | A kind of production method of high-purity crystallized maltose |
CN109439607A (en) | 2018-11-22 | 2019-03-08 | 湖南汇升生物科技有限公司 | A kind of application of maltogenic amylase production bacterial strain |
CN109370973A (en) | 2018-11-22 | 2019-02-22 | 湖南汇升生物科技有限公司 | A kind of maltogenic amylase production bacterial strain |
WO2020112599A1 (en) | 2018-11-28 | 2020-06-04 | Danisco Us Inc | Subtilisin variants having improved stability |
EP3660151A1 (en) | 2018-11-29 | 2020-06-03 | Henkel AG & Co. KGaA | Storage stable protease variants with improved performance |
EP3660146A1 (en) | 2018-11-29 | 2020-06-03 | Henkel AG & Co. KGaA | Storage stable protease variants with improved performance |
WO2020114968A1 (en) | 2018-12-03 | 2020-06-11 | Novozymes A/S | Powder detergent compositions |
WO2020114965A1 (en) | 2018-12-03 | 2020-06-11 | Novozymes A/S | LOW pH POWDER DETERGENT COMPOSITION |
WO2020115179A1 (en) | 2018-12-05 | 2020-06-11 | Novozymes A/S | Use of an enzyme granule |
WO2020123463A1 (en) | 2018-12-12 | 2020-06-18 | Novozymes A/S | Polypeptides having xylanase activity and polynucleotides encoding same |
CN109468301A (en) | 2018-12-13 | 2019-03-15 | 浙江大学 | A kind of lipase mutant and its preparation method and application that thermal stability improves |
WO2020131691A2 (en) | 2018-12-17 | 2020-06-25 | Gro Biosciences Inc. | Diselenide-stabilized feed enzymes |
CN109456957A (en) | 2018-12-19 | 2019-03-12 | 广州立白企业集团有限公司 | Ease variants, liquid detergent composition and its application |
WO2020125700A1 (en) | 2018-12-20 | 2020-06-25 | 南京百斯杰生物工程有限公司 | Glucose oxidase mutant and use thereof in industrial production |
CN109554355A (en) | 2018-12-20 | 2019-04-02 | 山东恒鲁生物科技有限公司 | Enhance active polypeptide and its application with cellulose degradation |
WO2020127775A1 (en) | 2018-12-21 | 2020-06-25 | Novozymes A/S | Detergent pouch comprising metalloproteases |
CN111378583A (en) | 2018-12-27 | 2020-07-07 | 青岛蔚蓝生物集团有限公司 | Trichoderma reesei and application thereof |
CN109929821A (en) | 2018-12-27 | 2019-06-25 | 江南大学 | A kind of cutin enzyme mutant and its application in plain boiled water processing |
CN109486689A (en) | 2018-12-27 | 2019-03-19 | 江南大学 | A kind of acid proof method of enhancing L-ASP |
WO2020135658A1 (en) | 2018-12-28 | 2020-07-02 | 丰益(上海)生物技术研发中心有限公司 | Polypeptide having phospholipase c activity and use thereof |
WO2020135657A1 (en) | 2018-12-28 | 2020-07-02 | 丰益(上海)生物技术研发中心有限公司 | Phospholipase c mutant with high enzyme activity |
CN111454929A (en) | 2019-01-22 | 2020-07-28 | 中国农业大学 | High-temperature-resistant xylanase gene and application thereof |
WO2020154387A1 (en) | 2019-01-23 | 2020-07-30 | Spogen Biotech Inc. | Compositions for treating citrus disease and promoting yield increase in row crops |
CN109593746A (en) | 2019-01-24 | 2019-04-09 | 江南大学 | The keratinase mutant and application that a kind of catalytic performance improves |
WO2020156419A1 (en) | 2019-01-28 | 2020-08-06 | Novozymes A/S | Subtilase variants and compositions comprising same |
WO2020156903A1 (en) | 2019-01-30 | 2020-08-06 | Novozymes A/S | Cognate foldase co-expression |
CN111500558A (en) | 2019-01-31 | 2020-08-07 | 东莞泛亚太生物科技有限公司 | Glucosidase with enhanced activity |
WO2020157714A1 (en) | 2019-02-01 | 2020-08-06 | Decco Worldwide Post-Harvest Holdings B.V. | Multilayer structure for active packaging, process and method of using the same |
US20200263734A1 (en) | 2019-02-19 | 2020-08-20 | Schaeffler Technologies AG & Co. KG | Electrically isolated non-sealed bearing |
WO2020169564A1 (en) | 2019-02-20 | 2020-08-27 | Basf Se | Industrial fermentation process for bacillus using defined medium and trace element feed |
WO2020169840A1 (en) | 2019-02-21 | 2020-08-27 | Cambridge Enterprise Limited | Bispecific proteins with a chimeric scaffold |
WO2020176443A1 (en) | 2019-02-25 | 2020-09-03 | Dupont Nutrition Biosciences Aps | Protein hydrolysates with increased yield of n-terminal amino acid |
WO2020174070A1 (en) | 2019-02-27 | 2020-09-03 | Cyca Oncosolutions Limited | Cell membrane penetrating conjugates for gene editing |
WO2020173817A1 (en) | 2019-02-28 | 2020-09-03 | Novozymes A/S | Calcite binding proteins |
CN109777795A (en) | 2019-03-12 | 2019-05-21 | 中粮集团有限公司 | Built-up starch enzyme preparation and its method of application and starch liquefacation in starch liquefacation |
WO2020190782A1 (en) | 2019-03-15 | 2020-09-24 | Danisco Us Inc | Improved lipase for defoaming |
WO2020187883A1 (en) | 2019-03-18 | 2020-09-24 | Novozymes A/S | Polypeptides having pullulanase activity suitable for use in liquefaction |
CN109810961A (en) | 2019-03-20 | 2019-05-28 | 中粮集团有限公司 | A- amylase mutant and its encoding gene and their application for high concentration starch liquefacation |
WO2020188095A1 (en) | 2019-03-21 | 2020-09-24 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
WO2020193534A2 (en) | 2019-03-25 | 2020-10-01 | Basf Se | Amylase enzymes |
CN109897842A (en) | 2019-03-25 | 2019-06-18 | 中国农业科学院饲料研究所 | Amylase mutant ZDAMYA and its encoding gene and application |
US10563185B1 (en) | 2019-03-25 | 2020-02-18 | Dongguan APAC Biotechnology Co., Ltd. | Beta-glucosidase having improved enzymatic activity |
WO2020193535A2 (en) | 2019-03-25 | 2020-10-01 | Basf Se | Amylase enzymes |
WO2020193532A1 (en) | 2019-03-25 | 2020-10-01 | Basf Se | Cleaning composition having amylase enzymes |
CN109776686A (en) | 2019-03-27 | 2019-05-21 | 云南师范大学 | A kind of pattern of fusion lipase and its preparation method and application that thermostability improves |
WO2020200234A1 (en) | 2019-04-01 | 2020-10-08 | Beijing Bytedance Network Technology Co., Ltd. | Alternative interpolation filters in video coding |
WO2020200198A1 (en) | 2019-04-02 | 2020-10-08 | Novozymes A/S | Liquid dishwashing detergent compositions |
WO2020201403A1 (en) | 2019-04-03 | 2020-10-08 | Novozymes A/S | Polypeptides having beta-glucanase activity, polynucleotides encoding same and uses thereof in cleaning and detergent compositions |
WO2020200322A1 (en) | 2019-04-05 | 2020-10-08 | Novozymes A/S | Redox enzymes in animal feed compositions |
WO2020200321A1 (en) | 2019-04-05 | 2020-10-08 | Novozymes A/S | Redox enzymes in animal feed compositions |
CN111793613A (en) | 2019-04-09 | 2020-10-20 | 青岛蔚蓝生物集团有限公司 | Low-temperature cellulase mutant and application thereof |
WO2020207944A1 (en) | 2019-04-10 | 2020-10-15 | Novozymes A/S | Polypeptide variants |
CN109825466A (en) | 2019-04-10 | 2019-05-31 | 江南大学 | A kind of method that straight chain maltopentaose generates enzyme secreting, expressing in bacillus subtilis |
WO2020208056A1 (en) | 2019-04-12 | 2020-10-15 | Novozymes A/S | Stabilized glycoside hydrolase variants |
DE102019111057A1 (en) | 2019-04-29 | 2020-10-29 | Henkel Ag & Co. Kgaa | Proteases with improved enzyme stability in detergents and cleaning agents III |
DE102019111047A1 (en) | 2019-04-29 | 2020-10-29 | Henkel Ag & Co. Kgaa | Improved cleaning performance against protein-sensitive soiling V |
DE102019111075A1 (en) | 2019-04-29 | 2020-10-29 | Henkel Ag & Co. Kgaa | Improved cleaning performance against protein-sensitive soiling VI |
CN110066777A (en) | 2019-04-30 | 2019-07-30 | 江南大学 | A kind of endoinulase and its application in production oligofructose |
WO2020225066A1 (en) | 2019-05-03 | 2020-11-12 | Xeda International S.A. | Method and assembly for treating a store of plant products at low temperature and high relative humidity |
CN110093326A (en) | 2019-05-06 | 2019-08-06 | 南京林业大学 | A kind of extracellular AA9 family polysaccharide monooxygenase EpLPMOa and its application |
WO2020225276A1 (en) | 2019-05-08 | 2020-11-12 | Bayer Aktiengesellschaft | Agrochemical formulation with enhanced performance and enhanced performance at low spray volumes and by uav application |
CN111909979A (en) | 2019-05-09 | 2020-11-10 | 武汉英凯生物技术研究院有限公司 | Preparation method of L-glufosinate-ammonium |
JP2020184937A (en) | 2019-05-15 | 2020-11-19 | 雪印種苗株式会社 | Compositions and mutant strains with enhanced cellulose degrading ability |
WO2020243738A1 (en) | 2019-05-24 | 2020-12-03 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
CN110157688A (en) | 2019-05-31 | 2019-08-23 | 江南大学 | A kind of linear maltooligosacchaeides generation enzyme mutant for producing maltopentaose ability and improving |
WO2020239064A1 (en) | 2019-05-31 | 2020-12-03 | 南京百斯杰生物工程有限公司 | Thermostable glucose oxidase |
CN110229800A (en) | 2019-06-11 | 2019-09-13 | 江南大学 | A kind of linear maltooligosacchaeides generation enzyme mutant for producing maltose ability and improving |
CN110129301A (en) | 2019-06-17 | 2019-08-16 | 云南师范大学 | The lipase mutant and its application that a kind of catalytic activity improves |
CN112574974A (en) | 2019-06-17 | 2021-03-30 | 云南师范大学 | Lipase mutant D163F with improved catalytic activity and application thereof |
CN112592907A (en) | 2019-06-17 | 2021-04-02 | 云南师范大学 | Lipase mutant D259Y with improved catalytic activity and application thereof |
CN112608912A (en) | 2019-06-17 | 2021-04-06 | 云南师范大学 | Lipase mutant D170A with improved catalytic activity and application thereof |
WO2020254336A1 (en) | 2019-06-21 | 2020-12-24 | Ecole Polytechnique Federale De Lausanne (Epfl) | Sensing platform |
WO2020264552A1 (en) | 2019-06-24 | 2020-12-30 | The Procter & Gamble Company | Cleaning compositions comprising amylase variants |
WO2020260223A1 (en) | 2019-06-24 | 2020-12-30 | Novozymes A/S | Alpha-amylase variants |
CN112143717A (en) | 2019-06-26 | 2020-12-29 | 青岛蔚蓝生物集团有限公司 | Glucose oxidase mutant with improved specific activity |
CN110495549A (en) | 2019-07-05 | 2019-11-26 | 中国农业大学 | A kind of 1,4 beta-glucanase and its application in inhibition Aspergillus ochraceus |
CN110343687A (en) | 2019-07-18 | 2019-10-18 | 南京林业大学 | A kind of Pullulan enzymatic mutant and its application with hypersecretion ability |
WO2021013685A1 (en) | 2019-07-22 | 2021-01-28 | Henkel Ag & Co. Kgaa | Dishwashing agent with bleaching catalyst and bacillus gibsonii protease |
WO2021013686A1 (en) | 2019-07-22 | 2021-01-28 | Henkel Ag & Co. Kgaa | Protease-containing cleaning agent for automatic metering |
DE102019210806A1 (en) | 2019-07-22 | 2021-01-28 | Henkel Ag & Co. Kgaa | Laundry detergent with a Bacillus gibsonii protease |
WO2021018321A2 (en) | 2019-07-31 | 2021-02-04 | Centro De Ingenieria Genetica Y Biotecnologia | Biopesticide and biofertiliser composition |
WO2021026201A1 (en) | 2019-08-05 | 2021-02-11 | Novozymes A/S | Enzyme blends and processes for producing a high protein feed ingredient from a whole stillage byproduct |
WO2021025872A1 (en) | 2019-08-06 | 2021-02-11 | Novozymes A/S | Fusion proteins for improved enzyme expression |
CN110592034A (en) | 2019-08-06 | 2019-12-20 | 广东溢多利生物科技股份有限公司 | Glucose oxidase mutant and carrier and application thereof |
WO2021030400A1 (en) | 2019-08-13 | 2021-02-18 | Novozymes Bioag A/S | Pesticidal combinations of yersinia and proteases |
WO2021032881A1 (en) | 2019-08-22 | 2021-02-25 | Basf Se | Amylase variants |
WO2021037878A1 (en) | 2019-08-27 | 2021-03-04 | Novozymes A/S | Composition comprising a lipase |
CN110423737A (en) | 2019-09-10 | 2019-11-08 | 白银赛诺生物科技有限公司 | From the heat resistant type alpha-amylase of Geobacillus stearothermophilus and its application |
WO2021055395A1 (en) | 2019-09-16 | 2021-03-25 | Novozymes A/S | Polypeptides having beta-glucanase activity and polynucleotides encoding same |
WO2021055316A1 (en) | 2019-09-16 | 2021-03-25 | Eastman Chemical Company | Agricultural inert package formulation containing a sulfopolymer |
CN110628738A (en) | 2019-09-27 | 2019-12-31 | 华东理工大学 | Method for improving activity of glucose oxidase, mutant and application thereof |
CN110746494A (en) | 2019-09-27 | 2020-02-04 | 深圳市诺维健生物技术有限责任公司 | A group of special dietary proteins |
WO2021058022A1 (en) | 2019-09-29 | 2021-04-01 | Novozymes A/S | Use of cellulase for improvement of sustainability of detergents |
CN111334494A (en) | 2019-10-09 | 2020-06-26 | 天津科技大学 | Screening of novel high-stability alkaline protease mutants |
CN110592051A (en) | 2019-10-14 | 2019-12-20 | 北京工商大学 | Mutant of xylanase T-Xyn and application thereof |
CN112680433A (en) | 2019-10-18 | 2021-04-20 | 清华大学 | Method for producing and secreting protein by using halophilic bacteria |
WO2021080948A2 (en) | 2019-10-24 | 2021-04-29 | Danisco Us Inc | Variant maltopentaose/maltohexaose-forming alpha-amylases |
US20210122997A1 (en) | 2019-10-24 | 2021-04-29 | The Procter & Gamble Company | Automatic dishwashing detergent composition comprising a protease |
US20210122998A1 (en) | 2019-10-24 | 2021-04-29 | The Procter & Gamble Company | Automatic dishwashing detergent composition comprising an amylase |
CN110760531A (en) | 2019-11-08 | 2020-02-07 | 广西中烟工业有限责任公司 | Method for splicing intron in pectinase gene |
CN112795555A (en) | 2019-11-13 | 2021-05-14 | 青岛蔚蓝生物集团有限公司 | High-specific-activity cellulase mutant and application thereof |
CN112795554A (en) | 2019-11-13 | 2021-05-14 | 青岛蔚蓝生物集团有限公司 | Low temperature resistant cellulase mutant |
WO2021101937A1 (en) | 2019-11-20 | 2021-05-27 | Novozymes Bioag A/S | Pseudomonas isolates and uses thereof |
WO2021099457A1 (en) | 2019-11-22 | 2021-05-27 | Novozymes A/S | Method for obtaining an oat-based product |
WO2021101949A1 (en) | 2019-11-22 | 2021-05-27 | Novozymes Bioag A/S | Paenibacillus isolates and uses thereof |
CN110885801A (en) | 2019-11-25 | 2020-03-17 | 中国海洋大学 | Glucose oxidase M5GOD and coding gene and application thereof |
CN110777136A (en) | 2019-11-26 | 2020-02-11 | 山西大学 | Alkaline protease mutant for washing and application thereof in liquid detergent |
CN110819612A (en) | 2019-11-29 | 2020-02-21 | 天津科技大学 | Screening of novel autocleavage-resistant alkaline protease |
US20210163995A1 (en) | 2019-11-29 | 2021-06-03 | Lallemand Hungary Liquidity Management Llc | Process for displacing an exogenous enzyme |
WO2021119304A1 (en) | 2019-12-10 | 2021-06-17 | Novozymes A/S | Microorganism for improved pentose fermentation |
CN110923222A (en) | 2019-12-13 | 2020-03-27 | 中国科学院天津工业生物技术研究所 | Novel alkaline protease acid mutant from bacillus licheniformis |
CN110923221A (en) | 2019-12-13 | 2020-03-27 | 中国科学院天津工业生物技术研究所 | Novel alkaline protease high-temperature mutant from bacillus licheniformis |
WO2021123184A2 (en) | 2019-12-19 | 2021-06-24 | Novozymes A/S | Alpha-amylase variants |
WO2021127319A1 (en) | 2019-12-19 | 2021-06-24 | The Procter & Gamble Company | Cleaning compositions comprising polypeptides having alpha amylase activity |
WO2021122120A2 (en) | 2019-12-20 | 2021-06-24 | Henkel Ag & Co. Kgaa | Cleaning compositions comprising dispersins viii |
WO2021133701A1 (en) | 2019-12-23 | 2021-07-01 | The Procter & Gamble Company | Compositions comprising enzymes |
WO2021130167A1 (en) | 2019-12-23 | 2021-07-01 | Novozymes A/S | Enzyme compositions and uses thereof |
WO2021133658A1 (en) | 2019-12-23 | 2021-07-01 | Cargill, Incorporated | Fermentation method and uses thereof |
CN111004786A (en) | 2019-12-25 | 2020-04-14 | 广东溢多利生物科技股份有限公司 | Glucose oxidase and carrier and application thereof |
CN113025595A (en) | 2019-12-25 | 2021-06-25 | 丰益(上海)生物技术研发中心有限公司 | Acid-tolerant lipases |
CN113025596A (en) | 2019-12-25 | 2021-06-25 | 丰益(上海)生物技术研发中心有限公司 | Methanol-tolerant lipase |
CN111004794A (en) | 2019-12-30 | 2020-04-14 | 江南大学 | Subtilisin E mutant with improved thermal stability and application thereof |
CN113122520A (en) | 2019-12-30 | 2021-07-16 | 丰益(上海)生物技术研发中心有限公司 | Novel glycerol mono-diacyl ester lipase |
CN110951628A (en) | 2019-12-30 | 2020-04-03 | 乐陵胜利新能源有限责任公司 | Construction method and application of trichoderma reesei engineering strain with high β -glucosidase activity for straw degradation |
WO2021144342A1 (en) | 2020-01-14 | 2021-07-22 | The Protein Brewery B.V. | Expression of ovalbumin and its natural variants |
CN110862979A (en) | 2020-01-20 | 2020-03-06 | 中国科学院天津工业生物技术研究所 | Mutant of alkaline protease and application thereof |
CN112552382A (en) | 2020-01-22 | 2021-03-26 | 天津科技大学 | Signal peptide mutant and application thereof |
WO2021148364A1 (en) | 2020-01-23 | 2021-07-29 | Novozymes A/S | Enzyme compositions and uses thereof |
WO2021152120A1 (en) | 2020-01-31 | 2021-08-05 | Novozymes A/S | Mannanase variants and polynucleotides encoding same |
WO2021152123A1 (en) | 2020-01-31 | 2021-08-05 | Novozymes A/S | Mannanase variants and polynucleotides encoding same |
US20210238201A1 (en) | 2020-02-05 | 2021-08-05 | Agrofresh Inc. | Antimicrobial compounds and compositions |
WO2021163030A2 (en) | 2020-02-10 | 2021-08-19 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
WO2021163036A1 (en) | 2020-02-10 | 2021-08-19 | Novozymes A/S | Raw starch hydrolysis process for producing a fermentation product |
WO2021170799A1 (en) | 2020-02-28 | 2021-09-02 | Chr. Hansen A/S | Lipases, compositions, methods and uses thereof |
DE102020105721A1 (en) | 2020-03-03 | 2021-09-09 | Henkel Ag & Co. Kgaa | Performance-Enhanced Protease Variants VII |
CN111369138A (en) | 2020-03-03 | 2020-07-03 | 浙江中控技术股份有限公司 | Method and device for generating job form |
DE102020105720A1 (en) | 2020-03-03 | 2021-09-09 | Henkel Ag & Co. Kgaa | Stability-improved protease variants VI |
US20210292688A1 (en) | 2020-03-20 | 2021-09-23 | Danstar Ferment Ag | Beta-glucosidase expressing yeast for enhanced flavor and aroma in beverage production |
WO2021202479A1 (en) | 2020-04-03 | 2021-10-07 | Novozymes A/S | Submerged fermentation process |
WO2021204838A1 (en) | 2020-04-08 | 2021-10-14 | Novozymes A/S | Carbohydrate binding module variants |
WO2021209548A1 (en) | 2020-04-15 | 2021-10-21 | Henlez Aps | Compositions and methods for treating hair follicle-linked conditions |
WO2021212095A1 (en) | 2020-04-17 | 2021-10-21 | Danisco Us Inc. | Glucoamylase and methods of use thereof |
WO2021214059A1 (en) | 2020-04-21 | 2021-10-28 | Novozymes A/S | Cleaning compositions comprising polypeptides having fructan degrading activity |
CN114591935A (en) | 2020-04-27 | 2022-06-07 | 青岛尚德生物技术有限公司 | Protease mutant BLAPR3 with improved heat stability and coding gene and application thereof |
CN114561375A (en) | 2020-04-27 | 2022-05-31 | 青岛尚德生物技术有限公司 | Protease mutant BLAPR2 with improved heat stability and coding gene and application thereof |
DE102020205400A1 (en) | 2020-04-29 | 2021-11-04 | Henkel Ag & Co. Kgaa | Highly alkaline laundry detergent with protease |
DE102020205381A1 (en) | 2020-04-29 | 2021-11-04 | Henkel Ag & Co. Kgaa | Highly alkaline laundry detergent with protease |
WO2021231623A1 (en) | 2020-05-13 | 2021-11-18 | Novozymes A/S | Engineered microorganism for improved pentose fermentation |
WO2021231621A1 (en) | 2020-05-13 | 2021-11-18 | Novozymes A/S | Improved microorganisms for arabinose fermentation |
WO2021230359A1 (en) | 2020-05-15 | 2021-11-18 | Jnc株式会社 | Antiviral agent |
WO2021233900A1 (en) | 2020-05-19 | 2021-11-25 | Xeda International S.A. | Novel method for treating fruits and vegetables |
WO2021236715A1 (en) | 2020-05-21 | 2021-11-25 | Dupont Nutrition Biosciences Aps | Unihibited amylases for brewing with high tannin materials |
CN111575265A (en) | 2020-05-22 | 2020-08-25 | 江南大学 | Keratinase mutant with improved thermal stability |
CN111621490A (en) | 2020-05-26 | 2020-09-04 | 江西师范大学 | Beta-glucosidase mutant SVS of penicillium oxalicum 16 and application thereof |
CN111518792A (en) | 2020-05-26 | 2020-08-11 | 江西师范大学 | Beta-glucosidase mutant TLE of penicillium oxalicum 16 and application thereof |
WO2021239267A1 (en) | 2020-05-29 | 2021-12-02 | Novozymes A/S | Pulse and/or legume protein-fortified doughs and baked goods comprising lipase |
WO2021247915A1 (en) | 2020-06-03 | 2021-12-09 | Sound Agriculture Company | Compounds and methods for stimulating plants |
WO2021248045A2 (en) | 2020-06-04 | 2021-12-09 | California Institute Of Technology | Novel signal peptides generated by attention-based neural networks |
WO2021255118A1 (en) | 2020-06-18 | 2021-12-23 | Bayer Aktiengesellschaft | Composition for use in agriculture |
CN111893126A (en) | 2020-07-01 | 2020-11-06 | 深圳润康生态环境股份有限公司 | Alkaline protease gene, alkaline protease, preparation method and application thereof |
WO2022014428A1 (en) | 2020-07-15 | 2022-01-20 | 花王株式会社 | Amylase-incorporated cleaning agent composition |
WO2022020665A2 (en) | 2020-07-23 | 2022-01-27 | Kiwi Health, Inc | Food supplement composition to aid in digestion of fructan, mannitol, and sorbitol |
CN111826377A (en) | 2020-07-30 | 2020-10-27 | 吉林中粮生化有限公司 | Signal peptide for promoting pullulanase extracellular expression |
WO2022029221A1 (en) | 2020-08-05 | 2022-02-10 | Syngenta Crop Protection Ag | Agricultural formulations having improved compatibility with liquid fertilizers |
WO2022029224A1 (en) | 2020-08-05 | 2022-02-10 | Syngenta Crop Protection Ag | Methods for improving the compatibility of crop protection formulations and tank mix applications with liquid fertilizers |
WO2022029293A1 (en) | 2020-08-07 | 2022-02-10 | Novozymes A/S | Controlled enzymatic browning of a non-meat protein containing material comprising pigment and laccase |
WO2022043273A2 (en) | 2020-08-24 | 2022-03-03 | Novozymes A/S | Oral care composition comprising a fructanase |
WO2022047264A1 (en) | 2020-08-28 | 2022-03-03 | Codexis, Inc. | Engineered amylase variants |
WO2022043547A1 (en) | 2020-08-28 | 2022-03-03 | Novozymes A/S | Protease variants with improved solubility |
WO2022043745A1 (en) | 2020-08-28 | 2022-03-03 | Kerry Luxembourg S.a.r.l. | Feed composition supplemented with a protease combination comprising neutral metalloprotease and serine alkaline protease at a given ratio |
WO2022043563A1 (en) | 2020-08-28 | 2022-03-03 | Novozymes A/S | Polyester degrading protease variants |
WO2022044629A1 (en) | 2020-08-31 | 2022-03-03 | 花王株式会社 | α-AMYLASE VARIANT |
WO2022049139A1 (en) | 2020-09-02 | 2022-03-10 | Xeda International S.A. | Method for protecting plant products during transport, and corresponding treatment device |
WO2022051661A1 (en) | 2020-09-03 | 2022-03-10 | Drexel University | Use of erythritol compositions as mammal-safe insecticides |
JP2022045888A (en) | 2020-09-09 | 2022-03-22 | 株式会社バイオインテグレンス | Method for preventing infection of coronavirus |
CN112063678A (en) | 2020-09-21 | 2020-12-11 | 中国药科大学 | Biosynthesis method of Siamenoside I |
WO2022063699A1 (en) | 2020-09-22 | 2022-03-31 | Basf Se | Improved combination of protease and protease inhibitor with secondary enzyme |
CN112111468A (en) | 2020-09-23 | 2020-12-22 | 江南大学 | Gamma-glutamine transpeptidase mutant and application thereof |
WO2022071451A1 (en) | 2020-10-02 | 2022-04-07 | 花王株式会社 | α-AMYLASE VARIANT |
WO2022074037A2 (en) | 2020-10-07 | 2022-04-14 | Novozymes A/S | Alpha-amylase variants |
WO2022074170A1 (en) | 2020-10-07 | 2022-04-14 | Novozymes A/S | Enzymatic preservation of probiotics in animal feed |
CN113061189A (en) | 2020-10-09 | 2021-07-02 | 山东省科学院生物研究所 | Biosensor based on specific binding of CBM and cellulose |
EP3984368A1 (en) | 2020-10-13 | 2022-04-20 | Mühlenchemie GmbH & Co. KG | Enzymatically stabilized pasta structure and method of preparing the same |
CN114369588A (en) | 2020-10-14 | 2022-04-19 | 潍坊康地恩生物科技有限公司 | Neutral cellulase mutant and application thereof |
WO2022090361A2 (en) | 2020-10-29 | 2022-05-05 | Novozymes A/S | Lipase variants and compositions comprising such lipase variants |
WO2022094214A1 (en) | 2020-10-30 | 2022-05-05 | Agrofresh Inc. | Treatment and system for cannabis plant species applications with ethylene inhibitors |
WO2022089571A1 (en) | 2020-10-30 | 2022-05-05 | Novozymes A/S | Detergent composition and cleaning method |
WO2022096692A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift, spreading, uptake and rainfastness properties |
WO2022096693A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Low drift, rainfastness, high uptake and ulv tank mix adjuvant formulation |
WO2022096688A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift, spreading and rainfastness properties |
WO2022096691A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift, uptake and rainfastness properties |
WO2022096695A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading, high uptake and ulv tank mix adjuvant formulation |
WO2022096694A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading and ulv tank mix adjuvant formulation |
WO2022096696A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading, high uptake and ulv tank mix adjuvant formulation |
CN112175976A (en) | 2020-11-12 | 2021-01-05 | 武汉轻工大学 | High-temperature-resistant lipase gene tllgold and application thereof |
WO2022103725A1 (en) | 2020-11-13 | 2022-05-19 | Novozymes A/S | Detergent composition comprising a lipase |
CN112301023A (en) | 2020-11-14 | 2021-02-02 | 山西大学 | 2709 alkaline protease mutant modified based on molecular dynamics calculation and application thereof |
WO2022106400A1 (en) | 2020-11-18 | 2022-05-27 | Novozymes A/S | Combination of immunochemically different proteases |
US20220154236A1 (en) | 2020-11-18 | 2022-05-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Recombinant endoxylanases and related compositions and methods of use |
CN112342208A (en) | 2020-12-01 | 2021-02-09 | 天津科技大学 | Pullulanase mutant |
CN114790451A (en) | 2020-12-01 | 2022-07-26 | 天津科技大学 | Pullulanase and application thereof |
CN115197924A (en) | 2020-12-01 | 2022-10-18 | 天津科技大学 | Pullulanase |
CN114621941A (en) | 2020-12-10 | 2022-06-14 | 丰益(上海)生物技术研发中心有限公司 | Protein with lysophospholipase and phospholipase activity |
WO2022129166A1 (en) | 2020-12-15 | 2022-06-23 | Novozymes A/S | Mutated host cells with reduced cell motility |
WO2022138668A1 (en) | 2020-12-21 | 2022-06-30 | 天野エンザイム株式会社 | Modified glucose dehydrogenase |
CN112458072A (en) | 2020-12-21 | 2021-03-09 | 山东隆科特酶制剂有限公司 | Alkaline protease mutant and preparation thereof |
CN112501149A (en) | 2020-12-21 | 2021-03-16 | 天津科技大学 | Alkaline protease mutant and gene, engineering bacterium, preparation method and application thereof |
CN112522227A (en) | 2020-12-21 | 2021-03-19 | 广东溢多利生物科技股份有限公司 | Catalase with high enzyme activity, gene, recombinant strain with high catalase yield and application |
US20220204956A1 (en) | 2020-12-22 | 2022-06-30 | Fornia Biosolutions, Inc. | Additional Endoglucanase Variants and Methods |
CN112522238A (en) | 2020-12-30 | 2021-03-19 | 浙江大学 | Method for producing amylase by using transgenic corn |
CN112574978A (en) | 2021-01-19 | 2021-03-30 | 青岛尚德生物技术有限公司 | Protease mutant capable of improving alcohol-soluble protein degradation capacity and coding gene and application thereof |
CN112662652A (en) | 2021-01-20 | 2021-04-16 | 天津科技大学 | Alkaline protease mutant with reduced collagen degradation activity |
CN112662653A (en) | 2021-01-26 | 2021-04-16 | 江南大学 | Keratinase mutant with improved low-temperature enzymolysis performance and application thereof |
CN112760299A (en) | 2021-02-06 | 2021-05-07 | 江南大学 | Glucose oxidase mutant with improved thermal stability as well as coding gene and application thereof |
WO2022173694A1 (en) | 2021-02-10 | 2022-08-18 | Novozymes A/S | Polypeptides having pectinase activity, polynucleotides encoding same, and uses thereof |
WO2022171120A1 (en) | 2021-02-10 | 2022-08-18 | Novozymes A/S | Enhanced enzymatic cleaner for membranes and method of cleaning thereof |
WO2022171780A2 (en) | 2021-02-12 | 2022-08-18 | Novozymes A/S | Alpha-amylase variants |
WO2022171667A1 (en) | 2021-02-12 | 2022-08-18 | Fresenius Kabi Ipsum S.R.L. | Subtilisin variants and their use |
WO2022175263A2 (en) | 2021-02-16 | 2022-08-25 | Dsm Ip Assets B.V. | Methods of selectively promoting animal welfare through modulation of microbiome |
WO2022175435A1 (en) | 2021-02-22 | 2022-08-25 | Basf Se | Amylase variants |
EP4047088A1 (en) | 2021-02-22 | 2022-08-24 | Basf Se | Amylase variants |
US20220283151A1 (en) | 2021-03-05 | 2022-09-08 | Brigham Young University | Method for controlling protein dimerization using an intramolecular to intermolecular conformational switch |
CN115074345A (en) | 2021-03-10 | 2022-09-20 | 中国农业科学院农业资源与农业区划研究所 | Heat-resistant beta-1, 4-endo-xylanase, coding gene and application thereof |
US20220298533A1 (en) | 2021-03-22 | 2022-09-22 | Cb Therapeutics, Inc. | Biosynthetic methods for the modification of cannabinoids |
CN114058637A (en) | 2021-03-31 | 2022-02-18 | 山西大禹生物工程股份有限公司 | Efficient expression method of aspergillus niger glucose oxidase gene |
WO2022214459A1 (en) | 2021-04-06 | 2022-10-13 | Dsm Ip Assets B.V. | Enzyme composition |
WO2022214457A1 (en) | 2021-04-06 | 2022-10-13 | Dsm Ip Assets B.V. | Enzyme composition |
WO2022225696A2 (en) | 2021-04-19 | 2022-10-27 | Basf Se | Systems and methods for generating divergent protein sequences |
CN113234705A (en) | 2021-04-21 | 2021-08-10 | 江南大学 | Acid-tolerant 1,3-1, 4-beta-glucanase mutants |
WO2022226376A2 (en) | 2021-04-22 | 2022-10-27 | Indigo Ag, Inc. | Endophyte compositions and methods for improved plant health |
CN113151327A (en) | 2021-04-23 | 2021-07-23 | 广西大学 | Mutant of bacillus cereus high-yield maltopentaose alpha-amylase and application thereof |
WO2022226158A2 (en) | 2021-04-23 | 2022-10-27 | Danisco Us Inc. | Trypsin-like serine proteases and uses thereof |
CN115247165A (en) | 2021-04-26 | 2022-10-28 | 宜昌东阳光生化制药有限公司 | Cellulase mutant with improved specific activity and thermal stability |
CN115247166A (en) | 2021-04-27 | 2022-10-28 | 南京百斯杰生物工程有限公司 | Protease mutant |
CN112877306A (en) | 2021-04-28 | 2021-06-01 | 中国农业科学院北京畜牧兽医研究所 | Super heat-resistant glucose oxidase AtGOD, gene and application thereof |
CN113215130A (en) | 2021-05-11 | 2021-08-06 | 集美大学 | Phospholipase C mutant, preparation method and application thereof |
CN113403290A (en) | 2021-05-26 | 2021-09-17 | 广东溢多利生物科技股份有限公司 | Glucose oxidase mutant with improved thermal stability as well as coding gene and application thereof |
WO2022251056A1 (en) | 2021-05-27 | 2022-12-01 | Novozymes A/S | Transcriptional regulators and polynucleotides encoding the same |
CN113528493A (en) | 2021-05-28 | 2021-10-22 | 江南大学 | Keratinase mutant with improved thermal stability and application thereof |
WO2022256274A1 (en) | 2021-05-30 | 2022-12-08 | Bee-Io-Honey Technologies Ltd. | Methods and systems for producing emulated honey |
CN113338044A (en) | 2021-05-31 | 2021-09-03 | 江南大学 | Method for modifying terylene based on Humicola insolens cutinase |
CN115478061A (en) | 2021-05-31 | 2022-12-16 | 宜昌东阳光药业股份有限公司 | Cellulase mutants and compositions thereof |
WO2022261003A1 (en) | 2021-06-07 | 2022-12-15 | Novozymes A/S | Engineered microorganism for improved ethanol fermentation |
WO2022268885A1 (en) | 2021-06-23 | 2022-12-29 | Novozymes A/S | Alpha-amylase polypeptides |
WO2022270590A1 (en) | 2021-06-23 | 2022-12-29 | 天野エンザイム株式会社 | Laccase |
CN115521925A (en) | 2021-06-24 | 2022-12-27 | 丰益(上海)生物技术研发中心有限公司 | Protein having lysophospholipase and/or phospholipase activity |
WO2023274282A1 (en) | 2021-06-29 | 2023-01-05 | Novozymes A/S | Processes for producing fermentation products using fiber-degrading enzymes in fermentation |
CN113667662A (en) | 2021-07-05 | 2021-11-19 | 南京纽田科技有限公司 | Construction of high-performance starch debranching enzyme chimera strain, production method and application thereof |
WO2023288294A1 (en) | 2021-07-16 | 2023-01-19 | Novozymes A/S | Compositions and methods for improving the rainfastness of proteins on plant surfaces |
WO2023004432A2 (en) | 2021-07-22 | 2023-01-26 | Solugen, Inc. | Compositions and methods for production of value-added chemicals |
WO2023002065A2 (en) | 2021-07-23 | 2023-01-26 | Università Degli Studi Dell'aquila | Fungus strain and uses thereof |
CN115704017A (en) | 2021-08-06 | 2023-02-17 | 青岛蔚蓝生物集团有限公司 | Alkaline xylanase mutant |
CN115704018A (en) | 2021-08-06 | 2023-02-17 | 青岛蔚蓝生物集团有限公司 | Alkaline xylanase mutant and application thereof |
CN115704019A (en) | 2021-08-06 | 2023-02-17 | 青岛蔚蓝生物集团有限公司 | High specific activity alkaline xylanase mutant |
CN113817709A (en) | 2021-08-12 | 2021-12-21 | 中国科学院天津工业生物技术研究所 | Carbohydrate-binding domain CBM68 and uses thereof |
WO2023019266A2 (en) | 2021-08-13 | 2023-02-16 | Anagram Therapeutics, Inc. | Methods and compositions for treating fructose intolerance and fructose malabsorption |
CN115703996A (en) | 2021-08-16 | 2023-02-17 | 潍坊康地恩生物科技有限公司 | Trichoderma reesei strain for high xylanase yield and application thereof |
WO2023023642A2 (en) | 2021-08-20 | 2023-02-23 | Danisco Us Inc. | Methods and compositions for enhanced protein production in bacillus cells |
CN113528476A (en) | 2021-08-20 | 2021-10-22 | 福建福大百特生物科技有限公司 | Glucose oxidase mutant and coding gene and efficient recombinant expression thereof |
WO2023032952A1 (en) | 2021-08-30 | 2023-03-09 | 天野エンザイム株式会社 | Enzymatic agent for transesterification containing lipase as active ingredient |
CN113584075A (en) | 2021-08-31 | 2021-11-02 | 浙江大学 | Method for producing alpha-amylase by using transgenic soybean and expression vector |
CN113881654A (en) | 2021-09-08 | 2022-01-04 | 暨南大学 | Alpha-amylase with improved resistance to pepsin |
CN113832130A (en) | 2021-10-05 | 2021-12-24 | 上海佶凯星生物科技有限公司 | Alkaline protease mutant for washing and application thereof in liquid detergent |
CN113862244A (en) | 2021-10-05 | 2021-12-31 | 上海佶凯星生物科技有限公司 | High-specific-activity alkaline protease mutant and application thereof in liquid detergent |
CN113832131A (en) | 2021-10-05 | 2021-12-24 | 上海佶凯星生物科技有限公司 | High-stability alkaline protease mutant and application thereof in liquid detergent |
CN113736817A (en) | 2021-10-08 | 2021-12-03 | 枣庄市杰诺生物酶有限公司 | Method for improving secretion efficiency and enzyme activity of alkaline lipase in pichia pastoris |
CN113755509A (en) | 2021-10-11 | 2021-12-07 | 南京正扬生物科技有限公司 | Lysophospholipase variant, construction method thereof and expression in aspergillus niger strain |
CN113846074A (en) | 2021-10-20 | 2021-12-28 | 南京林业大学 | Thermomyces lanuginosus lipase mutant G91C and application thereof |
CN114181916A (en) | 2021-11-16 | 2022-03-15 | 华东师范大学 | Artificially modified enzyme based on glucose oxidase and expression application thereof |
CN114107266A (en) | 2021-11-29 | 2022-03-01 | 青岛尚德生物技术有限公司 | Protease mutant with improved heat resistance, and coding gene and application thereof |
CN114350637A (en) | 2021-12-01 | 2022-04-15 | 武汉金科天成科技有限公司 | Endo-type inuunit of inulinase, preparation method and application thereof |
US20220087261A1 (en) | 2021-12-01 | 2022-03-24 | Syngenta Crop Protection Ag | Post-Harvest Fungicidal Uses |
CN113862233A (en) | 2021-12-03 | 2021-12-31 | 中国农业科学院北京畜牧兽医研究所 | Method for improving acid stability of glucose oxidase, mutant Q241E/R499E, gene and application |
CN114317490A (en) | 2021-12-03 | 2022-04-12 | 南通常佑药业科技有限公司 | Thermomyces lanuginosus lipase mutant and encoding gene thereof |
CN114317502A (en) | 2021-12-06 | 2022-04-12 | 江南大学 | Nattokinase mutant with high activity and high thermal stability |
CN115612628A (en) | 2022-01-12 | 2023-01-17 | 上海国龙生物科技有限公司 | Pichia pastoris, preparation method thereof and application of pichia pastoris in catalyzing sucrose to produce fructo-oligosaccharide |
CN114395540A (en) | 2022-01-25 | 2022-04-26 | 华南理工大学 | Application of aspergillus guani glucose oxidase in improving flour processing quality |
CN114457056A (en) | 2022-01-25 | 2022-05-10 | 华南理工大学 | Application of lactobacillus salinus xylanase in improvement of flour processing quality |
CN114395541A (en) | 2022-02-22 | 2022-04-26 | 广东溢多利生物科技股份有限公司 | Glucose oxidase mutant GOx1-MUT with improved thermal stability and specific activity, and coding gene and application thereof |
CN114574469A (en) | 2022-03-21 | 2022-06-03 | 江南大学 | Keratinase mutant based on directed evolution transformation and application thereof |
CN114752583A (en) | 2022-03-30 | 2022-07-15 | 齐鲁工业大学 | Heat-resistant beta-1, 3-1, 4-glucanase mutant and preparation method and application thereof |
CN114606216A (en) | 2022-03-31 | 2022-06-10 | 山东隆科特酶制剂有限公司 | Alpha-amylase mutant Q441N/N442H with improved expression level as well as coding gene and application thereof |
CN114540330A (en) | 2022-04-21 | 2022-05-27 | 深圳润康生态环境股份有限公司 | Alkaline protease mutant AprBpM and application thereof |
CN115029328A (en) | 2022-04-24 | 2022-09-09 | 广东溢多利生物科技股份有限公司 | Glucose oxidase mutant GOx-MUT 1-6 and coding gene and application thereof |
CN115029327A (en) | 2022-04-24 | 2022-09-09 | 广东溢多利生物科技股份有限公司 | Glucose oxidase mutant GOx-MUT 7-11 and coding gene and application thereof |
CN114806988A (en) | 2022-04-28 | 2022-07-29 | 青岛蔚蓝生物集团有限公司 | Bacillus subtilis and application thereof in production of glutaminase |
CN114806990A (en) | 2022-05-11 | 2022-07-29 | 辽宁大学 | Heat-resistant nattokinase recombinant gene engineering bacterium and construction method and application thereof |
CN114836408A (en) | 2022-05-28 | 2022-08-02 | 湖北大学 | Alkaline protease containing propeptide mutant and application |
CN114686386A (en) | 2022-06-01 | 2022-07-01 | 中国科学院天津工业生物技术研究所 | Pichia pastoris for producing methanol mycoprotein and co-producing cellulase and application thereof |
CN114736880A (en) | 2022-06-09 | 2022-07-12 | 中国农业科学院北京畜牧兽医研究所 | Mutant D497N of glucose oxidase GoxM10 with improved acid stability as well as derivative mutant and application thereof |
CN114736881A (en) | 2022-06-09 | 2022-07-12 | 中国农业科学院北京畜牧兽医研究所 | Glucose oxidase GoxM10 mutant A4D with improved acid stability and derivative mutant and application thereof |
CN114736879A (en) | 2022-06-09 | 2022-07-12 | 中国农业科学院北京畜牧兽医研究所 | Glucose oxidase GoxM10 mutant E361P with improved heat stability and derivative mutant and application thereof |
CN114958897A (en) | 2022-06-14 | 2022-08-30 | 中农华威生物制药(湖北)有限公司 | Bacillus subtilis construction method capable of efficiently expressing low-temperature keratinase for feed |
CN114774396A (en) | 2022-06-20 | 2022-07-22 | 山东龙昌动物保健品有限公司 | Keratinase mutant, compound preparation of keratinase mutant and bile acid and application of compound preparation in additive |
CN114908074A (en) | 2022-06-21 | 2022-08-16 | 山西大学 | Aqueous solution stable alkaline protease 2709 mutant and preparation method and application thereof |
CN115029337A (en) | 2022-06-28 | 2022-09-09 | 山东龙昌动物保健品有限公司 | Additive compounded by keratinase mutant and eucommia ulmoides leaf extract and application thereof |
CN115074347A (en) | 2022-06-29 | 2022-09-20 | 山东龙昌动物保健品有限公司 | Feed additive containing keratinase mutant and bile acid and application thereof |
CN115029334A (en) | 2022-07-12 | 2022-09-09 | 青岛蔚蓝生物集团有限公司 | High-specific-activity alkaline xylanase mutant |
CN115125226A (en) | 2022-07-26 | 2022-09-30 | 青岛蔚蓝生物集团有限公司 | High specific activity amylase mutant |
CN115717134A (en) | 2022-12-19 | 2023-02-28 | 无锡蔚蓝生物科技有限公司 | Lipase mutant and application thereof in natural vitamin E purification |
Non-Patent Citations (81)
Title |
---|
"Principles of Powder Technology", 1990, JOHN WILEY & SONS |
"Surfactant Science Series", vol. 71, 1998, MARCEL DEKKER, article "Powdered detergents", pages: 140 - 142 |
BAIRD, ZUBLENA: "SOIL FACTS: USING WETTING AGENTS (NONIONIC SURFACTANTS) ON SOIL", NORTH CAROLINA COOPERATIVE EXTENSION SERVICE PUBLICATION AG-439-25, 1993 |
BALLEZA ET AL., FEMS MICROBIOL. REV., vol. 33, no. 1, 2009, pages 133 - 151 |
BOUVAINE ET AL., PLOS ONE, vol. 9, no. 1, 2014, pages e86256 |
BOWIESAUER, PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 2152 - 2156 |
BURKE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 98, 2001, pages 6289 - 6294 |
C APINERA: "HANDBOOK OF VEGETABLE PESTS", 2001 |
C. E. CAPES: "Handbook of Powder Technology", vol. 1, 1980, ELSEVIER, article "Particle size enlargement" |
CARTER ET AL., PROTEINS: STRUCTURE. FUNCTION, AND GENETICS, vol. 6, 1989, pages 240 - 248 |
CHEN ET AL., PLANT CELL PHYSIOL., vol. 39, 1998, pages 935 - 941 |
CHOI ET AL., J. MICROBIOL. METHODS, vol. 64, 2006, pages 391 - 397 |
CHRISTENSEN ET AL., BIO TECHNOLOGY, vol. 6, 1988, pages 1419 - 1422 |
CHRISTOU, PLANT J., vol. 2, 1992, pages 275 - 281 |
COLLINS-RACIE ET AL., BIOTECHNOLOGY, vol. 13, 1995, pages 982 - 987 |
CONRAD ET AL., J. PLANT PHYSIOL., vol. 152, 1998, pages 708 - 711 |
CONTRERAS ET AL., BIOTECHNOLOGY, vol. 9, 1991, pages 378 - 381 |
COOPER ET AL., FMBO J, vol. 12, 1993, pages 2575 - 2583 |
CUNNINGHAMWELLS, SCIENCE, vol. 244, 1989, pages 1081 - 1085 |
DAVIS ET AL.: "Formulation of Microbial Biopesticides: Beneficial Microorganisms, Nematodes and Seed Treatments", 2012, SPRINGER SCIENCE & BUSINESS MEDIA |
DAWSON ET AL., SCIENCE, vol. 266, 1994, pages 776 - 779 |
DERBYSHIRE ET AL., GENE, vol. 46, 1986, pages 145 |
DONALD ET AL., J. BACTERIOL., vol. 195, no. 11, 2013, pages 2612 - 2620 |
EATON ET AL., BIOCHEMISTRY, vol. 25, 1986, pages 505 - 512 |
EDWARDSCORUZZI, ANN. REV. GENET., vol. 24, 1990, pages 275 - 303 |
FORD ET AL., PROTEIN EXPRESSION AND PURIFICATION, vol. 2, 1991, pages 95 - 107 |
FRANCK ET AL., CELL, vol. 21, 1980, pages 285 - 294 |
FRCUDL, MICROBIAL CELL FACTORIES, vol. 17, 2018, pages 52 |
GASSER ET AL., SCIENCE, vol. 244, 1990, pages 1293 |
GCISBCRG ET AL., CELL, vol. 156, no. 4, 2014, pages 812 - 824 |
GUOSHERMAN, MOL. CELLULAR BIOL., vol. 15, 1995, pages 5983 - 5990 |
HAMBRAEUS ET AL., MICROBIOLOGY, vol. 146, no. 12, 2000, pages 3051 - 3059 |
HEINZE ET AL., BMC MICROBIOLOGY, vol. 18, 2018, pages 56 |
HILTON ET AL., J. BIOL. CHEM., vol. 271, 1996, pages 4699 - 4708 |
HOOYKASSCHILPEROORT, PLANT MOL. BIOL., vol. 19, 1992, pages 675 - 689 |
HUE ET AL., J. BACTERIOL., vol. 177, 1995, pages 3465 - 3471 |
J. L. BOSE: "Springer Protocols", 2016, article "The Genetic Manipulation of Staphylococci" |
JUMPER ET AL.: "Highly accurate protein structure prediction with AlphaFold", NATURE, vol. 596, 2021, pages 583 - 589, XP055888904, DOI: 10.1038/s41586-021-03819-2 |
KABCRDINBLASI, FEMSMICROBIOL. REV., vol. 30, no. 6, 2006, pages 967 - 979 |
KAGAYA ET AL., MOL. GEN. GENET., vol. 248, 1995, pages 668 - 674 |
KYOZUKA ET AL., PLANT PHYSIOL., vol. 102, 1993, pages 991 - 1000 |
LABROU, PROTEIN DOWNSTREAM PROCESSING, vol. 1129, 2014, pages 3 - 10 |
LI ET AL., MICROBIAL CELL FACTORIES, vol. 16, 2017, pages 168 |
LOWMAN ET AL., BIOCHEMISTRY, vol. 30, 1991, pages 10832 - 10837 |
LUBERTOZZIKEASLING, BIOTECHN. ADVANCES, vol. 27, 2009, pages 53 - 75 |
MARTIN ET AL., J. IND. MICROBIOL. BIOTECHNOL., vol. 3, 2003, pages 568 - 576 |
MCCARTY: "WETTING AGENTS", CLEMSON UNIVERSITY COOPERATIVE EXTENSION SERVICE PUBLICATION, 2001 |
MITRAHIGGINS, PLANT MOL. BIOL., vol. 26, 1994, pages 863 - 878 |
MOROZOV ET AL., EUKARYOTIC CELL, vol. 5, no. 11, 2006, pages 1838 - 1846 |
MUKHERJEE ET AL., TRICHODERMA: BIOLOGY AND APPLICATIONS, 2013 |
NEEDLEMANWUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 - 453 |
NER ET AL., DNA, vol. 7, 1988, pages 127 |
NESS ET AL., NATURE BIOTECHNOLOGY, vol. 17, 1999, pages 893 - 896 |
OMIRULLEH ET AL., PLANT MOL. BIOL., vol. 21, 1993, pages 415 - 428 |
POTRYKUS, BIO TECHNOLOGY, vol. 8, 1990, pages 535 |
RASMUSSEN-WILSON ET AL., APPL. ENVIRON. MICROBIOL., vol. 63, 1997, pages 3488 - 3493 |
REIDHAAR-OLSONSAUER, SCIENCE, vol. 241, 1988, pages 53 - 57 |
RICE ET AL., EUROPEAN MOLECULAR BIOLOGY OPEN SOFTWARE SUITE, 2000 |
RICE ET AL.: "EMBOSS: The European Molecular Biology Open Software Suite", TRENDS GENET, vol. 16, 2000, pages 276 - 277, XP004200114, DOI: 10.1016/S0168-9525(00)02024-2 |
ROHEL ET AL., MOL. PLANT MICROBE INTERACT., vol. 14, no. 2, February 2001 (2001-02-01), pages 156 - 63 |
ROMANOS ET AL., YEAST, vol. 8, 1992, pages 423 - 488 |
SCHMOLLDATTENBOCK: "Fungal Biology", 2016, article "Gene Expression Systems in Fungi: Advancements and Applications" |
SCHMOLLDATTENBOCK: "Gene Expression Systems in Fungi: Advancements and Applications", FUNGAL BIOLOGY, 2016 |
SESHASAYEE ET AL., SUBCELLULAR BIOCHEMISTRY, vol. 52, 2011, pages 7 - 23 |
SHIMAMOTO ET AL., NATURE, vol. 338, 1989, pages 274 |
SHIMAMOTO, CURR. OPIN. BIOTECHNOL., vol. 5, 1994, pages 158 - 162 |
SMITH ET AL., J. MOL. BIOL., vol. 224, 1992, pages 899 - 904 |
SMOLKE ET AL.: "Synthetic Biology: Parts, Devices and Applications", CONSTITUTIVE AND REGULATED PROMOTERS IN YEAST: HOW TO DESIGN AND MAKE USE OF PROMOTERS IN S. CEREVISIAE, 2018 |
SONG ET AL., ONE, vol. 11, no. 7, 2016, pages e0158447 |
STEFFEYGRAY: "ILLINOIS AGRONOMY HANDBOOK", 2008, article "Managing Insect Pests" |
STEVENS, DRUG DISCOVERY WORLD, vol. 4, 2003, pages 35 - 48 |
STICKLCN, NATURE REVIEWS, vol. 9, 2008, pages 433 - 443 |
SVETINA ET AL., J. BIOTECHNOL., vol. 76, 2000, pages 245 - 251 |
TAGUE ET AL., PLANT PHYSIOLOGY, vol. 86, 1988, pages 506 |
VASIL ET AL., BIO TECHNOLOGY, vol. 10, 1992, pages 667 - 674 |
VOS ET AL., SCIENCE, vol. 255, 1992, pages 306 - 312 |
WINGFIELD, CURRENT PROTOCOLS IN PROTEIN SCIENCE, vol. 80, no. 1, 2015, pages 1 - 35 |
WLODAVER ET AL., FEBS LETT, vol. 309, 1992, pages 59 - 64 |
XU ET AL., BIOTECHNOLOGY LETTERS, vol. 40, 2018, pages 949 - 955 |
YELTON ET AL., PROC. NATL. ACAD. SCI. U A, vol. 81, 1984, pages 1470 - 1474 |
ZHANG ET AL., PLANT CELL, vol. 3, 1991, pages 1155 - 1165 |
Also Published As
Publication number | Publication date |
---|---|
WO2023225459A3 (en) | 2024-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11751515B2 (en) | Endophyte compositions and methods for improvement of plant traits in plants of agronomic importance | |
US11130966B2 (en) | Chromobacterium subtsugae genome | |
AU2018237187B2 (en) | Combinations of yersinia entomophaga and pesticides or other substances | |
Gnanamanickam | Biological control of crop diseases | |
US20210000121A1 (en) | Compositions and Methods Comprising Endophytic Bacterium for Application to Grasses to Increase Plant Growth, Suppress Soil Borne Fungal Diseases, and Reduce Vigor of Weedy Competitors | |
BR112017014230B1 (en) | SYNTHETIC COMBINATION AND METHODS TO PREPARE A SEED COMPRISING A POPULATION OF EDOPHYTES, AND TO MODULATE A PLANT CHARACTERISTICS | |
JP2017530965A (en) | Composition comprising recombinant Bacillus cells and another biopesticide | |
JP2022509508A (en) | Bacterial compositions and methods for controlling plant pests and improving plant health | |
Fenibo et al. | Biopesticides in sustainable agriculture: Current status and future prospects | |
Li et al. | Biocontrol potential and mode of action of entomopathogenic bacteria Xenorhabdus budapestensis C72 against Bipolaris maydis | |
WO2023288294A1 (en) | Compositions and methods for improving the rainfastness of proteins on plant surfaces | |
JP2022507370A (en) | Endogenous spore display platform, products and methods | |
EP3189145B1 (en) | Chromobacterium subtsugae genes | |
WO2023225459A2 (en) | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections | |
CA3223679A1 (en) | Compositions and methods for improving the rainfastness of proteins on plant surfaces | |
Huilgol et al. | Fungal biocontrol agents: an eco-friendly option for the management of plant diseases to attain sustainable agriculture in India | |
WO2021030400A1 (en) | Pesticidal combinations of yersinia and proteases | |
CN117715520A (en) | Compositions and methods for improving the rain tolerance of proteins on plant surfaces | |
Hubballi et al. | PGPM: Fundamental, Bioformulation, Commercialization, and Success at Farmer’s Field | |
Kumar et al. | Microbial biotechnology: role of microbes in sustainable agriculture | |
Chaturvedi et al. | 10 Biostimulants: An Alternative to Chemical Pesticides for Crop Protection | |
Chavan | Biocontrol of insect pests in agriculture using chitinolytic enzyme complex of Myrothecium verrucaria | |
Mathivanan | Harnessing fungal biocontrol agents for the management of plant diseases | |
Sarao et al. | INTEGRATED MANAGEMENT OF INSECT-PESTS IN RICE | |
Singh Saharan et al. | Disease Management |